{"doc_id": 0, "doc": {"person_id": 115972706, "visit_occurrence_id": 51275717, "death_date": null, "visit_concept_name": "Outpatient Visit", "visit_start_datetime": "2012-12-01 12:14:00", "visit_end_datetime": "2012-12-01 23:59:00", "visit_length_in_hours": 11.75, "integrated_visit_record": "## Visit\nThis visit record, was from Outpatient Visit, started at 2012-12-01 12:14:00, ended at 2012-12-01 23:59:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, spine; thoracic, 2 views\n- Radiologic examination, spine, lumbosacral; 2 or 3 views\n- Radiologic examination, spine, cervical; 2 or 3 views\n\n### Condition\n- Lumbosacral spondylosis without myelopathy\n- Acquired spondylolisthesis\n- Spondylolisthesis\n- Degeneration of intervertebral disc\n- Low back pain\n- Atherosclerosis of artery\n- Arthropathy\n- Neck pain\n\n### Drug\n- No drugs.\n\n", "approximate_token_count": 163, "patient_first_visit_date": "2008-01-24 10:08:00", "patient_last_visit_date": "2019-04-23 00:00:00", "end_obs_date": "2013-12-01", "hypertension_type": "recurrent", "hypertension_one_year_diagnosis": 1, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "recurrent", "hyperlipidemia_one_year_diagnosis": 1, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "recurrent", "chronic_kidney_disease_one_year_diagnosis": 1, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "recurrent", "coronary_arteriosclerosis_one_year_diagnosis": 1, "type_ii_diabetes_type": "recurrent", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 1, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "recurrent", "lupus_one_year_diagnosis": 1, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 1, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 463, "cumulated_visit_num": 463, "cumulated_approximate_token_count": 118331, "visit_cumulated": "## Visit\nThis visit record, was from Hospital, started at 2008-01-24 10:08:00, ended at 2008-02-01 13:40:00\nThe patient in this visit was 52 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Leukocytes [#/volume] in Specimen by Automated count: 8.7 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.4 (gram per deciliter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.6 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 1.09 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 28.6 (second)\n- Hemoglobin [Mass/volume] in Blood: 10.6 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.84 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 83.3 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.6 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.16 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- MCH [Entitic mass] by Automated count: 27.0 (picogram)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.9 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.74 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 77.6 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.4 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.93 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.7 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Prothrombin time (PT): 15.1 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 207 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2008-02-27 07:10:00, ended at 2008-02-27 23:59:00\nThe patient in this visit was 52 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Cellulitis and abscess of finger\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-03-14 00:00:00, ended at 2008-03-14 00:00:00\nThe patient in this visit was 52 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.2 (percent)\n- MCV [Entitic volume] by Automated count: 82.9 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.7 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.04 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.36 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.0 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.05 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 18 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 85 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.1 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 27.8 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.83 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 17.4 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 67.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 255 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-03-22 00:00:00, ended at 2008-03-22 00:00:00\nThe patient in this visit was 52 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.5 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 27.4 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.72 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 258 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.3 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.83 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 161 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.3 (percent)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.92 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.3 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 87 (unit per liter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.7 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 78 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 36 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.51 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.1 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 4.0 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- MCV [Entitic volume] by Automated count: 82.9 (femtoliter)\n- Tacrolimus [Mass/volume] in Blood: 9.1 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.7 (ratio)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.1 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 71.4 (percent)\n- Prothrombin time (PT): 19.2 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-04-24 00:00:00, ended at 2008-04-24 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.7 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 26.5 (picogram)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.09 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.5 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.41 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.7 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.1 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 6.2 (nanogram per milliliter)\n- Urate [Mass/volume] in Serum or Plasma: 4.3 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 3.1 (ratio)\n- Platelets [#/volume] in Blood by Automated count: 264 (thousand per microliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.76 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.9 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 36 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 104 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 151 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.8 (percent)\n- MCV [Entitic volume] by Automated count: 81.2 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.77 (thousand per microliter)\n- Prothrombin time (PT): 30.6 (second)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-05-10 00:00:00, ended at 2008-05-10 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Homocysteine [Moles/volume] in Serum or Plasma: 10.1 (micromole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-05-24 00:00:00, ended at 2008-05-24 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.3 (percent)\n- MCH [Entitic mass] by Automated count: 27.2 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 269 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: 4.4 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 88 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 82 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.0 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.50 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.5 (percent)\n- Prothrombin time (PT): 30.0 (second)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.41 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.33 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.76 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 45 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.1 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 82.3 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- INR in Platelet poor plasma by Coagulation assay: 3.0 (ratio)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.4 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 168 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.7 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 6.5 (nanogram per milliliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2008-05-30 08:07:00, ended at 2008-05-30 16:25:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Non-traumatic tendon rupture\n\n### Drug\n- isosorbide dinitrate 30 MG Oral Tablet, through Oral route, presumably until 2008-09-11. Instructions: take 30 mg by mouth. TID\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2008-05-30, presumably until 2008-05-30\n- Osmotic 24 HR nifedipine 30 MG Extended Release Oral Tablet, through Oral route, presumably until 2008-09-11. Instructions: take by mouth daily. \n- docusate sodium 100 MG Oral Capsule, through Oral route, presumably until 2009-05-22. Instructions: take by mouth as needed \n- cephalexin 500 MG Oral Capsule, through Oral route, started on 2008-05-30, presumably until 2008-06-17, with quantity of 12.0, with intended 0 refill(s). Instructions: take 1 Cap by mouth 4 times a day. \n- gabapentin 300 MG Oral Capsule, through Oral route, presumably until 2008-06-17. Instructions: take by mouth. TID\n- warfarin sodium 1 MG Oral Tablet, through Oral route, presumably until 2008-09-11. Instructions: take by mouth. \n- clopidogrel 75 MG Oral Tablet, through Oral route, presumably until 2011-03-29. Instructions: take by mouth daily. \n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2008-05-30, presumably until 2008-05-30, with quantity of 55.0, with intended 1 refill(s). Instructions: take 1-2 Tabs by mouth every 6 hours as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2008-06-19 13:04:00, ended at 2008-06-19 19:47:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Cataract\n\n### Drug\n- isosorbide dinitrate 30 MG Oral Tablet, through Oral route, presumably until 2009-06-26. Instructions: take 30 mg by mouth 2 times a day. \n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, presumably until 2008-09-11. Instructions: take 2 Caps by mouth 2 times a day. \n- gatifloxacin 3 MG/ML Ophthalmic Solution, through Intraocular route, started on 2008-06-19, presumably until 2008-06-19\n- tropicamide 10 MG/ML Ophthalmic Solution, through Intraocular route, started on 2008-06-19, presumably until 2008-06-19\n- Osmotic 24 HR nifedipine 30 MG Extended Release Oral Tablet, through Oral route, presumably until 2009-06-26. Instructions: take by mouth daily. \n- 24 HR metoprolol succinate 25 MG Extended Release Oral Tablet, through Oral route, presumably until 2009-09-01. Instructions: take 25 mg by mouth 2 times a day. \n- furosemide 40 MG Oral Tablet, through Oral route, presumably until 2008-09-11. Instructions: take by mouth daily. \n- gabapentin 300 MG Oral Tablet, through Oral route, presumably until 2009-05-22. Instructions: take 300 mg by mouth 2 times a day. \n- gabapentin 300 MG Oral Capsule, through Oral route, presumably until 2008-09-11. Instructions: take by mouth 2 times a day. \n- atorvastatin 20 MG Oral Tablet, through Oral route, presumably until 2009-05-22. Instructions: take by mouth daily. \n- phenylephrine hydrochloride 25 MG/ML Ophthalmic Solution, through Intraocular route, started on 2008-06-19, presumably until 2008-06-19\n- ketorolac tromethamine 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2008-06-19, presumably until 2008-06-19\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-06-26 00:00:00, ended at 2008-06-26 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 2.8 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.4 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 79.8 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 40 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.0 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.5 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 68 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.95 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.8 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 153 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.6 (percent)\n- MCH [Entitic mass] by Automated count: 26.0 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.7 (milligram per deciliter)\n- Prothrombin time (PT): 33.2 (second)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.23 (million per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 3.4 (ratio)\n- Monocytes [#/volume] in Blood by Automated count: 0.93 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 348 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 49 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 69.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.45 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: 4.9 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.81 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 77 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-07-25 00:00:00, ended at 2008-07-25 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.82 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.5 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 7.8 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.10 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19.1 (percent)\n- MCHC [Mass/volume] by Automated count: 32.2 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 78.2 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.65 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 346 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 48 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 56 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.76 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.3 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.9 (percent)\n- Prothrombin time (PT): 32.6 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 152 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.1 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 3.3 (ratio)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 6.8 (nanogram per milliliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 89 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 25.2 (picogram)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.8 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.06 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.8 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 4.1 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-08-08 00:00:00, ended at 2008-08-08 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Prothrombin time (PT): 26.5 (second)\n- INR in Platelet poor plasma by Coagulation assay: 2.6 (ratio)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-08-20 00:00:00, ended at 2008-08-20 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.1 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 59.5 (percent)\n- MCV [Entitic volume] by Automated count: 77.4 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 16.3 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 324 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 61 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.11 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 24.9 (picogram)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 64 (milligram per deciliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 1.0 (ratio)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 76 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.3 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.78 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 64 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.8 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 77 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.13 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 88 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 6.8 (nanogram per milliliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 141 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 11 (millimeter per hour)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.6 (percent)\n- MCHC [Mass/volume] by Automated count: 32.3 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.86 (thousand per microliter)\n- Prothrombin time (PT): 31.7 (second)\n- Urate [Mass/volume] in Serum or Plasma: 4.6 (milligram per deciliter)\n- Complement C3 [Mass/volume] in Serum or Plasma: 107 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.0 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 3.2 (ratio)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-09-04 00:00:00, ended at 2008-09-04 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Prothrombin time (PT): 19.9 (second)\n- INR in Platelet poor plasma by Coagulation assay: 1.8 (ratio)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-09-09 00:00:00, ended at 2008-09-09 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- MCV [Entitic volume] by Automated count: 77.1 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 307 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 41.4 (second)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 71 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 31.9 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 24.6 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 10.7 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 85 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.3 (thousand per microliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.33 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.4 (percent)\n- Prothrombin time (PT): 29.6 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.7 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 2.9 (ratio)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2008-09-11 10:38:00, ended at 2008-09-11 18:15:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- gatifloxacin 3 MG/ML Ophthalmic Solution, through Intraocular route, started on 2008-09-11, presumably until 2008-09-11\n- tropicamide 10 MG/ML Ophthalmic Solution, through Intraocular route, started on 2008-09-11, presumably until 2008-09-11\n- furosemide 20 MG Oral Tablet, through Oral route, presumably until 2010-09-01. Instructions: take by mouth daily. \n- metoclopramide 5 MG Oral Tablet, through Oral route, presumably until 2009-12-23. Instructions: take by mouth 2 times a day. 09/10/2008\n- phenylephrine hydrochloride 25 MG/ML Ophthalmic Solution, through Intraocular route, started on 2008-09-11, presumably until 2008-09-11\n- ketorolac tromethamine 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2008-09-11, presumably until 2008-09-11\n- tetracaine hydrochloride 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2008-09-11, presumably until 2008-09-11\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-09-23 00:00:00, ended at 2008-09-23 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.9 (percent)\n- MCV [Entitic volume] by Automated count: 77.0 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.2 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.2 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.83 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 316 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 35 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 73 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.3 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.0 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 153 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.9 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.3 (ratio)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Prothrombin time (PT): 24.3 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 4.0 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.14 (million per microliter)\n- MCH [Entitic mass] by Automated count: 24.8 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.52 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.71 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 75.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.1 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 8.3 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-10-09 00:00:00, ended at 2008-10-09 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 341 (microgram per deciliter)\n- Prothrombin time (PT): 25.1 (second)\n- INR in Platelet poor plasma by Coagulation assay: 2.3 (ratio)\n- Iron [Mass/volume] in Serum or Plasma: 9 (microgram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-10-24 00:00:00, ended at 2008-10-24 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.18 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.8 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 23.4 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 47 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.8 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.80 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.7 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.8 (percent)\n- MCV [Entitic volume] by Automated count: 73.8 (femtoliter)\n- Urate [Mass/volume] in Serum or Plasma: 4.5 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 349 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 140 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.7 (percent)\n- Tacrolimus [Mass/volume] in Blood: 7.0 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 70 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.11 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 82 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 31.7 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.83 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-11-05 00:00:00, ended at 2008-11-05 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- INR in Platelet poor plasma by Coagulation assay: 3.1 (ratio)\n- Prothrombin time (PT): 31.6 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-11-25 00:00:00, ended at 2008-11-25 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 71 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 83.9 (femtoliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.9 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 80.5 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 29.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.73 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 81 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 69 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 3.1 (ratio)\n- Platelets [#/volume] in Blood by Automated count: 266 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.63 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.7 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.0 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.85 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 58 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 130 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.7 (percent)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 47 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 26.6 (picogram)\n- MCHC [Mass/volume] by Automated count: 31.7 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 0.7 (ratio)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 59 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.6 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.39 (thousand per microliter)\n- Prothrombin time (PT): 31.2 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-11-25 00:00:00, ended at 2008-11-25 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 77 (unit per liter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.9 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 267 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.6 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.0 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Tacrolimus [Mass/volume] in Blood: 7.6 (nanogram per milliliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 78 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.72 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.7 (percent)\n- MCH [Entitic mass] by Automated count: 26.6 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 139 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 29.6 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.73 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.3 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.00 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 49 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 31.5 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.49 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- MCV [Entitic volume] by Automated count: 84.6 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 78.6 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-12-03 00:00:00, ended at 2008-12-03 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- INR in Platelet poor plasma by Coagulation assay: 2.0 (ratio)\n- Prothrombin time (PT): 22.4 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-12-09 00:00:00, ended at 2008-12-09 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 83.3 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.1 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 71 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.3 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.2 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.73 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 28.3 (picogram)\n- MCV [Entitic volume] by Automated count: 86.5 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.23 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.64 (million per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 40 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 89 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 27.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 10.07 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 262 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2008-12-09 15:14:00, ended at 2008-12-11 17:25:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 123 (unit per liter)\n- MCV [Entitic volume] by Automated count: 87.1 (femtoliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 50 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.11 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.55 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.8 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.1 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Prothrombin time (PT): 28.2 (second)\n- Eosinophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 3.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.70 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 27.5 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.2 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 52 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 253 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.5 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.54 (thousand per microliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Body height: 5' 3.6\" (inch (US))\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.5 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 2.7 (ratio)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.2 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 88.7 (percent)\n- Tacrolimus [Mass/volume] in Blood: 8.0 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 46.7 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Urinary tract infectious disease\n\n### Drug\n- amoxicillin 500 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2008-12-11, presumably until 2009-02-20, with quantity of 28.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 12 hours. \n- ascorbic acid 250 MG Oral Tablet, through Oral route, started on 2008-12-09, presumably until 2008-12-11\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2008-12-09, presumably until 2009-02-27. Instructions: take 325 mg by mouth 2 times a day. \n- furosemide 20 MG Oral Tablet, through Oral route, started on 2008-12-10, presumably until 2008-12-11\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2008-12-11, presumably until 2008-12-11\n- isosorbide dinitrate 10 MG Oral Tablet, through Oral route, started on 2008-12-09, presumably until 2008-12-11\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2008-12-09, presumably until 2008-12-09\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2008-12-09, presumably until 2008-12-11\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2008-12-10, presumably until 2008-12-11\n- Osmotic 24 HR nifedipine 30 MG Extended Release Oral Tablet, through Oral route, started on 2008-12-11, presumably until 2008-12-11\n- ciprofloxacin 500 MG Oral Tablet, through Oral route, presumably until 2008-12-11. Instructions: take 500 mg by mouth 2 times a day. \n- 500 ML glucose 50 MG/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2008-12-10, presumably until 2008-12-11\n- metoclopramide 5 MG Oral Tablet, through Oral route, started on 2008-12-09, presumably until 2008-12-11\n- warfarin sodium 4 MG Oral Tablet, through Oral route, started on 2008-12-09, presumably until 2008-12-10\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2008-12-11, presumably until 2008-12-11\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2008-12-10, presumably until 2008-12-11\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2008-12-09, presumably until 2008-12-11\n- atorvastatin 20 MG Oral Tablet, through Oral route, started on 2008-12-09, presumably until 2008-12-10\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2008-12-09, presumably until 2008-12-11\n- nitroglycerin 0.4 MG Sublingual Tablet, through Sublingual route, presumably until 2010-07-03. Instructions: 0.4 mg by Sublingual route as needed \n- ascorbic acid 500 MG Oral Tablet, through Oral route, presumably until 2009-05-22. Instructions: take 500 mg by mouth 2 times a day. \n- clopidogrel 75 MG Oral Tablet, through Oral route, started on 2008-12-10, presumably until 2008-12-11\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2008-12-10, presumably until 2008-12-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-12-24 00:00:00, ended at 2008-12-24 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 80 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.89 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.6 (percent)\n- Platelets [#/volume] in Blood by Automated count: 287 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 23.9 (percent)\n- MCH [Entitic mass] by Automated count: 28.0 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Prothrombin time (PT): 18.7 (second)\n- Tacrolimus [Mass/volume] in Blood: 20.7 (nanogram per milliliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 54 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.2 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 13.7 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.6 (ratio)\n- MCHC [Mass/volume] by Automated count: 32.1 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 87.0 (femtoliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.0 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Erythrocyte sedimentation rate: 0 (millimeter per hour)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.05 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.8 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.27 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 68.4 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 3.7 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 141 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.82 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-12-27 00:00:00, ended at 2008-12-27 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Tacrolimus [Mass/volume] in Blood: 9.3 (nanogram per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-01-06 00:00:00, ended at 2009-01-06 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- INR in Platelet poor plasma by Coagulation assay: 2.6 (ratio)\n- Prothrombin time (PT): 27.4 (second)\n- aPTT in Platelet poor plasma by Coagulation assay: 38.9 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-01-23 00:00:00, ended at 2009-01-23 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.78 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 12.2 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 5.5 (nanogram per milliliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.9 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.0 (percent)\n- MCH [Entitic mass] by Automated count: 28.9 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 71.4 (percent)\n- Prothrombin time (PT): 24.1 (second)\n- Triglyceride [Moles/volume] in Serum or Plasma: 55 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.89 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.1 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.59 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.4 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.2 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.3 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.91 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.0 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 3.7 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 148 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.2 (ratio)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 83 (unit per liter)\n- MCV [Entitic volume] by Automated count: 89.6 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 257 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-02-20 00:00:00, ended at 2009-02-20 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 60 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 68 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.84 (million per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 77.7 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 88 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.0 (percent)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 0.8 (ratio)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 2.9 (ratio)\n- MCH [Entitic mass] by Automated count: 30.2 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 6.86 (thousand per microliter)\n- Prothrombin time (PT): 29.4 (second)\n- Urate [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 73 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.80 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.0 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.2 (percent)\n- Tacrolimus [Mass/volume] in Blood: 4.8 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 148 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 79 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 222 (thousand per microliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 14.6 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.16 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.3 (percent)\n- MCV [Entitic volume] by Automated count: 90.9 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 38 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.9 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2009-02-21 15:20:00, ended at 2009-02-22 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Peritonsillar abscess\n\n### Drug\n- clindamycin 150 MG Oral Capsule, through Oral route, started on 2009-02-21, presumably until 2009-02-21\n- clindamycin 300 MG Oral Capsule, through Oral route, started on 2009-02-21, presumably until 2009-03-01, with quantity of 28.0, with intended 0 refill(s). Instructions: take 1 Cap by mouth 4 times a day. \n- acetaminophen 24 MG/ML / codeine phosphate 2.4 MG/ML Oral Solution, through Oral route, started on 2009-02-21, presumably until 2009-03-07, with intended 0 refill(s). Instructions: take 25 mL by mouth every 6 hours as needed for Pain. max 4 grams tylenol per day \n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2009-02-21, presumably until 2009-02-21\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-02-27 09:12:00, ended at 2009-02-27 17:05:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n- INR in Platelet poor plasma by Coagulation assay: 2.4 (ratio)\n- aPTT in Platelet poor plasma by Coagulation assay: 36.5 (second)\n- Prothrombin time (PT): 25.9 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 1 ML meperidine hydrochloride 25 MG/ML Cartridge, started on 2009-02-27, presumably until 2009-02-27\n- 2 ML ondansetron 2 MG/ML Injection, started on 2009-02-27, presumably until 2009-02-27\n- 1 ML promethazine hydrochloride 25 MG/ML Injection, started on 2009-02-27, presumably until 2009-02-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-03-04 00:00:00, ended at 2009-03-04 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 7.2 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2009-03-04 14:48:00, ended at 2009-03-04 17:51:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- aPTT in Platelet poor plasma by Coagulation assay: 51.1 (second)\n- Prothrombin time (PT): 30.1 (second)\n- INR in Platelet poor plasma by Coagulation assay: 2.9 (ratio)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Wrist joint pain\n\n### Drug\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2009-03-04, presumably until 2009-08-28, with quantity of 60.0, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-03-24 00:00:00, ended at 2009-03-24 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Leukocytes [#/volume] in Specimen by Automated count: 6.6 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.3 (percent)\n- MCV [Entitic volume] by Automated count: 90.1 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 66.9 (percent)\n- Platelets [#/volume] in Blood by Automated count: 313 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 8.0 (nanogram per milliliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.6 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.6 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.03 (thousand per microliter)\n- Prothrombin time (PT): 29.9 (second)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.65 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.9 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.4 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 2.9 (ratio)\n- MCH [Entitic mass] by Automated count: 29.4 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 15.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.38 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.07 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 4.1 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 139 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 86 (unit per liter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 56 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2009-04-07 00:00:00, ended at 2009-04-07 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Breast lump\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-04-15 11:24:00, ended at 2009-04-15 13:52:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alendronic acid 70 MG Oral Tablet, through Oral route, presumably until 2009-06-03. Instructions: take by mouth. \n- benzocaine 140 MG/ML / butamben 20 MG/ML / tetracaine 20 MG/ML Mucosal Spray, through Topical route, started on 2009-04-15, presumably until 2009-04-15\n- metoclopramide 5 MG Oral Tablet, through Oral route, presumably until 2009-05-22. Instructions: take by mouth. \n- atorvastatin 20 MG Oral Tablet, through Oral route, presumably until 2009-12-23. Instructions: take by mouth. \n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2009-04-15, presumably until 2009-04-15\n- mycophenolate mofetil 500 MG Oral Tablet, through Oral route, presumably until 2009-05-22. Instructions: take by mouth. \n- midazolam 1 MG/ML Injectable Solution, started on 2009-04-15, presumably until 2009-04-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2009-04-18 00:00:00, ended at 2009-04-18 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of function of stomach\n\n### Drug\n- ranitidine 300 MG Oral Tablet, through Oral route, started on 2009-04-18, presumably until 2012-05-31, with quantity of 90.0, with intended 4 refill(s). Instructions: take 300 mg by mouth daily with dinner. Take T PO every day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-04-22 00:00:00, ended at 2009-04-22 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- INR in Platelet poor plasma by Coagulation assay: 1.6 (ratio)\n- Monocytes/100 leukocytes in Blood by Automated count: 15.9 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 62.0 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.5 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20.3 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.45 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.3 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.13 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- MCV [Entitic volume] by Automated count: 91.0 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 240 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 14.5 (nanogram per milliliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.88 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.6 (thousand per microliter)\n- Prothrombin time (PT): 18.2 (second)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 79 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.53 (million per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.8 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 32 (milligram per deciliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 152 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.3 (percent)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.6 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 78 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-05-01 00:00:00, ended at 2009-05-01 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Prothrombin time (PT): 19.2 (second)\n- INR in Platelet poor plasma by Coagulation assay: 1.7 (ratio)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-05-22 00:00:00, ended at 2009-05-22 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.93 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 8.3 (nanogram per milliliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.7 (percent)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.8 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.8 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.93 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.3 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 49 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 76 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.5 (percent)\n- Prothrombin time (PT): 22.9 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 79 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 89.0 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.1 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 12 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 258 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: 3.0 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 144 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.77 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.0 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.1 (ratio)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.09 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.4 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.1 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 15.4 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2009-05-28 00:00:00, ended at 2009-05-28 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypersensitivity angiitis\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2009-05-28, presumably until 2009-10-24, with quantity of 30.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2009-05-29 00:00:00, ended at 2009-05-29 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of bone and articular cartilage\n\n### Drug\n- alendronic acid 70 MG Oral Tablet, through Oral route, started on 2009-05-29, presumably until 2009-09-23, with quantity of 4.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 7 days. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-06-24 00:00:00, ended at 2009-06-24 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 148 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.7 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 46 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 83 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.5 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20.8 (percent)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.8 (percent)\n- Tacrolimus [Mass/volume] in Blood: 8.8 (nanogram per milliliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 64.0 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.3 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.04 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 14.2 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.13 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- INR in Platelet poor plasma by Coagulation assay: 2.4 (ratio)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.34 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 85.6 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 287 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Prothrombin time (PT): 25.6 (second)\n- Urate [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 80 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 10 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.2 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.89 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.1 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-06-26 00:00:00, ended at 2009-06-26 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- tacrolimus 0.5 MG Oral Capsule, through Oral route, started on 2009-06-26, presumably until 2009-08-28, with quantity of 90.0, with intended 3 refill(s). Instructions: take 1 Cap by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2009-07-03 00:00:00, ended at 2009-07-03 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-07-24 00:00:00, ended at 2009-07-24 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.82 (million per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.7 (ratio)\n- Neutrophils [#/volume] in Blood by Automated count: 3.21 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20.2 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.8 (percent)\n- MCV [Entitic volume] by Automated count: 84.6 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.88 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.3 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.7 (milligram per deciliter)\n- Prothrombin time (PT): 28.0 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.06 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.9 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.4 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 7.7 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 62 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.1 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 65 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 27.8 (picogram)\n- Cholesterol [Mass/volume] in Serum or Plasma: 131 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 16.8 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 44 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.2 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 267 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-08-25 00:00:00, ended at 2009-08-25 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.4 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.7 (ratio)\n- Neutrophils [#/volume] in Blood by Automated count: 3.63 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 62.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 283 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 63 (unit per liter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.8 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19.0 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 82 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.11 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.1 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 133 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.8 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.0 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 85.1 (femtoliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.0 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 16.4 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.6 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Prothrombin time (PT): 28.4 (second)\n- Tacrolimus [Mass/volume] in Blood: 7.9 (nanogram per milliliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 56 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.59 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 27.4 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.95 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-09-01 00:00:00, ended at 2009-09-01 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-09-03 00:00:00, ended at 2009-09-03 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- General examination of patient\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2009-09-16 00:00:00, ended at 2009-09-16 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2009-09-16, presumably until 2010-09-23, with quantity of 180.0, with intended 11 refill(s). Instructions: take 3 Caps by mouth 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2009-09-23 00:00:00, ended at 2009-09-23 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of bone and articular cartilage\n\n### Drug\n- alendronic acid 70 MG Oral Tablet, through Oral route, started on 2009-09-23, presumably until 2010-02-23, with quantity of 4.0, with intended 11 refill(s). Instructions: take 1 Tab by mouth every 7 days. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-09-23 12:14:00, ended at 2009-09-23 23:59:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Lymphocytes [#/volume] in Blood by Automated count: 1.05 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.4 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 16.6 (percent)\n- Platelets [#/volume] in Blood by Automated count: 267 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 140 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.91 (thousand per microliter)\n- Prothrombin time (PT): 33.5 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.41 (million per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 3.4 (ratio)\n- MCV [Entitic volume] by Automated count: 83.6 (femtoliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.9 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.9 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 21.6 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 30 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 74 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 87 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 27.1 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 59.9 (percent)\n- Tacrolimus [Mass/volume] in Blood: 7.4 (nanogram per milliliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.6 (percent)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.81 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n- Disorder of phosphorus metabolism\n- Blood chemistry abnormal\n- Hyperlipidemia\n- Closed fracture of distal end of radius\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-09-30 13:55:43, ended at 2009-09-30 15:19:38\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypersensitivity angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-10-01 13:48:16, ended at 2009-10-01 15:06:06\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of left eye: 14 (millimeter mercury column)\n- Intraocular pressure of right eye: 13 (millimeter mercury column)\n\n### Procedure\n- Scanning computerized ophthalmic diagnostic imaging, posterior segment, (eg, scanning laser) with interpretation and report, unilateral\n\n### Condition\n- Disorder of eye due to diabetes mellitus\n- Vitreous hemorrhage\n- Vitreous opacities\n- Epiretinal membrane\n- Vitreous degeneration\n- Disorder of eye due to type 1 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-10-09 14:34:29, ended at 2009-10-09 15:16:10\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2009-10-14 00:00:00, ended at 2009-10-14 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-15 13:20:00, ended at 2009-10-15 23:59:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, pelvis; without contrast material(s)\n\n### Condition\n- Hypersensitivity angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-23 10:24:00, ended at 2009-10-23 11:45:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of lower extremity arteries or arterial bypass grafts; unilateral or limited study\n\n### Condition\n- Atherosclerosis of arteries of the extremities\n- Intermittent claudication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-10-23 10:25:09, ended at 2009-10-23 13:40:03\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Intermittent claudication\n- Primary diagnosis: Atherosclerosis of arteries of the extremities\n\n### Drug\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, presumably until 2009-10-24. Instructions: take by mouth as needed pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-23 11:46:00, ended at 2009-10-23 23:59:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.8 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 84 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Erythrocyte sedimentation rate: 3 (millimeter per hour)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 15.3 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.66 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 76 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 81.8 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 305 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 6.4 (nanogram per milliliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.5 (ratio)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.22 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.9 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 146 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.84 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.4 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.9 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20.7 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.90 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 25.6 (picogram)\n- Prothrombin time (PT): 26.4 (second)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.6 (percent)\n- MCHC [Mass/volume] by Automated count: 31.2 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Essential hypertension\n- Hypersensitivity angiitis\n- Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2009-10-24 00:00:00, ended at 2009-10-24 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Peripheral vascular disease\n\n### Drug\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2009-10-24, presumably until 2010-12-16, with quantity of 30.0, with intended 2 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed pain \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2009-10-24 00:00:00, ended at 2009-10-24 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypersensitivity angiitis\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2009-10-24, presumably until 2010-03-03, with quantity of 30.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-10-30 10:27:40, ended at 2009-10-30 14:31:37\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Aseptic necrosis of bone\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-30 10:32:00, ended at 2009-10-30 23:59:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, wrist; complete, minimum of 3 views\n\n### Condition\n- Wrist joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2009-11-03 00:00:00, ended at 2009-11-03 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypersensitivity angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-11-18 09:47:20, ended at 2009-11-18 10:26:37\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- Routine gynecologic examination\n\n### Condition\n- Postmenopausal bleeding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-21 10:45:00, ended at 2009-11-21 12:33:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Phosphate [Mass/volume] in Serum or Plasma: 2.7 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 42 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 69 (unit per liter)\n- Tacrolimus [Mass/volume] in Blood: 6.3 (nanogram per milliliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.8 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.6 (ratio)\n- Platelets [#/volume] in Blood by Automated count: 280 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 85 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 25.4 (picogram)\n- MCHC [Mass/volume] by Automated count: 31.8 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 16.2 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 138 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.5 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- MCV [Entitic volume] by Automated count: 80.0 (femtoliter)\n- Urate [Mass/volume] in Serum or Plasma: 3.1 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.05 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.8 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 1.01 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.11 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.6 (percent)\n- Prothrombin time (PT): 27.7 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.64 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.3 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hyperlipidemia\n- Transplanted kidney present\n- Blood chemistry abnormal\n- Disorder of phosphorus metabolism\n- Postmenopausal bleeding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-21 12:34:00, ended at 2009-11-21 23:59:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, pelvic (nonobstetric), real time with image documentation; complete\n- Ultrasound, transvaginal\n\n### Condition\n- Postmenopausal bleeding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2009-11-27 00:00:00, ended at 2009-11-27 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2009-11-27 00:00:00, ended at 2009-11-27 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Noninflammatory disorder of the female genital organs\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-11-27 10:40:56, ended at 2009-11-27 12:08:18\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n- Transplanted kidney present\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-03 15:26:00, ended at 2009-12-03 23:59:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Noninflammatory disorder of the female genital organs\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-12-15 12:41:04, ended at 2009-12-15 22:21:16\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Epigastric pain\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2009-12-15, presumably until 2010-03-31, with quantity of 30.0, with intended 12 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-15 13:49:00, ended at 2009-12-15 23:59:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.59 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- MCV [Entitic volume] by Automated count: 79.8 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 320 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.72 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.9 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.5 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.7 (percent)\n- MCHC [Mass/volume] by Automated count: 31.1 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 82.1 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.9 (percent)\n- MCH [Entitic mass] by Automated count: 24.8 (picogram)\n- Hemoglobin [Mass/volume] in Blood: 11.7 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.69 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.62 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Epigastric pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-15 13:49:00, ended at 2009-12-15 23:59:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 76 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 88 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Epigastric pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-16 12:24:00, ended at 2009-12-16 15:30:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Endoscopy and biopsy of upper gastrointestinal tract\n\n### Condition\n- Disorder of upper gastrointestinal tract\n- Dysphagia\n- Epigastric pain\n- Gastritis\n\n### Drug\n- benzocaine 140 MG/ML / butamben 20 MG/ML / tetracaine 20 MG/ML Mucosal Spray, through Topical route, started on 2009-12-16, presumably until 2009-12-16\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2009-12-16, presumably until 2009-12-16\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2009-12-23 00:00:00, ended at 2009-12-23 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n- Disorder of nervous system due to diabetes mellitus\n\n### Drug\n- metoclopramide 5 MG Oral Tablet, through Oral route, started on 2009-12-23, presumably until 2010-04-28, with quantity of 60.0, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day. 09/10/2008 \n- atorvastatin 20 MG Oral Tablet, through Oral route, started on 2009-12-23, presumably until 2010-12-31, with quantity of 30.0, with intended 11 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-24 11:21:00, ended at 2009-12-24 23:59:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Lymphocytes [#/volume] in Blood by Automated count: 0.92 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 24.4 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 3.91 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 77 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.76 (million per microliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 1.0 (ratio)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 75 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 78.1 (femtoliter)\n- Prothrombin time (PT): 36.3 (second)\n- C reactive protein [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 67 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 3.7 (ratio)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Complement C3 [Mass/volume] in Serum or Plasma: 97 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Tacrolimus [Mass/volume] in Blood: 8.5 (nanogram per milliliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.7 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.6 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 17.4 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 67.4 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 42 (milligram per deciliter)\n- Albumin [Mass/volume] in Urine: <3 (milligram per liter)\n- Albumin/Creatinine [Mass Ratio] in Urine: <30 (milligram per gram)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Erythrocyte sedimentation rate: 2 (millimeter per hour)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.9 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.2 (percent)\n- MCHC [Mass/volume] by Automated count: 31.4 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 143 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.0 (percent)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 85 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.8 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.1 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 310 (thousand per microliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 68 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.99 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hypersensitivity angiitis\n- Type 2 diabetes mellitus without complication\n- Transplanted kidney present\n- Hyperlipidemia\n- Essential hypertension\n- Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-12-29 10:13:32, ended at 2009-12-29 11:07:58\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypersensitivity angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-12-29 14:08:15, ended at 2009-12-29 17:53:03\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Varicose veins of lower extremity with inflammation\n\n### Drug\n- triamcinolone acetonide 0.001 MG/MG Topical Ointment, through Topical route, started on 2009-12-29, presumably until 2010-12-29, with intended 3 refill(s). Instructions: by Topical route 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-01 08:32:00, ended at 2010-01-01 12:05:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- Esophageal motility (manometric study of the esophagus and/or gastroesophageal junction) study with interpretation and report\n- Other nonoperative measurements and examinations\n- Esophageal function test, gastroesophageal reflux test with nasal catheter intraluminal impedance electrode(s) placement, recording, analysis and interpretation\n\n### Condition\n- Abdominal pain\n\n### Drug\n- benzocaine 140 MG/ML / butamben 20 MG/ML / tetracaine 20 MG/ML Mucosal Spray, through Topical route, started on 2010-01-01, presumably until 2010-01-01\n- lidocaine hydrochloride 0.02 MG/MG Topical Gel, through Submucosal route, started on 2010-01-01, presumably until 2010-01-01\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-01-07 00:00:00, ended at 2010-01-07 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Female genital organ symptoms\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-08 13:03:00, ended at 2010-01-08 23:59:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, pelvis; without contrast material(s), followed by contrast material(s) and further sequences\n\n### Condition\n- Female genital organ symptoms\n- Noninflammatory disorder of the female genital organs\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-01-14 00:00:00, ended at 2010-01-14 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Female genital organ symptoms\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-22 09:37:00, ended at 2010-01-22 23:59:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Prothrombin time (PT): 24.1 (second)\n- Tacrolimus [Mass/volume] in Blood: 5.5 (nanogram per milliliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 34 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 23.9 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 16.3 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.1 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.4 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 171 (unit per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 85 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.35 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 10.4 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.95 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 82 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.2 (ratio)\n- Neutrophils [#/volume] in Blood by Automated count: 3.80 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.6 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.99 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 17.0 (percent)\n- MCHC [Mass/volume] by Automated count: 31.1 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 318 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 148 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.3 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.8 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 76.6 (femtoliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hyperlipidemia\n- Essential hypertension\n- Hypersensitivity angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-02-03 10:49:40, ended at 2010-02-03 11:50:41\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Dysphagia\n- Acute pharyngitis\n- Nausea and vomiting\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2010-02-04 00:00:00, ended at 2010-02-04 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Diffuse spasm of esophagus\n\n### Drug\n- isosorbide dinitrate 30 MG Oral Tablet, through Oral route, started on 2010-02-12, presumably until 2010-06-19, with quantity of 60.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-02-09 16:04:00, ended at 2010-02-09 17:35:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Superficial foreign body\n\n### Drug\n- 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.005 UNT/ML / Bordetella pertussis toxoid vaccine, inactivated 0.016 MG/ML / diphtheria toxoid vaccine, inacti..., through Intramuscular route, started on 2010-02-09, presumably until 2010-02-09\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-19 10:46:00, ended at 2010-02-19 23:59:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, esophagus, including scout chest radiograph(s) and delayed image(s), when performed; single-contrast (eg, barium) study\n\n### Condition\n- Acute pharyngitis\n- Gastroesophageal reflux disease\n- Dysphagia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-02-23 00:00:00, ended at 2010-02-23 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-02-23 10:41:40, ended at 2010-02-23 11:57:43\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Neurogenic bladder\n- Transplanted kidney present\n- Hyperlipidemia\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-23 12:03:00, ended at 2010-02-23 23:59:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- INR in Platelet poor plasma by Coagulation assay: 2.1 (ratio)\n- Prothrombin time (PT): 22.7 (second)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Coronary arteriosclerosis\n- Hyperlipidemia\n- Renal disorder due to type 1 diabetes mellitus\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-02-24 00:00:00, ended at 2010-02-24 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mononeuritis\n\n### Drug\n- gabapentin 600 MG Oral Tablet, through Oral route, started on 2010-02-24, presumably until 2010-06-30, with quantity of 90.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-03-03 00:00:00, ended at 2010-03-03 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Systemic lupus erythematosus\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2010-03-03, presumably until 2010-07-22, with quantity of 30.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-12 09:54:00, ended at 2010-03-12 23:59:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Gastric emptying imaging study (eg, solid, liquid, or both)\n- Gastroesophageal reflux study\n\n### Condition\n- Peripheral vascular disease\n- Flatulence, eructation and gas pain\n- Hyperlipidemia\n- Nonproliferative retinopathy due to diabetes mellitus\n- Type 2 diabetes mellitus without complication\n- Nausea and vomiting\n- Coronary arteriosclerosis\n- Disorder of eye due to diabetes mellitus\n- Systemic lupus erythematosus\n- Chronic kidney disease stage 5 due to hypertension\n- End-stage renal disease\n- Osteoporosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-23 10:54:00, ended at 2010-03-23 23:59:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Albumin [Mass/volume] in Urine: <3 (milligram per liter)\n- Erythrocyte sedimentation rate: 9 (millimeter per hour)\n- Monocytes [#/volume] in Blood by Automated count: 0.91 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.5 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 68 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 76 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.8 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Complement C3 [Mass/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 23.5 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 4.27 (thousand per microliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 152 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.20 (million per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 4.5 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 0.9 (ratio)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.06 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 306 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.9 (ratio)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.7 (percent)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 84 (milligram per deciliter)\n- Prothrombin time (PT): 21.0 (second)\n- Triglyceride [Moles/volume] in Serum or Plasma: 41 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 79 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 76 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.3 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 73.2 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 67.7 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Albumin/Creatinine [Mass Ratio] in Urine: <30 (milligram per gram)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.1 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hyperlipidemia\n- Essential hypertension\n- Transplanted kidney present\n- Type 2 diabetes mellitus without complication\n- Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-03-31 09:38:18, ended at 2010-03-31 10:35:23\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- Laryngoscopy, flexible; diagnostic\n\n### Condition\n- Primary diagnosis: Dysphagia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-03-31 13:21:42, ended at 2010-03-31 13:58:25\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Anemia in chronic kidney disease\n\n### Drug\n- dexlansoprazole 30 MG Delayed Release Oral Capsule, through Oral route, presumably until 2010-06-19. Instructions: take by mouth. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-04-02 15:03:41, ended at 2010-04-02 15:49:08\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2.5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Diffuse spasm of esophagus\n- Dysphagia\n- Diarrhea\n- Primary diagnosis: Flatulence, eructation and gas pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-04 10:50:00, ended at 2010-04-04 23:59:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anemia in chronic kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-04-06 10:15:58, ended at 2010-04-06 11:20:42\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Systemic lupus erythematosus\n\n### Drug\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2010-04-06, presumably until 2010-04-28, with quantity of 14.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-06 13:35:00, ended at 2010-04-06 23:59:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, hand; 2 views\n- Ultrasound, pelvic (nonobstetric), real time with image documentation; complete\n- Ultrasound, transvaginal\n\n### Condition\n- Noninflammatory disorder of the female genital organs\n- Female genital organ symptoms\n- Systemic lupus erythematosus\n- Swelling of limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-04-09 00:00:00, ended at 2010-04-09 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Iron deficiency anemia\n- Feces contents abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-09 13:14:00, ended at 2010-04-09 23:59:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)\n\n### Condition\n- Lack of exercise\n- Disorder of bone and articular cartilage\n- Postmenopausal state\n- Disorder of endocrine system\n- Osteoporosis\n- Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-20 10:46:00, ended at 2010-04-20 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Albumin [Mass/volume] in Urine: 4 (milligram per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 153 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 391 (microgram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.24 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.4 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.6 (percent)\n- Platelets [#/volume] in Blood by Automated count: 370 (thousand per microliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 78 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 75 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.9 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 31.5 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.69 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 72.4 (percent)\n- Tacrolimus [Mass/volume] in Blood: 4.9 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 89 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 0.9 (ratio)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.7 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 2.8 (ratio)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.2 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.16 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 69 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.6 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 2.9 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.33 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 31 (milligram per deciliter)\n- Albumin/Creatinine [Mass Ratio] in Urine: 9 (milligram per gram)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.5 (percent)\n- MCH [Entitic mass] by Automated count: 22.6 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Prothrombin time (PT): 28.9 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Ferritin [Mass/volume] in Serum or Plasma: 3 (nanogram per milliliter)\n- Iron [Mass/volume] in Serum or Plasma: 10 (microgram per deciliter)\n- MCV [Entitic volume] by Automated count: 71.9 (femtoliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Anemia in chronic kidney disease\n- Transplanted kidney present\n- Systemic lupus erythematosus\n- Type 2 diabetes mellitus without complication\n- Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-21 11:07:00, ended at 2010-04-21 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, swallowing function, with cineradiography/videoradiography, including scout neck radiograph(s) and delayed image(s), when performed, contrast (eg, barium) study\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Dysphagia\n- Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-27 13:07:00, ended at 2010-04-27 16:20:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- Endoscopic biopsy of large intestine\n- Colonoscopy, flexible; with biopsy, single or multiple\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n\n### Condition\n- Feces contents abnormal\n- Inflammatory disorder of digestive tract\n- Iron deficiency anemia\n\n### Drug\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-04-27, presumably until 2010-04-27\n- midazolam 1 MG/ML Injectable Solution, started on 2010-04-27, presumably until 2010-04-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-04-28 00:00:00, ended at 2010-04-28 00:00:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2010-04-28, presumably until 2010-09-01, with quantity of 180.0, with intended 4 refill(s). Instructions: take 1 Tab by mouth 2 times a day. \n- metoprolol tartrate 50 MG Oral Tablet, through Oral route, started on 2010-04-28, presumably until 2010-04-28, with quantity of 120.0, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-28 14:00:00, ended at 2010-04-28 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of lower extremity arteries or arterial bypass grafts; unilateral or limited study\n\n### Condition\n- Intermittent claudication\n- Atherosclerosis of arteries of the extremities\n- Disorder of artery\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-04-28 14:01:54, ended at 2010-04-28 15:44:39\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Intermittent claudication\n- Primary diagnosis: Atherosclerosis of arteries of the extremities\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-05-05 08:25:00, ended at 2010-05-05 13:40:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2.5\" (inch (US))\n\n### Procedure\n- Other nonoperative measurements and examinations\n- Breath hydrogen or methane test (eg, for detection of lactase deficiency, fructose intolerance, bacterial overgrowth, or oro-cecal gastrointestinal transit)\n\n### Condition\n- Flatulence, eructation and gas pain\n- Diarrhea\n\n### Drug\n- lactulose 667 MG/ML Oral Solution, through Oral route, started on 2010-05-05, presumably until 2010-05-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2010-05-06 00:00:00, ended at 2010-05-06 00:00:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Iron deficiency anemia\n- Ulcerative colitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-05-07 11:40:00, ended at 2010-05-07 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.17 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 31.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 72.3 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 319 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 21 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 81 (milligram per deciliter)\n- Prothrombin time (PT): 20.2 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.9 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- INR in Platelet poor plasma by Coagulation assay: 1.8 (ratio)\n- Hemoglobin [Mass/volume] in Blood: 9.6 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 22.9 (picogram)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.9 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Ulcerative colitis\n- Iron deficiency anemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-05-10 10:31:00, ended at 2010-05-10 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomographic angiography, pelvis, with contrast material(s), including noncontrast images, if performed, and image postprocessing\n- Computed tomographic angiography, abdomen, with contrast material(s), including noncontrast images, if performed, and image postprocessing\n\n### Condition\n- Chronic vascular insufficiency of intestine\n- Disorder of intestine\n- Anemia\n- Iron deficiency anemia\n- Aneurysm of artery of lower extremity\n- Ulceration of intestine\n- Lymphadenopathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2010-05-15 00:00:00, ended at 2010-05-15 00:00:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Diarrhea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-05-19 08:47:33, ended at 2010-05-19 12:14:28\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Joint pain\n- Primary diagnosis: Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-05-19 08:49:00, ended at 2010-05-19 11:14:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, knee; 3 views\n- Radiologic examination, knee; both knees, standing, anteroposterior\n\n### Condition\n- Disorder of bone and articular cartilage\n- Synovial cyst of knee\n- Arthropathy of knee joint\n- Joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-05-19 11:15:00, ended at 2010-05-19 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, any joint of lower extremity; without contrast material\n\n### Condition\n- Synovial cyst of knee\n- Joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-05-21 11:17:26, ended at 2010-05-21 11:22:27\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Phlebitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-05-23 10:06:00, ended at 2010-05-23 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.47 (million per microliter)\n- Platelets [#/volume] in Blood by Automated count: 404 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 80 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 128 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.7 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 75.1 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 6.02 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.6 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.6 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 3.7 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- MCH [Entitic mass] by Automated count: 23.8 (picogram)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 21 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.9 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.86 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 7.1 (nanogram per milliliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 76 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 31.7 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 133 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 23.2 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.77 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 77.8 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 40 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n- Disorder of magnesium metabolism\n- Hyperlipidemia\n- Blood chemistry abnormal\n- Disorder of phosphorus metabolism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-05-29 09:47:29, ended at 2010-05-29 11:07:49\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Localized, primary osteoarthritis\n- Synovial cyst of knee\n- Joint pain\n- Osteoarthritis of knee\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-05-29 12:12:00, ended at 2010-05-29 13:15:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasonic guidance for needle placement (eg, biopsy, aspiration, injection, localization device), imaging supervision and interpretation\n\n### Condition\n- Localized, primary osteoarthritis\n- Synovial cyst of knee\n- Joint pain\n- Osteoarthritis of knee\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-06-04 14:18:00, ended at 2010-06-04 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Diarrhea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-06-19 00:00:00, ended at 2010-06-19 00:00:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Diffuse spasm of esophagus\n- Anemia in chronic kidney disease\n\n### Drug\n- isosorbide dinitrate 30 MG Oral Tablet, through Oral route, started on 2010-06-19, presumably until 2010-09-14, with quantity of 60.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day. \n- dexlansoprazole 30 MG Delayed Release Oral Capsule, through Oral route, started on 2010-06-19, presumably until 2010-06-25, with quantity of 30.0, with intended 12 refill(s). Instructions: take 1 Tab by mouth Every Day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-06-23 10:09:00, ended at 2010-06-23 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Urine: <3 (milligram per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.10 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.5 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 4.9 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 81 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.2 (ratio)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.0 (milligram per deciliter)\n- Prothrombin time (PT): 24.3 (second)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 73 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 11.6 (nanogram per milliliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 66 (milligram per deciliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 0.8 (ratio)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 27.0 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.2 (percent)\n- Platelets [#/volume] in Blood by Automated count: 258 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 76 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 30.6 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.8 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.01 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 68.4 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 79 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.94 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.9 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.0 (percent)\n- MCHC [Mass/volume] by Automated count: 31.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 85.3 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.83 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 49 (milligram per deciliter)\n- Albumin/Creatinine [Mass Ratio] in Urine: <30 (milligram per gram)\n- Cholesterol [Mass/volume] in Serum or Plasma: 155 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Hyperlipidemia\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-06-25 16:07:14, ended at 2010-06-25 17:16:45\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anemia in chronic kidney disease\n- Gastroesophageal reflux disease\n\n### Drug\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, presumably until 2010-10-01. Instructions: take 325 mg by mouth daily. \n- dexlansoprazole 30 MG Delayed Release Oral Capsule, through Oral route, started on 2010-06-25, presumably until 2010-07-08, with quantity of 30.0, with intended 12 refill(s). Instructions: take 1 Tab by mouth 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-06-29 00:00:00, ended at 2010-06-29 00:00:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Peripheral nerve disease\n\n### Drug\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2010-06-29, presumably until 2010-07-02, with quantity of 180.0, with intended 11 refill(s). Instructions: take 1 Cap by mouth 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-06-30 16:30:00, ended at 2010-06-30 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of artery\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-07-02 15:34:05, ended at 2010-07-02 16:36:23\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Peripheral nerve disease\n- Disorder of bone and articular cartilage\n- Female genital organ symptoms\n- Renal disorder due to type 1 diabetes mellitus\n- Transplanted kidney present\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, through Oral route, presumably until 2010-09-01. Instructions: take by mouth. Take 4.0 mg by mouth daily. 2.0mg in the morning and 2.0mg in the evening.\n- dexlansoprazole 30 MG Delayed Release Oral Capsule, through Oral route, presumably until 2010-08-17. Instructions: take by mouth. \n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2010-07-02, presumably until 2010-11-19, with quantity of 180.0, with intended 11 refill(s). Instructions: take 1 Cap by mouth 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-07-03 00:00:00, ended at 2010-07-03 00:00:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Angina pectoris\n\n### Drug\n- nitroglycerin 0.4 MG Sublingual Tablet, through Sublingual route, started on 2010-07-03, presumably until 2010-09-10, with intended 11 refill(s). Instructions: 1 Tab by Sublingual route as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-07-08 09:35:36, ended at 2010-07-08 10:14:53\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cyst of ovary\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-07-17 13:30:00, ended at 2010-07-17 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1.811\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Female genital organ symptoms\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-07-22 00:00:00, ended at 2010-07-22 00:00:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Systemic lupus erythematosus\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2010-07-22, presumably until 2011-02-23, with quantity of 30.0, with intended 2 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-07-24 00:00:00, ended at 2010-07-24 00:00:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Inconclusive mammography finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-07-24 08:57:00, ended at 2010-07-24 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- INR in Platelet poor plasma by Coagulation assay: 2.5 (ratio)\n- Prothrombin time (PT): 26.9 (second)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-07-29 00:00:00, ended at 2010-07-29 00:00:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Dysphagia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-07-31 10:58:00, ended at 2010-07-31 13:28:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, esophagus, including scout chest radiograph(s) and delayed image(s), when performed; single-contrast (eg, barium) study\n\n### Condition\n- Female genital organ symptoms\n- Transplanted kidney present\n- Dysphagia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-07-31 13:29:00, ended at 2010-07-31 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, pelvic (nonobstetric), real time with image documentation; complete\n- Ultrasound, transvaginal\n\n### Condition\n- Intra-abdominal and pelvic swelling, mass and lump\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-08-07 10:58:00, ended at 2010-08-07 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance imaging, breast, without and/or with contrast material(s); unilateral\n\n### Condition\n- Postmenopausal state\n- Benign neoplasm of skin\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-08-10 11:00:13, ended at 2010-08-10 12:32:22\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Arthrocentesis, aspiration and/or injection, major joint or bursa (eg, shoulder, hip, knee, subacromial bursa); without ultrasound guidance\n\n### Condition\n- Primary diagnosis: Systemic lupus erythematosus\n- Enthesopathy of hip region\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-08-14 13:30:00, ended at 2010-08-14 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1.811\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Female genital organ symptoms\n- Flatulence, eructation and gas pain\n- Cyst of ovary\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-08-17 00:00:00, ended at 2010-08-17 00:00:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Gastroesophageal reflux disease\n\n### Drug\n- dexlansoprazole 30 MG Delayed Release Oral Capsule, through Oral route, started on 2010-08-17, presumably until 2011-01-20, with quantity of 60.0, with intended 3 refill(s). Instructions: take 1 Cap by mouth 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-08-20 09:11:52, ended at 2010-08-20 10:24:54\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Dysphagia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-08-24 09:46:00, ended at 2010-08-24 11:29:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 47.8 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 1.13 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.2 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.1 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 93.0 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.63 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 81 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.7 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 2.8 (ratio)\n- Platelets [#/volume] in Blood by Automated count: 257 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 85 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.10 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 13.8 (percent)\n- MCH [Entitic mass] by Automated count: 30.8 (picogram)\n- Prothrombin time (PT): 29.2 (second)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.14 (million per microliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 4.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 15.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.0 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 151 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 1 (millimeter per hour)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 51 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 2.7 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 70.7 (percent)\n- Tacrolimus [Mass/volume] in Blood: 9.2 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2010-08-24 11:30:00, ended at 2010-09-01 17:00:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- MCH [Entitic mass] by Automated count: 31.5 (picogram)\n- Osmolality of Urine: 103 (milliosmole per kilogram)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.0 (percent)\n- Tacrolimus [Mass/volume] in Blood: 6.6 (nanogram per milliliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 88.1 (second)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 5.8 (ratio)\n- Prothrombin time (PT): 52.5 (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.87 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 228 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 15.0 (gram per deciliter)\n- Body height: 5' 2.5\" (inch (US))\n- Chloride [Moles/volume] in Serum or Plasma: 95 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 94.1 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 81 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.6 (thousand per microliter)\n\n### Procedure\n- Imaging supervision, interpretation and report for injection procedure(s) during cardiac catheterization; pulmonary angiography, aortography, and/or selective coronary angiography including venous bypass grafts and arterial conduits (whether native or use\n- Computed tomographic angiography, abdomen, with contrast material(s), including noncontrast images, if performed, and image postprocessing\n- Intravascular Doppler velocity and/or pressure derived coronary flow reserve measurement (coronary vessel or graft) during coronary angiography including pharmacologically induced stress; initial vessel (List separately in addition to code for primary pro\n- Collection of venous blood by venipuncture\n- Catheter placement in coronary artery(s), arterial coronary conduit(s), and/or venous coronary bypass graft(s) for coronary angiography without concomitant left heart catheterization\n- Computed tomographic angiography, pelvis, with contrast material(s), including noncontrast images, if performed, and image postprocessing\n- Cardiac blood pool imaging, gated equilibrium; multiple studies, wall motion study plus ejection fraction, at rest and stress (exercise and/or pharmacologic), with or without additional quantification\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Injection procedure during cardiac catheterization; for selective coronary angiography (injection of radiopaque material may be by hand)\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or \n- Therapeutic procedure, 1 or more areas, each 15 minutes; gait training (includes stair climbing)\n- Computed tomographic angiography, chest (noncoronary), with contrast material(s), including noncontrast images, if performed, and image postprocessing\n- Catheterization of left heart\n- Radiologic examination, spine; thoracic, 2 views\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Coronary arteriography using two catheters\n- Physical therapy evaluation\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; tracing only, without interpretation and report\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Chest pain\n- Coronary atherosclerosis\n- Angina pectoris\n- Nausea\n- Osteoporosis\n- Coag./bleeding tests abnormal\n- Coronary arteriosclerosis\n- Essential hypertension\n- Hyperlipidemia\n- Peripheral vascular disease\n- Systemic lupus erythematosus\n- Backache\n- Transplanted kidney present\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2010-08-27, presumably until 2010-09-01\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2010-08-25, presumably until 2010-09-01. Instructions: take 325 mg by mouth daily.\n- diltiazem hydrochloride 60 MG Oral Tablet, through Oral route, started on 2010-08-25, presumably until 2010-09-01\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2010-08-25, presumably until 2010-09-01\n- isosorbide dinitrate 10 MG Oral Tablet, through Oral route, started on 2010-08-24, presumably until 2010-09-01. Instructions: take 1 Tab by mouth 2 times a day. \n- 1000 ML potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2010-08-27, presumably until 2010-08-28\n- zolpidem tartrate 5 MG Oral Tablet, through Oral route, started on 2010-08-24, presumably until 2010-08-26. Instructions: Take as needed for sleep\n- diazepam 5 MG Oral Tablet, through Oral route, started on 2010-08-31, presumably until 2010-08-31\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2010-08-24, presumably until 2011-05-06, with quantity of 60.0, with intended 0 refill(s). Instructions: take by mouth. Take 4.0 mg by mouth daily. 2.0mg in the morning and 2.0mg in the evening.\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2010-08-26, presumably until 2010-09-01\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2010-08-29, presumably until 2010-09-01. Instructions: take by mouth as needed\n- warfarin sodium 4 MG Oral Tablet, through Oral route, started on 2010-08-25, presumably until 2010-10-01, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. \n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2010-08-24, presumably until 2010-09-01, with quantity of 180.0, with intended 4 refill(s). Instructions: take 1 Tab by mouth AM. \n- metoprolol tartrate 50 MG Oral Tablet, through Oral route, started on 2010-08-29, presumably until 2010-10-01, with quantity of 60.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every bedtime. \n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2010-08-29, presumably until 2010-08-30\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2010-08-25, presumably until 2010-09-01. Instructions: take 1 Tab by mouth daily.\n- isosorbide dinitrate 20 MG Oral Tablet, through Oral route, started on 2010-08-24, presumably until 2010-09-01. Instructions: take 1 Tab by mouth 2 times a day. \n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2010-08-24, presumably until 2010-09-01. Instructions: take 1 Cap by mouth 2 times a day. \n- atorvastatin 20 MG Oral Tablet, through Oral route, started on 2010-08-24, presumably until 2010-08-31. Instructions: take 1 Tab by mouth daily. \n- 1 ML vitamin K1 10 MG/ML Injection, through Intravenous route, started on 2010-08-28, presumably until 2010-08-28\n- hydromorphone hydrochloride 2 MG Oral Tablet, through Oral route, started on 2010-08-24, presumably until 2010-08-31\n- 2 ML ondansetron 2 MG/ML Injection, started on 2010-08-27, presumably until 2010-08-31\n- warfarin sodium 2 MG Oral Tablet, through Oral route, started on 2010-08-26, presumably until 2010-08-26\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2010-08-24, presumably until 2010-08-24\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-08-24, presumably until 2010-09-01\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2010-08-31, presumably until 2010-08-31\n- lidocaine 0.05 MG/MG Medicated Patch, through Topical route, started on 2010-08-26, presumably until 2010-08-31\n- nitroglycerin 0.4 MG Sublingual Tablet, through Sublingual route, started on 2010-08-24, presumably until 2010-08-26. Instructions: 1 Tab by Sublingual route as needed \n- mycophenolate mofetil 500 MG Oral Tablet, through Oral route, started on 2010-08-25, presumably until 2010-08-27\n- clopidogrel 75 MG Oral Tablet, through Oral route, started on 2010-08-27, presumably until 2010-09-01\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2010-08-27 09:40:53, ended at 2010-08-27 15:59:28\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; tracing only, without interpretation and report\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; interpretation and report only\n\n### Condition\n- Coronary arteriosclerosis\n- Chest pain\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-09-04 10:32:18, ended at 2010-09-04 10:57:31\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Phlebitis\n- Hypercoagulability state\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-09-08 00:00:00, ended at 2010-09-08 00:00:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-09-08 10:26:00, ended at 2010-09-08 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Albumin/Creatinine [Mass Ratio] in Urine: 11 (milligram per gram)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 85 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 71 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 75 (milligram per deciliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 1.1 (ratio)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.2 (percent)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 31.0 (second)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 330 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.50 (million per microliter)\n- Tacrolimus [Mass/volume] in Blood: 2.3 (nanogram per milliliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 14.3 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.9 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.07 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Albumin [Mass/volume] in Urine: 5 (milligram per liter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 88 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.7 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.88 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.0 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.5 (ratio)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.87 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.7 (percent)\n- MCV [Entitic volume] by Automated count: 96.0 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 68.6 (percent)\n- Prothrombin time (PT): 18.0 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 159 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 89 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.8 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 65 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Transplanted kidney present\n- Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-09-10 00:00:00, ended at 2010-09-10 00:00:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Angina pectoris\n\n### Drug\n- nitroglycerin 0.4 MG Sublingual Tablet, through Sublingual route, started on 2010-09-10, presumably until 2012-01-13, with intended 11 refill(s). Instructions: 1 Tab by Sublingual route as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-09-10 15:40:15, ended at 2010-09-10 16:31:17\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pain in limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-09-14 00:00:00, ended at 2010-09-14 00:00:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-09-14 08:45:00, ended at 2010-09-14 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.7 (percent)\n- MCH [Entitic mass] by Automated count: 31.8 (picogram)\n- Urate [Mass/volume] in Serum or Plasma: 2.5 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 64.6 (percent)\n- Platelets [#/volume] in Blood by Automated count: 277 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.60 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 80 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 94.2 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 15.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.56 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.5 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 5.7 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 76 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 150 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.6 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.5 (percent)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.03 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.83 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 46 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.1 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n- Diffuse spasm of esophagus\n- Coronary atherosclerosis\n- Renal disorder due to type 1 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-09-14 10:50:38, ended at 2010-09-14 12:16:40\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-09-14 13:08:24, ended at 2010-09-14 14:14:16\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Coronary atherosclerosis\n- Renal disorder due to type 1 diabetes mellitus\n- Transplanted kidney present\n- Primary diagnosis: Diffuse spasm of esophagus\n\n### Drug\n- isosorbide dinitrate 30 MG Oral Tablet, through Oral route, started on 2010-09-14, presumably until 2010-11-11, with quantity of 90.0, with intended 5 refill(s). Instructions: take 1.5 Tabs by mouth 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-09-22 09:07:00, ended at 2010-09-22 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Albumin/Creatinine [Mass Ratio] in Urine: <30 (milligram per gram)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.5 (percent)\n- MCV [Entitic volume] by Automated count: 95.4 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.77 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 106 (unit per liter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 67 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.4 (picogram)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.3 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 5.9 (nanogram per milliliter)\n- Albumin [Mass/volume] in Urine: <5 (milligram per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 154 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 77 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.7 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 50 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 0.9 (ratio)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.5 (percent)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.48 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.2 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 263 (thousand per microliter)\n- Prothrombin time (PT): 31.7 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 32.9 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 77 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 76 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.8 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 4.9 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 3.3 (ratio)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.70 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.3 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.5 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.99 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hyperlipidemia\n- Type 2 diabetes mellitus without complication\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-09-23 00:00:00, ended at 2010-09-23 00:00:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2010-09-23, presumably until 2011-05-06, with quantity of 180.0, with intended 11 refill(s). Instructions: take 3 Caps by mouth 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-09-29 11:06:00, ended at 2010-09-29 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- INR in Platelet poor plasma by Coagulation assay: 2.9 (ratio)\n- Prothrombin time (PT): 28.9 (second)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Epiretinal membrane\n- Renal disorder due to type 1 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-09-30 00:00:00, ended at 2010-09-30 00:00:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Dysphagia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-09-30 09:56:59, ended at 2010-09-30 15:01:08\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Determination of refractive state\n\n### Condition\n- Epiretinal membrane\n- Renal disorder due to type 1 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-09-30 12:55:51, ended at 2010-09-30 15:02:18\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of right eye: 12 (millimeter mercury column)\n- Intraocular pressure of left eye: 13 (millimeter mercury column)\n\n### Procedure\n- Scanning computerized ophthalmic diagnostic imaging, posterior segment, (eg, scanning laser) with interpretation and report, unilateral\n\n### Condition\n- Primary diagnosis: Epiretinal membrane\n- Disorder of eye due to type 1 diabetes mellitus\n- Proliferative retinopathy due to diabetes mellitus\n- Vitreous degeneration\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-10-01 13:45:00, ended at 2010-10-01 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1.811\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Breast lump\n\n### Drug\n- 24 HR metoprolol succinate 25 MG Extended Release Oral Tablet, through Oral route, presumably until 2010-11-05. Instructions: take 25 mg by mouth 2 times a day. 25mg in am, 50mg in pm \n- warfarin sodium 2 MG Oral Tablet, through Oral route, presumably until 2011-03-29. Instructions: take 2 mg by mouth. Twice weekly. Pomona days a week is 4mg. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-10-06 13:25:57, ended at 2010-10-06 14:15:30\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-10-12 07:59:00, ended at 2010-10-12 13:07:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Prothrombin time (PT): 24.9 (second)\n- INR in Platelet poor plasma by Coagulation assay: 2.4 (ratio)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-10-12 13:08:00, ended at 2010-10-12 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, breast(s) (unilateral or bilateral), real time with image documentation\n- Mammography; bilateral\n- Computer-aided detection (computer algorithm analysis of digital image data for lesion detection) with further review for interpretation, with or without digitization of film radiographic images; diagnostic mammography (List separately in addition to code\n\n### Condition\n- Abnormal findings on diagnostic imaging of breast\n- Disorder of breast\n- Postmenopausal state\n- Type 2 diabetes mellitus without complication\n- Breast lump\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-10-14 13:09:39, ended at 2010-10-14 14:04:31\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Diffuse spasm of esophagus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-10-16 12:28:00, ended at 2010-10-16 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Esophageal motility\n\n### Condition\n- Achalasia of esophagus\n- Dysphagia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-10-22 13:30:00, ended at 2010-10-22 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1.811\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Breast lump\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-10-24 00:00:00, ended at 2010-10-24 00:00:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Breast lump\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-11-04 00:00:00, ended at 2010-11-04 00:00:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Breast lump\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-11-05 00:00:00, ended at 2010-11-05 00:00:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Peripheral nerve disease\n- Transplanted kidney present\n\n### Drug\n- 24 HR metoprolol succinate 25 MG Extended Release Oral Tablet, through Oral route, started on 2010-11-05, presumably until 2011-05-25, with quantity of 90.0, with intended 6 refill(s). Instructions: take 1 Tab by mouth 2 times a day. 25mg in am, 50mg in pm \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-11-11 08:55:51, ended at 2010-11-11 09:23:01\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 0\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chest pain\n- Dysphagia\n- Primary diagnosis: Diffuse spasm of esophagus\n\n### Drug\n- isosorbide dinitrate 30 MG Oral Tablet, through Oral route, started on 2010-11-11, presumably until 2011-07-21, with quantity of 60.0, with intended 6 refill(s). Instructions: take 1 Tab by mouth 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-11-11 09:32:00, ended at 2010-11-11 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Prothrombin time (PT): 27.4 (second)\n- INR in Platelet poor plasma by Coagulation assay: 2.7 (ratio)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Diffuse spasm of esophagus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-11-15 09:21:00, ended at 2010-11-15 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Breast lump\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-11-16 15:04:00, ended at 2010-11-16 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance imaging, breast, without and/or with contrast material(s); bilateral\n\n### Condition\n- Breast lump\n- Postmenopausal state\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-11-17 13:09:09, ended at 2010-11-17 14:48:18\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- Duplex scan of lower extremity arteries or arterial bypass grafts; unilateral or limited study\n\n### Condition\n- Primary diagnosis: Peripheral vascular disease\n- Intermittent claudication\n- Atherosclerosis of arteries of the extremities\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-11-19 00:00:00, ended at 2010-11-19 00:00:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n- Peripheral nerve disease\n\n### Drug\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2010-11-19, presumably until 2011-05-06, with quantity of 180.0, with intended 11 refill(s). Instructions: take 1 Cap by mouth 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-11-23 10:24:00, ended at 2010-11-23 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 93 (unit per liter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 32.5 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.79 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.0 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 85 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.90 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 28.9 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.3 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.62 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.0 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 71.8 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.24 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.3 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 42 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 145 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 89.0 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 21 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 3.1 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.4 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.7 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.4 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 315 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 10.8 (nanogram per milliliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 4.9 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hyperlipidemia\n- Blood chemistry abnormal\n- Transplanted kidney present\n- Disorder of phosphorus metabolism\n- Disorder of magnesium metabolism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-11-25 10:46:45, ended at 2010-11-25 12:34:23\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Injection(s); single tendon sheath, or ligament, aponeurosis (eg, plantar  fascia )\n\n### Condition\n- Primary diagnosis: Acquired trigger finger\n\n### Drug\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2010-11-25, presumably until 2010-11-25, with intended 0 refill(s). Instructions: 0.7 mL by Injection route One Time. \n- betamethasone 3 MG/ML / betamethasone acetate 3 MG/ML Injectable Suspension, started on 2010-11-25, presumably until 2010-11-25, with quantity of 1.0, with intended 0 refill(s). Instructions: 0.7 mL by Injection route One Time. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-11-25 11:52:00, ended at 2010-11-25 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, wrist; complete, minimum of 3 views\n- Radiologic examination, hand; minimum of 3 views\n\n### Condition\n- Postprocedural state finding\n- Disorder of wrist joint\n- Wrist joint pain\n- Degenerative joint disease of hand\n- Pain in limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-11-30 00:00:00, ended at 2010-11-30 00:00:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-12-01 13:29:00, ended at 2010-12-01 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, pelvis; without contrast material(s), followed by contrast material(s) and further sequences\n\n### Condition\n- Noninflammatory disorder of the female genital organs\n- Flatulence, eructation and gas pain\n- Female genital organ symptoms\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-12-07 08:59:00, ended at 2010-12-07 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Tacrolimus [Mass/volume] in Blood: 3.4 (nanogram per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Essential hypertension\n- Renal disorder due to type 1 diabetes mellitus\n- Chest pain\n- Coronary atherosclerosis\n- Hyperlipidemia\n- Peripheral vascular disease\n- Systemic lupus erythematosus\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-12-07 13:05:06, ended at 2010-12-07 13:36:14\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Peripheral vascular disease\n- Hyperlipidemia\n- Transplanted kidney present\n- Renal disorder due to type 1 diabetes mellitus\n- Systemic lupus erythematosus\n- Chest pain\n- Coronary atherosclerosis\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-12-14 00:00:00, ended at 2010-12-14 00:00:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of nervous system due to diabetes mellitus\n\n### Drug\n- atorvastatin 20 MG Oral Tablet, through Oral route, started on 2010-12-14, presumably until 2011-12-14, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-12-15 00:00:00, ended at 2010-12-15 00:00:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of nervous system due to diabetes mellitus\n\n### Drug\n- atorvastatin 20 MG Oral Tablet, through Oral route, started on 2010-12-15, presumably until 2011-12-15, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-12-15 10:48:00, ended at 2010-12-15 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Prothrombin time (PT): 31.1 (second)\n- INR in Platelet poor plasma by Coagulation assay: 3.2 (ratio)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-12-16 00:00:00, ended at 2010-12-16 00:00:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Peripheral vascular disease\n\n### Drug\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2010-12-16, presumably until 2011-03-29, with quantity of 30.0, with intended 2 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed pain \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-12-21 14:55:02, ended at 2010-12-21 16:11:40\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), premalignant lesions (eg, actinic keratoses); first lesion\n\n### Condition\n- Primary diagnosis: Actinic keratosis\n- Discoloration of skin\n\n### Drug\n- tretinoin 0.25 MG/ML Topical Cream, through Topical route, started on 2010-12-21, presumably until 2010-12-31, with intended 0 refill(s). Instructions: by Topical route every bedtime. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-12-25 11:00:00, ended at 2010-12-25 13:24:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1.811\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Female genital organ symptoms\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-12-25 13:25:00, ended at 2010-12-25 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Cyst of ovary\n- Female genital organ symptoms\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-12-25 13:49:52, ended at 2010-12-25 14:29:20\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- Routine gynecologic examination\n- Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diag\n\n### Condition\n- Cyst of ovary\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-12-31 14:07:34, ended at 2010-12-31 15:26:37\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Injection(s); single tendon sheath, or ligament, aponeurosis (eg, plantar  fascia )\n- Arthrocentesis, aspiration and/or injection, intermediate joint or bursa (eg, temporomandibular, acromioclavicular, wrist, elbow or ankle, olecranon bursa); without ultrasound guidance\n\n### Condition\n- Aseptic necrosis of bone\n- Degenerative joint disease of hand\n\n### Drug\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2010-12-31, presumably until 2010-12-31, with intended 0 refill(s). Instructions: 0.7 mL by Injection route One Time. \n- betamethasone 3 MG/ML / betamethasone acetate 3 MG/ML Injectable Suspension, started on 2010-12-31, presumably until 2010-12-31, with quantity of 1.0, with intended 0 refill(s). Instructions: 0.7 mL by Injection route One Time. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-01-05 11:13:00, ended at 2011-01-05 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Tacrolimus [Mass/volume] in Blood: 5.6 (nanogram per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n- Hyperlipidemia\n- Type 1 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-01-05 13:56:27, ended at 2011-01-05 17:39:42\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n- Hyperlipidemia\n- Type 1 diabetes mellitus without complication\n\n### Drug\n- 0.5 ML Streptococcus pneumoniae type 1 capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 10A capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 11A capsular polysaccharide antigen 0.05 MG/ML / Streptococ..., through Subcutaneous route, started on 2011-01-05, presumably until 2011-01-06, with quantity of 1.0, with intended 0 refill(s). Instructions: 0.5 mL by SUBCUTANEOUS route One Time. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-01-18 12:50:00, ended at 2011-01-18 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Prothrombin time (PT): 23.2 (second)\n- INR in Platelet poor plasma by Coagulation assay: 2.2 (ratio)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Subsequent stage of staged operation\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2011-01-20 00:00:00, ended at 2011-01-20 00:00:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Gastroesophageal reflux disease\n\n### Drug\n- dexlansoprazole 30 MG Delayed Release Oral Capsule, through Oral route, started on 2011-01-20, presumably until 2011-01-25, with quantity of 60.0, with intended 3 refill(s). Instructions: take 1 Cap by mouth 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2011-01-25 00:00:00, ended at 2011-01-25 00:00:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Gastroesophageal reflux disease\n\n### Drug\n- dexlansoprazole 30 MG Delayed Release Oral Capsule, through Oral route, started on 2011-01-25, presumably until 2011-10-25, with quantity of 60.0, with intended 6 refill(s). Instructions: take 1 Cap by mouth 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-01-25 10:18:51, ended at 2011-01-25 13:14:24\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of right eye: 13 (millimeter mercury column)\n- Intraocular pressure of left eye: 12 (millimeter mercury column)\n\n### Procedure\n- Scanning computerized ophthalmic diagnostic imaging, posterior segment, with interpretation and report, unilateral or bilateral; retina\n\n### Condition\n- Proliferative retinopathy due to diabetes mellitus\n- Vitreous degeneration\n- Epiretinal membrane\n- Disorder of eye due to type 1 diabetes mellitus\n\n### Drug\n- triamcinolone acetonide 0.055 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, presumably until 2011-07-05. Instructions: 2 Sprays by Nasal route daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-01-29 00:00:00, ended at 2011-01-29 00:00:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Subsequent stage of staged operation\n\n### Condition\n- No conditions.\n\n### Drug\n- 0.6 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2011-01-29, presumably until 2011-02-25, with quantity of 20.0, with intended 1 refill(s). Instructions: inject 0.5 mL subcutaneous (under the skin) every 12 hours. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-02-04 10:44:43, ended at 2011-02-04 10:58:55\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Subsequent stage of staged operation\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-02-10 08:27:00, ended at 2011-02-11 16:20:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n- Prothrombin time (PT): 14.7 (second)\n- aPTT in Platelet poor plasma by Coagulation assay: 28.1 (second)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n\n### Procedure\n- Transection or avulsion of other spinal nerve, extradural\n- Other excision or avulsion of cranial and peripheral nerves\n- Collection of venous blood by venipuncture\n- Arthrodesis, wrist; with iliac or other autograft (includes obtaining graft)\n- Arthrodesis of carpometacarpal joint\n\n### Condition\n- Disorder of wrist joint\n- Arthralgia of the ankle and/or foot\n- Osteoarthritis of wrist\n- Wrist joint pain\n\n### Drug\n- isosorbide dinitrate 30 MG Oral Tablet, through Oral route, started on 2011-02-10, presumably until 2011-02-11. Instructions: take 1 Tab by mouth 2 times a day.\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2011-02-10, presumably until 2011-02-10\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2011-02-10, presumably until 2011-02-11. Instructions: take 3 Caps by mouth 2 times a day.\n- ascorbic acid 250 MG Oral Tablet, through Oral route, started on 2011-02-10, presumably until 2011-02-11\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2011-02-10, presumably until 2011-02-11\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2011-02-10, presumably until 2011-02-11. Instructions: take 1 Cap by mouth 2 times a day.\n- cefazolin 1000 MG Injection, through Intravenous route, started on 2011-02-10, presumably until 2011-02-11\n- 24 HR metoprolol succinate 25 MG Extended Release Oral Tablet, through Oral route, started on 2011-02-11, presumably until 2011-02-11\n- acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2011-02-10, presumably until 2011-02-11\n- warfarin sodium 4 MG Oral Tablet, through Oral route, started on 2011-02-10, presumably until 2011-02-10\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2011-02-11, presumably until 2011-02-11. Instructions: take 1 Tab by mouth daily.\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2011-02-10, presumably until 2011-02-11. Instructions: take 1 Cap by mouth 2 times a day.\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2011-02-10, presumably until 2011-02-10\n- atorvastatin 20 MG Oral Tablet, through Oral route, started on 2011-02-10, presumably until 2011-02-10. Instructions: take 1 Tab by mouth daily.\n- 24 HR diltiazem hydrochloride 120 MG Extended Release Oral Capsule, through Oral route, started on 2011-02-11, presumably until 2011-02-11\n- 2 ML ondansetron 2 MG/ML Injection, started on 2011-02-10, presumably until 2011-02-10\n- 0.6 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2011-02-11, presumably until 2011-02-11. Instructions: inject 0.5 mL subcutaneous (under the skin) every 12 hours.\n- hydroxyzine pamoate 25 MG Oral Capsule, through Oral route, started on 2011-02-11, presumably until 2011-02-11\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2011-02-10, presumably until 2011-02-11\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2011-02-10, presumably until 2011-02-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2011-02-12 00:00:00, ended at 2011-02-12 00:00:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-02-17 12:14:00, ended at 2011-02-17 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Prothrombin time (PT): 20.7 (second)\n- INR in Platelet poor plasma by Coagulation assay: 1.9 (ratio)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Subsequent stage of staged operation\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-02-22 10:11:00, ended at 2011-02-22 11:10:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 30.9 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 100 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.5 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.4 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.75 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 38 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 78 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.7 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.8 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 31 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 78.3 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.87 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 125 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.9 (percent)\n- Platelets [#/volume] in Blood by Automated count: 417 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.7 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.3 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: 2.9 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.5 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.92 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.9 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.58 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 72.4 (percent)\n- Tacrolimus [Mass/volume] in Blood: 3.2 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 7 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 24.2 (picogram)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Wrist joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-02-22 10:36:53, ended at 2011-02-22 11:58:07\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Degenerative joint disease of hand\n\n### Drug\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2011-02-22, presumably until 2011-07-05, with quantity of 90.0, with intended 2 refill(s). Instructions: take 100 mg by mouth 3 times a day. \n- acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, presumably until 2011-03-29. Instructions: take by mouth as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-02-22 11:11:00, ended at 2011-02-22 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, wrist; complete, minimum of 3 views\n\n### Condition\n- Wrist joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2011-02-23 00:00:00, ended at 2011-02-23 00:00:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Systemic lupus erythematosus\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2011-02-23, presumably until 2011-07-21, with quantity of 30.0, with intended 4 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-02-25 00:00:00, ended at 2011-02-25 00:00:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-02-25 10:40:34, ended at 2011-02-25 12:08:33\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n- Hyperlipidemia\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2011-03-15 13:32:00, ended at 2011-03-29 18:46:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.6 (percent)\n- Erythrocyte sedimentation rate: 24 (millimeter per hour)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.3 (percent)\n- Prothrombin time (PT): 19.6 (second)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 0.01 (nanogram per milliliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Body height: 5' 2\" (inch (US))\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.26 (millimole per liter)\n- INR in Platelet poor plasma by Coagulation assay: 1.8 (ratio)\n- Monocytes [#/volume] in Blood by Automated count: 1.30 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 13 (percent)\n- Neutrophils [#/volume] in Blood by Manual count: 4.3 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 67 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 84 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.7 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.4 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.7 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.2 (percent)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.9 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.34 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 24.5 (picogram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Complement C3 [Mass/volume] in Serum or Plasma: 112 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.15 (million per microliter)\n- MCV [Entitic volume] by Automated count: 76.4 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.8 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 98.5 (second)\n- Eosinophils/100 leukocytes in Blood by Manual count: 3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 15 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 8.16 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 85.8 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.1 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 519 (thousand per microliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.2 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.00 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.6 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 5.4 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n\n### Procedure\n- Ultrasound, pelvic (nonobstetric), real time with image documentation; complete\n- Radiologic examination, chest; single view, frontal\n- Total abdominal hysterectomy\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Other removal of both ovaries and tubes at same operative episode\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Pathology consultation during surgery; first tissue block, with frozen section(s), single specimen\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Ultrasound, transvaginal\n- Venous catheterization, not elsewhere classified\n- Injection of anesthetic agent into peripheral nerve for analgesia\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Excision of regional lymph nodes\n- Collection of venous blood by venipuncture\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n\n### Condition\n- Systemic lupus erythematosus\n- Primary malignant neoplasm of ovary\n- Fever\n- Osteoporosis\n- Pulmonary congestion and hypostasis\n- Hypercoagulability state\n- Peripheral vascular disease\n- Type 2 diabetes mellitus without complication\n- Diffuse spasm of esophagus\n- Disorder of uterus\n- Abdominal pain\n- Acute postoperative pain\n- Cyst of ovary\n- Infection due to Escherichia coli\n- Secondary malignant neoplastic disease\n- Urinary tract infectious disease\n- Noninflammatory disorder of the female genital organs\n- Coronary atherosclerosis\n- Transplanted kidney present\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2011-03-16, presumably until 2011-03-29\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2011-03-24, presumably until 2011-03-24\n- warfarin sodium 5 MG Oral Tablet, through Oral route, started on 2011-03-28, presumably until 2011-04-20, with quantity of 30.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. Follow up with the Anticoagulation Clinic regarding adjustment of your dosing. \n- acetaminophen 650 MG Rectal Suppository, through Rectal route, started on 2011-03-18, presumably until 2011-03-18\n- magnesium gluconate 500 MG Oral Tablet, through Oral route, started on 2011-03-28, presumably until 2011-03-29\n- zolpidem tartrate 5 MG Oral Tablet, through Oral route, started on 2011-03-16, presumably until 2011-03-16\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2011-03-16, presumably until 2011-03-29\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2011-03-16, presumably until 2011-03-29\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2011-03-17, presumably until 2011-03-17\n- 24 HR metoprolol succinate 25 MG Extended Release Oral Tablet, through Oral route, started on 2011-03-25, presumably until 2011-03-29\n- acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2011-03-16, presumably until 2011-09-25, with quantity of 40.0, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 to 6 hours as needed \n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2011-03-17, presumably until 2011-03-28\n- magnesium hydroxide 80 MG/ML Oral Suspension, through Oral route, started on 2011-03-17, presumably until 2011-03-17\n- warfarin sodium 4 MG Oral Tablet, through Oral route, started on 2011-03-26, presumably until 2011-03-27\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2011-03-16, presumably until 2011-03-29\n- levofloxacin 750 MG Oral Tablet, through Oral route, started on 2011-03-25, presumably until 2011-03-28\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2011-03-18, presumably until 2011-03-25\n- 1000 ML potassium chloride 0.02 MEQ/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2011-03-23, presumably until 2011-03-25\n- 2 ML ondansetron 2 MG/ML Injection, started on 2011-03-15, presumably until 2011-03-29\n- 1000 ML glucose 50 MG/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2011-03-16, presumably until 2011-03-16\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2011-03-16, presumably until 2011-03-16\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2011-03-15, presumably until 2011-03-18\n- 1 ML morphine sulfate 2 MG/ML Prefilled Syringe, started on 2011-03-15, presumably until 2011-03-15\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2011-03-16, presumably until 2011-03-22\n- 0.5 ML sumatriptan 12 MG/ML Injection, through Subcutaneous route, started on 2011-03-21, presumably until 2011-03-21\n- gabapentin 600 MG Oral Tablet, through Oral route, started on 2011-03-16, presumably until 2011-03-29\n- 0.6 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2011-03-29, presumably until 2011-04-20, with quantity of 28.0, with intended 3 refill(s). Instructions: inject 0.5 mL subcutaneous (under the skin) every 12 hours. The anticoagulation clinic will follow up with you regarding how long you need to continue the Lovenox. \n- 150 ML levofloxacin 5 MG/ML Injection, through Intravenous route, started on 2011-03-18, presumably until 2011-03-18\n- clopidogrel 75 MG Oral Tablet, through Oral route, started on 2011-03-29, presumably until 2011-03-29\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2011-03-18, presumably until 2011-03-29\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2011-03-16, presumably until 2011-03-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-03-31 13:18:14, ended at 2011-03-31 13:40:59\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Subsequent stage of staged operation\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-04-02 15:15:00, ended at 2011-04-02 16:50:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2.4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of ovary\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-04-02 16:51:00, ended at 2011-04-02 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- MCHC [Mass/volume] by Automated count: 31.0 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.4 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 602 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.52 (million per microliter)\n- MCH [Entitic mass] by Automated count: 23.1 (picogram)\n- Hemoglobin [Mass/volume] in Blood: 8.1 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 74.5 (femtoliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of ovary\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-04-06 14:08:59, ended at 2011-04-06 16:03:23\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Joint pain\n- Benign neoplasm of bone\n- Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-04-08 10:30:50, ended at 2011-04-08 13:26:27\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Noninflammatory disorder of the female genital organs\n- Joint pain\n- Primary diagnosis: Nausea\n- Chest pain\n- Synovial cyst of knee\n\n### Drug\n- metoclopramide 10 MG Oral Tablet, through Oral route, started on 2011-04-08, presumably until 2011-05-06, with quantity of 120.0, with intended 4 refill(s). Instructions: take 1 Tab by mouth 4 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-04-08 13:30:00, ended at 2011-04-08 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, any joint of lower extremity; without contrast material\n\n### Condition\n- Synovial cyst of knee\n- Joint pain\n- Knee joint effusion\n- Derangement of knee\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-04-12 10:13:11, ended at 2011-04-12 10:50:30\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-04-12 13:42:59, ended at 2011-04-12 15:36:57\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Injection(s); single tendon sheath, or ligament, aponeurosis (eg, plantar  fascia )\n\n### Condition\n- Acquired trigger finger\n- Degenerative joint disease of hand\n\n### Drug\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2011-04-12, presumably until 2011-04-12, with intended 0 refill(s). Instructions: 0.7 mL by Injection route One Time. \n- betamethasone 3 MG/ML / betamethasone acetate 3 MG/ML Injectable Suspension, started on 2011-04-12, presumably until 2011-04-12, with quantity of 1.0, with intended 0 refill(s). Instructions: 0.7 mL by Injection route One Time. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-04-12 13:44:00, ended at 2011-04-12 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, wrist; complete, minimum of 3 views\n\n### Condition\n- Systemic lupus erythematosus\n- Wrist joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2011-04-20 00:00:00, ended at 2011-04-20 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Subsequent stage of staged operation\n\n### Condition\n- No conditions.\n\n### Drug\n- warfarin sodium 2 MG Oral Tablet, through Oral route, presumably until 2012-02-14. Instructions: take 4 mg by mouth as directed. Take 4mg daily as directed by SHC OAC\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-04-20 13:52:00, ended at 2011-04-20 14:50:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Prothrombin time (PT): 17.7 (second)\n- INR in Platelet poor plasma by Coagulation assay: 1.5 (ratio)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Subsequent stage of staged operation\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-04-20 14:51:00, ended at 2011-04-20 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of artery\n- Venous thrombosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-04-22 13:15:00, ended at 2011-04-22 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2.205\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Breast lump\n- Primary malignant neoplasm of ovary\n\n### Drug\n- metoclopramide 10 MG Oral Tablet, through Oral route, presumably until 2011-10-25. Instructions: take  by mouth. ChemMapleton py only\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-04-30 00:00:00, ended at 2011-04-30 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-04-30 10:23:00, ended at 2011-04-30 10:44:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 115 (unit per liter)\n- Albumin [Mass/volume] in Urine: <5 (milligram per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 80 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.8 (percent)\n- MCV [Entitic volume] by Automated count: 72.7 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.5 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 67.5 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 148 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 68 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.6 (percent)\n- Platelets [#/volume] in Blood by Automated count: 365 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.5 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.6 (percent)\n- Hemoglobin [Mass/volume] in Blood: 8.2 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.75 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.83 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.1 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 58 (milligram per deciliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 0.7 (ratio)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.9 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.6 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 2.7 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Albumin/Creatinine [Mass Ratio] in Urine: <30 (milligram per gram)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.3 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.70 (million per microliter)\n- MCH [Entitic mass] by Automated count: 22.2 (picogram)\n- Triglyceride [Moles/volume] in Serum or Plasma: 48 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 30.5 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 72 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.81 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Senile osteoporosis\n- Postmenopausal state\n- Hyperlipidemia\n- Transplanted kidney present\n- Type 1 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-04-30 10:45:00, ended at 2011-04-30 11:07:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 16.3 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.70 (million per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 30.5 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.5 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.1 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 110 (unit per liter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.5 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.6 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.75 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 145 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 74 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.9 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.82 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 72.7 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.81 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.6 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 22.2 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 67.5 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 8.2 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 365 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 47 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-04-30 11:08:00, ended at 2011-04-30 13:28:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)\n\n### Condition\n- Disorder of bone and articular cartilage\n- Osteoporosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-04-30 13:29:00, ended at 2011-04-30 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2.402\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of ovary\n- Hyperlipidemia\n- Postmenopausal state\n- Transplanted kidney present\n- Type 1 diabetes mellitus without complication\n- Senile osteoporosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-05-03 10:30:53, ended at 2011-05-03 11:32:46\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Primary malignant neoplasm of ovary\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-05-05 00:00:00, ended at 2011-05-05 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Closed fracture of carpal bone\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-05-05 00:00:00, ended at 2011-05-05 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2011-05-05, presumably until 2011-09-07, with intended 6 refill(s). Instructions: take 2 Tabs by mouth 2 times a day. Take the day before taxotere, the day of taxotere and the day after taxotere\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-05-06 09:20:00, ended at 2011-05-06 17:11:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- Insertion of tunneled centrally inserted central venous access device, with subcutaneous port; age 5 years or older\n- Insertion of graft for vascular access\n- Fluoroscopic guidance for central venous access device placement, replacement (catheter only or complete), or removal (includes fluoroscopic guidance for vascular access and catheter manipulation, any necessary contrast injections through access site or c\n\n### Condition\n- Systemic lupus erythematosus\n- Primary malignant neoplasm of ovary\n- Transplanted kidney present\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, through Oral route, presumably until 2013-04-20. Instructions: take 1 mg by mouth 2 times a day. 1 tab in am 2 tabs PM\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2011-05-06, presumably until 2011-05-06\n- gabapentin 300 MG Oral Capsule, through Oral route, presumably until 2011-06-23. Instructions: take 300 mg by mouth 3 times a day.\n- 24 HR diltiazem hydrochloride 120 MG Extended Release Oral Capsule, through Oral route, presumably until 2011-09-29. Instructions: take 120 mg by mouth daily.\n- mycophenolate mofetil 500 MG Oral Tablet, through Oral route, presumably until 2011-12-03. Instructions: take 250 mg by mouth 2 times a day.\n- clopidogrel 75 MG Oral Tablet, through Oral route, presumably until 2015-01-23. Instructions: take 75 mg by mouth every morning.\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, presumably until 2011-09-24. Instructions: take 1 Tab by mouth as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-05-07 00:00:00, ended at 2011-05-07 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of ovary\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2011-05-07, presumably until 2011-09-15, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed.\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2011-05-07, presumably until 2011-09-15, with intended 5 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed.\n- prochlorperazine 10 MG Oral Tablet, through Oral route, started on 2011-05-07, presumably until 2011-12-24, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Nausea/Vomiting.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-05-07 12:34:00, ended at 2011-05-07 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.91 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.90 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.10 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 352 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 7.6 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.4 (percent)\n- MCV [Entitic volume] by Automated count: 71.9 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.9 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 31.0 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 83.3 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.43 (million per microliter)\n- MCH [Entitic mass] by Automated count: 22.3 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.3 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 24.7 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 118 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.0 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 105 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chest pain\n- Primary malignant neoplasm of ovary\n- Proliferative retinopathy due to diabetes mellitus\n- Coronary atherosclerosis\n- Disorder of eye due to type 1 diabetes mellitus\n- Vitreous degeneration\n- Degenerative joint disease of hand\n- Pain in limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-05-08 12:00:00, ended at 2011-05-08 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Transfusion, blood or blood components\n\n### Condition\n- No conditions.\n\n### Drug\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2011-05-08, presumably until 2011-05-08\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-05-10 00:00:00, ended at 2011-05-10 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-05-10 00:00:00, ended at 2011-05-10 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-05-11 00:00:00, ended at 2011-05-11 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Postprocedural state finding\n- Peripheral vascular disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-05-11 10:30:00, ended at 2011-05-11 14:12:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of lower extremity arteries or arterial bypass grafts; unilateral or limited study\n\n### Condition\n- Synovial cyst of knee\n- Joint pain\n- Atherosclerosis of arteries of the extremities\n- Intermittent claudication\n- Peripheral vascular disease\n- Postprocedural state finding\n- Benign neoplasm of bone\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-05-11 11:25:46, ended at 2011-05-11 14:17:17\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Peripheral vascular disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-05-11 14:13:00, ended at 2011-05-11 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, wrist; 2 views\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-05-17 11:43:00, ended at 2011-05-17 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- INR in Platelet poor plasma by Coagulation assay: 1.9 (ratio)\n- Prothrombin time (PT): 20.7 (second)\n\n### Procedure\n- Subsequent stage of staged operation\n- Collection of venous blood by venipuncture\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-05-21 13:53:32, ended at 2011-05-21 15:19:01\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of left eye: 12 (millimeter mercury column)\n- Intraocular pressure of right eye: 12 (millimeter mercury column)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- moxifloxacin 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2011-05-21, presumably until 2011-07-05, with intended 0 refill(s). Instructions: instill 1 Drop to left eye 4 times a day. For 5 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-05-24 13:42:16, ended at 2011-05-24 15:04:23\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Degenerative joint disease of hand\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-05-24 13:43:00, ended at 2011-05-24 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, wrist; complete, minimum of 3 views\n\n### Condition\n- Wrist joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2011-05-25 00:00:00, ended at 2011-05-25 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- 24 HR metoprolol succinate 25 MG Extended Release Oral Tablet, through Oral route, started on 2011-05-25, presumably until 2011-12-22, with intended 6 refill(s). Instructions: take 1 Tab by mouth 2 times a day. 25mg in am, 50mg in pm\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-05-25 13:30:00, ended at 2011-05-25 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anemia in chronic kidney disease\n- Chronic kidney disease stage 3\n\n### Drug\n- 0.5 ML darbepoetin alfa 0.2 MG/ML Prefilled Syringe, started on 2011-05-25, presumably until 2011-05-25\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2011-05-25, presumably until 2011-05-25\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-05-28 09:20:00, ended at 2011-05-28 09:55:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n- Systemic lupus erythematosus\n- Primary malignant neoplasm of ovary\n- Transplanted kidney present\n- Type 1 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-05-28 09:56:00, ended at 2011-05-28 10:29:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin/Creatinine [Mass Ratio] in Urine: 21 (milligram per gram)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.1 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 24.0 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 83.8 (percent)\n- Erythrocyte sedimentation rate: 9 (millimeter per hour)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.3 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.3 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 3.7 (nanogram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 24.6 (percent)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.7 (percent)\n- Prothrombin time (PT): 25.7 (second)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 0.8 (ratio)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.06 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.57 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.6 (percent)\n- MCV [Entitic volume] by Automated count: 74.3 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 417 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: <2.0 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Albumin [Mass/volume] in Urine: 8 (milligram per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 69 (milligram per deciliter)\n- Complement C3 [Mass/volume] in Serum or Plasma: 116 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.62 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.8 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 7.38 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 76 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 36 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 96 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 168 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.5 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 133 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.5 (ratio)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.5 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n\n### Procedure\n- Subsequent stage of staged operation\n\n### Condition\n- Systemic lupus erythematosus\n- Primary malignant neoplasm of ovary\n- Transplanted kidney present\n- Type 1 diabetes mellitus without complication\n- Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-05-28 10:30:00, ended at 2011-05-28 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1.811\" (inch (US))\n\n### Procedure\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n\n### Condition\n- Primary malignant neoplasm of ovary\n\n### Drug\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2011-05-28, presumably until 2011-05-28\n- lidocaine 25 MG/ML / prilocaine 25 MG/ML Topical Cream, through Topical route, started on 2011-05-28, presumably until 2012-05-27, with intended 3 refill(s). Instructions: by Topical route as needed (apply dime size amount to port site at least 30mins prior to needle insertion).\n- 2 ML ondansetron 2 MG/ML Injection, started on 2011-05-28, presumably until 2011-05-28\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2011-05-28, presumably until 2011-05-28\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-06-08 13:09:34, ended at 2011-06-08 13:44:59\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anemia in chronic kidney disease\n- Transplanted kidney present\n- Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-06-18 09:20:00, ended at 2011-06-18 09:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.55 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.0 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 74.8 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- Prothrombin time (PT): 20.4 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.3 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Platelets [#/volume] in Blood by Automated count: 400 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.31 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.35 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 89.9 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 97 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 23.7 (percent)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.3 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.8 (ratio)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.1 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 121 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7.0 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 24.0 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 2.8 (percent)\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n- Subsequent stage of staged operation\n\n### Condition\n- Primary malignant neoplasm of ovary\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2011-06-18, presumably until 2011-06-18\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2011-06-18, presumably until 2011-06-18\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-06-18 10:00:00, ended at 2011-06-18 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1.811\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of bone and articular cartilage\n- Osteoporosis\n- Pain in limb\n- Primary malignant neoplasm of ovary\n- Urinary tract infectious disease\n- Type 2 diabetes mellitus without complication\n- Renal disorder due to type 1 diabetes mellitus\n- Type 1 diabetes mellitus without complication\n- Systemic lupus erythematosus\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-06-21 14:57:35, ended at 2011-06-21 16:16:34\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n- Renal disorder due to type 1 diabetes mellitus\n- Coronary arteriosclerosis\n- Essential hypertension\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-06-21 16:51:00, ended at 2011-06-21 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, wrist; complete, minimum of 3 views\n\n### Condition\n- Wrist joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2011-06-23 00:00:00, ended at 2011-06-23 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Peripheral nerve disease\n\n### Drug\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2011-06-23, presumably until 2011-07-27, with intended 4 refill(s). Instructions: take 1 Cap by mouth 3 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2011-06-24 15:58:00, ended at 2011-06-25 00:24:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Manual count: 2 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.4 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.0 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 8 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Manual count: 0.0 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.92 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 1.5 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- Prothrombin time (PT): 20.7 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 127 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.3 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 60 (percent)\n- MCH [Entitic mass] by Automated count: 23.7 (picogram)\n- Monocytes [#/volume] in Blood by Manual count: 0.1 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 23.9 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.9 (ratio)\n- Platelets [#/volume] in Blood by Automated count: 246 (thousand per microliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 22 (percent)\n- MCV [Entitic volume] by Automated count: 74.1 (femtoliter)\n- Neutrophils [#/volume] in Blood by Manual count: 1.0 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 96 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.0 (percent)\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Hyperlipidemia\n- Primary malignant neoplasm of ovary\n- Coronary atherosclerosis\n- Precordial pain\n- Backache\n- Essential hypertension\n- Ulcerative colitis\n- Iron deficiency anemia\n- Chest pain\n- Gastroesophageal reflux disease\n- Renal disorder due to type 1 diabetes mellitus\n- Systemic lupus erythematosus\n\n### Drug\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2011-06-24, presumably until 2011-06-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-06-27 12:57:00, ended at 2011-06-27 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, upper extremity; without contrast material\n- 3D rendering with interpretation and reporting of computed tomography, magnetic resonance imaging, ultrasound, or other tomographic modality with image postprocessing under concurrent supervision; requiring image postprocessing on an independent workstati\n\n### Condition\n- Osteoarthritis of wrist\n- Imaging of musculoskeletal system abnormal\n- Disorder of wrist joint\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-06-29 15:20:13, ended at 2011-06-29 16:18:06\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of left eye: 11 (millimeter mercury column)\n- Intraocular pressure of right eye: 11 (millimeter mercury column)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of eyelid\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-07-05 13:10:31, ended at 2011-07-05 14:51:41\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Degenerative joint disease of hand\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-07-06 13:40:33, ended at 2011-07-06 14:59:10\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Gastroesophageal reflux disease\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2011-07-06, presumably until 2011-07-09, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-07-09 00:00:00, ended at 2011-07-09 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of ovary\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-07-09 10:12:00, ended at 2011-07-09 10:19:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.9 (ratio)\n- MCV [Entitic volume] by Automated count: 74.3 (femtoliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.3 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.27 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 133 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.7 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 24.7 (picogram)\n- Prothrombin time (PT): 20.9 (second)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 102 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 116 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.1 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.37 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 93.4 (percent)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.48 (million per microliter)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 371 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 5.7 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 24.4 (percent)\n\n### Procedure\n- Subsequent stage of staged operation\n\n### Condition\n- Systemic lupus erythematosus\n- Degenerative joint disease of hand\n- Primary malignant neoplasm of ovary\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-07-09 10:20:00, ended at 2011-07-09 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1.811\" (inch (US))\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n\n### Condition\n- Primary malignant neoplasm of ovary\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2011-07-09, presumably until 2011-07-09\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2011-07-09, presumably until 2011-07-09\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2011-07-09, presumably until 2011-07-09\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-07-20 12:18:00, ended at 2011-07-20 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Arthrocentesis, aspiration and/or injection, major joint or bursa (eg, shoulder, hip, knee, subacromial bursa); without ultrasound guidance\n- Ultrasonic guidance for needle placement (eg, biopsy, aspiration, injection, localization device), imaging supervision and interpretation\n\n### Condition\n- Synovial cyst of knee\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2011-07-21 00:00:00, ended at 2011-07-21 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Systemic lupus erythematosus\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2011-07-21, presumably until 2011-09-07, with intended 6 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2011-07-21 00:00:00, ended at 2011-07-21 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Diffuse spasm of esophagus\n\n### Drug\n- isosorbide dinitrate 30 MG Oral Tablet, through Oral route, started on 2011-07-21, presumably until 2012-02-29, with intended 6 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-07-23 10:09:00, ended at 2011-07-23 10:30:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- INR in Platelet poor plasma by Coagulation assay: 5.1 (ratio)\n- Prothrombin time (PT): 44.8 (second)\n\n### Procedure\n- Subsequent stage of staged operation\n- Collection of venous blood by venipuncture\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-07-23 10:31:00, ended at 2011-07-23 12:21:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of ovary\n- Systemic lupus erythematosus\n- Osteoporosis\n- Transplanted kidney present\n- Type 1 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-07-23 13:00:00, ended at 2011-07-23 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n- Primary malignant neoplasm of ovary\n- Osteoporosis\n- Systemic lupus erythematosus\n- Type 1 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-07-26 00:00:00, ended at 2011-07-26 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of ovary\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-07-26 10:22:13, ended at 2011-07-26 13:27:48\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of right eye: 12 (millimeter mercury column)\n- Intraocular pressure of left eye: 13 (millimeter mercury column)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of eyelid\n- Proliferative retinopathy due to diabetes mellitus\n- Epiretinal membrane\n- After-cataract with vision obscured following extraction of cataract\n- Vitreous degeneration\n- Tear film insufficiency\n- Disorder of eye due to type 1 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-07-27 00:00:00, ended at 2011-07-27 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Peripheral nerve disease\n\n### Drug\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2011-07-27, presumably until 2011-08-17, with intended 4 refill(s). Instructions: take 1 Cap by mouth 4 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-07-30 00:00:00, ended at 2011-07-30 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of ovary\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-07-30 09:30:00, ended at 2011-07-30 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.27 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.1 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 132 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.32 (million per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.9 (ratio)\n- MCHC [Mass/volume] by Automated count: 31.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 76.5 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 88.7 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 21 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.47 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7.2 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 24.9 (percent)\n- Prothrombin time (PT): 20.8 (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Body height: 5' 1.417\" (inch (US))\n- Glucose [Mass/volume] in Serum or Plasma: 121 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.6 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 89 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 10.4 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 392 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 24.1 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 5.81 (thousand per microliter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n\n### Condition\n- Primary malignant neoplasm of ovary\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2011-07-30, presumably until 2011-07-30\n- diphenhydramine hydrochloride 2.5 MG/ML Oral Solution, through Oral route, started on 2011-07-30, presumably until 2011-09-07, with intended 3 refill(s). Instructions: take 5 mL by mouth every 6 hours as needed. Mix 1:1 with Nystatin suspension.\n- triamcinolone acetonide 0.001 MG/MG Topical Ointment, through Topical route, presumably until 2012-07-21. Instructions: 1 Applicator by Topical route 2 times a day as needed.\n- mineral oil 0.425 MG/MG / petrolatum 0.568 MG/MG Ophthalmic Ointment, through Intraocular route, presumably until 2013-08-27. Instructions: 1 Drop by Ophthalmic route every bedtime.\n- nystatin 100000 UNT/ML Oral Suspension, through Oral route, started on 2011-07-30, presumably until 2011-12-24, with intended 3 refill(s). Instructions: take 5 mL by mouth 4 times a day. Mix 1:1 with Benadryl syrup.\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2011-07-30, presumably until 2011-07-30\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2011-07-30, presumably until 2011-07-30\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2011-07-30, presumably until 2011-07-30\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-08-11 13:26:02, ended at 2011-08-11 14:26:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of eye due to type 1 diabetes mellitus\n- Proliferative retinopathy due to diabetes mellitus\n- Macular edema due to diabetes mellitus\n- Vitreous degeneration\n- Epiretinal membrane\n- Tear film insufficiency\n- After-cataract with vision obscured following extraction of cataract\n- Primary diagnosis: Diarrhea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2011-08-13 00:00:00, ended at 2011-08-13 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of eyelid\n\n### Drug\n- doxycycline monohydrate 100 MG Oral Capsule, through Oral route, started on 2011-08-13, presumably until 2011-09-02, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-08-13 11:09:00, ended at 2011-08-13 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.3 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.4 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 71 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.22 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 73 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 30.7 (percent)\n- MCV [Entitic volume] by Automated count: 74.4 (femtoliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 54 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 1.3 (ratio)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.5 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.80 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 326 (thousand per microliter)\n- Prothrombin time (PT): 48.3 (second)\n- Albumin [Mass/volume] in Urine: <5 (milligram per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 98 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 20 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.79 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 6 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 38.2 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 138 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 56 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 24.4 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 0.99 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 11.0 (nanogram per milliliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 25.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 2.6 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 30.9 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 130 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 82 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.0 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 5.6 (ratio)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Albumin/Creatinine [Mass Ratio] in Urine: <30 (milligram per gram)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.0 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Subsequent stage of staged operation\n\n### Condition\n- Type 1 diabetes mellitus without complication\n- Transplanted kidney present\n- Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2011-08-17 00:00:00, ended at 2011-08-17 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Peripheral nerve disease\n\n### Drug\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2011-08-17, presumably until 2012-01-26, with intended 4 refill(s). Instructions: take 1 Cap by mouth 4 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-08-17 14:04:02, ended at 2011-08-17 14:52:09\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Joint pain\n- Synovial cyst of knee\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-08-17 15:25:00, ended at 2011-08-17 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- INR in Platelet poor plasma by Coagulation assay: 5.9 (ratio)\n- Prothrombin time (PT): 50.5 (second)\n\n### Procedure\n- Subsequent stage of staged operation\n\n### Condition\n- Joint pain\n- Macular edema due to diabetes mellitus\n- Synovial cyst of knee\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-08-17 15:51:28, ended at 2011-08-17 16:23:53\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of right eye: 17 (millimeter mercury column)\n- Intraocular pressure of left eye: 17 (millimeter mercury column)\n\n### Procedure\n- Intravitreal injection of a pharmacologic agent (separate procedure)\n\n### Condition\n- Primary diagnosis: Macular edema due to diabetes mellitus\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- lidocaine hydrochloride 0.035 MG/MG Ophthalmic Gel, through Intraocular route, started on 2011-08-17, presumably until 2011-09-21, with intended 0 refill(s). Instructions: instill 2 Drops to left eye One Time.\n- proparacaine hydrochloride 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2011-08-17, presumably until 2011-09-21, with intended 0 refill(s). Instructions: instill 1 Drop to left eye One Time.\n- ofloxacin 3 MG/ML Ophthalmic Solution, through Intraocular route, started on 2011-08-17, presumably until 2011-09-21, with intended 0 refill(s). Instructions: instill 1 Drop to left eye One Time.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-08-20 11:24:00, ended at 2011-08-20 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 23.0 (picogram)\n- MCHC [Mass/volume] by Automated count: 30.5 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.8 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.27 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 368 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.9 (ratio)\n- Prothrombin time (PT): 20.5 (second)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 39 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.1 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 93 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Body height: 5' 1.417\" (inch (US))\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 3.3 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 95.3 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 75.4 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 7.73 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 24.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.21 (million per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 110 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Subsequent stage of staged operation\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Systemic lupus erythematosus\n- Primary malignant neoplasm of ovary\n- Transplanted kidney present\n- Type 1 diabetes mellitus without complication\n- Osteoporosis\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2011-08-20, presumably until 2011-08-20\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2011-08-20, presumably until 2011-08-20\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2011-08-20, presumably until 2011-08-20\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-08-23 15:16:43, ended at 2011-08-23 16:48:02\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of right eye: 14 (millimeter mercury column)\n- Intraocular pressure of left eye: 13 (millimeter mercury column)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Macular edema due to diabetes mellitus\n- Type 2 diabetes mellitus without complication\n- Eye / vision finding\n- Tear film insufficiency\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-08-25 00:00:00, ended at 2011-08-25 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of ovary\n\n### Drug\n- lidocaine hydrochloride 20 MG/ML Mucous Membrane Topical Solution, through Oral route, started on 2011-08-25, presumably until 2011-12-24, with intended 1 refill(s). Instructions: take 10 mL by mouth 4 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-01 10:02:00, ended at 2011-09-01 13:49:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Glucose [Mass/volume] in Serum or Plasma: 84 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.2 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 7.0 (ratio)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.44 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 23.8 (picogram)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 12.1 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.8 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 119 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.15 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.72 (thousand per microliter)\n- Prothrombin time (PT): 57.4 (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 110 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.1 (gram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 51 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.3 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 247 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 22.5 (percent)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 62.9 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 44 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.2 (percent)\n- MCHC [Mass/volume] by Automated count: 31.4 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.86 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 26.5 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.4 (percent)\n- MCV [Entitic volume] by Automated count: 76.0 (femtoliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Subsequent stage of staged operation\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-01 13:50:00, ended at 2011-09-01 17:02:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Bone length studies (orthoroentgenogram, scanogram)\n- Radiologic examination, knee; 3 views\n\n### Condition\n- Atherosclerosis of artery\n- Joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-01 17:03:00, ended at 2011-09-01 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of extremity veins including responses to compression and other maneuvers; unilateral or limited study\n\n### Condition\n- Pain in limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-09-02 00:00:00, ended at 2011-09-02 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Diarrhea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-09-02 11:18:32, ended at 2011-09-02 13:52:02\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Urinary tract infectious disease\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- ciprofloxacin 250 MG Oral Tablet, through Oral route, started on 2011-09-02, presumably until 2011-09-07, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-02 13:38:00, ended at 2011-09-02 13:38:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n- Urinary tract infectious disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-02 13:39:00, ended at 2011-09-02 14:38:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- INR in Platelet poor plasma by Coagulation assay: 7.2 (ratio)\n- Prothrombin time (PT): 58.9 (second)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Subsequent stage of staged operation\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-02 14:39:00, ended at 2011-09-02 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, any joint of lower extremity; without contrast material\n\n### Condition\n- Synovial cyst of knee\n- Knee joint effusion\n- Edema\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-06 09:45:00, ended at 2011-09-06 09:56:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Prothrombin time (PT): 39.5 (second)\n- INR in Platelet poor plasma by Coagulation assay: 4.3 (ratio)\n\n### Procedure\n- Subsequent stage of staged operation\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-06 09:57:00, ended at 2011-09-06 17:30:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2011-09-06, presumably until 2011-09-06\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2011-09-06 17:31:00, ended at 2011-09-07 19:20:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 23.6 (nanogram per milliliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.1 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 22.3 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.1 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 8.5 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 4.7 (ratio)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.3 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 24.4 (picogram)\n- Monocytes [#/volume] in Blood by Manual count: 0.9 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 26 (percent)\n- Platelets [#/volume] in Blood by Automated count: 329 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.2 (gram per deciliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 76.0 (femtoliter)\n- Neutrophils [#/volume] in Blood by Manual count: 1.6 (thousand per microliter)\n- Prothrombin time (PT): 42.4 (second)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 0.03 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.4 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 24 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 107 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Manual count: 2 (percent)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.8 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 127 (millimole per liter)\n- Body height: 5' 2\" (inch (US))\n- Erythrocytes [#/volume] in Blood by Automated count: 3.59 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.8 (percent)\n- MCHC [Mass/volume] by Automated count: 32.0 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 36 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Computed tomography, head or brain; without contrast material\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Disorder of plasma protein metabolism\n- Nonproliferative retinopathy due to diabetes mellitus\n- Peripheral nerve disease\n- Disorder of eye due to type 1 diabetes mellitus\n- Transplanted kidney present\n- Cyst of ovary\n- Malnutrition (calorie)\n- Diffuse spasm of esophagus\n- Urinary tract infectious disease\n- Angina pectoris\n- Hypertensive heart disease without congestive heart failure\n- Anemia\n- Hypo-osmolality and or hyponatremia\n- Aplastic anemia\n- Disorder of nervous system due to diabetes mellitus\n- Headache\n- Edema\n- Primary malignant neoplasm of ovary\n- Disorder of function of stomach\n- Systemic lupus erythematosus\n\n### Drug\n- famotidine 40 MG Oral Tablet, through Oral route, started on 2011-09-07, presumably until 2011-09-07\n- isosorbide dinitrate 30 MG Oral Tablet, through Oral route, started on 2011-09-07, presumably until 2011-09-07. Instructions: take 1 Tab by mouth 2 times a day.\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2011-09-07, presumably until 2011-09-07\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2011-09-07, presumably until 2011-09-07. Instructions: take 2 mg by mouth 2 times a day.\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2011-09-06, presumably until 2011-09-06\n- ciprofloxacin 250 MG Oral Tablet, through Oral route, started on 2011-09-07, presumably until 2011-09-07. Instructions: take 1 Tab by mouth 2 times a day.\n- 24 HR metoprolol succinate 25 MG Extended Release Oral Tablet, through Oral route, started on 2011-09-07, presumably until 2011-09-07. Instructions: take 1 Tab by mouth 2 times a day. 25mg in am, 50mg in pm\n- furosemide 40 MG Oral Tablet, through Oral route, started on 2011-09-07, presumably until 2012-05-02, with intended 6 refill(s). Instructions: take 0.5 Tabs by mouth 2 times a day.\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2011-09-07, presumably until 2011-09-07. Instructions: take 1 Tab by mouth daily.\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2011-09-07, presumably until 2011-09-07. Instructions: take 1 Cap by mouth 4 times a day.\n- 24 HR diltiazem hydrochloride 120 MG Extended Release Oral Capsule, through Oral route, started on 2011-09-07, presumably until 2011-09-07. Instructions: take 120 mg by mouth daily.\n- nitroglycerin 0.4 MG Sublingual Tablet, through Sublingual route, started on 2011-09-07, presumably until 2011-09-07. Instructions: 1 Tab by Sublingual route as needed\n- clopidogrel 75 MG Oral Tablet, through Oral route, started on 2011-09-07, presumably until 2011-09-07. Instructions: take 75 mg by mouth daily.\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2011-09-07, presumably until 2011-09-07. Instructions: take 1 Tab by mouth as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-09-07 12:46:03, ended at 2011-09-07 17:09:56\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Ischemic heart disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-10 11:00:00, ended at 2011-09-10 12:26:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1.417\" (inch (US))\n\n### Procedure\n- Chemotherapy follow-up\n\n### Condition\n- Primary malignant neoplasm of ovary\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-10 12:27:00, ended at 2011-09-10 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of ovary\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-10 14:00:46, ended at 2011-09-10 14:23:22\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Subsequent stage of staged operation\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-09-14 00:00:00, ended at 2011-09-14 10:31:59\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of right eye: 12 (millimeter mercury column)\n- Intraocular pressure of left eye: 14 (millimeter mercury column)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Macular edema due to diabetes mellitus\n- After-cataract with vision obscured following extraction of cataract\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- prednisolone acetate 10 MG/ML Ophthalmic Suspension, through Intraocular route, started on 2011-09-14, presumably until 2011-09-28, with intended 1 refill(s). Instructions: instill 1 Drop to right eye 4 times a day. Begin using 4 days prior to laser and continue 4 days after laser\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-14 14:59:06, ended at 2011-09-14 14:59:14\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Subsequent stage of staged operation\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-15 11:53:00, ended at 2011-09-15 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, femur, 2 views\n\n### Condition\n- Disorder of bone and articular cartilage\n- Joint pain of pelvic region\n- Atherosclerosis of arteries of the extremities\n- Pain in limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-21 12:02:00, ended at 2011-09-21 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Prothrombin time (PT): 28.2 (second)\n- INR in Platelet poor plasma by Coagulation assay: 2.8 (ratio)\n\n### Procedure\n- Subsequent stage of staged operation\n- Collection of venous blood by venipuncture\n\n### Condition\n- Macular edema due to diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-09-21 14:08:31, ended at 2011-09-21 15:00:46\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Arthrocentesis, aspiration and/or injection, major joint or bursa (eg, shoulder, hip, knee, subacromial bursa); without ultrasound guidance\n\n### Condition\n- Primary diagnosis: Localized, primary osteoarthritis\n- Primary diagnosis: Osteoarthritis of knee\n\n### Drug\n- bupivacaine hydrochloride 2.5 MG/ML Injectable Solution, started on 2011-09-29, presumably until 2011-09-29, with intended 0 refill(s). Instructions: 10 mL by Injection route One Time.\n- triamcinolone acetonide 40 MG/ML Injectable Suspension, started on 2011-09-29, presumably until 2011-09-29, with intended 0 refill(s). Instructions: 1 mL by Injection route One Time.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2011-09-24 00:00:00, ended at 2011-09-24 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2011-09-24, presumably until 2012-03-13, with intended 2 refill(s). Instructions: take 500 mg by mouth as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-24 11:23:00, ended at 2011-09-24 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Prothrombin time (PT): 41.1 (second)\n- INR in Platelet poor plasma by Coagulation assay: 4.6 (ratio)\n\n### Procedure\n- Subsequent stage of staged operation\n- Collection of venous blood by venipuncture\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-28 11:59:00, ended at 2011-09-28 12:54:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.2 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 131 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.2 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 25.0 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.91 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 79.9 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 124 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.6 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.47 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 89 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 24.1 (percent)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.5 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.2 (percent)\n- MCV [Entitic volume] by Automated count: 76.8 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.78 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.68 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.6 (percent)\n- Platelets [#/volume] in Blood by Automated count: 376 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of ovary\n- Macular edema due to diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-28 12:55:00, ended at 2011-09-28 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Mammography; bilateral\n- Computer-aided detection (computer algorithm analysis of digital image data for lesion detection) with further review for interpretation, with or without digitization of film radiographic images; diagnostic mammography (List separately in addition to code\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2011-09-29 00:00:00, ended at 2011-09-29 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Gastroesophageal reflux disease\n- Diffuse spasm of esophagus\n\n### Drug\n- dexlansoprazole 30 MG Delayed Release Oral Capsule, through Oral route, started on 2011-09-29, presumably until 2012-05-25, with intended 11 refill(s). Instructions: take 30 mg by mouth 2 times a day.\n- 24 HR diltiazem hydrochloride 120 MG Extended Release Oral Capsule, through Oral route, started on 2011-09-29, presumably until 2012-01-22, with intended 3 refill(s). Instructions: take 1 Cap by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-09-30 09:45:43, ended at 2011-09-30 14:23:25\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malaise\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-30 11:00:00, ended at 2011-09-30 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Prothrombin time (PT): 21.5 (second)\n- INR in Platelet poor plasma by Coagulation assay: 2.0 (ratio)\n\n### Procedure\n- Subsequent stage of staged operation\n- Collection of venous blood by venipuncture\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-10-01 00:00:00, ended at 2011-10-01 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of ovary\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-10-01 09:09:00, ended at 2011-10-01 09:19:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Tacrolimus [Mass/volume] in Blood: 9.5 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n- Urinary tract infectious disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-10-01 09:20:00, ended at 2011-10-01 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n- Systemic lupus erythematosus\n- Type 1 diabetes mellitus without complication\n- Osteoporosis\n- Primary malignant neoplasm of ovary\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-10-08 09:35:00, ended at 2011-10-08 10:18:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.7 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.2 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 12.3 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 24.4 (picogram)\n- MCHC [Mass/volume] by Automated count: 32.2 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 67.7 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 2.7 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.8 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 23.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 82 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.4 (ratio)\n- MCV [Entitic volume] by Automated count: 75.9 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.30 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 301 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 3.9 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 103 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 131 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.86 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.60 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 17.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.78 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.9 (thousand per microliter)\n- Prothrombin time (PT): 24.7 (second)\n- Triglyceride [Moles/volume] in Serum or Plasma: 47 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n\n### Procedure\n- Subsequent stage of staged operation\n\n### Condition\n- End-stage renal disease\n- Transplanted kidney present\n- Acquired absence of cervix and uterus\n- Renal disorder due to type 1 diabetes mellitus\n- Systemic lupus erythematosus\n- Chronic glomerulonephritis associated with another disorder\n- Primary malignant neoplasm of ovary\n- Acquired absence of genital organ\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-10-08 10:22:00, ended at 2011-10-08 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2011-10-08, presumably until 2011-10-08\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-10-11 13:05:50, ended at 2011-10-11 14:34:36\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ankylosis of joint\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-10-11 13:24:00, ended at 2011-10-11 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, wrist; complete, minimum of 3 views\n\n### Condition\n- Wrist joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2011-10-18 00:00:00, ended at 2011-10-18 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Insomnia\n\n### Drug\n- zolpidem tartrate 10 MG Oral Tablet, through Oral route, started on 2011-10-18, presumably until 2012-10-31, with intended 11 refill(s). Instructions: take 1 Tab by mouth Every Day. Take as needed for sleep\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-10-18 11:05:57, ended at 2011-10-18 13:24:19\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malnutrition (calorie)\n- Systemic lupus erythematosus\n- Hypo-osmolality and or hyponatremia\n- Renal disorder due to type 1 diabetes mellitus\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-10-18 12:01:07, ended at 2011-10-18 13:25:15\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-10-18 14:10:00, ended at 2011-10-18 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance imaging, breast, without and/or with contrast material(s); bilateral\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-10-22 12:14:00, ended at 2011-10-22 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- INR in Platelet poor plasma by Coagulation assay: 2.4 (ratio)\n- Complement C3 [Mass/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 17 (millimeter per hour)\n- C reactive protein [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Prothrombin time (PT): 25.3 (second)\n\n### Procedure\n- Subsequent stage of staged operation\n\n### Condition\n- Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-10-25 13:17:00, ended at 2011-10-25 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1.614\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Breast lump\n- Primary malignant neoplasm of ovary\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-10-26 15:08:29, ended at 2011-10-26 16:19:23\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of left eye: 13 (millimeter mercury column)\n- Intraocular pressure of right eye: 14 (millimeter mercury column)\n\n### Procedure\n- Intravitreal injection of a pharmacologic agent (separate procedure)\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Primary diagnosis: Macular edema due to diabetes mellitus\n\n### Drug\n- lidocaine hydrochloride 0.035 MG/MG Ophthalmic Gel, through Intraocular route, started on 2011-10-26, presumably until 2011-11-03, with intended 0 refill(s). Instructions: instill 2 Drops to right eye One Time.\n- proparacaine hydrochloride 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2011-10-26, presumably until 2011-11-03, with intended 0 refill(s). Instructions: instill 1 Drop to right eye One Time.\n- ofloxacin 3 MG/ML Ophthalmic Solution, through Intraocular route, started on 2011-10-26, presumably until 2011-11-03, with intended 0 refill(s). Instructions: instill 1 Drop to right eye One Time.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-11-02 10:42:00, ended at 2011-11-02 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of lower extremity arteries or arterial bypass grafts; unilateral or limited study\n\n### Condition\n- Dysphagia\n- Chest pain\n- Peripheral vascular disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-11-02 13:19:36, ended at 2011-11-02 14:09:32\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Peripheral vascular disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-11-02 15:40:47, ended at 2011-11-02 16:20:17\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Diffuse spasm of esophagus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-11-03 10:24:48, ended at 2011-11-03 12:34:58\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of left eye: 16 (millimeter mercury column)\n- Intraocular pressure of right eye: 18 (millimeter mercury column)\n\n### Procedure\n- Intravitreal injection of a pharmacologic agent (separate procedure)\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Primary diagnosis: Macular edema due to diabetes mellitus\n\n### Drug\n- lidocaine hydrochloride 0.035 MG/MG Ophthalmic Gel, through Intraocular route, started on 2011-11-03, presumably until 2011-12-01, with intended 0 refill(s). Instructions: instill 2 Drops to left eye One Time.\n- proparacaine hydrochloride 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2011-11-03, presumably until 2011-12-01, with intended 0 refill(s). Instructions: instill 1 Drop to left eye One Time.\n- ofloxacin 3 MG/ML Ophthalmic Solution, through Intraocular route, started on 2011-11-03, presumably until 2011-12-01, with intended 0 refill(s). Instructions: instill 1 Drop to left eye One Time.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-11-09 13:57:36, ended at 2011-11-09 16:31:07\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of musculoskeletal system\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2011-11-22 00:00:00, ended at 2011-11-22 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, started on 2011-11-22, presumably until 2011-12-24, with intended 10 refill(s). Instructions: TAKE 3 CAPSULES 2 TIMES A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-11-25 12:11:00, ended at 2011-11-25 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Prothrombin time (PT): 26.0 (second)\n- INR in Platelet poor plasma by Coagulation assay: 2.5 (ratio)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Subsequent stage of staged operation\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-12-01 13:53:41, ended at 2011-12-01 15:20:44\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of left eye: 15 (millimeter mercury column)\n- Intraocular pressure of right eye: 17 (millimeter mercury column)\n\n### Procedure\n- Intravitreal injection of a pharmacologic agent (separate procedure)\n\n### Condition\n- Disorder of eye due to type 1 diabetes mellitus\n- Primary diagnosis: Macular edema due to diabetes mellitus\n\n### Drug\n- lidocaine hydrochloride 0.035 MG/MG Ophthalmic Gel, through Intraocular route, started on 2011-12-01, presumably until 2011-12-24, with intended 0 refill(s). Instructions: instill 2 Drops to left eye One Time.\n- proparacaine hydrochloride 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2011-12-01, presumably until 2011-12-24, with intended 0 refill(s). Instructions: instill 1 Drop to left eye One Time.\n- ofloxacin 3 MG/ML Ophthalmic Solution, through Intraocular route, started on 2011-12-01, presumably until 2011-12-27, with intended 0 refill(s). Instructions: instill 1 Drop to left eye One Time.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2011-12-03 00:00:00, ended at 2011-12-03 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- mycophenolate mofetil 500 MG Oral Tablet, through Oral route, started on 2011-12-03, presumably until 2011-12-24, with intended 11 refill(s). Instructions: take 0.5 Tabs by mouth 2 times a day. Patient will take 2 tabs twice daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-12-06 09:35:00, ended at 2011-12-06 10:09:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Tacrolimus [Mass/volume] in Blood: 8.0 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n- Transplanted kidney present\n- Type 1 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-12-06 10:10:00, ended at 2011-12-06 14:02:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.9 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.8 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 8.0 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 118 (unit per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.74 (million per microliter)\n- Platelets [#/volume] in Blood by Automated count: 363 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 42 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.1 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.79 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 133 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.9 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 8.5 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 22.7 (picogram)\n- MCHC [Mass/volume] by Automated count: 32.0 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.9 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.6 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 74.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 80 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 71.1 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.6 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.81 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.07 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-12-06 11:01:42, ended at 2011-12-06 11:53:53\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-12-06 13:50:20, ended at 2011-12-06 15:16:30\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Injection(s); single tendon sheath, or ligament, aponeurosis (eg, plantar  fascia )\n\n### Condition\n- Sprain of wrist\n- Acquired trigger finger\n- Wrist joint pain\n- Hand joint pain\n\n### Drug\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2011-12-06, presumably until 2011-12-06, with intended 0 refill(s). Instructions: 0.7 mL by Injection route One Time.\n- betamethasone 3 MG/ML / betamethasone acetate 3 MG/ML Injectable Suspension, started on 2011-12-06, presumably until 2011-12-06, with intended 0 refill(s). Instructions: 0.7 mL by Injection route One Time.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-12-06 14:03:00, ended at 2011-12-06 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, wrist; complete, minimum of 3 views\n\n### Condition\n- Wrist joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-12-07 11:00:00, ended at 2011-12-07 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n- Osteoporosis\n- Systemic lupus erythematosus\n- Type 1 diabetes mellitus without complication\n- Primary malignant neoplasm of ovary\n\n### Drug\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2011-12-07, presumably until 2011-12-07\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-12-21 00:00:00, ended at 2011-12-21 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of ovary\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-12-21 11:12:00, ended at 2011-12-21 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Prothrombin time (PT): 31.2 (second)\n- INR in Platelet poor plasma by Coagulation assay: 3.2 (ratio)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of ovary\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2011-12-22 00:00:00, ended at 2011-12-22 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Subsequent stage of staged operation\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2011-12-22 00:00:00, ended at 2011-12-22 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Peripheral nerve disease\n- Essential hypertension\n\n### Drug\n- 24 HR metoprolol succinate 25 MG Extended Release Oral Tablet, started on 2011-12-22, presumably until 2012-08-23, with intended 6 refill(s). Instructions: TAKE 1 TABLET (25MG) BY MOUTH IN AM AND 2 TABLETS (50MG) IN PM\n- gabapentin 300 MG Oral Capsule, started on 2011-12-22, presumably until 2011-12-24, with intended 3 refill(s). Instructions: TAKE 1 CAPSULE BY MOUTH 4 TIMES A DAY.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-12-24 11:00:00, ended at 2011-12-24 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2.205\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of ovary\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, presumably until 2012-05-02. Instructions: take 250 mg by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-12-27 13:45:09, ended at 2011-12-27 15:13:54\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n- Essential hypertension\n- Renal disorder due to type 1 diabetes mellitus\n- Transplanted kidney present\n- Pruritus of skin\n- Coronary arteriosclerosis\n\n### Drug\n- atorvastatin 20 MG Oral Tablet, through Oral route, presumably until 2014-04-26. Instructions: take 20 mg by mouth daily in the evening.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-01-01 11:48:00, ended at 2012-01-01 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin/Creatinine [Mass Ratio] in Urine: 8 (milligram per gram)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 62 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 62 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.68 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.94 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.7 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.8 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 21.4 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 70.8 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Albumin [Mass/volume] in Urine: 5 (milligram per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 67 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.8 (percent)\n- MCV [Entitic volume] by Automated count: 67.8 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 15.9 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 133 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 71 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 5.0 (nanogram per milliliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 1.0 (ratio)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 105 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 8.4 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.92 (thousand per microliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 1.57 (milli-international unit per liter)\n- Urate [Mass/volume] in Serum or Plasma: 4.0 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 4.9 (percent)\n- MCHC [Mass/volume] by Automated count: 31.6 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.7 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 132 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 47 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.10 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.3 (percent)\n- Platelets [#/volume] in Blood by Automated count: 387 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n- Hyperlipidemia\n- Type 1 diabetes mellitus without complication\n- Pruritus of skin\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-01-04 15:55:00, ended at 2012-01-04 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of ovary\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-01-11 11:24:00, ended at 2012-01-11 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n\n### Condition\n- Transplanted kidney present\n- Left lower quadrant pain\n- Primary malignant neoplasm of ovary\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-01-13 00:00:00, ended at 2012-01-13 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Angina pectoris\n\n### Drug\n- nitroglycerin 0.4 MG Sublingual Tablet, through Sublingual route, started on 2012-01-13, presumably until 2013-03-12, with intended 11 refill(s). Instructions: place 1 Tab under the tongue and let dissolve as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2012-01-21 00:00:00, ended at 2012-01-21 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Prothrombin time (PT): 21.3 (second)\n- INR in Platelet poor plasma by Coagulation assay: 2.0 (ratio)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-01-22 00:00:00, ended at 2012-01-22 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Diffuse spasm of esophagus\n- Gastroesophageal reflux disease\n\n### Drug\n- 24 HR diltiazem hydrochloride 120 MG Extended Release Oral Capsule, started on 2012-01-22, presumably until 2012-06-01, with intended 3 refill(s). Instructions: TAKE ONE CAPSULE BY MOUTH ONE TIME DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-01-24 00:00:00, ended at 2012-01-24 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2012-01-24, presumably until 2012-03-27, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-01-26 00:00:00, ended at 2012-01-26 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Peripheral nerve disease\n\n### Drug\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2012-01-26, presumably until 2012-07-21, with intended 6 refill(s). Instructions: take 1 Cap by mouth 4 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2012-01-26 00:00:00, ended at 2012-01-26 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Infective pneumonia\n\n### Drug\n- azithromycin 250 MG Oral Tablet, through Oral route, started on 2012-01-26, presumably until 2012-02-14, with intended 1 refill(s). Instructions: take 1 Tab by mouth as directed. 2 pills on the first day, then 1 per day for 4 days.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2012-02-02 00:00:00, ended at 2012-02-02 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Diarrhea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-02-08 13:51:58, ended at 2012-02-08 14:44:49\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Diarrhea\n\n### Drug\n- hyoscyamine sulfate 0.125 MG Sublingual Tablet, through Oral route, started on 2012-02-08, presumably until 2012-04-26, with intended 2 refill(s). Instructions: take 1 Tab by mouth 3 times a day as needed (cramping).\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-02-10 10:45:00, ended at 2012-02-10 11:32:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 73.2 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 97 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 95 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 29.0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.10 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.92 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.1 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 343 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 11.7 (nanogram per milliliter)\n- Urate [Mass/volume] in Serum or Plasma: 4.1 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 51 (nanogram per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 12.0 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.1 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.90 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 77 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.8 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.26 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 39 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.6 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 140 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.1 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.9 (percent)\n- MCH [Entitic mass] by Automated count: 23.5 (picogram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.4 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 69.4 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Anemia in chronic kidney disease\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-02-10 11:33:00, ended at 2012-02-10 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Diarrhea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-02-14 10:57:18, ended at 2012-02-14 12:34:07\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Immune defect\n- Transplanted kidney present\n- Dizziness and giddiness\n- Primary malignant neoplasm of ovary\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-02-28 11:23:34, ended at 2012-02-28 12:14:33\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Systemic lupus erythematosus\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2012-02-28, presumably until 2012-03-17, with intended 0 refill(s). Instructions: take 2 Tabs by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-02-28 13:36:00, ended at 2012-02-28 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocyte sedimentation rate: 6 (millimeter per hour)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Complement C3 [Mass/volume] in Serum or Plasma: 90 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-02-29 00:00:00, ended at 2012-02-29 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- isosorbide dinitrate 30 MG Oral Tablet, started on 2012-02-29, presumably until 2012-02-29, with intended 1 refill(s). Instructions: TAKE ONE TABLET BY MOUTH TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-02-29 00:00:00, ended at 2012-02-29 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Diffuse spasm of esophagus\n\n### Drug\n- isosorbide dinitrate 30 MG Oral Tablet, through Oral route, started on 2012-02-29, presumably until 2012-09-21, with intended 6 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-03-07 12:42:54, ended at 2012-03-07 14:14:26\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypertropia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-03-10 11:50:00, ended at 2012-03-10 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of blood specimen from a completely implantable venous access device\n\n### Condition\n- Primary malignant neoplasm of ovary\n- Transplanted kidney present\n\n### Drug\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2012-03-10, presumably until 2012-03-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-03-13 00:00:00, ended at 2012-03-13 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2012-03-13, presumably until 2012-04-26, with intended 2 refill(s). Instructions: take 500 mg by mouth as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-03-17 14:30:00, ended at 2012-03-17 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2.598\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of ovary\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-03-22 12:53:34, ended at 2012-03-22 14:49:38\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of left eye: 19 (millimeter mercury column)\n- Intraocular pressure of right eye: 18 (millimeter mercury column)\n\n### Procedure\n- Scanning computerized ophthalmic diagnostic imaging, posterior segment, with interpretation and report, unilateral or bilateral; retina\n\n### Condition\n- Proliferative retinopathy due to diabetes mellitus\n- Tear film insufficiency\n- Macular edema due to diabetes mellitus\n- Vitreous degeneration\n- Disorder of eye due to type 1 diabetes mellitus\n- Epiretinal membrane\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-03-24 11:55:00, ended at 2012-03-24 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- INR in Platelet poor plasma by Coagulation assay: 2.0 (ratio)\n- Prothrombin time (PT): 21.9 (second)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-03-27 00:00:00, ended at 2012-03-27 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Systemic lupus erythematosus\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2012-03-27, presumably until 2012-09-22, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2012-03-31 00:00:00, ended at 2012-03-31 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Anemia in chronic kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-04-07 10:57:59, ended at 2012-04-07 12:35:20\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of right eye: 13 (millimeter mercury column)\n- Intraocular pressure of left eye: 14 (millimeter mercury column)\n\n### Procedure\n- Closure of the lacrimal punctum; by plug, each\n\n### Condition\n- Vitreous degeneration\n- Macular edema due to diabetes mellitus\n- Tear film insufficiency\n- Epiretinal membrane\n- Disorder of eye due to type 1 diabetes mellitus\n- Proliferative retinopathy due to diabetes mellitus\n\n### Drug\n- ketotifen 0.25 MG/ML Ophthalmic Solution, through Intraocular route, presumably until 2019-04-18. Instructions: instill 1 Drop to both eyes every 6 hours as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-04-10 00:00:00, ended at 2012-04-10 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Tear film insufficiency\n\n### Drug\n- 0.4 ML cyclosporine 0.5 MG/ML Ophthalmic Suspension, through Intraocular route, started on 2012-04-10, presumably until 2012-04-24, with intended 0 refill(s). Instructions: 1 Drop by Ophthalmic route 2 times a day. To both eyes for two weeks.  \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-04-17 11:29:00, ended at 2012-04-17 11:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 81 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.40 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 60.8 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.8 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Iron [Mass/volume] in Serum or Plasma: 22 (microgram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 281 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 4.8 (nanogram per milliliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 42 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.6 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.05 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 107 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 146 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 24.1 (percent)\n- Ferritin [Mass/volume] in Serum or Plasma: 8 (nanogram per milliliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.8 (percent)\n- MCV [Entitic volume] by Automated count: 78.2 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.04 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.4 (gram per deciliter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 347 (microgram per deciliter)\n- MCH [Entitic mass] by Automated count: 25.5 (picogram)\n- MCHC [Mass/volume] by Automated count: 32.6 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 18.6 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.45 (million per microliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 6 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anemia in chronic kidney disease\n- Chronic kidney disease\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-04-17 12:00:00, ended at 2012-04-17 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of blood specimen from a completely implantable venous access device\n\n### Condition\n- Transplanted kidney present\n- Primary malignant neoplasm of ovary\n\n### Drug\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2012-04-17, presumably until 2012-04-17\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-04-24 10:53:00, ended at 2012-04-24 12:15:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Prothrombin time (PT): 17.7 (second)\n- INR in Platelet poor plasma by Coagulation assay: 1.5 (ratio)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2012-04-24 12:16:00, ended at 2012-04-24 20:29:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Glucose [Mass/volume] in Serum or Plasma: 88 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.4 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.8 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 77.9 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 258 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.58 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.98 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 25.2 (picogram)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.10 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.0 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 21.2 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.83 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.5 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 17.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.81 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20.5 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.7 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 58.7 (percent)\n\n### Procedure\n- Duplex scan of extremity veins including responses to compression and other maneuvers; unilateral or limited study\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Radiologic examination; forearm, 2 views\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Radiologic examination; humerus, minimum of 2 views\n\n### Condition\n- Essential hypertension\n- Swelling of limb\n- Disorder of eye due to diabetes mellitus\n- Swelling / lump finding\n- Complication associated with orthopedic device\n- Mechanical complication of internal orthopedic device, implant AND/OR graft\n- Nonproliferative retinopathy due to diabetes mellitus\n- Atherosclerosis of artery\n- Hyperlipidemia\n- Transplanted kidney present\n- Wrist joint pain\n- Late effect of medical and surgical care complication\n- Systemic lupus erythematosus\n- Coronary arteriosclerosis\n\n### Drug\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2012-04-24, presumably until 2012-04-24\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2012-04-24, presumably until 2012-04-24\n- ondansetron 4 MG Disintegrating Oral Tablet, through Oral route, started on 2012-04-24, presumably until 2012-04-24\n- 1 ML morphine sulfate 2 MG/ML Prefilled Syringe, started on 2012-04-24, presumably until 2012-04-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-04-26 10:20:00, ended at 2012-04-26 17:36:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Removal of implant; deep (eg, buried wire, pin, screw, metal band, nail, rod or plate)\n- Removal of implant from humerus\n- Removal of implanted devices from bone, radius and ulna\n\n### Condition\n- Disorder of wrist joint\n- Complication associated with orthopedic device\n- Late effect of medical and surgical care complication\n- Pain in limb\n- Wrist joint pain\n- Elbow joint pain\n\n### Drug\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2012-04-26, presumably until 2012-04-26\n- acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2012-04-26, presumably until 2012-07-21, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed (pain).\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2012-04-26, presumably until 2012-05-02, with intended 2 refill(s). Instructions: take 1 Cap by mouth 2 times a day.\n- 1 ML hydromorphone hydrochloride 2 MG/ML Prefilled Syringe, started on 2012-04-26, presumably until 2012-04-26\n- 12 HR oxycodone hydrochloride 10 MG Extended Release Oral Tablet, through Oral route, started on 2012-04-26, presumably until 2012-04-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 12 hours.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-04-27 00:00:00, ended at 2012-04-27 00:00:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-04-28 00:00:00, ended at 2012-04-28 00:00:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2012-04-28, presumably until 2013-04-20, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-04-28 10:44:00, ended at 2012-04-28 23:59:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Prothrombin time (PT): 24.7 (second)\n- INR in Platelet poor plasma by Coagulation assay: 2.4 (ratio)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-05-02 10:00:00, ended at 2012-05-02 23:59:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of lower extremity arteries or arterial bypass grafts; unilateral or limited study\n\n### Condition\n- Peripheral vascular disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-05-02 10:43:54, ended at 2012-05-02 12:34:08\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Peripheral vascular disease\n\n### Drug\n- furosemide 20 MG Oral Tablet, through Oral route, presumably until 2012-07-03. Instructions: take 20 mg by mouth daily.  \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-05-08 10:24:55, ended at 2012-05-08 14:06:54\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Wrist joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-05-08 14:00:00, ended at 2012-05-08 23:59:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.71 (million per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.95 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.10 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.6 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.9 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 52.9 (percent)\n- Erythrocyte sedimentation rate: 9 (millimeter per hour)\n- Monocytes/100 leukocytes in Blood by Automated count: 20.4 (percent)\n- MCV [Entitic volume] by Automated count: 77.4 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.47 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 316 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.7 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.7 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.7 (percent)\n- MCH [Entitic mass] by Automated count: 24.8 (picogram)\n- MCHC [Mass/volume] by Automated count: 32.1 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Wrist joint pain\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-05-09 13:29:51, ended at 2012-05-09 14:14:01\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1.5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Diffuse spasm of esophagus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-05-24 10:59:00, ended at 2012-05-24 23:59:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- INR in Platelet poor plasma by Coagulation assay: 2.0 (ratio)\n- Prothrombin time (PT): 22.0 (second)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-05-25 00:00:00, ended at 2012-05-25 00:00:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Gastroesophageal reflux disease\n- Diffuse spasm of esophagus\n\n### Drug\n- dexlansoprazole 30 MG Delayed Release Oral Capsule, through Oral route, started on 2012-05-25, presumably until 2013-06-29, with intended 11 refill(s). Instructions: take 30 mg by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-05-29 10:38:32, ended at 2012-05-29 11:26:22\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-05-29 11:58:00, ended at 2012-05-29 23:59:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, knee; both knees, standing, anteroposterior\n- Radiologic examination, knee; 3 views\n\n### Condition\n- Osteoarthritis of knee\n- Joint pain\n- Systemic lupus erythematosus\n- Disorder of bone and articular cartilage\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-05-31 14:52:50, ended at 2012-05-31 15:35:36\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-06-01 00:00:00, ended at 2012-06-01 00:00:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Diffuse spasm of esophagus\n- Gastroesophageal reflux disease\n- Dysphagia\n\n### Drug\n- 24 HR diltiazem hydrochloride 120 MG Extended Release Oral Capsule, through Oral route, started on 2012-06-01, presumably until 2012-10-24, with intended 5 refill(s). Instructions: take 1 Cap by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-06-05 14:26:54, ended at 2012-06-05 15:43:15\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Degenerative joint disease of hand\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-06-05 15:08:00, ended at 2012-06-05 23:59:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, wrist; complete, minimum of 3 views\n\n### Condition\n- Wrist joint pain\n- Disorder of wrist joint\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-06-06 00:00:00, ended at 2012-06-06 00:00:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 12 HR diltiazem hydrochloride 120 MG Extended Release Oral Capsule, through Oral route, started on 2012-06-06, presumably until 2013-06-06, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-06-06 00:00:00, ended at 2012-06-06 00:00:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Tear film insufficiency\n\n### Drug\n- 0.4 ML cyclosporine 0.5 MG/ML Ophthalmic Suspension, through Intraocular route, started on 2012-06-06, presumably until 2012-07-14, with intended 6 refill(s). Instructions: instill 1 Drop to both eyes 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-06-14 12:31:00, ended at 2012-06-14 23:59:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.3 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 17.8 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 79 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.3 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Albumin [Mass/volume] in Urine: <5 (milligram per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 76 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 15.8 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.64 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 64.6 (percent)\n- Platelets [#/volume] in Blood by Automated count: 301 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Albumin/Creatinine [Mass Ratio] in Urine: <30 (milligram per gram)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.00 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 24.9 (picogram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.7 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.6 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 77.0 (femtoliter)\n- Tacrolimus [Mass/volume] in Blood: 4.5 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.89 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.93 (million per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-06-14 13:55:29, ended at 2012-06-14 14:43:39\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Subsequent stage of staged operation\n\n### Condition\n- No conditions.\n\n### Drug\n- 0.6 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2012-06-14, presumably until 2012-07-05, with intended 1 refill(s). Instructions: inject 0.5 mL subcutaneous (under the skin) every 12 hours. As directed by SHC anticoag clinic.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2012-06-21 10:01:00, ended at 2012-06-23 19:50:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 11.1 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.5 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.48 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.4 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 32.2 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 77.3 (femtoliter)\n- Prothrombin time (PT): 14.6 (second)\n- aPTT in Platelet poor plasma by Coagulation assay: 37.6 (second)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.1 (thousand per microliter)\n- Body height: 5' 2.5\" (inch (US))\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 96 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 24.8 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 231 (thousand per microliter)\n\n### Procedure\n- Insertion of recombinant bone morphogenetic protein\n- Subsequent stage of staged operation\n- Injection of anesthetic agent into peripheral nerve for analgesia\n- Arthrodesis of carpometacarpal joint\n- Therapeutic procedure, 1 or more areas, each 15 minutes; gait training (includes stair climbing)\n- Excision of bone for graft, other bones\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n\n### Condition\n- Acute gastritis\n- Disorder of nervous system due to diabetes mellitus\n- Peripheral nerve disease\n- Disorder of eye due to type 1 diabetes mellitus\n- Disorder of wrist joint\n- Late effect of medical and surgical care complication\n- Peripheral vascular disease\n- Systemic lupus erythematosus\n- Tear film insufficiency\n- Complication of internal device\n- Diffuse spasm of esophagus\n- Essential hypertension\n- Insomnia\n- Nonproliferative retinopathy due to diabetes mellitus\n- Renal disorder due to type 1 diabetes mellitus\n- Disorder of bone and articular cartilage\n- Dysphagia\n- Mechanical complication of internal orthopedic device, implant AND/OR graft\n- Coronary arteriosclerosis\n- Gastroesophageal reflux disease\n- Hyperlipidemia\n- Transplanted kidney present\n- Localized osteoarthrosis uncertain if primary OR secondary\n\n### Drug\n- isosorbide dinitrate 30 MG Oral Tablet, through Oral route, started on 2012-06-21, presumably until 2012-06-23\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2012-06-21, presumably until 2012-06-22\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2012-06-21, presumably until 2012-06-23\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2012-06-21, presumably until 2012-06-21\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2012-06-22, presumably until 2012-06-23\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2012-06-22, presumably until 2012-06-23\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2012-06-22, presumably until 2012-06-23\n- mineral oil 0.425 MG/MG / petrolatum 0.568 MG/MG Ophthalmic Ointment, through Intraocular route, started on 2012-06-21, presumably until 2012-06-22\n- cefazolin 1000 MG Injection, through Intravenous route, started on 2012-06-22, presumably until 2012-06-23\n- 24 HR metoprolol succinate 25 MG Extended Release Oral Tablet, through Oral route, started on 2012-06-21, presumably until 2012-06-23\n- acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2012-06-21, presumably until 2012-10-31, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed for Pain.\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2012-06-21, presumably until 2012-08-28, with intended 2 refill(s). Instructions: take 1 Cap by mouth 2 times a day.\n- cephalexin 500 MG Oral Capsule, through Oral route, started on 2012-06-22, presumably until 2012-07-05, with intended 0 refill(s). Instructions: take 1 Cap by mouth every 6 hours.\n- warfarin sodium 4 MG Oral Tablet, through Oral route, started on 2012-06-22, presumably until 2012-06-23\n- 24 HR metoprolol succinate 50 MG Extended Release Oral Tablet, through Oral route, started on 2012-06-22, presumably until 2012-06-22\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2012-06-22, presumably until 2012-06-23\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2012-06-21, presumably until 2012-06-23\n- 24 HR diltiazem hydrochloride 120 MG Extended Release Oral Capsule, through Oral route, started on 2012-06-22, presumably until 2012-06-23\n- 2 ML ondansetron 2 MG/ML Injection, started on 2012-06-21, presumably until 2012-06-23\n- 0.6 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2012-06-22, presumably until 2012-06-23\n- 12 HR oxycodone hydrochloride 10 MG Extended Release Oral Tablet, through Oral route, started on 2012-06-22, presumably until 2012-08-28, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 12 hours.\n- 0.4 ML cyclosporine 0.5 MG/ML Ophthalmic Suspension, through Intraocular route, started on 2012-06-21, presumably until 2012-06-23\n- clopidogrel 75 MG Oral Tablet, through Oral route, started on 2012-06-22, presumably until 2012-06-23\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2012-06-22, presumably until 2012-06-23\n- zolpidem tartrate 10 MG Oral Tablet, through Oral route, started on 2012-06-23, presumably until 2012-06-23\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-06-26 00:00:00, ended at 2012-06-26 00:00:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Peripheral vascular disease\n- Angina pectoris\n\n### Drug\n- furosemide 40 MG Oral Tablet, through Oral route, started on 2012-06-26, presumably until 2013-06-26, with intended 6 refill(s). Instructions: take 0.5 Tabs by mouth 2 times a day.\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2012-06-27, presumably until 2012-08-10, with intended 0 refill(s). Instructions: take 500 mg by mouth as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-06-26 13:51:01, ended at 2012-06-26 14:38:04\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n- Coronary arteriosclerosis\n- Essential hypertension\n- Hyperlipidemia\n- Diffuse spasm of esophagus\n- Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-06-26 15:00:49, ended at 2012-06-26 15:11:30\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Subsequent stage of staged operation\n\n### Condition\n- No conditions.\n\n### Drug\n- warfarin sodium 4 MG Oral Tablet, started on 2012-06-26, presumably until 2012-11-23, with intended 0 refill(s). Instructions: Take 4 mg by mouth daily except 2 mg on Sat. and Sun. or as directed by SHC anticoag clinic.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-07-03 00:00:00, ended at 2012-07-03 00:00:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Renal disorder due to type 1 diabetes mellitus\n\n### Drug\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2012-07-03, presumably until 2012-11-09, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-07-05 11:09:40, ended at 2012-07-05 11:33:21\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Application of short arm cast\n- Radiologic examination, wrist; complete, minimum of 3 views\n\n### Condition\n- Disorder of cardiovascular system\n- Wrist joint pain\n\n### Drug\n- ranitidine 300 MG Oral Tablet, through Oral route, started on 2012-07-03, presumably until 2012-10-24. Instructions: take 300 mg by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-07-05 13:24:16, ended at 2012-07-05 14:19:25\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Application of short arm cast\n\n### Condition\n- Primary diagnosis: Wrist joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-07-05 13:33:00, ended at 2012-07-05 23:59:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, wrist; complete, minimum of 3 views\n\n### Condition\n- Wrist joint pain\n- Disorder of cardiovascular system\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-07-14 10:45:03, ended at 2012-07-14 11:32:24\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of right eye: 12 (millimeter mercury column)\n- Intraocular pressure of left eye: 12 (millimeter mercury column)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Proliferative retinopathy due to diabetes mellitus\n- Systemic lupus erythematosus\n- Tear film insufficiency\n- Disorder of eyelid\n- Macular edema due to diabetes mellitus\n- Vitreous degeneration\n- Epiretinal membrane\n- Disorder of eye due to type 1 diabetes mellitus\n\n### Drug\n- 0.4 ML cyclosporine 0.5 MG/ML Ophthalmic Suspension, through Intraocular route, started on 2012-07-14, presumably until 2012-09-11, with intended 6 refill(s). Instructions: instill 1 Drop to both eyes 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-07-18 16:06:00, ended at 2012-07-18 23:59:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of blood specimen from a completely implantable venous access device\n\n### Condition\n- Primary malignant neoplasm of ovary\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-07-21 00:00:00, ended at 2012-07-21 00:00:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2012-07-21, presumably until 2012-08-21, with intended 0 refill(s). Instructions: take 1 Cap by mouth 4 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-07-21 10:28:00, ended at 2012-07-21 23:59:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Macular edema due to diabetes mellitus\n- Proliferative retinopathy due to diabetes mellitus\n- Disorder of eye due to type 1 diabetes mellitus\n- Vitreous degeneration\n- Epigastric pain\n- Epiretinal membrane\n- Primary malignant neoplasm of ovary\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-07-21 13:53:03, ended at 2012-07-21 16:23:02\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of right eye: 14 (millimeter mercury column)\n- Intraocular pressure of left eye: 14 (millimeter mercury column)\n\n### Procedure\n- Scanning computerized ophthalmic diagnostic imaging, posterior segment, with interpretation and report, unilateral or bilateral; retina\n\n### Condition\n- Macular edema due to diabetes mellitus\n- Disorder of eye due to type 1 diabetes mellitus\n- Proliferative retinopathy due to diabetes mellitus\n- Epiretinal membrane\n- Vitreous degeneration\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2012-07-25 00:00:00, ended at 2012-07-25 00:00:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Aseptic necrosis of bone\n- Backache\n- Osteoporosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-07-25 12:03:00, ended at 2012-07-25 12:39:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 20 (nanogram per milliliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 20 (nanogram per milliliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Osteoporosis\n- Hyperparathyroidism\n- Aseptic necrosis of bone\n- Backache\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-07-25 12:40:00, ended at 2012-07-25 23:59:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, spine; thoracolumbar junction, minimum of 2 views\n\n### Condition\n- Backache\n- Pathological fracture of vertebra\n- Lumbosacral spondylosis without myelopathy\n- Aseptic necrosis of bone\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-07-28 10:04:00, ended at 2012-07-28 23:59:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Osteoporosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2012-08-05 00:00:00, ended at 2012-08-05 00:00:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Vitamin D deficiency\n- Primary diagnosis: Aseptic necrosis of bone\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-08-05 11:07:00, ended at 2012-08-05 23:59:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin/Creatinine [Mass Ratio] in Urine: <30 (milligram per gram)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.70 (million per microliter)\n- Platelets [#/volume] in Blood by Automated count: 332 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.24 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 63.8 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Erythrocyte sedimentation rate: 9 (millimeter per hour)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.8 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.22 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.2 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.6 (percent)\n- MCV [Entitic volume] by Automated count: 74.9 (femtoliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 99 (unit per liter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 21.3 (percent)\n- Tacrolimus [Mass/volume] in Blood: 5.6 (nanogram per milliliter)\n- Albumin [Mass/volume] in Urine: <5 (milligram per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.1 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 23.6 (picogram)\n- MCHC [Mass/volume] by Automated count: 31.5 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.01 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.6 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 15.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- End-stage renal disease\n- Transplanted kidney present\n- Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-08-17 11:32:04, ended at 2012-08-17 13:06:13\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Application of short arm cast\n\n### Condition\n- Wrist joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-08-17 11:42:00, ended at 2012-08-17 23:59:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, wrist; complete, minimum of 3 views\n\n### Condition\n- Wrist joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-08-21 00:00:00, ended at 2012-08-21 00:00:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2012-08-21, presumably until 2012-10-24, with intended 4 refill(s). Instructions: take 1 Cap by mouth 4 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-08-22 08:32:00, ended at 2012-08-22 23:59:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- INR in Platelet poor plasma by Coagulation assay: 2.2 (ratio)\n- Prothrombin time (PT): 23.1 (second)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-08-23 00:00:00, ended at 2012-08-23 00:00:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 24 HR metoprolol succinate 25 MG Extended Release Oral Tablet, started on 2012-08-23, presumably until 2012-08-28, with intended 6 refill(s). Instructions: TAKE 1 TABLET (25MG) BY MOUTH EVERY MORNING AND 2 TABLETS(50MG) EVERY EVENING\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-08-28 00:00:00, ended at 2012-08-28 00:00:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-08-28 10:27:27, ended at 2012-08-28 14:47:33\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Systemic lupus erythematosus\n- Immune defect\n- Transplanted kidney present\n- Disorder of bone and articular cartilage\n- Renal disorder due to type 1 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-09-08 17:12:00, ended at 2012-09-08 23:59:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, spinal canal and contents, without contrast material, followed by contrast material(s) and further sequences; lumbar\n\n### Condition\n- Ganglion cyst\n- Spondylolisthesis\n- Congenital anomaly of spine\n- Low back pain\n- Lumbosacral spondylosis without myelopathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-09-11 10:59:08, ended at 2012-09-11 12:48:53\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of left eye: 14 (millimeter mercury column)\n- Intraocular pressure of right eye: 13 (millimeter mercury column)\n\n### Procedure\n- Closure of the lacrimal punctum; by plug, each\n\n### Condition\n- Macular edema due to diabetes mellitus\n- Vitreous degeneration\n- Tear film insufficiency\n- Disorder of eye due to type 1 diabetes mellitus\n- Proliferative retinopathy due to diabetes mellitus\n- Epiretinal membrane\n\n### Drug\n- 0.4 ML cyclosporine 0.5 MG/ML Ophthalmic Suspension, through Intraocular route, started on 2012-09-11, presumably until 2012-10-31, with intended 6 refill(s). Instructions: instill 1 Drop to both eyes 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-09-14 16:23:03, ended at 2012-09-14 17:28:04\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Degenerative joint disease of hand\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-09-14 16:53:00, ended at 2012-09-14 23:59:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, wrist; complete, minimum of 3 views\n\n### Condition\n- Epiretinal membrane\n- Imaging of musculoskeletal system abnormal\n- Atherosclerosis of aorta\n- Callosity\n- Closed fracture of distal end of radius\n- Disorder of eye due to type 1 diabetes mellitus\n- Tear film insufficiency\n- Transplanted kidney present\n- Disorder of bone and articular cartilage\n- Proliferative retinopathy due to diabetes mellitus\n- Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-09-21 00:00:00, ended at 2012-09-21 00:00:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Diffuse spasm of esophagus\n\n### Drug\n- isosorbide dinitrate 30 MG Oral Tablet, through Oral route, started on 2012-09-21, presumably until 2013-05-08, with intended 6 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-09-22 00:00:00, ended at 2012-09-22 00:00:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Systemic lupus erythematosus\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2012-09-22, presumably until 2012-12-25, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-09-22 11:19:00, ended at 2012-09-22 23:59:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.3 (percent)\n- Tacrolimus [Mass/volume] in Blood: 11.4 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Albumin [Mass/volume] in Urine: <5 (milligram per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Albumin/Creatinine [Mass Ratio] in Urine: <30 (milligram per gram)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 94 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.4 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 23.3 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 306 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 3.0 (ratio)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.7 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 18.8 (percent)\n- MCV [Entitic volume] by Automated count: 72.4 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.21 (thousand per microliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.7 (percent)\n- MCHC [Mass/volume] by Automated count: 32.2 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.15 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.15 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.94 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.0 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 64.6 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Prothrombin time (PT): 29.3 (second)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n\n### Procedure\n- Collection of blood specimen from a completely implantable venous access device\n\n### Condition\n- End-stage renal disease\n- Primary malignant neoplasm of ovary\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-09-26 11:42:56, ended at 2012-09-26 12:18:38\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2.5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Low back pain\n- Lumbosacral spondylosis without myelopathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-09-26 12:50:00, ended at 2012-09-26 23:59:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, spine, lumbosacral; 2 or 3 views\n\n### Condition\n- Lumbosacral spondylosis without myelopathy\n- Spondylolisthesis\n- Disorder of trunk\n- Low back pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-10-16 00:00:00, ended at 2012-10-16 00:00:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- General examination of patient\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2012-10-17 00:00:00, ended at 2012-10-17 00:00:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 10 ML bupivacaine hydrochloride 5 MG/ML Injection, started on 2012-10-17, presumably until 2012-10-17\n- methylprednisolone acetate 80 MG/ML Injectable Suspension, started on 2012-10-17, presumably until 2012-10-17\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2012-10-17, presumably until 2012-10-17\n- iohexol, through Intravenous route, started on 2012-10-17, presumably until 2012-10-17\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-10-17 12:42:00, ended at 2012-10-17 17:04:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- INR in Platelet poor plasma by Coagulation assay: 2.2 (ratio)\n- Body height: 5' 2\" (inch (US))\n- Prothrombin time (PT): 22.9 (second)\n\n### Procedure\n- Injection of therapeutic substance into joint or ligament\n- Collection of venous blood by venipuncture\n- Radiologic examination, spine, single view, specify level\n- Injection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joint) with image guidance (fluoroscopy or CT), lumbar or sacral; single level\n- Injection of steroid\n- Injection of anesthetic agent into peripheral nerve for analgesia\n- Injection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joint) with image guidance (fluoroscopy or CT), lumbar or sacral; second level (List separately in addition to code for primary procedure)\n- Other x-ray of lumbosacral spine\n- Injection or infusion of other therapeutic or prophylactic substance\n\n### Condition\n- Essential hypertension\n- Lumbosacral spondylosis without myelopathy\n- Spondylosis without myelopathy\n- Backache\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-10-24 08:51:00, ended at 2012-10-24 09:31:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Tacrolimus [Mass/volume] in Blood: 4.1 (nanogram per milliliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-10-24 09:32:00, ended at 2012-10-24 23:59:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computer-aided detection (computer algorithm analysis of digital image data for lesion detection) with further review for interpretation, with or without digitization of film radiographic images; screening mammography (List separately in addition to code \n- Screening mammography, bilateral (2-view study of each breast)\n\n### Condition\n- Inconclusive mammography finding\n- Primary malignant neoplasm of ovary\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-10-24 12:53:32, ended at 2012-10-24 14:23:29\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Systemic lupus erythematosus\n- Diffuse spasm of esophagus\n- Dysphagia\n- Gastroesophageal reflux disease\n\n### Drug\n- ranitidine 300 MG Oral Tablet, through Oral route, started on 2012-10-24, presumably until 2014-02-15, with intended 4 refill(s). Instructions: take 300 mg by mouth 2 times a day.\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2012-10-24, presumably until 2013-01-26, with intended 4 refill(s). Instructions: take 1 Cap by mouth 4 times a day.\n- 24 HR diltiazem hydrochloride 120 MG Extended Release Oral Capsule, through Oral route, started on 2012-10-24, presumably until 2014-02-06, with intended 4 refill(s). Instructions: take 1 Cap by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-10-26 09:22:00, ended at 2012-10-26 13:12:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 31 (nanogram per milliliter)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 31 (nanogram per milliliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Aseptic necrosis of bone\n- Primary malignant neoplasm of ovary\n- Vitamin D deficiency\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-10-26 13:13:00, ended at 2012-10-26 23:59:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance imaging, breast, without and/or with contrast material(s); bilateral\n\n### Condition\n- Vitamin D deficiency\n- Aseptic necrosis of bone\n- Primary malignant neoplasm of ovary\n- Abnormal findings on diagnostic imaging of breast\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-10-31 13:30:00, ended at 2012-10-31 23:59:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of lower extremity arteries or arterial bypass grafts; unilateral or limited study\n\n### Condition\n- Intermittent claudication\n- Atherosclerosis of arteries of the extremities\n- Peripheral vascular disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-11-02 00:00:00, ended at 2012-11-02 00:00:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Renal disorder due to type 1 diabetes mellitus\n\n### Drug\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2012-11-02, presumably until 2012-11-02, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-11-02 15:00:00, ended at 2012-11-02 23:59:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2.598\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Renal disorder due to type 1 diabetes mellitus\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n- End-stage renal disease\n- Breast lump\n- Fibrocystic disease of breast\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-11-06 13:03:45, ended at 2012-11-06 15:04:31\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Lumbosacral spondylosis without myelopathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-11-09 00:00:00, ended at 2012-11-09 00:00:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Renal disorder due to type 1 diabetes mellitus\n\n### Drug\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2012-11-09, presumably until 2013-04-16, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-11-13 13:54:12, ended at 2012-11-13 15:08:42\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Degenerative joint disease of hand\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-11-13 13:55:00, ended at 2012-11-13 23:59:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, wrist; complete, minimum of 3 views\n\n### Condition\n- Wrist joint pain\n- Atherosclerosis of aorta\n- Disorder of bone and articular cartilage\n- Degenerative joint disease of hand\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2012-11-17 00:00:00, ended at 2012-11-17 00:00:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Systemic lupus erythematosus\n\n### Drug\n- 3 ML ibandronic acid 1 MG/ML Prefilled Syringe, through Intravenous route, started on 2012-11-20, presumably until 2013-11-20, with intended 0 refill(s). Instructions: 3 mL by Intravenous route One Time.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-11-17 14:20:00, ended at 2012-11-17 14:20:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Low back pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-11-20 09:00:00, ended at 2012-11-20 09:14:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 42 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 29.2 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.7 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.71 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.2 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.49 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 227 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 96 (unit per liter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.1 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 87.5 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.4 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.99 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 83 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.5 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.2 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 28.2 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 72.6 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.89 (thousand per microliter)\n\n### Procedure\n- Irrigation of implanted venous access device for drug delivery systems\n\n### Condition\n- Primary malignant neoplasm of ovary\n- End-stage renal disease\n- Transplanted kidney present\n\n### Drug\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2012-11-20, presumably until 2012-11-20\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-11-20 09:15:00, ended at 2012-11-20 23:59:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- INR in Platelet poor plasma by Coagulation assay: 3.2 (ratio)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Prothrombin time (PT): 30.7 (second)\n\n### Procedure\n- Irrigation of implanted venous access device for drug delivery systems\n- General examination of patient\n\n### Condition\n- Transplanted kidney present\n- Type 1 diabetes mellitus without complication\n- Primary malignant neoplasm of ovary\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-11-21 00:00:00, ended at 2012-11-21 00:00:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2012-11-21, presumably until 2013-02-14, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-11-23 00:00:00, ended at 2012-11-23 00:00:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Subsequent stage of staged operation\n\n### Condition\n- No conditions.\n\n### Drug\n- warfarin sodium 4 MG Oral Tablet, started on 2012-11-23, presumably until 2013-05-01, with intended 3 refill(s). Instructions: Take 4 mg by mouth daily except 2 mg on Sat. and Sun. or as directed by SHC anticoag clinic.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-11-24 10:23:00, ended at 2012-11-24 23:59:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2.205\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n- Primary malignant neoplasm of ovary\n- Mononeuritis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-11-27 14:08:55, ended at 2012-11-27 15:49:25\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Low back pain\n- Lumbosacral spondylosis without myelopathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-11-27 16:02:00, ended at 2012-11-27 23:59:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Low back pain\n- Lumbosacral spondylosis without myelopathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2012-11-29 00:00:00, ended at 2012-11-29 00:00:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of bone and articular cartilage\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-12-01 12:14:00, ended at 2012-12-01 23:59:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, spine; thoracic, 2 views\n- Radiologic examination, spine, lumbosacral; 2 or 3 views\n- Radiologic examination, spine, cervical; 2 or 3 views\n\n### Condition\n- Lumbosacral spondylosis without myelopathy\n- Acquired spondylolisthesis\n- Spondylolisthesis\n- Degeneration of intervertebral disc\n- Low back pain\n- Atherosclerosis of artery\n- Arthropathy\n- Neck pain\n\n### Drug\n- No drugs.\n\n"}, "target": "Yes", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Systemic lupus erythematosus within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Hospital, started at 2008-01-24 10:08:00, ended at 2008-02-01 13:40:00\nThe patient in this visit was 52 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Leukocytes [#/volume] in Specimen by Automated count: 8.7 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.4 (gram per deciliter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.6 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 1.09 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 28.6 (second)\n- Hemoglobin [Mass/volume] in Blood: 10.6 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.84 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 83.3 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.6 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.16 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- MCH [Entitic mass] by Automated count: 27.0 (picogram)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.9 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.74 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 77.6 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.4 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.93 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.7 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Prothrombin time (PT): 15.1 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 207 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2008-02-27 07:10:00, ended at 2008-02-27 23:59:00\nThe patient in this visit was 52 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Cellulitis and abscess of finger\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-03-14 00:00:00, ended at 2008-03-14 00:00:00\nThe patient in this visit was 52 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.2 (percent)\n- MCV [Entitic volume] by Automated count: 82.9 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.7 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.04 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.36 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.0 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.05 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 18 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 85 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.1 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 27.8 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.83 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 17.4 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 67.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 255 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-03-22 00:00:00, ended at 2008-03-22 00:00:00\nThe patient in this visit was 52 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.5 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 27.4 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.72 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 258 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.3 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.83 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 161 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.3 (percent)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.92 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.3 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 87 (unit per liter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.7 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 78 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 36 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.51 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.1 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 4.0 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- MCV [Entitic volume] by Automated count: 82.9 (femtoliter)\n- Tacrolimus [Mass/volume] in Blood: 9.1 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.7 (ratio)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.1 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 71.4 (percent)\n- Prothrombin time (PT): 19.2 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-04-24 00:00:00, ended at 2008-04-24 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.7 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 26.5 (picogram)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.09 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.5 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.41 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.7 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.1 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 6.2 (nanogram per milliliter)\n- Urate [Mass/volume] in Serum or Plasma: 4.3 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 3.1 (ratio)\n- Platelets [#/volume] in Blood by Automated count: 264 (thousand per microliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.76 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.9 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 36 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 104 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 151 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.8 (percent)\n- MCV [Entitic volume] by Automated count: 81.2 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.77 (thousand per microliter)\n- Prothrombin time (PT): 30.6 (second)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-05-10 00:00:00, ended at 2008-05-10 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Homocysteine [Moles/volume] in Serum or Plasma: 10.1 (micromole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-05-24 00:00:00, ended at 2008-05-24 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.3 (percent)\n- MCH [Entitic mass] by Automated count: 27.2 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 269 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: 4.4 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 88 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 82 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.0 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.50 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.5 (percent)\n- Prothrombin time (PT): 30.0 (second)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.41 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.33 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.76 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 45 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.1 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 82.3 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- INR in Platelet poor plasma by Coagulation assay: 3.0 (ratio)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.4 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 168 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.7 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 6.5 (nanogram per milliliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2008-05-30 08:07:00, ended at 2008-05-30 16:25:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Non-traumatic tendon rupture\n\n### Drug\n- isosorbide dinitrate 30 MG Oral Tablet, through Oral route, presumably until 2008-09-11. Instructions: take 30 mg by mouth. TID\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2008-05-30, presumably until 2008-05-30\n- Osmotic 24 HR nifedipine 30 MG Extended Release Oral Tablet, through Oral route, presumably until 2008-09-11. Instructions: take by mouth daily. \n- docusate sodium 100 MG Oral Capsule, through Oral route, presumably until 2009-05-22. Instructions: take by mouth as needed \n- cephalexin 500 MG Oral Capsule, through Oral route, started on 2008-05-30, presumably until 2008-06-17, with quantity of 12.0, with intended 0 refill(s). Instructions: take 1 Cap by mouth 4 times a day. \n- gabapentin 300 MG Oral Capsule, through Oral route, presumably until 2008-06-17. Instructions: take by mouth. TID\n- warfarin sodium 1 MG Oral Tablet, through Oral route, presumably until 2008-09-11. Instructions: take by mouth. \n- clopidogrel 75 MG Oral Tablet, through Oral route, presumably until 2011-03-29. Instructions: take by mouth daily. \n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2008-05-30, presumably until 2008-05-30, with quantity of 55.0, with intended 1 refill(s). Instructions: take 1-2 Tabs by mouth every 6 hours as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2008-06-19 13:04:00, ended at 2008-06-19 19:47:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Cataract\n\n### Drug\n- isosorbide dinitrate 30 MG Oral Tablet, through Oral route, presumably until 2009-06-26. Instructions: take 30 mg by mouth 2 times a day. \n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, presumably until 2008-09-11. Instructions: take 2 Caps by mouth 2 times a day. \n- gatifloxacin 3 MG/ML Ophthalmic Solution, through Intraocular route, started on 2008-06-19, presumably until 2008-06-19\n- tropicamide 10 MG/ML Ophthalmic Solution, through Intraocular route, started on 2008-06-19, presumably until 2008-06-19\n- Osmotic 24 HR nifedipine 30 MG Extended Release Oral Tablet, through Oral route, presumably until 2009-06-26. Instructions: take by mouth daily. \n- 24 HR metoprolol succinate 25 MG Extended Release Oral Tablet, through Oral route, presumably until 2009-09-01. Instructions: take 25 mg by mouth 2 times a day. \n- furosemide 40 MG Oral Tablet, through Oral route, presumably until 2008-09-11. Instructions: take by mouth daily. \n- gabapentin 300 MG Oral Tablet, through Oral route, presumably until 2009-05-22. Instructions: take 300 mg by mouth 2 times a day. \n- gabapentin 300 MG Oral Capsule, through Oral route, presumably until 2008-09-11. Instructions: take by mouth 2 times a day. \n- atorvastatin 20 MG Oral Tablet, through Oral route, presumably until 2009-05-22. Instructions: take by mouth daily. \n- phenylephrine hydrochloride 25 MG/ML Ophthalmic Solution, through Intraocular route, started on 2008-06-19, presumably until 2008-06-19\n- ketorolac tromethamine 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2008-06-19, presumably until 2008-06-19\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-06-26 00:00:00, ended at 2008-06-26 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 2.8 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.4 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 79.8 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 40 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.0 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.5 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 68 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.95 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.8 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 153 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.6 (percent)\n- MCH [Entitic mass] by Automated count: 26.0 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.7 (milligram per deciliter)\n- Prothrombin time (PT): 33.2 (second)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.23 (million per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 3.4 (ratio)\n- Monocytes [#/volume] in Blood by Automated count: 0.93 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 348 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 49 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 69.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.45 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: 4.9 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.81 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 77 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-07-25 00:00:00, ended at 2008-07-25 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.82 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.5 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 7.8 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.10 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19.1 (percent)\n- MCHC [Mass/volume] by Automated count: 32.2 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 78.2 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.65 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 346 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 48 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 56 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.76 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.3 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.9 (percent)\n- Prothrombin time (PT): 32.6 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 152 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.1 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 3.3 (ratio)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 6.8 (nanogram per milliliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 89 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 25.2 (picogram)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.8 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.06 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.8 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 4.1 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-08-08 00:00:00, ended at 2008-08-08 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Prothrombin time (PT): 26.5 (second)\n- INR in Platelet poor plasma by Coagulation assay: 2.6 (ratio)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-08-20 00:00:00, ended at 2008-08-20 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.1 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 59.5 (percent)\n- MCV [Entitic volume] by Automated count: 77.4 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 16.3 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 324 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 61 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.11 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 24.9 (picogram)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 64 (milligram per deciliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 1.0 (ratio)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 76 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.3 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.78 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 64 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.8 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 77 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.13 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 88 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 6.8 (nanogram per milliliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 141 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 11 (millimeter per hour)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.6 (percent)\n- MCHC [Mass/volume] by Automated count: 32.3 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.86 (thousand per microliter)\n- Prothrombin time (PT): 31.7 (second)\n- Urate [Mass/volume] in Serum or Plasma: 4.6 (milligram per deciliter)\n- Complement C3 [Mass/volume] in Serum or Plasma: 107 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.0 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 3.2 (ratio)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-09-04 00:00:00, ended at 2008-09-04 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Prothrombin time (PT): 19.9 (second)\n- INR in Platelet poor plasma by Coagulation assay: 1.8 (ratio)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-09-09 00:00:00, ended at 2008-09-09 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- MCV [Entitic volume] by Automated count: 77.1 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 307 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 41.4 (second)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 71 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 31.9 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 24.6 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 10.7 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 85 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.3 (thousand per microliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.33 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.4 (percent)\n- Prothrombin time (PT): 29.6 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.7 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 2.9 (ratio)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2008-09-11 10:38:00, ended at 2008-09-11 18:15:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- gatifloxacin 3 MG/ML Ophthalmic Solution, through Intraocular route, started on 2008-09-11, presumably until 2008-09-11\n- tropicamide 10 MG/ML Ophthalmic Solution, through Intraocular route, started on 2008-09-11, presumably until 2008-09-11\n- furosemide 20 MG Oral Tablet, through Oral route, presumably until 2010-09-01. Instructions: take by mouth daily. \n- metoclopramide 5 MG Oral Tablet, through Oral route, presumably until 2009-12-23. Instructions: take by mouth 2 times a day. 09/10/2008\n- phenylephrine hydrochloride 25 MG/ML Ophthalmic Solution, through Intraocular route, started on 2008-09-11, presumably until 2008-09-11\n- ketorolac tromethamine 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2008-09-11, presumably until 2008-09-11\n- tetracaine hydrochloride 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2008-09-11, presumably until 2008-09-11\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-09-23 00:00:00, ended at 2008-09-23 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.9 (percent)\n- MCV [Entitic volume] by Automated count: 77.0 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.2 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.2 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.83 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 316 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 35 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 73 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.3 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.0 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 153 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.9 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.3 (ratio)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Prothrombin time (PT): 24.3 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 4.0 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.14 (million per microliter)\n- MCH [Entitic mass] by Automated count: 24.8 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.52 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.71 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 75.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.1 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 8.3 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-10-09 00:00:00, ended at 2008-10-09 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 341 (microgram per deciliter)\n- Prothrombin time (PT): 25.1 (second)\n- INR in Platelet poor plasma by Coagulation assay: 2.3 (ratio)\n- Iron [Mass/volume] in Serum or Plasma: 9 (microgram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-10-24 00:00:00, ended at 2008-10-24 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.18 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.8 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 23.4 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 47 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.8 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.80 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.7 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.8 (percent)\n- MCV [Entitic volume] by Automated count: 73.8 (femtoliter)\n- Urate [Mass/volume] in Serum or Plasma: 4.5 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 349 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 140 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.7 (percent)\n- Tacrolimus [Mass/volume] in Blood: 7.0 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 70 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.11 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 82 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 31.7 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.83 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-11-05 00:00:00, ended at 2008-11-05 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- INR in Platelet poor plasma by Coagulation assay: 3.1 (ratio)\n- Prothrombin time (PT): 31.6 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-11-25 00:00:00, ended at 2008-11-25 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 71 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 83.9 (femtoliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.9 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 80.5 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 29.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.73 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 81 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 69 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 3.1 (ratio)\n- Platelets [#/volume] in Blood by Automated count: 266 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.63 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.7 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.0 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.85 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 58 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 130 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.7 (percent)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 47 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 26.6 (picogram)\n- MCHC [Mass/volume] by Automated count: 31.7 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 0.7 (ratio)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 59 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.6 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.39 (thousand per microliter)\n- Prothrombin time (PT): 31.2 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-11-25 00:00:00, ended at 2008-11-25 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 77 (unit per liter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.9 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 267 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.6 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.0 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Tacrolimus [Mass/volume] in Blood: 7.6 (nanogram per milliliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 78 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.72 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.7 (percent)\n- MCH [Entitic mass] by Automated count: 26.6 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 139 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 29.6 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.73 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.3 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.00 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 49 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 31.5 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.49 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- MCV [Entitic volume] by Automated count: 84.6 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 78.6 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-12-03 00:00:00, ended at 2008-12-03 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- INR in Platelet poor plasma by Coagulation assay: 2.0 (ratio)\n- Prothrombin time (PT): 22.4 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-12-09 00:00:00, ended at 2008-12-09 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 83.3 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.1 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 71 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.3 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.2 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.73 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 28.3 (picogram)\n- MCV [Entitic volume] by Automated count: 86.5 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.23 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.64 (million per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 40 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 89 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 27.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 10.07 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 262 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2008-12-09 15:14:00, ended at 2008-12-11 17:25:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 123 (unit per liter)\n- MCV [Entitic volume] by Automated count: 87.1 (femtoliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 50 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.11 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.55 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.8 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.1 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Prothrombin time (PT): 28.2 (second)\n- Eosinophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 3.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.70 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 27.5 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.2 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 52 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 253 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.5 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.54 (thousand per microliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Body height: 5' 3.6\" (inch (US))\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.5 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 2.7 (ratio)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.2 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 88.7 (percent)\n- Tacrolimus [Mass/volume] in Blood: 8.0 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 46.7 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Urinary tract infectious disease\n\n### Drug\n- amoxicillin 500 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2008-12-11, presumably until 2009-02-20, with quantity of 28.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 12 hours. \n- ascorbic acid 250 MG Oral Tablet, through Oral route, started on 2008-12-09, presumably until 2008-12-11\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2008-12-09, presumably until 2009-02-27. Instructions: take 325 mg by mouth 2 times a day. \n- furosemide 20 MG Oral Tablet, through Oral route, started on 2008-12-10, presumably until 2008-12-11\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2008-12-11, presumably until 2008-12-11\n- isosorbide dinitrate 10 MG Oral Tablet, through Oral route, started on 2008-12-09, presumably until 2008-12-11\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2008-12-09, presumably until 2008-12-09\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2008-12-09, presumably until 2008-12-11\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2008-12-10, presumably until 2008-12-11\n- Osmotic 24 HR nifedipine 30 MG Extended Release Oral Tablet, through Oral route, started on 2008-12-11, presumably until 2008-12-11\n- ciprofloxacin 500 MG Oral Tablet, through Oral route, presumably until 2008-12-11. Instructions: take 500 mg by mouth 2 times a day. \n- 500 ML glucose 50 MG/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2008-12-10, presumably until 2008-12-11\n- metoclopramide 5 MG Oral Tablet, through Oral route, started on 2008-12-09, presumably until 2008-12-11\n- warfarin sodium 4 MG Oral Tablet, through Oral route, started on 2008-12-09, presumably until 2008-12-10\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2008-12-11, presumably until 2008-12-11\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2008-12-10, presumably until 2008-12-11\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2008-12-09, presumably until 2008-12-11\n- atorvastatin 20 MG Oral Tablet, through Oral route, started on 2008-12-09, presumably until 2008-12-10\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2008-12-09, presumably until 2008-12-11\n- nitroglycerin 0.4 MG Sublingual Tablet, through Sublingual route, presumably until 2010-07-03. Instructions: 0.4 mg by Sublingual route as needed \n- ascorbic acid 500 MG Oral Tablet, through Oral route, presumably until 2009-05-22. Instructions: take 500 mg by mouth 2 times a day. \n- clopidogrel 75 MG Oral Tablet, through Oral route, started on 2008-12-10, presumably until 2008-12-11\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2008-12-10, presumably until 2008-12-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-12-24 00:00:00, ended at 2008-12-24 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 80 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.89 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.6 (percent)\n- Platelets [#/volume] in Blood by Automated count: 287 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 23.9 (percent)\n- MCH [Entitic mass] by Automated count: 28.0 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Prothrombin time (PT): 18.7 (second)\n- Tacrolimus [Mass/volume] in Blood: 20.7 (nanogram per milliliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 54 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.2 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 13.7 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.6 (ratio)\n- MCHC [Mass/volume] by Automated count: 32.1 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 87.0 (femtoliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.0 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Erythrocyte sedimentation rate: 0 (millimeter per hour)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.05 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.8 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.27 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 68.4 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 3.7 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 141 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.82 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-12-27 00:00:00, ended at 2008-12-27 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Tacrolimus [Mass/volume] in Blood: 9.3 (nanogram per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-01-06 00:00:00, ended at 2009-01-06 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- INR in Platelet poor plasma by Coagulation assay: 2.6 (ratio)\n- Prothrombin time (PT): 27.4 (second)\n- aPTT in Platelet poor plasma by Coagulation assay: 38.9 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-01-23 00:00:00, ended at 2009-01-23 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.78 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 12.2 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 5.5 (nanogram per milliliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.9 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.0 (percent)\n- MCH [Entitic mass] by Automated count: 28.9 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 71.4 (percent)\n- Prothrombin time (PT): 24.1 (second)\n- Triglyceride [Moles/volume] in Serum or Plasma: 55 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.89 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.1 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.59 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.4 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.2 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.3 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.91 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.0 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 3.7 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 148 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.2 (ratio)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 83 (unit per liter)\n- MCV [Entitic volume] by Automated count: 89.6 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 257 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-02-20 00:00:00, ended at 2009-02-20 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 60 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 68 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.84 (million per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 77.7 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 88 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.0 (percent)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 0.8 (ratio)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 2.9 (ratio)\n- MCH [Entitic mass] by Automated count: 30.2 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 6.86 (thousand per microliter)\n- Prothrombin time (PT): 29.4 (second)\n- Urate [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 73 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.80 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.0 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.2 (percent)\n- Tacrolimus [Mass/volume] in Blood: 4.8 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 148 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 79 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 222 (thousand per microliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 14.6 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.16 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.3 (percent)\n- MCV [Entitic volume] by Automated count: 90.9 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 38 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.9 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2009-02-21 15:20:00, ended at 2009-02-22 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Peritonsillar abscess\n\n### Drug\n- clindamycin 150 MG Oral Capsule, through Oral route, started on 2009-02-21, presumably until 2009-02-21\n- clindamycin 300 MG Oral Capsule, through Oral route, started on 2009-02-21, presumably until 2009-03-01, with quantity of 28.0, with intended 0 refill(s). Instructions: take 1 Cap by mouth 4 times a day. \n- acetaminophen 24 MG/ML / codeine phosphate 2.4 MG/ML Oral Solution, through Oral route, started on 2009-02-21, presumably until 2009-03-07, with intended 0 refill(s). Instructions: take 25 mL by mouth every 6 hours as needed for Pain. max 4 grams tylenol per day \n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2009-02-21, presumably until 2009-02-21\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-02-27 09:12:00, ended at 2009-02-27 17:05:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n- INR in Platelet poor plasma by Coagulation assay: 2.4 (ratio)\n- aPTT in Platelet poor plasma by Coagulation assay: 36.5 (second)\n- Prothrombin time (PT): 25.9 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 1 ML meperidine hydrochloride 25 MG/ML Cartridge, started on 2009-02-27, presumably until 2009-02-27\n- 2 ML ondansetron 2 MG/ML Injection, started on 2009-02-27, presumably until 2009-02-27\n- 1 ML promethazine hydrochloride 25 MG/ML Injection, started on 2009-02-27, presumably until 2009-02-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-03-04 00:00:00, ended at 2009-03-04 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 7.2 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2009-03-04 14:48:00, ended at 2009-03-04 17:51:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- aPTT in Platelet poor plasma by Coagulation assay: 51.1 (second)\n- Prothrombin time (PT): 30.1 (second)\n- INR in Platelet poor plasma by Coagulation assay: 2.9 (ratio)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Wrist joint pain\n\n### Drug\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2009-03-04, presumably until 2009-08-28, with quantity of 60.0, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-03-24 00:00:00, ended at 2009-03-24 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Leukocytes [#/volume] in Specimen by Automated count: 6.6 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.3 (percent)\n- MCV [Entitic volume] by Automated count: 90.1 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 66.9 (percent)\n- Platelets [#/volume] in Blood by Automated count: 313 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 8.0 (nanogram per milliliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.6 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.6 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.03 (thousand per microliter)\n- Prothrombin time (PT): 29.9 (second)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.65 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.9 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.4 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 2.9 (ratio)\n- MCH [Entitic mass] by Automated count: 29.4 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 15.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.38 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.07 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 4.1 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 139 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 86 (unit per liter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 56 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2009-04-07 00:00:00, ended at 2009-04-07 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Breast lump\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-04-15 11:24:00, ended at 2009-04-15 13:52:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alendronic acid 70 MG Oral Tablet, through Oral route, presumably until 2009-06-03. Instructions: take by mouth. \n- benzocaine 140 MG/ML / butamben 20 MG/ML / tetracaine 20 MG/ML Mucosal Spray, through Topical route, started on 2009-04-15, presumably until 2009-04-15\n- metoclopramide 5 MG Oral Tablet, through Oral route, presumably until 2009-05-22. Instructions: take by mouth. \n- atorvastatin 20 MG Oral Tablet, through Oral route, presumably until 2009-12-23. Instructions: take by mouth. \n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2009-04-15, presumably until 2009-04-15\n- mycophenolate mofetil 500 MG Oral Tablet, through Oral route, presumably until 2009-05-22. Instructions: take by mouth. \n- midazolam 1 MG/ML Injectable Solution, started on 2009-04-15, presumably until 2009-04-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2009-04-18 00:00:00, ended at 2009-04-18 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of function of stomach\n\n### Drug\n- ranitidine 300 MG Oral Tablet, through Oral route, started on 2009-04-18, presumably until 2012-05-31, with quantity of 90.0, with intended 4 refill(s). Instructions: take 300 mg by mouth daily with dinner. Take T PO every day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-04-22 00:00:00, ended at 2009-04-22 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- INR in Platelet poor plasma by Coagulation assay: 1.6 (ratio)\n- Monocytes/100 leukocytes in Blood by Automated count: 15.9 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 62.0 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.5 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20.3 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.45 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.3 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.13 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- MCV [Entitic volume] by Automated count: 91.0 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 240 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 14.5 (nanogram per milliliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.88 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.6 (thousand per microliter)\n- Prothrombin time (PT): 18.2 (second)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 79 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.53 (million per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.8 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 32 (milligram per deciliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 152 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.3 (percent)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.6 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 78 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-05-01 00:00:00, ended at 2009-05-01 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Prothrombin time (PT): 19.2 (second)\n- INR in Platelet poor plasma by Coagulation assay: 1.7 (ratio)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-05-22 00:00:00, ended at 2009-05-22 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.93 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 8.3 (nanogram per milliliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.7 (percent)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.8 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.8 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.93 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.3 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 49 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 76 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.5 (percent)\n- Prothrombin time (PT): 22.9 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 79 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 89.0 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.1 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 12 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 258 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: 3.0 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 144 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.77 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.0 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.1 (ratio)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.09 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.4 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.1 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 15.4 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2009-05-28 00:00:00, ended at 2009-05-28 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypersensitivity angiitis\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2009-05-28, presumably until 2009-10-24, with quantity of 30.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2009-05-29 00:00:00, ended at 2009-05-29 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of bone and articular cartilage\n\n### Drug\n- alendronic acid 70 MG Oral Tablet, through Oral route, started on 2009-05-29, presumably until 2009-09-23, with quantity of 4.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 7 days. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-06-24 00:00:00, ended at 2009-06-24 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 148 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.7 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 46 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 83 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.5 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20.8 (percent)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.8 (percent)\n- Tacrolimus [Mass/volume] in Blood: 8.8 (nanogram per milliliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 64.0 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.3 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.04 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 14.2 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.13 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- INR in Platelet poor plasma by Coagulation assay: 2.4 (ratio)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.34 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 85.6 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 287 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Prothrombin time (PT): 25.6 (second)\n- Urate [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 80 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 10 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.2 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.89 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.1 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-06-26 00:00:00, ended at 2009-06-26 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- tacrolimus 0.5 MG Oral Capsule, through Oral route, started on 2009-06-26, presumably until 2009-08-28, with quantity of 90.0, with intended 3 refill(s). Instructions: take 1 Cap by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2009-07-03 00:00:00, ended at 2009-07-03 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-07-24 00:00:00, ended at 2009-07-24 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.82 (million per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.7 (ratio)\n- Neutrophils [#/volume] in Blood by Automated count: 3.21 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20.2 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.8 (percent)\n- MCV [Entitic volume] by Automated count: 84.6 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.88 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.3 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.7 (milligram per deciliter)\n- Prothrombin time (PT): 28.0 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.06 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.9 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.4 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 7.7 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 62 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.1 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 65 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 27.8 (picogram)\n- Cholesterol [Mass/volume] in Serum or Plasma: 131 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 16.8 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 44 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.2 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 267 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-08-25 00:00:00, ended at 2009-08-25 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.4 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.7 (ratio)\n- Neutrophils [#/volume] in Blood by Automated count: 3.63 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 62.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 283 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 63 (unit per liter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.8 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19.0 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 82 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.11 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.1 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 133 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.8 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.0 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 85.1 (femtoliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.0 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 16.4 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.6 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Prothrombin time (PT): 28.4 (second)\n- Tacrolimus [Mass/volume] in Blood: 7.9 (nanogram per milliliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 56 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.59 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 27.4 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.95 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-09-01 00:00:00, ended at 2009-09-01 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-09-03 00:00:00, ended at 2009-09-03 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- General examination of patient\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2009-09-16 00:00:00, ended at 2009-09-16 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2009-09-16, presumably until 2010-09-23, with quantity of 180.0, with intended 11 refill(s). Instructions: take 3 Caps by mouth 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2009-09-23 00:00:00, ended at 2009-09-23 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of bone and articular cartilage\n\n### Drug\n- alendronic acid 70 MG Oral Tablet, through Oral route, started on 2009-09-23, presumably until 2010-02-23, with quantity of 4.0, with intended 11 refill(s). Instructions: take 1 Tab by mouth every 7 days. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-09-23 12:14:00, ended at 2009-09-23 23:59:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Lymphocytes [#/volume] in Blood by Automated count: 1.05 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.4 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 16.6 (percent)\n- Platelets [#/volume] in Blood by Automated count: 267 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 140 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.91 (thousand per microliter)\n- Prothrombin time (PT): 33.5 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.41 (million per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 3.4 (ratio)\n- MCV [Entitic volume] by Automated count: 83.6 (femtoliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.9 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.9 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 21.6 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 30 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 74 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 87 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 27.1 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 59.9 (percent)\n- Tacrolimus [Mass/volume] in Blood: 7.4 (nanogram per milliliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.6 (percent)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.81 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n- Disorder of phosphorus metabolism\n- Blood chemistry abnormal\n- Hyperlipidemia\n- Closed fracture of distal end of radius\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-09-30 13:55:43, ended at 2009-09-30 15:19:38\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypersensitivity angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-10-01 13:48:16, ended at 2009-10-01 15:06:06\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of left eye: 14 (millimeter mercury column)\n- Intraocular pressure of right eye: 13 (millimeter mercury column)\n\n### Procedure\n- Scanning computerized ophthalmic diagnostic imaging, posterior segment, (eg, scanning laser) with interpretation and report, unilateral\n\n### Condition\n- Disorder of eye due to diabetes mellitus\n- Vitreous hemorrhage\n- Vitreous opacities\n- Epiretinal membrane\n- Vitreous degeneration\n- Disorder of eye due to type 1 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-10-09 14:34:29, ended at 2009-10-09 15:16:10\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2009-10-14 00:00:00, ended at 2009-10-14 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-15 13:20:00, ended at 2009-10-15 23:59:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, pelvis; without contrast material(s)\n\n### Condition\n- Hypersensitivity angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-23 10:24:00, ended at 2009-10-23 11:45:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of lower extremity arteries or arterial bypass grafts; unilateral or limited study\n\n### Condition\n- Atherosclerosis of arteries of the extremities\n- Intermittent claudication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-10-23 10:25:09, ended at 2009-10-23 13:40:03\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Intermittent claudication\n- Primary diagnosis: Atherosclerosis of arteries of the extremities\n\n### Drug\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, presumably until 2009-10-24. Instructions: take by mouth as needed pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-23 11:46:00, ended at 2009-10-23 23:59:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.8 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 84 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Erythrocyte sedimentation rate: 3 (millimeter per hour)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 15.3 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.66 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 76 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 81.8 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 305 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 6.4 (nanogram per milliliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.5 (ratio)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.22 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.9 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 146 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.84 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.4 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.9 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20.7 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.90 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 25.6 (picogram)\n- Prothrombin time (PT): 26.4 (second)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.6 (percent)\n- MCHC [Mass/volume] by Automated count: 31.2 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Essential hypertension\n- Hypersensitivity angiitis\n- Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2009-10-24 00:00:00, ended at 2009-10-24 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Peripheral vascular disease\n\n### Drug\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2009-10-24, presumably until 2010-12-16, with quantity of 30.0, with intended 2 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed pain \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2009-10-24 00:00:00, ended at 2009-10-24 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypersensitivity angiitis\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2009-10-24, presumably until 2010-03-03, with quantity of 30.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-10-30 10:27:40, ended at 2009-10-30 14:31:37\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Aseptic necrosis of bone\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-30 10:32:00, ended at 2009-10-30 23:59:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, wrist; complete, minimum of 3 views\n\n### Condition\n- Wrist joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2009-11-03 00:00:00, ended at 2009-11-03 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypersensitivity angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-11-18 09:47:20, ended at 2009-11-18 10:26:37\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- Routine gynecologic examination\n\n### Condition\n- Postmenopausal bleeding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-21 10:45:00, ended at 2009-11-21 12:33:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Phosphate [Mass/volume] in Serum or Plasma: 2.7 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 42 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 69 (unit per liter)\n- Tacrolimus [Mass/volume] in Blood: 6.3 (nanogram per milliliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.8 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.6 (ratio)\n- Platelets [#/volume] in Blood by Automated count: 280 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 85 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 25.4 (picogram)\n- MCHC [Mass/volume] by Automated count: 31.8 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 16.2 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 138 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.5 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- MCV [Entitic volume] by Automated count: 80.0 (femtoliter)\n- Urate [Mass/volume] in Serum or Plasma: 3.1 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.05 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.8 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 1.01 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.11 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.6 (percent)\n- Prothrombin time (PT): 27.7 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.64 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.3 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hyperlipidemia\n- Transplanted kidney present\n- Blood chemistry abnormal\n- Disorder of phosphorus metabolism\n- Postmenopausal bleeding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-21 12:34:00, ended at 2009-11-21 23:59:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, pelvic (nonobstetric), real time with image documentation; complete\n- Ultrasound, transvaginal\n\n### Condition\n- Postmenopausal bleeding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2009-11-27 00:00:00, ended at 2009-11-27 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2009-11-27 00:00:00, ended at 2009-11-27 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Noninflammatory disorder of the female genital organs\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-11-27 10:40:56, ended at 2009-11-27 12:08:18\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n- Transplanted kidney present\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-03 15:26:00, ended at 2009-12-03 23:59:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Noninflammatory disorder of the female genital organs\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-12-15 12:41:04, ended at 2009-12-15 22:21:16\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Epigastric pain\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2009-12-15, presumably until 2010-03-31, with quantity of 30.0, with intended 12 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-15 13:49:00, ended at 2009-12-15 23:59:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.59 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- MCV [Entitic volume] by Automated count: 79.8 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 320 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.72 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.9 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.5 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.7 (percent)\n- MCHC [Mass/volume] by Automated count: 31.1 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 82.1 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.9 (percent)\n- MCH [Entitic mass] by Automated count: 24.8 (picogram)\n- Hemoglobin [Mass/volume] in Blood: 11.7 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.69 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.62 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Epigastric pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-15 13:49:00, ended at 2009-12-15 23:59:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 76 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 88 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Epigastric pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-16 12:24:00, ended at 2009-12-16 15:30:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Endoscopy and biopsy of upper gastrointestinal tract\n\n### Condition\n- Disorder of upper gastrointestinal tract\n- Dysphagia\n- Epigastric pain\n- Gastritis\n\n### Drug\n- benzocaine 140 MG/ML / butamben 20 MG/ML / tetracaine 20 MG/ML Mucosal Spray, through Topical route, started on 2009-12-16, presumably until 2009-12-16\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2009-12-16, presumably until 2009-12-16\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2009-12-23 00:00:00, ended at 2009-12-23 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n- Disorder of nervous system due to diabetes mellitus\n\n### Drug\n- metoclopramide 5 MG Oral Tablet, through Oral route, started on 2009-12-23, presumably until 2010-04-28, with quantity of 60.0, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day. 09/10/2008 \n- atorvastatin 20 MG Oral Tablet, through Oral route, started on 2009-12-23, presumably until 2010-12-31, with quantity of 30.0, with intended 11 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-24 11:21:00, ended at 2009-12-24 23:59:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Lymphocytes [#/volume] in Blood by Automated count: 0.92 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 24.4 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 3.91 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 77 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.76 (million per microliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 1.0 (ratio)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 75 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 78.1 (femtoliter)\n- Prothrombin time (PT): 36.3 (second)\n- C reactive protein [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 67 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 3.7 (ratio)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Complement C3 [Mass/volume] in Serum or Plasma: 97 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Tacrolimus [Mass/volume] in Blood: 8.5 (nanogram per milliliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.7 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.6 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 17.4 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 67.4 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 42 (milligram per deciliter)\n- Albumin [Mass/volume] in Urine: <3 (milligram per liter)\n- Albumin/Creatinine [Mass Ratio] in Urine: <30 (milligram per gram)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Erythrocyte sedimentation rate: 2 (millimeter per hour)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.9 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.2 (percent)\n- MCHC [Mass/volume] by Automated count: 31.4 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 143 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.0 (percent)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 85 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.8 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.1 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 310 (thousand per microliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 68 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.99 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hypersensitivity angiitis\n- Type 2 diabetes mellitus without complication\n- Transplanted kidney present\n- Hyperlipidemia\n- Essential hypertension\n- Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-12-29 10:13:32, ended at 2009-12-29 11:07:58\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypersensitivity angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-12-29 14:08:15, ended at 2009-12-29 17:53:03\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Varicose veins of lower extremity with inflammation\n\n### Drug\n- triamcinolone acetonide 0.001 MG/MG Topical Ointment, through Topical route, started on 2009-12-29, presumably until 2010-12-29, with intended 3 refill(s). Instructions: by Topical route 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-01 08:32:00, ended at 2010-01-01 12:05:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- Esophageal motility (manometric study of the esophagus and/or gastroesophageal junction) study with interpretation and report\n- Other nonoperative measurements and examinations\n- Esophageal function test, gastroesophageal reflux test with nasal catheter intraluminal impedance electrode(s) placement, recording, analysis and interpretation\n\n### Condition\n- Abdominal pain\n\n### Drug\n- benzocaine 140 MG/ML / butamben 20 MG/ML / tetracaine 20 MG/ML Mucosal Spray, through Topical route, started on 2010-01-01, presumably until 2010-01-01\n- lidocaine hydrochloride 0.02 MG/MG Topical Gel, through Submucosal route, started on 2010-01-01, presumably until 2010-01-01\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-01-07 00:00:00, ended at 2010-01-07 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Female genital organ symptoms\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-08 13:03:00, ended at 2010-01-08 23:59:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, pelvis; without contrast material(s), followed by contrast material(s) and further sequences\n\n### Condition\n- Female genital organ symptoms\n- Noninflammatory disorder of the female genital organs\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-01-14 00:00:00, ended at 2010-01-14 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Female genital organ symptoms\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-22 09:37:00, ended at 2010-01-22 23:59:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Prothrombin time (PT): 24.1 (second)\n- Tacrolimus [Mass/volume] in Blood: 5.5 (nanogram per milliliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 34 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 23.9 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 16.3 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.1 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.4 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 171 (unit per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 85 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.35 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 10.4 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.95 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 82 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.2 (ratio)\n- Neutrophils [#/volume] in Blood by Automated count: 3.80 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.6 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.99 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 17.0 (percent)\n- MCHC [Mass/volume] by Automated count: 31.1 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 318 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 148 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.3 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.8 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 76.6 (femtoliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hyperlipidemia\n- Essential hypertension\n- Hypersensitivity angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-02-03 10:49:40, ended at 2010-02-03 11:50:41\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Dysphagia\n- Acute pharyngitis\n- Nausea and vomiting\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2010-02-04 00:00:00, ended at 2010-02-04 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Diffuse spasm of esophagus\n\n### Drug\n- isosorbide dinitrate 30 MG Oral Tablet, through Oral route, started on 2010-02-12, presumably until 2010-06-19, with quantity of 60.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-02-09 16:04:00, ended at 2010-02-09 17:35:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Superficial foreign body\n\n### Drug\n- 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.005 UNT/ML / Bordetella pertussis toxoid vaccine, inactivated 0.016 MG/ML / diphtheria toxoid vaccine, inacti..., through Intramuscular route, started on 2010-02-09, presumably until 2010-02-09\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-19 10:46:00, ended at 2010-02-19 23:59:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, esophagus, including scout chest radiograph(s) and delayed image(s), when performed; single-contrast (eg, barium) study\n\n### Condition\n- Acute pharyngitis\n- Gastroesophageal reflux disease\n- Dysphagia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-02-23 00:00:00, ended at 2010-02-23 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-02-23 10:41:40, ended at 2010-02-23 11:57:43\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Neurogenic bladder\n- Transplanted kidney present\n- Hyperlipidemia\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-23 12:03:00, ended at 2010-02-23 23:59:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- INR in Platelet poor plasma by Coagulation assay: 2.1 (ratio)\n- Prothrombin time (PT): 22.7 (second)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Coronary arteriosclerosis\n- Hyperlipidemia\n- Renal disorder due to type 1 diabetes mellitus\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-02-24 00:00:00, ended at 2010-02-24 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mononeuritis\n\n### Drug\n- gabapentin 600 MG Oral Tablet, through Oral route, started on 2010-02-24, presumably until 2010-06-30, with quantity of 90.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-03-03 00:00:00, ended at 2010-03-03 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Systemic lupus erythematosus\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2010-03-03, presumably until 2010-07-22, with quantity of 30.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-12 09:54:00, ended at 2010-03-12 23:59:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Gastric emptying imaging study (eg, solid, liquid, or both)\n- Gastroesophageal reflux study\n\n### Condition\n- Peripheral vascular disease\n- Flatulence, eructation and gas pain\n- Hyperlipidemia\n- Nonproliferative retinopathy due to diabetes mellitus\n- Type 2 diabetes mellitus without complication\n- Nausea and vomiting\n- Coronary arteriosclerosis\n- Disorder of eye due to diabetes mellitus\n- Systemic lupus erythematosus\n- Chronic kidney disease stage 5 due to hypertension\n- End-stage renal disease\n- Osteoporosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-23 10:54:00, ended at 2010-03-23 23:59:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Albumin [Mass/volume] in Urine: <3 (milligram per liter)\n- Erythrocyte sedimentation rate: 9 (millimeter per hour)\n- Monocytes [#/volume] in Blood by Automated count: 0.91 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.5 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 68 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 76 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.8 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Complement C3 [Mass/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 23.5 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 4.27 (thousand per microliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 152 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.20 (million per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 4.5 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 0.9 (ratio)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.06 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 306 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.9 (ratio)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.7 (percent)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 84 (milligram per deciliter)\n- Prothrombin time (PT): 21.0 (second)\n- Triglyceride [Moles/volume] in Serum or Plasma: 41 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 79 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 76 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.3 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 73.2 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 67.7 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Albumin/Creatinine [Mass Ratio] in Urine: <30 (milligram per gram)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.1 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hyperlipidemia\n- Essential hypertension\n- Transplanted kidney present\n- Type 2 diabetes mellitus without complication\n- Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-03-31 09:38:18, ended at 2010-03-31 10:35:23\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- Laryngoscopy, flexible; diagnostic\n\n### Condition\n- Primary diagnosis: Dysphagia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-03-31 13:21:42, ended at 2010-03-31 13:58:25\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Anemia in chronic kidney disease\n\n### Drug\n- dexlansoprazole 30 MG Delayed Release Oral Capsule, through Oral route, presumably until 2010-06-19. Instructions: take by mouth. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-04-02 15:03:41, ended at 2010-04-02 15:49:08\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2.5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Diffuse spasm of esophagus\n- Dysphagia\n- Diarrhea\n- Primary diagnosis: Flatulence, eructation and gas pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-04 10:50:00, ended at 2010-04-04 23:59:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anemia in chronic kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-04-06 10:15:58, ended at 2010-04-06 11:20:42\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Systemic lupus erythematosus\n\n### Drug\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2010-04-06, presumably until 2010-04-28, with quantity of 14.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-06 13:35:00, ended at 2010-04-06 23:59:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, hand; 2 views\n- Ultrasound, pelvic (nonobstetric), real time with image documentation; complete\n- Ultrasound, transvaginal\n\n### Condition\n- Noninflammatory disorder of the female genital organs\n- Female genital organ symptoms\n- Systemic lupus erythematosus\n- Swelling of limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-04-09 00:00:00, ended at 2010-04-09 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Iron deficiency anemia\n- Feces contents abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-09 13:14:00, ended at 2010-04-09 23:59:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)\n\n### Condition\n- Lack of exercise\n- Disorder of bone and articular cartilage\n- Postmenopausal state\n- Disorder of endocrine system\n- Osteoporosis\n- Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-20 10:46:00, ended at 2010-04-20 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Albumin [Mass/volume] in Urine: 4 (milligram per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 153 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 391 (microgram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.24 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.4 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.6 (percent)\n- Platelets [#/volume] in Blood by Automated count: 370 (thousand per microliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 78 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 75 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.9 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 31.5 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.69 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 72.4 (percent)\n- Tacrolimus [Mass/volume] in Blood: 4.9 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 89 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 0.9 (ratio)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.7 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 2.8 (ratio)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.2 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.16 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 69 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.6 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 2.9 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.33 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 31 (milligram per deciliter)\n- Albumin/Creatinine [Mass Ratio] in Urine: 9 (milligram per gram)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.5 (percent)\n- MCH [Entitic mass] by Automated count: 22.6 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Prothrombin time (PT): 28.9 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Ferritin [Mass/volume] in Serum or Plasma: 3 (nanogram per milliliter)\n- Iron [Mass/volume] in Serum or Plasma: 10 (microgram per deciliter)\n- MCV [Entitic volume] by Automated count: 71.9 (femtoliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Anemia in chronic kidney disease\n- Transplanted kidney present\n- Systemic lupus erythematosus\n- Type 2 diabetes mellitus without complication\n- Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-21 11:07:00, ended at 2010-04-21 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, swallowing function, with cineradiography/videoradiography, including scout neck radiograph(s) and delayed image(s), when performed, contrast (eg, barium) study\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Dysphagia\n- Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-27 13:07:00, ended at 2010-04-27 16:20:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- Endoscopic biopsy of large intestine\n- Colonoscopy, flexible; with biopsy, single or multiple\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n\n### Condition\n- Feces contents abnormal\n- Inflammatory disorder of digestive tract\n- Iron deficiency anemia\n\n### Drug\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-04-27, presumably until 2010-04-27\n- midazolam 1 MG/ML Injectable Solution, started on 2010-04-27, presumably until 2010-04-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-04-28 00:00:00, ended at 2010-04-28 00:00:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2010-04-28, presumably until 2010-09-01, with quantity of 180.0, with intended 4 refill(s). Instructions: take 1 Tab by mouth 2 times a day. \n- metoprolol tartrate 50 MG Oral Tablet, through Oral route, started on 2010-04-28, presumably until 2010-04-28, with quantity of 120.0, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-28 14:00:00, ended at 2010-04-28 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of lower extremity arteries or arterial bypass grafts; unilateral or limited study\n\n### Condition\n- Intermittent claudication\n- Atherosclerosis of arteries of the extremities\n- Disorder of artery\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-04-28 14:01:54, ended at 2010-04-28 15:44:39\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Intermittent claudication\n- Primary diagnosis: Atherosclerosis of arteries of the extremities\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-05-05 08:25:00, ended at 2010-05-05 13:40:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2.5\" (inch (US))\n\n### Procedure\n- Other nonoperative measurements and examinations\n- Breath hydrogen or methane test (eg, for detection of lactase deficiency, fructose intolerance, bacterial overgrowth, or oro-cecal gastrointestinal transit)\n\n### Condition\n- Flatulence, eructation and gas pain\n- Diarrhea\n\n### Drug\n- lactulose 667 MG/ML Oral Solution, through Oral route, started on 2010-05-05, presumably until 2010-05-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2010-05-06 00:00:00, ended at 2010-05-06 00:00:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Iron deficiency anemia\n- Ulcerative colitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-05-07 11:40:00, ended at 2010-05-07 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.17 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 31.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 72.3 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 319 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 21 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 81 (milligram per deciliter)\n- Prothrombin time (PT): 20.2 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.9 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- INR in Platelet poor plasma by Coagulation assay: 1.8 (ratio)\n- Hemoglobin [Mass/volume] in Blood: 9.6 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 22.9 (picogram)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.9 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Ulcerative colitis\n- Iron deficiency anemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-05-10 10:31:00, ended at 2010-05-10 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomographic angiography, pelvis, with contrast material(s), including noncontrast images, if performed, and image postprocessing\n- Computed tomographic angiography, abdomen, with contrast material(s), including noncontrast images, if performed, and image postprocessing\n\n### Condition\n- Chronic vascular insufficiency of intestine\n- Disorder of intestine\n- Anemia\n- Iron deficiency anemia\n- Aneurysm of artery of lower extremity\n- Ulceration of intestine\n- Lymphadenopathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2010-05-15 00:00:00, ended at 2010-05-15 00:00:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Diarrhea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-05-19 08:47:33, ended at 2010-05-19 12:14:28\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Joint pain\n- Primary diagnosis: Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-05-19 08:49:00, ended at 2010-05-19 11:14:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, knee; 3 views\n- Radiologic examination, knee; both knees, standing, anteroposterior\n\n### Condition\n- Disorder of bone and articular cartilage\n- Synovial cyst of knee\n- Arthropathy of knee joint\n- Joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-05-19 11:15:00, ended at 2010-05-19 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, any joint of lower extremity; without contrast material\n\n### Condition\n- Synovial cyst of knee\n- Joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-05-21 11:17:26, ended at 2010-05-21 11:22:27\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Phlebitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-05-23 10:06:00, ended at 2010-05-23 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.47 (million per microliter)\n- Platelets [#/volume] in Blood by Automated count: 404 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 80 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 128 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.7 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 75.1 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 6.02 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.6 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.6 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 3.7 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- MCH [Entitic mass] by Automated count: 23.8 (picogram)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 21 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.9 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.86 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 7.1 (nanogram per milliliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 76 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 31.7 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 133 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 23.2 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.77 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 77.8 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 40 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n- Disorder of magnesium metabolism\n- Hyperlipidemia\n- Blood chemistry abnormal\n- Disorder of phosphorus metabolism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-05-29 09:47:29, ended at 2010-05-29 11:07:49\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Localized, primary osteoarthritis\n- Synovial cyst of knee\n- Joint pain\n- Osteoarthritis of knee\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-05-29 12:12:00, ended at 2010-05-29 13:15:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasonic guidance for needle placement (eg, biopsy, aspiration, injection, localization device), imaging supervision and interpretation\n\n### Condition\n- Localized, primary osteoarthritis\n- Synovial cyst of knee\n- Joint pain\n- Osteoarthritis of knee\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-06-04 14:18:00, ended at 2010-06-04 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Diarrhea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-06-19 00:00:00, ended at 2010-06-19 00:00:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Diffuse spasm of esophagus\n- Anemia in chronic kidney disease\n\n### Drug\n- isosorbide dinitrate 30 MG Oral Tablet, through Oral route, started on 2010-06-19, presumably until 2010-09-14, with quantity of 60.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day. \n- dexlansoprazole 30 MG Delayed Release Oral Capsule, through Oral route, started on 2010-06-19, presumably until 2010-06-25, with quantity of 30.0, with intended 12 refill(s). Instructions: take 1 Tab by mouth Every Day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-06-23 10:09:00, ended at 2010-06-23 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Urine: <3 (milligram per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.10 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.5 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 4.9 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 81 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.2 (ratio)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.0 (milligram per deciliter)\n- Prothrombin time (PT): 24.3 (second)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 73 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 11.6 (nanogram per milliliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 66 (milligram per deciliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 0.8 (ratio)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 27.0 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.2 (percent)\n- Platelets [#/volume] in Blood by Automated count: 258 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 76 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 30.6 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.8 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.01 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 68.4 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 79 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.94 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.9 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.0 (percent)\n- MCHC [Mass/volume] by Automated count: 31.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 85.3 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.83 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 49 (milligram per deciliter)\n- Albumin/Creatinine [Mass Ratio] in Urine: <30 (milligram per gram)\n- Cholesterol [Mass/volume] in Serum or Plasma: 155 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Hyperlipidemia\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-06-25 16:07:14, ended at 2010-06-25 17:16:45\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anemia in chronic kidney disease\n- Gastroesophageal reflux disease\n\n### Drug\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, presumably until 2010-10-01. Instructions: take 325 mg by mouth daily. \n- dexlansoprazole 30 MG Delayed Release Oral Capsule, through Oral route, started on 2010-06-25, presumably until 2010-07-08, with quantity of 30.0, with intended 12 refill(s). Instructions: take 1 Tab by mouth 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-06-29 00:00:00, ended at 2010-06-29 00:00:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Peripheral nerve disease\n\n### Drug\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2010-06-29, presumably until 2010-07-02, with quantity of 180.0, with intended 11 refill(s). Instructions: take 1 Cap by mouth 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-06-30 16:30:00, ended at 2010-06-30 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of artery\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-07-02 15:34:05, ended at 2010-07-02 16:36:23\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Peripheral nerve disease\n- Disorder of bone and articular cartilage\n- Female genital organ symptoms\n- Renal disorder due to type 1 diabetes mellitus\n- Transplanted kidney present\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, through Oral route, presumably until 2010-09-01. Instructions: take by mouth. Take 4.0 mg by mouth daily. 2.0mg in the morning and 2.0mg in the evening.\n- dexlansoprazole 30 MG Delayed Release Oral Capsule, through Oral route, presumably until 2010-08-17. Instructions: take by mouth. \n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2010-07-02, presumably until 2010-11-19, with quantity of 180.0, with intended 11 refill(s). Instructions: take 1 Cap by mouth 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-07-03 00:00:00, ended at 2010-07-03 00:00:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Angina pectoris\n\n### Drug\n- nitroglycerin 0.4 MG Sublingual Tablet, through Sublingual route, started on 2010-07-03, presumably until 2010-09-10, with intended 11 refill(s). Instructions: 1 Tab by Sublingual route as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-07-08 09:35:36, ended at 2010-07-08 10:14:53\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cyst of ovary\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-07-17 13:30:00, ended at 2010-07-17 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1.811\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Female genital organ symptoms\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-07-22 00:00:00, ended at 2010-07-22 00:00:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Systemic lupus erythematosus\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2010-07-22, presumably until 2011-02-23, with quantity of 30.0, with intended 2 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-07-24 00:00:00, ended at 2010-07-24 00:00:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Inconclusive mammography finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-07-24 08:57:00, ended at 2010-07-24 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- INR in Platelet poor plasma by Coagulation assay: 2.5 (ratio)\n- Prothrombin time (PT): 26.9 (second)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-07-29 00:00:00, ended at 2010-07-29 00:00:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Dysphagia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-07-31 10:58:00, ended at 2010-07-31 13:28:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, esophagus, including scout chest radiograph(s) and delayed image(s), when performed; single-contrast (eg, barium) study\n\n### Condition\n- Female genital organ symptoms\n- Transplanted kidney present\n- Dysphagia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-07-31 13:29:00, ended at 2010-07-31 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, pelvic (nonobstetric), real time with image documentation; complete\n- Ultrasound, transvaginal\n\n### Condition\n- Intra-abdominal and pelvic swelling, mass and lump\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-08-07 10:58:00, ended at 2010-08-07 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance imaging, breast, without and/or with contrast material(s); unilateral\n\n### Condition\n- Postmenopausal state\n- Benign neoplasm of skin\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-08-10 11:00:13, ended at 2010-08-10 12:32:22\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Arthrocentesis, aspiration and/or injection, major joint or bursa (eg, shoulder, hip, knee, subacromial bursa); without ultrasound guidance\n\n### Condition\n- Primary diagnosis: Systemic lupus erythematosus\n- Enthesopathy of hip region\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-08-14 13:30:00, ended at 2010-08-14 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1.811\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Female genital organ symptoms\n- Flatulence, eructation and gas pain\n- Cyst of ovary\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-08-17 00:00:00, ended at 2010-08-17 00:00:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Gastroesophageal reflux disease\n\n### Drug\n- dexlansoprazole 30 MG Delayed Release Oral Capsule, through Oral route, started on 2010-08-17, presumably until 2011-01-20, with quantity of 60.0, with intended 3 refill(s). Instructions: take 1 Cap by mouth 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-08-20 09:11:52, ended at 2010-08-20 10:24:54\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Dysphagia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-08-24 09:46:00, ended at 2010-08-24 11:29:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 47.8 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 1.13 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.2 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.1 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 93.0 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.63 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 81 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.7 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 2.8 (ratio)\n- Platelets [#/volume] in Blood by Automated count: 257 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 85 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.10 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 13.8 (percent)\n- MCH [Entitic mass] by Automated count: 30.8 (picogram)\n- Prothrombin time (PT): 29.2 (second)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.14 (million per microliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 4.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 15.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.0 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 151 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 1 (millimeter per hour)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 51 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 2.7 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 70.7 (percent)\n- Tacrolimus [Mass/volume] in Blood: 9.2 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2010-08-24 11:30:00, ended at 2010-09-01 17:00:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- MCH [Entitic mass] by Automated count: 31.5 (picogram)\n- Osmolality of Urine: 103 (milliosmole per kilogram)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.0 (percent)\n- Tacrolimus [Mass/volume] in Blood: 6.6 (nanogram per milliliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 88.1 (second)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 5.8 (ratio)\n- Prothrombin time (PT): 52.5 (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.87 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 228 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 15.0 (gram per deciliter)\n- Body height: 5' 2.5\" (inch (US))\n- Chloride [Moles/volume] in Serum or Plasma: 95 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 94.1 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 81 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.6 (thousand per microliter)\n\n### Procedure\n- Imaging supervision, interpretation and report for injection procedure(s) during cardiac catheterization; pulmonary angiography, aortography, and/or selective coronary angiography including venous bypass grafts and arterial conduits (whether native or use\n- Computed tomographic angiography, abdomen, with contrast material(s), including noncontrast images, if performed, and image postprocessing\n- Intravascular Doppler velocity and/or pressure derived coronary flow reserve measurement (coronary vessel or graft) during coronary angiography including pharmacologically induced stress; initial vessel (List separately in addition to code for primary pro\n- Collection of venous blood by venipuncture\n- Catheter placement in coronary artery(s), arterial coronary conduit(s), and/or venous coronary bypass graft(s) for coronary angiography without concomitant left heart catheterization\n- Computed tomographic angiography, pelvis, with contrast material(s), including noncontrast images, if performed, and image postprocessing\n- Cardiac blood pool imaging, gated equilibrium; multiple studies, wall motion study plus ejection fraction, at rest and stress (exercise and/or pharmacologic), with or without additional quantification\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Injection procedure during cardiac catheterization; for selective coronary angiography (injection of radiopaque material may be by hand)\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or \n- Therapeutic procedure, 1 or more areas, each 15 minutes; gait training (includes stair climbing)\n- Computed tomographic angiography, chest (noncoronary), with contrast material(s), including noncontrast images, if performed, and image postprocessing\n- Catheterization of left heart\n- Radiologic examination, spine; thoracic, 2 views\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Coronary arteriography using two catheters\n- Physical therapy evaluation\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; tracing only, without interpretation and report\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Chest pain\n- Coronary atherosclerosis\n- Angina pectoris\n- Nausea\n- Osteoporosis\n- Coag./bleeding tests abnormal\n- Coronary arteriosclerosis\n- Essential hypertension\n- Hyperlipidemia\n- Peripheral vascular disease\n- Systemic lupus erythematosus\n- Backache\n- Transplanted kidney present\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2010-08-27, presumably until 2010-09-01\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2010-08-25, presumably until 2010-09-01. Instructions: take 325 mg by mouth daily.\n- diltiazem hydrochloride 60 MG Oral Tablet, through Oral route, started on 2010-08-25, presumably until 2010-09-01\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2010-08-25, presumably until 2010-09-01\n- isosorbide dinitrate 10 MG Oral Tablet, through Oral route, started on 2010-08-24, presumably until 2010-09-01. Instructions: take 1 Tab by mouth 2 times a day. \n- 1000 ML potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2010-08-27, presumably until 2010-08-28\n- zolpidem tartrate 5 MG Oral Tablet, through Oral route, started on 2010-08-24, presumably until 2010-08-26. Instructions: Take as needed for sleep\n- diazepam 5 MG Oral Tablet, through Oral route, started on 2010-08-31, presumably until 2010-08-31\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2010-08-24, presumably until 2011-05-06, with quantity of 60.0, with intended 0 refill(s). Instructions: take by mouth. Take 4.0 mg by mouth daily. 2.0mg in the morning and 2.0mg in the evening.\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2010-08-26, presumably until 2010-09-01\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2010-08-29, presumably until 2010-09-01. Instructions: take by mouth as needed\n- warfarin sodium 4 MG Oral Tablet, through Oral route, started on 2010-08-25, presumably until 2010-10-01, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. \n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2010-08-24, presumably until 2010-09-01, with quantity of 180.0, with intended 4 refill(s). Instructions: take 1 Tab by mouth AM. \n- metoprolol tartrate 50 MG Oral Tablet, through Oral route, started on 2010-08-29, presumably until 2010-10-01, with quantity of 60.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every bedtime. \n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2010-08-29, presumably until 2010-08-30\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2010-08-25, presumably until 2010-09-01. Instructions: take 1 Tab by mouth daily.\n- isosorbide dinitrate 20 MG Oral Tablet, through Oral route, started on 2010-08-24, presumably until 2010-09-01. Instructions: take 1 Tab by mouth 2 times a day. \n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2010-08-24, presumably until 2010-09-01. Instructions: take 1 Cap by mouth 2 times a day. \n- atorvastatin 20 MG Oral Tablet, through Oral route, started on 2010-08-24, presumably until 2010-08-31. Instructions: take 1 Tab by mouth daily. \n- 1 ML vitamin K1 10 MG/ML Injection, through Intravenous route, started on 2010-08-28, presumably until 2010-08-28\n- hydromorphone hydrochloride 2 MG Oral Tablet, through Oral route, started on 2010-08-24, presumably until 2010-08-31\n- 2 ML ondansetron 2 MG/ML Injection, started on 2010-08-27, presumably until 2010-08-31\n- warfarin sodium 2 MG Oral Tablet, through Oral route, started on 2010-08-26, presumably until 2010-08-26\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2010-08-24, presumably until 2010-08-24\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-08-24, presumably until 2010-09-01\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2010-08-31, presumably until 2010-08-31\n- lidocaine 0.05 MG/MG Medicated Patch, through Topical route, started on 2010-08-26, presumably until 2010-08-31\n- nitroglycerin 0.4 MG Sublingual Tablet, through Sublingual route, started on 2010-08-24, presumably until 2010-08-26. Instructions: 1 Tab by Sublingual route as needed \n- mycophenolate mofetil 500 MG Oral Tablet, through Oral route, started on 2010-08-25, presumably until 2010-08-27\n- clopidogrel 75 MG Oral Tablet, through Oral route, started on 2010-08-27, presumably until 2010-09-01\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2010-08-27 09:40:53, ended at 2010-08-27 15:59:28\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; tracing only, without interpretation and report\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; interpretation and report only\n\n### Condition\n- Coronary arteriosclerosis\n- Chest pain\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-09-04 10:32:18, ended at 2010-09-04 10:57:31\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Phlebitis\n- Hypercoagulability state\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-09-08 00:00:00, ended at 2010-09-08 00:00:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-09-08 10:26:00, ended at 2010-09-08 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Albumin/Creatinine [Mass Ratio] in Urine: 11 (milligram per gram)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 85 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 71 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 75 (milligram per deciliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 1.1 (ratio)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.2 (percent)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 31.0 (second)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 330 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.50 (million per microliter)\n- Tacrolimus [Mass/volume] in Blood: 2.3 (nanogram per milliliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 14.3 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.9 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.07 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Albumin [Mass/volume] in Urine: 5 (milligram per liter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 88 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.7 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.88 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.0 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.5 (ratio)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.87 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.7 (percent)\n- MCV [Entitic volume] by Automated count: 96.0 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 68.6 (percent)\n- Prothrombin time (PT): 18.0 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 159 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 89 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.8 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 65 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Transplanted kidney present\n- Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-09-10 00:00:00, ended at 2010-09-10 00:00:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Angina pectoris\n\n### Drug\n- nitroglycerin 0.4 MG Sublingual Tablet, through Sublingual route, started on 2010-09-10, presumably until 2012-01-13, with intended 11 refill(s). Instructions: 1 Tab by Sublingual route as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-09-10 15:40:15, ended at 2010-09-10 16:31:17\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pain in limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-09-14 00:00:00, ended at 2010-09-14 00:00:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-09-14 08:45:00, ended at 2010-09-14 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.7 (percent)\n- MCH [Entitic mass] by Automated count: 31.8 (picogram)\n- Urate [Mass/volume] in Serum or Plasma: 2.5 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 64.6 (percent)\n- Platelets [#/volume] in Blood by Automated count: 277 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.60 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 80 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 94.2 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 15.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.56 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.5 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 5.7 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 76 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 150 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.6 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.5 (percent)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.03 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.83 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 46 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.1 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n- Diffuse spasm of esophagus\n- Coronary atherosclerosis\n- Renal disorder due to type 1 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-09-14 10:50:38, ended at 2010-09-14 12:16:40\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-09-14 13:08:24, ended at 2010-09-14 14:14:16\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Coronary atherosclerosis\n- Renal disorder due to type 1 diabetes mellitus\n- Transplanted kidney present\n- Primary diagnosis: Diffuse spasm of esophagus\n\n### Drug\n- isosorbide dinitrate 30 MG Oral Tablet, through Oral route, started on 2010-09-14, presumably until 2010-11-11, with quantity of 90.0, with intended 5 refill(s). Instructions: take 1.5 Tabs by mouth 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-09-22 09:07:00, ended at 2010-09-22 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Albumin/Creatinine [Mass Ratio] in Urine: <30 (milligram per gram)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.5 (percent)\n- MCV [Entitic volume] by Automated count: 95.4 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.77 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 106 (unit per liter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 67 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.4 (picogram)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.3 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 5.9 (nanogram per milliliter)\n- Albumin [Mass/volume] in Urine: <5 (milligram per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 154 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 77 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.7 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 50 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 0.9 (ratio)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.5 (percent)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.48 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.2 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 263 (thousand per microliter)\n- Prothrombin time (PT): 31.7 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 32.9 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 77 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 76 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.8 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 4.9 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 3.3 (ratio)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.70 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.3 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.5 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.99 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hyperlipidemia\n- Type 2 diabetes mellitus without complication\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-09-23 00:00:00, ended at 2010-09-23 00:00:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2010-09-23, presumably until 2011-05-06, with quantity of 180.0, with intended 11 refill(s). Instructions: take 3 Caps by mouth 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-09-29 11:06:00, ended at 2010-09-29 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- INR in Platelet poor plasma by Coagulation assay: 2.9 (ratio)\n- Prothrombin time (PT): 28.9 (second)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Epiretinal membrane\n- Renal disorder due to type 1 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-09-30 00:00:00, ended at 2010-09-30 00:00:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Dysphagia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-09-30 09:56:59, ended at 2010-09-30 15:01:08\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Determination of refractive state\n\n### Condition\n- Epiretinal membrane\n- Renal disorder due to type 1 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-09-30 12:55:51, ended at 2010-09-30 15:02:18\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of right eye: 12 (millimeter mercury column)\n- Intraocular pressure of left eye: 13 (millimeter mercury column)\n\n### Procedure\n- Scanning computerized ophthalmic diagnostic imaging, posterior segment, (eg, scanning laser) with interpretation and report, unilateral\n\n### Condition\n- Primary diagnosis: Epiretinal membrane\n- Disorder of eye due to type 1 diabetes mellitus\n- Proliferative retinopathy due to diabetes mellitus\n- Vitreous degeneration\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-10-01 13:45:00, ended at 2010-10-01 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1.811\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Breast lump\n\n### Drug\n- 24 HR metoprolol succinate 25 MG Extended Release Oral Tablet, through Oral route, presumably until 2010-11-05. Instructions: take 25 mg by mouth 2 times a day. 25mg in am, 50mg in pm \n- warfarin sodium 2 MG Oral Tablet, through Oral route, presumably until 2011-03-29. Instructions: take 2 mg by mouth. Twice weekly. Pomona days a week is 4mg. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-10-06 13:25:57, ended at 2010-10-06 14:15:30\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-10-12 07:59:00, ended at 2010-10-12 13:07:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Prothrombin time (PT): 24.9 (second)\n- INR in Platelet poor plasma by Coagulation assay: 2.4 (ratio)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-10-12 13:08:00, ended at 2010-10-12 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, breast(s) (unilateral or bilateral), real time with image documentation\n- Mammography; bilateral\n- Computer-aided detection (computer algorithm analysis of digital image data for lesion detection) with further review for interpretation, with or without digitization of film radiographic images; diagnostic mammography (List separately in addition to code\n\n### Condition\n- Abnormal findings on diagnostic imaging of breast\n- Disorder of breast\n- Postmenopausal state\n- Type 2 diabetes mellitus without complication\n- Breast lump\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-10-14 13:09:39, ended at 2010-10-14 14:04:31\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Diffuse spasm of esophagus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-10-16 12:28:00, ended at 2010-10-16 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Esophageal motility\n\n### Condition\n- Achalasia of esophagus\n- Dysphagia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-10-22 13:30:00, ended at 2010-10-22 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1.811\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Breast lump\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-10-24 00:00:00, ended at 2010-10-24 00:00:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Breast lump\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-11-04 00:00:00, ended at 2010-11-04 00:00:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Breast lump\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-11-05 00:00:00, ended at 2010-11-05 00:00:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Peripheral nerve disease\n- Transplanted kidney present\n\n### Drug\n- 24 HR metoprolol succinate 25 MG Extended Release Oral Tablet, through Oral route, started on 2010-11-05, presumably until 2011-05-25, with quantity of 90.0, with intended 6 refill(s). Instructions: take 1 Tab by mouth 2 times a day. 25mg in am, 50mg in pm \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-11-11 08:55:51, ended at 2010-11-11 09:23:01\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 0\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chest pain\n- Dysphagia\n- Primary diagnosis: Diffuse spasm of esophagus\n\n### Drug\n- isosorbide dinitrate 30 MG Oral Tablet, through Oral route, started on 2010-11-11, presumably until 2011-07-21, with quantity of 60.0, with intended 6 refill(s). Instructions: take 1 Tab by mouth 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-11-11 09:32:00, ended at 2010-11-11 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Prothrombin time (PT): 27.4 (second)\n- INR in Platelet poor plasma by Coagulation assay: 2.7 (ratio)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Diffuse spasm of esophagus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-11-15 09:21:00, ended at 2010-11-15 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Breast lump\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-11-16 15:04:00, ended at 2010-11-16 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance imaging, breast, without and/or with contrast material(s); bilateral\n\n### Condition\n- Breast lump\n- Postmenopausal state\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-11-17 13:09:09, ended at 2010-11-17 14:48:18\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- Duplex scan of lower extremity arteries or arterial bypass grafts; unilateral or limited study\n\n### Condition\n- Primary diagnosis: Peripheral vascular disease\n- Intermittent claudication\n- Atherosclerosis of arteries of the extremities\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-11-19 00:00:00, ended at 2010-11-19 00:00:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n- Peripheral nerve disease\n\n### Drug\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2010-11-19, presumably until 2011-05-06, with quantity of 180.0, with intended 11 refill(s). Instructions: take 1 Cap by mouth 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-11-23 10:24:00, ended at 2010-11-23 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 93 (unit per liter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 32.5 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.79 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.0 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 85 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.90 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 28.9 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.3 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.62 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.0 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 71.8 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.24 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.3 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 42 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 145 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 89.0 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 21 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 3.1 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.4 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.7 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.4 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 315 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 10.8 (nanogram per milliliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 4.9 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hyperlipidemia\n- Blood chemistry abnormal\n- Transplanted kidney present\n- Disorder of phosphorus metabolism\n- Disorder of magnesium metabolism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-11-25 10:46:45, ended at 2010-11-25 12:34:23\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Injection(s); single tendon sheath, or ligament, aponeurosis (eg, plantar  fascia )\n\n### Condition\n- Primary diagnosis: Acquired trigger finger\n\n### Drug\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2010-11-25, presumably until 2010-11-25, with intended 0 refill(s). Instructions: 0.7 mL by Injection route One Time. \n- betamethasone 3 MG/ML / betamethasone acetate 3 MG/ML Injectable Suspension, started on 2010-11-25, presumably until 2010-11-25, with quantity of 1.0, with intended 0 refill(s). Instructions: 0.7 mL by Injection route One Time. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-11-25 11:52:00, ended at 2010-11-25 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, wrist; complete, minimum of 3 views\n- Radiologic examination, hand; minimum of 3 views\n\n### Condition\n- Postprocedural state finding\n- Disorder of wrist joint\n- Wrist joint pain\n- Degenerative joint disease of hand\n- Pain in limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-11-30 00:00:00, ended at 2010-11-30 00:00:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-12-01 13:29:00, ended at 2010-12-01 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, pelvis; without contrast material(s), followed by contrast material(s) and further sequences\n\n### Condition\n- Noninflammatory disorder of the female genital organs\n- Flatulence, eructation and gas pain\n- Female genital organ symptoms\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-12-07 08:59:00, ended at 2010-12-07 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Tacrolimus [Mass/volume] in Blood: 3.4 (nanogram per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Essential hypertension\n- Renal disorder due to type 1 diabetes mellitus\n- Chest pain\n- Coronary atherosclerosis\n- Hyperlipidemia\n- Peripheral vascular disease\n- Systemic lupus erythematosus\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-12-07 13:05:06, ended at 2010-12-07 13:36:14\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Peripheral vascular disease\n- Hyperlipidemia\n- Transplanted kidney present\n- Renal disorder due to type 1 diabetes mellitus\n- Systemic lupus erythematosus\n- Chest pain\n- Coronary atherosclerosis\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-12-14 00:00:00, ended at 2010-12-14 00:00:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of nervous system due to diabetes mellitus\n\n### Drug\n- atorvastatin 20 MG Oral Tablet, through Oral route, started on 2010-12-14, presumably until 2011-12-14, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-12-15 00:00:00, ended at 2010-12-15 00:00:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of nervous system due to diabetes mellitus\n\n### Drug\n- atorvastatin 20 MG Oral Tablet, through Oral route, started on 2010-12-15, presumably until 2011-12-15, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-12-15 10:48:00, ended at 2010-12-15 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Prothrombin time (PT): 31.1 (second)\n- INR in Platelet poor plasma by Coagulation assay: 3.2 (ratio)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-12-16 00:00:00, ended at 2010-12-16 00:00:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Peripheral vascular disease\n\n### Drug\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2010-12-16, presumably until 2011-03-29, with quantity of 30.0, with intended 2 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed pain \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-12-21 14:55:02, ended at 2010-12-21 16:11:40\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), premalignant lesions (eg, actinic keratoses); first lesion\n\n### Condition\n- Primary diagnosis: Actinic keratosis\n- Discoloration of skin\n\n### Drug\n- tretinoin 0.25 MG/ML Topical Cream, through Topical route, started on 2010-12-21, presumably until 2010-12-31, with intended 0 refill(s). Instructions: by Topical route every bedtime. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-12-25 11:00:00, ended at 2010-12-25 13:24:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1.811\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Female genital organ symptoms\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-12-25 13:25:00, ended at 2010-12-25 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Cyst of ovary\n- Female genital organ symptoms\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-12-25 13:49:52, ended at 2010-12-25 14:29:20\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- Routine gynecologic examination\n- Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diag\n\n### Condition\n- Cyst of ovary\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-12-31 14:07:34, ended at 2010-12-31 15:26:37\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Injection(s); single tendon sheath, or ligament, aponeurosis (eg, plantar  fascia )\n- Arthrocentesis, aspiration and/or injection, intermediate joint or bursa (eg, temporomandibular, acromioclavicular, wrist, elbow or ankle, olecranon bursa); without ultrasound guidance\n\n### Condition\n- Aseptic necrosis of bone\n- Degenerative joint disease of hand\n\n### Drug\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2010-12-31, presumably until 2010-12-31, with intended 0 refill(s). Instructions: 0.7 mL by Injection route One Time. \n- betamethasone 3 MG/ML / betamethasone acetate 3 MG/ML Injectable Suspension, started on 2010-12-31, presumably until 2010-12-31, with quantity of 1.0, with intended 0 refill(s). Instructions: 0.7 mL by Injection route One Time. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-01-05 11:13:00, ended at 2011-01-05 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Tacrolimus [Mass/volume] in Blood: 5.6 (nanogram per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n- Hyperlipidemia\n- Type 1 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-01-05 13:56:27, ended at 2011-01-05 17:39:42\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n- Hyperlipidemia\n- Type 1 diabetes mellitus without complication\n\n### Drug\n- 0.5 ML Streptococcus pneumoniae type 1 capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 10A capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 11A capsular polysaccharide antigen 0.05 MG/ML / Streptococ..., through Subcutaneous route, started on 2011-01-05, presumably until 2011-01-06, with quantity of 1.0, with intended 0 refill(s). Instructions: 0.5 mL by SUBCUTANEOUS route One Time. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-01-18 12:50:00, ended at 2011-01-18 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Prothrombin time (PT): 23.2 (second)\n- INR in Platelet poor plasma by Coagulation assay: 2.2 (ratio)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Subsequent stage of staged operation\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2011-01-20 00:00:00, ended at 2011-01-20 00:00:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Gastroesophageal reflux disease\n\n### Drug\n- dexlansoprazole 30 MG Delayed Release Oral Capsule, through Oral route, started on 2011-01-20, presumably until 2011-01-25, with quantity of 60.0, with intended 3 refill(s). Instructions: take 1 Cap by mouth 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2011-01-25 00:00:00, ended at 2011-01-25 00:00:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Gastroesophageal reflux disease\n\n### Drug\n- dexlansoprazole 30 MG Delayed Release Oral Capsule, through Oral route, started on 2011-01-25, presumably until 2011-10-25, with quantity of 60.0, with intended 6 refill(s). Instructions: take 1 Cap by mouth 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-01-25 10:18:51, ended at 2011-01-25 13:14:24\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of right eye: 13 (millimeter mercury column)\n- Intraocular pressure of left eye: 12 (millimeter mercury column)\n\n### Procedure\n- Scanning computerized ophthalmic diagnostic imaging, posterior segment, with interpretation and report, unilateral or bilateral; retina\n\n### Condition\n- Proliferative retinopathy due to diabetes mellitus\n- Vitreous degeneration\n- Epiretinal membrane\n- Disorder of eye due to type 1 diabetes mellitus\n\n### Drug\n- triamcinolone acetonide 0.055 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, presumably until 2011-07-05. Instructions: 2 Sprays by Nasal route daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-01-29 00:00:00, ended at 2011-01-29 00:00:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Subsequent stage of staged operation\n\n### Condition\n- No conditions.\n\n### Drug\n- 0.6 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2011-01-29, presumably until 2011-02-25, with quantity of 20.0, with intended 1 refill(s). Instructions: inject 0.5 mL subcutaneous (under the skin) every 12 hours. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-02-04 10:44:43, ended at 2011-02-04 10:58:55\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Subsequent stage of staged operation\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-02-10 08:27:00, ended at 2011-02-11 16:20:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n- Prothrombin time (PT): 14.7 (second)\n- aPTT in Platelet poor plasma by Coagulation assay: 28.1 (second)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n\n### Procedure\n- Transection or avulsion of other spinal nerve, extradural\n- Other excision or avulsion of cranial and peripheral nerves\n- Collection of venous blood by venipuncture\n- Arthrodesis, wrist; with iliac or other autograft (includes obtaining graft)\n- Arthrodesis of carpometacarpal joint\n\n### Condition\n- Disorder of wrist joint\n- Arthralgia of the ankle and/or foot\n- Osteoarthritis of wrist\n- Wrist joint pain\n\n### Drug\n- isosorbide dinitrate 30 MG Oral Tablet, through Oral route, started on 2011-02-10, presumably until 2011-02-11. Instructions: take 1 Tab by mouth 2 times a day.\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2011-02-10, presumably until 2011-02-10\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2011-02-10, presumably until 2011-02-11. Instructions: take 3 Caps by mouth 2 times a day.\n- ascorbic acid 250 MG Oral Tablet, through Oral route, started on 2011-02-10, presumably until 2011-02-11\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2011-02-10, presumably until 2011-02-11\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2011-02-10, presumably until 2011-02-11. Instructions: take 1 Cap by mouth 2 times a day.\n- cefazolin 1000 MG Injection, through Intravenous route, started on 2011-02-10, presumably until 2011-02-11\n- 24 HR metoprolol succinate 25 MG Extended Release Oral Tablet, through Oral route, started on 2011-02-11, presumably until 2011-02-11\n- acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2011-02-10, presumably until 2011-02-11\n- warfarin sodium 4 MG Oral Tablet, through Oral route, started on 2011-02-10, presumably until 2011-02-10\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2011-02-11, presumably until 2011-02-11. Instructions: take 1 Tab by mouth daily.\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2011-02-10, presumably until 2011-02-11. Instructions: take 1 Cap by mouth 2 times a day.\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2011-02-10, presumably until 2011-02-10\n- atorvastatin 20 MG Oral Tablet, through Oral route, started on 2011-02-10, presumably until 2011-02-10. Instructions: take 1 Tab by mouth daily.\n- 24 HR diltiazem hydrochloride 120 MG Extended Release Oral Capsule, through Oral route, started on 2011-02-11, presumably until 2011-02-11\n- 2 ML ondansetron 2 MG/ML Injection, started on 2011-02-10, presumably until 2011-02-10\n- 0.6 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2011-02-11, presumably until 2011-02-11. Instructions: inject 0.5 mL subcutaneous (under the skin) every 12 hours.\n- hydroxyzine pamoate 25 MG Oral Capsule, through Oral route, started on 2011-02-11, presumably until 2011-02-11\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2011-02-10, presumably until 2011-02-11\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2011-02-10, presumably until 2011-02-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2011-02-12 00:00:00, ended at 2011-02-12 00:00:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-02-17 12:14:00, ended at 2011-02-17 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Prothrombin time (PT): 20.7 (second)\n- INR in Platelet poor plasma by Coagulation assay: 1.9 (ratio)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Subsequent stage of staged operation\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-02-22 10:11:00, ended at 2011-02-22 11:10:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 30.9 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 100 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.5 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.4 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.75 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 38 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 78 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.7 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.8 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 31 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 78.3 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.87 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 125 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.9 (percent)\n- Platelets [#/volume] in Blood by Automated count: 417 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.7 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.3 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: 2.9 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.5 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.92 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.9 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.58 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 72.4 (percent)\n- Tacrolimus [Mass/volume] in Blood: 3.2 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 7 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 24.2 (picogram)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Wrist joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-02-22 10:36:53, ended at 2011-02-22 11:58:07\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Degenerative joint disease of hand\n\n### Drug\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2011-02-22, presumably until 2011-07-05, with quantity of 90.0, with intended 2 refill(s). Instructions: take 100 mg by mouth 3 times a day. \n- acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, presumably until 2011-03-29. Instructions: take by mouth as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-02-22 11:11:00, ended at 2011-02-22 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, wrist; complete, minimum of 3 views\n\n### Condition\n- Wrist joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2011-02-23 00:00:00, ended at 2011-02-23 00:00:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Systemic lupus erythematosus\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2011-02-23, presumably until 2011-07-21, with quantity of 30.0, with intended 4 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-02-25 00:00:00, ended at 2011-02-25 00:00:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-02-25 10:40:34, ended at 2011-02-25 12:08:33\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n- Hyperlipidemia\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2011-03-15 13:32:00, ended at 2011-03-29 18:46:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.6 (percent)\n- Erythrocyte sedimentation rate: 24 (millimeter per hour)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.3 (percent)\n- Prothrombin time (PT): 19.6 (second)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 0.01 (nanogram per milliliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Body height: 5' 2\" (inch (US))\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.26 (millimole per liter)\n- INR in Platelet poor plasma by Coagulation assay: 1.8 (ratio)\n- Monocytes [#/volume] in Blood by Automated count: 1.30 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 13 (percent)\n- Neutrophils [#/volume] in Blood by Manual count: 4.3 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 67 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 84 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.7 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.4 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.7 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.2 (percent)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.9 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.34 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 24.5 (picogram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Complement C3 [Mass/volume] in Serum or Plasma: 112 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.15 (million per microliter)\n- MCV [Entitic volume] by Automated count: 76.4 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.8 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 98.5 (second)\n- Eosinophils/100 leukocytes in Blood by Manual count: 3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 15 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 8.16 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 85.8 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.1 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 519 (thousand per microliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.2 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.00 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.6 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 5.4 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n\n### Procedure\n- Ultrasound, pelvic (nonobstetric), real time with image documentation; complete\n- Radiologic examination, chest; single view, frontal\n- Total abdominal hysterectomy\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Other removal of both ovaries and tubes at same operative episode\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Pathology consultation during surgery; first tissue block, with frozen section(s), single specimen\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Ultrasound, transvaginal\n- Venous catheterization, not elsewhere classified\n- Injection of anesthetic agent into peripheral nerve for analgesia\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Excision of regional lymph nodes\n- Collection of venous blood by venipuncture\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n\n### Condition\n- Systemic lupus erythematosus\n- Primary malignant neoplasm of ovary\n- Fever\n- Osteoporosis\n- Pulmonary congestion and hypostasis\n- Hypercoagulability state\n- Peripheral vascular disease\n- Type 2 diabetes mellitus without complication\n- Diffuse spasm of esophagus\n- Disorder of uterus\n- Abdominal pain\n- Acute postoperative pain\n- Cyst of ovary\n- Infection due to Escherichia coli\n- Secondary malignant neoplastic disease\n- Urinary tract infectious disease\n- Noninflammatory disorder of the female genital organs\n- Coronary atherosclerosis\n- Transplanted kidney present\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2011-03-16, presumably until 2011-03-29\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2011-03-24, presumably until 2011-03-24\n- warfarin sodium 5 MG Oral Tablet, through Oral route, started on 2011-03-28, presumably until 2011-04-20, with quantity of 30.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. Follow up with the Anticoagulation Clinic regarding adjustment of your dosing. \n- acetaminophen 650 MG Rectal Suppository, through Rectal route, started on 2011-03-18, presumably until 2011-03-18\n- magnesium gluconate 500 MG Oral Tablet, through Oral route, started on 2011-03-28, presumably until 2011-03-29\n- zolpidem tartrate 5 MG Oral Tablet, through Oral route, started on 2011-03-16, presumably until 2011-03-16\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2011-03-16, presumably until 2011-03-29\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2011-03-16, presumably until 2011-03-29\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2011-03-17, presumably until 2011-03-17\n- 24 HR metoprolol succinate 25 MG Extended Release Oral Tablet, through Oral route, started on 2011-03-25, presumably until 2011-03-29\n- acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2011-03-16, presumably until 2011-09-25, with quantity of 40.0, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 to 6 hours as needed \n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2011-03-17, presumably until 2011-03-28\n- magnesium hydroxide 80 MG/ML Oral Suspension, through Oral route, started on 2011-03-17, presumably until 2011-03-17\n- warfarin sodium 4 MG Oral Tablet, through Oral route, started on 2011-03-26, presumably until 2011-03-27\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2011-03-16, presumably until 2011-03-29\n- levofloxacin 750 MG Oral Tablet, through Oral route, started on 2011-03-25, presumably until 2011-03-28\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2011-03-18, presumably until 2011-03-25\n- 1000 ML potassium chloride 0.02 MEQ/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2011-03-23, presumably until 2011-03-25\n- 2 ML ondansetron 2 MG/ML Injection, started on 2011-03-15, presumably until 2011-03-29\n- 1000 ML glucose 50 MG/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2011-03-16, presumably until 2011-03-16\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2011-03-16, presumably until 2011-03-16\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2011-03-15, presumably until 2011-03-18\n- 1 ML morphine sulfate 2 MG/ML Prefilled Syringe, started on 2011-03-15, presumably until 2011-03-15\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2011-03-16, presumably until 2011-03-22\n- 0.5 ML sumatriptan 12 MG/ML Injection, through Subcutaneous route, started on 2011-03-21, presumably until 2011-03-21\n- gabapentin 600 MG Oral Tablet, through Oral route, started on 2011-03-16, presumably until 2011-03-29\n- 0.6 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2011-03-29, presumably until 2011-04-20, with quantity of 28.0, with intended 3 refill(s). Instructions: inject 0.5 mL subcutaneous (under the skin) every 12 hours. The anticoagulation clinic will follow up with you regarding how long you need to continue the Lovenox. \n- 150 ML levofloxacin 5 MG/ML Injection, through Intravenous route, started on 2011-03-18, presumably until 2011-03-18\n- clopidogrel 75 MG Oral Tablet, through Oral route, started on 2011-03-29, presumably until 2011-03-29\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2011-03-18, presumably until 2011-03-29\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2011-03-16, presumably until 2011-03-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-03-31 13:18:14, ended at 2011-03-31 13:40:59\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Subsequent stage of staged operation\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-04-02 15:15:00, ended at 2011-04-02 16:50:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2.4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of ovary\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-04-02 16:51:00, ended at 2011-04-02 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- MCHC [Mass/volume] by Automated count: 31.0 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.4 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 602 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.52 (million per microliter)\n- MCH [Entitic mass] by Automated count: 23.1 (picogram)\n- Hemoglobin [Mass/volume] in Blood: 8.1 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 74.5 (femtoliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of ovary\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-04-06 14:08:59, ended at 2011-04-06 16:03:23\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Joint pain\n- Benign neoplasm of bone\n- Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-04-08 10:30:50, ended at 2011-04-08 13:26:27\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Noninflammatory disorder of the female genital organs\n- Joint pain\n- Primary diagnosis: Nausea\n- Chest pain\n- Synovial cyst of knee\n\n### Drug\n- metoclopramide 10 MG Oral Tablet, through Oral route, started on 2011-04-08, presumably until 2011-05-06, with quantity of 120.0, with intended 4 refill(s). Instructions: take 1 Tab by mouth 4 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-04-08 13:30:00, ended at 2011-04-08 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, any joint of lower extremity; without contrast material\n\n### Condition\n- Synovial cyst of knee\n- Joint pain\n- Knee joint effusion\n- Derangement of knee\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-04-12 10:13:11, ended at 2011-04-12 10:50:30\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-04-12 13:42:59, ended at 2011-04-12 15:36:57\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Injection(s); single tendon sheath, or ligament, aponeurosis (eg, plantar  fascia )\n\n### Condition\n- Acquired trigger finger\n- Degenerative joint disease of hand\n\n### Drug\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2011-04-12, presumably until 2011-04-12, with intended 0 refill(s). Instructions: 0.7 mL by Injection route One Time. \n- betamethasone 3 MG/ML / betamethasone acetate 3 MG/ML Injectable Suspension, started on 2011-04-12, presumably until 2011-04-12, with quantity of 1.0, with intended 0 refill(s). Instructions: 0.7 mL by Injection route One Time. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-04-12 13:44:00, ended at 2011-04-12 23:59:00\nThe patient in this visit was 55 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, wrist; complete, minimum of 3 views\n\n### Condition\n- Systemic lupus erythematosus\n- Wrist joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2011-04-20 00:00:00, ended at 2011-04-20 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Subsequent stage of staged operation\n\n### Condition\n- No conditions.\n\n### Drug\n- warfarin sodium 2 MG Oral Tablet, through Oral route, presumably until 2012-02-14. Instructions: take 4 mg by mouth as directed. Take 4mg daily as directed by SHC OAC\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-04-20 13:52:00, ended at 2011-04-20 14:50:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Prothrombin time (PT): 17.7 (second)\n- INR in Platelet poor plasma by Coagulation assay: 1.5 (ratio)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Subsequent stage of staged operation\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-04-20 14:51:00, ended at 2011-04-20 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of artery\n- Venous thrombosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-04-22 13:15:00, ended at 2011-04-22 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2.205\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Breast lump\n- Primary malignant neoplasm of ovary\n\n### Drug\n- metoclopramide 10 MG Oral Tablet, through Oral route, presumably until 2011-10-25. Instructions: take  by mouth. ChemMapleton py only\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-04-30 00:00:00, ended at 2011-04-30 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-04-30 10:23:00, ended at 2011-04-30 10:44:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 115 (unit per liter)\n- Albumin [Mass/volume] in Urine: <5 (milligram per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 80 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.8 (percent)\n- MCV [Entitic volume] by Automated count: 72.7 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.5 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 67.5 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 148 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 68 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.6 (percent)\n- Platelets [#/volume] in Blood by Automated count: 365 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.5 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.6 (percent)\n- Hemoglobin [Mass/volume] in Blood: 8.2 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.75 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.83 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.1 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 58 (milligram per deciliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 0.7 (ratio)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.9 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.6 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 2.7 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Albumin/Creatinine [Mass Ratio] in Urine: <30 (milligram per gram)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.3 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.70 (million per microliter)\n- MCH [Entitic mass] by Automated count: 22.2 (picogram)\n- Triglyceride [Moles/volume] in Serum or Plasma: 48 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 30.5 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 72 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.81 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Senile osteoporosis\n- Postmenopausal state\n- Hyperlipidemia\n- Transplanted kidney present\n- Type 1 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-04-30 10:45:00, ended at 2011-04-30 11:07:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 16.3 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.70 (million per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 30.5 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.5 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.1 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 110 (unit per liter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.5 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.6 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.75 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 145 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 74 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.9 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.82 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 72.7 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.81 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.6 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 22.2 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 67.5 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 8.2 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 365 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 47 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-04-30 11:08:00, ended at 2011-04-30 13:28:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)\n\n### Condition\n- Disorder of bone and articular cartilage\n- Osteoporosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-04-30 13:29:00, ended at 2011-04-30 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2.402\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of ovary\n- Hyperlipidemia\n- Postmenopausal state\n- Transplanted kidney present\n- Type 1 diabetes mellitus without complication\n- Senile osteoporosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-05-03 10:30:53, ended at 2011-05-03 11:32:46\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Primary malignant neoplasm of ovary\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-05-05 00:00:00, ended at 2011-05-05 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Closed fracture of carpal bone\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-05-05 00:00:00, ended at 2011-05-05 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2011-05-05, presumably until 2011-09-07, with intended 6 refill(s). Instructions: take 2 Tabs by mouth 2 times a day. Take the day before taxotere, the day of taxotere and the day after taxotere\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-05-06 09:20:00, ended at 2011-05-06 17:11:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- Insertion of tunneled centrally inserted central venous access device, with subcutaneous port; age 5 years or older\n- Insertion of graft for vascular access\n- Fluoroscopic guidance for central venous access device placement, replacement (catheter only or complete), or removal (includes fluoroscopic guidance for vascular access and catheter manipulation, any necessary contrast injections through access site or c\n\n### Condition\n- Systemic lupus erythematosus\n- Primary malignant neoplasm of ovary\n- Transplanted kidney present\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, through Oral route, presumably until 2013-04-20. Instructions: take 1 mg by mouth 2 times a day. 1 tab in am 2 tabs PM\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2011-05-06, presumably until 2011-05-06\n- gabapentin 300 MG Oral Capsule, through Oral route, presumably until 2011-06-23. Instructions: take 300 mg by mouth 3 times a day.\n- 24 HR diltiazem hydrochloride 120 MG Extended Release Oral Capsule, through Oral route, presumably until 2011-09-29. Instructions: take 120 mg by mouth daily.\n- mycophenolate mofetil 500 MG Oral Tablet, through Oral route, presumably until 2011-12-03. Instructions: take 250 mg by mouth 2 times a day.\n- clopidogrel 75 MG Oral Tablet, through Oral route, presumably until 2015-01-23. Instructions: take 75 mg by mouth every morning.\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, presumably until 2011-09-24. Instructions: take 1 Tab by mouth as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-05-07 00:00:00, ended at 2011-05-07 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of ovary\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2011-05-07, presumably until 2011-09-15, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed.\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2011-05-07, presumably until 2011-09-15, with intended 5 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed.\n- prochlorperazine 10 MG Oral Tablet, through Oral route, started on 2011-05-07, presumably until 2011-12-24, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Nausea/Vomiting.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-05-07 12:34:00, ended at 2011-05-07 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.91 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.90 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.10 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 352 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 7.6 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.4 (percent)\n- MCV [Entitic volume] by Automated count: 71.9 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.9 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 31.0 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 83.3 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.43 (million per microliter)\n- MCH [Entitic mass] by Automated count: 22.3 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.3 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 24.7 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 118 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.0 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 105 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chest pain\n- Primary malignant neoplasm of ovary\n- Proliferative retinopathy due to diabetes mellitus\n- Coronary atherosclerosis\n- Disorder of eye due to type 1 diabetes mellitus\n- Vitreous degeneration\n- Degenerative joint disease of hand\n- Pain in limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-05-08 12:00:00, ended at 2011-05-08 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Transfusion, blood or blood components\n\n### Condition\n- No conditions.\n\n### Drug\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2011-05-08, presumably until 2011-05-08\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-05-10 00:00:00, ended at 2011-05-10 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-05-10 00:00:00, ended at 2011-05-10 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-05-11 00:00:00, ended at 2011-05-11 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Postprocedural state finding\n- Peripheral vascular disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-05-11 10:30:00, ended at 2011-05-11 14:12:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of lower extremity arteries or arterial bypass grafts; unilateral or limited study\n\n### Condition\n- Synovial cyst of knee\n- Joint pain\n- Atherosclerosis of arteries of the extremities\n- Intermittent claudication\n- Peripheral vascular disease\n- Postprocedural state finding\n- Benign neoplasm of bone\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-05-11 11:25:46, ended at 2011-05-11 14:17:17\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Peripheral vascular disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-05-11 14:13:00, ended at 2011-05-11 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, wrist; 2 views\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-05-17 11:43:00, ended at 2011-05-17 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- INR in Platelet poor plasma by Coagulation assay: 1.9 (ratio)\n- Prothrombin time (PT): 20.7 (second)\n\n### Procedure\n- Subsequent stage of staged operation\n- Collection of venous blood by venipuncture\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-05-21 13:53:32, ended at 2011-05-21 15:19:01\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of left eye: 12 (millimeter mercury column)\n- Intraocular pressure of right eye: 12 (millimeter mercury column)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- moxifloxacin 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2011-05-21, presumably until 2011-07-05, with intended 0 refill(s). Instructions: instill 1 Drop to left eye 4 times a day. For 5 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-05-24 13:42:16, ended at 2011-05-24 15:04:23\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Degenerative joint disease of hand\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-05-24 13:43:00, ended at 2011-05-24 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, wrist; complete, minimum of 3 views\n\n### Condition\n- Wrist joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2011-05-25 00:00:00, ended at 2011-05-25 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- 24 HR metoprolol succinate 25 MG Extended Release Oral Tablet, through Oral route, started on 2011-05-25, presumably until 2011-12-22, with intended 6 refill(s). Instructions: take 1 Tab by mouth 2 times a day. 25mg in am, 50mg in pm\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-05-25 13:30:00, ended at 2011-05-25 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anemia in chronic kidney disease\n- Chronic kidney disease stage 3\n\n### Drug\n- 0.5 ML darbepoetin alfa 0.2 MG/ML Prefilled Syringe, started on 2011-05-25, presumably until 2011-05-25\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2011-05-25, presumably until 2011-05-25\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-05-28 09:20:00, ended at 2011-05-28 09:55:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n- Systemic lupus erythematosus\n- Primary malignant neoplasm of ovary\n- Transplanted kidney present\n- Type 1 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-05-28 09:56:00, ended at 2011-05-28 10:29:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin/Creatinine [Mass Ratio] in Urine: 21 (milligram per gram)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.1 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 24.0 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 83.8 (percent)\n- Erythrocyte sedimentation rate: 9 (millimeter per hour)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.3 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.3 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 3.7 (nanogram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 24.6 (percent)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.7 (percent)\n- Prothrombin time (PT): 25.7 (second)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 0.8 (ratio)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.06 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.57 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.6 (percent)\n- MCV [Entitic volume] by Automated count: 74.3 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 417 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: <2.0 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Albumin [Mass/volume] in Urine: 8 (milligram per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 69 (milligram per deciliter)\n- Complement C3 [Mass/volume] in Serum or Plasma: 116 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.62 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.8 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 7.38 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 76 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 36 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 96 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 168 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.5 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 133 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.5 (ratio)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.5 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n\n### Procedure\n- Subsequent stage of staged operation\n\n### Condition\n- Systemic lupus erythematosus\n- Primary malignant neoplasm of ovary\n- Transplanted kidney present\n- Type 1 diabetes mellitus without complication\n- Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-05-28 10:30:00, ended at 2011-05-28 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1.811\" (inch (US))\n\n### Procedure\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n\n### Condition\n- Primary malignant neoplasm of ovary\n\n### Drug\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2011-05-28, presumably until 2011-05-28\n- lidocaine 25 MG/ML / prilocaine 25 MG/ML Topical Cream, through Topical route, started on 2011-05-28, presumably until 2012-05-27, with intended 3 refill(s). Instructions: by Topical route as needed (apply dime size amount to port site at least 30mins prior to needle insertion).\n- 2 ML ondansetron 2 MG/ML Injection, started on 2011-05-28, presumably until 2011-05-28\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2011-05-28, presumably until 2011-05-28\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-06-08 13:09:34, ended at 2011-06-08 13:44:59\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anemia in chronic kidney disease\n- Transplanted kidney present\n- Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-06-18 09:20:00, ended at 2011-06-18 09:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.55 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.0 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 74.8 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- Prothrombin time (PT): 20.4 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.3 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Platelets [#/volume] in Blood by Automated count: 400 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.31 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.35 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 89.9 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 97 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 23.7 (percent)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.3 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.8 (ratio)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.1 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 121 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7.0 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 24.0 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 2.8 (percent)\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n- Subsequent stage of staged operation\n\n### Condition\n- Primary malignant neoplasm of ovary\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2011-06-18, presumably until 2011-06-18\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2011-06-18, presumably until 2011-06-18\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-06-18 10:00:00, ended at 2011-06-18 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1.811\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of bone and articular cartilage\n- Osteoporosis\n- Pain in limb\n- Primary malignant neoplasm of ovary\n- Urinary tract infectious disease\n- Type 2 diabetes mellitus without complication\n- Renal disorder due to type 1 diabetes mellitus\n- Type 1 diabetes mellitus without complication\n- Systemic lupus erythematosus\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-06-21 14:57:35, ended at 2011-06-21 16:16:34\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n- Renal disorder due to type 1 diabetes mellitus\n- Coronary arteriosclerosis\n- Essential hypertension\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-06-21 16:51:00, ended at 2011-06-21 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, wrist; complete, minimum of 3 views\n\n### Condition\n- Wrist joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2011-06-23 00:00:00, ended at 2011-06-23 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Peripheral nerve disease\n\n### Drug\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2011-06-23, presumably until 2011-07-27, with intended 4 refill(s). Instructions: take 1 Cap by mouth 3 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2011-06-24 15:58:00, ended at 2011-06-25 00:24:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Manual count: 2 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.4 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.0 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 8 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Manual count: 0.0 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.92 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 1.5 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- Prothrombin time (PT): 20.7 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 127 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.3 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 60 (percent)\n- MCH [Entitic mass] by Automated count: 23.7 (picogram)\n- Monocytes [#/volume] in Blood by Manual count: 0.1 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 23.9 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.9 (ratio)\n- Platelets [#/volume] in Blood by Automated count: 246 (thousand per microliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 22 (percent)\n- MCV [Entitic volume] by Automated count: 74.1 (femtoliter)\n- Neutrophils [#/volume] in Blood by Manual count: 1.0 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 96 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.0 (percent)\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Hyperlipidemia\n- Primary malignant neoplasm of ovary\n- Coronary atherosclerosis\n- Precordial pain\n- Backache\n- Essential hypertension\n- Ulcerative colitis\n- Iron deficiency anemia\n- Chest pain\n- Gastroesophageal reflux disease\n- Renal disorder due to type 1 diabetes mellitus\n- Systemic lupus erythematosus\n\n### Drug\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2011-06-24, presumably until 2011-06-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-06-27 12:57:00, ended at 2011-06-27 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, upper extremity; without contrast material\n- 3D rendering with interpretation and reporting of computed tomography, magnetic resonance imaging, ultrasound, or other tomographic modality with image postprocessing under concurrent supervision; requiring image postprocessing on an independent workstati\n\n### Condition\n- Osteoarthritis of wrist\n- Imaging of musculoskeletal system abnormal\n- Disorder of wrist joint\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-06-29 15:20:13, ended at 2011-06-29 16:18:06\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of left eye: 11 (millimeter mercury column)\n- Intraocular pressure of right eye: 11 (millimeter mercury column)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of eyelid\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-07-05 13:10:31, ended at 2011-07-05 14:51:41\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Degenerative joint disease of hand\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-07-06 13:40:33, ended at 2011-07-06 14:59:10\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Gastroesophageal reflux disease\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2011-07-06, presumably until 2011-07-09, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-07-09 00:00:00, ended at 2011-07-09 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of ovary\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-07-09 10:12:00, ended at 2011-07-09 10:19:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.9 (ratio)\n- MCV [Entitic volume] by Automated count: 74.3 (femtoliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.3 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.27 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 133 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.7 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 24.7 (picogram)\n- Prothrombin time (PT): 20.9 (second)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 102 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 116 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.1 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.37 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 93.4 (percent)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.48 (million per microliter)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 371 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 5.7 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 24.4 (percent)\n\n### Procedure\n- Subsequent stage of staged operation\n\n### Condition\n- Systemic lupus erythematosus\n- Degenerative joint disease of hand\n- Primary malignant neoplasm of ovary\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-07-09 10:20:00, ended at 2011-07-09 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1.811\" (inch (US))\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n\n### Condition\n- Primary malignant neoplasm of ovary\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2011-07-09, presumably until 2011-07-09\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2011-07-09, presumably until 2011-07-09\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2011-07-09, presumably until 2011-07-09\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-07-20 12:18:00, ended at 2011-07-20 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Arthrocentesis, aspiration and/or injection, major joint or bursa (eg, shoulder, hip, knee, subacromial bursa); without ultrasound guidance\n- Ultrasonic guidance for needle placement (eg, biopsy, aspiration, injection, localization device), imaging supervision and interpretation\n\n### Condition\n- Synovial cyst of knee\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2011-07-21 00:00:00, ended at 2011-07-21 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Systemic lupus erythematosus\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2011-07-21, presumably until 2011-09-07, with intended 6 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2011-07-21 00:00:00, ended at 2011-07-21 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Diffuse spasm of esophagus\n\n### Drug\n- isosorbide dinitrate 30 MG Oral Tablet, through Oral route, started on 2011-07-21, presumably until 2012-02-29, with intended 6 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-07-23 10:09:00, ended at 2011-07-23 10:30:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- INR in Platelet poor plasma by Coagulation assay: 5.1 (ratio)\n- Prothrombin time (PT): 44.8 (second)\n\n### Procedure\n- Subsequent stage of staged operation\n- Collection of venous blood by venipuncture\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-07-23 10:31:00, ended at 2011-07-23 12:21:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of ovary\n- Systemic lupus erythematosus\n- Osteoporosis\n- Transplanted kidney present\n- Type 1 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-07-23 13:00:00, ended at 2011-07-23 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n- Primary malignant neoplasm of ovary\n- Osteoporosis\n- Systemic lupus erythematosus\n- Type 1 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-07-26 00:00:00, ended at 2011-07-26 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of ovary\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-07-26 10:22:13, ended at 2011-07-26 13:27:48\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of right eye: 12 (millimeter mercury column)\n- Intraocular pressure of left eye: 13 (millimeter mercury column)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of eyelid\n- Proliferative retinopathy due to diabetes mellitus\n- Epiretinal membrane\n- After-cataract with vision obscured following extraction of cataract\n- Vitreous degeneration\n- Tear film insufficiency\n- Disorder of eye due to type 1 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-07-27 00:00:00, ended at 2011-07-27 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Peripheral nerve disease\n\n### Drug\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2011-07-27, presumably until 2011-08-17, with intended 4 refill(s). Instructions: take 1 Cap by mouth 4 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-07-30 00:00:00, ended at 2011-07-30 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of ovary\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-07-30 09:30:00, ended at 2011-07-30 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.27 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.1 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 132 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.32 (million per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.9 (ratio)\n- MCHC [Mass/volume] by Automated count: 31.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 76.5 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 88.7 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 21 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.47 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7.2 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 24.9 (percent)\n- Prothrombin time (PT): 20.8 (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Body height: 5' 1.417\" (inch (US))\n- Glucose [Mass/volume] in Serum or Plasma: 121 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.6 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 89 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 10.4 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 392 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 24.1 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 5.81 (thousand per microliter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n\n### Condition\n- Primary malignant neoplasm of ovary\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2011-07-30, presumably until 2011-07-30\n- diphenhydramine hydrochloride 2.5 MG/ML Oral Solution, through Oral route, started on 2011-07-30, presumably until 2011-09-07, with intended 3 refill(s). Instructions: take 5 mL by mouth every 6 hours as needed. Mix 1:1 with Nystatin suspension.\n- triamcinolone acetonide 0.001 MG/MG Topical Ointment, through Topical route, presumably until 2012-07-21. Instructions: 1 Applicator by Topical route 2 times a day as needed.\n- mineral oil 0.425 MG/MG / petrolatum 0.568 MG/MG Ophthalmic Ointment, through Intraocular route, presumably until 2013-08-27. Instructions: 1 Drop by Ophthalmic route every bedtime.\n- nystatin 100000 UNT/ML Oral Suspension, through Oral route, started on 2011-07-30, presumably until 2011-12-24, with intended 3 refill(s). Instructions: take 5 mL by mouth 4 times a day. Mix 1:1 with Benadryl syrup.\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2011-07-30, presumably until 2011-07-30\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2011-07-30, presumably until 2011-07-30\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2011-07-30, presumably until 2011-07-30\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-08-11 13:26:02, ended at 2011-08-11 14:26:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of eye due to type 1 diabetes mellitus\n- Proliferative retinopathy due to diabetes mellitus\n- Macular edema due to diabetes mellitus\n- Vitreous degeneration\n- Epiretinal membrane\n- Tear film insufficiency\n- After-cataract with vision obscured following extraction of cataract\n- Primary diagnosis: Diarrhea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2011-08-13 00:00:00, ended at 2011-08-13 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of eyelid\n\n### Drug\n- doxycycline monohydrate 100 MG Oral Capsule, through Oral route, started on 2011-08-13, presumably until 2011-09-02, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-08-13 11:09:00, ended at 2011-08-13 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.3 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.4 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 71 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.22 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 73 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 30.7 (percent)\n- MCV [Entitic volume] by Automated count: 74.4 (femtoliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 54 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 1.3 (ratio)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.5 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.80 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 326 (thousand per microliter)\n- Prothrombin time (PT): 48.3 (second)\n- Albumin [Mass/volume] in Urine: <5 (milligram per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 98 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 20 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.79 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 6 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 38.2 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 138 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 56 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 24.4 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 0.99 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 11.0 (nanogram per milliliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 25.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 2.6 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 30.9 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 130 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 82 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.0 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 5.6 (ratio)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Albumin/Creatinine [Mass Ratio] in Urine: <30 (milligram per gram)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.0 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Subsequent stage of staged operation\n\n### Condition\n- Type 1 diabetes mellitus without complication\n- Transplanted kidney present\n- Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2011-08-17 00:00:00, ended at 2011-08-17 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Peripheral nerve disease\n\n### Drug\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2011-08-17, presumably until 2012-01-26, with intended 4 refill(s). Instructions: take 1 Cap by mouth 4 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-08-17 14:04:02, ended at 2011-08-17 14:52:09\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Joint pain\n- Synovial cyst of knee\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-08-17 15:25:00, ended at 2011-08-17 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- INR in Platelet poor plasma by Coagulation assay: 5.9 (ratio)\n- Prothrombin time (PT): 50.5 (second)\n\n### Procedure\n- Subsequent stage of staged operation\n\n### Condition\n- Joint pain\n- Macular edema due to diabetes mellitus\n- Synovial cyst of knee\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-08-17 15:51:28, ended at 2011-08-17 16:23:53\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of right eye: 17 (millimeter mercury column)\n- Intraocular pressure of left eye: 17 (millimeter mercury column)\n\n### Procedure\n- Intravitreal injection of a pharmacologic agent (separate procedure)\n\n### Condition\n- Primary diagnosis: Macular edema due to diabetes mellitus\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- lidocaine hydrochloride 0.035 MG/MG Ophthalmic Gel, through Intraocular route, started on 2011-08-17, presumably until 2011-09-21, with intended 0 refill(s). Instructions: instill 2 Drops to left eye One Time.\n- proparacaine hydrochloride 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2011-08-17, presumably until 2011-09-21, with intended 0 refill(s). Instructions: instill 1 Drop to left eye One Time.\n- ofloxacin 3 MG/ML Ophthalmic Solution, through Intraocular route, started on 2011-08-17, presumably until 2011-09-21, with intended 0 refill(s). Instructions: instill 1 Drop to left eye One Time.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-08-20 11:24:00, ended at 2011-08-20 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 23.0 (picogram)\n- MCHC [Mass/volume] by Automated count: 30.5 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.8 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.27 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 368 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.9 (ratio)\n- Prothrombin time (PT): 20.5 (second)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 39 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.1 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 93 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Body height: 5' 1.417\" (inch (US))\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 3.3 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 95.3 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 75.4 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 7.73 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 24.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.21 (million per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 110 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Subsequent stage of staged operation\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Systemic lupus erythematosus\n- Primary malignant neoplasm of ovary\n- Transplanted kidney present\n- Type 1 diabetes mellitus without complication\n- Osteoporosis\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2011-08-20, presumably until 2011-08-20\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2011-08-20, presumably until 2011-08-20\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2011-08-20, presumably until 2011-08-20\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-08-23 15:16:43, ended at 2011-08-23 16:48:02\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of right eye: 14 (millimeter mercury column)\n- Intraocular pressure of left eye: 13 (millimeter mercury column)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Macular edema due to diabetes mellitus\n- Type 2 diabetes mellitus without complication\n- Eye / vision finding\n- Tear film insufficiency\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-08-25 00:00:00, ended at 2011-08-25 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of ovary\n\n### Drug\n- lidocaine hydrochloride 20 MG/ML Mucous Membrane Topical Solution, through Oral route, started on 2011-08-25, presumably until 2011-12-24, with intended 1 refill(s). Instructions: take 10 mL by mouth 4 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-01 10:02:00, ended at 2011-09-01 13:49:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Glucose [Mass/volume] in Serum or Plasma: 84 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.2 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 7.0 (ratio)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.44 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 23.8 (picogram)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 12.1 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.8 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 119 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.15 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.72 (thousand per microliter)\n- Prothrombin time (PT): 57.4 (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 110 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.1 (gram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 51 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.3 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 247 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 22.5 (percent)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 62.9 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 44 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.2 (percent)\n- MCHC [Mass/volume] by Automated count: 31.4 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.86 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 26.5 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.4 (percent)\n- MCV [Entitic volume] by Automated count: 76.0 (femtoliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Subsequent stage of staged operation\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-01 13:50:00, ended at 2011-09-01 17:02:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Bone length studies (orthoroentgenogram, scanogram)\n- Radiologic examination, knee; 3 views\n\n### Condition\n- Atherosclerosis of artery\n- Joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-01 17:03:00, ended at 2011-09-01 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of extremity veins including responses to compression and other maneuvers; unilateral or limited study\n\n### Condition\n- Pain in limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-09-02 00:00:00, ended at 2011-09-02 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Diarrhea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-09-02 11:18:32, ended at 2011-09-02 13:52:02\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Urinary tract infectious disease\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- ciprofloxacin 250 MG Oral Tablet, through Oral route, started on 2011-09-02, presumably until 2011-09-07, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-02 13:38:00, ended at 2011-09-02 13:38:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n- Urinary tract infectious disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-02 13:39:00, ended at 2011-09-02 14:38:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- INR in Platelet poor plasma by Coagulation assay: 7.2 (ratio)\n- Prothrombin time (PT): 58.9 (second)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Subsequent stage of staged operation\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-02 14:39:00, ended at 2011-09-02 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, any joint of lower extremity; without contrast material\n\n### Condition\n- Synovial cyst of knee\n- Knee joint effusion\n- Edema\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-06 09:45:00, ended at 2011-09-06 09:56:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Prothrombin time (PT): 39.5 (second)\n- INR in Platelet poor plasma by Coagulation assay: 4.3 (ratio)\n\n### Procedure\n- Subsequent stage of staged operation\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-06 09:57:00, ended at 2011-09-06 17:30:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2011-09-06, presumably until 2011-09-06\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2011-09-06 17:31:00, ended at 2011-09-07 19:20:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 23.6 (nanogram per milliliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.1 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 22.3 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.1 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 8.5 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 4.7 (ratio)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.3 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 24.4 (picogram)\n- Monocytes [#/volume] in Blood by Manual count: 0.9 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 26 (percent)\n- Platelets [#/volume] in Blood by Automated count: 329 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.2 (gram per deciliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 76.0 (femtoliter)\n- Neutrophils [#/volume] in Blood by Manual count: 1.6 (thousand per microliter)\n- Prothrombin time (PT): 42.4 (second)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 0.03 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.4 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 24 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 107 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Manual count: 2 (percent)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.8 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 127 (millimole per liter)\n- Body height: 5' 2\" (inch (US))\n- Erythrocytes [#/volume] in Blood by Automated count: 3.59 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.8 (percent)\n- MCHC [Mass/volume] by Automated count: 32.0 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 36 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Computed tomography, head or brain; without contrast material\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Disorder of plasma protein metabolism\n- Nonproliferative retinopathy due to diabetes mellitus\n- Peripheral nerve disease\n- Disorder of eye due to type 1 diabetes mellitus\n- Transplanted kidney present\n- Cyst of ovary\n- Malnutrition (calorie)\n- Diffuse spasm of esophagus\n- Urinary tract infectious disease\n- Angina pectoris\n- Hypertensive heart disease without congestive heart failure\n- Anemia\n- Hypo-osmolality and or hyponatremia\n- Aplastic anemia\n- Disorder of nervous system due to diabetes mellitus\n- Headache\n- Edema\n- Primary malignant neoplasm of ovary\n- Disorder of function of stomach\n- Systemic lupus erythematosus\n\n### Drug\n- famotidine 40 MG Oral Tablet, through Oral route, started on 2011-09-07, presumably until 2011-09-07\n- isosorbide dinitrate 30 MG Oral Tablet, through Oral route, started on 2011-09-07, presumably until 2011-09-07. Instructions: take 1 Tab by mouth 2 times a day.\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2011-09-07, presumably until 2011-09-07\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2011-09-07, presumably until 2011-09-07. Instructions: take 2 mg by mouth 2 times a day.\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2011-09-06, presumably until 2011-09-06\n- ciprofloxacin 250 MG Oral Tablet, through Oral route, started on 2011-09-07, presumably until 2011-09-07. Instructions: take 1 Tab by mouth 2 times a day.\n- 24 HR metoprolol succinate 25 MG Extended Release Oral Tablet, through Oral route, started on 2011-09-07, presumably until 2011-09-07. Instructions: take 1 Tab by mouth 2 times a day. 25mg in am, 50mg in pm\n- furosemide 40 MG Oral Tablet, through Oral route, started on 2011-09-07, presumably until 2012-05-02, with intended 6 refill(s). Instructions: take 0.5 Tabs by mouth 2 times a day.\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2011-09-07, presumably until 2011-09-07. Instructions: take 1 Tab by mouth daily.\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2011-09-07, presumably until 2011-09-07. Instructions: take 1 Cap by mouth 4 times a day.\n- 24 HR diltiazem hydrochloride 120 MG Extended Release Oral Capsule, through Oral route, started on 2011-09-07, presumably until 2011-09-07. Instructions: take 120 mg by mouth daily.\n- nitroglycerin 0.4 MG Sublingual Tablet, through Sublingual route, started on 2011-09-07, presumably until 2011-09-07. Instructions: 1 Tab by Sublingual route as needed\n- clopidogrel 75 MG Oral Tablet, through Oral route, started on 2011-09-07, presumably until 2011-09-07. Instructions: take 75 mg by mouth daily.\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2011-09-07, presumably until 2011-09-07. Instructions: take 1 Tab by mouth as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-09-07 12:46:03, ended at 2011-09-07 17:09:56\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Ischemic heart disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-10 11:00:00, ended at 2011-09-10 12:26:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1.417\" (inch (US))\n\n### Procedure\n- Chemotherapy follow-up\n\n### Condition\n- Primary malignant neoplasm of ovary\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-10 12:27:00, ended at 2011-09-10 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of ovary\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-10 14:00:46, ended at 2011-09-10 14:23:22\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Subsequent stage of staged operation\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-09-14 00:00:00, ended at 2011-09-14 10:31:59\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of right eye: 12 (millimeter mercury column)\n- Intraocular pressure of left eye: 14 (millimeter mercury column)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Macular edema due to diabetes mellitus\n- After-cataract with vision obscured following extraction of cataract\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- prednisolone acetate 10 MG/ML Ophthalmic Suspension, through Intraocular route, started on 2011-09-14, presumably until 2011-09-28, with intended 1 refill(s). Instructions: instill 1 Drop to right eye 4 times a day. Begin using 4 days prior to laser and continue 4 days after laser\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-14 14:59:06, ended at 2011-09-14 14:59:14\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Subsequent stage of staged operation\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-15 11:53:00, ended at 2011-09-15 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, femur, 2 views\n\n### Condition\n- Disorder of bone and articular cartilage\n- Joint pain of pelvic region\n- Atherosclerosis of arteries of the extremities\n- Pain in limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-21 12:02:00, ended at 2011-09-21 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Prothrombin time (PT): 28.2 (second)\n- INR in Platelet poor plasma by Coagulation assay: 2.8 (ratio)\n\n### Procedure\n- Subsequent stage of staged operation\n- Collection of venous blood by venipuncture\n\n### Condition\n- Macular edema due to diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-09-21 14:08:31, ended at 2011-09-21 15:00:46\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Arthrocentesis, aspiration and/or injection, major joint or bursa (eg, shoulder, hip, knee, subacromial bursa); without ultrasound guidance\n\n### Condition\n- Primary diagnosis: Localized, primary osteoarthritis\n- Primary diagnosis: Osteoarthritis of knee\n\n### Drug\n- bupivacaine hydrochloride 2.5 MG/ML Injectable Solution, started on 2011-09-29, presumably until 2011-09-29, with intended 0 refill(s). Instructions: 10 mL by Injection route One Time.\n- triamcinolone acetonide 40 MG/ML Injectable Suspension, started on 2011-09-29, presumably until 2011-09-29, with intended 0 refill(s). Instructions: 1 mL by Injection route One Time.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2011-09-24 00:00:00, ended at 2011-09-24 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2011-09-24, presumably until 2012-03-13, with intended 2 refill(s). Instructions: take 500 mg by mouth as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-24 11:23:00, ended at 2011-09-24 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Prothrombin time (PT): 41.1 (second)\n- INR in Platelet poor plasma by Coagulation assay: 4.6 (ratio)\n\n### Procedure\n- Subsequent stage of staged operation\n- Collection of venous blood by venipuncture\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-28 11:59:00, ended at 2011-09-28 12:54:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.2 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 131 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.2 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 25.0 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.91 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 79.9 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 124 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.6 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.47 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 89 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 24.1 (percent)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.5 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.2 (percent)\n- MCV [Entitic volume] by Automated count: 76.8 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.78 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.68 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.6 (percent)\n- Platelets [#/volume] in Blood by Automated count: 376 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of ovary\n- Macular edema due to diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-28 12:55:00, ended at 2011-09-28 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Mammography; bilateral\n- Computer-aided detection (computer algorithm analysis of digital image data for lesion detection) with further review for interpretation, with or without digitization of film radiographic images; diagnostic mammography (List separately in addition to code\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2011-09-29 00:00:00, ended at 2011-09-29 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Gastroesophageal reflux disease\n- Diffuse spasm of esophagus\n\n### Drug\n- dexlansoprazole 30 MG Delayed Release Oral Capsule, through Oral route, started on 2011-09-29, presumably until 2012-05-25, with intended 11 refill(s). Instructions: take 30 mg by mouth 2 times a day.\n- 24 HR diltiazem hydrochloride 120 MG Extended Release Oral Capsule, through Oral route, started on 2011-09-29, presumably until 2012-01-22, with intended 3 refill(s). Instructions: take 1 Cap by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-09-30 09:45:43, ended at 2011-09-30 14:23:25\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malaise\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-30 11:00:00, ended at 2011-09-30 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Prothrombin time (PT): 21.5 (second)\n- INR in Platelet poor plasma by Coagulation assay: 2.0 (ratio)\n\n### Procedure\n- Subsequent stage of staged operation\n- Collection of venous blood by venipuncture\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-10-01 00:00:00, ended at 2011-10-01 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of ovary\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-10-01 09:09:00, ended at 2011-10-01 09:19:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Tacrolimus [Mass/volume] in Blood: 9.5 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n- Urinary tract infectious disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-10-01 09:20:00, ended at 2011-10-01 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n- Systemic lupus erythematosus\n- Type 1 diabetes mellitus without complication\n- Osteoporosis\n- Primary malignant neoplasm of ovary\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-10-08 09:35:00, ended at 2011-10-08 10:18:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.7 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.2 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 12.3 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 24.4 (picogram)\n- MCHC [Mass/volume] by Automated count: 32.2 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 67.7 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 2.7 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.8 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 23.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 82 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.4 (ratio)\n- MCV [Entitic volume] by Automated count: 75.9 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.30 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 301 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 3.9 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 103 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 131 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.86 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.60 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 17.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.78 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.9 (thousand per microliter)\n- Prothrombin time (PT): 24.7 (second)\n- Triglyceride [Moles/volume] in Serum or Plasma: 47 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n\n### Procedure\n- Subsequent stage of staged operation\n\n### Condition\n- End-stage renal disease\n- Transplanted kidney present\n- Acquired absence of cervix and uterus\n- Renal disorder due to type 1 diabetes mellitus\n- Systemic lupus erythematosus\n- Chronic glomerulonephritis associated with another disorder\n- Primary malignant neoplasm of ovary\n- Acquired absence of genital organ\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-10-08 10:22:00, ended at 2011-10-08 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2011-10-08, presumably until 2011-10-08\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-10-11 13:05:50, ended at 2011-10-11 14:34:36\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ankylosis of joint\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-10-11 13:24:00, ended at 2011-10-11 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, wrist; complete, minimum of 3 views\n\n### Condition\n- Wrist joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2011-10-18 00:00:00, ended at 2011-10-18 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Insomnia\n\n### Drug\n- zolpidem tartrate 10 MG Oral Tablet, through Oral route, started on 2011-10-18, presumably until 2012-10-31, with intended 11 refill(s). Instructions: take 1 Tab by mouth Every Day. Take as needed for sleep\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-10-18 11:05:57, ended at 2011-10-18 13:24:19\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malnutrition (calorie)\n- Systemic lupus erythematosus\n- Hypo-osmolality and or hyponatremia\n- Renal disorder due to type 1 diabetes mellitus\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-10-18 12:01:07, ended at 2011-10-18 13:25:15\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-10-18 14:10:00, ended at 2011-10-18 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance imaging, breast, without and/or with contrast material(s); bilateral\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-10-22 12:14:00, ended at 2011-10-22 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- INR in Platelet poor plasma by Coagulation assay: 2.4 (ratio)\n- Complement C3 [Mass/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 17 (millimeter per hour)\n- C reactive protein [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Prothrombin time (PT): 25.3 (second)\n\n### Procedure\n- Subsequent stage of staged operation\n\n### Condition\n- Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-10-25 13:17:00, ended at 2011-10-25 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1.614\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Breast lump\n- Primary malignant neoplasm of ovary\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-10-26 15:08:29, ended at 2011-10-26 16:19:23\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of left eye: 13 (millimeter mercury column)\n- Intraocular pressure of right eye: 14 (millimeter mercury column)\n\n### Procedure\n- Intravitreal injection of a pharmacologic agent (separate procedure)\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Primary diagnosis: Macular edema due to diabetes mellitus\n\n### Drug\n- lidocaine hydrochloride 0.035 MG/MG Ophthalmic Gel, through Intraocular route, started on 2011-10-26, presumably until 2011-11-03, with intended 0 refill(s). Instructions: instill 2 Drops to right eye One Time.\n- proparacaine hydrochloride 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2011-10-26, presumably until 2011-11-03, with intended 0 refill(s). Instructions: instill 1 Drop to right eye One Time.\n- ofloxacin 3 MG/ML Ophthalmic Solution, through Intraocular route, started on 2011-10-26, presumably until 2011-11-03, with intended 0 refill(s). Instructions: instill 1 Drop to right eye One Time.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-11-02 10:42:00, ended at 2011-11-02 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of lower extremity arteries or arterial bypass grafts; unilateral or limited study\n\n### Condition\n- Dysphagia\n- Chest pain\n- Peripheral vascular disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-11-02 13:19:36, ended at 2011-11-02 14:09:32\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Peripheral vascular disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-11-02 15:40:47, ended at 2011-11-02 16:20:17\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Diffuse spasm of esophagus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-11-03 10:24:48, ended at 2011-11-03 12:34:58\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of left eye: 16 (millimeter mercury column)\n- Intraocular pressure of right eye: 18 (millimeter mercury column)\n\n### Procedure\n- Intravitreal injection of a pharmacologic agent (separate procedure)\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Primary diagnosis: Macular edema due to diabetes mellitus\n\n### Drug\n- lidocaine hydrochloride 0.035 MG/MG Ophthalmic Gel, through Intraocular route, started on 2011-11-03, presumably until 2011-12-01, with intended 0 refill(s). Instructions: instill 2 Drops to left eye One Time.\n- proparacaine hydrochloride 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2011-11-03, presumably until 2011-12-01, with intended 0 refill(s). Instructions: instill 1 Drop to left eye One Time.\n- ofloxacin 3 MG/ML Ophthalmic Solution, through Intraocular route, started on 2011-11-03, presumably until 2011-12-01, with intended 0 refill(s). Instructions: instill 1 Drop to left eye One Time.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-11-09 13:57:36, ended at 2011-11-09 16:31:07\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of musculoskeletal system\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2011-11-22 00:00:00, ended at 2011-11-22 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, started on 2011-11-22, presumably until 2011-12-24, with intended 10 refill(s). Instructions: TAKE 3 CAPSULES 2 TIMES A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-11-25 12:11:00, ended at 2011-11-25 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Prothrombin time (PT): 26.0 (second)\n- INR in Platelet poor plasma by Coagulation assay: 2.5 (ratio)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Subsequent stage of staged operation\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-12-01 13:53:41, ended at 2011-12-01 15:20:44\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of left eye: 15 (millimeter mercury column)\n- Intraocular pressure of right eye: 17 (millimeter mercury column)\n\n### Procedure\n- Intravitreal injection of a pharmacologic agent (separate procedure)\n\n### Condition\n- Disorder of eye due to type 1 diabetes mellitus\n- Primary diagnosis: Macular edema due to diabetes mellitus\n\n### Drug\n- lidocaine hydrochloride 0.035 MG/MG Ophthalmic Gel, through Intraocular route, started on 2011-12-01, presumably until 2011-12-24, with intended 0 refill(s). Instructions: instill 2 Drops to left eye One Time.\n- proparacaine hydrochloride 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2011-12-01, presumably until 2011-12-24, with intended 0 refill(s). Instructions: instill 1 Drop to left eye One Time.\n- ofloxacin 3 MG/ML Ophthalmic Solution, through Intraocular route, started on 2011-12-01, presumably until 2011-12-27, with intended 0 refill(s). Instructions: instill 1 Drop to left eye One Time.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2011-12-03 00:00:00, ended at 2011-12-03 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- mycophenolate mofetil 500 MG Oral Tablet, through Oral route, started on 2011-12-03, presumably until 2011-12-24, with intended 11 refill(s). Instructions: take 0.5 Tabs by mouth 2 times a day. Patient will take 2 tabs twice daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-12-06 09:35:00, ended at 2011-12-06 10:09:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Tacrolimus [Mass/volume] in Blood: 8.0 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n- Transplanted kidney present\n- Type 1 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-12-06 10:10:00, ended at 2011-12-06 14:02:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.9 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.8 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 8.0 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 118 (unit per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.74 (million per microliter)\n- Platelets [#/volume] in Blood by Automated count: 363 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 42 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.1 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.79 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 133 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.9 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 8.5 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 22.7 (picogram)\n- MCHC [Mass/volume] by Automated count: 32.0 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.9 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.6 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 74.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 80 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 71.1 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.6 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.81 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.07 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-12-06 11:01:42, ended at 2011-12-06 11:53:53\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-12-06 13:50:20, ended at 2011-12-06 15:16:30\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Injection(s); single tendon sheath, or ligament, aponeurosis (eg, plantar  fascia )\n\n### Condition\n- Sprain of wrist\n- Acquired trigger finger\n- Wrist joint pain\n- Hand joint pain\n\n### Drug\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2011-12-06, presumably until 2011-12-06, with intended 0 refill(s). Instructions: 0.7 mL by Injection route One Time.\n- betamethasone 3 MG/ML / betamethasone acetate 3 MG/ML Injectable Suspension, started on 2011-12-06, presumably until 2011-12-06, with intended 0 refill(s). Instructions: 0.7 mL by Injection route One Time.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-12-06 14:03:00, ended at 2011-12-06 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, wrist; complete, minimum of 3 views\n\n### Condition\n- Wrist joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-12-07 11:00:00, ended at 2011-12-07 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n- Osteoporosis\n- Systemic lupus erythematosus\n- Type 1 diabetes mellitus without complication\n- Primary malignant neoplasm of ovary\n\n### Drug\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2011-12-07, presumably until 2011-12-07\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-12-21 00:00:00, ended at 2011-12-21 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of ovary\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-12-21 11:12:00, ended at 2011-12-21 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Prothrombin time (PT): 31.2 (second)\n- INR in Platelet poor plasma by Coagulation assay: 3.2 (ratio)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of ovary\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2011-12-22 00:00:00, ended at 2011-12-22 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Subsequent stage of staged operation\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2011-12-22 00:00:00, ended at 2011-12-22 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Peripheral nerve disease\n- Essential hypertension\n\n### Drug\n- 24 HR metoprolol succinate 25 MG Extended Release Oral Tablet, started on 2011-12-22, presumably until 2012-08-23, with intended 6 refill(s). Instructions: TAKE 1 TABLET (25MG) BY MOUTH IN AM AND 2 TABLETS (50MG) IN PM\n- gabapentin 300 MG Oral Capsule, started on 2011-12-22, presumably until 2011-12-24, with intended 3 refill(s). Instructions: TAKE 1 CAPSULE BY MOUTH 4 TIMES A DAY.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-12-24 11:00:00, ended at 2011-12-24 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2.205\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of ovary\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, presumably until 2012-05-02. Instructions: take 250 mg by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-12-27 13:45:09, ended at 2011-12-27 15:13:54\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n- Essential hypertension\n- Renal disorder due to type 1 diabetes mellitus\n- Transplanted kidney present\n- Pruritus of skin\n- Coronary arteriosclerosis\n\n### Drug\n- atorvastatin 20 MG Oral Tablet, through Oral route, presumably until 2014-04-26. Instructions: take 20 mg by mouth daily in the evening.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-01-01 11:48:00, ended at 2012-01-01 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin/Creatinine [Mass Ratio] in Urine: 8 (milligram per gram)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 62 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 62 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.68 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.94 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.7 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.8 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 21.4 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 70.8 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Albumin [Mass/volume] in Urine: 5 (milligram per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 67 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.8 (percent)\n- MCV [Entitic volume] by Automated count: 67.8 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 15.9 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 133 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 71 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 5.0 (nanogram per milliliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 1.0 (ratio)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 105 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 8.4 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.92 (thousand per microliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 1.57 (milli-international unit per liter)\n- Urate [Mass/volume] in Serum or Plasma: 4.0 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 4.9 (percent)\n- MCHC [Mass/volume] by Automated count: 31.6 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.7 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 132 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 47 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.10 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.3 (percent)\n- Platelets [#/volume] in Blood by Automated count: 387 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n- Hyperlipidemia\n- Type 1 diabetes mellitus without complication\n- Pruritus of skin\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-01-04 15:55:00, ended at 2012-01-04 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of ovary\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-01-11 11:24:00, ended at 2012-01-11 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n\n### Condition\n- Transplanted kidney present\n- Left lower quadrant pain\n- Primary malignant neoplasm of ovary\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-01-13 00:00:00, ended at 2012-01-13 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Angina pectoris\n\n### Drug\n- nitroglycerin 0.4 MG Sublingual Tablet, through Sublingual route, started on 2012-01-13, presumably until 2013-03-12, with intended 11 refill(s). Instructions: place 1 Tab under the tongue and let dissolve as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2012-01-21 00:00:00, ended at 2012-01-21 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Prothrombin time (PT): 21.3 (second)\n- INR in Platelet poor plasma by Coagulation assay: 2.0 (ratio)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-01-22 00:00:00, ended at 2012-01-22 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Diffuse spasm of esophagus\n- Gastroesophageal reflux disease\n\n### Drug\n- 24 HR diltiazem hydrochloride 120 MG Extended Release Oral Capsule, started on 2012-01-22, presumably until 2012-06-01, with intended 3 refill(s). Instructions: TAKE ONE CAPSULE BY MOUTH ONE TIME DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-01-24 00:00:00, ended at 2012-01-24 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2012-01-24, presumably until 2012-03-27, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-01-26 00:00:00, ended at 2012-01-26 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Peripheral nerve disease\n\n### Drug\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2012-01-26, presumably until 2012-07-21, with intended 6 refill(s). Instructions: take 1 Cap by mouth 4 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2012-01-26 00:00:00, ended at 2012-01-26 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Infective pneumonia\n\n### Drug\n- azithromycin 250 MG Oral Tablet, through Oral route, started on 2012-01-26, presumably until 2012-02-14, with intended 1 refill(s). Instructions: take 1 Tab by mouth as directed. 2 pills on the first day, then 1 per day for 4 days.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2012-02-02 00:00:00, ended at 2012-02-02 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Diarrhea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-02-08 13:51:58, ended at 2012-02-08 14:44:49\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Diarrhea\n\n### Drug\n- hyoscyamine sulfate 0.125 MG Sublingual Tablet, through Oral route, started on 2012-02-08, presumably until 2012-04-26, with intended 2 refill(s). Instructions: take 1 Tab by mouth 3 times a day as needed (cramping).\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-02-10 10:45:00, ended at 2012-02-10 11:32:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 73.2 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 97 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 95 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 29.0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.10 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.92 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.1 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 343 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 11.7 (nanogram per milliliter)\n- Urate [Mass/volume] in Serum or Plasma: 4.1 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 51 (nanogram per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 12.0 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.1 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.90 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 77 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.8 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.26 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 39 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.6 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 140 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.1 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.9 (percent)\n- MCH [Entitic mass] by Automated count: 23.5 (picogram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.4 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 69.4 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Anemia in chronic kidney disease\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-02-10 11:33:00, ended at 2012-02-10 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Diarrhea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-02-14 10:57:18, ended at 2012-02-14 12:34:07\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Immune defect\n- Transplanted kidney present\n- Dizziness and giddiness\n- Primary malignant neoplasm of ovary\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-02-28 11:23:34, ended at 2012-02-28 12:14:33\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Systemic lupus erythematosus\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2012-02-28, presumably until 2012-03-17, with intended 0 refill(s). Instructions: take 2 Tabs by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-02-28 13:36:00, ended at 2012-02-28 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocyte sedimentation rate: 6 (millimeter per hour)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Complement C3 [Mass/volume] in Serum or Plasma: 90 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-02-29 00:00:00, ended at 2012-02-29 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- isosorbide dinitrate 30 MG Oral Tablet, started on 2012-02-29, presumably until 2012-02-29, with intended 1 refill(s). Instructions: TAKE ONE TABLET BY MOUTH TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-02-29 00:00:00, ended at 2012-02-29 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Diffuse spasm of esophagus\n\n### Drug\n- isosorbide dinitrate 30 MG Oral Tablet, through Oral route, started on 2012-02-29, presumably until 2012-09-21, with intended 6 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-03-07 12:42:54, ended at 2012-03-07 14:14:26\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypertropia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-03-10 11:50:00, ended at 2012-03-10 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of blood specimen from a completely implantable venous access device\n\n### Condition\n- Primary malignant neoplasm of ovary\n- Transplanted kidney present\n\n### Drug\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2012-03-10, presumably until 2012-03-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-03-13 00:00:00, ended at 2012-03-13 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2012-03-13, presumably until 2012-04-26, with intended 2 refill(s). Instructions: take 500 mg by mouth as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-03-17 14:30:00, ended at 2012-03-17 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2.598\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of ovary\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-03-22 12:53:34, ended at 2012-03-22 14:49:38\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of left eye: 19 (millimeter mercury column)\n- Intraocular pressure of right eye: 18 (millimeter mercury column)\n\n### Procedure\n- Scanning computerized ophthalmic diagnostic imaging, posterior segment, with interpretation and report, unilateral or bilateral; retina\n\n### Condition\n- Proliferative retinopathy due to diabetes mellitus\n- Tear film insufficiency\n- Macular edema due to diabetes mellitus\n- Vitreous degeneration\n- Disorder of eye due to type 1 diabetes mellitus\n- Epiretinal membrane\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-03-24 11:55:00, ended at 2012-03-24 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- INR in Platelet poor plasma by Coagulation assay: 2.0 (ratio)\n- Prothrombin time (PT): 21.9 (second)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-03-27 00:00:00, ended at 2012-03-27 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Systemic lupus erythematosus\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2012-03-27, presumably until 2012-09-22, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2012-03-31 00:00:00, ended at 2012-03-31 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Anemia in chronic kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-04-07 10:57:59, ended at 2012-04-07 12:35:20\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of right eye: 13 (millimeter mercury column)\n- Intraocular pressure of left eye: 14 (millimeter mercury column)\n\n### Procedure\n- Closure of the lacrimal punctum; by plug, each\n\n### Condition\n- Vitreous degeneration\n- Macular edema due to diabetes mellitus\n- Tear film insufficiency\n- Epiretinal membrane\n- Disorder of eye due to type 1 diabetes mellitus\n- Proliferative retinopathy due to diabetes mellitus\n\n### Drug\n- ketotifen 0.25 MG/ML Ophthalmic Solution, through Intraocular route, presumably until 2019-04-18. Instructions: instill 1 Drop to both eyes every 6 hours as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-04-10 00:00:00, ended at 2012-04-10 00:00:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Tear film insufficiency\n\n### Drug\n- 0.4 ML cyclosporine 0.5 MG/ML Ophthalmic Suspension, through Intraocular route, started on 2012-04-10, presumably until 2012-04-24, with intended 0 refill(s). Instructions: 1 Drop by Ophthalmic route 2 times a day. To both eyes for two weeks.  \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-04-17 11:29:00, ended at 2012-04-17 11:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 81 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.40 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 60.8 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.8 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Iron [Mass/volume] in Serum or Plasma: 22 (microgram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 281 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 4.8 (nanogram per milliliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 42 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.6 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.05 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 107 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 146 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 24.1 (percent)\n- Ferritin [Mass/volume] in Serum or Plasma: 8 (nanogram per milliliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.8 (percent)\n- MCV [Entitic volume] by Automated count: 78.2 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.04 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.4 (gram per deciliter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 347 (microgram per deciliter)\n- MCH [Entitic mass] by Automated count: 25.5 (picogram)\n- MCHC [Mass/volume] by Automated count: 32.6 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 18.6 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.45 (million per microliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 6 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anemia in chronic kidney disease\n- Chronic kidney disease\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-04-17 12:00:00, ended at 2012-04-17 23:59:00\nThe patient in this visit was 56 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of blood specimen from a completely implantable venous access device\n\n### Condition\n- Transplanted kidney present\n- Primary malignant neoplasm of ovary\n\n### Drug\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2012-04-17, presumably until 2012-04-17\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-04-24 10:53:00, ended at 2012-04-24 12:15:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Prothrombin time (PT): 17.7 (second)\n- INR in Platelet poor plasma by Coagulation assay: 1.5 (ratio)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2012-04-24 12:16:00, ended at 2012-04-24 20:29:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Glucose [Mass/volume] in Serum or Plasma: 88 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.4 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.8 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 77.9 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 258 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.58 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.98 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 25.2 (picogram)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.10 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.0 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 21.2 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.83 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.5 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 17.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.81 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20.5 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.7 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 58.7 (percent)\n\n### Procedure\n- Duplex scan of extremity veins including responses to compression and other maneuvers; unilateral or limited study\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Radiologic examination; forearm, 2 views\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Radiologic examination; humerus, minimum of 2 views\n\n### Condition\n- Essential hypertension\n- Swelling of limb\n- Disorder of eye due to diabetes mellitus\n- Swelling / lump finding\n- Complication associated with orthopedic device\n- Mechanical complication of internal orthopedic device, implant AND/OR graft\n- Nonproliferative retinopathy due to diabetes mellitus\n- Atherosclerosis of artery\n- Hyperlipidemia\n- Transplanted kidney present\n- Wrist joint pain\n- Late effect of medical and surgical care complication\n- Systemic lupus erythematosus\n- Coronary arteriosclerosis\n\n### Drug\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2012-04-24, presumably until 2012-04-24\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2012-04-24, presumably until 2012-04-24\n- ondansetron 4 MG Disintegrating Oral Tablet, through Oral route, started on 2012-04-24, presumably until 2012-04-24\n- 1 ML morphine sulfate 2 MG/ML Prefilled Syringe, started on 2012-04-24, presumably until 2012-04-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-04-26 10:20:00, ended at 2012-04-26 17:36:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Removal of implant; deep (eg, buried wire, pin, screw, metal band, nail, rod or plate)\n- Removal of implant from humerus\n- Removal of implanted devices from bone, radius and ulna\n\n### Condition\n- Disorder of wrist joint\n- Complication associated with orthopedic device\n- Late effect of medical and surgical care complication\n- Pain in limb\n- Wrist joint pain\n- Elbow joint pain\n\n### Drug\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2012-04-26, presumably until 2012-04-26\n- acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2012-04-26, presumably until 2012-07-21, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed (pain).\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2012-04-26, presumably until 2012-05-02, with intended 2 refill(s). Instructions: take 1 Cap by mouth 2 times a day.\n- 1 ML hydromorphone hydrochloride 2 MG/ML Prefilled Syringe, started on 2012-04-26, presumably until 2012-04-26\n- 12 HR oxycodone hydrochloride 10 MG Extended Release Oral Tablet, through Oral route, started on 2012-04-26, presumably until 2012-04-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 12 hours.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-04-27 00:00:00, ended at 2012-04-27 00:00:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-04-28 00:00:00, ended at 2012-04-28 00:00:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2012-04-28, presumably until 2013-04-20, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-04-28 10:44:00, ended at 2012-04-28 23:59:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Prothrombin time (PT): 24.7 (second)\n- INR in Platelet poor plasma by Coagulation assay: 2.4 (ratio)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-05-02 10:00:00, ended at 2012-05-02 23:59:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of lower extremity arteries or arterial bypass grafts; unilateral or limited study\n\n### Condition\n- Peripheral vascular disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-05-02 10:43:54, ended at 2012-05-02 12:34:08\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Peripheral vascular disease\n\n### Drug\n- furosemide 20 MG Oral Tablet, through Oral route, presumably until 2012-07-03. Instructions: take 20 mg by mouth daily.  \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-05-08 10:24:55, ended at 2012-05-08 14:06:54\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Wrist joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-05-08 14:00:00, ended at 2012-05-08 23:59:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.71 (million per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.95 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.10 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.6 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.9 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 52.9 (percent)\n- Erythrocyte sedimentation rate: 9 (millimeter per hour)\n- Monocytes/100 leukocytes in Blood by Automated count: 20.4 (percent)\n- MCV [Entitic volume] by Automated count: 77.4 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.47 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 316 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.7 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.7 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.7 (percent)\n- MCH [Entitic mass] by Automated count: 24.8 (picogram)\n- MCHC [Mass/volume] by Automated count: 32.1 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Wrist joint pain\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-05-09 13:29:51, ended at 2012-05-09 14:14:01\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1.5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Diffuse spasm of esophagus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-05-24 10:59:00, ended at 2012-05-24 23:59:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- INR in Platelet poor plasma by Coagulation assay: 2.0 (ratio)\n- Prothrombin time (PT): 22.0 (second)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-05-25 00:00:00, ended at 2012-05-25 00:00:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Gastroesophageal reflux disease\n- Diffuse spasm of esophagus\n\n### Drug\n- dexlansoprazole 30 MG Delayed Release Oral Capsule, through Oral route, started on 2012-05-25, presumably until 2013-06-29, with intended 11 refill(s). Instructions: take 30 mg by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-05-29 10:38:32, ended at 2012-05-29 11:26:22\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-05-29 11:58:00, ended at 2012-05-29 23:59:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, knee; both knees, standing, anteroposterior\n- Radiologic examination, knee; 3 views\n\n### Condition\n- Osteoarthritis of knee\n- Joint pain\n- Systemic lupus erythematosus\n- Disorder of bone and articular cartilage\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-05-31 14:52:50, ended at 2012-05-31 15:35:36\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-06-01 00:00:00, ended at 2012-06-01 00:00:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Diffuse spasm of esophagus\n- Gastroesophageal reflux disease\n- Dysphagia\n\n### Drug\n- 24 HR diltiazem hydrochloride 120 MG Extended Release Oral Capsule, through Oral route, started on 2012-06-01, presumably until 2012-10-24, with intended 5 refill(s). Instructions: take 1 Cap by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-06-05 14:26:54, ended at 2012-06-05 15:43:15\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Degenerative joint disease of hand\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-06-05 15:08:00, ended at 2012-06-05 23:59:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, wrist; complete, minimum of 3 views\n\n### Condition\n- Wrist joint pain\n- Disorder of wrist joint\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-06-06 00:00:00, ended at 2012-06-06 00:00:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 12 HR diltiazem hydrochloride 120 MG Extended Release Oral Capsule, through Oral route, started on 2012-06-06, presumably until 2013-06-06, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-06-06 00:00:00, ended at 2012-06-06 00:00:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Tear film insufficiency\n\n### Drug\n- 0.4 ML cyclosporine 0.5 MG/ML Ophthalmic Suspension, through Intraocular route, started on 2012-06-06, presumably until 2012-07-14, with intended 6 refill(s). Instructions: instill 1 Drop to both eyes 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-06-14 12:31:00, ended at 2012-06-14 23:59:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.3 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 17.8 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 79 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.3 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Albumin [Mass/volume] in Urine: <5 (milligram per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 76 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 15.8 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.64 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 64.6 (percent)\n- Platelets [#/volume] in Blood by Automated count: 301 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Albumin/Creatinine [Mass Ratio] in Urine: <30 (milligram per gram)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.00 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 24.9 (picogram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.7 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.6 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 77.0 (femtoliter)\n- Tacrolimus [Mass/volume] in Blood: 4.5 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.89 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.93 (million per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-06-14 13:55:29, ended at 2012-06-14 14:43:39\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Subsequent stage of staged operation\n\n### Condition\n- No conditions.\n\n### Drug\n- 0.6 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2012-06-14, presumably until 2012-07-05, with intended 1 refill(s). Instructions: inject 0.5 mL subcutaneous (under the skin) every 12 hours. As directed by SHC anticoag clinic.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2012-06-21 10:01:00, ended at 2012-06-23 19:50:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 11.1 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.5 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.48 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.4 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 32.2 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 77.3 (femtoliter)\n- Prothrombin time (PT): 14.6 (second)\n- aPTT in Platelet poor plasma by Coagulation assay: 37.6 (second)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.1 (thousand per microliter)\n- Body height: 5' 2.5\" (inch (US))\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 96 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 24.8 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 231 (thousand per microliter)\n\n### Procedure\n- Insertion of recombinant bone morphogenetic protein\n- Subsequent stage of staged operation\n- Injection of anesthetic agent into peripheral nerve for analgesia\n- Arthrodesis of carpometacarpal joint\n- Therapeutic procedure, 1 or more areas, each 15 minutes; gait training (includes stair climbing)\n- Excision of bone for graft, other bones\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n\n### Condition\n- Acute gastritis\n- Disorder of nervous system due to diabetes mellitus\n- Peripheral nerve disease\n- Disorder of eye due to type 1 diabetes mellitus\n- Disorder of wrist joint\n- Late effect of medical and surgical care complication\n- Peripheral vascular disease\n- Systemic lupus erythematosus\n- Tear film insufficiency\n- Complication of internal device\n- Diffuse spasm of esophagus\n- Essential hypertension\n- Insomnia\n- Nonproliferative retinopathy due to diabetes mellitus\n- Renal disorder due to type 1 diabetes mellitus\n- Disorder of bone and articular cartilage\n- Dysphagia\n- Mechanical complication of internal orthopedic device, implant AND/OR graft\n- Coronary arteriosclerosis\n- Gastroesophageal reflux disease\n- Hyperlipidemia\n- Transplanted kidney present\n- Localized osteoarthrosis uncertain if primary OR secondary\n\n### Drug\n- isosorbide dinitrate 30 MG Oral Tablet, through Oral route, started on 2012-06-21, presumably until 2012-06-23\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2012-06-21, presumably until 2012-06-22\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2012-06-21, presumably until 2012-06-23\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2012-06-21, presumably until 2012-06-21\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2012-06-22, presumably until 2012-06-23\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2012-06-22, presumably until 2012-06-23\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2012-06-22, presumably until 2012-06-23\n- mineral oil 0.425 MG/MG / petrolatum 0.568 MG/MG Ophthalmic Ointment, through Intraocular route, started on 2012-06-21, presumably until 2012-06-22\n- cefazolin 1000 MG Injection, through Intravenous route, started on 2012-06-22, presumably until 2012-06-23\n- 24 HR metoprolol succinate 25 MG Extended Release Oral Tablet, through Oral route, started on 2012-06-21, presumably until 2012-06-23\n- acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2012-06-21, presumably until 2012-10-31, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed for Pain.\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2012-06-21, presumably until 2012-08-28, with intended 2 refill(s). Instructions: take 1 Cap by mouth 2 times a day.\n- cephalexin 500 MG Oral Capsule, through Oral route, started on 2012-06-22, presumably until 2012-07-05, with intended 0 refill(s). Instructions: take 1 Cap by mouth every 6 hours.\n- warfarin sodium 4 MG Oral Tablet, through Oral route, started on 2012-06-22, presumably until 2012-06-23\n- 24 HR metoprolol succinate 50 MG Extended Release Oral Tablet, through Oral route, started on 2012-06-22, presumably until 2012-06-22\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2012-06-22, presumably until 2012-06-23\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2012-06-21, presumably until 2012-06-23\n- 24 HR diltiazem hydrochloride 120 MG Extended Release Oral Capsule, through Oral route, started on 2012-06-22, presumably until 2012-06-23\n- 2 ML ondansetron 2 MG/ML Injection, started on 2012-06-21, presumably until 2012-06-23\n- 0.6 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2012-06-22, presumably until 2012-06-23\n- 12 HR oxycodone hydrochloride 10 MG Extended Release Oral Tablet, through Oral route, started on 2012-06-22, presumably until 2012-08-28, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 12 hours.\n- 0.4 ML cyclosporine 0.5 MG/ML Ophthalmic Suspension, through Intraocular route, started on 2012-06-21, presumably until 2012-06-23\n- clopidogrel 75 MG Oral Tablet, through Oral route, started on 2012-06-22, presumably until 2012-06-23\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2012-06-22, presumably until 2012-06-23\n- zolpidem tartrate 10 MG Oral Tablet, through Oral route, started on 2012-06-23, presumably until 2012-06-23\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-06-26 00:00:00, ended at 2012-06-26 00:00:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Peripheral vascular disease\n- Angina pectoris\n\n### Drug\n- furosemide 40 MG Oral Tablet, through Oral route, started on 2012-06-26, presumably until 2013-06-26, with intended 6 refill(s). Instructions: take 0.5 Tabs by mouth 2 times a day.\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2012-06-27, presumably until 2012-08-10, with intended 0 refill(s). Instructions: take 500 mg by mouth as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-06-26 13:51:01, ended at 2012-06-26 14:38:04\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n- Coronary arteriosclerosis\n- Essential hypertension\n- Hyperlipidemia\n- Diffuse spasm of esophagus\n- Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-06-26 15:00:49, ended at 2012-06-26 15:11:30\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Subsequent stage of staged operation\n\n### Condition\n- No conditions.\n\n### Drug\n- warfarin sodium 4 MG Oral Tablet, started on 2012-06-26, presumably until 2012-11-23, with intended 0 refill(s). Instructions: Take 4 mg by mouth daily except 2 mg on Sat. and Sun. or as directed by SHC anticoag clinic.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-07-03 00:00:00, ended at 2012-07-03 00:00:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Renal disorder due to type 1 diabetes mellitus\n\n### Drug\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2012-07-03, presumably until 2012-11-09, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-07-05 11:09:40, ended at 2012-07-05 11:33:21\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Application of short arm cast\n- Radiologic examination, wrist; complete, minimum of 3 views\n\n### Condition\n- Disorder of cardiovascular system\n- Wrist joint pain\n\n### Drug\n- ranitidine 300 MG Oral Tablet, through Oral route, started on 2012-07-03, presumably until 2012-10-24. Instructions: take 300 mg by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-07-05 13:24:16, ended at 2012-07-05 14:19:25\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Application of short arm cast\n\n### Condition\n- Primary diagnosis: Wrist joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-07-05 13:33:00, ended at 2012-07-05 23:59:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, wrist; complete, minimum of 3 views\n\n### Condition\n- Wrist joint pain\n- Disorder of cardiovascular system\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-07-14 10:45:03, ended at 2012-07-14 11:32:24\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of right eye: 12 (millimeter mercury column)\n- Intraocular pressure of left eye: 12 (millimeter mercury column)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Proliferative retinopathy due to diabetes mellitus\n- Systemic lupus erythematosus\n- Tear film insufficiency\n- Disorder of eyelid\n- Macular edema due to diabetes mellitus\n- Vitreous degeneration\n- Epiretinal membrane\n- Disorder of eye due to type 1 diabetes mellitus\n\n### Drug\n- 0.4 ML cyclosporine 0.5 MG/ML Ophthalmic Suspension, through Intraocular route, started on 2012-07-14, presumably until 2012-09-11, with intended 6 refill(s). Instructions: instill 1 Drop to both eyes 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-07-18 16:06:00, ended at 2012-07-18 23:59:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of blood specimen from a completely implantable venous access device\n\n### Condition\n- Primary malignant neoplasm of ovary\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-07-21 00:00:00, ended at 2012-07-21 00:00:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2012-07-21, presumably until 2012-08-21, with intended 0 refill(s). Instructions: take 1 Cap by mouth 4 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-07-21 10:28:00, ended at 2012-07-21 23:59:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Macular edema due to diabetes mellitus\n- Proliferative retinopathy due to diabetes mellitus\n- Disorder of eye due to type 1 diabetes mellitus\n- Vitreous degeneration\n- Epigastric pain\n- Epiretinal membrane\n- Primary malignant neoplasm of ovary\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-07-21 13:53:03, ended at 2012-07-21 16:23:02\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of right eye: 14 (millimeter mercury column)\n- Intraocular pressure of left eye: 14 (millimeter mercury column)\n\n### Procedure\n- Scanning computerized ophthalmic diagnostic imaging, posterior segment, with interpretation and report, unilateral or bilateral; retina\n\n### Condition\n- Macular edema due to diabetes mellitus\n- Disorder of eye due to type 1 diabetes mellitus\n- Proliferative retinopathy due to diabetes mellitus\n- Epiretinal membrane\n- Vitreous degeneration\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2012-07-25 00:00:00, ended at 2012-07-25 00:00:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Aseptic necrosis of bone\n- Backache\n- Osteoporosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-07-25 12:03:00, ended at 2012-07-25 12:39:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 20 (nanogram per milliliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 20 (nanogram per milliliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Osteoporosis\n- Hyperparathyroidism\n- Aseptic necrosis of bone\n- Backache\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-07-25 12:40:00, ended at 2012-07-25 23:59:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, spine; thoracolumbar junction, minimum of 2 views\n\n### Condition\n- Backache\n- Pathological fracture of vertebra\n- Lumbosacral spondylosis without myelopathy\n- Aseptic necrosis of bone\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-07-28 10:04:00, ended at 2012-07-28 23:59:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Osteoporosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2012-08-05 00:00:00, ended at 2012-08-05 00:00:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Vitamin D deficiency\n- Primary diagnosis: Aseptic necrosis of bone\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-08-05 11:07:00, ended at 2012-08-05 23:59:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin/Creatinine [Mass Ratio] in Urine: <30 (milligram per gram)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.70 (million per microliter)\n- Platelets [#/volume] in Blood by Automated count: 332 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.24 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 63.8 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Erythrocyte sedimentation rate: 9 (millimeter per hour)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.8 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.22 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.2 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.6 (percent)\n- MCV [Entitic volume] by Automated count: 74.9 (femtoliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 99 (unit per liter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 21.3 (percent)\n- Tacrolimus [Mass/volume] in Blood: 5.6 (nanogram per milliliter)\n- Albumin [Mass/volume] in Urine: <5 (milligram per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.1 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 23.6 (picogram)\n- MCHC [Mass/volume] by Automated count: 31.5 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.01 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.6 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 15.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- End-stage renal disease\n- Transplanted kidney present\n- Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-08-17 11:32:04, ended at 2012-08-17 13:06:13\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Application of short arm cast\n\n### Condition\n- Wrist joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-08-17 11:42:00, ended at 2012-08-17 23:59:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, wrist; complete, minimum of 3 views\n\n### Condition\n- Wrist joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-08-21 00:00:00, ended at 2012-08-21 00:00:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2012-08-21, presumably until 2012-10-24, with intended 4 refill(s). Instructions: take 1 Cap by mouth 4 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-08-22 08:32:00, ended at 2012-08-22 23:59:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- INR in Platelet poor plasma by Coagulation assay: 2.2 (ratio)\n- Prothrombin time (PT): 23.1 (second)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-08-23 00:00:00, ended at 2012-08-23 00:00:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 24 HR metoprolol succinate 25 MG Extended Release Oral Tablet, started on 2012-08-23, presumably until 2012-08-28, with intended 6 refill(s). Instructions: TAKE 1 TABLET (25MG) BY MOUTH EVERY MORNING AND 2 TABLETS(50MG) EVERY EVENING\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-08-28 00:00:00, ended at 2012-08-28 00:00:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-08-28 10:27:27, ended at 2012-08-28 14:47:33\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Systemic lupus erythematosus\n- Immune defect\n- Transplanted kidney present\n- Disorder of bone and articular cartilage\n- Renal disorder due to type 1 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-09-08 17:12:00, ended at 2012-09-08 23:59:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, spinal canal and contents, without contrast material, followed by contrast material(s) and further sequences; lumbar\n\n### Condition\n- Ganglion cyst\n- Spondylolisthesis\n- Congenital anomaly of spine\n- Low back pain\n- Lumbosacral spondylosis without myelopathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-09-11 10:59:08, ended at 2012-09-11 12:48:53\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of left eye: 14 (millimeter mercury column)\n- Intraocular pressure of right eye: 13 (millimeter mercury column)\n\n### Procedure\n- Closure of the lacrimal punctum; by plug, each\n\n### Condition\n- Macular edema due to diabetes mellitus\n- Vitreous degeneration\n- Tear film insufficiency\n- Disorder of eye due to type 1 diabetes mellitus\n- Proliferative retinopathy due to diabetes mellitus\n- Epiretinal membrane\n\n### Drug\n- 0.4 ML cyclosporine 0.5 MG/ML Ophthalmic Suspension, through Intraocular route, started on 2012-09-11, presumably until 2012-10-31, with intended 6 refill(s). Instructions: instill 1 Drop to both eyes 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-09-14 16:23:03, ended at 2012-09-14 17:28:04\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Degenerative joint disease of hand\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-09-14 16:53:00, ended at 2012-09-14 23:59:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, wrist; complete, minimum of 3 views\n\n### Condition\n- Epiretinal membrane\n- Imaging of musculoskeletal system abnormal\n- Atherosclerosis of aorta\n- Callosity\n- Closed fracture of distal end of radius\n- Disorder of eye due to type 1 diabetes mellitus\n- Tear film insufficiency\n- Transplanted kidney present\n- Disorder of bone and articular cartilage\n- Proliferative retinopathy due to diabetes mellitus\n- Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-09-21 00:00:00, ended at 2012-09-21 00:00:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Diffuse spasm of esophagus\n\n### Drug\n- isosorbide dinitrate 30 MG Oral Tablet, through Oral route, started on 2012-09-21, presumably until 2013-05-08, with intended 6 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-09-22 00:00:00, ended at 2012-09-22 00:00:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Systemic lupus erythematosus\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2012-09-22, presumably until 2012-12-25, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-09-22 11:19:00, ended at 2012-09-22 23:59:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.3 (percent)\n- Tacrolimus [Mass/volume] in Blood: 11.4 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Albumin [Mass/volume] in Urine: <5 (milligram per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Albumin/Creatinine [Mass Ratio] in Urine: <30 (milligram per gram)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 94 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.4 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 23.3 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 306 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 3.0 (ratio)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.7 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 18.8 (percent)\n- MCV [Entitic volume] by Automated count: 72.4 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.21 (thousand per microliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.7 (percent)\n- MCHC [Mass/volume] by Automated count: 32.2 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.15 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.15 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.94 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.0 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 64.6 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Prothrombin time (PT): 29.3 (second)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n\n### Procedure\n- Collection of blood specimen from a completely implantable venous access device\n\n### Condition\n- End-stage renal disease\n- Primary malignant neoplasm of ovary\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-09-26 11:42:56, ended at 2012-09-26 12:18:38\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2.5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Low back pain\n- Lumbosacral spondylosis without myelopathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-09-26 12:50:00, ended at 2012-09-26 23:59:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, spine, lumbosacral; 2 or 3 views\n\n### Condition\n- Lumbosacral spondylosis without myelopathy\n- Spondylolisthesis\n- Disorder of trunk\n- Low back pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-10-16 00:00:00, ended at 2012-10-16 00:00:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- General examination of patient\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2012-10-17 00:00:00, ended at 2012-10-17 00:00:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 10 ML bupivacaine hydrochloride 5 MG/ML Injection, started on 2012-10-17, presumably until 2012-10-17\n- methylprednisolone acetate 80 MG/ML Injectable Suspension, started on 2012-10-17, presumably until 2012-10-17\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2012-10-17, presumably until 2012-10-17\n- iohexol, through Intravenous route, started on 2012-10-17, presumably until 2012-10-17\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-10-17 12:42:00, ended at 2012-10-17 17:04:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- INR in Platelet poor plasma by Coagulation assay: 2.2 (ratio)\n- Body height: 5' 2\" (inch (US))\n- Prothrombin time (PT): 22.9 (second)\n\n### Procedure\n- Injection of therapeutic substance into joint or ligament\n- Collection of venous blood by venipuncture\n- Radiologic examination, spine, single view, specify level\n- Injection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joint) with image guidance (fluoroscopy or CT), lumbar or sacral; single level\n- Injection of steroid\n- Injection of anesthetic agent into peripheral nerve for analgesia\n- Injection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joint) with image guidance (fluoroscopy or CT), lumbar or sacral; second level (List separately in addition to code for primary procedure)\n- Other x-ray of lumbosacral spine\n- Injection or infusion of other therapeutic or prophylactic substance\n\n### Condition\n- Essential hypertension\n- Lumbosacral spondylosis without myelopathy\n- Spondylosis without myelopathy\n- Backache\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-10-24 08:51:00, ended at 2012-10-24 09:31:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Tacrolimus [Mass/volume] in Blood: 4.1 (nanogram per milliliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-10-24 09:32:00, ended at 2012-10-24 23:59:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computer-aided detection (computer algorithm analysis of digital image data for lesion detection) with further review for interpretation, with or without digitization of film radiographic images; screening mammography (List separately in addition to code \n- Screening mammography, bilateral (2-view study of each breast)\n\n### Condition\n- Inconclusive mammography finding\n- Primary malignant neoplasm of ovary\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-10-24 12:53:32, ended at 2012-10-24 14:23:29\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Systemic lupus erythematosus\n- Diffuse spasm of esophagus\n- Dysphagia\n- Gastroesophageal reflux disease\n\n### Drug\n- ranitidine 300 MG Oral Tablet, through Oral route, started on 2012-10-24, presumably until 2014-02-15, with intended 4 refill(s). Instructions: take 300 mg by mouth 2 times a day.\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2012-10-24, presumably until 2013-01-26, with intended 4 refill(s). Instructions: take 1 Cap by mouth 4 times a day.\n- 24 HR diltiazem hydrochloride 120 MG Extended Release Oral Capsule, through Oral route, started on 2012-10-24, presumably until 2014-02-06, with intended 4 refill(s). Instructions: take 1 Cap by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-10-26 09:22:00, ended at 2012-10-26 13:12:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 31 (nanogram per milliliter)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 31 (nanogram per milliliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Aseptic necrosis of bone\n- Primary malignant neoplasm of ovary\n- Vitamin D deficiency\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-10-26 13:13:00, ended at 2012-10-26 23:59:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance imaging, breast, without and/or with contrast material(s); bilateral\n\n### Condition\n- Vitamin D deficiency\n- Aseptic necrosis of bone\n- Primary malignant neoplasm of ovary\n- Abnormal findings on diagnostic imaging of breast\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-10-31 13:30:00, ended at 2012-10-31 23:59:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of lower extremity arteries or arterial bypass grafts; unilateral or limited study\n\n### Condition\n- Intermittent claudication\n- Atherosclerosis of arteries of the extremities\n- Peripheral vascular disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-11-02 00:00:00, ended at 2012-11-02 00:00:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Renal disorder due to type 1 diabetes mellitus\n\n### Drug\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2012-11-02, presumably until 2012-11-02, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-11-02 15:00:00, ended at 2012-11-02 23:59:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2.598\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Renal disorder due to type 1 diabetes mellitus\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n- End-stage renal disease\n- Breast lump\n- Fibrocystic disease of breast\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-11-06 13:03:45, ended at 2012-11-06 15:04:31\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Lumbosacral spondylosis without myelopathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-11-09 00:00:00, ended at 2012-11-09 00:00:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Renal disorder due to type 1 diabetes mellitus\n\n### Drug\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2012-11-09, presumably until 2013-04-16, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-11-13 13:54:12, ended at 2012-11-13 15:08:42\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Degenerative joint disease of hand\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-11-13 13:55:00, ended at 2012-11-13 23:59:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, wrist; complete, minimum of 3 views\n\n### Condition\n- Wrist joint pain\n- Atherosclerosis of aorta\n- Disorder of bone and articular cartilage\n- Degenerative joint disease of hand\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2012-11-17 00:00:00, ended at 2012-11-17 00:00:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Systemic lupus erythematosus\n\n### Drug\n- 3 ML ibandronic acid 1 MG/ML Prefilled Syringe, through Intravenous route, started on 2012-11-20, presumably until 2013-11-20, with intended 0 refill(s). Instructions: 3 mL by Intravenous route One Time.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-11-17 14:20:00, ended at 2012-11-17 14:20:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Low back pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-11-20 09:00:00, ended at 2012-11-20 09:14:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 42 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 29.2 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.7 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.71 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.2 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.49 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 227 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 96 (unit per liter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.1 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 87.5 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.4 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.99 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 83 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.5 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.2 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 28.2 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 72.6 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.89 (thousand per microliter)\n\n### Procedure\n- Irrigation of implanted venous access device for drug delivery systems\n\n### Condition\n- Primary malignant neoplasm of ovary\n- End-stage renal disease\n- Transplanted kidney present\n\n### Drug\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2012-11-20, presumably until 2012-11-20\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-11-20 09:15:00, ended at 2012-11-20 23:59:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- INR in Platelet poor plasma by Coagulation assay: 3.2 (ratio)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Prothrombin time (PT): 30.7 (second)\n\n### Procedure\n- Irrigation of implanted venous access device for drug delivery systems\n- General examination of patient\n\n### Condition\n- Transplanted kidney present\n- Type 1 diabetes mellitus without complication\n- Primary malignant neoplasm of ovary\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-11-21 00:00:00, ended at 2012-11-21 00:00:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2012-11-21, presumably until 2013-02-14, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-11-23 00:00:00, ended at 2012-11-23 00:00:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Subsequent stage of staged operation\n\n### Condition\n- No conditions.\n\n### Drug\n- warfarin sodium 4 MG Oral Tablet, started on 2012-11-23, presumably until 2013-05-01, with intended 3 refill(s). Instructions: Take 4 mg by mouth daily except 2 mg on Sat. and Sun. or as directed by SHC anticoag clinic.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-11-24 10:23:00, ended at 2012-11-24 23:59:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2.205\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n- Primary malignant neoplasm of ovary\n- Mononeuritis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-11-27 14:08:55, ended at 2012-11-27 15:49:25\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Low back pain\n- Lumbosacral spondylosis without myelopathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-11-27 16:02:00, ended at 2012-11-27 23:59:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Low back pain\n- Lumbosacral spondylosis without myelopathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2012-11-29 00:00:00, ended at 2012-11-29 00:00:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of bone and articular cartilage\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-12-01 12:14:00, ended at 2012-12-01 23:59:00\nThe patient in this visit was 57 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, spine; thoracic, 2 views\n- Radiologic examination, spine, lumbosacral; 2 or 3 views\n- Radiologic examination, spine, cervical; 2 or 3 views\n\n### Condition\n- Lumbosacral spondylosis without myelopathy\n- Acquired spondylolisthesis\n- Spondylolisthesis\n- Degeneration of intervertebral disc\n- Low back pain\n- Atherosclerosis of artery\n- Arthropathy\n- Neck pain\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Systemic lupus erythematosus within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of lupus means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "83c2a3c718679756c2b94a6f51d3c46f9586caa5c55024fe6004f68d4968c412", "prompt_hash": "74766c5c99ca2cb52c35501738805a726eb6638122c92e4542d536cf3185965b", "target_hash": "85a39ab345d672ff8ca9b9c6876f3adcacf45ee7c1e2dbd2408fd338bd55e07e", "exact_match": 0.0, "f1_gu_yn": [1, 0], "recall_gu_yn": [1, 0]}
{"doc_id": 1, "doc": {"person_id": 115968088, "visit_occurrence_id": 99474812, "death_date": null, "visit_concept_name": "Outpatient Visit", "visit_start_datetime": "2017-03-03 11:28:00", "visit_end_datetime": "2017-03-03 23:59:00", "visit_length_in_hours": 12.516666666666667, "integrated_visit_record": "## Visit\nThis visit record, was from Outpatient Visit, started at 2017-03-03 11:28:00, ended at 2017-03-03 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- IgG [Mass/volume] in Serum or Plasma: 801 (milligram per deciliter)\n\n### Procedure\n- Diagnostic bone marrow; biopsy(ies)\n- Collection of venous blood by venipuncture\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Decalcification procedure (List separately in addition to code for surgical pathology examination)\n\n### Condition\n- Acute deep vein thrombosis of lower limb\n- Primary diagnosis: Acute leukemia in remission\n- Acute myeloid leukemia, disease\n- Myeloid leukemia\n- Pancytopenia\n- Pulmonary embolism\n\n### Drug\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2017-03-03, presumably until 2017-03-03\n- lidocaine hydrochloride 20 MG/ML Injectable Solution, started on 2017-03-03, presumably until 2017-03-03\n\n", "approximate_token_count": 289, "patient_first_visit_date": "2015-12-01 20:00:00", "patient_last_visit_date": "2022-07-23 00:00:00", "end_obs_date": "2018-03-03", "hypertension_type": "recurrent", "hypertension_one_year_diagnosis": 0, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "recurrent", "asthma_one_year_diagnosis": 1, "hyperlipidemia_type": "recurrent", "hyperlipidemia_one_year_diagnosis": 1, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "recurrent", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "recurrent", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 129, "cumulated_visit_num": 129, "cumulated_approximate_token_count": 67666, "visit_cumulated": "## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2015-12-01 20:00:00, ended at 2015-12-26 16:51:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: <10 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.46 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 7.56 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 56.8 (second)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Leukocytes [#/volume] in Body fluid by Manual count: 1 (milli-international unit per milliliter)\n- MCHC [Mass/volume] by Automated count: 36.4 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 5.9 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 7 (thousand per microliter)\n- Prothrombin time (PT): 27.8 (second)\n- Activated protein C resistance [Time Ratio] in Platelet poor plasma by Coagulation assay: 2.7 (ratio)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 21.1 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 889 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Left ventricular Ejection fraction: 63.0 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Procalcitonin [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.7 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 78.1 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 0.51 (thousand per microliter)\n- Protein S actual/normal in Platelet poor plasma by Coagulation assay: 82 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 99 (unit per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Blasts/100 leukocytes in Blood by Manual count: 91 (percent)\n- Body height: 6' 3.984\" (inch (US))\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 995 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.38 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 98.1 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.08 (thousand per microliter)\n- Protein C actual/normal in Platelet poor plasma by Coagulation assay: 60 (percent)\n- Thrombin time: 18.4 (second)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.46 (million per microliter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: >20000 (microgram of fibrinogen equivalent unit per milliliter)\n- Lactate [Moles/volume] in Blood: 1.6 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 96.3 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.0 (gram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: <2.0 (milligram per deciliter)\n- Base excess in Blood by calculation: -2 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.3 (percent)\n- MCH [Entitic mass] by Automated count: 33.0 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 4.9 (percent)\n- Thyrotropin [Units/volume] in Serum or Plasma: 2.82 (micro-international unit per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.8 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.8 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 9 (percent)\n\n### Procedure\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Duplex scan of extremity veins including responses to compression and other maneuvers; unilateral or limited study\n- Radiologic examination, chest; single view, frontal\n- Collection of venous blood by venipuncture\n- Insertion of peripherally inserted central venous catheter (PICC), without subcutaneous port or pump, without imaging guidance; age 5 years or older\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Introduction of Other Antineoplastic into Central Vein, Percutaneous Approach\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Computed tomography, maxillofacial area; with contrast material(s)\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Medical nutrition therapy; re-assessment and intervention, individual, face-to-face with the patient, each 15 minutes\n- Decalcification procedure (List separately in addition to code for surgical pathology examination)\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n- Morphometric analysis, tumor\n- Extraction of Iliac Bone Marrow, Percutaneous Approach, Diagnostic\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Hospital discharge day management; more than 30 minutes\n\n### Condition\n- Abnormal finding on evaluation procedure\n- Disorder due to and following accidental poisoning\n- Disorder of nasal cavity\n- Dyspnea\n- Jaw pain\n- Neutropenia\n- Ulcerative stomatitis\n- Candidiasis of mouth\n- Chest pain\n- Disorder due to and following drug poisoning\n- Thrombocytopenic disorder\n- Abnormal findings on diagnostic imaging of lung\n- Acute myeloid leukemia, disease\n- Candidiasis of the esophagus\n- Pancytopenia\n- Uncomplicated asthma\n- Anemia\n- Acute leukemia in remission\n- Neck pain\n- Fever\n- Tumor lysis syndrome\n- Acute monocytic/monoblastic leukemia\n- Electrocardiogram abnormal\n- Pneumonia\n- Posttraumatic stress disorder\n- Anemia in neoplastic disease\n- Essential hypertension\n- Primary diagnosis: Leukocytosis\n- Localized edema\n- Cough\n\n### Drug\n- fluconazole 200 MG Oral Tablet, through Oral route, started on 2015-12-15, presumably until 2016-01-23, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily\n- vitamin K1 5 MG Oral Tablet, through Oral route, started on 2015-12-07, presumably until 2015-12-10\n- calcium carbonate 1000 MG Chewable Tablet, through Oral route, started on 2015-12-14, presumably until 2015-12-14\n- 14 ACTUAT fluticasone propionate 0.25 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler, through Oral route, started on 2015-11-07, presumably until 2015-12-01, with intended 1 refill(s). Instructions: take 1 Puff by mouth 2 times a day Rinse mouth after each use\n- vancomycin 1000 MG Injection, through Intravenous route, started on 2015-12-04, presumably until 2015-12-23\n- 2 ML prochlorperazine 5 MG/ML Injection, started on 2015-12-09, presumably until 2015-12-20\n- benzocaine 0.2 MG/MG Oral Paste, through Submucosal route, started on 2015-12-14, presumably until 2015-12-20\n- allopurinol 300 MG Oral Tablet, through Oral route, started on 2015-12-02, presumably until 2015-12-09\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2015-12-07, presumably until 2015-12-21\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2015-12-02, presumably until 2015-12-10\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2015-12-04, presumably until 2016-01-15, with intended 0 refill(s). Instructions: take 1 Tab by mouth every morning before breakfast\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2015-12-03, presumably until 2015-12-24\n- zolpidem tartrate 5 MG Oral Tablet, through Oral route, started on 2015-12-02, presumably until 2015-12-19\n- diphenhydramine hydrochloride 2.5 MG/ML Oral Solution, through Oral route, started on 2015-12-13, presumably until 2015-12-26\n- diphenhydramine hydrochloride 20 MG/ML / zinc acetate 1 MG/ML Topical Cream, through Topical route, started on 2015-12-04, presumably until 2015-12-07\n- lidocaine 40 MG/ML Topical Cream, through Topical route, started on 2015-12-02, presumably until 2015-12-02\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2015-12-04, presumably until 2016-06-10, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every 6 hours as needed for Pain or Fever\n- trazodone hydrochloride 50 MG Oral Tablet, through Oral route, started on 2015-12-18, presumably until 2015-12-18\n- vancomycin 500 MG Injection, through Intravenous route, started on 2015-12-22, presumably until 2015-12-23\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2015-12-02, presumably until 2015-12-21\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2015-12-03, presumably until 2015-12-25\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2015-12-02, presumably until 2015-12-07\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2015-12-11, presumably until 2015-12-11\n- 1 ML hydralazine hydrochloride 20 MG/ML Injection, started on 2015-12-14, presumably until 2015-12-14\n- acetaminophen 325 MG / butalbital 50 MG / caffeine 40 MG Oral Tablet, through Oral route, started on 2015-12-18, presumably until 2015-12-26\n- allopurinol 100 MG Oral Tablet, through Oral route, started on 2015-12-01, presumably until 2015-12-01\n- nystatin 100000 UNT/ML Oral Suspension, through Oral route, started on 2015-12-14, presumably until 2015-12-26\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-12-09, presumably until 2015-12-09\n- cyclobenzaprine hydrochloride 10 MG Oral Tablet, through Oral route, started on 2015-12-04, presumably until 2015-12-12\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2015-12-05, presumably until 2016-01-15, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every bedtime as needed (constipation)\n- dronabinol 5 MG Oral Capsule, through Oral route, started on 2015-12-22, presumably until 2015-12-25\n- NDA021457 200 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Oral route, started on 2015-11-07, presumably until 2015-12-01, with intended 1 refill(s). Instructions: take 2 Puffs by mouth every 4 to 6 hours as needed\n- valacyclovir 500 MG Oral Tablet, through Oral route, started on 2015-12-02, presumably until 2016-01-09, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 14 days\n- hydromorphone hydrochloride 2 MG Oral Tablet, through Oral route, started on 2015-12-17, presumably until 2015-12-17\n- cefepime 2000 MG Injection, through Intravenous route, started on 2015-12-04, presumably until 2015-12-26\n- prochlorperazine 10 MG Oral Tablet, through Oral route, started on 2015-12-19, presumably until 2015-12-19\n- tretinoin 10 MG Oral Capsule, through Oral route, started on 2015-12-02, presumably until 2015-12-03\n- calcium acetate 667 MG Oral Capsule, through Oral route, started on 2015-12-05, presumably until 2015-12-11\n- camphor 5 MG/ML / menthol 5 MG/ML Topical Lotion, through Topical route, started on 2015-12-04, presumably until 2015-12-08\n- 4 ML daunorubicin 5 MG/ML Injection, through Intravenous route, started on 2015-12-05, presumably until 2015-12-07\n- 2 ML ondansetron 2 MG/ML Injection, started on 2015-12-05, presumably until 2015-12-18\n- 1 ML hydromorphone hydrochloride 2 MG/ML Prefilled Syringe, started on 2015-12-02, presumably until 2015-12-02\n- promethazine hydrochloride 12.5 MG Oral Tablet, through Oral route, started on 2015-12-18, presumably until 2015-12-19\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2015-12-01, presumably until 2015-12-26\n- lidocaine hydrochloride 20 MG/ML Mucous Membrane Topical Solution, through Submucosal route, started on 2015-12-13, presumably until 2015-12-26\n- magnesium sulfate 20 MG/ML Injection, through Intravenous route, started on 2015-12-15, presumably until 2015-12-15\n- sorafenib 200 MG Oral Tablet, through Oral route, started on 2015-12-12, presumably until 2015-12-22\n- valacyclovir 1000 MG Oral Tablet, through Oral route, started on 2015-12-12, presumably until 2015-12-13\n- 100 ML potassium chloride 0.2 MEQ/ML Injection, through Intravenous route, started on 2015-12-26, presumably until 2015-12-26\n- ondansetron 4 MG Oral Tablet, through Oral route, started on 2015-12-07, presumably until 2016-01-15, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Nausea\n- azithromycin 250 MG Oral Tablet, through Oral route, started on 2015-12-05, presumably until 2015-12-09\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2015-12-03, presumably until 2015-12-13\n- glucose 50 MG/ML Injection, through Intravenous route, started on 2015-12-04, presumably until 2015-12-26\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2015-12-14, presumably until 2016-01-15, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed for Pain\n- aluminum hydroxide 40 MG/ML / magnesium hydroxide 40 MG/ML / simethicone 4 MG/ML Oral Suspension, through Oral route, started on 2015-12-13, presumably until 2015-12-26\n- zolpidem tartrate 10 MG Oral Tablet, through Oral route, started on 2015-11-07, presumably until 2016-01-15, with intended 0 refill(s). Instructions: take 1 Tab by mouth every bedtime as needed For sleep\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-12-02 00:00:00, ended at 2015-12-02 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Illness\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-12-03 00:00:00, ended at 2015-12-03 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Illness\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-12-12 00:00:00, ended at 2015-12-12 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Illness\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-01-02 00:00:00, ended at 2016-01-02 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-01-02 14:10:00, ended at 2016-01-02 23:59:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.5 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 38.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 356 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- MCV [Entitic volume] by Automated count: 93.0 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 1.50 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.65 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.8 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 17.7 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 148 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 24.6 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.35 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.0 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 84 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 8.4 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.62 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 42.9 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n\n### Procedure\n- Decalcification procedure (List separately in addition to code for surgical pathology examination)\n- Diagnostic bone marrow; biopsy(ies)\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n\n### Condition\n- Acute myeloid leukemia, disease\n- Pancytopenia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-01-02 15:32:29, ended at 2016-01-02 16:59:57\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 3.984\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-01-09 00:00:00, ended at 2016-01-09 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-01-09 11:17:00, ended at 2016-01-09 23:59:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 83 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.8 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.2 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 31.4 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.24 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.4 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 297 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 10.3 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 95.1 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.84 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 2.1 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.69 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 101 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.73 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 52.8 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- MCH [Entitic mass] by Automated count: 31.7 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-01-09 13:08:35, ended at 2016-01-09 15:22:19\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-01-13 00:00:00, ended at 2016-01-13 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-01-15 00:00:00, ended at 2016-01-15 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 57.5 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-01-15 00:00:00, ended at 2016-01-15 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-01-15 09:00:00, ended at 2016-01-15 12:01:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Disorder due to and following accidental poisoning\n- Disorder due to and following drug poisoning\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2016-01-15 12:02:00, ended at 2016-01-23 12:34:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Lymphocytes [#/volume] in Blood by Automated count: 1.79 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Thrombin time: 17.0 (second)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 231 (unit per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.6 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 6.0 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 2.2 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.4 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 90 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.7 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 0.1 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.85 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.9 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 268 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 79 (unit per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 7.31 (thousand per microliter)\n- Prothrombin time (PT): 14.4 (second)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 95.6 (femtoliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.3 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Body height: 6' 5.362\" (inch (US))\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 1743 (microgram of fibrinogen equivalent unit per milliliter)\n- MCH [Entitic mass] by Automated count: 32.1 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 78.9 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 33.7 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.96 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 26.5 (second)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 285 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.6 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n\n### Procedure\n- Hospital discharge day management; more than 30 minutes\n- Collection of venous blood by venipuncture\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Introduction of Other Antineoplastic into Central Vein, Percutaneous Approach\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Physical therapy evaluation\n\n### Condition\n- Insomnia\n- Acute myeloid leukemia, disease\n- Primary diagnosis: Leukocytosis\n- Acute leukemia in remission\n- Candidiasis of mouth\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2016-01-15, presumably until 2016-01-22\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2016-01-16, presumably until 2016-01-23\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2016-01-17, presumably until 2016-01-17\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2016-01-15, presumably until 2016-01-15\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2016-01-15, presumably until 2016-01-23\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2016-01-15, presumably until 2016-01-18\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2016-01-20, presumably until 2016-01-20\n- nystatin 100000 UNT/ML Oral Suspension, through Oral route, started on 2016-01-22, presumably until 2016-01-30, with intended 3 refill(s). Instructions: 5 mL by Swish & Swallow route 3 times a day\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2016-01-17, presumably until 2016-01-20\n- dronabinol 5 MG Oral Capsule, through Oral route, started on 2016-01-15, presumably until 2016-01-22\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2016-01-19, presumably until 2016-01-23\n- 4 ML daunorubicin 5 MG/ML Injection, through Intravenous route, started on 2016-01-16, presumably until 2016-01-18\n- magnesium sulfate 20 MG/ML Injection, through Intravenous route, started on 2016-01-15, presumably until 2016-01-15\n- sorafenib 200 MG Oral Tablet, through Oral route, started on 2016-01-20, presumably until 2016-02-03, with intended 0 refill(s). Instructions: take 2 Tabs by mouth 2 times a day\n- alteplase 1 MG/ML Injectable Solution, through Intraluminal route, started on 2016-01-16, presumably until 2016-01-16\n- fluconazole 200 MG Oral Tablet, through Oral route, started on 2016-01-15, presumably until 2016-01-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-01-26 11:33:00, ended at 2016-01-26 23:59:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.9 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.8 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.14 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 69 (unit per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.0 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.13 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.20 (million per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.9 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 15.2 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 111 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 1.5 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 74.5 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 0.23 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 12 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 8.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 29 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-01-26 13:06:52, ended at 2016-01-26 15:18:21\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 5.008\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2016-01-29 23:51:00, ended at 2016-02-03 15:30:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.89 (million per microliter)\n- Lactate [Moles/volume] in Blood: 1.6 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Manual count: 1.21 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 96 (percent)\n- MCV [Entitic volume] by Automated count: 91.0 (femtoliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Body height: 6' 4.772\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Leukocytes [#/volume] in Body fluid by Manual count: 3 (milli-international unit per milliliter)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 1.6 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Blasts/100 leukocytes in Blood by Manual count: 3 (percent)\n- Eosinophils [#/volume] in Blood by Manual count: 0.04 (thousand per microliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 97 (unit per liter)\n- Base excess in Blood by calculation: 0 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.3 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.3 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 2 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.7 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 25.9 (percent)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 153 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.1 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 40 (thousand per microliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.30 (thousand per microliter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.91 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Computed tomography, head or brain; without contrast material\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Hospital discharge day management; more than 30 minutes\n- Drainage of Spinal Canal, Percutaneous Approach, Diagnostic\n- Spinal puncture, lumbar, diagnostic\n- Insertion of peripherally inserted central venous catheter (PICC), without subcutaneous port or pump, without imaging guidance; age 5 years or older\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); concurrent infusion (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n- Radiologic examination, chest; single view, frontal\n\n### Condition\n- Hypokalemia\n- Fever\n- Pancytopenia\n- Sepsis due to Escherichia coli\n- Hypomagnesemia\n- Spasm\n- Acute leukemia in remission\n- Ulcerative stomatitis\n- Candidiasis of the esophagus\n- Nausea\n- Primary diagnosis: Neutropenia\n\n### Drug\n- 0.5 ML filgrastim 0.6 MG/ML Prefilled Syringe, started on 2016-01-31, presumably until 2016-02-02\n- nystatin 100 UNT/MG Topical Ointment, through Topical route, started on 2016-01-28, presumably until 2016-02-13, with intended 0 refill(s). Instructions: 1 Application by Topical route 2 times a day\n- loperamide hydrochloride 2 MG Oral Capsule, through Oral route, started on 2016-01-30, presumably until 2016-01-30\n- pantoprazole 20 MG Delayed Release Oral Tablet, through Oral route, started on 2016-01-30, presumably until 2016-01-30\n- acyclovir 400 MG Oral Tablet, through Oral route, started on 2016-01-28, presumably until 2016-02-03, with intended 0 refill(s). Instructions: take 1 Tab by mouth 4 times a day for 10 days\n- 100 ML potassium chloride 0.1 MEQ/ML Injection, through Intravenous route, started on 2016-01-30, presumably until 2016-01-30\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2016-01-31, presumably until 2016-02-03\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2016-01-30, presumably until 2016-02-03\n- lidocaine 40 MG/ML Topical Cream, through Topical route, started on 2016-02-02, presumably until 2016-02-02\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2016-01-30, presumably until 2016-02-01\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2016-01-30, presumably until 2016-01-30\n- cyclobenzaprine hydrochloride 5 MG Oral Tablet, through Oral route, started on 2016-02-01, presumably until 2016-06-01, with intended 0 refill(s). Instructions: Take 1 to 2 tabs PO q8h PRN muscle spasma\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2016-02-02, presumably until 2016-02-02\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2016-02-02, presumably until 2016-05-08, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day\n- omeprazole 40 MG Delayed Release Oral Capsule, through Oral route, started on 2015-08-20, presumably until 2016-05-05, with intended 0 refill(s). Instructions: take 1 Lebow by mouth every morning\n- nystatin 100000 UNT/ML Oral Suspension, through Oral route, presumably until 2016-02-13, with intended 0 refill(s). Instructions: 500,000 Units by Swish & Swallow route 3 times a day as needed (mouth sores.)\n- oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2016-02-03, presumably until 2016-06-18, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain\n- cyclobenzaprine hydrochloride 10 MG Oral Tablet, through Oral route, started on 2016-02-02, presumably until 2016-02-03\n- dronabinol 5 MG Oral Capsule, through Oral route, started on 2016-01-30, presumably until 2016-02-02\n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, presumably until 2016-06-29, with intended 0 refill(s). Instructions: 2 Puffs by Inhalation route every 4 hours as needed\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2016-02-03, presumably until 2016-05-08, with intended 0 refill(s). Instructions: take 1 Packet by mouth daily as needed\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2016-01-30, presumably until 2016-01-30\n- cefepime 2000 MG Injection, through Intravenous route, started on 2016-01-30, presumably until 2016-01-30\n- 2 ML ondansetron 2 MG/ML Injection, started on 2016-01-30, presumably until 2016-02-01\n- magnesium sulfate 20 MG/ML Injection, through Intravenous route, started on 2016-01-30, presumably until 2016-02-01\n- loratadine 10 MG Oral Tablet, through Oral route, started on 2016-01-31, presumably until 2016-02-02\n- sorafenib 200 MG Oral Tablet, through Oral route, started on 2016-01-30, presumably until 2016-02-02\n- glucose 50 MG/ML Injection, through Intravenous route, started on 2016-01-30, presumably until 2016-01-30\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2016-02-01, presumably until 2016-02-02\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2016-02-02, presumably until 2016-02-13, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 10 days\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2016-01-30, presumably until 2016-01-30\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-02-04 00:00:00, ended at 2016-02-04 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-02-04 00:00:00, ended at 2016-02-04 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-02-04 13:49:57, ended at 2016-02-04 13:50:08\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute leukemia in remission\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-02-09 13:49:27, ended at 2016-02-09 13:49:40\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute leukemia in remission\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-02-13 11:30:00, ended at 2016-02-13 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 93 (unit per liter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 10.4 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 37 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.1 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.6 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.4 (picogram)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Manual count: 3.00 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.1 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 92.1 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Leukocytes [#/volume] in Body fluid by Manual count: 6 (milli-international unit per milliliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.82 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 303 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.32 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 125 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 33 (percent)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Pancytopenia\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-02-13 12:13:42, ended at 2016-02-13 13:28:05\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute leukemia in remission\n\n### Drug\n- dronabinol 5 MG Oral Capsule, through Oral route, presumably until 2016-07-20, with intended 0 refill(s). Instructions: take 5 mg by mouth every bedtime as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-02-27 00:00:00, ended at 2016-02-27 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- prednisolone acetate 10 MG/ML Ophthalmic Suspension, started on 2016-03-07, presumably until 2016-03-13, with intended 2 refill(s). Instructions: Instill 1 drop to both eyes 4 x per day starting 12 hrs prior to 1st dose of chemo (3/13) until 12 hrs after last dose (3/19).\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-02-27 11:36:00, ended at 2016-02-27 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- MCH [Entitic mass] by Automated count: 31.7 (picogram)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 12 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.2 (percent)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.2 (percent)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.9 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 67 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.19 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 11.8 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 28.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.40 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.9 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 57.4 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.73 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.70 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 227 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 135 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.5 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.60 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.1 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pancytopenia\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-02-27 11:57:50, ended at 2016-02-27 15:46:04\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute leukemia in remission\n\n### Drug\n- sorafenib 200 MG Oral Tablet, through Oral route, started on 2016-02-27, presumably until 2016-04-13, with intended 3 refill(s). Instructions: take 2 Tabs by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-02-27 14:59:22, ended at 2016-02-27 14:59:34\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute leukemia in remission\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-03-07 09:10:00, ended at 2016-03-07 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.2 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.5 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 49.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 213 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 55 (unit per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.0 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.6 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.4 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 31.2 (percent)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.54 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.48 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.8 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.35 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.84 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 114 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.29 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 95.3 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 54 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.7 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-03-08 07:04:00, ended at 2016-03-08 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 5.165\" (inch (US))\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Acute leukemia in remission\n\n### Drug\n- cytarabine 20 MG/ML Injectable Solution, started on 2016-03-08, presumably until 2016-03-08\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2016-03-08, presumably until 2016-05-05, with intended 4 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2016-03-08, presumably until 2016-03-08\n- dexamethasone 2 MG Oral Tablet, through Oral route, started on 2016-03-08, presumably until 2016-03-08\n- prochlorperazine 10 MG Oral Tablet, through Oral route, started on 2016-03-08, presumably until 2016-05-05, with intended 4 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Nausea/Vomiting\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-03-10 07:03:00, ended at 2016-03-10 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 5.165\" (inch (US))\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n\n### Condition\n- Acute leukemia in remission\n\n### Drug\n- cytarabine 20 MG/ML Injectable Solution, started on 2016-03-10, presumably until 2016-03-10\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2016-03-10, presumably until 2016-03-10\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2016-03-10, presumably until 2016-03-10\n- dexamethasone 2 MG Oral Tablet, through Oral route, started on 2016-03-10, presumably until 2016-03-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-03-12 07:06:00, ended at 2016-03-12 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 5.165\" (inch (US))\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Acute leukemia in remission\n\n### Drug\n- cytarabine 20 MG/ML Injectable Solution, started on 2016-03-12, presumably until 2016-03-12\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2016-03-12, presumably until 2016-03-12\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2016-03-12, presumably until 2016-03-12\n- dexamethasone 2 MG Oral Tablet, through Oral route, started on 2016-03-12, presumably until 2016-03-12\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-03-12, presumably until 2016-03-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-03-19 12:10:33, ended at 2016-03-19 15:02:25\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute leukemia in remission\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-03-23 08:10:00, ended at 2016-03-23 12:42:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.9 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 1.0 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 89 (unit per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.89 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 89.2 (percent)\n- Platelets [#/volume] in Blood by Automated count: 19 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 81 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 145 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.1 (percent)\n- MCH [Entitic mass] by Automated count: 31.3 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 7.9 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 7.9 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.2 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.88 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 90.2 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-03-23 12:43:00, ended at 2016-03-23 13:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 57.7 (percent)\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Disorder due to and following accidental poisoning\n- Disorder due to and following drug poisoning\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-03-23 13:30:36, ended at 2016-03-23 13:30:52\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute leukemia in remission\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-03-23 14:00:00, ended at 2016-03-23 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n- Diffusing capacity (eg, carbon monoxide, membrane) (List separately in addition to code for primary procedure)\n\n### Condition\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-04-06 13:47:00, ended at 2016-04-06 14:52:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atelectasis\n- Acute leukemia in remission\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-04-06 14:53:00, ended at 2016-04-06 15:25:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Atelectasis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-04-06 15:26:00, ended at 2016-04-06 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.72 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 326 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 127.9 (second)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.3 (percent)\n- Leukocytes [#/volume] in Body fluid by Manual count: 1 (milli-international unit per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 73 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.1 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.43 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 155 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.2 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 48 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- MCHC [Mass/volume] by Automated count: 34.8 (gram per deciliter)\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 28 (nanogram per milliliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Monocytes [#/volume] in Blood by Manual count: 0.57 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.7 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 1.71 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 79 (unit per liter)\n- MCH [Entitic mass] by Automated count: 32.4 (picogram)\n- Prothrombin time (PT): 14.3 (second)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 28 (nanogram per milliliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 30 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n\n### Procedure\n- Decalcification procedure (List separately in addition to code for surgical pathology examination)\n- Diagnostic bone marrow; biopsy(ies)\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n\n### Condition\n- Acute myeloid leukemia, disease\n- Anemia\n\n### Drug\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2016-04-06, presumably until 2016-04-06\n- hydromorphone hydrochloride 2 MG Oral Tablet, through Oral route, started on 2016-04-06, presumably until 2016-04-06\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-04-08 14:26:37, ended at 2016-04-08 15:56:32\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 3.984\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute myeloid leukemia, disease\n\n### Drug\n- phenytoin sodium 100 MG Extended Release Oral Capsule, through Oral route, started on 2016-04-08, presumably until 2016-05-08, with intended 0 refill(s). Instructions: take 3 Caps by mouth 3 times a day Take on day of admission\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-04-09 08:20:00, ended at 2016-04-09 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 92 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 170 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 75 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.1 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.5 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 26 (percent)\n- Monocytes [#/volume] in Blood by Manual count: 1.06 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 31.4 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.6 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 1.46 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.69 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 19 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.71 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Leukocytes [#/volume] in Body fluid by Manual count: 1 (milli-international unit per milliliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 42 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 11.6 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 93.6 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 46 (percent)\n- Platelets [#/volume] in Blood by Automated count: 240 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Pancytopenia\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-04-09 09:22:00, ended at 2016-04-09 10:35:08\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute leukemia in remission\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2016-04-13 17:02:00, ended at 2016-05-08 11:20:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 90 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.92 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Glucose [Mass/volume] in Blood: 227 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 363 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 82 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 9.1 (nanogram per milliliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection: <135 (international unit per milliliter)\n- Lactate [Moles/volume] in Blood: 0.9 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 95.7 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.95 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 91.8 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 39 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 8.8 (percent)\n- Leukocytes [#/volume] in Body fluid by Manual count: 2 (milli-international unit per milliliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.3 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.49 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.1 (picogram)\n- MCHC [Mass/volume] by Automated count: 35.4 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.2 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 6.72 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Body height: 6' 3.787\" (inch (US))\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 94 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.01 (million per microliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.4 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 295 (unit per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.84 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Haptoglobin [Mass/volume] in Serum or Plasma: 124 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.1 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.5 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 55 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 3 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.19 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.4 (percent)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.4 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.06 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 1.50 (thousand per microliter)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 7.1 (microgram per milliliter)\n\n### Procedure\n- Introduction of Other Antineoplastic into Central Vein, Percutaneous Approach\n- Transplant preparation of hematopoietic progenitor cells; cell concentration in plasma, mononuclear, or buffy coat layer\n- Medical nutrition therapy; re-assessment and intervention, individual, face-to-face with the patient, each 15 minutes\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Physical therapy evaluation\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Collection of venous blood by venipuncture\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Hospital discharge day management; more than 30 minutes\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Transfusion of Nonautologous Hematopoietic Stem Cells into Central Vein, Percutaneous Approach (Deprecated)\n- Hematopoietic progenitor cell (HPC); allogeneic transplantation per donor\n\n### Condition\n- Acute myeloid leukemia, disease\n- Nasal congestion\n- Backache\n- ABO incompatibility reaction\n- Muscle pain\n- Type 2 diabetes mellitus without complication\n- Atelectasis\n- Constipation\n- Disorder of nasal cavity\n- Hypo-osmolality and or hyponatremia\n- Smoke inhalation injury\n- Nausea and vomiting\n- Oral ulcerative mucositis due to antineoplastic therapy\n- Chronic pain\n- Chronic rhinitis\n- Disturbance of salivary secretion\n- Fever\n- Pancytopenia due to antineoplastic chemotherapy\n- Primary diagnosis: Acute leukemia in remission\n- Candidiasis of mouth\n- Hypervolemia\n- Neutropenia\n- Pulmonary embolism\n- Deficiency of macronutrients\n- Diarrhea\n\n### Drug\n- hydrocortisone 100 MG Injection, started on 2016-04-21, presumably until 2016-04-21\n- dronabinol 2.5 MG Oral Capsule, through Oral route, started on 2016-04-13, presumably until 2016-05-07\n- fluconazole 200 MG Oral Tablet, through Oral route, started on 2016-05-03, presumably until 2016-07-13, with intended 3 refill(s). Instructions: take 2 Tabs by mouth daily\n- famotidine 20 MG Oral Tablet, through Oral route, started on 2016-04-13, presumably until 2016-05-08\n- loperamide hydrochloride 2 MG Oral Capsule, through Oral route, started on 2016-04-27, presumably until 2016-05-02\n- vancomycin 1000 MG Injection, through Intravenous route, started on 2016-05-01, presumably until 2016-05-02\n- pseudoephedrine hydrochloride 30 MG Oral Tablet, through Oral route, started on 2016-04-19, presumably until 2016-04-20\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2016-04-19, presumably until 2016-04-21\n- 2 ML prochlorperazine 5 MG/ML Injection, started on 2016-04-16, presumably until 2016-05-07\n- acyclovir 400 MG Oral Tablet, through Oral route, started on 2016-04-13, presumably until 2016-06-10, with intended 12 refill(s). Instructions: take 1 Tab by mouth 3 times a day\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2016-04-19, presumably until 2016-04-22\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2016-04-24, presumably until 2016-04-27\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2016-05-05, presumably until 2016-07-15, with intended 4 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed\n- phenytoin sodium 100 MG Extended Release Oral Capsule, through Oral route, started on 2016-04-14, presumably until 2016-04-17\n- diphenhydramine hydrochloride 2.5 MG/ML Oral Solution, through Oral route, started on 2016-04-26, presumably until 2016-05-06\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2016-05-03, presumably until 2016-07-15, with intended 6 refill(s). Instructions: Take as directed twice a day per BMT team\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2016-04-19, presumably until 2016-04-24\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2016-04-26, presumably until 2016-04-26\n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2016-04-13, presumably until 2016-05-18, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 10 days\n- clotrimazole 10 MG Oral Lozenge, through Submucosal route, started on 2016-04-23, presumably until 2016-05-01\n- 0.8 ML enoxaparin sodium 150 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2016-04-14, presumably until 2016-04-16\n- 1 ML hydralazine hydrochloride 20 MG/ML Injection, started on 2016-04-24, presumably until 2016-04-24\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2016-04-27, presumably until 2016-05-08, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n- dibucaine 0.01 MG/MG Topical Ointment, through Topical route, started on 2016-04-28, presumably until 2016-04-29\n- omeprazole 40 MG Delayed Release Oral Capsule, through Oral route, started on 2016-05-05, presumably until 2016-06-09, with intended 2 refill(s). Instructions: take 40 mg by mouth every morning\n- nystatin 100000 UNT/ML Oral Suspension, through Oromucosal route, started on 2016-05-01, presumably until 2016-05-07, with intended 0 refill(s). Instructions: 10 mL by Swish & Spit route 4 times a day\n- cholecalciferol 0.025 MG Oral Tablet, through Oral route, started on 2016-04-24, presumably until 2016-05-08\n- 10 ML furosemide 10 MG/ML Injection, started on 2016-04-18, presumably until 2016-04-21\n- ursodiol 300 MG Oral Capsule, through Oral route, started on 2016-04-14, presumably until 2016-07-15, with intended 2 refill(s). Instructions: take 2 Caps by mouth 2 times a day\n- ciprofloxacin 100 MG/ML Oral Suspension, through Oral route, started on 2016-04-27, presumably until 2016-05-07\n- 2 ML famotidine 10 MG/ML Injection, through Intravenous route, started on 2016-04-27, presumably until 2016-05-05\n- atropine sulfate 0.025 MG / diphenoxylate hydrochloride 2.5 MG Oral Tablet, through Oral route, started on 2016-04-30, presumably until 2016-04-30\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2016-05-03, presumably until 2016-05-14, with intended 3 refill(s). Instructions: 3 mL by Intravenous route every bedtime as needed ( Flush each catheter lumen if not in use.)\n- cefepime 2000 MG Injection, through Intravenous route, started on 2016-05-01, presumably until 2016-05-06\n- prochlorperazine 10 MG Oral Tablet, through Oral route, started on 2016-05-05, presumably until 2016-07-15, with intended 4 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Nausea/Vomiting\n- olanzapine 5 MG Disintegrating Oral Tablet, through Oral route, started on 2016-04-20, presumably until 2016-05-07\n- 1000 ML potassium chloride 0.02 MEQ/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-05-06, presumably until 2016-05-08\n- tacrolimus 0.5 MG Oral Capsule, started on 2016-05-03, presumably until 2016-11-02, with intended 6 refill(s). Instructions: Take as directed twice a day per BMT team.\n- 2 ML ondansetron 2 MG/ML Injection, started on 2016-05-07, presumably until 2016-05-07\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2016-04-19, presumably until 2016-05-01\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2016-05-03, presumably until 2016-05-03\n- lidocaine hydrochloride 20 MG/ML Mucous Membrane Topical Solution, through Submucosal route, started on 2016-04-26, presumably until 2016-05-06\n- magnesium sulfate 20 MG/ML Injection, through Intravenous route, started on 2016-04-18, presumably until 2016-05-06\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2016-06-02, presumably until 2016-12-01, with intended 6 refill(s). Instructions: take 1 Tab by mouth daily in the morning\n- 200 ML fluconazole 2 MG/ML Injection, through Intravenous route, started on 2016-04-22, presumably until 2016-05-04\n- glucose 50 MG/ML Injection, through Intravenous route, started on 2016-05-01, presumably until 2016-05-06\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2016-04-19, presumably until 2016-04-30\n- rivaroxaban 10 MG Oral Tablet, through Oral route, presumably until 2016-05-08, with intended 0 refill(s). Instructions: take 10 mg by mouth\n- 72 HR scopolamine 0.0139 MG/HR Transdermal System, through Transdermal route, started on 2016-04-16, presumably until 2016-04-25\n- aluminum hydroxide 40 MG/ML / magnesium hydroxide 40 MG/ML / simethicone 4 MG/ML Oral Suspension, through Oral route, started on 2016-04-20, presumably until 2016-05-06\n- sodium chloride 6.5 MG/ML Nasal Spray, through Nasal route, started on 2016-04-29, presumably until 2016-04-29\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2016-04-25, presumably until 2016-05-06\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-04-19 00:00:00, ended at 2016-04-19 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-04-19 15:29:59, ended at 2016-04-19 15:30:13\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-05-09 13:00:00, ended at 2016-05-09 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 78 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.30 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 38.3 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.0 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.09 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.4 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.8 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 0.70 (thousand per microliter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.0 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.4 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 1.6 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.61 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 50 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 44.3 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 167 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.25 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.5 (picogram)\n\n### Procedure\n- Intravenous infusion, hydration; initial, 31 minutes to 1 hour\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Acute myeloid leukemia, disease\n- Acute leukemia in remission\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2016-05-09, presumably until 2016-05-09\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-05-09, presumably until 2016-05-09\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-05-10 11:57:00, ended at 2016-05-10 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 28 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 71 (unit per liter)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.5 (percent)\n- Monocytes [#/volume] in Blood by Manual count: 0.54 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 5.0 (nanogram per milliliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14 (percent)\n- MCV [Entitic volume] by Automated count: 93.9 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.7 (percent)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.25 (thousand per microliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 28 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.02 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 148 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 1.8 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.7 (picogram)\n- Neutrophils/100 leukocytes in Blood by Manual count: 44 (percent)\n- Platelets [#/volume] in Blood by Automated count: 57 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.08 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.05 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 30 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n\n### Procedure\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n- Intravenous infusion, hydration; initial, 31 minutes to 1 hour\n- Medical nutrition therapy; re-assessment and intervention, individual, face-to-face with the patient, each 15 minutes\n\n### Condition\n- Acute leukemia in remission\n- Acute myeloid leukemia, disease\n\n### Drug\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2016-05-10, presumably until 2016-05-10\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-05-10, presumably until 2016-05-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-05-12 07:46:00, ended at 2016-05-12 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 77 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 1.9 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.92 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.14 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.3 (percent)\n- MCH [Entitic mass] by Automated count: 31.9 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 118 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.25 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.08 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.1 (percent)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4 (percent)\n- Monocytes [#/volume] in Blood by Manual count: 0.82 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 8.0 (nanogram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- MCV [Entitic volume] by Automated count: 93.6 (femtoliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 10.0 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 13 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 43 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 36 (percent)\n- Platelets [#/volume] in Blood by Automated count: 74 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n\n### Procedure\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Medical nutrition therapy; re-assessment and intervention, individual, face-to-face with the patient, each 15 minutes\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); concurrent infusion (List separately in addition to code for primary procedure)\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Acute leukemia in remission\n- Acute myeloid leukemia, disease\n\n### Drug\n- ergocalciferol 1.25 MG Oral Capsule, through Oral route, started on 2016-05-12, presumably until 2016-05-12, with intended 0 refill(s). Instructions: take 1 Cap by mouth every 7 days\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-05-12, presumably until 2016-05-12\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2016-05-12, presumably until 2016-05-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-05-14 09:50:00, ended at 2016-05-14 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 91 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 120 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.61 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.16 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.9 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 2.1 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.21 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10 (percent)\n- MCV [Entitic volume] by Automated count: 95.7 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 29 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.23 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 92 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 8.1 (nanogram per milliliter)\n- MCH [Entitic mass] by Automated count: 32.4 (picogram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 10.5 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.0 (percent)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.02 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 43 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n\n### Procedure\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n\n### Condition\n- Acute leukemia in remission\n- Acute myeloid leukemia, disease\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2016-05-14, presumably until 2016-05-14\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2016-05-14, presumably until 2016-11-02, with intended 0 refill(s). Instructions: take 0.5 Tabs by mouth every 4 hours as needed\n- 2 ML ondansetron 2 MG/ML Injection, started on 2016-05-14, presumably until 2016-05-14\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-05-14, presumably until 2016-05-14\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2016-05-14, presumably until 2016-05-14\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-05-17 07:40:00, ended at 2016-05-17 08:16:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.3 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 40 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.0 (picogram)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 77 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Body height: 6' 3.984\" (inch (US))\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.3 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.28 (million per microliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.89 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Leukocytes [#/volume] in Body fluid by Manual count: 1 (milli-international unit per milliliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 106 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.08 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 21 (percent)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 121 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.46 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.16 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 7 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 2.2 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 95.5 (femtoliter)\n- Tacrolimus [Mass/volume] in Blood: 12.2 (nanogram per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 10.5 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 22 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Collection of venous blood by venipuncture\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Acute leukemia in remission\n- Nausea\n- Acute myeloid leukemia, disease\n\n### Drug\n- 2 ML ondansetron 2 MG/ML Injection, started on 2016-05-17, presumably until 2016-05-17\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-05-17, presumably until 2016-05-17\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-05-17 08:17:00, ended at 2016-05-17 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-05-19 08:10:00, ended at 2016-05-19 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Serum or Plasma: 117 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 122 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.8 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.57 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 21.2 (percent)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 79 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.15 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 2.7 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.7 (percent)\n- IgG [Mass/volume] in Serum or Plasma: 887 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.2 (percent)\n- MCV [Entitic volume] by Automated count: 95.7 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.77 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 1.15 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 9.2 (nanogram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.36 (million per microliter)\n- MCH [Entitic mass] by Automated count: 32.2 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 28.7 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.14 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 43.1 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n\n### Procedure\n- Medical nutrition therapy; re-assessment and intervention, individual, face-to-face with the patient, each 15 minutes\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acute myeloid leukemia, disease\n- Acute leukemia in remission\n- Blepharitis\n\n### Drug\n- azithromycin 10 MG/ML Ophthalmic Solution, through Intraocular route, started on 2016-05-19, presumably until 2016-05-26, with intended 1 refill(s). Instructions: instill 1 Drop to both eyes 3 times a day\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2016-05-19, presumably until 2016-07-20, with intended 6 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-05-21 07:40:00, ended at 2016-05-21 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 1.42 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6 (percent)\n- Eosinophils [#/volume] in Blood by Manual count: 0.17 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.8 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 170 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 79 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 2.9 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.04 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 36 (percent)\n- Tacrolimus [Mass/volume] in Blood: 10.3 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 96.0 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 39 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.45 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.5 (picogram)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.1 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 11.2 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.52 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 117 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n\n### Procedure\n- Medical nutrition therapy; re-assessment and intervention, individual, face-to-face with the patient, each 15 minutes\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Acute myeloid leukemia, disease\n- Disorder of transplanted bone marrow\n- Acute leukemia in remission\n\n### Drug\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-05-21, presumably until 2016-05-21\n- magnesium sulfate 20 MG/ML Injection, through Intravenous route, started on 2016-05-21, presumably until 2016-05-21\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2016-05-21, presumably until 2016-05-21\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2016-05-24 00:00:00, ended at 2016-05-24 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anogenital herpesviral infection\n- Blepharitis\n- Blepharitis of left eyelid\n- Primary diagnosis: Neutropenia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-05-24 09:20:00, ended at 2016-05-24 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 171 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 96.9 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 8.6 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.1 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.45 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.38 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.3 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 97 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.29 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.8 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.64 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19.3 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 43.0 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection: <135 (international unit per milliliter)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 28.2 (percent)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 21.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 1.43 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 85 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.94 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.7 (picogram)\n- Tacrolimus [Mass/volume] in Blood: 9.1 (nanogram per milliliter)\n\n### Procedure\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n- Intravenous infusion, hydration; initial, 31 minutes to 1 hour\n\n### Condition\n- Blepharitis\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-05-26 08:40:00, ended at 2016-05-26 11:16:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.54 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.31 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 50 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 9 (percent)\n- Platelets [#/volume] in Blood by Automated count: 61 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 21.8 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 174 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.5 (percent)\n- MCH [Entitic mass] by Automated count: 33.6 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 98.2 (femtoliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.02 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 30 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 44 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 99 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 11.1 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 10.6 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.54 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.31 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 357 (unit per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.4 (thousand per microliter)\n\n### Procedure\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); concurrent infusion (List separately in addition to code for primary procedure)\n- Medical nutrition therapy; re-assessment and intervention, individual, face-to-face with the patient, each 15 minutes\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Acute myeloid leukemia, disease\n- Acute leukemia in remission\n\n### Drug\n- azithromycin 10 MG/ML Ophthalmic Solution, through Intraocular route, started on 2016-05-26, presumably until 2016-06-10, with intended 6 refill(s). Instructions: instill 1 Drop to both eyes 3 times a day\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-05-26, presumably until 2016-05-26\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2016-05-26, presumably until 2016-05-26\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-05-26 11:17:00, ended at 2016-05-26 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Acute leukemia in remission\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2016-05-28 00:00:00, ended at 2016-05-28 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anogenital herpesviral infection\n- Neutropenia\n- Primary diagnosis: Acute leukemia in remission\n- Cytomegalovirus infection\n- Blepharitis\n- Blepharitis of left eyelid\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-05-28 09:10:00, ended at 2016-05-28 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.36 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.9 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 47.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 99 (unit per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 26.4 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 44 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.30 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.7 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 52 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 22.2 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 129 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 1.95 (thousand per microliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.1 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.69 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 98.7 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 57 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 1.09 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.56 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 8.7 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.8 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 10.4 (nanogram per milliliter)\n\n### Procedure\n- Intravenous infusion, hydration; initial, 31 minutes to 1 hour\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary diagnosis: Acute leukemia in remission\n- Acute myeloid leukemia, disease\n\n### Drug\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-05-28, presumably until 2016-05-28\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-05-31 07:50:00, ended at 2016-05-31 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Eosinophils/100 leukocytes in Blood by Automated count: 10.6 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.93 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 21.1 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 53.3 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 21.8 (percent)\n- MCH [Entitic mass] by Automated count: 33.4 (picogram)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 154 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.60 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.84 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.47 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 13.7 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 121 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 56 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.7 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.3 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.35 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 9.4 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 63 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.39 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.4 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 99.5 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 41 (thousand per microliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection: <135 (international unit per milliliter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n\n### Procedure\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n\n### Condition\n- Acute myeloid leukemia, disease\n- Acute leukemia in remission\n- Primary diagnosis: Anogenital herpesviral infection\n\n### Drug\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-05-31, presumably until 2016-05-31\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-06-03 00:00:00, ended at 2016-06-03 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-06-03 08:50:00, ended at 2016-06-03 19:34:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 76 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 113 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.27 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.52 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.81 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.4 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 21.9 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.28 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.2 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.85 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.54 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 122 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 20.1 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 82 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.8 (percent)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 32 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 11.0 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 60.2 (percent)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 12.2 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 133 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.5 (picogram)\n- MCV [Entitic volume] by Automated count: 99.9 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 9.9 (nanogram per milliliter)\n\n### Procedure\n- Intravenous infusion, hydration; initial, 31 minutes to 1 hour\n- Collection of venous blood by venipuncture\n- Medical nutrition therapy; re-assessment and intervention, individual, face-to-face with the patient, each 15 minutes\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Neutropenia\n- Acute myeloid leukemia, disease\n- Acute leukemia in remission\n\n### Drug\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-06-03, presumably until 2016-06-03\n- nystatin 100 UNT/MG Topical Powder, through Topical route, started on 2016-06-03, presumably until 2016-06-09, with intended 1 refill(s). Instructions: by Topical route 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2016-06-03 19:35:00, ended at 2016-06-10 14:28:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 158 (unit per liter)\n- Body height: 6' 5\" (inch (US))\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection: 1028 (international unit per milliliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 21.9 (percent)\n- Glucose [Mass/volume] in Blood: 366 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.4 (picogram)\n- MCV [Entitic volume] by Automated count: 104.7 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.77 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.02 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.61 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.31 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 8.6 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 156 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.73 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.50 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 87.2 (percent)\n- Cytomegalovirus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection: 3.01 (log international unit per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.1 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 49 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.4 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 97 (unit per liter)\n- Base excess in Blood by calculation: -4 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 325 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.5 (percent)\n- IgG [Mass/volume] in Serum or Plasma: 914 (milligram per deciliter)\n- Leukocytes [#/volume] in Body fluid by Manual count: 3 (milli-international unit per milliliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 68 (thousand per microliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 98 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Eosinophils [#/volume] in Blood by Manual count: 0.40 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.6 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 9.1 (nanogram per milliliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.25 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 185 (unit per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.4 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.1 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.78 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 10.6 (microgram per milliliter)\n\n### Procedure\n- Excision of Duodenum, Via Natural or Artificial Opening Endoscopic, Diagnostic\n- Insertion of peripherally inserted central venous catheter (PICC), without subcutaneous port or pump, without imaging guidance; age 5 years or older\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Computed tomography, thorax, diagnostic; without contrast material\n- Sigmoidoscopy, flexible; with biopsy, single or multiple\n- Computed tomography, abdomen and pelvis; without contrast material\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Collection of venous blood by venipuncture\n- Excision of Stomach, Via Natural or Artificial Opening Endoscopic, Diagnostic\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Sigmoidoscopy, flexible; with control of bleeding, any method\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Physical therapy evaluation\n- Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple\n- Ultrasound, abdominal, real time with image documentation; limited (eg, single organ, quadrant, follow-up)\n- Excision of Sigmoid Colon, Via Natural or Artificial Opening Endoscopic, Diagnostic\n\n### Condition\n- Blepharitis\n- Duodenitis\n- Elevated level of transaminase and lactic acid dehydrogenase\n- Erythema of skin\n- Uncomplicated asthma\n- Amblyopia\n- Ascites\n- Atelectasis\n- Chronic ulcer of foot\n- Hepatosplenomegaly\n- Blepharitis of left eyelid\n- Dehydration\n- Diarrhea\n- Hypomagnesemia\n- Nausea\n- Pancytopenia due to antineoplastic chemotherapy\n- Acute renal failure syndrome\n- Conjunctivitis\n- Hyperglycemia\n- Large liver\n- Nausea and vomiting\n- Secondary hypertension\n- Viral enteritis\n- Acute leukemia in remission\n- Fever\n- Taste sense altered\n- Disorder of gallbladder\n- Neutropenia\n- Cytomegalovirus infection\n- Diaphragmatic hernia\n- Visual field defect\n- Residual hemorrhoidal skin tags\n- Acute myeloid leukemia, disease\n\n### Drug\n- dronabinol 2.5 MG Oral Capsule, through Oral route, started on 2016-06-03, presumably until 2016-06-09\n- fluconazole 200 MG Oral Tablet, through Oral route, started on 2016-06-05, presumably until 2016-06-10\n- codeine phosphate 2 MG/ML / guaifenesin 20 MG/ML Oral Solution, through Oral route, started on 2016-06-06, presumably until 2016-06-06\n- phenol 14 MG/ML Mucosal Spray, through Submucosal route, started on 2016-06-06, presumably until 2016-06-06\n- methylprednisolone 40 MG Injection, started on 2016-06-06, presumably until 2016-06-08\n- acyclovir 400 MG Oral Tablet, through Oral route, started on 2016-06-03, presumably until 2016-06-06\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2016-06-05, presumably until 2016-06-09\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2016-06-07, presumably until 2016-06-08\n- ganciclovir 500 MG Injection, through Intravenous route, started on 2016-06-06, presumably until 2016-06-10\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2016-06-05, presumably until 2016-06-10\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2016-06-03, presumably until 2016-06-09\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2016-06-04, presumably until 2016-06-05\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2016-06-09, presumably until 2016-07-15, with intended 0 refill(s). Instructions: take 8 Tabs by mouth daily Follow provider instructions regarding decrease in dose\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2016-06-07, presumably until 2016-06-07\n- clotrimazole 10 MG Oral Lozenge, through Submucosal route, started on 2016-06-05, presumably until 2016-06-06\n- baclofen 10 MG Oral Tablet, through Oral route, started on 2016-06-07, presumably until 2016-08-13, with intended 0 refill(s). Instructions: take 1 Tab by mouth 3 times a day as needed (Hiccups)\n- omeprazole 40 MG Delayed Release Oral Capsule, through Oral route, started on 2016-06-09, presumably until 2016-12-01, with intended 2 refill(s). Instructions: take 40 mg by mouth 2 times a day\n- nystatin 100000 UNT/ML Oral Suspension, through Oral route, started on 2016-06-07, presumably until 2016-06-25, with intended 0 refill(s). Instructions: 5 mL by Swish & Swallow route 4 times a day\n- ursodiol 300 MG Oral Capsule, through Oral route, started on 2016-06-03, presumably until 2016-06-10\n- bacitracin 0.5 UNT/MG / polymyxin B 10 UNT/MG Topical Ointment, through Topical route, started on 2016-06-06, presumably until 2016-06-22, with intended 0 refill(s). Instructions: Apply a thin layer to right 5th toe ulcer BID\n- cefepime 2000 MG Injection, through Intravenous route, started on 2016-06-03, presumably until 2016-06-08\n- prochlorperazine 10 MG Oral Tablet, through Oral route, started on 2016-06-05, presumably until 2016-06-08\n- 1000 ML potassium chloride 0.02 MEQ/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-06-03, presumably until 2016-06-10\n- hypromellose 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2016-06-05, presumably until 2016-06-25, with intended 0 refill(s). Instructions: instill 1 Drop to both eyes 4 times a day as needed\n- tacrolimus 0.5 MG Oral Capsule, through Oral route, started on 2016-06-05, presumably until 2016-06-10\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2016-06-03, presumably until 2016-06-07\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-06-04, presumably until 2016-06-04\n- sucralfate 100 MG/ML Oral Suspension, through Oral route, started on 2016-06-06, presumably until 2016-06-25, with intended 0 refill(s). Instructions: take 10 mL by mouth every 6 hours as needed (Stomach upset)\n- prednisone 50 MG Oral Tablet, through Oral route, started on 2016-06-09, presumably until 2016-06-10\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2016-06-05, presumably until 2016-06-10\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2016-06-03, presumably until 2016-06-10\n- glucose 50 MG/ML Injection, through Intravenous route, started on 2016-06-03, presumably until 2016-06-08\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2016-06-05, presumably until 2016-06-06\n- nystatin 100 UNT/MG Topical Powder, through Topical route, started on 2016-06-04, presumably until 2016-06-25, with intended 1 refill(s). Instructions: Apply to affected areas in groin & axilla twice a day\n- prednisone 20 MG Oral Tablet, through Oral route, started on 2016-06-09, presumably until 2016-06-09\n- ondansetron 8 MG Disintegrating Oral Tablet, through Oral route, started on 2016-06-05, presumably until 2016-06-10\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2016-06-04, presumably until 2016-06-09\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-06-04 00:00:00, ended at 2016-06-04 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Nausea and vomiting\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-06-04 00:00:00, ended at 2016-06-04 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2016-06-04 00:00:00, ended at 2016-06-04 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2016-06-04, presumably until 2016-06-04\n- midazolam 1 MG/ML Injectable Solution, started on 2016-06-04, presumably until 2016-06-04\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-06-11 15:20:00, ended at 2016-06-11 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- MCV [Entitic volume] by Automated count: 104.5 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 66 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 5.2 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 122 (unit per liter)\n- Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection: 805 (international unit per milliliter)\n- Glucose [Mass/volume] in Serum or Plasma: 250 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.8 (percent)\n- MCH [Entitic mass] by Automated count: 33.7 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 64 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 12.5 (gram per deciliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.2 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 67 (percent)\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 35 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Cytomegalovirus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection: 2.91 (log international unit per milliliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.1 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.87 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.71 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 7.6 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 21.4 (percent)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.98 (thousand per microliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 35 (nanogram per milliliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.24 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.0 (gram per deciliter)\n\n### Procedure\n- Medical nutrition therapy; re-assessment and intervention, individual, face-to-face with the patient, each 15 minutes\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n- Intravenous infusion, hydration; initial, 31 minutes to 1 hour\n- Collection of venous blood by venipuncture\n\n### Condition\n- Cytomegalovirus infection\n- Acute leukemia in remission\n- Acute myeloid leukemia, disease\n\n### Drug\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-06-11, presumably until 2016-06-11\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-06-14 16:00:00, ended at 2016-06-14 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.91 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.21 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.4 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 132 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 76.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 37 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.1 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.9 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 118 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.66 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 251 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 103.4 (femtoliter)\n- Tacrolimus [Mass/volume] in Blood: 6.0 (nanogram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 22.9 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.8 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.89 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.68 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.0 (percent)\n- MCH [Entitic mass] by Automated count: 34.8 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.5 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n\n### Procedure\n- Medical nutrition therapy; re-assessment and intervention, individual, face-to-face with the patient, each 15 minutes\n- Intravenous infusion, hydration; initial, 31 minutes to 1 hour\n- Collection of venous blood by venipuncture\n\n### Condition\n- Cytomegalovirus infection\n- Acute leukemia in remission\n\n### Drug\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-06-14, presumably until 2016-06-14\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-06-16 15:47:00, ended at 2016-06-16 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.80 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.3 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.7 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 12.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 105.5 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 3.3 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.65 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 28 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 6.6 (nanogram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 40 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 116 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.4 (percent)\n- MCH [Entitic mass] by Automated count: 33.8 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 290 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.1 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 22.4 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 80.7 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.3 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.74 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.52 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n\n### Procedure\n- Intravenous infusion, hydration; initial, 31 minutes to 1 hour\n- Medical nutrition therapy; re-assessment and intervention, individual, face-to-face with the patient, each 15 minutes\n\n### Condition\n- Acute leukemia in remission\n\n### Drug\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-06-16, presumably until 2016-06-16\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-06-18 09:26:00, ended at 2016-06-18 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Acute myeloid leukemia, disease\n- Acute leukemia in remission\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-06-22 11:30:00, ended at 2016-06-22 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 106.7 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 2.5 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 86.3 (percent)\n- Platelets [#/volume] in Blood by Automated count: 31 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.77 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.0 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 34.9 (picogram)\n- Tacrolimus [Mass/volume] in Blood: 6.4 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 22 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.77 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 21.9 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.10 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.43 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection: <135 (international unit per milliliter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 283 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 42 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 112 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.9 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.43 (thousand per microliter)\n\n### Procedure\n- Medical nutrition therapy; re-assessment and intervention, individual, face-to-face with the patient, each 15 minutes\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n- Intravenous infusion, hydration; initial, 31 minutes to 1 hour\n\n### Condition\n- Acute leukemia in remission\n\n### Drug\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-06-22, presumably until 2016-06-22\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-06-25 09:30:00, ended at 2016-06-25 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 39 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.79 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 244 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 100 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.36 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.13 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 84.3 (percent)\n- Tacrolimus [Mass/volume] in Blood: 5.0 (nanogram per milliliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.5 (percent)\n- MCV [Entitic volume] by Automated count: 105.9 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 34 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.0 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.74 (million per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.4 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.6 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.87 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 34.7 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 3.9 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.3 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.1 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 21.3 (percent)\n- MCHC [Mass/volume] by Automated count: 32.8 (gram per deciliter)\n\n### Procedure\n- Intravenous infusion, hydration; initial, 31 minutes to 1 hour\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acute myeloid leukemia, disease\n- Acute leukemia in remission\n- Cytomegalovirus infection\n\n### Drug\n- nystatin 100000 UNT/ML Oral Suspension, through Oral route, started on 2016-06-25, presumably until 2016-11-25, with intended 0 refill(s). Instructions: 5 mL by Swish & Swallow route 4 times a day\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-06-25, presumably until 2016-06-25\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-06-29 11:20:00, ended at 2016-06-29 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 42 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.01 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 5.9 (nanogram per milliliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 283 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.3 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.1 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.7 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.83 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.4 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 34.8 (picogram)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 92 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.75 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.31 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 88.1 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection: <135 (international unit per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 13.3 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 2.5 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 105.2 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n\n### Procedure\n- Intravenous infusion, hydration; initial, 31 minutes to 1 hour\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Acute leukemia in remission\n- Acute myeloid leukemia, disease\n- Cytomegalovirus infection\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-07-02 11:30:00, ended at 2016-07-02 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.7 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.85 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 84.2 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.7 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.8 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.56 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 96 (unit per liter)\n- MCV [Entitic volume] by Automated count: 106.4 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.32 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 8.8 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 22 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 43 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 40 (unit per liter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.5 (percent)\n- MCH [Entitic mass] by Automated count: 35.1 (picogram)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.92 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.0 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 270 (milligram per deciliter)\n\n### Procedure\n- Intravenous infusion, hydration; initial, 31 minutes to 1 hour\n\n### Condition\n- Acute leukemia in remission\n\n### Drug\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-07-02, presumably until 2016-07-02\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-07-06 11:20:00, ended at 2016-07-06 11:55:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 3.95 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.4 (percent)\n- MCHC [Mass/volume] by Automated count: 32.9 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.9 (percent)\n- Platelets [#/volume] in Blood by Automated count: 51 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 89 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.94 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.8 (percent)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.2 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.0 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 233 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.35 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 34.5 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 10.6 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 104.7 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.19 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 13.6 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.64 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 82.4 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n\n### Procedure\n- Intravenous infusion, hydration; initial, 31 minutes to 1 hour\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Acute leukemia in remission\n\n### Drug\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-07-06, presumably until 2016-07-06\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-07-06 11:56:00, ended at 2016-07-06 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Acute myeloid leukemia, disease\n- Cough\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-07-09 11:30:00, ended at 2016-07-09 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.9 (percent)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.75 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.0 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 106.4 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.1 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 266 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.18 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 83.6 (percent)\n- Platelets [#/volume] in Blood by Automated count: 43 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.2 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.96 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 35.2 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.8 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 90 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.31 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 8.4 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.52 (thousand per microliter)\n\n### Procedure\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Decalcification procedure (List separately in addition to code for surgical pathology examination)\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n- Diagnostic bone marrow; biopsy(ies)\n\n### Condition\n- Acute leukemia in remission\n- Pancytopenia\n\n### Drug\n- cholecalciferol 0.025 MG Oral Capsule, through Oral route, presumably until 2016-12-01, with intended 0 refill(s). Instructions: take 1 Cap by mouth every day\n- docusate sodium 100 MG Oral Capsule, through Oral route, presumably until 2016-07-15, with intended 0 refill(s). Instructions: take 200 mg by mouth 2 times a day\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2016-07-09, presumably until 2016-07-09\n- hydromorphone hydrochloride 2 MG Oral Tablet, through Oral route, started on 2016-07-09, presumably until 2016-07-09\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-07-09, presumably until 2016-07-09\n- lidocaine hydrochloride 20 MG/ML Injectable Solution, started on 2016-07-09, presumably until 2016-07-09\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2016-07-09, presumably until 2016-07-09\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-07-15 00:00:00, ended at 2016-07-15 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2016-07-15, presumably until 2016-07-15, with intended 6 refill(s). Instructions: take 8 Tabs by mouth daily Follow provider instructions regarding decrease in dose\n- baclofen 10 MG Oral Tablet, through Oral route, started on 2016-07-15, presumably until 2016-08-13, with intended 6 refill(s). Instructions: take 1 Tab by mouth 3 times a day\n- sucralfate 1000 MG Oral Tablet, through Oral route, started on 2016-07-15, presumably until 2016-07-15, with intended 6 refill(s). Instructions: take 1 Tab by mouth 4 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-07-15 11:12:00, ended at 2016-07-15 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.1 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 173 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 73 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.9 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.05 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 80.1 (percent)\n- Tacrolimus [Mass/volume] in Blood: 17.2 (nanogram per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.24 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.1 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 34.4 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 101.3 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 91 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.48 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.4 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.84 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.47 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-07-15 13:48:42, ended at 2016-07-15 14:36:39\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 3.984\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute myeloid leukemia, disease\n\n### Drug\n- fluconazole 200 MG Oral Tablet, through Oral route, started on 2016-07-13, presumably until 2016-08-13, with intended 3 refill(s). Instructions: take 2 Tabs by mouth daily\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2016-07-15, presumably until 2016-11-02, with intended 6 refill(s). Instructions: take 2 Caps by mouth 2 times a day Take as directed twice a day per BMT team\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2016-07-15, presumably until 2016-07-20, with intended 6 refill(s). Instructions: take 8 Tabs by mouth daily Follow provider instructions regarding decrease in dose\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-07-20 00:00:00, ended at 2016-07-20 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- dronabinol 5 MG Oral Capsule, through Oral route, started on 2016-07-20, presumably until 2016-11-02, with intended 3 refill(s). Instructions: take 1 Cap by mouth 2 times a day as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-07-20 00:00:00, ended at 2016-07-20 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acyclovir 400 MG Oral Tablet, through Oral route, started on 2016-07-20, presumably until 2016-12-01, with intended 11 refill(s). Instructions: take 1 Tab by mouth 3 times a day\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2016-07-20, presumably until 2016-09-28, with intended 6 refill(s). Instructions: take 8 Tabs by mouth daily Follow provider instructions regarding decrease in dose\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2016-07-20, presumably until 2016-11-05, with intended 6 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-07-29 13:44:00, ended at 2016-07-29 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.56 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 192 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 13.7 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 105 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 30 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 141 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.39 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 101.9 (femtoliter)\n- MCH [Entitic mass] by Automated count: 34.7 (picogram)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.1 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.44 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.68 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.94 (million per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 52 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.5 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 84.6 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.0 (percent)\n- Tacrolimus [Mass/volume] in Blood: 18.7 (nanogram per milliliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-07-29 15:06:10, ended at 2016-07-29 16:34:49\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute leukemia in remission\n\n### Drug\n- posaconazole 100 MG Delayed Release Oral Tablet, through Oral route, started on 2016-07-29, presumably until 2016-12-01, with intended 4 refill(s). Instructions: take 3 Tabs by mouth daily\n- budesonide 3 MG Delayed Release Oral Capsule, through Oral route, started on 2016-07-29, presumably until 2016-10-26, with intended 6 refill(s). Instructions: take 1 Cap by mouth 3 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-08-12 12:18:00, ended at 2016-08-12 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection: <135 (international unit per milliliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 29 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.00 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.3 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.96 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.2 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.04 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.6 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.0 (percent)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 97 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 144 (unit per liter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.57 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 34.5 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 84.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 71 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.7 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.55 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.7 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 8.4 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 41 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 365 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 102.5 (femtoliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-08-12 14:10:02, ended at 2016-08-12 15:38:14\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 3.984\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute leukemia in remission\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-08-26 00:00:00, ended at 2016-08-26 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperglycemia\n\n### Drug\n- insulin, regular, human 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2016-08-26, presumably until 2017-08-26, with intended 6 refill(s). Instructions: inject 1-10 Units subcutaneous (under the skin) 4 times a day before meals and bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-08-26 12:08:00, ended at 2016-08-26 13:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.35 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 154 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.4 (percent)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Glucose [Mass/volume] in Blood: 492 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 34.0 (picogram)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.06 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.6 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 62 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 21.0 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 96 (millimole per liter)\n- Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection: <135 (international unit per milliliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.65 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 607 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.6 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 13.2 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 131 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 78 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.61 (thousand per microliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 102.1 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 78.8 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.37 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 14.9 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 28 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-08-26 14:00:00, ended at 2016-08-26 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.92 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 143 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 20 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 602 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 70 (unit per liter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Reticulocytes [#/volume] in Blood by Automated count: 56.3 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 129 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 27 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- IgG [Mass/volume] in Serum or Plasma: 942 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 97 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.0 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 1.31 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 474 (unit per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n\n### Condition\n- Acute myeloid leukemia, disease\n\n### Drug\n- insulin aspart, human 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2016-08-26, presumably until 2016-08-26\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2016-08-26, presumably until 2016-08-26\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-08-26 15:36:09, ended at 2016-08-26 15:36:40\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 413 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute leukemia in remission\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2016-08-28 00:00:00, ended at 2016-08-28 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Gastroesophageal reflux disease without esophagitis\n- Primary diagnosis: Acute leukemia in remission\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2016-08-28 00:00:00, ended at 2016-08-28 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Gastroesophageal reflux disease without esophagitis\n- Neutropenia\n- Cytomegalovirus infection\n- Anogenital herpesviral infection\n- Primary diagnosis: Acute leukemia in remission\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2016-09-05 12:41:00, ended at 2016-09-06 16:05:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.3 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- IgG [Mass/volume] in Serum or Plasma: 720 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 79 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.7 (percent)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Glucose [Mass/volume] in Blood: 216 (milligram per deciliter)\n- Heparin unfractionated [Units/volume] in Platelet poor plasma: >1.10 (unit per milliliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 81.3 (percent)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.3 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.67 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 13.1 (nanogram per milliliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 141 (unit per liter)\n- Body height: 6' 4\" (inch (US))\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 100.7 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.46 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 27 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.02 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.9 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.7 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.9 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.10 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 344 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.99 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 55 (thousand per microliter)\n- Prothrombin time (PT): 14.9 (second)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 97.4 (second)\n\n### Procedure\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Computed tomographic angiography, chest (noncoronary), with contrast material(s), including noncontrast images, if performed, and image postprocessing\n- Duplex scan of extremity veins including responses to compression and other maneuvers; complete bilateral study\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Collection of venous blood by venipuncture\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Physical therapy evaluation\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n\n### Condition\n- Dyspnea\n- Acute deep vein thrombosis of lower limb\n- Acute leukemia in remission\n- Cardiomegaly\n- Drug-induced diabetes mellitus\n- Primary diagnosis: Pulmonary embolism\n- Acute myeloid leukemia, disease\n- Systemic lupus erythematosus\n- Disorder of soft tissue\n- Electrocardiogram abnormal\n\n### Drug\n- rivaroxaban 15 MG Oral Tablet, through Oral route, started on 2016-09-06, presumably until 2016-09-06\n- acyclovir 400 MG Oral Tablet, through Oral route, started on 2016-09-05, presumably until 2016-09-06\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2016-09-05, presumably until 2016-09-06\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2016-09-06, presumably until 2016-09-06\n- insulin isophane, human 100 UNT/ML Injectable Suspension, through Subcutaneous route, started on 2016-08-26, presumably until 2016-11-01, with intended 0 refill(s). Instructions: INJECT SUBCUTANEOUSLY 2 TIMES A DAY AS DIRECTED BY BMT TEAM\n- nystatin 100000 UNT/ML Oral Suspension, through Oral route, started on 2016-09-06, presumably until 2016-09-06\n- dronabinol 5 MG Oral Capsule, through Oral route, started on 2016-09-06, presumably until 2016-09-06\n- insulin lispro 100 UNT/ML Injectable Solution, started on 2016-06-10, presumably until 2016-09-27, with intended 3 refill(s). Instructions: INJECT 0-12 UNITS SUBCUTANEOUSLY 4 TIMES A DAY BEFORE MEALS AND BEDTIME\n- posaconazole 100 MG Delayed Release Oral Tablet, through Oral route, started on 2016-09-05, presumably until 2016-09-06\n- magnesium sulfate 20 MG/ML Injection, through Intravenous route, started on 2016-09-06, presumably until 2016-09-06\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2016-09-06, presumably until 2016-09-06\n- budesonide 3 MG Delayed Release Oral Capsule, through Oral route, started on 2016-09-05, presumably until 2016-09-06\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2016-09-06, presumably until 2016-09-06\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-09-06 00:00:00, ended at 2016-09-06 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 58.2 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-09-06 08:00:00, ended at 2016-09-06 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 213 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-09-08 08:35:00, ended at 2016-09-08 10:16:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Leukocytes [#/volume] in Specimen by Automated count: 4.9 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.49 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.8 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.8 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.87 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 137 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 39 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 13.1 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 13.6 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 33 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection: <135 (international unit per milliliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.6 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 63 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.99 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- MCV [Entitic volume] by Automated count: 99.7 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 88 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.90 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 300 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.48 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 79.9 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-09-08 10:17:00, ended at 2016-09-08 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Medical nutrition therapy; re-assessment and intervention, individual, face-to-face with the patient, each 15 minutes\n\n### Condition\n- Primary diagnosis: Acute leukemia in remission\n\n### Drug\n- rivaroxaban 15 MG Oral Tablet, through Oral route, started on 2016-09-08, presumably until 2016-11-05, with intended 0 refill(s). Instructions: take 15 mg by mouth 2 times a day\n- rivaroxaban 20 MG Oral Tablet, through Oral route, started on 2016-09-08, presumably until 2016-09-28, with intended 12 refill(s). Instructions: take 1 Tab by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-09-27 13:07:00, ended at 2016-09-27 16:50:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.0 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection: <135 (international unit per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 12.9 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.5 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.52 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.89 (million per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 78.8 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 65 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 551 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.5 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.52 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 3.3 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 109 (unit per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.2 (percent)\n- Platelets [#/volume] in Blood by Automated count: 104 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 133 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 27 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.92 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.5 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 98.9 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.41 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-09-27 15:07:51, ended at 2016-09-27 16:40:54\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 3.984\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute leukemia in remission\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-09-27 16:51:00, ended at 2016-09-27 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 478 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Intravenous infusion, hydration; initial, 31 minutes to 1 hour\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n\n### Condition\n- Hyperglycemia\n- Lymphocytopenia\n- Acute monocytic/monoblastic leukemia\n- Acute myeloid leukemia, disease\n\n### Drug\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2016-09-27, presumably until 2016-12-01, with intended 1 refill(s). Instructions: inject 1-10 Units subcutaneous (under the skin) 3 times a day before meals follow moderate sliding scale 3 times daily before meals\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-09-27, presumably until 2016-09-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-10-25 11:33:00, ended at 2016-10-25 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.0 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 16.7 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 68 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection: <135 (international unit per milliliter)\n- Glucose [Mass/volume] in Serum or Plasma: 120 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.57 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 164 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 41 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.16 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.2 (percent)\n- MCH [Entitic mass] by Automated count: 32.7 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 64.2 (percent)\n- Platelets [#/volume] in Blood by Automated count: 134 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.4 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.0 (percent)\n- MCV [Entitic volume] by Automated count: 100.0 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.60 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.61 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 11.8 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 13.7 (nanogram per milliliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.19 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-10-25 15:35:15, ended at 2016-10-25 15:35:52\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute leukemia in remission\n- Pulmonary embolism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2016-11-01 00:00:00, ended at 2016-11-01 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n\n### Condition\n- Primary diagnosis: Acute leukemia in remission\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-11-01 14:47:00, ended at 2016-11-01 20:58:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- MCV [Entitic volume] by Automated count: 98.1 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 57 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 162 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.9 (percent)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 82 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.1 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 121 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.5 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.47 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 21 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 149 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 39 (unit per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.53 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 15.9 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.31 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 69.1 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.44 (million per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.19 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.7 (percent)\n- MCH [Entitic mass] by Automated count: 33.4 (picogram)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.3 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Acute leukemia in remission\n- Acute myeloid leukemia, disease\n\n### Drug\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2016-11-01, presumably until 2016-11-01\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, presumably until 2016-11-05, with intended 0 refill(s). Instructions: inject 10 Units subcutaneous (under the skin) daily in the evening\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2016-11-01 20:59:00, ended at 2016-11-03 17:38:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.7 (percent)\n- Prothrombin time (PT): 16.4 (second)\n- Tacrolimus [Mass/volume] in Blood: 9.8 (nanogram per milliliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 20.3 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 1.92 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.2 (percent)\n- Heparin unfractionated [Units/volume] in Platelet poor plasma: >1.10 (unit per milliliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.59 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 59.2 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 39 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.0 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.12 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.25 (million per microliter)\n- Platelets [#/volume] in Blood by Automated count: 149 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 68.2 (second)\n- Glucose [Mass/volume] in Blood: 93 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.1 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.66 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 98.4 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 5.7 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.7 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 141 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.2 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 21.0 (percent)\n\n### Procedure\n- Inspection of Lower Intestinal Tract, Via Natural or Artificial Opening Endoscopic\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); concurrent infusion (List separately in addition to code for primary procedure)\n- Sigmoidoscopy, flexible; with biopsy, single or multiple\n- Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple\n- Collection of venous blood by venipuncture\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Excision of Stomach, Via Natural or Artificial Opening Endoscopic, Diagnostic\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Leukemia in remission\n- Epigastric pain\n- Nausea and vomiting\n- Primary diagnosis: Acute leukemia in remission\n- Chronic gastritis\n- Headache\n- Drug-induced diabetes mellitus\n- Hyperlipidemia\n- Acute myeloid leukemia, disease\n- Diaphragmatic hernia\n\n### Drug\n- 2 ML prochlorperazine 5 MG/ML Injection, started on 2016-11-02, presumably until 2016-11-03\n- clindamycin 10 MG/ML Topical Lotion, through Topical route, presumably until 2016-11-05, with intended 0 refill(s). Instructions: 1 Application by Topical route 2 times a day\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2016-11-02, presumably until 2016-11-02\n- ondansetron 8 MG Oral Tablet, through Oral route, presumably until 2017-01-27, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed (nausea)\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2016-11-02, presumably until 2016-11-03\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2016-11-02, presumably until 2016-12-01, with intended 6 refill(s). Instructions: take 2 mg by mouth every morning \n- lorazepam 1 MG Oral Tablet, through Oral route, presumably until 2016-11-25, with intended 0 refill(s). Instructions: take 0.5 mg by mouth every 4 hours as needed (nausea)\n- dronabinol 5 MG Oral Capsule, through Oral route, presumably until 2017-03-29, with intended 0 refill(s). Instructions: take 5 mg by mouth every bedtime as needed\n- posaconazole 100 MG Delayed Release Oral Tablet, through Oral route, started on 2016-11-02, presumably until 2016-11-03\n- ketoconazole 20 MG/ML Topical Cream, through Topical route, presumably until 2016-11-05, with intended 0 refill(s). Instructions: 1 Application by Topical route 2 times a day\n- tacrolimus 0.5 MG Oral Capsule, through Oral route, presumably until 2016-11-02, with intended 0 refill(s). Instructions: take 0.5 mg by mouth 2 times a day\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-11-02, presumably until 2016-11-03\n- magnesium sulfate 20 MG/ML Injection, through Intravenous route, started on 2016-11-02, presumably until 2016-11-03\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2016-11-02, presumably until 2016-11-03\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2016-11-02, presumably until 2016-11-02\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2016-11-02, presumably until 2016-11-02\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2016-11-03 00:00:00, ended at 2016-11-03 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- midazolam 1 MG/ML Injectable Solution, started on 2016-11-03, presumably until 2016-11-03\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-11-05 10:20:00, ended at 2016-11-05 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.27 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.8 (percent)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.2 (percent)\n- MCV [Entitic volume] by Automated count: 98.1 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 147 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 9.7 (nanogram per milliliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 161 (unit per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.3 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.56 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.3 (picogram)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.61 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.4 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 66.5 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.18 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 149 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.2 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.69 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 17.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.9 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.9 (gram per deciliter)\n\n### Procedure\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n- Medical nutrition therapy; re-assessment and intervention, individual, face-to-face with the patient, each 15 minutes\n- Intravenous infusion, hydration; initial, 31 minutes to 1 hour\n\n### Condition\n- Acute myeloid leukemia, disease\n- Acute leukemia in remission\n\n### Drug\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-11-05, presumably until 2016-11-05\n- rivaroxaban 20 MG Oral Tablet, through Oral route, presumably until 2016-12-01, with intended 0 refill(s). Instructions: take 20 mg by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-11-11 13:32:00, ended at 2016-11-11 13:32:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.66 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.51 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.6 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.6 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.0 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 16.2 (percent)\n- Platelets [#/volume] in Blood by Automated count: 145 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.59 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 149 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.1 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.72 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.2 (percent)\n- MCV [Entitic volume] by Automated count: 98.5 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.7 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.5 (percent)\n- Tacrolimus [Mass/volume] in Blood: 10.7 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 168 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 67.0 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 46 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.37 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-11-11 14:55:18, ended at 2016-11-11 15:59:42\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 3 - 5 (per high power field)\n- Thyrotropin [Units/volume] in Serum or Plasma: 1.61 (micro-international unit per milliliter)\n- Body height: 6' 3.98\" (inch (US))\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acute leukemia in remission\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-11-25 09:54:00, ended at 2016-11-25 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Hemoglobin [Mass/volume] in Blood: 11.2 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.99 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.49 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 97.6 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 16.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.67 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 46 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.8 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.7 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 130 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 57 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.24 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 63.6 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 196 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.2 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.1 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.67 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.59 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 4.6 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.9 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.1 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 13.9 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 161 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-11-25 11:18:11, ended at 2016-11-25 12:14:08\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 3.984\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute leukemia in remission\n\n### Drug\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2016-11-25, presumably until 2018-04-17, with intended 1 refill(s). Instructions: take 0.5 Tabs by mouth every 4 hours as needed (nausea)\n- nystatin 100000 UNT/ML Oral Suspension, through Oral route, started on 2016-11-25, presumably until 2017-04-08, with intended 0 refill(s). Instructions: 5 mL by Swish & Swallow route 4 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-12-01 00:00:00, ended at 2016-12-01 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute leukemia in remission\n\n### Drug\n- acyclovir 400 MG Oral Tablet, through Oral route, started on 2016-12-01, presumably until 2017-02-23, with intended 11 refill(s). Instructions: take 1 Tab by mouth 3 times a day\n- cholecalciferol 0.025 MG Oral Capsule, through Oral route, started on 2016-12-01, presumably until 2016-12-01, with intended 6 refill(s). Instructions: take 1 Cap by mouth every day\n- omeprazole 40 MG Delayed Release Oral Capsule, through Oral route, started on 2016-12-01, presumably until 2017-02-23, with intended 2 refill(s). Instructions: take 40 mg by mouth 2 times a day\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2016-12-01, presumably until 2017-01-27, with intended 1 refill(s). Instructions: inject 1-10 Units subcutaneous (under the skin) 3 times a day before meals follow moderate sliding scale 3 times daily before meals\n- posaconazole 100 MG Delayed Release Oral Tablet, through Oral route, started on 2016-12-01, presumably until 2016-12-14, with intended 4 refill(s). Instructions: take 3 Tabs by mouth daily\n- tacrolimus 0.5 MG Oral Capsule, through Oral route, started on 2016-12-01, presumably until 2017-04-08, with intended 6 refill(s). Instructions: take 1 Cap by mouth 2 times a day\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2016-12-01, presumably until 2017-01-27, with intended 6 refill(s). Instructions: take 1 Tab by mouth daily in the morning\n- rivaroxaban 20 MG Oral Tablet, through Oral route, started on 2016-12-01, presumably until 2017-03-08, with intended 6 refill(s). Instructions: take 20 mg by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-12-14 00:00:00, ended at 2016-12-14 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- posaconazole 100 MG Delayed Release Oral Tablet, through Oral route, started on 2016-12-14, presumably until 2017-01-27, with intended 6 refill(s). Instructions: take 3 Tabs by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-30 12:55:00, ended at 2016-12-30 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.02 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.37 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.8 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 128 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.7 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.9 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 60.6 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.4 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 7.7 (percent)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 96.2 (femtoliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.91 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.7 (percent)\n- MCH [Entitic mass] by Automated count: 31.8 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.62 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.7 (percent)\n- Testosterone [Mass/volume] in Serum or Plasma: 820 (nanogram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 159 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.7 (percent)\n- Tacrolimus [Mass/volume] in Blood: 2.8 (nanogram per milliliter)\n- Platelets [#/volume] in Blood by Automated count: 172 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.68 (million per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.94 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-12-30 15:30:13, ended at 2016-12-30 16:24:58\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-12-30 16:34:44, ended at 2016-12-30 17:52:33\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 3.984\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic graft-versus-host disease\n\n### Drug\n- hydrocortisone 0.025 MG/MG Topical Ointment, through Topical route, started on 2016-12-30, presumably until 2017-12-30, with intended 0 refill(s). Instructions: by Topical route daily Apply to face at night\n- hydrocortisone 25 MG/ML Topical Cream, through Topical route, started on 2016-12-30, presumably until 2016-12-30, with intended 0 refill(s). Instructions: by Topical route Morning\n- fluocinonide 0.5 MG/ML Topical Cream, through Topical route, started on 2016-12-30, presumably until 2017-12-30, with intended 0 refill(s). Instructions: by Topical route Apply to chest, arms, upper back and neck in the morning\n- fluocinonide 0.0005 MG/MG Topical Ointment, started on 2016-12-30, presumably until 2016-12-30, with intended 0 refill(s). Instructions: Apply to chest, arms, upper back and neck at night\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-01-03 00:00:00, ended at 2017-01-03 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sildenafil 50 MG Oral Tablet, through Oral route, started on 2017-01-03, presumably until 2018-01-03, with intended 1 refill(s). Instructions: take 1 Tab by mouth as needed (1 hour before sexual activity)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-01-27 10:44:00, ended at 2017-01-27 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Eosinophils [#/volume] in Blood by Automated count: 0.51 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: <1.0 (nanogram per milliliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 17.9 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 111 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 0.81 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.7 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.6 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.8 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 34.0 (percent)\n- MCH [Entitic mass] by Automated count: 31.8 (picogram)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 113 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.70 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 19.1 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 28.2 (percent)\n- Platelets [#/volume] in Blood by Automated count: 152 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.1 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.87 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 96.2 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.55 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 2.9 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.97 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-01-27 11:22:55, ended at 2017-01-27 12:04:35\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 3.984\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Eruption\n\n### Drug\n- tacrolimus 0.001 MG/MG Topical Ointment, started on 2017-01-27, presumably until 2017-04-08, with intended 3 refill(s). Instructions: Apply topically as directed twice daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-01-27 13:56:55, ended at 2017-01-27 14:52:06\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 3.984\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute leukemia in remission\n\n### Drug\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2017-01-27, presumably until 2017-04-08, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- furosemide 40 MG Oral Tablet, through Oral route, started on 2017-01-27, presumably until 2017-04-08, with intended 2 refill(s). Instructions: take 1 Tab by mouth daily as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-02-03 00:00:00, ended at 2017-02-03 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- azithromycin 250 MG Oral Tablet, through Oral route, started on 2017-02-03, presumably until 2017-04-07, with intended 0 refill(s). Instructions: take 1 Tab by mouth as directed Take 2 tabs on day 1 and 1 tab each of the following days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-02-10 00:00:00, ended at 2017-02-10 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Graft versus host disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-02-10 10:28:00, ended at 2017-02-10 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Hemoglobin [Mass/volume] in Blood: 12.3 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.5 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.55 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 16.0 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.1 (percent)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.11 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 100 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.6 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.93 (million per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 37.2 (percent)\n- Platelets [#/volume] in Blood by Automated count: 163 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 38 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 32.3 (percent)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: <1.0 (nanogram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.14 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.4 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 95.0 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.47 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 1.28 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 109 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.3 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-02-23 00:00:00, ended at 2017-02-23 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acyclovir 400 MG Oral Tablet, through Oral route, started on 2017-02-23, presumably until 2017-03-08, with intended 11 refill(s). Instructions: take 1 Tab by mouth 3 times a day\n- omeprazole 40 MG Delayed Release Oral Capsule, through Oral route, started on 2017-02-23, presumably until 2017-06-03, with intended 2 refill(s). Instructions: take 40 mg by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-03-03 00:00:00, ended at 2017-03-03 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute myeloid leukemia, disease\n\n### Drug\n- amoxicillin 500 MG Oral Tablet, through Oral route, started on 2017-03-03, presumably until 2017-03-03, with intended 0 refill(s). Instructions: take 4 Tabs by mouth One Time for 1 dose 1 hour before dental work\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-03-03 07:02:00, ended at 2017-03-03 09:32:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 135 (milligram per deciliter)\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- Hepatosplenomegaly\n- Acute myeloid leukemia, disease\n- Localized enlarged lymph nodes\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-03-03 09:33:00, ended at 2017-03-03 11:27:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 94.9 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 21.3 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 15.9 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 50.4 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.97 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.90 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.0 (percent)\n- Tacrolimus [Mass/volume] in Blood: <1.0 (nanogram per milliliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.28 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 11.6 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.8 (percent)\n- Globulin [Mass/volume] in Serum: 2.7 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 2.5 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.24 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 0.39 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 140 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.7 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.53 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 113 (unit per liter)\n- MCH [Entitic mass] by Automated count: 32.5 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 119 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-03-03 11:28:00, ended at 2017-03-03 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- IgG [Mass/volume] in Serum or Plasma: 801 (milligram per deciliter)\n\n### Procedure\n- Diagnostic bone marrow; biopsy(ies)\n- Collection of venous blood by venipuncture\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Decalcification procedure (List separately in addition to code for surgical pathology examination)\n\n### Condition\n- Acute deep vein thrombosis of lower limb\n- Primary diagnosis: Acute leukemia in remission\n- Acute myeloid leukemia, disease\n- Myeloid leukemia\n- Pancytopenia\n- Pulmonary embolism\n\n### Drug\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2017-03-03, presumably until 2017-03-03\n- lidocaine hydrochloride 20 MG/ML Injectable Solution, started on 2017-03-03, presumably until 2017-03-03\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Systemic lupus erythematosus within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2015-12-01 20:00:00, ended at 2015-12-26 16:51:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: <10 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.46 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 7.56 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 56.8 (second)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Leukocytes [#/volume] in Body fluid by Manual count: 1 (milli-international unit per milliliter)\n- MCHC [Mass/volume] by Automated count: 36.4 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 5.9 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 7 (thousand per microliter)\n- Prothrombin time (PT): 27.8 (second)\n- Activated protein C resistance [Time Ratio] in Platelet poor plasma by Coagulation assay: 2.7 (ratio)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 21.1 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 889 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Left ventricular Ejection fraction: 63.0 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Procalcitonin [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.7 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 78.1 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 0.51 (thousand per microliter)\n- Protein S actual/normal in Platelet poor plasma by Coagulation assay: 82 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 99 (unit per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Blasts/100 leukocytes in Blood by Manual count: 91 (percent)\n- Body height: 6' 3.984\" (inch (US))\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 995 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.38 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 98.1 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.08 (thousand per microliter)\n- Protein C actual/normal in Platelet poor plasma by Coagulation assay: 60 (percent)\n- Thrombin time: 18.4 (second)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.46 (million per microliter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: >20000 (microgram of fibrinogen equivalent unit per milliliter)\n- Lactate [Moles/volume] in Blood: 1.6 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 96.3 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.0 (gram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: <2.0 (milligram per deciliter)\n- Base excess in Blood by calculation: -2 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.3 (percent)\n- MCH [Entitic mass] by Automated count: 33.0 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 4.9 (percent)\n- Thyrotropin [Units/volume] in Serum or Plasma: 2.82 (micro-international unit per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.8 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.8 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 9 (percent)\n\n### Procedure\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Duplex scan of extremity veins including responses to compression and other maneuvers; unilateral or limited study\n- Radiologic examination, chest; single view, frontal\n- Collection of venous blood by venipuncture\n- Insertion of peripherally inserted central venous catheter (PICC), without subcutaneous port or pump, without imaging guidance; age 5 years or older\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Introduction of Other Antineoplastic into Central Vein, Percutaneous Approach\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Computed tomography, maxillofacial area; with contrast material(s)\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Medical nutrition therapy; re-assessment and intervention, individual, face-to-face with the patient, each 15 minutes\n- Decalcification procedure (List separately in addition to code for surgical pathology examination)\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n- Morphometric analysis, tumor\n- Extraction of Iliac Bone Marrow, Percutaneous Approach, Diagnostic\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Hospital discharge day management; more than 30 minutes\n\n### Condition\n- Abnormal finding on evaluation procedure\n- Disorder due to and following accidental poisoning\n- Disorder of nasal cavity\n- Dyspnea\n- Jaw pain\n- Neutropenia\n- Ulcerative stomatitis\n- Candidiasis of mouth\n- Chest pain\n- Disorder due to and following drug poisoning\n- Thrombocytopenic disorder\n- Abnormal findings on diagnostic imaging of lung\n- Acute myeloid leukemia, disease\n- Candidiasis of the esophagus\n- Pancytopenia\n- Uncomplicated asthma\n- Anemia\n- Acute leukemia in remission\n- Neck pain\n- Fever\n- Tumor lysis syndrome\n- Acute monocytic/monoblastic leukemia\n- Electrocardiogram abnormal\n- Pneumonia\n- Posttraumatic stress disorder\n- Anemia in neoplastic disease\n- Essential hypertension\n- Primary diagnosis: Leukocytosis\n- Localized edema\n- Cough\n\n### Drug\n- fluconazole 200 MG Oral Tablet, through Oral route, started on 2015-12-15, presumably until 2016-01-23, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily\n- vitamin K1 5 MG Oral Tablet, through Oral route, started on 2015-12-07, presumably until 2015-12-10\n- calcium carbonate 1000 MG Chewable Tablet, through Oral route, started on 2015-12-14, presumably until 2015-12-14\n- 14 ACTUAT fluticasone propionate 0.25 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler, through Oral route, started on 2015-11-07, presumably until 2015-12-01, with intended 1 refill(s). Instructions: take 1 Puff by mouth 2 times a day Rinse mouth after each use\n- vancomycin 1000 MG Injection, through Intravenous route, started on 2015-12-04, presumably until 2015-12-23\n- 2 ML prochlorperazine 5 MG/ML Injection, started on 2015-12-09, presumably until 2015-12-20\n- benzocaine 0.2 MG/MG Oral Paste, through Submucosal route, started on 2015-12-14, presumably until 2015-12-20\n- allopurinol 300 MG Oral Tablet, through Oral route, started on 2015-12-02, presumably until 2015-12-09\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2015-12-07, presumably until 2015-12-21\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2015-12-02, presumably until 2015-12-10\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2015-12-04, presumably until 2016-01-15, with intended 0 refill(s). Instructions: take 1 Tab by mouth every morning before breakfast\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2015-12-03, presumably until 2015-12-24\n- zolpidem tartrate 5 MG Oral Tablet, through Oral route, started on 2015-12-02, presumably until 2015-12-19\n- diphenhydramine hydrochloride 2.5 MG/ML Oral Solution, through Oral route, started on 2015-12-13, presumably until 2015-12-26\n- diphenhydramine hydrochloride 20 MG/ML / zinc acetate 1 MG/ML Topical Cream, through Topical route, started on 2015-12-04, presumably until 2015-12-07\n- lidocaine 40 MG/ML Topical Cream, through Topical route, started on 2015-12-02, presumably until 2015-12-02\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2015-12-04, presumably until 2016-06-10, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every 6 hours as needed for Pain or Fever\n- trazodone hydrochloride 50 MG Oral Tablet, through Oral route, started on 2015-12-18, presumably until 2015-12-18\n- vancomycin 500 MG Injection, through Intravenous route, started on 2015-12-22, presumably until 2015-12-23\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2015-12-02, presumably until 2015-12-21\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2015-12-03, presumably until 2015-12-25\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2015-12-02, presumably until 2015-12-07\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2015-12-11, presumably until 2015-12-11\n- 1 ML hydralazine hydrochloride 20 MG/ML Injection, started on 2015-12-14, presumably until 2015-12-14\n- acetaminophen 325 MG / butalbital 50 MG / caffeine 40 MG Oral Tablet, through Oral route, started on 2015-12-18, presumably until 2015-12-26\n- allopurinol 100 MG Oral Tablet, through Oral route, started on 2015-12-01, presumably until 2015-12-01\n- nystatin 100000 UNT/ML Oral Suspension, through Oral route, started on 2015-12-14, presumably until 2015-12-26\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-12-09, presumably until 2015-12-09\n- cyclobenzaprine hydrochloride 10 MG Oral Tablet, through Oral route, started on 2015-12-04, presumably until 2015-12-12\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2015-12-05, presumably until 2016-01-15, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every bedtime as needed (constipation)\n- dronabinol 5 MG Oral Capsule, through Oral route, started on 2015-12-22, presumably until 2015-12-25\n- NDA021457 200 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Oral route, started on 2015-11-07, presumably until 2015-12-01, with intended 1 refill(s). Instructions: take 2 Puffs by mouth every 4 to 6 hours as needed\n- valacyclovir 500 MG Oral Tablet, through Oral route, started on 2015-12-02, presumably until 2016-01-09, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 14 days\n- hydromorphone hydrochloride 2 MG Oral Tablet, through Oral route, started on 2015-12-17, presumably until 2015-12-17\n- cefepime 2000 MG Injection, through Intravenous route, started on 2015-12-04, presumably until 2015-12-26\n- prochlorperazine 10 MG Oral Tablet, through Oral route, started on 2015-12-19, presumably until 2015-12-19\n- tretinoin 10 MG Oral Capsule, through Oral route, started on 2015-12-02, presumably until 2015-12-03\n- calcium acetate 667 MG Oral Capsule, through Oral route, started on 2015-12-05, presumably until 2015-12-11\n- camphor 5 MG/ML / menthol 5 MG/ML Topical Lotion, through Topical route, started on 2015-12-04, presumably until 2015-12-08\n- 4 ML daunorubicin 5 MG/ML Injection, through Intravenous route, started on 2015-12-05, presumably until 2015-12-07\n- 2 ML ondansetron 2 MG/ML Injection, started on 2015-12-05, presumably until 2015-12-18\n- 1 ML hydromorphone hydrochloride 2 MG/ML Prefilled Syringe, started on 2015-12-02, presumably until 2015-12-02\n- promethazine hydrochloride 12.5 MG Oral Tablet, through Oral route, started on 2015-12-18, presumably until 2015-12-19\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2015-12-01, presumably until 2015-12-26\n- lidocaine hydrochloride 20 MG/ML Mucous Membrane Topical Solution, through Submucosal route, started on 2015-12-13, presumably until 2015-12-26\n- magnesium sulfate 20 MG/ML Injection, through Intravenous route, started on 2015-12-15, presumably until 2015-12-15\n- sorafenib 200 MG Oral Tablet, through Oral route, started on 2015-12-12, presumably until 2015-12-22\n- valacyclovir 1000 MG Oral Tablet, through Oral route, started on 2015-12-12, presumably until 2015-12-13\n- 100 ML potassium chloride 0.2 MEQ/ML Injection, through Intravenous route, started on 2015-12-26, presumably until 2015-12-26\n- ondansetron 4 MG Oral Tablet, through Oral route, started on 2015-12-07, presumably until 2016-01-15, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Nausea\n- azithromycin 250 MG Oral Tablet, through Oral route, started on 2015-12-05, presumably until 2015-12-09\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2015-12-03, presumably until 2015-12-13\n- glucose 50 MG/ML Injection, through Intravenous route, started on 2015-12-04, presumably until 2015-12-26\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2015-12-14, presumably until 2016-01-15, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed for Pain\n- aluminum hydroxide 40 MG/ML / magnesium hydroxide 40 MG/ML / simethicone 4 MG/ML Oral Suspension, through Oral route, started on 2015-12-13, presumably until 2015-12-26\n- zolpidem tartrate 10 MG Oral Tablet, through Oral route, started on 2015-11-07, presumably until 2016-01-15, with intended 0 refill(s). Instructions: take 1 Tab by mouth every bedtime as needed For sleep\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-12-02 00:00:00, ended at 2015-12-02 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Illness\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-12-03 00:00:00, ended at 2015-12-03 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Illness\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-12-12 00:00:00, ended at 2015-12-12 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Illness\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-01-02 00:00:00, ended at 2016-01-02 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-01-02 14:10:00, ended at 2016-01-02 23:59:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.5 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 38.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 356 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- MCV [Entitic volume] by Automated count: 93.0 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 1.50 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.65 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.8 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 17.7 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 148 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 24.6 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.35 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.0 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 84 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 8.4 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.62 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 42.9 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n\n### Procedure\n- Decalcification procedure (List separately in addition to code for surgical pathology examination)\n- Diagnostic bone marrow; biopsy(ies)\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n\n### Condition\n- Acute myeloid leukemia, disease\n- Pancytopenia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-01-02 15:32:29, ended at 2016-01-02 16:59:57\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 3.984\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-01-09 00:00:00, ended at 2016-01-09 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-01-09 11:17:00, ended at 2016-01-09 23:59:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 83 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.8 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.2 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 31.4 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.24 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.4 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 297 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 10.3 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 95.1 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.84 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 2.1 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.69 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 101 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.73 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 52.8 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- MCH [Entitic mass] by Automated count: 31.7 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-01-09 13:08:35, ended at 2016-01-09 15:22:19\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-01-13 00:00:00, ended at 2016-01-13 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-01-15 00:00:00, ended at 2016-01-15 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 57.5 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-01-15 00:00:00, ended at 2016-01-15 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-01-15 09:00:00, ended at 2016-01-15 12:01:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Disorder due to and following accidental poisoning\n- Disorder due to and following drug poisoning\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2016-01-15 12:02:00, ended at 2016-01-23 12:34:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Lymphocytes [#/volume] in Blood by Automated count: 1.79 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Thrombin time: 17.0 (second)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 231 (unit per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.6 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 6.0 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 2.2 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.4 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 90 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.7 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 0.1 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.85 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.9 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 268 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 79 (unit per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 7.31 (thousand per microliter)\n- Prothrombin time (PT): 14.4 (second)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 95.6 (femtoliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.3 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Body height: 6' 5.362\" (inch (US))\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 1743 (microgram of fibrinogen equivalent unit per milliliter)\n- MCH [Entitic mass] by Automated count: 32.1 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 78.9 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 33.7 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.96 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 26.5 (second)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 285 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.6 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n\n### Procedure\n- Hospital discharge day management; more than 30 minutes\n- Collection of venous blood by venipuncture\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Introduction of Other Antineoplastic into Central Vein, Percutaneous Approach\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Physical therapy evaluation\n\n### Condition\n- Insomnia\n- Acute myeloid leukemia, disease\n- Primary diagnosis: Leukocytosis\n- Acute leukemia in remission\n- Candidiasis of mouth\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2016-01-15, presumably until 2016-01-22\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2016-01-16, presumably until 2016-01-23\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2016-01-17, presumably until 2016-01-17\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2016-01-15, presumably until 2016-01-15\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2016-01-15, presumably until 2016-01-23\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2016-01-15, presumably until 2016-01-18\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2016-01-20, presumably until 2016-01-20\n- nystatin 100000 UNT/ML Oral Suspension, through Oral route, started on 2016-01-22, presumably until 2016-01-30, with intended 3 refill(s). Instructions: 5 mL by Swish & Swallow route 3 times a day\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2016-01-17, presumably until 2016-01-20\n- dronabinol 5 MG Oral Capsule, through Oral route, started on 2016-01-15, presumably until 2016-01-22\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2016-01-19, presumably until 2016-01-23\n- 4 ML daunorubicin 5 MG/ML Injection, through Intravenous route, started on 2016-01-16, presumably until 2016-01-18\n- magnesium sulfate 20 MG/ML Injection, through Intravenous route, started on 2016-01-15, presumably until 2016-01-15\n- sorafenib 200 MG Oral Tablet, through Oral route, started on 2016-01-20, presumably until 2016-02-03, with intended 0 refill(s). Instructions: take 2 Tabs by mouth 2 times a day\n- alteplase 1 MG/ML Injectable Solution, through Intraluminal route, started on 2016-01-16, presumably until 2016-01-16\n- fluconazole 200 MG Oral Tablet, through Oral route, started on 2016-01-15, presumably until 2016-01-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-01-26 11:33:00, ended at 2016-01-26 23:59:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.9 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.8 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.14 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 69 (unit per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.0 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.13 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.20 (million per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.9 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 15.2 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 111 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 1.5 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 74.5 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 0.23 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 12 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 8.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 29 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-01-26 13:06:52, ended at 2016-01-26 15:18:21\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 5.008\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2016-01-29 23:51:00, ended at 2016-02-03 15:30:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.89 (million per microliter)\n- Lactate [Moles/volume] in Blood: 1.6 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Manual count: 1.21 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 96 (percent)\n- MCV [Entitic volume] by Automated count: 91.0 (femtoliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Body height: 6' 4.772\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Leukocytes [#/volume] in Body fluid by Manual count: 3 (milli-international unit per milliliter)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 1.6 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Blasts/100 leukocytes in Blood by Manual count: 3 (percent)\n- Eosinophils [#/volume] in Blood by Manual count: 0.04 (thousand per microliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 97 (unit per liter)\n- Base excess in Blood by calculation: 0 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.3 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.3 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 2 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.7 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 25.9 (percent)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 153 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.1 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 40 (thousand per microliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.30 (thousand per microliter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.91 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Computed tomography, head or brain; without contrast material\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Hospital discharge day management; more than 30 minutes\n- Drainage of Spinal Canal, Percutaneous Approach, Diagnostic\n- Spinal puncture, lumbar, diagnostic\n- Insertion of peripherally inserted central venous catheter (PICC), without subcutaneous port or pump, without imaging guidance; age 5 years or older\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); concurrent infusion (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n- Radiologic examination, chest; single view, frontal\n\n### Condition\n- Hypokalemia\n- Fever\n- Pancytopenia\n- Sepsis due to Escherichia coli\n- Hypomagnesemia\n- Spasm\n- Acute leukemia in remission\n- Ulcerative stomatitis\n- Candidiasis of the esophagus\n- Nausea\n- Primary diagnosis: Neutropenia\n\n### Drug\n- 0.5 ML filgrastim 0.6 MG/ML Prefilled Syringe, started on 2016-01-31, presumably until 2016-02-02\n- nystatin 100 UNT/MG Topical Ointment, through Topical route, started on 2016-01-28, presumably until 2016-02-13, with intended 0 refill(s). Instructions: 1 Application by Topical route 2 times a day\n- loperamide hydrochloride 2 MG Oral Capsule, through Oral route, started on 2016-01-30, presumably until 2016-01-30\n- pantoprazole 20 MG Delayed Release Oral Tablet, through Oral route, started on 2016-01-30, presumably until 2016-01-30\n- acyclovir 400 MG Oral Tablet, through Oral route, started on 2016-01-28, presumably until 2016-02-03, with intended 0 refill(s). Instructions: take 1 Tab by mouth 4 times a day for 10 days\n- 100 ML potassium chloride 0.1 MEQ/ML Injection, through Intravenous route, started on 2016-01-30, presumably until 2016-01-30\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2016-01-31, presumably until 2016-02-03\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2016-01-30, presumably until 2016-02-03\n- lidocaine 40 MG/ML Topical Cream, through Topical route, started on 2016-02-02, presumably until 2016-02-02\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2016-01-30, presumably until 2016-02-01\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2016-01-30, presumably until 2016-01-30\n- cyclobenzaprine hydrochloride 5 MG Oral Tablet, through Oral route, started on 2016-02-01, presumably until 2016-06-01, with intended 0 refill(s). Instructions: Take 1 to 2 tabs PO q8h PRN muscle spasma\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2016-02-02, presumably until 2016-02-02\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2016-02-02, presumably until 2016-05-08, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day\n- omeprazole 40 MG Delayed Release Oral Capsule, through Oral route, started on 2015-08-20, presumably until 2016-05-05, with intended 0 refill(s). Instructions: take 1 Lebow by mouth every morning\n- nystatin 100000 UNT/ML Oral Suspension, through Oral route, presumably until 2016-02-13, with intended 0 refill(s). Instructions: 500,000 Units by Swish & Swallow route 3 times a day as needed (mouth sores.)\n- oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2016-02-03, presumably until 2016-06-18, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain\n- cyclobenzaprine hydrochloride 10 MG Oral Tablet, through Oral route, started on 2016-02-02, presumably until 2016-02-03\n- dronabinol 5 MG Oral Capsule, through Oral route, started on 2016-01-30, presumably until 2016-02-02\n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, presumably until 2016-06-29, with intended 0 refill(s). Instructions: 2 Puffs by Inhalation route every 4 hours as needed\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2016-02-03, presumably until 2016-05-08, with intended 0 refill(s). Instructions: take 1 Packet by mouth daily as needed\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2016-01-30, presumably until 2016-01-30\n- cefepime 2000 MG Injection, through Intravenous route, started on 2016-01-30, presumably until 2016-01-30\n- 2 ML ondansetron 2 MG/ML Injection, started on 2016-01-30, presumably until 2016-02-01\n- magnesium sulfate 20 MG/ML Injection, through Intravenous route, started on 2016-01-30, presumably until 2016-02-01\n- loratadine 10 MG Oral Tablet, through Oral route, started on 2016-01-31, presumably until 2016-02-02\n- sorafenib 200 MG Oral Tablet, through Oral route, started on 2016-01-30, presumably until 2016-02-02\n- glucose 50 MG/ML Injection, through Intravenous route, started on 2016-01-30, presumably until 2016-01-30\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2016-02-01, presumably until 2016-02-02\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2016-02-02, presumably until 2016-02-13, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 10 days\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2016-01-30, presumably until 2016-01-30\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-02-04 00:00:00, ended at 2016-02-04 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-02-04 00:00:00, ended at 2016-02-04 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-02-04 13:49:57, ended at 2016-02-04 13:50:08\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute leukemia in remission\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-02-09 13:49:27, ended at 2016-02-09 13:49:40\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute leukemia in remission\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-02-13 11:30:00, ended at 2016-02-13 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 93 (unit per liter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 10.4 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 37 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.1 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.6 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.4 (picogram)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Manual count: 3.00 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.1 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 92.1 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Leukocytes [#/volume] in Body fluid by Manual count: 6 (milli-international unit per milliliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.82 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 303 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.32 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 125 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 33 (percent)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Pancytopenia\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-02-13 12:13:42, ended at 2016-02-13 13:28:05\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute leukemia in remission\n\n### Drug\n- dronabinol 5 MG Oral Capsule, through Oral route, presumably until 2016-07-20, with intended 0 refill(s). Instructions: take 5 mg by mouth every bedtime as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-02-27 00:00:00, ended at 2016-02-27 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- prednisolone acetate 10 MG/ML Ophthalmic Suspension, started on 2016-03-07, presumably until 2016-03-13, with intended 2 refill(s). Instructions: Instill 1 drop to both eyes 4 x per day starting 12 hrs prior to 1st dose of chemo (3/13) until 12 hrs after last dose (3/19).\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-02-27 11:36:00, ended at 2016-02-27 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- MCH [Entitic mass] by Automated count: 31.7 (picogram)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 12 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.2 (percent)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.2 (percent)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.9 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 67 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.19 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 11.8 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 28.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.40 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.9 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 57.4 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.73 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.70 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 227 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 135 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.5 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.60 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.1 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pancytopenia\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-02-27 11:57:50, ended at 2016-02-27 15:46:04\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute leukemia in remission\n\n### Drug\n- sorafenib 200 MG Oral Tablet, through Oral route, started on 2016-02-27, presumably until 2016-04-13, with intended 3 refill(s). Instructions: take 2 Tabs by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-02-27 14:59:22, ended at 2016-02-27 14:59:34\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute leukemia in remission\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-03-07 09:10:00, ended at 2016-03-07 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.2 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.5 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 49.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 213 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 55 (unit per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.0 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.6 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.4 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 31.2 (percent)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.54 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.48 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.8 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.35 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.84 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 114 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.29 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 95.3 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 54 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.7 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-03-08 07:04:00, ended at 2016-03-08 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 5.165\" (inch (US))\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Acute leukemia in remission\n\n### Drug\n- cytarabine 20 MG/ML Injectable Solution, started on 2016-03-08, presumably until 2016-03-08\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2016-03-08, presumably until 2016-05-05, with intended 4 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2016-03-08, presumably until 2016-03-08\n- dexamethasone 2 MG Oral Tablet, through Oral route, started on 2016-03-08, presumably until 2016-03-08\n- prochlorperazine 10 MG Oral Tablet, through Oral route, started on 2016-03-08, presumably until 2016-05-05, with intended 4 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Nausea/Vomiting\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-03-10 07:03:00, ended at 2016-03-10 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 5.165\" (inch (US))\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n\n### Condition\n- Acute leukemia in remission\n\n### Drug\n- cytarabine 20 MG/ML Injectable Solution, started on 2016-03-10, presumably until 2016-03-10\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2016-03-10, presumably until 2016-03-10\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2016-03-10, presumably until 2016-03-10\n- dexamethasone 2 MG Oral Tablet, through Oral route, started on 2016-03-10, presumably until 2016-03-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-03-12 07:06:00, ended at 2016-03-12 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 5.165\" (inch (US))\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Acute leukemia in remission\n\n### Drug\n- cytarabine 20 MG/ML Injectable Solution, started on 2016-03-12, presumably until 2016-03-12\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2016-03-12, presumably until 2016-03-12\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2016-03-12, presumably until 2016-03-12\n- dexamethasone 2 MG Oral Tablet, through Oral route, started on 2016-03-12, presumably until 2016-03-12\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-03-12, presumably until 2016-03-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-03-19 12:10:33, ended at 2016-03-19 15:02:25\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute leukemia in remission\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-03-23 08:10:00, ended at 2016-03-23 12:42:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.9 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 1.0 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 89 (unit per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.89 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 89.2 (percent)\n- Platelets [#/volume] in Blood by Automated count: 19 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 81 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 145 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.1 (percent)\n- MCH [Entitic mass] by Automated count: 31.3 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 7.9 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 7.9 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.2 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.88 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 90.2 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-03-23 12:43:00, ended at 2016-03-23 13:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 57.7 (percent)\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Disorder due to and following accidental poisoning\n- Disorder due to and following drug poisoning\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-03-23 13:30:36, ended at 2016-03-23 13:30:52\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute leukemia in remission\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-03-23 14:00:00, ended at 2016-03-23 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n- Diffusing capacity (eg, carbon monoxide, membrane) (List separately in addition to code for primary procedure)\n\n### Condition\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-04-06 13:47:00, ended at 2016-04-06 14:52:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atelectasis\n- Acute leukemia in remission\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-04-06 14:53:00, ended at 2016-04-06 15:25:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Atelectasis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-04-06 15:26:00, ended at 2016-04-06 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.72 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 326 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 127.9 (second)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.3 (percent)\n- Leukocytes [#/volume] in Body fluid by Manual count: 1 (milli-international unit per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 73 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.1 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.43 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 155 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.2 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 48 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- MCHC [Mass/volume] by Automated count: 34.8 (gram per deciliter)\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 28 (nanogram per milliliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Monocytes [#/volume] in Blood by Manual count: 0.57 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.7 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 1.71 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 79 (unit per liter)\n- MCH [Entitic mass] by Automated count: 32.4 (picogram)\n- Prothrombin time (PT): 14.3 (second)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 28 (nanogram per milliliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 30 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n\n### Procedure\n- Decalcification procedure (List separately in addition to code for surgical pathology examination)\n- Diagnostic bone marrow; biopsy(ies)\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n\n### Condition\n- Acute myeloid leukemia, disease\n- Anemia\n\n### Drug\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2016-04-06, presumably until 2016-04-06\n- hydromorphone hydrochloride 2 MG Oral Tablet, through Oral route, started on 2016-04-06, presumably until 2016-04-06\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-04-08 14:26:37, ended at 2016-04-08 15:56:32\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 3.984\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute myeloid leukemia, disease\n\n### Drug\n- phenytoin sodium 100 MG Extended Release Oral Capsule, through Oral route, started on 2016-04-08, presumably until 2016-05-08, with intended 0 refill(s). Instructions: take 3 Caps by mouth 3 times a day Take on day of admission\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-04-09 08:20:00, ended at 2016-04-09 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 92 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 170 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 75 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.1 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.5 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 26 (percent)\n- Monocytes [#/volume] in Blood by Manual count: 1.06 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 31.4 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.6 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 1.46 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.69 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 19 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.71 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Leukocytes [#/volume] in Body fluid by Manual count: 1 (milli-international unit per milliliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 42 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 11.6 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 93.6 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 46 (percent)\n- Platelets [#/volume] in Blood by Automated count: 240 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Pancytopenia\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-04-09 09:22:00, ended at 2016-04-09 10:35:08\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute leukemia in remission\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2016-04-13 17:02:00, ended at 2016-05-08 11:20:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 90 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.92 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Glucose [Mass/volume] in Blood: 227 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 363 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 82 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 9.1 (nanogram per milliliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection: <135 (international unit per milliliter)\n- Lactate [Moles/volume] in Blood: 0.9 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 95.7 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.95 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 91.8 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 39 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 8.8 (percent)\n- Leukocytes [#/volume] in Body fluid by Manual count: 2 (milli-international unit per milliliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.3 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.49 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.1 (picogram)\n- MCHC [Mass/volume] by Automated count: 35.4 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.2 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 6.72 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Body height: 6' 3.787\" (inch (US))\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 94 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.01 (million per microliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.4 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 295 (unit per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.84 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Haptoglobin [Mass/volume] in Serum or Plasma: 124 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.1 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.5 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 55 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 3 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.19 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.4 (percent)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.4 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.06 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 1.50 (thousand per microliter)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 7.1 (microgram per milliliter)\n\n### Procedure\n- Introduction of Other Antineoplastic into Central Vein, Percutaneous Approach\n- Transplant preparation of hematopoietic progenitor cells; cell concentration in plasma, mononuclear, or buffy coat layer\n- Medical nutrition therapy; re-assessment and intervention, individual, face-to-face with the patient, each 15 minutes\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Physical therapy evaluation\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Collection of venous blood by venipuncture\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Hospital discharge day management; more than 30 minutes\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Transfusion of Nonautologous Hematopoietic Stem Cells into Central Vein, Percutaneous Approach (Deprecated)\n- Hematopoietic progenitor cell (HPC); allogeneic transplantation per donor\n\n### Condition\n- Acute myeloid leukemia, disease\n- Nasal congestion\n- Backache\n- ABO incompatibility reaction\n- Muscle pain\n- Type 2 diabetes mellitus without complication\n- Atelectasis\n- Constipation\n- Disorder of nasal cavity\n- Hypo-osmolality and or hyponatremia\n- Smoke inhalation injury\n- Nausea and vomiting\n- Oral ulcerative mucositis due to antineoplastic therapy\n- Chronic pain\n- Chronic rhinitis\n- Disturbance of salivary secretion\n- Fever\n- Pancytopenia due to antineoplastic chemotherapy\n- Primary diagnosis: Acute leukemia in remission\n- Candidiasis of mouth\n- Hypervolemia\n- Neutropenia\n- Pulmonary embolism\n- Deficiency of macronutrients\n- Diarrhea\n\n### Drug\n- hydrocortisone 100 MG Injection, started on 2016-04-21, presumably until 2016-04-21\n- dronabinol 2.5 MG Oral Capsule, through Oral route, started on 2016-04-13, presumably until 2016-05-07\n- fluconazole 200 MG Oral Tablet, through Oral route, started on 2016-05-03, presumably until 2016-07-13, with intended 3 refill(s). Instructions: take 2 Tabs by mouth daily\n- famotidine 20 MG Oral Tablet, through Oral route, started on 2016-04-13, presumably until 2016-05-08\n- loperamide hydrochloride 2 MG Oral Capsule, through Oral route, started on 2016-04-27, presumably until 2016-05-02\n- vancomycin 1000 MG Injection, through Intravenous route, started on 2016-05-01, presumably until 2016-05-02\n- pseudoephedrine hydrochloride 30 MG Oral Tablet, through Oral route, started on 2016-04-19, presumably until 2016-04-20\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2016-04-19, presumably until 2016-04-21\n- 2 ML prochlorperazine 5 MG/ML Injection, started on 2016-04-16, presumably until 2016-05-07\n- acyclovir 400 MG Oral Tablet, through Oral route, started on 2016-04-13, presumably until 2016-06-10, with intended 12 refill(s). Instructions: take 1 Tab by mouth 3 times a day\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2016-04-19, presumably until 2016-04-22\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2016-04-24, presumably until 2016-04-27\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2016-05-05, presumably until 2016-07-15, with intended 4 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed\n- phenytoin sodium 100 MG Extended Release Oral Capsule, through Oral route, started on 2016-04-14, presumably until 2016-04-17\n- diphenhydramine hydrochloride 2.5 MG/ML Oral Solution, through Oral route, started on 2016-04-26, presumably until 2016-05-06\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2016-05-03, presumably until 2016-07-15, with intended 6 refill(s). Instructions: Take as directed twice a day per BMT team\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2016-04-19, presumably until 2016-04-24\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2016-04-26, presumably until 2016-04-26\n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2016-04-13, presumably until 2016-05-18, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 10 days\n- clotrimazole 10 MG Oral Lozenge, through Submucosal route, started on 2016-04-23, presumably until 2016-05-01\n- 0.8 ML enoxaparin sodium 150 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2016-04-14, presumably until 2016-04-16\n- 1 ML hydralazine hydrochloride 20 MG/ML Injection, started on 2016-04-24, presumably until 2016-04-24\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2016-04-27, presumably until 2016-05-08, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n- dibucaine 0.01 MG/MG Topical Ointment, through Topical route, started on 2016-04-28, presumably until 2016-04-29\n- omeprazole 40 MG Delayed Release Oral Capsule, through Oral route, started on 2016-05-05, presumably until 2016-06-09, with intended 2 refill(s). Instructions: take 40 mg by mouth every morning\n- nystatin 100000 UNT/ML Oral Suspension, through Oromucosal route, started on 2016-05-01, presumably until 2016-05-07, with intended 0 refill(s). Instructions: 10 mL by Swish & Spit route 4 times a day\n- cholecalciferol 0.025 MG Oral Tablet, through Oral route, started on 2016-04-24, presumably until 2016-05-08\n- 10 ML furosemide 10 MG/ML Injection, started on 2016-04-18, presumably until 2016-04-21\n- ursodiol 300 MG Oral Capsule, through Oral route, started on 2016-04-14, presumably until 2016-07-15, with intended 2 refill(s). Instructions: take 2 Caps by mouth 2 times a day\n- ciprofloxacin 100 MG/ML Oral Suspension, through Oral route, started on 2016-04-27, presumably until 2016-05-07\n- 2 ML famotidine 10 MG/ML Injection, through Intravenous route, started on 2016-04-27, presumably until 2016-05-05\n- atropine sulfate 0.025 MG / diphenoxylate hydrochloride 2.5 MG Oral Tablet, through Oral route, started on 2016-04-30, presumably until 2016-04-30\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2016-05-03, presumably until 2016-05-14, with intended 3 refill(s). Instructions: 3 mL by Intravenous route every bedtime as needed ( Flush each catheter lumen if not in use.)\n- cefepime 2000 MG Injection, through Intravenous route, started on 2016-05-01, presumably until 2016-05-06\n- prochlorperazine 10 MG Oral Tablet, through Oral route, started on 2016-05-05, presumably until 2016-07-15, with intended 4 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Nausea/Vomiting\n- olanzapine 5 MG Disintegrating Oral Tablet, through Oral route, started on 2016-04-20, presumably until 2016-05-07\n- 1000 ML potassium chloride 0.02 MEQ/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-05-06, presumably until 2016-05-08\n- tacrolimus 0.5 MG Oral Capsule, started on 2016-05-03, presumably until 2016-11-02, with intended 6 refill(s). Instructions: Take as directed twice a day per BMT team.\n- 2 ML ondansetron 2 MG/ML Injection, started on 2016-05-07, presumably until 2016-05-07\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2016-04-19, presumably until 2016-05-01\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2016-05-03, presumably until 2016-05-03\n- lidocaine hydrochloride 20 MG/ML Mucous Membrane Topical Solution, through Submucosal route, started on 2016-04-26, presumably until 2016-05-06\n- magnesium sulfate 20 MG/ML Injection, through Intravenous route, started on 2016-04-18, presumably until 2016-05-06\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2016-06-02, presumably until 2016-12-01, with intended 6 refill(s). Instructions: take 1 Tab by mouth daily in the morning\n- 200 ML fluconazole 2 MG/ML Injection, through Intravenous route, started on 2016-04-22, presumably until 2016-05-04\n- glucose 50 MG/ML Injection, through Intravenous route, started on 2016-05-01, presumably until 2016-05-06\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2016-04-19, presumably until 2016-04-30\n- rivaroxaban 10 MG Oral Tablet, through Oral route, presumably until 2016-05-08, with intended 0 refill(s). Instructions: take 10 mg by mouth\n- 72 HR scopolamine 0.0139 MG/HR Transdermal System, through Transdermal route, started on 2016-04-16, presumably until 2016-04-25\n- aluminum hydroxide 40 MG/ML / magnesium hydroxide 40 MG/ML / simethicone 4 MG/ML Oral Suspension, through Oral route, started on 2016-04-20, presumably until 2016-05-06\n- sodium chloride 6.5 MG/ML Nasal Spray, through Nasal route, started on 2016-04-29, presumably until 2016-04-29\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2016-04-25, presumably until 2016-05-06\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-04-19 00:00:00, ended at 2016-04-19 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-04-19 15:29:59, ended at 2016-04-19 15:30:13\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-05-09 13:00:00, ended at 2016-05-09 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 78 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.30 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 38.3 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.0 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.09 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.4 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.8 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 0.70 (thousand per microliter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.0 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.4 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 1.6 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.61 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 50 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 44.3 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 167 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.25 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.5 (picogram)\n\n### Procedure\n- Intravenous infusion, hydration; initial, 31 minutes to 1 hour\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Acute myeloid leukemia, disease\n- Acute leukemia in remission\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2016-05-09, presumably until 2016-05-09\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-05-09, presumably until 2016-05-09\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-05-10 11:57:00, ended at 2016-05-10 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 28 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 71 (unit per liter)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.5 (percent)\n- Monocytes [#/volume] in Blood by Manual count: 0.54 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 5.0 (nanogram per milliliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14 (percent)\n- MCV [Entitic volume] by Automated count: 93.9 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.7 (percent)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.25 (thousand per microliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 28 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.02 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 148 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 1.8 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.7 (picogram)\n- Neutrophils/100 leukocytes in Blood by Manual count: 44 (percent)\n- Platelets [#/volume] in Blood by Automated count: 57 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.08 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.05 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 30 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n\n### Procedure\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n- Intravenous infusion, hydration; initial, 31 minutes to 1 hour\n- Medical nutrition therapy; re-assessment and intervention, individual, face-to-face with the patient, each 15 minutes\n\n### Condition\n- Acute leukemia in remission\n- Acute myeloid leukemia, disease\n\n### Drug\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2016-05-10, presumably until 2016-05-10\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-05-10, presumably until 2016-05-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-05-12 07:46:00, ended at 2016-05-12 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 77 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 1.9 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.92 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.14 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.3 (percent)\n- MCH [Entitic mass] by Automated count: 31.9 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 118 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.25 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.08 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.1 (percent)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4 (percent)\n- Monocytes [#/volume] in Blood by Manual count: 0.82 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 8.0 (nanogram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- MCV [Entitic volume] by Automated count: 93.6 (femtoliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 10.0 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 13 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 43 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 36 (percent)\n- Platelets [#/volume] in Blood by Automated count: 74 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n\n### Procedure\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Medical nutrition therapy; re-assessment and intervention, individual, face-to-face with the patient, each 15 minutes\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); concurrent infusion (List separately in addition to code for primary procedure)\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Acute leukemia in remission\n- Acute myeloid leukemia, disease\n\n### Drug\n- ergocalciferol 1.25 MG Oral Capsule, through Oral route, started on 2016-05-12, presumably until 2016-05-12, with intended 0 refill(s). Instructions: take 1 Cap by mouth every 7 days\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-05-12, presumably until 2016-05-12\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2016-05-12, presumably until 2016-05-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-05-14 09:50:00, ended at 2016-05-14 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 91 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 120 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.61 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.16 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.9 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 2.1 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.21 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10 (percent)\n- MCV [Entitic volume] by Automated count: 95.7 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 29 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.23 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 92 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 8.1 (nanogram per milliliter)\n- MCH [Entitic mass] by Automated count: 32.4 (picogram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 10.5 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.0 (percent)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.02 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 43 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n\n### Procedure\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n\n### Condition\n- Acute leukemia in remission\n- Acute myeloid leukemia, disease\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2016-05-14, presumably until 2016-05-14\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2016-05-14, presumably until 2016-11-02, with intended 0 refill(s). Instructions: take 0.5 Tabs by mouth every 4 hours as needed\n- 2 ML ondansetron 2 MG/ML Injection, started on 2016-05-14, presumably until 2016-05-14\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-05-14, presumably until 2016-05-14\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2016-05-14, presumably until 2016-05-14\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-05-17 07:40:00, ended at 2016-05-17 08:16:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.3 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 40 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.0 (picogram)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 77 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Body height: 6' 3.984\" (inch (US))\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.3 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.28 (million per microliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.89 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Leukocytes [#/volume] in Body fluid by Manual count: 1 (milli-international unit per milliliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 106 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.08 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 21 (percent)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 121 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.46 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.16 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 7 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 2.2 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 95.5 (femtoliter)\n- Tacrolimus [Mass/volume] in Blood: 12.2 (nanogram per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 10.5 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 22 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Collection of venous blood by venipuncture\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Acute leukemia in remission\n- Nausea\n- Acute myeloid leukemia, disease\n\n### Drug\n- 2 ML ondansetron 2 MG/ML Injection, started on 2016-05-17, presumably until 2016-05-17\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-05-17, presumably until 2016-05-17\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-05-17 08:17:00, ended at 2016-05-17 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-05-19 08:10:00, ended at 2016-05-19 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Serum or Plasma: 117 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 122 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.8 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.57 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 21.2 (percent)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 79 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.15 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 2.7 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.7 (percent)\n- IgG [Mass/volume] in Serum or Plasma: 887 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.2 (percent)\n- MCV [Entitic volume] by Automated count: 95.7 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.77 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 1.15 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 9.2 (nanogram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.36 (million per microliter)\n- MCH [Entitic mass] by Automated count: 32.2 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 28.7 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.14 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 43.1 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n\n### Procedure\n- Medical nutrition therapy; re-assessment and intervention, individual, face-to-face with the patient, each 15 minutes\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acute myeloid leukemia, disease\n- Acute leukemia in remission\n- Blepharitis\n\n### Drug\n- azithromycin 10 MG/ML Ophthalmic Solution, through Intraocular route, started on 2016-05-19, presumably until 2016-05-26, with intended 1 refill(s). Instructions: instill 1 Drop to both eyes 3 times a day\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2016-05-19, presumably until 2016-07-20, with intended 6 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-05-21 07:40:00, ended at 2016-05-21 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 1.42 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6 (percent)\n- Eosinophils [#/volume] in Blood by Manual count: 0.17 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.8 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 170 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 79 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 2.9 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.04 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 36 (percent)\n- Tacrolimus [Mass/volume] in Blood: 10.3 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 96.0 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 39 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.45 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.5 (picogram)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.1 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 11.2 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.52 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 117 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n\n### Procedure\n- Medical nutrition therapy; re-assessment and intervention, individual, face-to-face with the patient, each 15 minutes\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Acute myeloid leukemia, disease\n- Disorder of transplanted bone marrow\n- Acute leukemia in remission\n\n### Drug\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-05-21, presumably until 2016-05-21\n- magnesium sulfate 20 MG/ML Injection, through Intravenous route, started on 2016-05-21, presumably until 2016-05-21\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2016-05-21, presumably until 2016-05-21\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2016-05-24 00:00:00, ended at 2016-05-24 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anogenital herpesviral infection\n- Blepharitis\n- Blepharitis of left eyelid\n- Primary diagnosis: Neutropenia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-05-24 09:20:00, ended at 2016-05-24 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 171 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 96.9 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 8.6 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.1 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.45 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.38 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.3 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 97 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.29 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.8 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.64 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19.3 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 43.0 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection: <135 (international unit per milliliter)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 28.2 (percent)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 21.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 1.43 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 85 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.94 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.7 (picogram)\n- Tacrolimus [Mass/volume] in Blood: 9.1 (nanogram per milliliter)\n\n### Procedure\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n- Intravenous infusion, hydration; initial, 31 minutes to 1 hour\n\n### Condition\n- Blepharitis\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-05-26 08:40:00, ended at 2016-05-26 11:16:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.54 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.31 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 50 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 9 (percent)\n- Platelets [#/volume] in Blood by Automated count: 61 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 21.8 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 174 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.5 (percent)\n- MCH [Entitic mass] by Automated count: 33.6 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 98.2 (femtoliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.02 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 30 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 44 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 99 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 11.1 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 10.6 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.54 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.31 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 357 (unit per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.4 (thousand per microliter)\n\n### Procedure\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); concurrent infusion (List separately in addition to code for primary procedure)\n- Medical nutrition therapy; re-assessment and intervention, individual, face-to-face with the patient, each 15 minutes\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Acute myeloid leukemia, disease\n- Acute leukemia in remission\n\n### Drug\n- azithromycin 10 MG/ML Ophthalmic Solution, through Intraocular route, started on 2016-05-26, presumably until 2016-06-10, with intended 6 refill(s). Instructions: instill 1 Drop to both eyes 3 times a day\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-05-26, presumably until 2016-05-26\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2016-05-26, presumably until 2016-05-26\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-05-26 11:17:00, ended at 2016-05-26 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Acute leukemia in remission\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2016-05-28 00:00:00, ended at 2016-05-28 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anogenital herpesviral infection\n- Neutropenia\n- Primary diagnosis: Acute leukemia in remission\n- Cytomegalovirus infection\n- Blepharitis\n- Blepharitis of left eyelid\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-05-28 09:10:00, ended at 2016-05-28 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.36 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.9 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 47.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 99 (unit per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 26.4 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 44 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.30 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.7 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 52 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 22.2 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 129 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 1.95 (thousand per microliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.1 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.69 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 98.7 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 57 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 1.09 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.56 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 8.7 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.8 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 10.4 (nanogram per milliliter)\n\n### Procedure\n- Intravenous infusion, hydration; initial, 31 minutes to 1 hour\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary diagnosis: Acute leukemia in remission\n- Acute myeloid leukemia, disease\n\n### Drug\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-05-28, presumably until 2016-05-28\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-05-31 07:50:00, ended at 2016-05-31 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Eosinophils/100 leukocytes in Blood by Automated count: 10.6 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.93 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 21.1 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 53.3 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 21.8 (percent)\n- MCH [Entitic mass] by Automated count: 33.4 (picogram)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 154 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.60 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.84 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.47 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 13.7 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 121 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 56 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.7 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.3 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.35 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 9.4 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 63 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.39 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.4 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 99.5 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 41 (thousand per microliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection: <135 (international unit per milliliter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n\n### Procedure\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n\n### Condition\n- Acute myeloid leukemia, disease\n- Acute leukemia in remission\n- Primary diagnosis: Anogenital herpesviral infection\n\n### Drug\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-05-31, presumably until 2016-05-31\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-06-03 00:00:00, ended at 2016-06-03 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-06-03 08:50:00, ended at 2016-06-03 19:34:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 76 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 113 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.27 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.52 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.81 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.4 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 21.9 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.28 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.2 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.85 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.54 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 122 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 20.1 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 82 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.8 (percent)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 32 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 11.0 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 60.2 (percent)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 12.2 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 133 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.5 (picogram)\n- MCV [Entitic volume] by Automated count: 99.9 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 9.9 (nanogram per milliliter)\n\n### Procedure\n- Intravenous infusion, hydration; initial, 31 minutes to 1 hour\n- Collection of venous blood by venipuncture\n- Medical nutrition therapy; re-assessment and intervention, individual, face-to-face with the patient, each 15 minutes\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Neutropenia\n- Acute myeloid leukemia, disease\n- Acute leukemia in remission\n\n### Drug\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-06-03, presumably until 2016-06-03\n- nystatin 100 UNT/MG Topical Powder, through Topical route, started on 2016-06-03, presumably until 2016-06-09, with intended 1 refill(s). Instructions: by Topical route 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2016-06-03 19:35:00, ended at 2016-06-10 14:28:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 158 (unit per liter)\n- Body height: 6' 5\" (inch (US))\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection: 1028 (international unit per milliliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 21.9 (percent)\n- Glucose [Mass/volume] in Blood: 366 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.4 (picogram)\n- MCV [Entitic volume] by Automated count: 104.7 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.77 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.02 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.61 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.31 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 8.6 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 156 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.73 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.50 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 87.2 (percent)\n- Cytomegalovirus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection: 3.01 (log international unit per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.1 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 49 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.4 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 97 (unit per liter)\n- Base excess in Blood by calculation: -4 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 325 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.5 (percent)\n- IgG [Mass/volume] in Serum or Plasma: 914 (milligram per deciliter)\n- Leukocytes [#/volume] in Body fluid by Manual count: 3 (milli-international unit per milliliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 68 (thousand per microliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 98 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Eosinophils [#/volume] in Blood by Manual count: 0.40 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.6 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 9.1 (nanogram per milliliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.25 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 185 (unit per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.4 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.1 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.78 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 10.6 (microgram per milliliter)\n\n### Procedure\n- Excision of Duodenum, Via Natural or Artificial Opening Endoscopic, Diagnostic\n- Insertion of peripherally inserted central venous catheter (PICC), without subcutaneous port or pump, without imaging guidance; age 5 years or older\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Computed tomography, thorax, diagnostic; without contrast material\n- Sigmoidoscopy, flexible; with biopsy, single or multiple\n- Computed tomography, abdomen and pelvis; without contrast material\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Collection of venous blood by venipuncture\n- Excision of Stomach, Via Natural or Artificial Opening Endoscopic, Diagnostic\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Sigmoidoscopy, flexible; with control of bleeding, any method\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Physical therapy evaluation\n- Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple\n- Ultrasound, abdominal, real time with image documentation; limited (eg, single organ, quadrant, follow-up)\n- Excision of Sigmoid Colon, Via Natural or Artificial Opening Endoscopic, Diagnostic\n\n### Condition\n- Blepharitis\n- Duodenitis\n- Elevated level of transaminase and lactic acid dehydrogenase\n- Erythema of skin\n- Uncomplicated asthma\n- Amblyopia\n- Ascites\n- Atelectasis\n- Chronic ulcer of foot\n- Hepatosplenomegaly\n- Blepharitis of left eyelid\n- Dehydration\n- Diarrhea\n- Hypomagnesemia\n- Nausea\n- Pancytopenia due to antineoplastic chemotherapy\n- Acute renal failure syndrome\n- Conjunctivitis\n- Hyperglycemia\n- Large liver\n- Nausea and vomiting\n- Secondary hypertension\n- Viral enteritis\n- Acute leukemia in remission\n- Fever\n- Taste sense altered\n- Disorder of gallbladder\n- Neutropenia\n- Cytomegalovirus infection\n- Diaphragmatic hernia\n- Visual field defect\n- Residual hemorrhoidal skin tags\n- Acute myeloid leukemia, disease\n\n### Drug\n- dronabinol 2.5 MG Oral Capsule, through Oral route, started on 2016-06-03, presumably until 2016-06-09\n- fluconazole 200 MG Oral Tablet, through Oral route, started on 2016-06-05, presumably until 2016-06-10\n- codeine phosphate 2 MG/ML / guaifenesin 20 MG/ML Oral Solution, through Oral route, started on 2016-06-06, presumably until 2016-06-06\n- phenol 14 MG/ML Mucosal Spray, through Submucosal route, started on 2016-06-06, presumably until 2016-06-06\n- methylprednisolone 40 MG Injection, started on 2016-06-06, presumably until 2016-06-08\n- acyclovir 400 MG Oral Tablet, through Oral route, started on 2016-06-03, presumably until 2016-06-06\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2016-06-05, presumably until 2016-06-09\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2016-06-07, presumably until 2016-06-08\n- ganciclovir 500 MG Injection, through Intravenous route, started on 2016-06-06, presumably until 2016-06-10\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2016-06-05, presumably until 2016-06-10\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2016-06-03, presumably until 2016-06-09\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2016-06-04, presumably until 2016-06-05\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2016-06-09, presumably until 2016-07-15, with intended 0 refill(s). Instructions: take 8 Tabs by mouth daily Follow provider instructions regarding decrease in dose\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2016-06-07, presumably until 2016-06-07\n- clotrimazole 10 MG Oral Lozenge, through Submucosal route, started on 2016-06-05, presumably until 2016-06-06\n- baclofen 10 MG Oral Tablet, through Oral route, started on 2016-06-07, presumably until 2016-08-13, with intended 0 refill(s). Instructions: take 1 Tab by mouth 3 times a day as needed (Hiccups)\n- omeprazole 40 MG Delayed Release Oral Capsule, through Oral route, started on 2016-06-09, presumably until 2016-12-01, with intended 2 refill(s). Instructions: take 40 mg by mouth 2 times a day\n- nystatin 100000 UNT/ML Oral Suspension, through Oral route, started on 2016-06-07, presumably until 2016-06-25, with intended 0 refill(s). Instructions: 5 mL by Swish & Swallow route 4 times a day\n- ursodiol 300 MG Oral Capsule, through Oral route, started on 2016-06-03, presumably until 2016-06-10\n- bacitracin 0.5 UNT/MG / polymyxin B 10 UNT/MG Topical Ointment, through Topical route, started on 2016-06-06, presumably until 2016-06-22, with intended 0 refill(s). Instructions: Apply a thin layer to right 5th toe ulcer BID\n- cefepime 2000 MG Injection, through Intravenous route, started on 2016-06-03, presumably until 2016-06-08\n- prochlorperazine 10 MG Oral Tablet, through Oral route, started on 2016-06-05, presumably until 2016-06-08\n- 1000 ML potassium chloride 0.02 MEQ/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-06-03, presumably until 2016-06-10\n- hypromellose 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2016-06-05, presumably until 2016-06-25, with intended 0 refill(s). Instructions: instill 1 Drop to both eyes 4 times a day as needed\n- tacrolimus 0.5 MG Oral Capsule, through Oral route, started on 2016-06-05, presumably until 2016-06-10\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2016-06-03, presumably until 2016-06-07\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-06-04, presumably until 2016-06-04\n- sucralfate 100 MG/ML Oral Suspension, through Oral route, started on 2016-06-06, presumably until 2016-06-25, with intended 0 refill(s). Instructions: take 10 mL by mouth every 6 hours as needed (Stomach upset)\n- prednisone 50 MG Oral Tablet, through Oral route, started on 2016-06-09, presumably until 2016-06-10\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2016-06-05, presumably until 2016-06-10\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2016-06-03, presumably until 2016-06-10\n- glucose 50 MG/ML Injection, through Intravenous route, started on 2016-06-03, presumably until 2016-06-08\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2016-06-05, presumably until 2016-06-06\n- nystatin 100 UNT/MG Topical Powder, through Topical route, started on 2016-06-04, presumably until 2016-06-25, with intended 1 refill(s). Instructions: Apply to affected areas in groin & axilla twice a day\n- prednisone 20 MG Oral Tablet, through Oral route, started on 2016-06-09, presumably until 2016-06-09\n- ondansetron 8 MG Disintegrating Oral Tablet, through Oral route, started on 2016-06-05, presumably until 2016-06-10\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2016-06-04, presumably until 2016-06-09\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-06-04 00:00:00, ended at 2016-06-04 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Nausea and vomiting\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-06-04 00:00:00, ended at 2016-06-04 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2016-06-04 00:00:00, ended at 2016-06-04 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2016-06-04, presumably until 2016-06-04\n- midazolam 1 MG/ML Injectable Solution, started on 2016-06-04, presumably until 2016-06-04\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-06-11 15:20:00, ended at 2016-06-11 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- MCV [Entitic volume] by Automated count: 104.5 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 66 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 5.2 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 122 (unit per liter)\n- Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection: 805 (international unit per milliliter)\n- Glucose [Mass/volume] in Serum or Plasma: 250 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.8 (percent)\n- MCH [Entitic mass] by Automated count: 33.7 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 64 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 12.5 (gram per deciliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.2 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 67 (percent)\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 35 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Cytomegalovirus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection: 2.91 (log international unit per milliliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.1 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.87 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.71 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 7.6 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 21.4 (percent)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.98 (thousand per microliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 35 (nanogram per milliliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.24 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.0 (gram per deciliter)\n\n### Procedure\n- Medical nutrition therapy; re-assessment and intervention, individual, face-to-face with the patient, each 15 minutes\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n- Intravenous infusion, hydration; initial, 31 minutes to 1 hour\n- Collection of venous blood by venipuncture\n\n### Condition\n- Cytomegalovirus infection\n- Acute leukemia in remission\n- Acute myeloid leukemia, disease\n\n### Drug\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-06-11, presumably until 2016-06-11\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-06-14 16:00:00, ended at 2016-06-14 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.91 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.21 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.4 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 132 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 76.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 37 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.1 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.9 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 118 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.66 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 251 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 103.4 (femtoliter)\n- Tacrolimus [Mass/volume] in Blood: 6.0 (nanogram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 22.9 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.8 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.89 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.68 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.0 (percent)\n- MCH [Entitic mass] by Automated count: 34.8 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.5 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n\n### Procedure\n- Medical nutrition therapy; re-assessment and intervention, individual, face-to-face with the patient, each 15 minutes\n- Intravenous infusion, hydration; initial, 31 minutes to 1 hour\n- Collection of venous blood by venipuncture\n\n### Condition\n- Cytomegalovirus infection\n- Acute leukemia in remission\n\n### Drug\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-06-14, presumably until 2016-06-14\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-06-16 15:47:00, ended at 2016-06-16 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.80 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.3 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.7 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 12.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 105.5 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 3.3 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.65 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 28 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 6.6 (nanogram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 40 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 116 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.4 (percent)\n- MCH [Entitic mass] by Automated count: 33.8 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 290 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.1 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 22.4 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 80.7 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.3 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.74 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.52 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n\n### Procedure\n- Intravenous infusion, hydration; initial, 31 minutes to 1 hour\n- Medical nutrition therapy; re-assessment and intervention, individual, face-to-face with the patient, each 15 minutes\n\n### Condition\n- Acute leukemia in remission\n\n### Drug\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-06-16, presumably until 2016-06-16\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-06-18 09:26:00, ended at 2016-06-18 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Acute myeloid leukemia, disease\n- Acute leukemia in remission\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-06-22 11:30:00, ended at 2016-06-22 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 106.7 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 2.5 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 86.3 (percent)\n- Platelets [#/volume] in Blood by Automated count: 31 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.77 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.0 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 34.9 (picogram)\n- Tacrolimus [Mass/volume] in Blood: 6.4 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 22 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.77 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 21.9 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.10 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.43 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection: <135 (international unit per milliliter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 283 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 42 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 112 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.9 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.43 (thousand per microliter)\n\n### Procedure\n- Medical nutrition therapy; re-assessment and intervention, individual, face-to-face with the patient, each 15 minutes\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n- Intravenous infusion, hydration; initial, 31 minutes to 1 hour\n\n### Condition\n- Acute leukemia in remission\n\n### Drug\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-06-22, presumably until 2016-06-22\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-06-25 09:30:00, ended at 2016-06-25 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 39 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.79 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 244 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 100 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.36 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.13 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 84.3 (percent)\n- Tacrolimus [Mass/volume] in Blood: 5.0 (nanogram per milliliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.5 (percent)\n- MCV [Entitic volume] by Automated count: 105.9 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 34 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.0 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.74 (million per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.4 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.6 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.87 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 34.7 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 3.9 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.3 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.1 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 21.3 (percent)\n- MCHC [Mass/volume] by Automated count: 32.8 (gram per deciliter)\n\n### Procedure\n- Intravenous infusion, hydration; initial, 31 minutes to 1 hour\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acute myeloid leukemia, disease\n- Acute leukemia in remission\n- Cytomegalovirus infection\n\n### Drug\n- nystatin 100000 UNT/ML Oral Suspension, through Oral route, started on 2016-06-25, presumably until 2016-11-25, with intended 0 refill(s). Instructions: 5 mL by Swish & Swallow route 4 times a day\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-06-25, presumably until 2016-06-25\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-06-29 11:20:00, ended at 2016-06-29 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 42 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.01 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 5.9 (nanogram per milliliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 283 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.3 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.1 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.7 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.83 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.4 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 34.8 (picogram)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 92 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.75 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.31 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 88.1 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection: <135 (international unit per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 13.3 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 2.5 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 105.2 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n\n### Procedure\n- Intravenous infusion, hydration; initial, 31 minutes to 1 hour\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Acute leukemia in remission\n- Acute myeloid leukemia, disease\n- Cytomegalovirus infection\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-07-02 11:30:00, ended at 2016-07-02 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.7 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.85 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 84.2 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.7 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.8 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.56 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 96 (unit per liter)\n- MCV [Entitic volume] by Automated count: 106.4 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.32 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 8.8 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 22 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 43 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 40 (unit per liter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.5 (percent)\n- MCH [Entitic mass] by Automated count: 35.1 (picogram)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.92 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.0 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 270 (milligram per deciliter)\n\n### Procedure\n- Intravenous infusion, hydration; initial, 31 minutes to 1 hour\n\n### Condition\n- Acute leukemia in remission\n\n### Drug\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-07-02, presumably until 2016-07-02\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-07-06 11:20:00, ended at 2016-07-06 11:55:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 3.95 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.4 (percent)\n- MCHC [Mass/volume] by Automated count: 32.9 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.9 (percent)\n- Platelets [#/volume] in Blood by Automated count: 51 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 89 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.94 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.8 (percent)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.2 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.0 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 233 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.35 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 34.5 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 10.6 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 104.7 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.19 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 13.6 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.64 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 82.4 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n\n### Procedure\n- Intravenous infusion, hydration; initial, 31 minutes to 1 hour\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Acute leukemia in remission\n\n### Drug\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-07-06, presumably until 2016-07-06\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-07-06 11:56:00, ended at 2016-07-06 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Acute myeloid leukemia, disease\n- Cough\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-07-09 11:30:00, ended at 2016-07-09 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.9 (percent)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.75 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.0 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 106.4 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.1 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 266 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.18 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 83.6 (percent)\n- Platelets [#/volume] in Blood by Automated count: 43 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.2 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.96 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 35.2 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.8 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 90 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.31 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 8.4 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.52 (thousand per microliter)\n\n### Procedure\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Decalcification procedure (List separately in addition to code for surgical pathology examination)\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n- Diagnostic bone marrow; biopsy(ies)\n\n### Condition\n- Acute leukemia in remission\n- Pancytopenia\n\n### Drug\n- cholecalciferol 0.025 MG Oral Capsule, through Oral route, presumably until 2016-12-01, with intended 0 refill(s). Instructions: take 1 Cap by mouth every day\n- docusate sodium 100 MG Oral Capsule, through Oral route, presumably until 2016-07-15, with intended 0 refill(s). Instructions: take 200 mg by mouth 2 times a day\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2016-07-09, presumably until 2016-07-09\n- hydromorphone hydrochloride 2 MG Oral Tablet, through Oral route, started on 2016-07-09, presumably until 2016-07-09\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-07-09, presumably until 2016-07-09\n- lidocaine hydrochloride 20 MG/ML Injectable Solution, started on 2016-07-09, presumably until 2016-07-09\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2016-07-09, presumably until 2016-07-09\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-07-15 00:00:00, ended at 2016-07-15 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2016-07-15, presumably until 2016-07-15, with intended 6 refill(s). Instructions: take 8 Tabs by mouth daily Follow provider instructions regarding decrease in dose\n- baclofen 10 MG Oral Tablet, through Oral route, started on 2016-07-15, presumably until 2016-08-13, with intended 6 refill(s). Instructions: take 1 Tab by mouth 3 times a day\n- sucralfate 1000 MG Oral Tablet, through Oral route, started on 2016-07-15, presumably until 2016-07-15, with intended 6 refill(s). Instructions: take 1 Tab by mouth 4 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-07-15 11:12:00, ended at 2016-07-15 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.1 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 173 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 73 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.9 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.05 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 80.1 (percent)\n- Tacrolimus [Mass/volume] in Blood: 17.2 (nanogram per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.24 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.1 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 34.4 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 101.3 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 91 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.48 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.4 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.84 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.47 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-07-15 13:48:42, ended at 2016-07-15 14:36:39\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 3.984\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute myeloid leukemia, disease\n\n### Drug\n- fluconazole 200 MG Oral Tablet, through Oral route, started on 2016-07-13, presumably until 2016-08-13, with intended 3 refill(s). Instructions: take 2 Tabs by mouth daily\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2016-07-15, presumably until 2016-11-02, with intended 6 refill(s). Instructions: take 2 Caps by mouth 2 times a day Take as directed twice a day per BMT team\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2016-07-15, presumably until 2016-07-20, with intended 6 refill(s). Instructions: take 8 Tabs by mouth daily Follow provider instructions regarding decrease in dose\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-07-20 00:00:00, ended at 2016-07-20 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- dronabinol 5 MG Oral Capsule, through Oral route, started on 2016-07-20, presumably until 2016-11-02, with intended 3 refill(s). Instructions: take 1 Cap by mouth 2 times a day as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-07-20 00:00:00, ended at 2016-07-20 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acyclovir 400 MG Oral Tablet, through Oral route, started on 2016-07-20, presumably until 2016-12-01, with intended 11 refill(s). Instructions: take 1 Tab by mouth 3 times a day\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2016-07-20, presumably until 2016-09-28, with intended 6 refill(s). Instructions: take 8 Tabs by mouth daily Follow provider instructions regarding decrease in dose\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2016-07-20, presumably until 2016-11-05, with intended 6 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-07-29 13:44:00, ended at 2016-07-29 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.56 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 192 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 13.7 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 105 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 30 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 141 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.39 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 101.9 (femtoliter)\n- MCH [Entitic mass] by Automated count: 34.7 (picogram)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.1 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.44 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.68 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.94 (million per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 52 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.5 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 84.6 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.0 (percent)\n- Tacrolimus [Mass/volume] in Blood: 18.7 (nanogram per milliliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-07-29 15:06:10, ended at 2016-07-29 16:34:49\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute leukemia in remission\n\n### Drug\n- posaconazole 100 MG Delayed Release Oral Tablet, through Oral route, started on 2016-07-29, presumably until 2016-12-01, with intended 4 refill(s). Instructions: take 3 Tabs by mouth daily\n- budesonide 3 MG Delayed Release Oral Capsule, through Oral route, started on 2016-07-29, presumably until 2016-10-26, with intended 6 refill(s). Instructions: take 1 Cap by mouth 3 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-08-12 12:18:00, ended at 2016-08-12 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection: <135 (international unit per milliliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 29 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.00 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.3 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.96 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.2 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.04 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.6 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.0 (percent)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 97 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 144 (unit per liter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.57 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 34.5 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 84.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 71 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.7 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.55 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.7 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 8.4 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 41 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 365 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 102.5 (femtoliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-08-12 14:10:02, ended at 2016-08-12 15:38:14\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 3.984\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute leukemia in remission\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-08-26 00:00:00, ended at 2016-08-26 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperglycemia\n\n### Drug\n- insulin, regular, human 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2016-08-26, presumably until 2017-08-26, with intended 6 refill(s). Instructions: inject 1-10 Units subcutaneous (under the skin) 4 times a day before meals and bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-08-26 12:08:00, ended at 2016-08-26 13:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.35 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 154 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.4 (percent)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Glucose [Mass/volume] in Blood: 492 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 34.0 (picogram)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.06 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.6 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 62 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 21.0 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 96 (millimole per liter)\n- Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection: <135 (international unit per milliliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.65 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 607 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.6 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 13.2 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 131 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 78 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.61 (thousand per microliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 102.1 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 78.8 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.37 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 14.9 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 28 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-08-26 14:00:00, ended at 2016-08-26 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.92 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 143 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 20 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 602 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 70 (unit per liter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Reticulocytes [#/volume] in Blood by Automated count: 56.3 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 129 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 27 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- IgG [Mass/volume] in Serum or Plasma: 942 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 97 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.0 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 1.31 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 474 (unit per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n\n### Condition\n- Acute myeloid leukemia, disease\n\n### Drug\n- insulin aspart, human 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2016-08-26, presumably until 2016-08-26\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2016-08-26, presumably until 2016-08-26\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-08-26 15:36:09, ended at 2016-08-26 15:36:40\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 413 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute leukemia in remission\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2016-08-28 00:00:00, ended at 2016-08-28 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Gastroesophageal reflux disease without esophagitis\n- Primary diagnosis: Acute leukemia in remission\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2016-08-28 00:00:00, ended at 2016-08-28 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Gastroesophageal reflux disease without esophagitis\n- Neutropenia\n- Cytomegalovirus infection\n- Anogenital herpesviral infection\n- Primary diagnosis: Acute leukemia in remission\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2016-09-05 12:41:00, ended at 2016-09-06 16:05:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.3 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- IgG [Mass/volume] in Serum or Plasma: 720 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 79 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.7 (percent)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Glucose [Mass/volume] in Blood: 216 (milligram per deciliter)\n- Heparin unfractionated [Units/volume] in Platelet poor plasma: >1.10 (unit per milliliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 81.3 (percent)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.3 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.67 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 13.1 (nanogram per milliliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 141 (unit per liter)\n- Body height: 6' 4\" (inch (US))\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 100.7 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.46 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 27 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.02 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.9 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.7 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.9 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.10 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 344 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.99 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 55 (thousand per microliter)\n- Prothrombin time (PT): 14.9 (second)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 97.4 (second)\n\n### Procedure\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Computed tomographic angiography, chest (noncoronary), with contrast material(s), including noncontrast images, if performed, and image postprocessing\n- Duplex scan of extremity veins including responses to compression and other maneuvers; complete bilateral study\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Collection of venous blood by venipuncture\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Physical therapy evaluation\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n\n### Condition\n- Dyspnea\n- Acute deep vein thrombosis of lower limb\n- Acute leukemia in remission\n- Cardiomegaly\n- Drug-induced diabetes mellitus\n- Primary diagnosis: Pulmonary embolism\n- Acute myeloid leukemia, disease\n- Systemic lupus erythematosus\n- Disorder of soft tissue\n- Electrocardiogram abnormal\n\n### Drug\n- rivaroxaban 15 MG Oral Tablet, through Oral route, started on 2016-09-06, presumably until 2016-09-06\n- acyclovir 400 MG Oral Tablet, through Oral route, started on 2016-09-05, presumably until 2016-09-06\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2016-09-05, presumably until 2016-09-06\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2016-09-06, presumably until 2016-09-06\n- insulin isophane, human 100 UNT/ML Injectable Suspension, through Subcutaneous route, started on 2016-08-26, presumably until 2016-11-01, with intended 0 refill(s). Instructions: INJECT SUBCUTANEOUSLY 2 TIMES A DAY AS DIRECTED BY BMT TEAM\n- nystatin 100000 UNT/ML Oral Suspension, through Oral route, started on 2016-09-06, presumably until 2016-09-06\n- dronabinol 5 MG Oral Capsule, through Oral route, started on 2016-09-06, presumably until 2016-09-06\n- insulin lispro 100 UNT/ML Injectable Solution, started on 2016-06-10, presumably until 2016-09-27, with intended 3 refill(s). Instructions: INJECT 0-12 UNITS SUBCUTANEOUSLY 4 TIMES A DAY BEFORE MEALS AND BEDTIME\n- posaconazole 100 MG Delayed Release Oral Tablet, through Oral route, started on 2016-09-05, presumably until 2016-09-06\n- magnesium sulfate 20 MG/ML Injection, through Intravenous route, started on 2016-09-06, presumably until 2016-09-06\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2016-09-06, presumably until 2016-09-06\n- budesonide 3 MG Delayed Release Oral Capsule, through Oral route, started on 2016-09-05, presumably until 2016-09-06\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2016-09-06, presumably until 2016-09-06\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-09-06 00:00:00, ended at 2016-09-06 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 58.2 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-09-06 08:00:00, ended at 2016-09-06 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 213 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-09-08 08:35:00, ended at 2016-09-08 10:16:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Leukocytes [#/volume] in Specimen by Automated count: 4.9 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.49 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.8 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.8 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.87 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 137 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 39 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 13.1 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 13.6 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 33 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection: <135 (international unit per milliliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.6 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 63 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.99 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- MCV [Entitic volume] by Automated count: 99.7 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 88 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.90 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 300 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.48 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 79.9 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-09-08 10:17:00, ended at 2016-09-08 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Medical nutrition therapy; re-assessment and intervention, individual, face-to-face with the patient, each 15 minutes\n\n### Condition\n- Primary diagnosis: Acute leukemia in remission\n\n### Drug\n- rivaroxaban 15 MG Oral Tablet, through Oral route, started on 2016-09-08, presumably until 2016-11-05, with intended 0 refill(s). Instructions: take 15 mg by mouth 2 times a day\n- rivaroxaban 20 MG Oral Tablet, through Oral route, started on 2016-09-08, presumably until 2016-09-28, with intended 12 refill(s). Instructions: take 1 Tab by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-09-27 13:07:00, ended at 2016-09-27 16:50:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.0 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection: <135 (international unit per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 12.9 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.5 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.52 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.89 (million per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 78.8 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 65 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 551 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.5 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.52 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 3.3 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 109 (unit per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.2 (percent)\n- Platelets [#/volume] in Blood by Automated count: 104 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 133 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 27 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.92 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.5 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 98.9 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.41 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-09-27 15:07:51, ended at 2016-09-27 16:40:54\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 3.984\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute leukemia in remission\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-09-27 16:51:00, ended at 2016-09-27 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 478 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Intravenous infusion, hydration; initial, 31 minutes to 1 hour\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n\n### Condition\n- Hyperglycemia\n- Lymphocytopenia\n- Acute monocytic/monoblastic leukemia\n- Acute myeloid leukemia, disease\n\n### Drug\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2016-09-27, presumably until 2016-12-01, with intended 1 refill(s). Instructions: inject 1-10 Units subcutaneous (under the skin) 3 times a day before meals follow moderate sliding scale 3 times daily before meals\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-09-27, presumably until 2016-09-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-10-25 11:33:00, ended at 2016-10-25 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.0 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 16.7 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 68 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection: <135 (international unit per milliliter)\n- Glucose [Mass/volume] in Serum or Plasma: 120 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.57 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 164 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 41 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.16 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.2 (percent)\n- MCH [Entitic mass] by Automated count: 32.7 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 64.2 (percent)\n- Platelets [#/volume] in Blood by Automated count: 134 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.4 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.0 (percent)\n- MCV [Entitic volume] by Automated count: 100.0 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.60 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.61 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 11.8 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 13.7 (nanogram per milliliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.19 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-10-25 15:35:15, ended at 2016-10-25 15:35:52\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute leukemia in remission\n- Pulmonary embolism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2016-11-01 00:00:00, ended at 2016-11-01 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n\n### Condition\n- Primary diagnosis: Acute leukemia in remission\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-11-01 14:47:00, ended at 2016-11-01 20:58:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- MCV [Entitic volume] by Automated count: 98.1 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 57 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 162 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.9 (percent)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 82 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.1 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 121 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.5 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.47 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 21 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 149 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 39 (unit per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.53 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 15.9 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.31 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 69.1 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.44 (million per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.19 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.7 (percent)\n- MCH [Entitic mass] by Automated count: 33.4 (picogram)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.3 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Acute leukemia in remission\n- Acute myeloid leukemia, disease\n\n### Drug\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2016-11-01, presumably until 2016-11-01\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, presumably until 2016-11-05, with intended 0 refill(s). Instructions: inject 10 Units subcutaneous (under the skin) daily in the evening\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2016-11-01 20:59:00, ended at 2016-11-03 17:38:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.7 (percent)\n- Prothrombin time (PT): 16.4 (second)\n- Tacrolimus [Mass/volume] in Blood: 9.8 (nanogram per milliliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 20.3 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 1.92 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.2 (percent)\n- Heparin unfractionated [Units/volume] in Platelet poor plasma: >1.10 (unit per milliliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.59 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 59.2 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 39 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.0 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.12 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.25 (million per microliter)\n- Platelets [#/volume] in Blood by Automated count: 149 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 68.2 (second)\n- Glucose [Mass/volume] in Blood: 93 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.1 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.66 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 98.4 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 5.7 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.7 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 141 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.2 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 21.0 (percent)\n\n### Procedure\n- Inspection of Lower Intestinal Tract, Via Natural or Artificial Opening Endoscopic\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); concurrent infusion (List separately in addition to code for primary procedure)\n- Sigmoidoscopy, flexible; with biopsy, single or multiple\n- Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple\n- Collection of venous blood by venipuncture\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Excision of Stomach, Via Natural or Artificial Opening Endoscopic, Diagnostic\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Leukemia in remission\n- Epigastric pain\n- Nausea and vomiting\n- Primary diagnosis: Acute leukemia in remission\n- Chronic gastritis\n- Headache\n- Drug-induced diabetes mellitus\n- Hyperlipidemia\n- Acute myeloid leukemia, disease\n- Diaphragmatic hernia\n\n### Drug\n- 2 ML prochlorperazine 5 MG/ML Injection, started on 2016-11-02, presumably until 2016-11-03\n- clindamycin 10 MG/ML Topical Lotion, through Topical route, presumably until 2016-11-05, with intended 0 refill(s). Instructions: 1 Application by Topical route 2 times a day\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2016-11-02, presumably until 2016-11-02\n- ondansetron 8 MG Oral Tablet, through Oral route, presumably until 2017-01-27, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed (nausea)\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2016-11-02, presumably until 2016-11-03\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2016-11-02, presumably until 2016-12-01, with intended 6 refill(s). Instructions: take 2 mg by mouth every morning \n- lorazepam 1 MG Oral Tablet, through Oral route, presumably until 2016-11-25, with intended 0 refill(s). Instructions: take 0.5 mg by mouth every 4 hours as needed (nausea)\n- dronabinol 5 MG Oral Capsule, through Oral route, presumably until 2017-03-29, with intended 0 refill(s). Instructions: take 5 mg by mouth every bedtime as needed\n- posaconazole 100 MG Delayed Release Oral Tablet, through Oral route, started on 2016-11-02, presumably until 2016-11-03\n- ketoconazole 20 MG/ML Topical Cream, through Topical route, presumably until 2016-11-05, with intended 0 refill(s). Instructions: 1 Application by Topical route 2 times a day\n- tacrolimus 0.5 MG Oral Capsule, through Oral route, presumably until 2016-11-02, with intended 0 refill(s). Instructions: take 0.5 mg by mouth 2 times a day\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-11-02, presumably until 2016-11-03\n- magnesium sulfate 20 MG/ML Injection, through Intravenous route, started on 2016-11-02, presumably until 2016-11-03\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2016-11-02, presumably until 2016-11-03\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2016-11-02, presumably until 2016-11-02\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2016-11-02, presumably until 2016-11-02\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2016-11-03 00:00:00, ended at 2016-11-03 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- midazolam 1 MG/ML Injectable Solution, started on 2016-11-03, presumably until 2016-11-03\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-11-05 10:20:00, ended at 2016-11-05 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.27 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.8 (percent)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.2 (percent)\n- MCV [Entitic volume] by Automated count: 98.1 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 147 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 9.7 (nanogram per milliliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 161 (unit per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.3 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.56 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.3 (picogram)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.61 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.4 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 66.5 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.18 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 149 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.2 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.69 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 17.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.9 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.9 (gram per deciliter)\n\n### Procedure\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n- Medical nutrition therapy; re-assessment and intervention, individual, face-to-face with the patient, each 15 minutes\n- Intravenous infusion, hydration; initial, 31 minutes to 1 hour\n\n### Condition\n- Acute myeloid leukemia, disease\n- Acute leukemia in remission\n\n### Drug\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-11-05, presumably until 2016-11-05\n- rivaroxaban 20 MG Oral Tablet, through Oral route, presumably until 2016-12-01, with intended 0 refill(s). Instructions: take 20 mg by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-11-11 13:32:00, ended at 2016-11-11 13:32:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.66 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.51 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.6 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.6 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.0 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 16.2 (percent)\n- Platelets [#/volume] in Blood by Automated count: 145 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.59 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 149 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.1 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.72 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.2 (percent)\n- MCV [Entitic volume] by Automated count: 98.5 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.7 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.5 (percent)\n- Tacrolimus [Mass/volume] in Blood: 10.7 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 168 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 67.0 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 46 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.37 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-11-11 14:55:18, ended at 2016-11-11 15:59:42\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 3 - 5 (per high power field)\n- Thyrotropin [Units/volume] in Serum or Plasma: 1.61 (micro-international unit per milliliter)\n- Body height: 6' 3.98\" (inch (US))\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acute leukemia in remission\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-11-25 09:54:00, ended at 2016-11-25 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Hemoglobin [Mass/volume] in Blood: 11.2 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.99 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.49 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 97.6 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 16.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.67 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 46 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.8 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.7 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 130 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 57 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.24 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 63.6 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 196 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.2 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.1 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.67 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.59 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 4.6 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.9 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.1 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 13.9 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 161 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-11-25 11:18:11, ended at 2016-11-25 12:14:08\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 3.984\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute leukemia in remission\n\n### Drug\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2016-11-25, presumably until 2018-04-17, with intended 1 refill(s). Instructions: take 0.5 Tabs by mouth every 4 hours as needed (nausea)\n- nystatin 100000 UNT/ML Oral Suspension, through Oral route, started on 2016-11-25, presumably until 2017-04-08, with intended 0 refill(s). Instructions: 5 mL by Swish & Swallow route 4 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-12-01 00:00:00, ended at 2016-12-01 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute leukemia in remission\n\n### Drug\n- acyclovir 400 MG Oral Tablet, through Oral route, started on 2016-12-01, presumably until 2017-02-23, with intended 11 refill(s). Instructions: take 1 Tab by mouth 3 times a day\n- cholecalciferol 0.025 MG Oral Capsule, through Oral route, started on 2016-12-01, presumably until 2016-12-01, with intended 6 refill(s). Instructions: take 1 Cap by mouth every day\n- omeprazole 40 MG Delayed Release Oral Capsule, through Oral route, started on 2016-12-01, presumably until 2017-02-23, with intended 2 refill(s). Instructions: take 40 mg by mouth 2 times a day\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2016-12-01, presumably until 2017-01-27, with intended 1 refill(s). Instructions: inject 1-10 Units subcutaneous (under the skin) 3 times a day before meals follow moderate sliding scale 3 times daily before meals\n- posaconazole 100 MG Delayed Release Oral Tablet, through Oral route, started on 2016-12-01, presumably until 2016-12-14, with intended 4 refill(s). Instructions: take 3 Tabs by mouth daily\n- tacrolimus 0.5 MG Oral Capsule, through Oral route, started on 2016-12-01, presumably until 2017-04-08, with intended 6 refill(s). Instructions: take 1 Cap by mouth 2 times a day\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2016-12-01, presumably until 2017-01-27, with intended 6 refill(s). Instructions: take 1 Tab by mouth daily in the morning\n- rivaroxaban 20 MG Oral Tablet, through Oral route, started on 2016-12-01, presumably until 2017-03-08, with intended 6 refill(s). Instructions: take 20 mg by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-12-14 00:00:00, ended at 2016-12-14 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- posaconazole 100 MG Delayed Release Oral Tablet, through Oral route, started on 2016-12-14, presumably until 2017-01-27, with intended 6 refill(s). Instructions: take 3 Tabs by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-30 12:55:00, ended at 2016-12-30 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.02 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.37 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.8 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 128 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.7 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.9 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 60.6 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.4 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 7.7 (percent)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 96.2 (femtoliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.91 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.7 (percent)\n- MCH [Entitic mass] by Automated count: 31.8 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.62 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.7 (percent)\n- Testosterone [Mass/volume] in Serum or Plasma: 820 (nanogram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 159 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.7 (percent)\n- Tacrolimus [Mass/volume] in Blood: 2.8 (nanogram per milliliter)\n- Platelets [#/volume] in Blood by Automated count: 172 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.68 (million per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.94 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-12-30 15:30:13, ended at 2016-12-30 16:24:58\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-12-30 16:34:44, ended at 2016-12-30 17:52:33\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 3.984\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic graft-versus-host disease\n\n### Drug\n- hydrocortisone 0.025 MG/MG Topical Ointment, through Topical route, started on 2016-12-30, presumably until 2017-12-30, with intended 0 refill(s). Instructions: by Topical route daily Apply to face at night\n- hydrocortisone 25 MG/ML Topical Cream, through Topical route, started on 2016-12-30, presumably until 2016-12-30, with intended 0 refill(s). Instructions: by Topical route Morning\n- fluocinonide 0.5 MG/ML Topical Cream, through Topical route, started on 2016-12-30, presumably until 2017-12-30, with intended 0 refill(s). Instructions: by Topical route Apply to chest, arms, upper back and neck in the morning\n- fluocinonide 0.0005 MG/MG Topical Ointment, started on 2016-12-30, presumably until 2016-12-30, with intended 0 refill(s). Instructions: Apply to chest, arms, upper back and neck at night\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-01-03 00:00:00, ended at 2017-01-03 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sildenafil 50 MG Oral Tablet, through Oral route, started on 2017-01-03, presumably until 2018-01-03, with intended 1 refill(s). Instructions: take 1 Tab by mouth as needed (1 hour before sexual activity)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-01-27 10:44:00, ended at 2017-01-27 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Eosinophils [#/volume] in Blood by Automated count: 0.51 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: <1.0 (nanogram per milliliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 17.9 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 111 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 0.81 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.7 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.6 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.8 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 34.0 (percent)\n- MCH [Entitic mass] by Automated count: 31.8 (picogram)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 113 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.70 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 19.1 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 28.2 (percent)\n- Platelets [#/volume] in Blood by Automated count: 152 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.1 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.87 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 96.2 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.55 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 2.9 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.97 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-01-27 11:22:55, ended at 2017-01-27 12:04:35\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 3.984\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Eruption\n\n### Drug\n- tacrolimus 0.001 MG/MG Topical Ointment, started on 2017-01-27, presumably until 2017-04-08, with intended 3 refill(s). Instructions: Apply topically as directed twice daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-01-27 13:56:55, ended at 2017-01-27 14:52:06\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 3.984\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute leukemia in remission\n\n### Drug\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2017-01-27, presumably until 2017-04-08, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- furosemide 40 MG Oral Tablet, through Oral route, started on 2017-01-27, presumably until 2017-04-08, with intended 2 refill(s). Instructions: take 1 Tab by mouth daily as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-02-03 00:00:00, ended at 2017-02-03 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- azithromycin 250 MG Oral Tablet, through Oral route, started on 2017-02-03, presumably until 2017-04-07, with intended 0 refill(s). Instructions: take 1 Tab by mouth as directed Take 2 tabs on day 1 and 1 tab each of the following days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-02-10 00:00:00, ended at 2017-02-10 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Graft versus host disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-02-10 10:28:00, ended at 2017-02-10 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Hemoglobin [Mass/volume] in Blood: 12.3 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.5 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.55 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 16.0 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.1 (percent)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.11 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 100 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.6 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.93 (million per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 37.2 (percent)\n- Platelets [#/volume] in Blood by Automated count: 163 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 38 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 32.3 (percent)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: <1.0 (nanogram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.14 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.4 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 95.0 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.47 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 1.28 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 109 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.3 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-02-23 00:00:00, ended at 2017-02-23 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acyclovir 400 MG Oral Tablet, through Oral route, started on 2017-02-23, presumably until 2017-03-08, with intended 11 refill(s). Instructions: take 1 Tab by mouth 3 times a day\n- omeprazole 40 MG Delayed Release Oral Capsule, through Oral route, started on 2017-02-23, presumably until 2017-06-03, with intended 2 refill(s). Instructions: take 40 mg by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-03-03 00:00:00, ended at 2017-03-03 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute myeloid leukemia, disease\n\n### Drug\n- amoxicillin 500 MG Oral Tablet, through Oral route, started on 2017-03-03, presumably until 2017-03-03, with intended 0 refill(s). Instructions: take 4 Tabs by mouth One Time for 1 dose 1 hour before dental work\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-03-03 07:02:00, ended at 2017-03-03 09:32:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 135 (milligram per deciliter)\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- Hepatosplenomegaly\n- Acute myeloid leukemia, disease\n- Localized enlarged lymph nodes\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-03-03 09:33:00, ended at 2017-03-03 11:27:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 94.9 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 21.3 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 15.9 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 50.4 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.97 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.90 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.0 (percent)\n- Tacrolimus [Mass/volume] in Blood: <1.0 (nanogram per milliliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.28 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 11.6 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.8 (percent)\n- Globulin [Mass/volume] in Serum: 2.7 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 2.5 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.24 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 0.39 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 140 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.7 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.53 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 113 (unit per liter)\n- MCH [Entitic mass] by Automated count: 32.5 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 119 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-03-03 11:28:00, ended at 2017-03-03 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- IgG [Mass/volume] in Serum or Plasma: 801 (milligram per deciliter)\n\n### Procedure\n- Diagnostic bone marrow; biopsy(ies)\n- Collection of venous blood by venipuncture\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Decalcification procedure (List separately in addition to code for surgical pathology examination)\n\n### Condition\n- Acute deep vein thrombosis of lower limb\n- Primary diagnosis: Acute leukemia in remission\n- Acute myeloid leukemia, disease\n- Myeloid leukemia\n- Pancytopenia\n- Pulmonary embolism\n\n### Drug\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2017-03-03, presumably until 2017-03-03\n- lidocaine hydrochloride 20 MG/ML Injectable Solution, started on 2017-03-03, presumably until 2017-03-03\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Systemic lupus erythematosus within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of lupus means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "b3c0f7bf9f5b92054e6fe3d6205816e1d5c9871796515da60425e2c1538b4a5c", "prompt_hash": "5601cdc34ef559fc863f9854a560907044a682f9d26420267f619abe0b88589b", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 2, "doc": {"person_id": 115968499, "visit_occurrence_id": 181212563, "death_date": null, "visit_concept_name": "Telehealth", "visit_start_datetime": "2021-06-14 00:00:00", "visit_end_datetime": "2021-06-14 00:00:00", "visit_length_in_hours": 0.0, "integrated_visit_record": "## Visit\nThis visit record, was from Telehealth, started at 2021-06-14 00:00:00, ended at 2021-06-14 00:00:00\nThe patient in this visit was 33 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Loss of consciousness\n\n### Drug\n- No drugs.\n\n", "approximate_token_count": 85, "patient_first_visit_date": "2019-10-17 11:25:38", "patient_last_visit_date": "2023-02-02 15:25:59", "end_obs_date": "2022-06-14", "hypertension_type": "new", "hypertension_one_year_diagnosis": 0, "obesity_type": "new", "obesity_one_year_diagnosis": 1, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "new", "hyperlipidemia_one_year_diagnosis": 0, "depressive_disorder_type": "recurrent", "depressive_disorder_one_year_diagnosis": 1, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "recurrent", "lupus_one_year_diagnosis": 1, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 21, "cumulated_visit_num": 21, "cumulated_approximate_token_count": 6572, "visit_cumulated": "## Visit\nThis visit record, was from Office Visit, started at 2019-10-17 11:25:38, ended at 2019-10-17 13:32:13\nThe patient in this visit was 32 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Loss of consciousness\n\n### Drug\n- pramipexole dihydrochloride 1 MG Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: Take 1 tablet (1 mg total) by mouth every bedtime\n- ondansetron 8 MG Oral Tablet, through Oral route, presumably until 2021-06-18, with intended 0 refill(s). Instructions: take by mouth\n- levetiracetam 500 MG Oral Tablet, through Oral route, presumably until 2020-01-25, with intended 0 refill(s). Instructions: take by mouth\n- tizanidine 4 MG Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: Take 1 tablet (4 mg total) by mouth every 6 hours as needed\n- lamotrigine 25 MG Oral Tablet, through Oral route, presumably until 2022-11-15, with intended 0 refill(s). Instructions: take 150 mg by mouth 2 times a day 150mg BID\n- rivaroxaban 20 MG Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: Take 1 tablet (20 mg total) by mouth daily with dinner\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-11-06 00:00:00, ended at 2019-11-06 00:00:00\nThe patient in this visit was 32 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Loss of consciousness\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-11-28 00:00:00, ended at 2019-11-28 00:00:00\nThe patient in this visit was 32 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2019-11-28, presumably until 2020-02-21, with intended 0 refill(s). Instructions: take 1 Tab (0.5 mg total) by mouth once as needed (15 minutes prior to MRI brain)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2020-01-20 08:12:00, ended at 2020-01-25 15:33:00\nThe patient in this visit was 32 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Neutrophils [#/volume] in Blood by Automated count: 5.06 (thousand per microliter)\n- levETIRAcetam [Mass/volume] in Serum or Plasma: <2.0 (microgram per milliliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.1 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.7 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 94.1 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.40 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.9 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 31.7 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 25.0 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.88 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Globulin [Mass/volume] in Serum: 2.7 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 29.8 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.06 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.92 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 310 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 109 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.17 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 80 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.2 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.2 (percent)\n\n### Procedure\n- Electroencephalogram with video (VEEG), review of data, technical description by EEG technologist, 2-12 hours; unmonitored\n- Hospital discharge day management; more than 30 minutes\n- Electroencephalogram (EEG), continuous recording, physician or other qualified health care professional review of recorded events, analysis of spike and seizure detection, each increment of greater than 12 hours, up to 26 hours of EEG recording, interpret\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of moderate complexity. Counseling and/or coordination\n- Monitoring of Central Nervous Electrical Activity, External Approach\n- Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (Lis\n- Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; read by instrument assisted direct optical observation (eg, utilizing immunoassay [eg, dipsticks, cups, cards, or cartridges]), includes sample validation when per\n- Electroencephalogram with video (VEEG), review of data, technical description by EEG technologist, each increment of 12-26 hours; unmonitored\n- Electroencephalogram (EEG), continuous recording, physician or other qualified health care professional review of recorded events, analysis of spike and seizure detection, interpretation and report, 2-12 hours of EEG recording; with video (VEEG)\n- Collection of venous blood by venipuncture\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Electroencephalogram (EEG) continuous recording, with video when performed, setup, patient education, and takedown when performed, administered in person by EEG technologist, minimum of 8 channels\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n\n### Condition\n- Epigastric pain\n- Primary diagnosis: Mental alertness - finding\n- Seizure\n- Digestive system finding\n- Electrocardiogram abnormal\n- Nervous system symptoms\n- Nystagmus\n- Cyclical vomiting syndrome\n- Hypothyroidism\n- Migraine\n- Major depression, single episode\n- Nausea and vomiting\n- Somatoform disorder\n- Epilepsy\n- Posttraumatic stress disorder\n\n### Drug\n- pramipexole dihydrochloride 1 MG Oral Tablet, through Oral route, started on 2020-01-20, presumably until 2020-01-24\n- levothyroxine sodium 0.05 MG Oral Tablet, through Oral route, started on 2020-01-20, presumably until 2020-01-24\n- promethazine hydrochloride 25 MG Oral Tablet, through Oral route, started on 2020-01-21, presumably until 2020-01-25\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2020-01-24, presumably until 2020-01-25\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2020-01-25, presumably until 2020-01-25\n- quetiapine 25 MG Oral Tablet, through Oral route, started on 2020-01-20, presumably until 2020-01-24\n- lamotrigine 100 MG Oral Tablet, through Oral route, started on 2020-01-24, presumably until 2020-01-25\n- ondansetron 4 MG Disintegrating Oral Tablet, through Oral route, started on 2020-01-21, presumably until 2020-01-25\n- 2 ML ondansetron 2 MG/ML Injection, started on 2020-01-21, presumably until 2020-01-21\n- tizanidine 4 MG Oral Tablet, through Oral route, started on 2020-01-24, presumably until 2020-01-25\n- lamotrigine 25 MG Oral Tablet, through Oral route, started on 2020-01-25, presumably until 2020-01-25\n- rivaroxaban 20 MG Oral Tablet, through Oral route, started on 2020-01-20, presumably until 2020-01-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-02-21 10:48:43, ended at 2020-02-21 14:33:33\nThe patient in this visit was 32 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mental alertness - finding\n\n### Drug\n- quetiapine 50 MG Oral Tablet, through Oral route, presumably until 2021-06-18, with intended 0 refill(s). Instructions: take 200 mg by mouth daily \n- hydroxychloroquine sulfate 200 MG Oral Tablet, through Oral route, presumably until 2022-05-30, with intended 0 refill(s). Instructions: take 400 mg by mouth every day \n- lamotrigine 100 MG Oral Tablet, through Oral route, started on 2020-02-21, presumably until 2021-06-18, with intended 0 refill(s). Instructions: take 1 Tab (100 mg total) by mouth 2 times a day Takes with 25mg tablet for a total of 125mg bid.\n- 168 HR estradiol 0.00208 MG/HR Transdermal System, through Transdermal route, presumably until 2021-06-18, with intended 0 refill(s). Instructions: apply to skin\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-05-05 13:28:24, ended at 2020-05-05 14:05:34\nThe patient in this visit was 32 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Nausea and vomiting\n- Peptic ulcer\n\n### Drug\n- leflunomide 10 MG Oral Tablet, through Oral route, presumably until 2020-06-03, with intended 0 refill(s). Instructions: take 10 mg by mouth daily\n- ondansetron 8 MG Disintegrating Oral Tablet, through Oral route, started on 2020-05-05, presumably until 2021-06-18, with intended 6 refill(s). Instructions: take 1 Tab (8 mg total) by mouth every 8 hours\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-05-29 07:07:00, ended at 2020-05-29 23:59:00\nThe patient in this visit was 32 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Gastric emptying imaging study (eg, solid, liquid, or both)\n\n### Condition\n- Gastroparesis syndrome\n- Nausea and vomiting\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-06-03 00:00:00, ended at 2020-06-03 00:00:00\nThe patient in this visit was 32 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Migraine without aura\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-06-12 00:00:00, ended at 2020-06-12 00:00:00\nThe patient in this visit was 32 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- omeprazole 20 MG Delayed Release Oral Capsule, through Oral route, started on 2020-06-12, presumably until 2020-06-25, with intended 3 refill(s). Instructions: take 40 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-06-25 11:10:18, ended at 2020-06-25 11:27:50\nThe patient in this visit was 32 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Gastroparesis syndrome\n- Melena\n- Primary diagnosis: Disorder of upper gastrointestinal tract\n- Primary diagnosis: Epigastric pain\n\n### Drug\n- omeprazole 40 MG Delayed Release Oral Capsule, through Oral route, started on 2020-06-25, presumably until 2021-06-18, with intended 3 refill(s). Instructions: take 40 mg by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-07-01 14:23:00, ended at 2020-07-01 14:23:00\nThe patient in this visit was 32 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Nausea and vomiting\n- Peptic ulcer\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-08-12 13:24:39, ended at 2020-08-12 13:57:39\nThe patient in this visit was 32 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Postoperative state\n- Gastric ulcer without hemorrhage AND without perforation\n- Primary diagnosis: Nausea and vomiting\n- Hereditary thrombophilia\n- Mood disorder\n- Anxiety disorder\n- Seizure\n- Disorder of thyroid gland\n\n### Drug\n- folic acid 1 MG Oral Tablet, through Oral route, presumably until 2022-02-09, with intended 0 refill(s). Instructions: take 1 mg by mouth daily\n- cholecalciferol 0.125 MG Oral Capsule, through Oral route, with intended 0 refill(s). Instructions: Take 1 capsule (5,000 units total) by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-08-19 00:00:00, ended at 2020-08-19 00:00:00\nThe patient in this visit was 32 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for upper gastrointestinal endoscopic procedures, endoscope introduced proximal to duodenum; not otherwise specified\n\n### Condition\n- Disorder of upper gastrointestinal tract\n- Chronic gastritis\n- Nausea\n\n### Drug\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2020-08-19, presumably until 2020-08-19\n- 2 ML ondansetron 2 MG/ML Injection, started on 2020-08-19, presumably until 2020-08-19\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2020-08-19 00:00:00, ended at 2020-08-19 00:00:00\nThe patient in this visit was 32 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple\n- Esophagogastroduodenoscopy, flexible, transoral; with directed submucosal injection(s), any substance\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-08-19 10:25:00, ended at 2020-08-19 13:54:00\nThe patient in this visit was 32 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple\n- Esophagogastroduodenoscopy, flexible, transoral; with directed submucosal injection(s), any substance\n\n### Condition\n- Acquired absence of organ\n- Systemic lupus erythematosus\n- Anxiety disorder\n- Cracked tooth\n- Gastric ulcer without hemorrhage AND without perforation\n- Chronic gastritis\n- Disorder of digestive system\n- Hypothyroidism\n- Osteoarthritis\n- Steatosis of liver\n- Seizure\n- Nausea\n- Disorder of upper gastrointestinal tract\n- Major depression, single episode\n- Migraine without aura\n- Nausea and vomiting\n- Adult hypertrophic pyloric stenosis\n\n### Drug\n- onabotulinumtoxinA 100 UNT Injection, started on 2020-08-19, presumably until 2020-08-19\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-09-29 10:33:30, ended at 2020-09-29 10:50:23\nThe patient in this visit was 33 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Diarrhea\n\n### Drug\n- rifaximin 550 MG Oral Tablet, through Oral route, started on 2020-09-29, presumably until 2020-10-13, with intended 0 refill(s). Instructions: take 1 Tab (550 mg total) by mouth 3 times a day for 14 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-10-08 00:00:00, ended at 2020-10-08 00:00:00\nThe patient in this visit was 33 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- frovatriptan 2.5 MG Oral Tablet, started on 2020-10-08, presumably until 2021-06-18, with intended 2 refill(s). Instructions: Take 1 tab at onset of headache. May repeat in 2 hrs if needed. Limit 2 doses/24 hours. Limit to 10 days per month.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2021-06-05 00:00:00, ended at 2021-06-05 00:00:00\nThe patient in this visit was 33 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 13.1 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.3 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 25.1 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.3 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 66.9 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- lamoTRIgine [Mass/volume] in Serum or Plasma: 0.9 (microgram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.89 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.9 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 83 (milligram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Monocytes [#/volume] in Blood by Automated count: 0.39 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 146 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 115 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 12.4 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.3 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 277 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.32 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.84 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 28.7 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 3.3 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 69 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- MCV [Entitic volume] by Automated count: 86.8 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.91 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 20 (millimole per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.5 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2021-06-05 18:45:00, ended at 2021-06-06 00:55:00\nThe patient in this visit was 33 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 69 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 83 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.3 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 86.8 (femtoliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.32 (million per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.3 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 146 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.3 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.84 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 25.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 277 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.5 (percent)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.39 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 20 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.89 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.4 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.7 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 66.9 (percent)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.3 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.9 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 115 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.91 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Collection of venous blood by venipuncture\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Electrocardiogram abnormal\n- Epigastric pain\n- Stool finding\n- Disorder of digestive system\n- Systemic lupus erythematosus\n- Acquired absence of organ\n- Nervous system symptoms\n- Primary diagnosis: Organic personality disorder\n- Hypothyroidism\n- Seizure\n\n### Drug\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2021-06-05, presumably until 2021-06-05\n- 2 ML prochlorperazine 5 MG/ML Injection, started on 2021-06-05, presumably until 2021-06-05\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2021-06-05, presumably until 2021-06-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-06-09 10:08:15, ended at 2021-06-09 10:44:05\nThe patient in this visit was 33 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mental alertness - finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-06-14 00:00:00, ended at 2021-06-14 00:00:00\nThe patient in this visit was 33 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Loss of consciousness\n\n### Drug\n- No drugs.\n\n"}, "target": "Yes", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Systemic lupus erythematosus within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-10-17 11:25:38, ended at 2019-10-17 13:32:13\nThe patient in this visit was 32 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Loss of consciousness\n\n### Drug\n- pramipexole dihydrochloride 1 MG Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: Take 1 tablet (1 mg total) by mouth every bedtime\n- ondansetron 8 MG Oral Tablet, through Oral route, presumably until 2021-06-18, with intended 0 refill(s). Instructions: take by mouth\n- levetiracetam 500 MG Oral Tablet, through Oral route, presumably until 2020-01-25, with intended 0 refill(s). Instructions: take by mouth\n- tizanidine 4 MG Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: Take 1 tablet (4 mg total) by mouth every 6 hours as needed\n- lamotrigine 25 MG Oral Tablet, through Oral route, presumably until 2022-11-15, with intended 0 refill(s). Instructions: take 150 mg by mouth 2 times a day 150mg BID\n- rivaroxaban 20 MG Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: Take 1 tablet (20 mg total) by mouth daily with dinner\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-11-06 00:00:00, ended at 2019-11-06 00:00:00\nThe patient in this visit was 32 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Loss of consciousness\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-11-28 00:00:00, ended at 2019-11-28 00:00:00\nThe patient in this visit was 32 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2019-11-28, presumably until 2020-02-21, with intended 0 refill(s). Instructions: take 1 Tab (0.5 mg total) by mouth once as needed (15 minutes prior to MRI brain)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2020-01-20 08:12:00, ended at 2020-01-25 15:33:00\nThe patient in this visit was 32 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Neutrophils [#/volume] in Blood by Automated count: 5.06 (thousand per microliter)\n- levETIRAcetam [Mass/volume] in Serum or Plasma: <2.0 (microgram per milliliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.1 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.7 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 94.1 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.40 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.9 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 31.7 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 25.0 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.88 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Globulin [Mass/volume] in Serum: 2.7 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 29.8 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.06 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.92 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 310 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 109 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.17 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 80 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.2 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.2 (percent)\n\n### Procedure\n- Electroencephalogram with video (VEEG), review of data, technical description by EEG technologist, 2-12 hours; unmonitored\n- Hospital discharge day management; more than 30 minutes\n- Electroencephalogram (EEG), continuous recording, physician or other qualified health care professional review of recorded events, analysis of spike and seizure detection, each increment of greater than 12 hours, up to 26 hours of EEG recording, interpret\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of moderate complexity. Counseling and/or coordination\n- Monitoring of Central Nervous Electrical Activity, External Approach\n- Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (Lis\n- Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; read by instrument assisted direct optical observation (eg, utilizing immunoassay [eg, dipsticks, cups, cards, or cartridges]), includes sample validation when per\n- Electroencephalogram with video (VEEG), review of data, technical description by EEG technologist, each increment of 12-26 hours; unmonitored\n- Electroencephalogram (EEG), continuous recording, physician or other qualified health care professional review of recorded events, analysis of spike and seizure detection, interpretation and report, 2-12 hours of EEG recording; with video (VEEG)\n- Collection of venous blood by venipuncture\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Electroencephalogram (EEG) continuous recording, with video when performed, setup, patient education, and takedown when performed, administered in person by EEG technologist, minimum of 8 channels\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n\n### Condition\n- Epigastric pain\n- Primary diagnosis: Mental alertness - finding\n- Seizure\n- Digestive system finding\n- Electrocardiogram abnormal\n- Nervous system symptoms\n- Nystagmus\n- Cyclical vomiting syndrome\n- Hypothyroidism\n- Migraine\n- Major depression, single episode\n- Nausea and vomiting\n- Somatoform disorder\n- Epilepsy\n- Posttraumatic stress disorder\n\n### Drug\n- pramipexole dihydrochloride 1 MG Oral Tablet, through Oral route, started on 2020-01-20, presumably until 2020-01-24\n- levothyroxine sodium 0.05 MG Oral Tablet, through Oral route, started on 2020-01-20, presumably until 2020-01-24\n- promethazine hydrochloride 25 MG Oral Tablet, through Oral route, started on 2020-01-21, presumably until 2020-01-25\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2020-01-24, presumably until 2020-01-25\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2020-01-25, presumably until 2020-01-25\n- quetiapine 25 MG Oral Tablet, through Oral route, started on 2020-01-20, presumably until 2020-01-24\n- lamotrigine 100 MG Oral Tablet, through Oral route, started on 2020-01-24, presumably until 2020-01-25\n- ondansetron 4 MG Disintegrating Oral Tablet, through Oral route, started on 2020-01-21, presumably until 2020-01-25\n- 2 ML ondansetron 2 MG/ML Injection, started on 2020-01-21, presumably until 2020-01-21\n- tizanidine 4 MG Oral Tablet, through Oral route, started on 2020-01-24, presumably until 2020-01-25\n- lamotrigine 25 MG Oral Tablet, through Oral route, started on 2020-01-25, presumably until 2020-01-25\n- rivaroxaban 20 MG Oral Tablet, through Oral route, started on 2020-01-20, presumably until 2020-01-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-02-21 10:48:43, ended at 2020-02-21 14:33:33\nThe patient in this visit was 32 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mental alertness - finding\n\n### Drug\n- quetiapine 50 MG Oral Tablet, through Oral route, presumably until 2021-06-18, with intended 0 refill(s). Instructions: take 200 mg by mouth daily \n- hydroxychloroquine sulfate 200 MG Oral Tablet, through Oral route, presumably until 2022-05-30, with intended 0 refill(s). Instructions: take 400 mg by mouth every day \n- lamotrigine 100 MG Oral Tablet, through Oral route, started on 2020-02-21, presumably until 2021-06-18, with intended 0 refill(s). Instructions: take 1 Tab (100 mg total) by mouth 2 times a day Takes with 25mg tablet for a total of 125mg bid.\n- 168 HR estradiol 0.00208 MG/HR Transdermal System, through Transdermal route, presumably until 2021-06-18, with intended 0 refill(s). Instructions: apply to skin\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-05-05 13:28:24, ended at 2020-05-05 14:05:34\nThe patient in this visit was 32 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Nausea and vomiting\n- Peptic ulcer\n\n### Drug\n- leflunomide 10 MG Oral Tablet, through Oral route, presumably until 2020-06-03, with intended 0 refill(s). Instructions: take 10 mg by mouth daily\n- ondansetron 8 MG Disintegrating Oral Tablet, through Oral route, started on 2020-05-05, presumably until 2021-06-18, with intended 6 refill(s). Instructions: take 1 Tab (8 mg total) by mouth every 8 hours\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-05-29 07:07:00, ended at 2020-05-29 23:59:00\nThe patient in this visit was 32 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Gastric emptying imaging study (eg, solid, liquid, or both)\n\n### Condition\n- Gastroparesis syndrome\n- Nausea and vomiting\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-06-03 00:00:00, ended at 2020-06-03 00:00:00\nThe patient in this visit was 32 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Migraine without aura\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-06-12 00:00:00, ended at 2020-06-12 00:00:00\nThe patient in this visit was 32 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- omeprazole 20 MG Delayed Release Oral Capsule, through Oral route, started on 2020-06-12, presumably until 2020-06-25, with intended 3 refill(s). Instructions: take 40 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-06-25 11:10:18, ended at 2020-06-25 11:27:50\nThe patient in this visit was 32 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Gastroparesis syndrome\n- Melena\n- Primary diagnosis: Disorder of upper gastrointestinal tract\n- Primary diagnosis: Epigastric pain\n\n### Drug\n- omeprazole 40 MG Delayed Release Oral Capsule, through Oral route, started on 2020-06-25, presumably until 2021-06-18, with intended 3 refill(s). Instructions: take 40 mg by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-07-01 14:23:00, ended at 2020-07-01 14:23:00\nThe patient in this visit was 32 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Nausea and vomiting\n- Peptic ulcer\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-08-12 13:24:39, ended at 2020-08-12 13:57:39\nThe patient in this visit was 32 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Postoperative state\n- Gastric ulcer without hemorrhage AND without perforation\n- Primary diagnosis: Nausea and vomiting\n- Hereditary thrombophilia\n- Mood disorder\n- Anxiety disorder\n- Seizure\n- Disorder of thyroid gland\n\n### Drug\n- folic acid 1 MG Oral Tablet, through Oral route, presumably until 2022-02-09, with intended 0 refill(s). Instructions: take 1 mg by mouth daily\n- cholecalciferol 0.125 MG Oral Capsule, through Oral route, with intended 0 refill(s). Instructions: Take 1 capsule (5,000 units total) by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-08-19 00:00:00, ended at 2020-08-19 00:00:00\nThe patient in this visit was 32 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for upper gastrointestinal endoscopic procedures, endoscope introduced proximal to duodenum; not otherwise specified\n\n### Condition\n- Disorder of upper gastrointestinal tract\n- Chronic gastritis\n- Nausea\n\n### Drug\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2020-08-19, presumably until 2020-08-19\n- 2 ML ondansetron 2 MG/ML Injection, started on 2020-08-19, presumably until 2020-08-19\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2020-08-19 00:00:00, ended at 2020-08-19 00:00:00\nThe patient in this visit was 32 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple\n- Esophagogastroduodenoscopy, flexible, transoral; with directed submucosal injection(s), any substance\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-08-19 10:25:00, ended at 2020-08-19 13:54:00\nThe patient in this visit was 32 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple\n- Esophagogastroduodenoscopy, flexible, transoral; with directed submucosal injection(s), any substance\n\n### Condition\n- Acquired absence of organ\n- Systemic lupus erythematosus\n- Anxiety disorder\n- Cracked tooth\n- Gastric ulcer without hemorrhage AND without perforation\n- Chronic gastritis\n- Disorder of digestive system\n- Hypothyroidism\n- Osteoarthritis\n- Steatosis of liver\n- Seizure\n- Nausea\n- Disorder of upper gastrointestinal tract\n- Major depression, single episode\n- Migraine without aura\n- Nausea and vomiting\n- Adult hypertrophic pyloric stenosis\n\n### Drug\n- onabotulinumtoxinA 100 UNT Injection, started on 2020-08-19, presumably until 2020-08-19\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-09-29 10:33:30, ended at 2020-09-29 10:50:23\nThe patient in this visit was 33 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Diarrhea\n\n### Drug\n- rifaximin 550 MG Oral Tablet, through Oral route, started on 2020-09-29, presumably until 2020-10-13, with intended 0 refill(s). Instructions: take 1 Tab (550 mg total) by mouth 3 times a day for 14 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-10-08 00:00:00, ended at 2020-10-08 00:00:00\nThe patient in this visit was 33 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- frovatriptan 2.5 MG Oral Tablet, started on 2020-10-08, presumably until 2021-06-18, with intended 2 refill(s). Instructions: Take 1 tab at onset of headache. May repeat in 2 hrs if needed. Limit 2 doses/24 hours. Limit to 10 days per month.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2021-06-05 00:00:00, ended at 2021-06-05 00:00:00\nThe patient in this visit was 33 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 13.1 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.3 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 25.1 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.3 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 66.9 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- lamoTRIgine [Mass/volume] in Serum or Plasma: 0.9 (microgram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.89 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.9 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 83 (milligram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Monocytes [#/volume] in Blood by Automated count: 0.39 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 146 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 115 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 12.4 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.3 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 277 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.32 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.84 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 28.7 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 3.3 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 69 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- MCV [Entitic volume] by Automated count: 86.8 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.91 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 20 (millimole per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.5 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2021-06-05 18:45:00, ended at 2021-06-06 00:55:00\nThe patient in this visit was 33 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 69 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 83 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.3 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 86.8 (femtoliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.32 (million per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.3 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 146 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.3 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.84 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 25.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 277 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.5 (percent)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.39 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 20 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.89 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.4 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.7 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 66.9 (percent)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.3 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.9 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 115 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.91 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Collection of venous blood by venipuncture\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Electrocardiogram abnormal\n- Epigastric pain\n- Stool finding\n- Disorder of digestive system\n- Systemic lupus erythematosus\n- Acquired absence of organ\n- Nervous system symptoms\n- Primary diagnosis: Organic personality disorder\n- Hypothyroidism\n- Seizure\n\n### Drug\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2021-06-05, presumably until 2021-06-05\n- 2 ML prochlorperazine 5 MG/ML Injection, started on 2021-06-05, presumably until 2021-06-05\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2021-06-05, presumably until 2021-06-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-06-09 10:08:15, ended at 2021-06-09 10:44:05\nThe patient in this visit was 33 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mental alertness - finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-06-14 00:00:00, ended at 2021-06-14 00:00:00\nThe patient in this visit was 33 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Loss of consciousness\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Systemic lupus erythematosus within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of lupus means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "3886dbbf1839cb2d9f9e91a9b66ce2003eee880ed3fb404b0ab5a81ddbffeece", "prompt_hash": "cea1610487fdbf5a4262db6d85f415f1d33923af12e8ceba1c2dafac13e395d6", "target_hash": "85a39ab345d672ff8ca9b9c6876f3adcacf45ee7c1e2dbd2408fd338bd55e07e", "exact_match": 0.0, "f1_gu_yn": [1, 0], "recall_gu_yn": [1, 0]}
{"doc_id": 3, "doc": {"person_id": 115969719, "visit_occurrence_id": 171104968, "death_date": null, "visit_concept_name": "Pharmacy visit", "visit_start_datetime": "2021-01-10 00:00:00", "visit_end_datetime": "2021-01-10 00:00:00", "visit_length_in_hours": 0.0, "integrated_visit_record": "## Visit\nThis visit record, was from Pharmacy visit, started at 2021-01-10 00:00:00, ended at 2021-01-10 00:00:00\nThe patient in this visit was 41 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- carvedilol 6.25 MG Oral Tablet, started on 2021-01-11, presumably until 2022-01-17, with intended 3 refill(s). Instructions: GENERIC FOR COREG, TAKE 1 TABLET BY MOUTH TWICE DAILY\n\n", "approximate_token_count": 122, "patient_first_visit_date": "2013-04-05 00:00:00", "patient_last_visit_date": "2023-02-07 15:29:02", "end_obs_date": "2022-01-10", "hypertension_type": "new", "hypertension_one_year_diagnosis": 0, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "new", "hyperlipidemia_one_year_diagnosis": 0, "depressive_disorder_type": "recurrent", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 1, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "recurrent", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "recurrent", "heart_failure_one_year_diagnosis": 1, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 443, "cumulated_visit_num": 443, "cumulated_approximate_token_count": 109213, "visit_cumulated": "## Visit\nThis visit record, was from Case Management Visit, started at 2013-04-05 00:00:00, ended at 2013-04-05 00:00:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Heterozygous thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-04-12 12:45:00, ended at 2013-04-12 12:59:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 139 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 50 (unit per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 49 (percent)\n- Monocytes [#/volume] in Blood by Manual count: 0.4 (thousand per microliter)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 7.68 (percent)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Iron [Mass/volume] in Serum or Plasma: 184 (microgram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 941 (nanogram per milliliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 6.0 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 3 (percent)\n- Neutrophils [#/volume] in Blood by Manual count: 5.8 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 113 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 118 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 17.0 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 5.72 (milli-international unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 101 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.6 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Manual count: 1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.3 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 56.1 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 52 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.03 (million per microliter)\n- Globulin [Mass/volume] in Serum: 4.8 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 5.1 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 16.8 (picogram)\n- MCHC [Mass/volume] by Automated count: 29.9 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 32.3 (percent)\n- Reticulocytes [#/volume] in Blood by Automated count: 247.6 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.1 (thousand per microliter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 183 (microgram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 38 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Heterozygous thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-04-12 13:00:00, ended at 2013-04-12 23:59:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3.701\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Heterozygous thalassemia\n- Primary diagnosis: Thalassemia\n\n### Drug\n- deferasirox 500 MG Tablet for Oral Suspension, through Oral route, started on 2013-04-12, presumably until 2013-06-13, with intended 2 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n- econazole nitrate 10 MG/ML Topical Cream, through Topical route, presumably until 2013-05-18. Instructions: by Topical route 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-04-13 00:00:00, ended at 2013-04-13 00:00:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-04-13 00:00:00, ended at 2013-04-13 00:00:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-04-14 00:00:00, ended at 2013-04-14 00:00:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-05-06 00:00:00, ended at 2013-05-06 00:00:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-05-06 00:00:00, ended at 2013-05-06 00:00:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acquired absence of organ\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-05-06 10:02:58, ended at 2013-05-06 10:54:08\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anemia\n- Splenomegaly\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- 0.5 ML Haemophilus influenzae type b strain 1482, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.068 MG/ML Injection, through Intramuscular route, started on 2013-05-06, presumably until 2013-05-07, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-05-06 11:28:00, ended at 2013-05-06 23:59:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Hemoglobin [Mass/volume] in Blood: 4.9 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 31.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 55.1 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 34 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 8.3 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.2 (thousand per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 980 (nanogram per milliliter)\n- Globulin [Mass/volume] in Serum: 4.4 (gram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.2 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.1 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 44 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 176 (microgram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 115 (thousand per microliter)\n- Thrombin time: 15.2 (second)\n- Thyrotropin [Units/volume] in Serum or Plasma: 6.41 (milli-international unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 110 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 31.5 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 15.5 (percent)\n- Iron [Mass/volume] in Serum or Plasma: 185 (microgram per deciliter)\n- MCH [Entitic mass] by Automated count: 17.5 (picogram)\n- Prothrombin time (PT): 15.2 (second)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 1.1 (nanogram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 62 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 85 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.3 (ratio)\n- aPTT in Platelet poor plasma by Coagulation assay: 69.4 (second)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Choriogonadotropin.intact+Beta subunit [Units/volume] in Serum or Plasma: 25336 (milli-international unit per milliliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.81 (million per microliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 105 (percent)\n- Neutrophils [#/volume] in Blood by Manual count: 3.8 (thousand per microliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 325 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 60 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Manual count: 2 (percent)\n- Lymphocytes [#/volume] in Blood by Manual count: 6.1 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 1 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Beta thalassemia\n- Splenomegaly\n- Thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-05-10 00:00:00, ended at 2013-05-10 00:00:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-05-10 00:00:00, ended at 2013-05-10 00:00:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-05-17 00:00:00, ended at 2013-05-17 00:00:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Cardiac arrhythmia\n- Premature beats\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-05-18 09:00:00, ended at 2013-05-18 23:59:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Cardiomyopathy associated with another disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-05-18 10:33:27, ended at 2013-05-18 11:54:52\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n- Unplanned pregnancy\n- Anemia\n\n### Drug\n- folic acid 1 MG Oral Tablet, through Oral route, presumably until 2014-02-01. Instructions: take 1 mg by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-05-20 00:00:00, ended at 2013-05-20 00:00:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ulcer of lower extremity\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-05-24 00:00:00, ended at 2013-05-24 00:00:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-05-24 16:00:00, ended at 2013-05-24 16:03:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3.78\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Beta thalassemia\n- Finding related to pregnancy\n- Primary diagnosis: Unplanned pregnancy\n- Blood coagulation disorder\n- Complication occurring during pregnancy\n- Anemia\n- Thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-05-24 16:04:00, ended at 2013-05-24 17:42:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.52 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 83 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.1 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.3 (ratio)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 112 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 16.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.6 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 3.6 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 47 (percent)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 1 (percent)\n- Neutrophils [#/volume] in Blood by Manual count: 3.9 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Ferritin [Mass/volume] in Serum or Plasma: 880 (nanogram per milliliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- MCHC [Mass/volume] by Automated count: 29.3 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 4.8 (gram per deciliter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 181 (microgram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 47 (percent)\n- MCH [Entitic mass] by Automated count: 18.8 (picogram)\n- aPTT in Platelet poor plasma by Coagulation assay: 57.8 (second)\n- Globulin [Mass/volume] in Serum: 4.2 (gram per deciliter)\n- Iron [Mass/volume] in Serum or Plasma: 137 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 76 (percent)\n- Platelets [#/volume] in Blood by Automated count: 156 (thousand per microliter)\n- Prothrombin time (PT): 15.6 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 38 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 33.3 (percent)\n- MCV [Entitic volume] by Automated count: 64.4 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.9 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-05-24 17:43:00, ended at 2013-05-24 23:59:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-05-25 00:00:00, ended at 2013-05-25 00:00:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-05-26 00:00:00, ended at 2013-05-26 00:00:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-05-31 15:18:00, ended at 2013-05-31 15:55:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Glucose [Mass/volume] in Serum or Plasma: 84 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 30.4 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.3 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.0 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 56.7 (femtoliter)\n- Neutrophils [#/volume] in Blood by Manual count: 3.7 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 50 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 152 (microgram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 4.8 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 3 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 32.0 (percent)\n- Ferritin [Mass/volume] in Serum or Plasma: 870 (nanogram per milliliter)\n- Iron [Mass/volume] in Serum or Plasma: 155 (microgram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 54 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 112 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 46 (unit per liter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.2 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 13.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 4.2 (gram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 102 (percent)\n- Platelets [#/volume] in Blood by Automated count: 131 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 7.8 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Manual count: 2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.45 (million per microliter)\n- MCH [Entitic mass] by Automated count: 17.2 (picogram)\n- Globulin [Mass/volume] in Serum: 3.9 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 33 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Beta thalassemia\n- Thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-05-31 15:56:00, ended at 2013-05-31 23:59:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3.78\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anemia\n- Hypercoagulability state\n- Postpartum finding\n- Primary diagnosis: Unplanned pregnancy\n- Complication occurring during pregnancy\n- Finding related to pregnancy\n- Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-06-07 14:58:47, ended at 2013-06-07 15:58:07\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Unplanned pregnancy\n- Anemia\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2013-06-09 00:00:00, ended at 2013-06-09 00:00:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for intraperitoneal procedures in upper abdomen including laparoscopy; not otherwise specified\n- Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous\n\n### Condition\n- Anemia\n- Beta thalassemia\n- Splenomegaly\n\n### Drug\n- neostigmine methylsulfate 0.5 MG/ML Injectable Solution, started on 2013-06-09, presumably until 2013-06-09\n- 10 ML calcium chloride 100 MG/ML Injection, through Intravenous route, started on 2013-06-09, presumably until 2013-06-09\n- glycopyrrolate 0.2 MG/ML Injectable Solution, started on 2013-06-09, presumably until 2013-06-09\n- 2 ML magnesium sulfate 500 MG/ML Injection, through Intravenous route, started on 2013-06-09, presumably until 2013-06-09\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2013-06-09, presumably until 2013-06-09\n- 50 ML clindamycin 12 MG/ML Injection, through Intravenous route, started on 2013-06-09, presumably until 2013-06-09\n- 2 ML lidocaine hydrochloride 20 MG/ML Injection, started on 2013-06-09, presumably until 2013-06-09\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2013-06-09, presumably until 2013-06-09\n- 2 ML ondansetron 2 MG/ML Injection, started on 2013-06-09, presumably until 2013-06-09\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2013-06-09, presumably until 2013-06-09\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-06-09 00:00:00, ended at 2013-06-09 00:00:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Unplanned pregnancy\n- Primary diagnosis: Beta thalassemia\n- Acquired absence of organ\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2013-06-09 09:10:00, ended at 2013-06-13 17:29:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.3 (ratio)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.82 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.4 (percent)\n- MCV [Entitic volume] by Automated count: 71.5 (femtoliter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Body height: 5' 4.016\" (inch (US))\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 30.6 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.4 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 21.0 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 295 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 64.3 (second)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.18 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 37.3 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): N/A (milliliter per minute per square meter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.9 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 74 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.7 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Prothrombin time (PT): 15.1 (second)\n\n### Procedure\n- Total splenectomy\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Packed blood cell transfusion\n- Collection of venous blood by venipuncture\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Splitting of blood or blood products, each unit\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Congestive heart failure\n- Electrocardiogram abnormal\n- Hemochromatosis following repeated red blood cell transfusion\n- Acquired hypothyroidism\n- Anemia\n- Chronic cor pulmonale\n- Blood coagulation disorder\n- Candidiasis\n- Heart disease in mother complicating pregnancy, childbirth AND/OR puerperium\n- Maternal AND/OR fetal condition affecting labor AND/OR delivery\n- Paroxysmal ventricular tachycardia\n- Right bundle branch block\n- Anemia during pregnancy - baby not yet delivered\n- Complication occurring during pregnancy\n- Thalassemia\n- Thyroid dysfunction during pregnancy, childbirth and the puerperium\n- Congenital arteriovenous malformation of gastrointestinal tract\n- Hypercoagulability state\n- Premature beats\n- Splenomegaly\n- Primary diagnosis: Acquired absence of organ\n- Beta thalassemia\n- Congenital anomaly of gastrointestinal tract\n- Finding related to pregnancy\n- Cardiac arrhythmia\n\n### Drug\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2013-06-09, presumably until 2013-06-11\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2013-06-11, presumably until 2013-06-11\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2013-06-12, presumably until 2013-06-13\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2013-06-10, presumably until 2013-06-22, with intended 1 refill(s). Instructions: inject 0.4 mL subcutaneous (under the skin) One Time.\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2013-06-10, presumably until 2013-06-10\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2013-06-12, presumably until 2013-07-15, with intended 1 refill(s). Instructions: take 1 Cap by mouth 2 times a day.\n- 10 ML furosemide 10 MG/ML Injection, started on 2013-06-10, presumably until 2013-06-10\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2013-06-09, presumably until 2013-06-12\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2013-06-12, presumably until 2014-01-03, with intended 1 refill(s). Instructions: take 1 Packet by mouth daily.\n- 2 ML ondansetron 2 MG/ML Injection, started on 2013-06-09, presumably until 2013-06-12\n- 1 ML hydromorphone hydrochloride 2 MG/ML Prefilled Syringe, started on 2013-06-09, presumably until 2013-06-09\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2013-06-09, presumably until 2013-06-09\n- levothyroxine sodium 0.075 MG Oral Tablet, through Oral route, started on 2013-06-10, presumably until 2013-06-13\n- 12 HR oxycodone hydrochloride 10 MG Extended Release Oral Tablet, through Oral route, started on 2013-06-10, presumably until 2013-12-10, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 12 hours.\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2013-06-10, presumably until 2013-12-10, with intended 0 refill(s). Instructions: take 1-4 Tabs by mouth every 4 hours as needed for Pain.\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2013-06-10, presumably until 2013-09-22, with intended 0 refill(s). Instructions: take 1 Tab by mouth every morning with breakfast.\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2013-06-11, presumably until 2013-06-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2013-06-10 00:00:00, ended at 2013-06-10 00:00:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 10 ML bupivacaine hydrochloride 2.5 MG/ML Injection, started on 2013-06-10, presumably until 2013-06-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-06-18 00:00:00, ended at 2013-06-18 00:00:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acquired absence of organ\n\n### Drug\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2013-06-18, presumably until 2013-12-15, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-06-21 00:00:00, ended at 2013-06-21 00:00:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acquired absence of organ\n\n### Drug\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2013-06-21, presumably until 2014-06-21, with intended 1 refill(s). Instructions: inject 0.4 mL subcutaneous (under the skin) One Time.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-06-21 15:15:00, ended at 2013-06-21 15:25:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Eosinophils/100 leukocytes in Blood by Manual count: 2 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 23.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 7.4 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 59 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.2 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 228 (microgram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 29 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 141 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 84 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 66.2 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 1081 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Manual count: 0.1 (thousand per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 2314 (nanogram per milliliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 17 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 60 (unit per liter)\n- Basophils/100 leukocytes in Blood by Manual count: 1 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- MCH [Entitic mass] by Automated count: 20.6 (picogram)\n- MCHC [Mass/volume] by Automated count: 31.0 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.9 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.2 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.61 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.0 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 3.2 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Manual count: 6.6 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- Monocytes/100 leukocytes in Blood by Manual count: 8 (percent)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 33.4 (percent)\n- Iron [Mass/volume] in Serum or Plasma: 38 (microgram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Unplanned pregnancy\n- Thalassemia\n- Beta thalassemia\n- Acquired absence of organ\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-06-21 15:26:00, ended at 2013-06-21 23:59:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3.78\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acquired absence of organ\n- Finding related to pregnancy\n- Disorder of iron metabolism\n- Unplanned pregnancy\n- Coag./bleeding tests abnormal\n- Complication occurring during pregnancy\n- Blood coagulation disorder\n- Anemia\n- Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-06-22 00:00:00, ended at 2013-06-22 00:00:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypercoagulability state\n\n### Drug\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2013-06-22, presumably until 2013-08-22, with intended 6 refill(s). Instructions: inject 0.4 mL subcutaneous (under the skin) daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-06-23 14:00:00, ended at 2013-06-23 23:59:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Transfusion, blood or blood components\n\n### Condition\n- Anemia\n- Beta thalassemia\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2013-06-23, presumably until 2013-06-23\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2013-06-23, presumably until 2013-06-23\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-06-27 00:00:00, ended at 2013-06-27 00:00:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-06-27 14:32:00, ended at 2013-06-27 14:44:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Hemoglobin [Mass/volume] in Blood: 9.4 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 73.1 (femtoliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.5 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 21.9 (picogram)\n- Urate [Mass/volume] in Serum or Plasma: 3.1 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 50 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 145 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 30.0 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 73 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.9 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.29 (million per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Lymphocytes [#/volume] in Blood by Manual count: 2.3 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.0 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 19 (percent)\n- Monocytes/100 leukocytes in Blood by Manual count: 8 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.0 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 891 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 80 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Manual count: 8.7 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 133 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 38.6 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.4 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-06-27 14:45:00, ended at 2013-06-27 23:59:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Beta thalassemia\n- Anemia\n- Primary diagnosis: Hypercoagulability state\n- Primary gout\n\n### Drug\n- colchicine 0.6 MG Oral Tablet, through Oral route, started on 2013-06-27, presumably until 2013-06-27\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2013-06-27, presumably until 2013-06-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-07-07 15:07:33, ended at 2013-07-07 17:00:47\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypercoagulability state\n- Primary diagnosis: Beta thalassemia\n- Unplanned pregnancy\n- Acquired absence of organ\n- Gout\n- Monoarthritis\n- Anemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-07-09 00:00:00, ended at 2013-07-09 00:00:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Gout\n\n### Drug\n- prednisone 20 MG Oral Tablet, through Oral route, started on 2013-07-09, presumably until 2013-08-23, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-07-10 00:00:00, ended at 2013-07-10 00:00:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Gout\n\n### Drug\n- colchicine 0.6 MG Oral Tablet, started on 2013-07-10, presumably until 2013-09-16, with intended 0 refill(s). Instructions: Please 2 tablets on the first day and take one tablet daily until symptoms resolve.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-07-15 00:00:00, ended at 2013-07-15 00:00:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acquired absence of organ\n- Beta thalassemia\n\n### Drug\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2013-07-15, presumably until 2013-11-08, with intended 1 refill(s). Instructions: take 1 Cap by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-07-26 13:20:00, ended at 2013-07-26 23:59:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 35.2 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.31 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 14 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 57 (percent)\n- Platelets [#/volume] in Blood by Automated count: 750 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 7.8 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Manual count: 2 (percent)\n- Iron [Mass/volume] in Serum or Plasma: 225 (microgram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.6 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.4 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 2.9 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 30.4 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 2.6 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.2 (thousand per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 1232 (nanogram per milliliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 25.8 (percent)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 194 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 116 (percent)\n- MCH [Entitic mass] by Automated count: 23.7 (picogram)\n- MCV [Entitic volume] by Automated count: 77.8 (femtoliter)\n- Neutrophils [#/volume] in Blood by Manual count: 6.7 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 104 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 25 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Transfusion, blood or blood components\n\n### Condition\n- Anemia\n- Primary diagnosis: Thalassemia\n- Beta thalassemia\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2013-07-26, presumably until 2013-07-26\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2013-07-26, presumably until 2013-07-26\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-08-19 00:00:00, ended at 2013-08-19 00:00:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-08-19 14:45:00, ended at 2013-08-19 23:59:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Manual count: 4 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 84 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 17.0 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 79.8 (femtoliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.27 (million per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 1031 (nanogram per milliliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- Iron [Mass/volume] in Serum or Plasma: 207 (microgram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.2 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Manual count: 11.2 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 659 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Basophils/100 leukocytes in Blood by Manual count: 2 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 2.4 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Hemoglobin [Mass/volume] in Blood: 8.3 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 3.6 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 28.5 (percent)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 21 (percent)\n- MCH [Entitic mass] by Automated count: 25.2 (picogram)\n- Prothrombin time (PT): 13.7 (second)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 107 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 191 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 108 (percent)\n- MCHC [Mass/volume] by Automated count: 31.6 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 58 (percent)\n- Eosinophils [#/volume] in Blood by Manual count: 0.7 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 4.1 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Basophils [#/volume] in Blood by Manual count: 0.3 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.1 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 7 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 34.1 (second)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Beta thalassemia\n- Anemia\n- Thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-08-22 00:00:00, ended at 2013-08-22 00:00:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-08-22 00:00:00, ended at 2013-08-22 00:00:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypercoagulability state\n\n### Drug\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2013-08-22, presumably until 2014-04-18, with intended 6 refill(s). Instructions: inject 0.4 mL subcutaneous (under the skin) daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-08-22 00:00:00, ended at 2013-08-22 00:00:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-08-23 00:00:00, ended at 2013-08-23 00:00:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Gout\n\n### Drug\n- prednisone 20 MG Oral Tablet, through Oral route, started on 2013-08-23, presumably until 2014-02-01, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-08-23 14:13:00, ended at 2013-08-23 14:25:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Monocytes [#/volume] in Blood by Manual count: 1.6 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Manual count: 13.1 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 27.9 (percent)\n- MCH [Entitic mass] by Automated count: 25.2 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 720 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 28.6 (percent)\n- Lymphocytes [#/volume] in Blood by Manual count: 1.5 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 79 (percent)\n- Hemoglobin [Mass/volume] in Blood: 8.3 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 9 (percent)\n- MCHC [Mass/volume] by Automated count: 29.7 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.28 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 16.2 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 85.1 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 10 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-08-23 14:26:00, ended at 2013-08-23 23:59:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3.78\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anemia\n- Unplanned pregnancy\n- Beta thalassemia\n- Acquired absence of organ\n- Primary diagnosis: Hypercoagulability state\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-09-07 00:00:00, ended at 2013-09-07 00:00:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Anemia\n- Beta thalassemia\n- Unplanned pregnancy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-09-08 13:38:00, ended at 2013-09-08 23:59:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Monocytes [#/volume] in Blood by Manual count: 1.8 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 50 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 38 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 921 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- MCV [Entitic volume] by Automated count: N/A (femtoliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 26 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.7 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.31 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 7.8 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 16 (percent)\n- Neutrophils [#/volume] in Blood by Manual count: 4.1 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 759 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 116 (unit per liter)\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.4 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 1.1 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 103 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.0 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Cells counted [#] in Chorionic villus sample by Molecular genetics method: 50 (cells)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.1 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Beta thalassemia\n- Primary diagnosis: Anemia\n- Thalassemia\n- Unplanned pregnancy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-09-09 14:30:00, ended at 2013-09-09 23:59:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Transfusion, blood or blood components\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-09-16 10:02:47, ended at 2013-09-16 11:09:16\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Cardiomyopathy associated with another disorder\n- Primary diagnosis: Beta thalassemia\n- Unplanned pregnancy\n- Anemia\n- Congestive heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-09-22 00:00:00, ended at 2013-09-22 00:00:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acquired absence of organ\n\n### Drug\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2013-09-22, presumably until 2014-09-22, with intended 0 refill(s). Instructions: take 1 Tab by mouth every morning with breakfast.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-10-11 14:06:00, ended at 2013-10-11 14:29:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Platelets [#/volume] in Blood by Automated count: 744 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 26 (percent)\n- Neutrophils [#/volume] in Blood by Manual count: 6.1 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Basophils [#/volume] in Blood by Manual count: 0.3 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.17 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 27.5 (percent)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 454 (microgram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 86.8 (femtoliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.5 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 2.9 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 119 (unit per liter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 52 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.2 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 30.0 (percent)\n- Ferritin [Mass/volume] in Serum or Plasma: 894 (nanogram per milliliter)\n- Globulin [Mass/volume] in Serum: 4.1 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 8.1 (gram per deciliter)\n- Iron [Mass/volume] in Serum or Plasma: 259 (microgram per deciliter)\n- MCH [Entitic mass] by Automated count: 25.4 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Manual count: 3 (percent)\n- Eosinophils/100 leukocytes in Blood by Manual count: 2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.0 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 29.2 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 14 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 57 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Beta thalassemia\n- Anemia\n- Thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-10-11 14:30:00, ended at 2013-10-11 23:59:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cardiomyopathy associated with another disorder\n- Acquired absence of organ\n- Abnormal glucose tolerance in mother complicating pregnancy, childbirth AND/OR puerperium\n- Finding related to pregnancy\n- Congestive heart failure\n- Hypercoagulability state\n- Anemia\n- Unplanned pregnancy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-10-12 00:00:00, ended at 2013-10-12 00:00:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-10-13 08:30:00, ended at 2013-10-13 23:59:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Transfusion, blood or blood components\n\n### Condition\n- Beta thalassemia\n- Anemia\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2013-10-13, presumably until 2013-10-13\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2013-10-13, presumably until 2013-10-13\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-11-08 13:22:00, ended at 2013-11-08 13:31:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.38 (million per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Iron [Mass/volume] in Serum or Plasma: 287 (microgram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 2.6 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Manual count: 9.6 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 144 (unit per liter)\n- Basophils [#/volume] in Blood by Manual count: 0.3 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 18 (percent)\n- MCH [Entitic mass] by Automated count: 22.8 (picogram)\n- MCHC [Mass/volume] by Automated count: 26.7 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 259 (microgram per deciliter)\n- Basophils/100 leukocytes in Blood by Manual count: 2 (percent)\n- Globulin [Mass/volume] in Serum: 4.2 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.8 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.9 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 7.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 85.3 (femtoliter)\n- Monocytes [#/volume] in Blood by Manual count: 2.0 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Ferritin [Mass/volume] in Serum or Plasma: 1085 (nanogram per milliliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 14.5 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 14 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 30.5 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 113 (milligram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 111 (percent)\n- Platelets [#/volume] in Blood by Automated count: 760 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 64 (percent)\n- Cells counted [#] in Chorionic villus sample by Molecular genetics method: 50 (cells)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Beta thalassemia\n- Thalassemia\n- Anemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-11-08 13:32:00, ended at 2013-11-08 23:59:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.173\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cardiomyopathy associated with another disorder\n- Beta thalassemia\n- Hypercoagulability state\n- Abnormal glucose tolerance in mother complicating pregnancy, childbirth AND/OR puerperium\n- Congestive heart failure\n- Finding related to pregnancy\n- Anemia\n- Unplanned pregnancy\n- Acquired absence of organ\n\n### Drug\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2013-11-08, presumably until 2014-01-03, with intended 3 refill(s). Instructions: take 1 Cap by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-11-10 00:00:00, ended at 2013-11-10 00:00:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-11-10 00:00:00, ended at 2013-11-10 00:00:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Unplanned pregnancy\n- Primary diagnosis: Beta thalassemia\n- Anemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-11-11 17:11:00, ended at 2013-11-11 23:59:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Beta thalassemia\n- Anemia\n- Unplanned pregnancy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-11-12 13:22:00, ended at 2013-11-12 23:59:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Transfusion, blood or blood components\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2013-11-12, presumably until 2013-11-12\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2013-11-12, presumably until 2013-11-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-12-09 00:00:00, ended at 2013-12-09 00:00:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 48 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-12-09 00:00:00, ended at 2013-12-09 08:37:12\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Congestive heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-01-03 15:46:00, ended at 2014-01-03 16:03:00\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.6 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 2.4 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 1006 (thousand per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 86 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Manual count: 2 (percent)\n- Hemoglobin [Mass/volume] in Blood: 8.5 (gram per deciliter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 221 (microgram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 56 (percent)\n- Ferritin [Mass/volume] in Serum or Plasma: 3363 (nanogram per milliliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 13.2 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 26 (percent)\n- MCH [Entitic mass] by Automated count: 18.8 (picogram)\n- Monocytes/100 leukocytes in Blood by Manual count: 10 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.54 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 110 (milligram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 48 (percent)\n- MCHC [Mass/volume] by Automated count: 28.8 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 65.3 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Manual count: 2 (percent)\n- Iron [Mass/volume] in Serum or Plasma: 106 (microgram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.1 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 227 (unit per liter)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 149 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 42.1 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Anemia\n- Beta thalassemia\n- Thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-01-03 16:04:00, ended at 2014-01-03 23:59:00\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.173\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypercoagulability state\n- Acquired absence of organ\n- Anemia\n- Beta thalassemia\n- Primary diagnosis: Cardiomyopathy associated with another disorder\n- Essential thrombocythemia\n\n### Drug\n- levothyroxine sodium 0.1 MG Oral Tablet, started on 2013-12-06, presumably until 2014-02-01\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-02-21 00:00:00, ended at 2014-02-21 00:00:00\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-02-21 15:54:00, ended at 2014-02-21 23:59:00\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acquired absence of organ\n- Beta thalassemia\n- Disorder of iron metabolism\n- Hypercoagulability state\n- Primary diagnosis: Anemia\n- Thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-04-12 09:45:00, ended at 2014-04-12 23:59:00\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s)\n\n### Condition\n- Hemochromatosis\n- Thalassemia\n- Beta thalassemia\n- Chronic nonalcoholic liver disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-04-13 00:00:00, ended at 2014-04-13 00:00:00\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n- Anemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-04-18 12:59:00, ended at 2014-04-18 13:15:00\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 3.74 (million per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 28 (percent)\n- MCH [Entitic mass] by Automated count: 19.6 (picogram)\n- Monocytes/100 leukocytes in Blood by Manual count: 8 (percent)\n- Ferritin [Mass/volume] in Serum or Plasma: 4289 (nanogram per milliliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 106 (percent)\n- MCHC [Mass/volume] by Automated count: 26.6 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 170 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 4.3 (milligram per deciliter)\n- Cells counted [#] in Chorionic villus sample by Molecular genetics method: 25 (cells)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 190 (microgram per deciliter)\n- MCV [Entitic volume] by Automated count: 73.6 (femtoliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.7 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 114 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 114 (milligram per deciliter)\n- Iron [Mass/volume] in Serum or Plasma: 201 (microgram per deciliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 3.02 (milli-international unit per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.4 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 67 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 33.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 7.3 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Manual count: 6.0 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.3 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 2.6 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 56 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 607 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.5 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 27.5 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Anemia\n- Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-04-18 13:16:00, ended at 2014-04-18 23:59:00\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypercoagulability state\n- Refractory anemia (clinical)\n- Acquired absence of organ\n- Chronic combined systolic and diastolic heart failure\n- Sideroblastic anemia\n- Anemia\n- Cardiomyopathy associated with another disorder\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-04-19 00:00:00, ended at 2014-04-19 00:00:00\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- deferasirox 500 MG Tablet for Oral Suspension, through Oral route, started on 2014-04-19, presumably until 2014-07-05, with intended 2 refill(s). Instructions: take 3 Tabs by mouth as directed. Take 2 tabs (1000 mg) in am and 1 tab (500 mg ) in pm both with a glass of juice\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-05-30 00:00:00, ended at 2014-05-30 00:00:00\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n- Disorder of skin and/or subcutaneous tissue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-05-30 00:00:00, ended at 2014-05-30 00:00:00\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-30 12:35:00, ended at 2014-05-30 12:48:00\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Manual count: 0.2 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.7 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 7.0 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 28 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.1 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 104 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.4 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 167 (unit per liter)\n- Basophils/100 leukocytes in Blood by Manual count: 2 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 5.1 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Ferritin [Mass/volume] in Serum or Plasma: 5780 (nanogram per milliliter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 190 (microgram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 48 (percent)\n- Reticulocytes [#/volume] in Blood by Automated count: 106.3 (thousand per microliter)\n- Iron [Mass/volume] in Serum or Plasma: 262 (microgram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 5.5 (thousand per microliter)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 3.18 (percent)\n- Eosinophils/100 leukocytes in Blood by Manual count: 6 (percent)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 138 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.5 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 157 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.9 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 25.9 (percent)\n- Platelets [#/volume] in Blood by Automated count: 639 (thousand per microliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Cells counted [#] in Chorionic villus sample by Molecular genetics method: 50 (cells)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.35 (million per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 111 (unit per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Monocytes/100 leukocytes in Blood by Manual count: 12 (percent)\n- Neutrophils [#/volume] in Blood by Manual count: 3.7 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-30 12:49:00, ended at 2014-05-30 23:59:00\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypercoagulability state\n- Anemia\n- Ulcer of lower extremity\n- Acquired absence of organ\n- Cardiomyopathy associated with another disorder\n- Beta thalassemia\n- Primary diagnosis: Hemochromatosis following repeated red blood cell transfusion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-06-27 13:10:00, ended at 2014-06-27 18:51:00\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Beta thalassemia\n- Primary diagnosis: Ulcer of lower extremity\n- Hemochromatosis following repeated red blood cell transfusion\n\n### Drug\n- ciclopirox 7.7 MG/ML Topical Cream, through Topical route, started on 2014-06-27, presumably until 2014-07-12, with intended 1 refill(s). Instructions: by Topical route 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-06-27 18:52:00, ended at 2014-06-27 23:59:00\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ulcer of lower extremity\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-07-03 00:00:00, ended at 2014-07-03 00:00:00\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Ulcer of lower extremity\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-07-05 00:00:00, ended at 2014-07-05 00:00:00\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- deferasirox 500 MG Tablet for Oral Suspension, through Oral route, started on 2014-07-05, presumably until 2015-04-24, with intended 0 refill(s). Instructions: take 3.5 Tabs by mouth Every Day. Take 2 tabs (1000 mg) in am and 1.5 tab (750 mg ) in pm both with a glass of juice\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-07-07 15:00:00, ended at 2014-07-07 23:59:00\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Limited bilateral noninvasive physiologic studies of upper or lower extremity arteries, (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus bidirectional, Doppler waveform recording \n\n### Condition\n- Ulcer of lower extremity\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-07-12 14:30:00, ended at 2014-07-12 23:59:00\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.961\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Ulcer of lower extremity\n\n### Drug\n- tacrolimus 0.001 MG/MG Topical Ointment, started on 2014-07-12, presumably until 2014-11-14, with intended 3 refill(s). Instructions: Apply topically as directed once daily, for skin surround the ulcers.\n- fluocinonide 0.0005 MG/MG Topical Ointment, started on 2014-07-12, presumably until 2015-07-12, with intended 3 refill(s). Instructions: Apply topically to affected area once daily, to skin surrounding ulcers.\n- ciclopirox 7.7 MG/ML Topical Cream, started on 2014-07-12, presumably until 2014-11-14, with intended 2 refill(s). Instructions: Apply to affected area twice daily as directed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-07-26 15:14:00, ended at 2014-07-26 23:59:00\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.961\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Ulcer of lower extremity\n- Beta thalassemia\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2014-07-26, presumably until 2014-08-16, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed. As needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-08-16 15:15:00, ended at 2014-08-16 23:59:00\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.961\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Beta thalassemia\n- Localized infection of skin AND/OR subcutaneous tissue\n- Primary diagnosis: Ulcer of lower extremity\n\n### Drug\n- sulfamethoxazole 800 MG / trimethoprim 160 MG Oral Tablet, through Oral route, started on 2014-08-16, presumably until 2014-11-14, with intended 3 refill(s). Instructions: take 1 tablet by mouth 2 times a day. Stop medication immediately if rash or flu like symptoms develop and notify physician\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2014-08-16, presumably until 2014-11-14, with intended 0 refill(s). Instructions: take 1 tablet by mouth every 4 hours as needed. As needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-08-17 07:08:00, ended at 2014-08-17 23:59:00\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ulcer of lower extremity\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-08-24 14:46:00, ended at 2014-08-24 23:59:00\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.961\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic ulcer of skin\n\n### Drug\n- acetaminophen 300 MG / codeine phosphate 30 MG Oral Tablet, through Oral route, started on 2014-08-24, presumably until 2014-08-31, with intended 0 refill(s). Instructions: take 1 tablet by mouth every 4 hours as needed.\n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2014-08-24, presumably until 2014-09-03, with intended 0 refill(s). Instructions: take 1 tablet by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-08-31 14:30:00, ended at 2014-08-31 23:59:00\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ulcer of lower extremity\n- Primary diagnosis: Inflammatory dermatosis\n\n### Drug\n- triamcinolone acetonide 0.001 MG/MG Topical Ointment, started on 2014-08-31, presumably until 2014-11-14, with intended 0 refill(s). Instructions: Apply to itchy area of L upper thigh\n- acetaminophen 300 MG / codeine phosphate 30 MG Oral Tablet, through Oral route, started on 2014-08-31, presumably until 2014-09-12, with intended 0 refill(s). Instructions: take 1 tablet by mouth every 4 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-09-07 14:21:00, ended at 2014-09-07 23:59:00\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.961\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Ankle ulcer\n\n### Drug\n- lidocaine 25 MG/ML / prilocaine 25 MG/ML Topical Cream, through Topical route, started on 2014-09-07, presumably until 2014-11-14, with intended 0 refill(s). Instructions: by Topical route as needed.\n- collagenase 0.25 UNT/MG Topical Ointment, through Topical route, started on 2014-09-07, presumably until 2014-09-12, with intended 0 refill(s). Instructions: by Topical route daily. To affected area\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-09-12 15:30:00, ended at 2014-09-12 23:59:00\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Ankle ulcer\n\n### Drug\n- acetaminophen 300 MG / codeine phosphate 30 MG Oral Tablet, through Oral route, started on 2014-09-12, presumably until 2015-03-11, with intended 0 refill(s). Instructions: take 1 tablet by mouth every 4 hours as needed.\n- collagenase 0.25 UNT/MG Topical Ointment, through Topical route, started on 2014-09-12, presumably until 2014-09-17, with intended 0 refill(s). Instructions: by Topical route daily. To affected area\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-09-17 00:00:00, ended at 2014-09-17 00:00:00\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ankle ulcer\n\n### Drug\n- collagenase 0.25 UNT/MG Topical Ointment, through Topical route, started on 2014-09-17, presumably until 2014-10-26, with intended 0 refill(s). Instructions: by Topical route 2 times a day. To affected area\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-09-20 10:08:18, ended at 2014-09-20 13:18:50\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Ankle ulcer\n- Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-09-28 14:54:00, ended at 2014-09-28 23:59:00\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.961\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pain in limb\n- Primary diagnosis: Ankle ulcer\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-10-12 14:30:00, ended at 2014-10-12 23:59:00\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.961\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Ankle ulcer\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-10-24 09:10:01, ended at 2014-10-24 10:32:16\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic pain\n- Primary diagnosis: Pain in limb\n\n### Drug\n- deferasirox 250 MG Tablet for Oral Suspension, started on 2014-10-18, presumably until 2014-11-14, with intended 0 refill(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-10-24 09:11:00, ended at 2014-10-24 09:16:00\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, foot; complete, minimum of 3 views\n\n### Condition\n- Pain in limb\n- Swelling / lump finding\n- Thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-10-25 00:00:00, ended at 2014-10-25 00:00:00\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ankle ulcer\n\n### Drug\n- collagenase 0.25 UNT/MG Topical Ointment, through Topical route, started on 2014-10-26, presumably until 2014-11-14, with intended 4 refill(s). Instructions: by Topical route 2 times a day. To affected area\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-11-08 15:45:00, ended at 2014-11-08 23:59:00\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.961\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Ankle ulcer\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-11-13 00:00:00, ended at 2014-11-13 00:00:00\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-11-14 00:00:00, ended at 2014-11-14 00:00:00\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Anemia\n- Acquired absence of organ\n- Beta thalassemia\n- Hemochromatosis following repeated red blood cell transfusion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-11-14 15:22:00, ended at 2014-11-14 15:44:00\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Ferritin [Mass/volume] in Serum or Plasma: 2927 (nanogram per milliliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 191 (microgram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 637 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 35.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.28 (million per microliter)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Reticulocytes [#/volume] in Blood by Automated count: 191.7 (thousand per microliter)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 5.84 (percent)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.9 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 111 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 6.2 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 48 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 24.5 (percent)\n- MCH [Entitic mass] by Automated count: 19.5 (picogram)\n- Monocytes [#/volume] in Blood by Manual count: 0.5 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Manual count: 6.2 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 4.8 (milligram per deciliter)\n- Cells counted [#] in Chorionic villus sample by Molecular genetics method: 50 (cells)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 134 (percent)\n- Monocytes/100 leukocytes in Blood by Manual count: 4 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.4 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 6.4 (gram per deciliter)\n- Iron [Mass/volume] in Serum or Plasma: 256 (microgram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 46 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 144 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 26.1 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 74.5 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.9 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Beta thalassemia\n- Hemochromatosis following repeated red blood cell transfusion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-11-14 15:45:00, ended at 2014-11-14 23:59:00\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hemochromatosis following repeated red blood cell transfusion\n- Beta thalassemia\n- Ankle ulcer\n- Hemoglobin E/beta thalassemia disease\n- Primary diagnosis: Anemia\n- Hypercoagulability state\n- Acquired hypothyroidism\n- Sideroblastic anemia\n\n### Drug\n- levothyroxine sodium 0.1 MG Oral Tablet, through Oral route, started on 2014-11-14, presumably until 2015-04-24, with intended 3 refill(s). Instructions: take 1 Tab by mouth every morning before breakfast.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-12-19 14:30:00, ended at 2014-12-19 23:59:00\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ulcer of lower extremity\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-01-12 12:45:00, ended at 2015-01-12 23:59:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n- Varicose veins of lower extremity with inflammation\n- Ankle ulcer\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-01-16 00:00:00, ended at 2015-01-16 00:00:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-01-16 00:00:00, ended at 2015-01-16 00:00:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-01-16 00:00:00, ended at 2015-01-16 00:00:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- deferasirox 500 MG Tablet for Oral Suspension, through Oral route, started on 2015-01-16, presumably until 2015-04-24, with intended 2 refill(s). Instructions: take 2 Tabs by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-01-16 13:29:00, ended at 2015-01-16 13:43:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 149 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 4.6 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Manual count: 3.4 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Iron [Mass/volume] in Serum or Plasma: 267 (microgram per deciliter)\n- MCH [Entitic mass] by Automated count: 19.5 (picogram)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 76 (unit per liter)\n- Basophils/100 leukocytes in Blood by Manual count: 2 (percent)\n- MCHC [Mass/volume] by Automated count: 24.7 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 583 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 72 (unit per liter)\n- Cells counted [#] in Chorionic villus sample by Molecular genetics method: 50 (cells)\n- Eosinophils [#/volume] in Blood by Manual count: 0.2 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 79.3 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 16 (percent)\n- Reticulocytes [#/volume] in Blood by Automated count: 228.9 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Ferritin [Mass/volume] in Serum or Plasma: 2447 (nanogram per milliliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 135 (percent)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 7.06 (percent)\n- Eosinophils/100 leukocytes in Blood by Manual count: 2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.24 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 69 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 6.3 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.6 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 3.4 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.4 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Basophils [#/volume] in Blood by Manual count: 0.2 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 25.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 34 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 198 (microgram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 40 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 36.9 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.1 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-01-16 13:44:00, ended at 2015-01-16 23:59:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypercoagulability state\n- Hemochromatosis following repeated red blood cell transfusion\n- Acquired absence of organ\n- Large liver\n- Primary diagnosis: Anemia\n- Beta thalassemia\n- Cardiomyopathy associated with another disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-01-18 11:12:00, ended at 2015-01-18 23:59:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Transfusion, blood or blood components\n\n### Condition\n- Beta thalassemia\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2015-01-18, presumably until 2015-01-18\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2015-01-18, presumably until 2015-01-18\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-01-19 13:00:00, ended at 2015-01-19 23:59:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.5\" (inch (US))\n\n### Procedure\n- Biopsy of skin, subcutaneous tissue and/or mucous membrane (including simple closure), unless otherwise listed; single lesion\n\n### Condition\n- Ankle ulcer\n- Ulcer of lower extremity\n- Varicose veins of lower extremity with inflammation\n- Primary diagnosis: Disorder of skin and/or subcutaneous tissue\n- Beta thalassemia\n- Pain in limb\n\n### Drug\n- acetaminophen 300 MG / codeine phosphate 30 MG Oral Tablet, through Oral route, started on 2015-01-19, presumably until 2015-07-18, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-01-30 00:00:00, ended at 2015-01-30 00:00:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Ankle ulcer\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-02-01 00:00:00, ended at 2015-02-01 00:00:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder due to infection\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-02-09 14:39:25, ended at 2015-02-09 17:19:16\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Debridement, subcutaneous tissue (includes epidermis and dermis, if performed); first 20 sq cm or less\n\n### Condition\n- Edema\n- Ankle ulcer\n- Primary diagnosis: Beta thalassemia\n- Anemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-02-26 12:15:00, ended at 2015-02-26 23:59:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of extremity veins including responses to compression and other maneuvers; unilateral or limited study\n\n### Condition\n- Peripheral vascular disease\n- Edema\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-02-28 11:12:08, ended at 2015-02-28 12:35:06\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Debridement (eg, high pressure waterjet with/without suction, sharp selective debridement with scissors, scalpel and forceps), open wound, (eg, fibrin, devitalized epidermis and/or dermis, exudate, debris, biofilm), including topical application(s), wound\n\n### Condition\n- Primary diagnosis: Ankle ulcer\n- Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-03-21 13:30:00, ended at 2015-03-21 23:59:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Ankle ulcer\n- Lichen\n\n### Drug\n- mupirocin 0.02 MG/MG Topical Ointment, started on 2015-03-21, presumably until 2015-12-13, with intended 3 refill(s). Instructions: Apply topically as directed twice daily to affected area(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-03-28 11:03:05, ended at 2015-03-28 11:50:27\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Ankle ulcer\n- Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-04-16 00:00:00, ended at 2015-04-16 00:00:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anemia\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-04-18 00:00:00, ended at 2015-04-18 00:00:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hemochromatosis\n- Acquired hypothyroidism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-04-24 15:03:00, ended at 2015-04-24 15:19:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.25 (million per microliter)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 89 (milligram per deciliter)\n- Leukocytes [#/volume] in Body fluid by Manual count: 2034 (milli-international unit per milliliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10 (percent)\n- Platelets [#/volume] in Blood by Automated count: 561 (thousand per microliter)\n- Thyroxine (T4) [Mass/volume] in Serum or Plasma: 10.9 (microgram per deciliter)\n- Iron [Mass/volume] in Serum or Plasma: 328 (microgram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 51 (percent)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Reticulocytes [#/volume] in Blood by Automated count: 1416.3 (thousand per microliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 6.74 (micro-international unit per milliliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 6.0 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 6.7 (gram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 174 (percent)\n- MCH [Entitic mass] by Automated count: 20.5 (picogram)\n- MCHC [Mass/volume] by Automated count: 25.3 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.06 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.1 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.4 (percent)\n- Triiodothyronine (T3) [Mass/volume] in Serum or Plasma: 90 (nanogram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 99 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 109 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 33.4 (percent)\n- Ferritin [Mass/volume] in Serum or Plasma: 2918.7 (nanogram per milliliter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 189 (microgram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 3 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.6 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 34 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 64 (unit per liter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.11 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 5.41 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 81.1 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 43.55 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Anemia\n- Hemochromatosis\n- Acquired hypothyroidism\n- Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-04-24 15:20:00, ended at 2015-04-24 23:59:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Thyrotropin [Units/volume] in Serum or Plasma: 6.76 (micro-international unit per milliliter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 1.2 (nanogram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Anemia\n- Thalassemia\n- Ankle ulcer\n- Hypercoagulability state\n- Hemochromatosis\n- Hemochromatosis following repeated red blood cell transfusion\n- Acquired hypothyroidism\n- Primary diagnosis: Beta thalassemia\n- Cardiomyopathy associated with another disorder\n- Acquired absence of organ\n\n### Drug\n- deferasirox 500 MG Tablet for Oral Suspension, through Oral route, started on 2015-04-24, presumably until 2015-05-04, with intended 0 refill(s). Instructions: take 4 Tabs by mouth Every Day Take 2 tabs (1000 mg) in am and 2 tab (750 mg ) in pm both with a glass of juice\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-04-25 00:00:00, ended at 2015-04-25 00:00:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- levothyroxine sodium 0.1 MG Oral Tablet, through Oral route, started on 2015-04-25, presumably until 2016-02-19, with intended 3 refill(s). Instructions: take 1 Tab by mouth every morning before breakfast\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-05-04 00:00:00, ended at 2015-05-04 00:00:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- deferasirox 500 MG Tablet for Oral Suspension, through Oral route, started on 2015-05-04, presumably until 2015-05-11, with intended 0 refill(s). Instructions: take 4 Tabs by mouth Every Day Take 2 tabs (1000 mg) in am and 2 tab (1000 mg ) in pm both with a glass of juice\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-05-11 00:00:00, ended at 2015-05-11 00:00:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- deferasirox 500 MG Tablet for Oral Suspension, started on 2015-05-11, presumably until 2015-06-01, with intended 1 refill(s). Instructions: DISSOLVE TWO TABLETS (1,000 MG) IN 8 OZ. OF WATER, APPLE OR ORANGE JUICE AND DRINK ENTIRE SOLUTION TWICE A DAY.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-05-18 12:55:00, ended at 2015-05-18 23:59:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.764\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acquired absence of organ\n- Primary diagnosis: Hereditary hemolytic anemia\n- Hypercoagulability state\n- Congestive heart failure\n- Hemochromatosis following repeated red blood cell transfusion\n- Beta thalassemia\n- Cardiomyopathy associated with another disorder\n- Ankle ulcer\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-05-28 11:30:00, ended at 2015-05-28 23:59:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.567\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Peripheral venous insufficiency\n- Primary diagnosis: Acne\n- Lichen\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-05-31 00:00:00, ended at 2015-05-31 00:00:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- deferasirox 500 MG Tablet for Oral Suspension, started on 2015-06-04, presumably until 2015-08-17, with intended 1 refill(s). Instructions: DISSOLVE TWO TABLETS (1,000 MG) IN 8 OZ. OF WATER, APPLE OR ORANGE JUICE AND DRINK ENTIRE SOLUTION TWICE A DAY.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-06-01 00:00:00, ended at 2015-06-01 00:00:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- deferasirox 500 MG Tablet for Oral Suspension, started on 2015-06-01, presumably until 2015-09-19, with intended 0 refill(s). Instructions: DISSOLVE TWO TABLETS (1,000 MG) IN 8 OZ. OF WATER, APPLE OR ORANGE JUICE AND DRINK ENTIRE SOLUTION TWICE A DAY.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-06-01 12:22:00, ended at 2015-06-01 23:59:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, lower extremity other than joint; without contrast material(s)\n\n### Condition\n- Chronic pain\n- Pain in limb\n- Beta thalassemia\n- Degenerative joint disease of ankle AND/OR foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-06-07 11:45:16, ended at 2015-06-07 14:36:49\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acne\n- Primary diagnosis: Lichen\n\n### Drug\n- clobetasol propionate 0.0005 MG/MG Topical Ointment, through Topical route, started on 2015-06-07, presumably until 2016-06-06, with intended 0 refill(s). Instructions: by Topical route 2 times a day To itchy skin of ankle. Avoid area of prior ulceration.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-07-26 12:56:16, ended at 2015-07-26 17:20:37\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Eruption\n- Lichen\n\n### Drug\n- biotin 1 MG Oral Capsule, through Oral route, presumably until 2017-02-10, with intended 0 refill(s). Instructions: take by mouth\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-08-17 00:00:00, ended at 2015-08-17 00:00:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- deferasirox 500 MG Tablet for Oral Suspension, started on 2015-08-17, presumably until 2015-09-19, with intended 0 refill(s). Instructions: DISSOLVE TWO TABLETS (1,000 MG) IN 8 OZ OF WATER, APPLE OR ORANGE JUICE AND DRINK ENTIRE SOLUTION TWICE A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-08-22 00:00:00, ended at 2015-08-22 00:00:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-08-22 00:00:00, ended at 2015-08-22 00:00:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-08-27 00:00:00, ended at 2015-08-27 00:00:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-08-28 00:00:00, ended at 2015-08-28 00:00:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Choriogonadotropin.intact+Beta subunit [Units/volume] in Serum or Plasma: <1 (milli-international unit per milliliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 2.43 (micro-international unit per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n- Pregnancy test equivocal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-08-28 00:00:00, ended at 2015-08-28 00:00:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- deferasirox 360 MG Oral Tablet, through Oral route, started on 2015-08-28, presumably until 2015-09-19, with intended 3 refill(s). Instructions: take 4 Tabs by mouth Every Day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-28 12:54:00, ended at 2015-08-28 23:59:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 100 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 6.7 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 20.5 (picogram)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 7.0 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 56 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 5.0 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Iron [Mass/volume] in Serum or Plasma: 221 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 45 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.26 (million per microliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.69 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.5 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Ferritin [Mass/volume] in Serum or Plasma: 1695.7 (nanogram per milliliter)\n- MCHC [Mass/volume] by Automated count: 26.9 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 37 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 35.1 (percent)\n- Lymphocytes [#/volume] in Blood by Manual count: 5.64 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 76.4 (femtoliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 24.9 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 49 (percent)\n- Platelets [#/volume] in Blood by Automated count: 609 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.35 (thousand per microliter)\n- Leukocytes [#/volume] in Body fluid by Manual count: 1381 (milli-international unit per milliliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Beta thalassemia\n- Pregnancy test equivocal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-08-28 13:03:53, ended at 2015-08-28 16:36:52\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hemoglobin E/beta thalassemia disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-30 12:30:00, ended at 2015-08-30 23:59:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Transfusion, blood or blood components\n\n### Condition\n- Beta thalassemia\n\n### Drug\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2015-08-30, presumably until 2015-08-30\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-09-19 00:00:00, ended at 2015-09-19 00:00:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- deferasirox 500 MG Tablet for Oral Suspension, started on 2015-09-19, presumably until 2015-09-26, with intended 2 refill(s). Instructions: DISSOLVE TWO TABLETS (1,000 MG) IN 8 OZ OF WATER, APPLE OR ORANGE JUICE AND DRINK ENTIRE SOLUTION TWICE A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-09-19 00:00:00, ended at 2015-09-19 00:00:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- deferasirox 500 MG Tablet for Oral Suspension, started on 2015-09-19, presumably until 2015-09-19, with intended 0 refill(s). Instructions: DISSOLVE TWO TABLETS (1,000 MG) IN 8 OZ. OF WATER, APPLE OR ORANGE JUICE AND DRINK ENTIRE SOLUTION TWICE A DAY.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-09-26 00:00:00, ended at 2015-09-26 00:00:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- deferasirox 500 MG Tablet for Oral Suspension, started on 2015-09-26, presumably until 2015-12-18, with intended 2 refill(s). Instructions: DISSOLVE TWO TABLETS (1,000 MG) IN 8 OZ OF WATER, APPLE OR ORANGE JUICE AND DRINK ENTIRE SOLUTION TWICE A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-10-12 00:00:00, ended at 2015-10-12 00:00:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- deferasirox 500 MG Tablet for Oral Suspension, started on 2015-10-14, presumably until 2015-10-14, with intended 2 refill(s). Instructions: DISSOLVE TWO TABLETS (1,000 MG) IN 8 OZ OF WATER, APPLE OR ORANGE JUICE AND DRINK ENTIRE SOLUTION TWICE A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-10-29 00:00:00, ended at 2015-10-29 00:00:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-10-30 00:00:00, ended at 2015-10-30 00:00:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- deferasirox 360 MG Oral Tablet, through Oral route, started on 2015-10-30, presumably until 2016-03-31, with intended 3 refill(s). Instructions: take 1,400 mg by mouth Every Day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-12-11 00:00:00, ended at 2015-12-11 00:00:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute bronchitis\n\n### Drug\n- benzonatate 100 MG Oral Capsule, through Oral route, started on 2015-12-14, presumably until 2016-06-11, with intended 0 refill(s). Instructions: take 1 Cap by mouth 3 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-12-13 11:24:30, ended at 2015-12-13 12:06:51\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute bronchitis\n\n### Drug\n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2015-12-13, presumably until 2017-02-10, with intended 0 refill(s). Instructions: 2 Puffs by Inhalation route every 6 hours as needed\n- 12 HR guaifenesin 1200 MG Extended Release Oral Tablet, through Oral route, started on 2015-12-13, presumably until 2016-06-11, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- benzonatate 100 MG Oral Capsule, through Oral route, started on 2015-12-13, presumably until 2015-12-14, with intended 0 refill(s). Instructions: take 1 Cap by mouth 3 times a day\n- azithromycin 250 MG Oral Tablet, through Oral route, started on 2015-12-13, presumably until 2015-12-18, with intended 0 refill(s). Instructions: take 1 Tab by mouth as directed for 5 days 2 tabs on day 1, then 1 tab daily thereafter\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-12-17 00:00:00, ended at 2015-12-17 00:00:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, started on 2015-12-25, presumably until 2016-06-11, with intended 2 refill(s). Instructions: USE 2 SPRAYS BY NASAL ROUTE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-12-17 15:15:53, ended at 2015-12-17 18:02:50\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.567\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Lichen simplex chronicus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-12-17 16:32:00, ended at 2015-12-17 23:59:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 97 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 88 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 39 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Eosinophils [#/volume] in Blood by Manual count: 0.20 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 6.9 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 6.53 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 34.9 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.2 (percent)\n- Iron [Mass/volume] in Serum or Plasma: 305 (microgram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 8.6 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 33 (percent)\n- Monocytes [#/volume] in Blood by Manual count: 2.18 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 40 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 50 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 6.7 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.43 (million per microliter)\n- Leukocytes [#/volume] in Body fluid by Manual count: 1087 (milli-international unit per milliliter)\n- Sodium [Moles/volume] in Serum or Plasma: 133 (millimole per liter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 2.75 (micro-international unit per milliliter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.2 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 26.3 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 687 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 22 (milligram per deciliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 1354.7 (nanogram per milliliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 19.8 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 20.1 (picogram)\n- MCV [Entitic volume] by Automated count: 76.3 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-12-18 16:46:14, ended at 2015-12-18 17:25:35\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acquired absence of spleen\n- Beta thalassemia\n- Primary diagnosis: Hemochromatosis following repeated red blood cell transfusion\n- Disorder of bone\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-01-22 00:00:00, ended at 2016-01-22 00:00:00\nThe patient in this visit was 36 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n- Disorder of iron metabolism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-01-29 00:00:00, ended at 2016-01-29 00:00:00\nThe patient in this visit was 36 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n- Acquired hypothyroidism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-02-18 16:54:00, ended at 2016-02-18 23:59:00\nThe patient in this visit was 36 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.6 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 40 (percent)\n- MCH [Entitic mass] by Automated count: 19.5 (picogram)\n- MCHC [Mass/volume] by Automated count: 24.6 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 625 (thousand per microliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 29 (nanogram per milliliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 29 (nanogram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 48 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 105 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Globulin [Mass/volume] in Serum: 4.4 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 6.5 (gram per deciliter)\n- Iron [Mass/volume] in Serum or Plasma: 141 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 59 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 20.2 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 8.08 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 51 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 4.7 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.62 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.5 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 79.6 (femtoliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.34 (million per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 1244.7 (nanogram per milliliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 36 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 36.4 (percent)\n- Leukocytes [#/volume] in Body fluid by Manual count: 930 (milli-international unit per milliliter)\n- Sodium [Moles/volume] in Serum or Plasma: 132 (millimole per liter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 3.56 (micro-international unit per milliliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Disorder of iron metabolism\n- Beta thalassemia\n- Disorder of bone\n- Acquired hypothyroidism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-02-19 16:11:13, ended at 2016-02-19 16:45:27\nThe patient in this visit was 36 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-02-20 11:00:00, ended at 2016-02-20 23:59:00\nThe patient in this visit was 36 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Transfusion, blood or blood components\n\n### Condition\n- Acquired hypothyroidism\n- Beta thalassemia\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2016-02-20, presumably until 2016-02-20\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2016-02-20, presumably until 2016-02-20\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-03-31 00:00:00, ended at 2016-03-31 00:00:00\nThe patient in this visit was 36 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Beta thalassemia\n- Primary diagnosis: Disorder of iron metabolism\n\n### Drug\n- deferasirox 360 MG Oral Tablet, through Oral route, started on 2016-03-31, presumably until 2016-04-01, with intended 5 refill(s). Instructions: take 1,400 mg by mouth Every Day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-04-01 00:00:00, ended at 2016-04-01 00:00:00\nThe patient in this visit was 36 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Beta thalassemia\n- Disorder of iron metabolism\n\n### Drug\n- deferasirox 360 MG Oral Tablet, through Oral route, started on 2016-04-01, presumably until 2016-12-23, with intended 5 refill(s). Instructions: take 1,440 mg by mouth Every Day Weight: 65.5 kg\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-04-08 00:00:00, ended at 2016-04-08 00:00:00\nThe patient in this visit was 36 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- levothyroxine sodium 0.1 MG Oral Tablet, started on 2016-04-08, presumably until 2016-11-17, with intended 2 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY MORNING BEFORE BREAKFAST\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-06-23 00:00:00, ended at 2016-06-23 00:00:00\nThe patient in this visit was 36 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n- Anemia\n- Disorder of iron metabolism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-06-23 14:12:00, ended at 2016-06-23 23:59:00\nThe patient in this visit was 36 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.64 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.80 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 23.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 13.3 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 90 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Iron [Mass/volume] in Serum or Plasma: 195 (microgram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.06 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.9 (gram per deciliter)\n- Reticulocytes [#/volume] in Blood by Automated count: 201.9 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 32.1 (percent)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 6.2 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 4.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 50 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 28 (percent)\n- MCHC [Mass/volume] by Automated count: 26.9 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 6.37 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 80 (milligram per deciliter)\n- Leukocytes [#/volume] in Body fluid by Manual count: 1044 (milli-international unit per milliliter)\n- MCH [Entitic mass] by Automated count: 19.7 (picogram)\n- MCV [Entitic volume] by Automated count: 73.4 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 657 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.17 (million per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 657.6 (nanogram per milliliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 64 (percent)\n- Lymphocytes [#/volume] in Blood by Manual count: 3.72 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Anemia\n- Disorder of iron metabolism\n- Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-06-24 00:00:00, ended at 2016-06-24 00:00:00\nThe patient in this visit was 36 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-06-25 11:10:00, ended at 2016-06-25 23:59:00\nThe patient in this visit was 36 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Transfusion, blood or blood components\n\n### Condition\n- Beta thalassemia\n- Acquired hypothyroidism\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2016-06-25, presumably until 2016-06-25\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2016-06-25, presumably until 2016-06-25\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-08-14 00:00:00, ended at 2016-08-14 00:00:00\nThe patient in this visit was 36 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n- Disorder of iron metabolism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-08-19 15:18:00, ended at 2016-08-19 23:59:00\nThe patient in this visit was 36 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 48 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 37.3 (percent)\n- Ferritin [Mass/volume] in Serum or Plasma: 934.7 (nanogram per milliliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.3 (gram per deciliter)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 7.28 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 13.3 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 76.6 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 52 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 132 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.7 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 36 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 4.7 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.27 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 7.5 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Iron [Mass/volume] in Serum or Plasma: 175 (microgram per deciliter)\n- MCHC [Mass/volume] by Automated count: 28.2 (gram per deciliter)\n- Reticulocytes [#/volume] in Blood by Automated count: 261.0 (thousand per microliter)\n- Leukocytes [#/volume] in Body fluid by Manual count: 1056 (milli-international unit per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 69 (percent)\n- Monocytes [#/volume] in Blood by Manual count: 1.06 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 88 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.60 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.49 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 4.79 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 21.6 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 723 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Beta thalassemia\n- Disorder of iron metabolism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-11-03 00:00:00, ended at 2016-11-03 00:00:00\nThe patient in this visit was 36 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2016-11-27, presumably until 2016-12-08, with intended 0 refill(s). Instructions: take 1 Tab by mouth 3 times a day as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-11-05 00:00:00, ended at 2016-11-05 00:00:00\nThe patient in this visit was 36 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n- Disorder of iron metabolism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-11-11 00:00:00, ended at 2016-11-11 00:00:00\nThe patient in this visit was 36 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Beta thalassemia\n- Primary diagnosis: Meningitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-11-11 14:39:00, ended at 2016-11-11 23:59:00\nThe patient in this visit was 36 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- MCHC [Mass/volume] by Automated count: 29.9 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 61 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 41.3 (percent)\n- Leukocytes [#/volume] in Body fluid by Manual count: 30 (milli-international unit per milliliter)\n- Platelets [#/volume] in Blood by Automated count: 584 (thousand per microliter)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 9.50 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 27.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 16.5 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 73.5 (femtoliter)\n- Monocytes [#/volume] in Blood by Manual count: 2.15 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 22 (percent)\n- MCH [Entitic mass] by Automated count: 22.0 (picogram)\n- Ferritin [Mass/volume] in Serum or Plasma: 3664.8 (nanogram per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 8.2 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.71 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 3.63 (thousand per microliter)\n- Reticulocytes [#/volume] in Blood by Automated count: 352.9 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Beta thalassemia\n- Disorder of iron metabolism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-11-17 00:00:00, ended at 2016-11-17 00:00:00\nThe patient in this visit was 36 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- levothyroxine sodium 0.1 MG Oral Tablet, through Oral route, started on 2016-11-17, presumably until 2016-12-30, with intended 0 refill(s). Instructions: take 1 Tab by mouth every morning before breakfast\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2016-11-17, presumably until 2016-12-08, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed\n- ondansetron 4 MG Oral Tablet, through Oral route, started on 2016-11-17, presumably until 2016-12-08, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-11-27 14:44:48, ended at 2016-11-27 17:43:47\nThe patient in this visit was 36 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Localized edema\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-12-08 00:00:00, ended at 2016-12-08 00:00:00\nThe patient in this visit was 36 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2016-12-08, presumably until 2017-02-10, with intended 0 refill(s). Instructions: take 1 Tab by mouth 3 times a day as needed\n- ondansetron 4 MG Oral Tablet, through Oral route, started on 2016-12-08, presumably until 2017-06-11, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-12-17 00:00:00, ended at 2016-12-17 00:00:00\nThe patient in this visit was 36 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pneumococcal meningitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-12-18 08:51:03, ended at 2016-12-18 10:03:33\nThe patient in this visit was 36 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Rheumatic disease of mitral valve\n- Pneumococcal meningitis\n- Pyogenic arthritis of shoulder region\n- Primary diagnosis: Cough\n- Pneumococcal arthritis\n\n### Drug\n- codeine phosphate 2 MG/ML / guaifenesin 20 MG/ML Oral Solution, through Oral route, started on 2016-12-18, presumably until 2017-02-10, with intended 0 refill(s). Instructions: take 5 mL by mouth 3 times a day as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-18 10:11:00, ended at 2016-12-18 23:59:00\nThe patient in this visit was 36 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Abnormal findings on diagnostic imaging of lung\n- Cough\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-12-23 00:00:00, ended at 2016-12-23 00:00:00\nThe patient in this visit was 36 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of iron metabolism\n- Beta thalassemia\n\n### Drug\n- deferasirox 360 MG Oral Tablet, through Oral route, started on 2016-12-23, presumably until 2017-06-17, with intended 5 refill(s). Instructions: take 1,440 mg by mouth every day Weight: 65.5 kg\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-12-30 00:00:00, ended at 2016-12-30 00:00:00\nThe patient in this visit was 36 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- levothyroxine sodium 0.1 MG Oral Tablet, through Oral route, started on 2016-12-30, presumably until 2017-04-01, with intended 12 refill(s). Instructions: take 1 Tab by mouth every morning before breakfast\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-01-05 00:00:00, ended at 2017-01-05 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n- Blood chemistry abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-01-08 00:00:00, ended at 2017-01-08 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-01-17 08:50:00, ended at 2017-01-17 23:59:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material, followed by contrast material(s) and further sequences\n\n### Condition\n- Pneumococcal infectious disease\n- Streptococcal infectious disease\n- Disorder of brain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-02-02 15:25:22, ended at 2017-02-02 18:56:15\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Telogen effluvium\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-02-05 11:38:59, ended at 2017-02-05 12:25:33\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acquired absence of spleen\n- Rheumatic disease of mitral valve\n- Primary diagnosis: Nonspecific tuberculin test reaction\n- Imaging of brain abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-02-10 14:37:00, ended at 2017-02-10 23:59:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 89 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 107 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 6.8 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.90 (thousand per microliter)\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 32 (nanogram per milliliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 17.9 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 20.2 (picogram)\n- Eosinophils [#/volume] in Blood by Manual count: 0.54 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 35.4 (percent)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 40 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 44 (percent)\n- Thyrotropin [Units/volume] in Serum or Plasma: 4.30 (micro-international unit per milliliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 32 (nanogram per milliliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 6.9 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 8.8 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 25.9 (percent)\n- MCV [Entitic volume] by Automated count: 77.2 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 604 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.65 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.36 (million per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 1125.0 (nanogram per milliliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.0 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Leukocytes [#/volume] in Body fluid by Manual count: 1035 (milli-international unit per milliliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 7.16 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 26.1 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Meningitis\n- Beta thalassemia\n- Blood chemistry abnormal\n- Nonspecific tuberculin test reaction\n- Telogen effluvium\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-02-10 14:50:23, ended at 2017-02-10 15:47:52\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hemoglobin E/beta thalassemia disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-02-11 12:00:00, ended at 2017-02-11 23:59:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Transfusion, blood or blood components\n\n### Condition\n- Beta thalassemia\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2017-02-11, presumably until 2017-02-11\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2017-02-11, presumably until 2017-02-11\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-03-01 00:00:00, ended at 2017-03-01 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Non-rheumatic mitral valve stenosis with regurgitation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-03-02 14:04:44, ended at 2017-03-02 15:59:30\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Electrocardiogram abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-03-03 00:00:00, ended at 2017-03-03 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-03-30 09:00:00, ended at 2017-03-30 23:59:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 56.3 (percent)\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Non-rheumatic mitral valve stenosis with regurgitation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-04-01 13:20:44, ended at 2017-04-01 15:37:11\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypothyroidism\n\n### Drug\n- levothyroxine sodium 0.125 MG Oral Tablet, through Oral route, started on 2017-04-01, presumably until 2018-04-08, with intended 12 refill(s). Instructions: take 1 Tab by mouth every morning before breakfast\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-04-17 00:00:00, ended at 2017-04-17 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cardiomyopathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-04-20 09:25:07, ended at 2017-04-20 11:25:29\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Hemochromatosis following repeated red blood cell transfusion\n- Cardiomyopathy\n- Lupus anticoagulant disorder\n- Acquired absence of spleen\n- Primary diagnosis: Rheumatic disease of mitral AND aortic valves\n- Beta thalassemia\n- Electrocardiogram abnormal\n\n### Drug\n- losartan potassium 50 MG Oral Tablet, through Oral route, started on 2017-04-20, presumably until 2017-05-07, with intended 6 refill(s). Instructions: take 1 Tab by mouth daily\n- hydrochlorothiazide 25 MG / spironolactone 25 MG Oral Tablet, through Oral route, started on 2017-04-20, presumably until 2017-06-04, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-04-20 11:34:00, ended at 2017-04-20 23:59:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Glucose [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 6.9 (gram per deciliter)\n- Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma: 197 (picogram per milliliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 2.17 (micro-international unit per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 32.4 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 96 (unit per liter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 7.0 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.31 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 15.3 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.84 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- MCHC [Mass/volume] by Automated count: 27.9 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.5 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 37 (percent)\n- MCH [Entitic mass] by Automated count: 21.2 (picogram)\n- MCV [Entitic volume] by Automated count: 76.0 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 45 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 24.6 (percent)\n- Lymphocytes [#/volume] in Blood by Manual count: 5.66 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 572 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.23 (million per microliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 445 (unit per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 7.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.58 (milligram per deciliter)\n- Leukocytes [#/volume] in Body fluid by Manual count: 854 (milli-international unit per milliliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hypothyroidism\n- Acquired absence of spleen\n- Congestive heart failure\n- Rheumatic disease of mitral AND aortic valves\n- Beta thalassemia\n- Chronic combined systolic and diastolic heart failure\n- Cardiomyopathy\n- Hemochromatosis following repeated red blood cell transfusion\n- Lupus anticoagulant disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-04-22 00:00:00, ended at 2017-04-22 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n- Heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-04-23 13:22:36, ended at 2017-04-23 13:58:41\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute upper respiratory infection\n\n### Drug\n- codeine phosphate 2 MG/ML / guaifenesin 20 MG/ML Oral Solution, through Oral route, started on 2017-04-23, presumably until 2017-08-10, with intended 0 refill(s). Instructions: take 5 mL by mouth every bedtime as needed\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2017-04-23, presumably until 2017-08-10, with intended 0 refill(s). Instructions: 1 Spray by Nasal route 2 times a day\n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2017-04-23, presumably until 2017-08-17, with intended 0 refill(s). Instructions: 2 Puffs by Inhalation route every 6 hours as needed (coughing)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-04-30 00:00:00, ended at 2017-04-30 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Lupus anticoagulant disorder\n- Primary diagnosis: Cardiomyopathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-05-07 00:00:00, ended at 2017-05-07 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hemochromatosis following repeated red blood cell transfusion\n- Lupus anticoagulant disorder\n- Cardiomyopathy\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-05-07 00:00:00, ended at 2017-05-07 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acquired absence of spleen\n- Hemochromatosis following repeated red blood cell transfusion\n- Cardiomyopathy\n- Rheumatic disease of mitral AND aortic valves\n- Lupus anticoagulant disorder\n- Beta thalassemia\n\n### Drug\n- losartan potassium 50 MG Oral Tablet, through Oral route, started on 2017-05-07, presumably until 2017-07-10, with intended 6 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-05-07 00:00:00, ended at 2017-05-07 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-05-07 07:52:42, ended at 2017-05-07 14:14:40\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Cardiomyopathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-05-07 10:04:00, ended at 2017-05-07 23:59:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 0.53 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum: 1 (beta-2 GPI IgG Ab unit)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Beta thalassemia\n- Acquired absence of spleen\n- Anemia\n- Heart failure\n- Cardiomyopathy\n- Lupus anticoagulant disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-05-13 00:00:00, ended at 2017-05-13 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-05-13 00:00:00, ended at 2017-05-13 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n- Blood chemistry abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-05-15 00:00:00, ended at 2017-05-15 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n- Heart failure\n\n### Drug\n- hydrochlorothiazide 25 MG Oral Tablet, through Oral route, started on 2017-06-04, presumably until 2017-07-10, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n- eplerenone 25 MG Oral Tablet, through Oral route, started on 2017-06-04, presumably until 2017-08-10, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-05-17 14:26:00, ended at 2017-05-17 23:59:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum: 1 (beta-2 GPI IgG Ab unit)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Leukocytes [#/volume] in Body fluid by Manual count: 560 (milli-international unit per milliliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.60 (milligram per deciliter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 324 (microgram of fibrinogen equivalent unit per milliliter)\n- Glucose [Mass/volume] in Serum or Plasma: 113 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 20.4 (picogram)\n- Neutrophils/100 leukocytes in Blood by Manual count: 33 (percent)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 6.0 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Ferritin [Mass/volume] in Serum or Plasma: 799.0 (nanogram per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 6.3 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 10.18 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 28.0 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.1 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 48 (percent)\n- Platelets [#/volume] in Blood by Automated count: 570 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Monocytes [#/volume] in Blood by Manual count: 1.70 (thousand per microliter)\n- Prothrombin time (PT): 14.5 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 6.2 (milligram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 284 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 21.2 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 72.8 (femtoliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 33.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.11 (million per microliter)\n- Thrombin time: 15.3 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 29.5 (second)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 92 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.42 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 22.6 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Beta thalassemia\n- Blood chemistry abnormal\n- Cardiomyopathy\n- Lupus anticoagulant disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-05-19 07:10:00, ended at 2017-05-19 23:59:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Transfusion, blood or blood components\n\n### Condition\n- Beta thalassemia\n- Coag./bleeding tests abnormal\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2017-05-19, presumably until 2017-05-19\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2017-05-19, presumably until 2017-05-19\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-06-09 00:00:00, ended at 2017-06-09 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n- Coag./bleeding tests abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-06-11 00:00:00, ended at 2017-06-11 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-06-11 00:00:00, ended at 2017-06-11 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- ondansetron 4 MG Oral Tablet, through Oral route, started on 2017-06-11, presumably until 2017-07-10, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-06-11 07:30:00, ended at 2017-06-11 07:50:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s)\n- Cardiac magnetic resonance imaging for morphology and function without contrast material\n\n### Condition\n- Cardiomyopathy\n- Beta thalassemia\n- Hemochromatosis following repeated red blood cell transfusion\n- Lupus anticoagulant disorder\n- Splenomegaly\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-06-11 07:51:00, ended at 2017-06-11 23:59:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, abdominal, real time with image documentation; complete\n\n### Condition\n- Hemochromatosis following repeated red blood cell transfusion\n- Lupus anticoagulant disorder\n- Gallstone\n- Cardiomyopathy\n- Beta thalassemia\n- Disease of liver\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-06-17 00:00:00, ended at 2017-06-17 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Beta thalassemia\n- Disorder of iron metabolism\n\n### Drug\n- deferasirox 360 MG Oral Tablet, through Oral route, started on 2017-06-17, presumably until 2017-12-09, with intended 5 refill(s). Instructions: take 1,530 mg by mouth every day Weight: 65.5 kg\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-06-20 00:00:00, ended at 2017-06-20 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Non-rheumatic mitral valve stenosis with regurgitation\n- Rheumatic tricuspid valve regurgitation\n- Primary diagnosis: Aortic incompetence, non-rheumatic\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-06-20 15:06:00, ended at 2017-06-20 23:59:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 25.7 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.1 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 40 (percent)\n- MCHC [Mass/volume] by Automated count: 29.0 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 638 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 7.5 (gram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4 (percent)\n- Monocytes [#/volume] in Blood by Manual count: 0.92 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Eosinophils [#/volume] in Blood by Manual count: 0.62 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 36.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.29 (million per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 8.5 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin: 128 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 22.7 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 86 (unit per liter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 312 (microgram of fibrinogen equivalent unit per milliliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 300 (milligram per deciliter)\n- Leukocytes [#/volume] in Body fluid by Manual count: 807 (milli-international unit per milliliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 15.4 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 6.16 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.8 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Prothrombin time (PT): 14.3 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 78.3 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 39 (percent)\n- aPTT in Platelet poor plasma by Coagulation assay: 28.9 (second)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 7.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.91 (milligram per deciliter)\n- Thrombin time: 14.9 (second)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Rheumatic tricuspid valve regurgitation\n- Beta thalassemia\n- Non-rheumatic mitral valve stenosis with regurgitation\n- Aortic incompetence, non-rheumatic\n- Coag./bleeding tests abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-06-21 08:00:00, ended at 2017-06-21 23:59:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Transfusion, blood or blood components\n\n### Condition\n- Aortic incompetence, non-rheumatic\n- Beta thalassemia\n- Rheumatic tricuspid valve regurgitation\n- Hemoglobin E/beta thalassemia disease\n- Non-rheumatic mitral valve stenosis with regurgitation\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2017-06-21, presumably until 2017-06-21\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2017-06-21, presumably until 2017-06-21\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-06-22 00:00:00, ended at 2017-06-22 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-06-25 00:00:00, ended at 2017-06-25 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Non-rheumatic mitral valve stenosis with regurgitation\n- Aortic incompetence, non-rheumatic\n- Beta thalassemia\n- Rheumatic tricuspid valve regurgitation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-06-25 09:16:19, ended at 2017-06-25 10:19:32\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Leukocytes [#/volume] in Specimen by Automated count: 9.2 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 38 (percent)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 27.03 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.68 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 3.50 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.4 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 26 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.1 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 525 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 78.7 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Eosinophils [#/volume] in Blood by Manual count: 0.46 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 6.0 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5 (percent)\n- MCH [Entitic mass] by Automated count: 25.1 (picogram)\n- Monocytes [#/volume] in Blood by Manual count: 1.01 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 39 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 72 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 33.2 (percent)\n- MCHC [Mass/volume] by Automated count: 31.9 (gram per deciliter)\n- Reticulocytes [#/volume] in Blood by Automated count: 995.1 (thousand per microliter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.67 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.2 (gram per deciliter)\n- Leukocytes [#/volume] in Body fluid by Manual count: 642 (milli-international unit per milliliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11 (percent)\n- Body height: 5' 5\" (inch (US))\n- Glucose [Mass/volume] in Serum or Plasma: 84 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-06-25 10:45:18, ended at 2017-06-25 12:22:28\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5.315\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Primary diagnosis: Aortic incompetence, non-rheumatic\n- Non-rheumatic mitral valve stenosis with regurgitation\n- Rheumatic tricuspid valve regurgitation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-06-25 13:15:00, ended at 2017-06-25 23:59:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Beta thalassemia\n- Aortic incompetence, non-rheumatic\n- Rheumatic tricuspid valve regurgitation\n- Non-rheumatic mitral valve stenosis with regurgitation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-06-26 13:21:00, ended at 2017-06-26 23:59:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Aortic incompetence, non-rheumatic\n- Rheumatic tricuspid valve regurgitation\n- Non-rheumatic mitral valve stenosis with regurgitation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2017-07-01 00:00:00, ended at 2017-07-01 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Insertion of non-tunneled centrally inserted central venous catheter; age 5 years or older\n- Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous\n- Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (Lis\n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n- Insertion and placement of flow directed catheter (eg, Swan-Ganz) for monitoring purposes\n- Anesthesia for procedures on heart, pericardial sac, and great vessels of chest; with pump oxygenator, age 1 year or older, for all noncoronary bypass procedures (eg, valve procedures) or for re-operation for coronary bypass more than 1 month after origin\n- Echocardiography, transesophageal, real-time with image documentation (2D) (with or without M-mode recording); including probe placement, image acquisition, interpretation and report\n\n### Condition\n- Aortic incompetence, non-rheumatic\n- Rheumatic tricuspid valve regurgitation\n- Non-rheumatic mitral valve stenosis with regurgitation\n\n### Drug\n- 10 ML calcium chloride 100 MG/ML Injection, through Intravenous route, started on 2017-07-01, presumably until 2017-07-01\n- vancomycin 1000 MG Injection, through Intravenous route, started on 2017-07-01, presumably until 2017-07-01\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2017-07-01, presumably until 2017-07-01\n- 10 ML epinephrine 0.1 MG/ML Prefilled Syringe, through Intravenous route, started on 2017-07-01, presumably until 2017-07-01\n- 100 ML potassium chloride 0.4 MEQ/ML Injection, through Intravenous route, started on 2017-07-01, presumably until 2017-07-01\n- 5 ML protamine sulfate (USP) 10 MG/ML Injection, through Intravenous route, started on 2017-07-01, presumably until 2017-07-01\n- 1 ML ephedrine sulfate 50 MG/ML Injection, started on 2017-07-01, presumably until 2017-07-01\n- 250 ML norepinephrine 0.016 MG/ML Injection, through Intravenous route, started on 2017-07-01, presumably until 2017-07-01\n- 250 ML nitroglycerin 0.2 MG/ML Injection, through Intravenous route, started on 2017-07-01, presumably until 2017-07-01\n- 250 ML mannitol 200 MG/ML Injection, through Intravenous route, started on 2017-07-01, presumably until 2017-07-01\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2017-07-01, presumably until 2017-07-01\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2017-07-01, presumably until 2017-07-01\n- vasopressin (USP) 20 UNT/ML Injectable Solution, through Intravenous route, started on 2017-07-01, presumably until 2017-07-01\n- 2 ML lidocaine hydrochloride 20 MG/ML Injection, started on 2017-07-01, presumably until 2017-07-01\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2017-07-01, presumably until 2017-07-01\n- methadone hydrochloride 10 MG/ML Injectable Solution, started on 2017-07-01, presumably until 2017-07-01\n- 6-aminocaproic acid 250 MG/ML Injectable Solution, through Intravenous route, started on 2017-07-01, presumably until 2017-07-01\n- 2 ML dexmedetomidine 0.1 MG/ML Injection, through Intravenous route, started on 2017-07-01, presumably until 2017-07-01\n- midazolam 1 MG/ML Injectable Solution, started on 2017-07-01, presumably until 2017-07-01\n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2017-07-01, presumably until 2017-07-01\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2017-07-01 05:05:00, ended at 2017-07-10 13:08:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 70 (unit per liter)\n- Base excess in Blood by calculation: 3 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 30.0 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 99 (percent)\n- Procalcitonin [Mass/volume] in Serum or Plasma: 0.5 (nanogram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 124 (unit per liter)\n- Body height: 5' 5\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.16 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 3.1 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 41 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.67 (million per microliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 342 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.7 (percent)\n- Lymphocytes [#/volume] in Blood by Manual count: 9.20 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 5 (percent)\n- MCHC [Mass/volume] by Automated count: 32.9 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 89.5 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 359 (thousand per microliter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.40 (millimole per liter)\n- Carbon dioxide [Partial pressure] in Arterial blood: 46.3 (millimeter mercury column)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 84 (millimeter mercury column)\n- Oxygen [Partial pressure] in Arterial blood: >500.0 (millimeter mercury column)\n- Potassium [Moles/volume] in Serum or Plasma: 6.2 (millimole per liter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 39.6 (millimeter mercury column)\n- Leukocytes [#/volume] in Body fluid by Manual count: 681 (milli-international unit per milliliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 42.9 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 149 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4 (percent)\n- Monocytes [#/volume] in Blood by Manual count: 3.15 (thousand per microliter)\n- Prothrombin time (PT): 20.3 (second)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 6.2 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.99 (thousand per microliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 4 - 5 (per high power field)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.4 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 81 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Base excess in Arterial blood by calculation: 2.5 (millimole per liter)\n- Bicarbonate [Moles/volume] in Specimen: 27.1 (millimole per liter)\n- Glucose [Mass/volume] in Blood: 334 (milligram per deciliter)\n- Lactate [Moles/volume] in Blood: 2.7 (millimole per liter)\n- Phosphate [Mass/volume] in Serum or Plasma: 6.1 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 43 (milligram per deciliter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 5.5 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 27.6 (picogram)\n- aPTT in Platelet poor plasma by Coagulation assay: 65.8 (second)\n\n### Procedure\n- Treatment of swallowing dysfunction and/or oral function for feeding\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Drainage of Right Pleural Cavity with Drainage Device, Percutaneous Approach\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Replacement of Aortic Valve with Zooplastic Tissue, Open Approach\n- Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Inspection of Larynx, Via Natural or Artificial Opening Endoscopic\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A problem focused interval history; A problem focused examination; Medical decision making that is straightforward or o\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Repair Atrial Septum, Open Approach\n- Flexible endoscopic evaluation of swallowing by cine or video recording\n- Supplement Tricuspid Valve with Synthetic Substitute, Open Approach\n- Radiologic examination, chest; single view, frontal\n- Supplement Mitral Valve with Synthetic Substitute, Open Approach\n- Collection of venous blood by venipuncture\n- Demonstration and/or evaluation of patient utilization of an aerosol generator, nebulizer, metered dose inhaler or IPPB device\n- Evaluation of oral and pharyngeal swallowing function\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Physical therapy evaluation: moderate complexity, requiring these components: A history of present problem with 1-2 personal factors and/or comorbidities that impact the plan of care; An examination of body systems using standardized tests and measures in\n- Introduction of Vasopressor into Peripheral Vein, Percutaneous Approach\n- Controlled ventilation procedure and therapy, initiation and management\n- Therapeutic procedure, 1 or more areas, each 15 minutes; gait training (includes stair climbing)\n- Performance of Cardiac Output, Continuous\n- Behavioral and qualitative analysis of voice and resonance\n\n### Condition\n- Acquired absence of spleen\n- Blood coagulation disorder\n- Cardiomyopathy\n- Disorder of vocal cord\n- First degree atrioventricular block\n- Hemoglobinopathy\n- Non-rheumatic heart valve disorder\n- Pain in left foot\n- Pneumococcal meningitis\n- Tachycardia\n- Abnormal findings on diagnostic imaging of lung\n- Allergic condition\n- Pleural effusion\n- Transplanted heart valve present\n- Vascular complication of medical care\n- Beta thalassemia\n- Chronic pulmonary edema\n- Hyperkalemia\n- Lupus anticoagulant disorder\n- Atelectasis\n- Pneumothorax\n- Postoperative state\n- Rupture of chordae tendineae\n- Atrial flutter\n- Congenital absence of spleen\n- Primary diagnosis: Heart failure\n- Atrial fibrillation\n- Electrocardiogram abnormal\n- Acute pulmonary edema\n- Chronic ulcer of skin of ankle\n- Disorder of bilirubin metabolism\n- Disorder of bone\n- Hemochromatosis following repeated red blood cell transfusion\n- Paroxysmal atrial fibrillation\n- Pneumothorax due to and following procedure\n- Acute bronchitis\n- Anemia of chronic disease\n- Combined disorders of mitral, aortic and tricuspid valves\n- Hypothyroidism\n\n### Drug\n- amiodarone hydrochloride 200 MG Oral Tablet, through Oral route, started on 2017-07-07, presumably until 2017-08-11, with intended 0 refill(s). Instructions: 400 mg twice daily for one week, then 200 mg twice daily for one week then 200 mg daily for 2 weeks.\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2017-07-01, presumably until 2017-07-03\n- calcium carbonate 1000 MG Chewable Tablet, through Oral route, started on 2017-07-04, presumably until 2018-12-13, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed (indigestion)\n- folic acid 1 MG Oral Tablet, through Oral route, started on 2017-07-04, presumably until 2017-07-10\n- Abuse-Deterrent 12 HR oxycodone hydrochloride 10 MG Extended Release Oral Tablet, through Oral route, started on 2017-07-05, presumably until 2017-08-11, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 12 hours\n- chlorhexidine gluconate 1.2 MG/ML Mouthwash, through Submucosal route, started on 2017-07-01, presumably until 2017-07-02\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2017-07-08, presumably until 2017-08-11, with intended 0 refill(s). Instructions: 40 mg twice daily for one week, 20 mg twice daily for one week, then 20 mg daily.\n- 100 ML potassium chloride 0.1 MEQ/ML Injection, through Intravenous route, started on 2017-07-07, presumably until 2017-07-08\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2017-07-04, presumably until 2017-09-11, with intended 0 refill(s). Instructions: take 1 Tab by mouth every morning before breakfast\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2017-07-05, presumably until 2017-07-08\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2017-07-01, presumably until 2017-07-02\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2017-07-04, presumably until 2017-07-05\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2017-07-07, presumably until 2017-07-08\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2017-07-03, presumably until 2017-09-04, with intended 0 refill(s). Instructions: take 2 Caps by mouth 2 times a day as needed for Constipation\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2017-07-04, presumably until 2017-08-17, with intended 0 refill(s). Instructions: 3 mL by Nebulization route every 6 hours as needed\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2017-07-07, presumably until 2017-08-11, with intended 0 refill(s). Instructions: 40 meq twice daily for one week, 20 meq twice daily for one week, then 20 meq daily while on Lasix.\n- deferasirox 360 MG Oral Tablet, through Oral route, started on 2017-07-05, presumably until 2017-07-06\n- insulin isophane, human 100 UNT/ML Injectable Suspension, through Subcutaneous route, started on 2017-07-02, presumably until 2017-07-04\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2017-07-08, presumably until 2017-07-09\n- 10 ML furosemide 10 MG/ML Injection, started on 2017-07-04, presumably until 2017-07-10\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2017-07-03, presumably until 2017-08-11, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- levothyroxine sodium 0.1 MG Oral Tablet, through Oral route, started on 2017-07-03, presumably until 2017-07-10\n- levothyroxine sodium 0.025 MG Oral Tablet, through Oral route, started on 2017-07-03, presumably until 2017-07-10\n- ferrous sulfate 140 MG Extended Release Oral Tablet, through Oral route, started on 2017-07-04, presumably until 2017-07-04\n- levothyroxine sodium 0.1 MG Injection, through Intravenous route, started on 2017-07-02, presumably until 2017-07-02\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2017-07-10, presumably until 2017-08-10, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every bedtime as needed\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2017-07-02, presumably until 2017-07-02\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2017-07-01, presumably until 2017-07-02\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2017-07-02, presumably until 2017-07-03\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2017-07-03, presumably until 2017-09-11, with intended 0 refill(s). Instructions: take 1 Tab by mouth every morning with breakfast\n- eplerenone 25 MG Oral Tablet, through Oral route, started on 2017-07-09, presumably until 2017-07-10\n- 50 ML potassium chloride 0.4 MEQ/ML Injection, through Intravenous route, started on 2017-07-05, presumably until 2017-07-05\n- acetaminophen 32 MG/ML Oral Solution, through Oral route, started on 2017-07-05, presumably until 2017-07-10\n- sodium polystyrene sulfonate 250 MG/ML Oral Suspension, through Oral route, started on 2017-07-08, presumably until 2017-07-08\n- 2 ML ondansetron 2 MG/ML Injection, started on 2017-07-02, presumably until 2017-07-10\n- 1 ML ketorolac tromethamine 15 MG/ML Injection, started on 2017-07-06, presumably until 2017-07-09\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2017-07-02, presumably until 2017-07-07\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2017-07-01, presumably until 2017-07-01\n- 100 ML amiodarone hydrochloride 1.5 MG/ML Injection, through Intravenous route, started on 2017-07-03, presumably until 2017-07-07\n- magnesium sulfate 20 MG/ML Injection, through Intravenous route, started on 2017-07-10, presumably until 2017-07-10\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2017-07-02, presumably until 2017-08-11, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed\n- 100 ML clevidipine 0.5 MG/ML Injection, through Intravenous route, started on 2017-07-01, presumably until 2017-07-02\n- ascorbic acid 500 MG Oral Tablet, through Oral route, started on 2017-07-04, presumably until 2017-07-10\n- aluminum hydroxide 40 MG/ML / magnesium hydroxide 40 MG/ML / simethicone 4 MG/ML Oral Suspension, through Oral route, started on 2017-07-07, presumably until 2017-07-07\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2017-07-03, presumably until 2017-07-09\n- ondansetron 8 MG Disintegrating Oral Tablet, through Oral route, started on 2017-07-10, presumably until 2017-07-10\n- 100 ML dexmedetomidine 0.004 MG/ML Injection, through Intravenous route, started on 2017-07-01, presumably until 2017-07-02\n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2017-07-01, presumably until 2017-07-01\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2017-07-06, presumably until 2017-07-07\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-07-06 00:00:00, ended at 2017-07-06 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart valve present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-07-10 00:00:00, ended at 2017-07-10 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pleural effusion\n\n### Drug\n- ondansetron 4 MG Oral Tablet, through Oral route, started on 2017-07-10, presumably until 2017-08-24, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2017-07-14 00:00:00, ended at 2017-07-14 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 19 (millimole per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 4.7 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 7.3 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 96 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 53 (milligram per deciliter)\n- Leukocytes [#/volume] in Body fluid by Manual count: 74 (milli-international unit per milliliter)\n- MCV [Entitic volume] by Automated count: 75.3 (femtoliter)\n- Oxygen [Partial pressure] in Arterial blood: 44.3 (millimeter mercury column)\n- Sodium [Moles/volume] in Serum or Plasma: 126 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 7.4 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 4 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 2.2 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 40 (unit per liter)\n- Base excess in Blood by calculation: -7 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 7.1 (milligram per deciliter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 24.5 (millimeter mercury column)\n- Glucose [Mass/volume] in Serum or Plasma: 156 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 458 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 6.7 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 94 (unit per liter)\n- Base excess in Arterial blood by calculation: -8.9 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 39.4 (percent)\n- Glucose [Mass/volume] in Blood: 448 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 2.60 (thousand per microliter)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 82 (millimeter mercury column)\n- Bicarbonate [Moles/volume] in Specimen: 16.8 (millimole per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.00 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 20 (millimole per liter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 666 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 24.3 (percent)\n- Monocytes [#/volume] in Blood by Manual count: 1.95 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 41.7 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Carbon dioxide [Partial pressure] in Venous blood: 32.1 (millimeter mercury column)\n- Chloride [Moles/volume] in Serum or Plasma: 94 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.47 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.23 (million per microliter)\n- Hemoglobin [Mass/volume] in Arterial blood: 6.8 (gram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 824 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 30.4 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Carbon dioxide [Partial pressure] in Arterial blood: 34.6 (millimeter mercury column)\n- Globulin [Mass/volume] in Serum: 4.9 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 65.1 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 22.9 (picogram)\n- Methemoglobin/Hemoglobin.total in Blood: 1.6 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 62 (percent)\n- Prothrombin time (PT): 25.0 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-07-14 00:00:00, ended at 2017-07-14 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Dyspnea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2017-07-14 10:50:00, ended at 2017-08-11 12:15:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.55 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.72 (million per microliter)\n- Globulin [Mass/volume] in Serum: 4.9 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 11 - 20 (per high power field)\n- Magnesium [Mass/volume] in Serum or Plasma: 3.0 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 6.7 (millimole per liter)\n- Bicarbonate [Moles/volume] in Specimen: 32.5 (millimole per liter)\n- Body height: 5' 4.961\" (inch (US))\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 4 - 5 (per high power field)\n- Heparin unfractionated [Units/volume] in Platelet poor plasma: <0.10 (unit per milliliter)\n- Leukocytes [#/volume] in Body fluid by Manual count: 8 (milli-international unit per milliliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.41 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 27.9 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 27.88 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 86 (percent)\n- Oxygen [Partial pressure] in Arterial blood: 87.1 (millimeter mercury column)\n- Phosphate [Mass/volume] in Serum or Plasma: 7.2 (milligram per deciliter)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 10.7 (percent)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 6.0 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 8.9 (gram per deciliter)\n- Lactate [Moles/volume] in Serum or Plasma: 5.4 (millimole per liter)\n- Left ventricular Ejection fraction: 51.7 (percent)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 127 (unit per liter)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 99 (percent)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 3.703 (nanogram per milliliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- IgA [Mass/volume] in Serum or Plasma: 268 (milligram per deciliter)\n- IgG [Mass/volume] in Serum or Plasma: 1670 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Prothrombin time (PT): 25.6 (second)\n- Thyrotropin [Units/volume] in Serum or Plasma: 2.15 (micro-international unit per milliliter)\n- Base excess in Arterial blood by calculation: 7.9 (millimole per liter)\n- Carbon dioxide [Partial pressure] in Arterial blood: 47.8 (millimeter mercury column)\n- Ferritin [Mass/volume] in Serum or Plasma: 2657.1 (nanogram per milliliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 72.8 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 91.0 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 85.1 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: <10 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.6 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 94 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.18 (thousand per microliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 29.4 (milligram per deciliter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 43.7 (millimeter mercury column)\n- Erythrocyte sedimentation rate: 39 (millimeter per hour)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 10 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 824 (unit per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 148 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: <10 (unit per liter)\n- Base excess in Blood by calculation: 2 (millimole per liter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.59 (millimole per liter)\n- Glucose [Mass/volume] in Blood: 98 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.2 (percent)\n- Iron [Mass/volume] in Serum or Plasma: 47 (microgram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.0 (percent)\n- Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma: >30000 (picogram per milliliter)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 99 (millimeter mercury column)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 29.4 (microgram per milliliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 98.0 (second)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.47 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 42.0 (percent)\n- Erythropoietin (EPO) [Units/volume] in Serum or Plasma: 50.5 (milli-international unit per milliliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 6.19 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 2.08 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Manual count: 5.31 (thousand per microliter)\n- Procalcitonin [Mass/volume] in Serum or Plasma: 62.2 (nanogram per milliliter)\n- Basophils/100 leukocytes in Blood by Automated count: 4 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 7.4 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 3.32 (thousand per microliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 666 (milligram per deciliter)\n- Lactate [Moles/volume] in Blood: 4.9 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 643 (thousand per microliter)\n\n### Procedure\n- Radiologic examination, wrist; complete, minimum of 3 views\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A problem focused interval history; A problem focused examination; Medical decision making that is straightforward or o\n- Echocardiography, transesophageal, real-time with image documentation (2D) (with or without M-mode recording); including probe placement, image acquisition, interpretation and report\n- Continuous inhalation treatment with aerosol medication for acute airway obstruction; first hour\n- Treatment of swallowing dysfunction and/or oral function for feeding\n- Collection of venous blood by venipuncture\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Drainage of Right Pleural Cavity with Drainage Device, Open Approach\n- Physical therapy evaluation: low complexity, requiring these components: A history with no personal factors and/or comorbidities that impact the plan of care; An examination of body system(s) using standardized tests and measures addressing 1-2 elements f\n- Ultrasonography of Right and Left Heart, Transesophageal\n- Introduction of Vasopressor into Peripheral Vein, Percutaneous Approach\n- Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Computed tomography, thorax, diagnostic; without contrast material\n- Arterial puncture, withdrawal of blood for diagnosis\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n- Evaluation of oral and pharyngeal swallowing function\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Occupational therapy evaluation, moderate complexity, requiring these components: An occupational profile and medical and therapy history, which includes an expanded review of medical and/or therapy records and additional review of physical, cognitive, or\n- Replacement of Mitral Valve with Zooplastic Tissue, Open Approach\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Performance of Cardiac Output, Continuous\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Therapeutic procedure, 1 or more areas, each 15 minutes; gait training (includes stair climbing)\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Ultrasound, abdominal, real time with image documentation; limited (eg, single organ, quadrant, follow-up)\n- Continuous inhalation treatment with aerosol medication for acute airway obstruction; each additional hour (List separately in addition to code for primary procedure)\n- Radiologic examination, abdomen; single anteroposterior view\n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n- Computed tomographic angiography, chest (noncoronary), with contrast material(s), including noncontrast images, if performed, and image postprocessing\n- Reposition Coronary Artery, One Artery, Open Approach\n- Drainage of Sternum, Open Approach\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A detailed or comprehensive history; A detailed or comprehensive examination; and Medical decision making that is straightforward or of \n- Level III - Surgical pathology, gross and microscopic examination Abortion, induced Abscess Aneurysm - arterial/ventricular Anus, tag Appendix, other than incidental Artery, atheromatous plaque Bartholin's gland cyst Bone fragment(s), other than pathologi\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Computed tomography, abdomen and pelvis; without contrast material\n- Insertion of peripherally inserted central venous catheter (PICC), without subcutaneous port or pump, without imaging guidance; age 5 years or older\n- Replacement of Thoracic Aorta, Ascending/Arch with Zooplastic Tissue, Open Approach\n- Controlled ventilation procedure and therapy, initiation and management\n- Demonstration and/or evaluation of patient utilization of an aerosol generator, nebulizer, metered dose inhaler or IPPB device\n- Therapeutic procedure, 1 or more areas, each 15 minutes; neuromuscular reeducation of movement, balance, coordination, kinesthetic sense, posture, and/or proprioception for sitting and/or standing activities\n- Re-evaluation of physical therapy established plan of care, requiring these components: An examination including a review of history and use of standardized tests and measures is required; and Revised plan of care using a standardized patient assessment i\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); complete\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Radiologic examination, chest; single view, frontal\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, follow-up or limited study\n- Continuous positive airway pressure ventilation (CPAP), initiation and management\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n\n### Condition\n- Abnormal findings on diagnostic imaging of lung\n- Acute posthemorrhagic anemia\n- Allergic condition\n- Cardiogenic shock\n- Delirium\n- Late effect of complications of procedure\n- Paroxysmal atrial fibrillation\n- Pneumothorax\n- Acute ischemic heart disease\n- Anemia of chronic disease\n- Congestive heart failure\n- Electrocardiogram abnormal\n- Heart disease\n- Hypoxemia\n- Lower abdominal pain\n- Atelectasis\n- Non-rheumatic heart valve disorder\n- Sepsis due to methicillin resistant Staphylococcus aureus\n- Acute pulmonary edema\n- Beta thalassemia\n- Blood coagulation disorder\n- Cardiomegaly\n- Disorder of bilirubin metabolism\n- Disorder of iron metabolism\n- Generalized abdominal pain\n- Heart failure\n- Hypo-osmolality and or hyponatremia\n- Pleural effusion\n- Supraventricular tachycardia\n- Wrist joint pain\n- Abdominal distension, gaseous\n- Acquired absence of spleen\n- Acute on chronic systolic heart failure\n- Gallstone\n- Genetic anomaly of leukocyte\n- Hemoglobin E/beta thalassemia disease\n- Hyperkalemia\n- Osteomyelitis\n- Sepsis\n- Tachycardia\n- Transplanted heart valve present\n- Valvular endocarditis\n- Acquired coagulation factor deficiency\n- Acute hypoxemic respiratory failure\n- Cardiomyopathy\n- Dyspnea\n- Hemochromatosis following repeated red blood cell transfusion\n- Hepatic failure\n- Hereditary hemolytic anemia\n- Postprocedural infection\n- Systemic lupus erythematosus\n- Abdominal tenderness\n- Atrial fibrillation\n- Congenital absence of spleen\n- Fever\n- First degree atrioventricular block\n- Lupus anticoagulant disorder\n- Persistent pain following procedure\n- Pneumonia due to methicillin susceptible Staphylococcus aureus\n- Post-thoracotomy pain syndrome\n- Postoperative seroma\n- Primary diagnosis: Postoperative state\n- Acute tubular necrosis\n- Anemia\n- Bacteremia\n- Chronic pulmonary edema\n- Disorder of mediastinum\n- Disorder of skin and/or subcutaneous tissue\n- Hypothyroidism\n- Illness\n- Infective endocarditis\n- Inflammatory disorder of mediastinum\n- Large liver\n- Septic shock\n- Acute renal failure syndrome\n- Disorder of nasal cavity\n- Hemoglobinopathy\n\n### Drug\n- 0.5 ML filgrastim 0.6 MG/ML Prefilled Syringe, started on 2017-07-23, presumably until 2017-07-29\n- amiodarone hydrochloride 200 MG Oral Tablet, through Oral route, started on 2017-07-24, presumably until 2017-07-26\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2017-07-29, presumably until 2017-08-01\n- 50 ML sodium bicarbonate 84 MG/ML Injection, through Intravenous route, started on 2017-07-14, presumably until 2017-07-14\n- famotidine 20 MG Oral Tablet, through Oral route, started on 2017-08-03, presumably until 2017-08-11\n- folic acid 1 MG Oral Tablet, through Oral route, started on 2017-07-30, presumably until 2017-08-11\n- guaifenesin 20 MG/ML Oral Solution, through Oral route, started on 2017-08-03, presumably until 2017-08-03\n- vancomycin 1000 MG Injection, through Intravenous route, started on 2017-07-14, presumably until 2017-08-10\n- 100 ML milrinone lactate 0.2 MG/ML Injection, through Intravenous route, started on 2017-07-14, presumably until 2017-07-14\n- 1 ML ketorolac tromethamine 30 MG/ML Injection, started on 2017-07-27, presumably until 2017-07-27\n- gabapentin 50 MG/ML Oral Solution, through Oral route, started on 2017-07-31, presumably until 2017-08-02\n- 50 ML potassium chloride 0.2 MEQ/ML Injection, through Intravenous route, started on 2017-08-04, presumably until 2017-08-05\n- chlorhexidine gluconate 1.2 MG/ML Mouthwash, through Submucosal route, started on 2017-07-29, presumably until 2017-08-01\n- rifampin 300 MG Oral Capsule, through Oral route, started on 2017-07-23, presumably until 2017-08-20, with intended 0 refill(s). Instructions: take 3 Caps by mouth every day\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2017-08-10, presumably until 2017-08-20, with intended 0 refill(s). Instructions: take 2 Tabs by mouth 2 times a day For 2 weeks, then 1 tab po BID for 2 weeks then stop\n- 100 ML potassium chloride 0.1 MEQ/ML Injection, through Intravenous route, started on 2017-08-03, presumably until 2017-08-03\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2017-07-16, presumably until 2017-07-29\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2017-08-02, presumably until 2017-08-10\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, presumably until 2017-08-17, with intended 0 refill(s). Instructions: 1 Spray by Nasal route 2 times a day as needed\n- naloxone hydrochloride 0.4 MG/ML Injectable Solution, started on 2017-07-29, presumably until 2017-07-29\n- docusate sodium 10 MG/ML Oral Solution, through Oral route, started on 2017-07-18, presumably until 2017-08-01\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2017-07-15, presumably until 2023-01-05, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every 4 hours as needed\n- melatonin 1 MG Oral Tablet, through Oral route, started on 2017-07-31, presumably until 2017-08-10\n- potassium chloride 20 MEQ Powder for Oral Solution, through Oral route, started on 2017-08-05, presumably until 2017-08-10\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2017-07-30, presumably until 2017-07-30\n- mineral oil 0.15 MG/MG / petrolatum 0.83 MG/MG Ophthalmic Ointment, through Intraocular route, started on 2017-07-31, presumably until 2017-08-01\n- trazodone hydrochloride 50 MG Oral Tablet, through Oral route, started on 2017-07-31, presumably until 2017-07-31\n- vancomycin 500 MG Injection, through Intravenous route, started on 2017-07-27, presumably until 2017-07-27\n- oxymetazoline hydrochloride 0.5 MG/ML Nasal Spray, through Nasal route, started on 2017-07-29, presumably until 2017-07-29\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2017-07-14, presumably until 2017-08-07\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2017-07-25, presumably until 2017-08-11\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2017-07-18, presumably until 2017-07-29\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2017-08-10, presumably until 2017-08-17, with intended 0 refill(s). Instructions: take 4 Tabs by mouth 2 times a day 40 meq twice daily for 2 weeks, then 20 meq BID for 2 weeks.\n- levothyroxine sodium 0.125 MG Oral Tablet, through Oral route, started on 2017-07-25, presumably until 2017-07-26\n- deferasirox 360 MG Oral Tablet, through Oral route, started on 2017-07-29, presumably until 2017-08-07\n- 250 ML norepinephrine 0.016 MG/ML Injection, through Intravenous route, started on 2017-07-14, presumably until 2017-07-16\n- quetiapine 25 MG Oral Tablet, through Oral route, started on 2017-07-31, presumably until 2017-08-10\n- melatonin 3 MG Oral Tablet, through Oral route, started on 2017-07-31, presumably until 2017-08-10\n- magnesium hydroxide 80 MG/ML Oral Suspension, through Oral route, started on 2017-08-01, presumably until 2017-08-01\n- insulin isophane, human 100 UNT/ML Injectable Suspension, through Subcutaneous route, started on 2017-07-30, presumably until 2017-08-03\n- 10 ML furosemide 10 MG/ML Injection, started on 2017-07-14, presumably until 2017-08-11\n- levothyroxine sodium 0.1 MG Oral Tablet, through Oral route, started on 2017-07-27, presumably until 2017-08-11\n- levothyroxine sodium 0.025 MG Oral Tablet, through Oral route, started on 2017-07-27, presumably until 2017-08-11\n- oxycodone hydrochloride 1 MG/ML Oral Solution, through Oral route, started on 2017-07-15, presumably until 2017-08-11\n- levothyroxine sodium 0.1 MG Injection, through Intravenous route, started on 2017-07-14, presumably until 2017-07-24\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2017-07-30, presumably until 2017-08-01\n- chlorothiazide 500 MG Injection, through Intravenous route, started on 2017-07-14, presumably until 2017-07-20\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2017-08-03, presumably until 2017-08-24, with intended 0 refill(s). Instructions: take 1 Cap by mouth 3 times a day 1 week, then 300mg BID for 1 week, then 300mg DAILY for 1 week, then stop\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2017-07-14, presumably until 2017-08-02\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2017-07-14, presumably until 2017-07-14\n- 2 ML famotidine 10 MG/ML Injection, through Intravenous route, started on 2017-07-29, presumably until 2017-08-03\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2017-07-18, presumably until 2017-08-11\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2017-07-14, presumably until 2017-07-14\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2017-07-16, presumably until 2017-08-11\n- 50 ML glucose 500 MG/ML Prefilled Syringe, through Intravenous route, started on 2017-07-14, presumably until 2017-07-18\n- 50 ML potassium chloride 0.4 MEQ/ML Injection, through Intravenous route, started on 2017-07-17, presumably until 2017-07-27\n- acetaminophen 32 MG/ML Oral Solution, through Oral route, started on 2017-07-21, presumably until 2017-08-09\n- 2 ML ondansetron 2 MG/ML Injection, started on 2017-07-18, presumably until 2017-08-10\n- 1 ML ketorolac tromethamine 15 MG/ML Injection, started on 2017-07-19, presumably until 2017-08-04\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2017-07-14, presumably until 2017-08-11\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2017-07-16, presumably until 2017-07-27\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2017-08-10, presumably until 2017-08-10\n- magnesium sulfate 20 MG/ML Injection, through Intravenous route, started on 2017-07-19, presumably until 2017-08-11\n- chlorothiazide 250 MG Oral Tablet, through Oral route, started on 2017-07-24, presumably until 2017-07-29\n- loratadine 10 MG Oral Tablet, through Oral route, started on 2017-07-23, presumably until 2017-07-29\n- 1 ML epoetin alfa 40000 UNT/ML Injection, started on 2017-07-27, presumably until 2017-08-10\n- gabapentin 100 MG Oral Capsule, through Oral route, started on 2017-07-27, presumably until 2017-08-05\n- 100 ML propofol 10 MG/ML Injection, through Intravenous route, started on 2017-07-18, presumably until 2017-07-18\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2017-07-30, presumably until 2017-08-20, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed for Pain Take 1-2 tabs q 6 hours for pain\n- 100 ML clevidipine 0.5 MG/ML Injection, through Intravenous route, started on 2017-07-29, presumably until 2017-07-29\n- bumetanide 0.25 MG/ML Injectable Solution, through Intravenous route, started on 2017-07-14, presumably until 2017-07-14\n- glucose 4000 MG Chewable Tablet, through Oral route, started on 2017-07-18, presumably until 2017-07-29\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2017-07-30, presumably until 2017-07-30\n- sodium chloride 6.5 MG/ML Nasal Spray, through Nasal route, started on 2017-08-02, presumably until 2017-08-02\n- 100 ML dexmedetomidine 0.004 MG/ML Injection, through Intravenous route, started on 2017-07-29, presumably until 2017-07-30\n- alteplase 1 MG/ML Injectable Solution, through Intraluminal route, started on 2017-08-06, presumably until 2017-08-06\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2017-07-17, presumably until 2017-08-10\n- cefazolin 2000 MG Injection, through Intravenous route, started on 2017-07-15, presumably until 2017-07-31\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2017-07-18 00:00:00, ended at 2017-07-18 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for sternal debridement\n\n### Condition\n- Hypothyroidism\n- Paroxysmal atrial fibrillation\n- Postprocedural infection\n- Sepsis\n- Beta thalassemia\n\n### Drug\n- 10 ML furosemide 10 MG/ML Injection, started on 2017-07-18, presumably until 2017-07-18\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2017-07-18, presumably until 2017-07-18\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2017-07-18, presumably until 2017-07-18\n- midazolam 1 MG/ML Injectable Solution, started on 2017-07-18, presumably until 2017-07-18\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2017-07-18 00:00:00, ended at 2017-07-18 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- vancomycin 1000 MG Injection, through Intravenous route, started on 2017-07-18, presumably until 2017-07-18\n- gentamicin 40 MG/ML Injectable Solution, through Intravenous route, started on 2017-07-18, presumably until 2017-07-18\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-07-19 00:00:00, ended at 2017-07-19 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Cardiomyopathy\n- Lupus anticoagulant disorder\n- Rheumatic disease of mitral AND aortic valves\n- Acquired absence of spleen\n- Hemochromatosis following repeated red blood cell transfusion\n- Beta thalassemia\n\n### Drug\n- hydrochlorothiazide 25 MG / spironolactone 25 MG Oral Tablet, started on 2017-07-20, presumably until 2017-08-10, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-07-26 00:00:00, ended at 2017-07-26 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Cardiomyopathy\n- Atrial fibrillation\n- Atrial flutter\n- Electrocardiogram abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-07-28 00:00:00, ended at 2017-07-28 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Illness\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2017-07-28 00:00:00, ended at 2017-07-28 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sodium chloride 0.154 MEQ/ML Irrigation Solution, through Topical route, started on 2017-07-28, presumably until 2017-07-28\n- rifampin 600 MG Injection, through Intravenous route, started on 2017-07-28, presumably until 2017-07-28\n- povidone-iodine 50 MG/ML Ophthalmic Solution, through Intraocular route, started on 2017-07-28, presumably until 2017-07-28\n- thrombin, bovine 2000 UNT/ML Topical Solution, through Topical route, started on 2017-07-28, presumably until 2017-07-28\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2017-07-28 00:00:00, ended at 2017-07-28 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for procedures on heart, pericardial sac, and great vessels of chest; with pump oxygenator, age 1 year or older, for all noncoronary bypass procedures (eg, valve procedures) or for re-operation for coronary bypass more than 1 month after origin\n- Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous\n- Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); follow-up or limited study (List separately in addition to codes for echocardiographic imaging)\n- Echocardiography, transesophageal, real-time with image documentation (2D) (with or without M-mode recording); including probe placement, image acquisition, interpretation and report\n- Insertion of non-tunneled centrally inserted central venous catheter; age 5 years or older\n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n\n### Condition\n- Pleural effusion\n- Pneumothorax\n- Valvular endocarditis\n\n### Drug\n- hydrocortisone 100 MG Injection, started on 2017-07-28, presumably until 2017-07-28\n- 10 ML calcium chloride 100 MG/ML Injection, through Intravenous route, started on 2017-07-28, presumably until 2017-07-28\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2017-07-28, presumably until 2017-07-28\n- vancomycin 1000 MG Injection, through Intravenous route, started on 2017-07-28, presumably until 2017-07-28\n- 10 ML epinephrine 0.1 MG/ML Prefilled Syringe, through Intravenous route, started on 2017-07-28, presumably until 2017-07-28\n- rifampin 600 MG Injection, through Intravenous route, started on 2017-07-28, presumably until 2017-07-28\n- anti-inhibitor coagulant complex 1 UNT Injection, through Intravenous route, started on 2017-07-28, presumably until 2017-07-28\n- cefazolin 1000 MG Injection, started on 2017-07-28, presumably until 2017-07-28\n- 250 ML norepinephrine 0.016 MG/ML Injection, through Intravenous route, started on 2017-07-28, presumably until 2017-07-28\n- 10 ML furosemide 10 MG/ML Injection, started on 2017-07-28, presumably until 2017-07-28\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2017-07-28, presumably until 2017-07-28\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2017-07-28, presumably until 2017-07-28\n- vasopressin (USP) 20 UNT/ML Injectable Solution, through Intravenous route, started on 2017-07-28, presumably until 2017-07-28\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2017-07-28, presumably until 2017-07-28\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2017-07-28, presumably until 2017-07-28\n- 6-aminocaproic acid 250 MG/ML Injectable Solution, through Intravenous route, started on 2017-07-28, presumably until 2017-07-28\n- 2 ML dexmedetomidine 0.1 MG/ML Injection, through Intravenous route, started on 2017-07-28, presumably until 2017-07-28\n- midazolam 1 MG/ML Injectable Solution, started on 2017-07-28, presumably until 2017-07-29\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-08-17 00:00:00, ended at 2017-08-17 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2017-08-17, presumably until 2018-10-09, with intended 3 refill(s). Instructions: 3 mL by Nebulization route every 6 hours as needed\n- potassium chloride 1.33 MEQ/ML Oral Solution, started on 2017-08-17, presumably until 2017-08-20, with intended 0 refill(s). Instructions: Take 30ml two times a day for 2 weeks. Then take 15ml two times a day for 2 weeks.\n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2017-08-17, presumably until 2018-08-17, with intended 3 refill(s). Instructions: 2 Puffs by Inhalation route every 6 hours as needed (coughing)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-08-17 00:00:00, ended at 2017-08-17 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Blood chemistry abnormal\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2017-08-17 16:56:00, ended at 2017-08-20 14:06:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- C reactive protein [Mass/volume] in Serum or Plasma: 3.9 (milligram per deciliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 2.4 (ratio)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 4.3 (ratio)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.04 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 8.7 (gram per deciliter)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 5.68 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 128 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 25 (millimeter per hour)\n- Ferritin [Mass/volume] in Serum or Plasma: 1300.6 (nanogram per milliliter)\n- Glucose [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.1 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 31.1 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.52 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 74 (percent)\n- Reticulocytes [#/volume] in Blood by Automated count: 209.2 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 72 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 1.30 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 23.6 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 8 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.68 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 2.22 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.6 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.8 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 95 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 33.0 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 3 - 5 (per high power field)\n- MCV [Entitic volume] by Automated count: 76.3 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma: 2116 (picogram per milliliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.2 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 128 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 30 (milligram per deciliter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 14 (unit per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Leukocytes [#/volume] in Body fluid by Manual count: 291 (milli-international unit per milliliter)\n- Prothrombin time (PT): 15.9 (second)\n- Basophils/100 leukocytes in Blood by Automated count: 4 (percent)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Body height: 5' 5\" (inch (US))\n- Eosinophils/100 leukocytes in Blood by Automated count: 7 (percent)\n- Iron [Mass/volume] in Serum or Plasma: 96 (microgram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 614 (thousand per microliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 2.93 (micro-international unit per milliliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.1 (percent)\n\n### Procedure\n- Occupational therapy evaluation, low complexity, requiring these components: An occupational profile and medical and therapy history, which includes a brief history including review of medical and/or therapy records relating to the presenting problem; An \n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n- Physical therapy evaluation: low complexity, requiring these components: A history with no personal factors and/or comorbidities that impact the plan of care; An examination of body system(s) using standardized tests and measures addressing 1-2 elements f\n- Therapeutic procedure, 1 or more areas, each 15 minutes; gait training (includes stair climbing)\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of moderate complexity. Counseling and/or coordination\n- Hospital discharge day management; 30 minutes or less\n- Radiologic examination, chest; single view, frontal\n\n### Condition\n- Acute osteomyelitis\n- Chronic osteomyelitis\n- Non-rheumatic heart valve disorder\n- Postoperative state\n- Tachycardia\n- Acquired absence of spleen\n- Chronic pulmonary edema\n- Congestive heart failure\n- Paroxysmal atrial fibrillation\n- Disorder of prosthetic cardiac valve\n- Disorder of vein\n- Beta thalassemia\n- Hypokalemia\n- Infection by methicillin sensitive Staphylococcus aureus\n- Acute on chronic combined systolic and diastolic heart failure\n- Acute on chronic diastolic heart failure\n- Generalized skin eruption caused by drug and medicament\n- Heart failure\n- Primary diagnosis: Infective endocarditis\n- Localized edema\n- Lupus anticoagulant disorder\n- Hypothyroidism\n- Transplanted heart valve present\n\n### Drug\n- folic acid 1 MG Oral Tablet, through Oral route, started on 2017-08-17, presumably until 2017-08-20\n- daptomycin 500 MG Injection, through Intravenous route, started on 2017-08-18, presumably until 2017-08-20\n- rifampin 300 MG Oral Capsule, through Oral route, started on 2017-08-17, presumably until 2017-09-14, with intended 0 refill(s). Instructions: take 1 Cap by mouth 3 times a day after meals for 25 days\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2017-08-18, presumably until 2017-08-20\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2017-08-17, presumably until 2017-08-18\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2017-08-18, presumably until 2017-08-19\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2017-08-17, presumably until 2017-08-18\n- levothyroxine sodium 0.125 MG Oral Tablet, through Oral route, started on 2017-08-18, presumably until 2017-08-20\n- deferasirox 360 MG Oral Tablet, through Oral route, started on 2017-08-18, presumably until 2017-08-20\n- furosemide 40 MG Oral Tablet, through Oral route, started on 2017-08-20, presumably until 2017-11-11, with intended 3 refill(s). Instructions: take 2 Tabs by mouth every morning\n- melatonin 3 MG Oral Tablet, through Oral route, started on 2017-08-20, presumably until 2017-12-30, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every bedtime as needed\n- 10 ML furosemide 10 MG/ML Injection, started on 2017-08-17, presumably until 2017-08-20\n- oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2017-08-20, presumably until 2017-09-04, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2017-08-17, presumably until 2017-08-17\n- potassium chloride 1.33 MEQ/ML Oral Solution, through Oral route, started on 2017-08-20, presumably until 2018-03-29, with intended 0 refill(s). Instructions: take 15 mL by mouth daily\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2017-08-17, presumably until 2017-08-20\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2017-08-18, presumably until 2017-08-20\n- carvedilol 3.125 MG Oral Tablet, through Oral route, started on 2017-08-18, presumably until 2017-08-19\n- carvedilol 6.25 MG Oral Tablet, through Oral route, started on 2017-08-20, presumably until 2017-09-16, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- 2 ML ondansetron 2 MG/ML Injection, started on 2017-08-17, presumably until 2017-08-20\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2017-08-17, presumably until 2017-08-19\n- magnesium sulfate 20 MG/ML Injection, through Intravenous route, started on 2017-08-17, presumably until 2017-08-19\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2017-08-17, presumably until 2017-08-20\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2017-08-18, presumably until 2017-08-19\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2017-08-17, presumably until 2017-08-17\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-08-28 00:00:00, ended at 2017-08-28 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Heart failure\n- Malaise\n- Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-09-01 15:00:00, ended at 2017-09-01 23:59:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Glucose [Mass/volume] in Serum or Plasma: 112 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 74 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 68.6 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.9 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 1351 (unit per liter)\n- Erythrocyte sedimentation rate: 34 (millimeter per hour)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.7 (percent)\n- MCHC [Mass/volume] by Automated count: 32.5 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 22 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 37.6 (percent)\n- Globulin [Mass/volume] in Serum: 5.2 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 503 (thousand per microliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.73 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.6 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.90 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 8.7 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 93 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 97 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 22.3 (picogram)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hemoglobin E/beta thalassemia disease\n- Infective endocarditis\n- Acute insomnia\n- Beta thalassemia\n- Postoperative state\n- Transplanted heart valve present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-09-02 00:00:00, ended at 2017-09-02 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Heart failure\n- Chest pain\n\n### Drug\n- ondansetron 4 MG Oral Tablet, through Oral route, started on 2017-09-02, presumably until 2018-08-26, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2017-09-02, presumably until 2018-03-01, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-09-04 13:24:35, ended at 2017-09-04 15:48:53\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); each additional vaccine (single or combination vaccine/toxoid) (List separately in addition to code for primary procedure)\n\n### Condition\n- Acquired absence of spleen\n- Primary diagnosis: Congenital absence of spleen\n- Postoperative state\n- Beta thalassemia\n- Cardiomyopathy\n- Disorder of bilirubin metabolism\n- Hemochromatosis following repeated red blood cell transfusion\n- Transplanted heart valve present\n- Heart failure\n- Infective endocarditis\n- Hereditary hemolytic anemia\n\n### Drug\n- 0.5 ML meningococcal group B vaccine 0.1 MG/ML / Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen 0.1 MG/ML / Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen 0.1 MG/ML / Neisseria meningitidis serogr..., through Intramuscular route, started on 2017-09-04, presumably until 2017-09-04, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time\n- meningococcal group A polysaccharide 0.1 MG/ML / meningococcal group C polysaccharide 0.1 MG/ML / meningococcal polysaccharide vaccine group W-135 0.1 MG/ML / meningococcal polysaccharide vaccine group Y 0.1 MG/ML Injectable Solution, through Subcutaneous route, started on 2017-09-04, presumably until 2017-09-04, with intended 0 refill(s). Instructions: inject 0.5 mL subcutaneous (under the skin) One Time\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-09-10 00:00:00, ended at 2017-09-10 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2017-09-11, presumably until 2017-10-06, with intended 0 refill(s). Instructions: take 1 Tab by mouth every morning before breakfast\n- acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2017-09-11, presumably until 2017-09-23, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed for Pain (7-10/10 pain)\n- gabapentin 100 MG Oral Capsule, through Oral route, started on 2017-09-11, presumably until 2017-09-24, with intended 0 refill(s). Instructions: take 1 Cap by mouth 3 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-09-11 00:00:00, ended at 2017-09-11 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chest pain\n- Heart failure\n\n### Drug\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2017-09-11, presumably until 2017-11-03, with intended 11 refill(s). Instructions: take 1 Tab by mouth every morning with breakfast\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-09-14 15:24:06, ended at 2017-09-14 16:26:20\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Varicose veins of lower extremity with inflammation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-09-16 00:00:00, ended at 2017-09-16 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- carvedilol 6.25 MG Oral Tablet, through Oral route, started on 2017-09-16, presumably until 2017-11-03, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-09-22 14:21:00, ended at 2017-09-22 23:59:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Glucose [Mass/volume] in Serum or Plasma: 114 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 30.2 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.96 (million per microliter)\n- Globulin [Mass/volume] in Serum: 5.1 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 482 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.8 (gram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 22 (millimeter per hour)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 113 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 19.2 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 19.6 (picogram)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.63 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 25.7 (percent)\n- Hemoglobin [Mass/volume] in Blood: 7.8 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 65.0 (femtoliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Transfusion, blood or blood components\n\n### Condition\n- Transplanted heart valve present\n- Infective endocarditis\n- Postoperative state\n- Beta thalassemia\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2017-09-22, presumably until 2017-09-22\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2017-09-22, presumably until 2017-09-22\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-09-24 07:00:00, ended at 2017-09-24 23:59:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Transfusion, blood or blood components\n\n### Condition\n- Beta thalassemia\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2017-09-24, presumably until 2017-09-24\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2017-09-24, presumably until 2017-09-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-09-24 10:28:36, ended at 2017-09-24 14:26:23\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5.039\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Infective endocarditis\n\n### Drug\n- gabapentin 100 MG Oral Capsule, through Oral route, started on 2017-09-24, presumably until 2017-10-06, with intended 0 refill(s). Instructions: take 1 Cap by mouth 3 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-09-30 00:00:00, ended at 2017-09-30 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Lupus anticoagulant disorder\n- Acquired absence of spleen\n- Cardiomyopathy\n- Hemochromatosis following repeated red blood cell transfusion\n- Rheumatic disease of mitral AND aortic valves\n- Beta thalassemia\n\n### Drug\n- hydrochlorothiazide 25 MG / spironolactone 25 MG Oral Tablet, started on 2017-09-30, presumably until 2017-09-30, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-09-30 14:04:55, ended at 2017-09-30 15:59:32\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); each additional vaccine (single or combination vaccine/toxoid) (List separately in addition to code for primary procedure)\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n\n### Condition\n- Infection by methicillin sensitive Staphylococcus aureus\n- Late effect of medical and surgical care complication\n- Primary diagnosis: Acquired absence of spleen\n\n### Drug\n- levofloxacin 500 MG Oral Tablet, through Oral route, started on 2017-09-30, presumably until 2017-10-05, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily for 5 doses\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-10-06 00:00:00, ended at 2017-10-06 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2017-10-08, presumably until 2018-10-08, with intended 3 refill(s). Instructions: take 1 Tab by mouth every morning before breakfast\n- gabapentin 100 MG Oral Capsule, through Oral route, started on 2017-10-08, presumably until 2017-10-20, with intended 3 refill(s). Instructions: take 1 Cap by mouth 3 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-10-22 00:00:00, ended at 2017-10-22 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-10-22 00:00:00, ended at 2017-10-22 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute insomnia\n\n### Drug\n- zolpidem tartrate 10 MG Oral Tablet, through Oral route, started on 2017-10-22, presumably until 2017-11-24, with intended 0 refill(s). Instructions: take 1 Tab by mouth every bedtime as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-11-01 00:00:00, ended at 2017-11-01 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- furosemide 40 MG Oral Tablet, through Oral route, started on 2017-11-11, presumably until 2018-09-06, with intended 12 refill(s). Instructions: take 2 Tabs by mouth every morning\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-11-03 00:00:00, ended at 2017-11-03 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- furosemide 40 MG Oral Tablet, through Oral route, started on 2017-11-03, presumably until 2017-11-11, with intended 12 refill(s). Instructions: take 1 Tab by mouth daily in the evening\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2017-11-03, presumably until 2018-09-14, with intended 12 refill(s). Instructions: take 1 Tab by mouth every morning with breakfast\n- carvedilol 6.25 MG Oral Tablet, through Oral route, started on 2017-11-03, presumably until 2018-09-14, with intended 12 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-11-22 13:21:00, ended at 2017-11-22 23:59:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 7.6 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.5 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 30.6 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Prothrombin time (PT): 15.4 (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 7.2 (gram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 82 (percent)\n- MCV [Entitic volume] by Automated count: 69.9 (femtoliter)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 14.05 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 132 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Ferritin [Mass/volume] in Serum or Plasma: 1718.8 (nanogram per milliliter)\n- Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin: 166 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.4 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Monocytes [#/volume] in Blood by Manual count: 0.88 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.4 (gram per deciliter)\n- Reticulocytes [#/volume] in Blood by Automated count: 476.5 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Leukocytes [#/volume] in Body fluid by Manual count: 763 (milli-international unit per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.1 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 573 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 33.2 (second)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.63 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 106 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 23.7 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.6 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 36.7 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.39 (million per microliter)\n- Iron [Mass/volume] in Serum or Plasma: 248 (microgram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 5.50 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.63 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 21.4 (picogram)\n- Neutrophils/100 leukocytes in Blood by Manual count: 31 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 44 (percent)\n\n### Procedure\n- Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; read by instrument assisted direct optical observation (eg, utilizing immunoassay [eg, dipsticks, cups, cards, or cartridges]), includes sample validation when per\n- Collection of venous blood by venipuncture\n\n### Condition\n- Postoperative state\n- Transplanted heart valve present\n- Blood chemistry abnormal\n- Disorder of bilirubin metabolism\n- Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-11-24 00:00:00, ended at 2017-11-24 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-11-24 00:00:00, ended at 2017-11-24 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-11-24 00:00:00, ended at 2017-11-24 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute insomnia\n\n### Drug\n- zolpidem tartrate 10 MG Oral Tablet, through Oral route, started on 2017-11-24, presumably until 2017-12-29, with intended 0 refill(s). Instructions: take 1 Tab by mouth every bedtime as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-11-24 00:00:00, ended at 2017-11-24 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-11-24 12:30:00, ended at 2017-11-24 23:59:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5.039\" (inch (US))\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n\n### Procedure\n- Transfusion, blood or blood components\n\n### Condition\n- Beta thalassemia\n- Hemochromatosis following repeated red blood cell transfusion\n- Primary diagnosis: Disorder of bilirubin metabolism\n- Hemoglobin E/beta thalassemia disease\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2017-11-24, presumably until 2017-11-24\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2017-11-24, presumably until 2017-11-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-12-09 00:00:00, ended at 2017-12-09 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of iron metabolism\n- Beta thalassemia\n\n### Drug\n- deferasirox 360 MG Oral Tablet, through Oral route, started on 2017-12-09, presumably until 2017-12-15, with intended 5 refill(s). Instructions: take 1,530 mg by mouth every day Weight: 65.5 kg\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-12-15 00:00:00, ended at 2017-12-15 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute renal failure syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-12-18 14:31:37, ended at 2017-12-18 16:30:49\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 6.7 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 101 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 28 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.71 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 122 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 8.9 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hemochromatosis following repeated red blood cell transfusion\n- Disorder of bilirubin metabolism\n- Infective endocarditis\n- Primary diagnosis: Postoperative state\n- Transplanted heart valve present\n- Congenital absence of spleen\n- Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-12-22 00:00:00, ended at 2017-12-22 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Infective endocarditis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-12-29 00:00:00, ended at 2017-12-29 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hereditary hemolytic anemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-12-29 00:00:00, ended at 2017-12-29 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute insomnia\n\n### Drug\n- zolpidem tartrate 10 MG Oral Tablet, through Oral route, started on 2017-12-29, presumably until 2018-01-28, with intended 0 refill(s). Instructions: take 1 Tab by mouth every bedtime as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-01-06 00:00:00, ended at 2018-01-06 00:00:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n- Disorder of iron metabolism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-01-12 08:41:23, ended at 2018-01-12 09:46:22\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acquired absence of spleen\n- Disorder of bilirubin metabolism\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-01-12 10:33:00, ended at 2018-01-12 23:59:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 6.7 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.73 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.25 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 4.2 (gram per deciliter)\n- Iron [Mass/volume] in Serum or Plasma: 324 (microgram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 22.4 (picogram)\n- Monocytes [#/volume] in Blood by Manual count: 1.51 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 8.8 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 7.4 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 24.9 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 669 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 105 (unit per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Erythrocyte sedimentation rate: 6 (millimeter per hour)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 36 (milligram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 58 (percent)\n- Lymphocytes [#/volume] in Blood by Manual count: 9.32 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 37 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.33 (million per microliter)\n- MCV [Entitic volume] by Automated count: 74.8 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 50 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 130 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 7.5 (gram per deciliter)\n- Leukocytes [#/volume] in Body fluid by Manual count: 327 (milli-international unit per milliliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 25.2 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 36.7 (percent)\n- Ferritin [Mass/volume] in Serum or Plasma: 1216.5 (nanogram per milliliter)\n- MCHC [Mass/volume] by Automated count: 29.9 (gram per deciliter)\n\n### Procedure\n- Transfusion, blood or blood components\n- Collection of venous blood by venipuncture\n\n### Condition\n- Disorder of iron metabolism\n- Hereditary hemolytic anemia\n- Infective endocarditis\n- Beta thalassemia\n- Disorder of bilirubin metabolism\n- Hemochromatosis following repeated red blood cell transfusion\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2018-01-12, presumably until 2018-01-12\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2018-01-12, presumably until 2018-01-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-01-12 16:17:17, ended at 2018-01-12 17:18:45\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- IgA [Mass/volume] in Serum or Plasma: 200 (milligram per deciliter)\n- IgG [Mass/volume] in Serum or Plasma: 2050 (milligram per deciliter)\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hemochromatosis following repeated red blood cell transfusion\n- Hereditary hemolytic anemia\n- Disorder of bilirubin metabolism\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-01-13 00:00:00, ended at 2018-01-13 00:00:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Stress\n- Primary diagnosis: Beta thalassemia\n- Emotional state finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-01-28 00:00:00, ended at 2018-01-28 00:00:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute insomnia\n\n### Drug\n- zolpidem tartrate 10 MG Oral Tablet, through Oral route, started on 2018-01-28, presumably until 2018-03-01, with intended 1 refill(s). Instructions: take 1 Tab by mouth every bedtime as needed for Insomnia\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-02-05 08:35:42, ended at 2018-02-05 09:56:41\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Major depression, single episode\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-03-01 00:00:00, ended at 2018-03-01 00:00:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Insomnia\n\n### Drug\n- zolpidem tartrate 10 MG Oral Tablet, through Oral route, started on 2018-03-01, presumably until 2018-03-31, with intended 1 refill(s). Instructions: take 1 Tab by mouth every bedtime as needed for Insomnia\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-03-09 14:43:00, ended at 2018-03-09 23:59:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Leukocytes [#/volume] in Body fluid by Manual count: 411 (milli-international unit per milliliter)\n- Reticulocytes [#/volume] in Blood by Automated count: 154.0 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 23.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 42 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Iron [Mass/volume] in Serum or Plasma: 309 (microgram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 43 (percent)\n- MCHC [Mass/volume] by Automated count: 30.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 72.1 (femtoliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.79 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 614 (thousand per microliter)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 4.68 (percent)\n- Lymphocytes [#/volume] in Blood by Manual count: 12.81 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 35.0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.29 (million per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 615.9 (nanogram per milliliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 73 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 29.8 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 22.1 (picogram)\n- Hemoglobin [Mass/volume] in Blood: 7.3 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Infective endocarditis\n- Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-03-09 14:50:47, ended at 2018-03-09 16:32:12\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 6.3 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 94 (unit per liter)\n- Body height: 5' 5\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.05 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.6 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 39 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 85 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 35 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.1 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hemochromatosis following repeated red blood cell transfusion\n- Acquired absence of spleen\n- Primary diagnosis: Beta thalassemia\n- Hereditary hemolytic anemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-03-10 00:00:00, ended at 2018-03-10 00:00:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Beta thalassemia\n- Anemia\n- Primary diagnosis: Hemochromatosis following repeated red blood cell transfusion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-03-10 12:20:00, ended at 2018-03-10 23:59:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Transfusion, blood or blood components\n\n### Condition\n- Hemochromatosis following repeated red blood cell transfusion\n- Acquired absence of spleen\n- Hereditary hemolytic anemia\n- Beta thalassemia\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2018-03-10, presumably until 2018-03-10\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2018-03-10, presumably until 2018-03-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-03-11 00:00:00, ended at 2018-03-11 00:00:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n- Hemochromatosis following repeated red blood cell transfusion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-03-12 00:00:00, ended at 2018-03-12 00:00:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- potassium chloride 1.33 MEQ/ML Oral Solution, through Oral route, started on 2018-03-29, presumably until 2018-11-08, with intended 3 refill(s). Instructions: take 15 mL by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-03-25 11:59:41, ended at 2018-03-25 13:51:38\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypertrophic scar\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-03-31 00:00:00, ended at 2018-03-31 00:00:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- zolpidem tartrate 10 MG Oral Tablet, through Oral route, started on 2018-03-31, presumably until 2018-06-04, with intended 1 refill(s). Instructions: take 1 Tab by mouth every bedtime as needed for Insomnia\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-04-01 00:00:00, ended at 2018-04-01 00:00:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of iron metabolism\n- Beta thalassemia\n\n### Drug\n- deferasirox 360 MG Oral Tablet, through Oral route, started on 2018-04-01, presumably until 2019-02-02, with intended 5 refill(s). Instructions: take 1,080 mg by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-04-05 00:00:00, ended at 2018-04-05 00:00:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-04-08 00:00:00, ended at 2018-04-08 00:00:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- levothyroxine sodium 0.125 MG Oral Tablet, through Oral route, started on 2018-04-08, presumably until 2018-12-17, with intended 12 refill(s). Instructions: take 1 Tab by mouth every morning before breakfast\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-04-22 07:17:00, ended at 2018-04-22 23:59:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s)\n- Cardiac magnetic resonance imaging for morphology and function without contrast material\n\n### Condition\n- Hemochromatosis\n- Beta thalassemia\n- Hemochromatosis following repeated red blood cell transfusion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-04-27 00:00:00, ended at 2018-04-27 00:00:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-04-27 00:00:00, ended at 2018-04-27 00:00:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hemochromatosis following repeated red blood cell transfusion\n- Anemia\n- Beta thalassemia\n\n### Drug\n- deferiprone 500 MG Oral Tablet, through Oral route, started on 2018-04-27, presumably until 2019-04-04, with intended 3 refill(s). Instructions: take 1,500 mg by mouth 3 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-05-03 00:00:00, ended at 2018-05-03 00:00:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-05-09 14:24:00, ended at 2018-05-09 23:59:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- MCH [Entitic mass] by Automated count: 20.2 (picogram)\n- Leukocytes [#/volume] in Body fluid by Manual count: 274 (milli-international unit per milliliter)\n- MCHC [Mass/volume] by Automated count: 29.7 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.31 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 30.9 (percent)\n- MCV [Entitic volume] by Automated count: 68.0 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7 (percent)\n- Monocytes [#/volume] in Blood by Manual count: 2.18 (thousand per microliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 75 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 56 (percent)\n- Ferritin [Mass/volume] in Serum or Plasma: 608.9 (nanogram per milliliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 22.8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 31.2 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 31 (percent)\n- Reticulocytes [#/volume] in Blood by Automated count: 149.1 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 4.49 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.36 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 6.8 (gram per deciliter)\n- Iron [Mass/volume] in Serum or Plasma: 281 (microgram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 9.67 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 681 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-05-10 11:52:59, ended at 2018-05-10 13:18:19\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n- Cardiomyopathy\n- Transplanted heart valve present\n- Hemochromatosis following repeated red blood cell transfusion\n- Hereditary hemolytic anemia\n- Heart failure\n- Postoperative state\n- Acquired absence of spleen\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-05-10 13:10:00, ended at 2018-05-10 23:59:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Transfusion, blood or blood components\n\n### Condition\n- Hemochromatosis following repeated red blood cell transfusion\n- Acquired absence of spleen\n- Beta thalassemia\n- Hereditary hemolytic anemia\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2018-05-10, presumably until 2018-05-10\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2018-05-10, presumably until 2018-05-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-05-17 00:00:00, ended at 2018-05-17 00:00:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- benzonatate 100 MG Oral Capsule, through Oral route, started on 2018-05-18, presumably until 2019-05-18, with intended 0 refill(s). Instructions: take 1 Cap by mouth 3 times a day as needed for Cough\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-05-28 00:00:00, ended at 2018-05-28 00:00:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-05-30 14:31:00, ended at 2018-05-30 23:59:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Ferritin [Mass/volume] in Serum or Plasma: 624.8 (nanogram per milliliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 19.0 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 7.79 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.38 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Manual count: 2.28 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12 (percent)\n- Iron [Mass/volume] in Serum or Plasma: 270 (microgram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 22.6 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 3 (percent)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 69 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 39 (percent)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 3.9 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 35.4 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 41 (percent)\n- MCH [Entitic mass] by Automated count: 22.4 (picogram)\n- MCHC [Mass/volume] by Automated count: 31.4 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 71.4 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 535 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Hemoglobin [Mass/volume] in Blood: 7.1 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.17 (million per microliter)\n- Leukocytes [#/volume] in Body fluid by Manual count: 163 (milli-international unit per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-06-04 00:00:00, ended at 2018-06-04 00:00:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- zolpidem tartrate 10 MG Oral Tablet, through Oral route, started on 2018-06-04, presumably until 2018-06-09, with intended 1 refill(s). Instructions: take 1 Tab by mouth every bedtime as needed for Insomnia\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-06-09 00:00:00, ended at 2018-06-09 00:00:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- zolpidem tartrate 10 MG Oral Tablet, through Oral route, started on 2018-06-09, presumably until 2018-08-25, with intended 1 refill(s). Instructions: take 1 Tab by mouth every bedtime as needed for Insomnia\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-06-09 00:00:00, ended at 2018-06-09 00:00:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-06-17 00:00:00, ended at 2018-06-17 00:00:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-07-01 12:00:00, ended at 2018-07-01 23:59:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Hematocrit [Volume Fraction] of Blood by Automated count: 24.4 (percent)\n- Iron [Mass/volume] in Serum or Plasma: 333 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 71 (percent)\n- MCH [Entitic mass] by Automated count: 21.7 (picogram)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.21 (million per microliter)\n- Platelets [#/volume] in Blood by Automated count: 560 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.40 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 19.8 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 28.6 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.99 (thousand per microliter)\n- Leukocytes [#/volume] in Body fluid by Manual count: 468 (milli-international unit per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 7.0 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 35.4 (percent)\n- Ferritin [Mass/volume] in Serum or Plasma: 465.6 (nanogram per milliliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 6.34 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 32 (percent)\n- MCV [Entitic volume] by Automated count: 75.8 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 55 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-07-02 08:50:00, ended at 2018-07-02 23:59:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Transfusion, blood or blood components\n\n### Condition\n- Hereditary hemolytic anemia\n- Hemochromatosis following repeated red blood cell transfusion\n- Beta thalassemia\n- Acquired absence of spleen\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2018-07-02, presumably until 2018-07-02\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2018-07-02, presumably until 2018-07-02\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-08-25 00:00:00, ended at 2018-08-25 00:00:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Beta thalassemia\n\n### Drug\n- zolpidem tartrate 10 MG Oral Tablet, through Oral route, started on 2018-08-25, presumably until 2018-11-12, with intended 1 refill(s). Instructions: take 1 Tab by mouth every bedtime as needed for Insomnia\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-08-26 00:00:00, ended at 2018-08-26 00:00:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Heart failure\n- Chest pain\n\n### Drug\n- ondansetron 4 MG Oral Tablet, through Oral route, started on 2018-08-26, presumably until 2019-09-02, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-08-29 13:20:00, ended at 2018-08-29 23:59:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 2.99 (million per microliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 19 (percent)\n- Ferritin [Mass/volume] in Serum or Plasma: 391.5 (nanogram per milliliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 30.1 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 22.1 (picogram)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 12.11 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 30.3 (percent)\n- Iron [Mass/volume] in Serum or Plasma: 383 (microgram per deciliter)\n- Leukocytes [#/volume] in Body fluid by Manual count: 410 (milli-international unit per milliliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.20 (thousand per microliter)\n- Reticulocytes [#/volume] in Blood by Automated count: 362.7 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 24.2 (percent)\n- Lymphocytes [#/volume] in Blood by Manual count: 20.77 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 80.9 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 581 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Eosinophils [#/volume] in Blood by Manual count: 0.60 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 27.3 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 6.6 (gram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 73 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 69 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-08-31 07:00:00, ended at 2018-08-31 23:59:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Transfusion, blood or blood components\n\n### Condition\n- Beta thalassemia\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2018-08-31, presumably until 2018-08-31\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2018-08-31, presumably until 2018-08-31\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-09-03 00:00:00, ended at 2018-09-03 00:00:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- furosemide 40 MG Oral Tablet, through Oral route, started on 2018-09-06, presumably until 2019-11-12, with intended 12 refill(s). Instructions: take 1 Tab by mouth daily in the evening\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-09-14 00:00:00, ended at 2018-09-14 00:00:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- aspirin 81 MG Chewable Tablet, started on 2018-09-14, presumably until 2018-10-25, with intended 11 refill(s). Instructions: CHEW AND SWALLOW 1 TABLET BY MOUTH EVERY MORNING WITH BREAKFAST\n- carvedilol 6.25 MG Oral Tablet, started on 2018-09-14, presumably until 2018-10-25, with intended 11 refill(s). Instructions: TAKE 1 TABLET BY MOUTH TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-09-16 00:00:00, ended at 2018-09-16 00:00:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Beta thalassemia\n- Primary diagnosis: Congenital absence of spleen\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-10-08 00:00:00, ended at 2018-10-08 00:00:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypertrophic scar\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-10-09 00:00:00, ended at 2018-10-09 00:00:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2018-10-11, presumably until 2019-06-13, with intended 3 refill(s). Instructions: 3 mL by Nebulization route every 6 hours as needed (Wheezing/ Shortness of breath) **APPT REQUIRED PRIOR TO NEXT REFILL\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-10-21 00:00:00, ended at 2018-10-21 00:00:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Blood glucose abnormal\n- Anemia\n- Fatigue\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-10-24 14:15:00, ended at 2018-10-24 23:59:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Ferritin [Mass/volume] in Serum or Plasma: 214.5 (nanogram per milliliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 3.17 (micro-international unit per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 77 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.74 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 107 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 23.7 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.3 (percent)\n- MCH [Entitic mass] by Automated count: 22.6 (picogram)\n- Monocytes [#/volume] in Blood by Manual count: 1.58 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.1 (gram per deciliter)\n- Iron [Mass/volume] in Serum or Plasma: 404 (microgram per deciliter)\n- Leukocytes [#/volume] in Body fluid by Manual count: 746 (milli-international unit per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 30 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Globulin [Mass/volume] in Serum: 3.9 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 6.8 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 78.9 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 22 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 7.3 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.53 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 29.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 17.5 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 10.68 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9 (percent)\n- Platelets [#/volume] in Blood by Automated count: 564 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 28.6 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.00 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 61 (percent)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 3.7 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Beta thalassemia\n- Anemia\n- Blood glucose abnormal\n- Fatigue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-10-25 00:00:00, ended at 2018-10-25 00:00:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-10-25 00:00:00, ended at 2018-10-25 00:00:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- aspirin 81 MG Chewable Tablet, started on 2018-10-25, presumably until 2019-11-17, with intended 3 refill(s). Instructions: CHEW AND SWALLOW 1 TABLET BY MOUTH EVERY MORNING WITH BREAKFAST\n- carvedilol 6.25 MG Oral Tablet, through Oral route, started on 2018-10-25, presumably until 2019-11-17, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-10-26 08:22:16, ended at 2018-10-26 09:47:33\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); each additional vaccine (single or combination vaccine/toxoid) (List separately in addition to code for primary procedure)\n\n### Condition\n- Primary diagnosis: Acquired absence of spleen\n\n### Drug\n- azithromycin 500 MG Oral Tablet, through Oral route, started on 2018-10-26, presumably until 2018-10-29, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily for 3 days\n- levofloxacin 500 MG Oral Tablet, through Oral route, started on 2018-10-26, presumably until 2018-10-31, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily for 5 days\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2018-10-26, presumably until 2018-11-02, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 7 days\n- typhoid Vi polysaccharide vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution, through Intramuscular route, started on 2018-10-26, presumably until 2018-10-26, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-10-26 11:00:00, ended at 2018-10-26 23:59:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Transfusion, blood or blood components\n\n### Condition\n- Congenital absence of spleen\n- Beta thalassemia\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2018-10-26, presumably until 2018-10-26\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2018-10-26, presumably until 2018-10-26\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-10-26 14:56:44, ended at 2018-10-26 16:12:22\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Congenital absence of spleen\n- Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-11-08 00:00:00, ended at 2018-11-08 00:00:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- potassium chloride 1.33 MEQ/ML Oral Solution, through Oral route, started on 2018-11-08, presumably until 2019-12-19, with intended 4 refill(s). Instructions: TAKE 15 ML BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-11-12 00:00:00, ended at 2018-11-12 00:00:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Beta thalassemia\n\n### Drug\n- zolpidem tartrate 10 MG Oral Tablet, through Oral route, started on 2018-11-12, presumably until 2018-12-17, with intended 1 refill(s). Instructions: take 1 Tab by mouth every bedtime as needed for Insomnia\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-12-03 00:00:00, ended at 2018-12-03 00:00:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- General finding of observation of patient\n- Primary diagnosis: Cough\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-12-09 00:00:00, ended at 2018-12-09 00:00:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-12-13 15:00:00, ended at 2018-12-13 23:59:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Non-rheumatic heart valve disorder\n- Non-rheumatic mitral valve disease\n- Tricuspid valve disorder, non-rheumatic\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-12-14 14:44:00, ended at 2018-12-14 23:59:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Heart failure\n- Hemochromatosis following repeated red blood cell transfusion\n- Beta thalassemia\n- Cough\n- Abnormal findings on diagnostic imaging of lung\n- Postoperative state\n- Transplanted heart valve present\n- Cardiomyopathy\n- Acquired absence of spleen\n- Hereditary hemolytic anemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-12-14 15:37:36, ended at 2018-12-14 17:05:19\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cough\n\n### Drug\n- codeine phosphate 2 MG/ML / guaifenesin 20 MG/ML Oral Solution, through Oral route, started on 2018-12-14, presumably until 2019-06-12, with intended 0 refill(s). Instructions: take 5 mL by mouth 3 times a day as needed\n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2018-12-14, presumably until 2019-12-14, with intended 0 refill(s). Instructions: 2 Puffs by Inhalation route every 6 hours as needed\n- 200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2018-12-14, presumably until 2019-12-14, with intended 0 refill(s). Instructions: 2 Puffs by Inhalation route every 6 hours\n- benzonatate 100 MG Oral Capsule, through Oral route, started on 2018-12-14, presumably until 2019-12-14, with intended 0 refill(s). Instructions: take 1 Cap by mouth 3 times a day\n- azithromycin 250 MG Oral Tablet, started on 2018-12-14, presumably until 2018-12-19, with intended 0 refill(s). Instructions: 2 tabs  (500mg) at once on day one, then 1 tab (250mg) daily for days 2-5.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-12-17 00:00:00, ended at 2018-12-17 00:00:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Beta thalassemia\n\n### Drug\n- levothyroxine sodium 0.125 MG Oral Tablet, through Oral route, started on 2018-12-17, presumably until 2020-01-11, with intended 12 refill(s). Instructions: take 1 Tab by mouth every morning before breakfast\n- zolpidem tartrate 10 MG Oral Tablet, through Oral route, started on 2018-12-17, presumably until 2019-02-07, with intended 1 refill(s). Instructions: take 1 Tab by mouth every bedtime as needed for Insomnia\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-12-19 15:02:00, ended at 2018-12-19 23:59:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 5.1 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.73 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.85 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.01 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 25 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 59 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4 (percent)\n- MCH [Entitic mass] by Automated count: 21.3 (picogram)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 24.1 (percent)\n- Lymphocytes [#/volume] in Blood by Manual count: 5.33 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 80.1 (femtoliter)\n- Monocytes [#/volume] in Blood by Manual count: 2.13 (thousand per microliter)\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 40 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 75 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 35.6 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 107 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 21.3 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 26.6 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.0 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 6.4 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 696 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-12-21 09:07:00, ended at 2018-12-21 23:59:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Transfusion, blood or blood components\n\n### Condition\n- Beta thalassemia\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2018-12-21, presumably until 2018-12-21\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2018-12-21, presumably until 2018-12-21\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-02-02 00:00:00, ended at 2019-02-02 00:00:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of iron metabolism\n- Beta thalassemia\n\n### Drug\n- deferasirox 360 MG Oral Tablet, through Oral route, started on 2019-02-02, presumably until 2019-10-06, with intended 5 refill(s). Instructions: take 1,080 mg by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-02-07 00:00:00, ended at 2019-02-07 00:00:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Beta thalassemia\n\n### Drug\n- zolpidem tartrate 10 MG Oral Tablet, through Oral route, started on 2019-02-07, presumably until 2019-02-15, with intended 1 refill(s). Instructions: take 1 Tab by mouth every bedtime as needed for Insomnia\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-02-10 00:00:00, ended at 2019-02-10 00:00:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-02-13 13:58:00, ended at 2019-02-13 23:59:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.90 (million per microliter)\n- MCH [Entitic mass] by Automated count: 21.0 (picogram)\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 22.7 (percent)\n- Hemoglobin [Mass/volume] in Blood: 6.1 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 8.67 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 44 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 8.0 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 5.5 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 33.0 (percent)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 26 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 19.7 (thousand per microliter)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 6.3 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 4.7 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.71 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 40 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 66 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 132 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 26.9 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 78.3 (femtoliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.20 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.18 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 441 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Beta thalassemia\n- Hemochromatosis following repeated red blood cell transfusion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-02-15 00:00:00, ended at 2019-02-15 00:00:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Iron saturation [Mass Fraction] in Serum or Plasma: 40 (percent)\n- Ferritin [Mass/volume] in Serum or Plasma: 397 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hemochromatosis following repeated red blood cell transfusion\n- Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-02-15 00:00:00, ended at 2019-02-15 00:00:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Beta thalassemia\n- Primary diagnosis: Hemochromatosis following repeated red blood cell transfusion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-02-15 00:00:00, ended at 2019-02-15 00:00:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Beta thalassemia\n\n### Drug\n- zolpidem tartrate 10 MG Oral Tablet, through Oral route, started on 2019-02-15, presumably until 2019-05-13, with intended 1 refill(s). Instructions: take 1 Tab by mouth every bedtime as needed for Insomnia\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-02-15 08:00:00, ended at 2019-02-15 23:59:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Transfusion, blood or blood components\n\n### Condition\n- Beta thalassemia\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2019-02-15, presumably until 2019-02-15\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2019-02-15, presumably until 2019-02-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-03-04 10:10:37, ended at 2019-03-04 11:10:33\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- Injection, intralesional; up to and including 7 lesions\n\n### Condition\n- Primary diagnosis: Hypertrophic scar\n\n### Drug\n- triamcinolone acetonide 10 MG/ML Injectable Suspension, started on 2019-03-04, presumably until 2019-03-04\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-04-04 00:00:00, ended at 2019-04-04 00:00:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-04-04 00:00:00, ended at 2019-04-04 00:00:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hemochromatosis following repeated red blood cell transfusion\n- Anemia\n- Beta thalassemia\n\n### Drug\n- deferiprone 500 MG Oral Tablet, through Oral route, started on 2019-04-04, presumably until 2019-08-17, with intended 3 refill(s). Instructions: take 1,500 mg by mouth 3 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-04-08 00:00:00, ended at 2019-04-08 00:00:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- gabapentin 100 MG Oral Capsule, started on 2019-04-08, presumably until 2019-04-08, with intended 12 refill(s). Instructions: TAKE 1 CAPSULE BY MOUTH THREE TIMES DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-04-10 14:44:00, ended at 2019-04-10 23:59:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 32.1 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 21.2 (percent)\n- MCHC [Mass/volume] by Automated count: 28.3 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 5.3 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.72 (million per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 326 (nanogram per milliliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 39 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 125 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 40 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 4.7 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 62 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 22.2 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 8.87 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 22.1 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 8.0 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 6.0 (gram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 78 (percent)\n- MCV [Entitic volume] by Automated count: 77.9 (femtoliter)\n- Monocytes [#/volume] in Blood by Manual count: 2.88 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.70 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 460 (thousand per microliter)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 8.3 (percent)\n- Eosinophils [#/volume] in Blood by Manual count: 0.67 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Beta thalassemia\n- Hemochromatosis following repeated red blood cell transfusion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-04-11 10:30:00, ended at 2019-04-11 23:59:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Transfusion, blood or blood components\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n- Hypertrophic scar\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2019-04-11, presumably until 2019-04-11\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2019-04-11, presumably until 2019-04-11\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-05-13 00:00:00, ended at 2019-05-13 00:00:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Beta thalassemia\n\n### Drug\n- zolpidem tartrate 10 MG Oral Tablet, through Oral route, started on 2019-05-13, presumably until 2019-08-16, with intended 1 refill(s). Instructions: take 1 Tab (10 mg total) by mouth every bedtime as needed for Insomnia\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-05-26 00:00:00, ended at 2019-05-26 00:00:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n- Anemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-06-05 14:46:00, ended at 2019-06-05 23:59:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 5.0 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 60 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 6.2 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.76 (milligram per deciliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 230 (nanogram per milliliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 37 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 16.4 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 40 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 14 (percent)\n- Platelets [#/volume] in Blood by Automated count: 636 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 62 (percent)\n- Monocytes [#/volume] in Blood by Manual count: 2.30 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.9 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 30.6 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.0 (gram per deciliter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.80 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 28.8 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 76.8 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (unit per liter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.16 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 21.5 (percent)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 1.4 (percent)\n- Lymphocytes [#/volume] in Blood by Manual count: 6.56 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 4.6 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 22.1 (picogram)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hemochromatosis following repeated red blood cell transfusion\n- Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-06-06 07:22:00, ended at 2019-06-06 08:49:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Cardiac magnetic resonance imaging for morphology and function without contrast material\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s)\n\n### Condition\n- Hemochromatosis following repeated red blood cell transfusion\n- Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-06-06 08:50:00, ended at 2019-06-06 23:59:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Transfusion, blood or blood components\n\n### Condition\n- Anemia\n- Beta thalassemia\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2019-06-06, presumably until 2019-06-06\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2019-06-06, presumably until 2019-06-06\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-07-27 12:25:00, ended at 2019-07-27 23:59:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.77 (milligram per deciliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 141 (nanogram per milliliter)\n- MCHC [Mass/volume] by Automated count: 27.5 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.93 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 5.6 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 22.9 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 5 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 7 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 32.7 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 22 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 22.0 (picogram)\n- Neutrophils/100 leukocytes in Blood by Manual count: 45 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.9 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 33 (percent)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 4.4 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 61 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 97 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 6.3 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.0 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 16.0 (thousand per microliter)\n- Anion gap in Serum or Plasma: 15 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Manual count: 1.31 (thousand per microliter)\n- Iron [Mass/volume] in Serum or Plasma: 327 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 54 (percent)\n- Lymphocytes [#/volume] in Blood by Manual count: 6.16 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.86 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 80.1 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 511 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Beta thalassemia\n- Hemochromatosis following repeated red blood cell transfusion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-07-28 00:00:00, ended at 2019-07-28 00:00:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-07-28 10:20:00, ended at 2019-07-28 23:59:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Transfusion, blood or blood components\n\n### Condition\n- Hereditary hemolytic anemia\n- Beta thalassemia\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2019-07-28, presumably until 2019-07-28\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2019-07-28, presumably until 2019-07-28\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-08-01 10:01:48, ended at 2019-08-01 11:49:02\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.291\" (inch (US))\n\n### Procedure\n- Injection, intralesional; up to and including 7 lesions\n\n### Condition\n- Primary diagnosis: Hypertrophic scar\n- Neuralgia\n\n### Drug\n- triamcinolone acetonide 10 MG/ML Injectable Suspension, started on 2019-08-01, presumably until 2019-08-01\n- lidocaine 25 MG/ML / prilocaine 25 MG/ML Topical Cream, through Topical route, started on 2019-08-01, presumably until 2019-08-01\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-08-02 00:00:00, ended at 2019-08-02 00:00:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n- Emotional state finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-08-16 00:00:00, ended at 2019-08-16 00:00:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Beta thalassemia\n- Primary diagnosis: Disorder of hematopoietic structure\n\n### Drug\n- zolpidem tartrate 10 MG Oral Tablet, through Oral route, started on 2019-08-16, presumably until 2019-10-24, with intended 1 refill(s). Instructions: take 1 Tab (10 mg total) by mouth every bedtime as needed for Insomnia\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-08-17 00:00:00, ended at 2019-08-17 00:00:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Beta thalassemia\n- Anemia\n- Hemochromatosis following repeated red blood cell transfusion\n\n### Drug\n- deferiprone 500 MG Oral Tablet, through Oral route, started on 2019-08-17, presumably until 2019-09-01, with intended 3 refill(s). Instructions: take 1,500 mg by mouth 3 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-08-24 00:00:00, ended at 2019-08-24 00:00:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anemia\n- Beta thalassemia\n- Hemochromatosis following repeated red blood cell transfusion\n\n### Drug\n- deferiprone 500 MG Oral Tablet, through Oral route, started on 2019-08-24, presumably until 2019-08-24, with intended 3 refill(s). Instructions: take 1,500 mg by mouth 3 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-09-01 00:00:00, ended at 2019-09-01 00:00:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hemochromatosis following repeated red blood cell transfusion\n- Anemia\n- Beta thalassemia\n\n### Drug\n- deferiprone 500 MG Oral Tablet, through Oral route, started on 2019-09-01, presumably until 2019-11-21, with intended 11 refill(s). Instructions: take 1,500 mg by mouth 3 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-09-02 00:00:00, ended at 2019-09-02 00:00:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of hematopoietic structure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-09-02 00:00:00, ended at 2019-09-02 00:00:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Heart failure\n- Chest pain\n\n### Drug\n- ondansetron 4 MG Oral Tablet, started on 2019-09-02, presumably until 2020-10-15, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 8 HOURS AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-09-12 00:00:00, ended at 2019-09-12 00:00:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hemochromatosis following repeated red blood cell transfusion\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-09-12 00:00:00, ended at 2019-09-12 00:00:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cardiomyopathy\n- Heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-09-15 00:00:00, ended at 2019-09-15 00:00:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n- Hemochromatosis following repeated red blood cell transfusion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-09-18 13:30:00, ended at 2019-09-18 23:59:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 63 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 31.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 6.3 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.44 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 22.3 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 4.9 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Ferritin [Mass/volume] in Serum or Plasma: 141 (nanogram per milliliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.80 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.04 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.3 (gram per deciliter)\n- Iron [Mass/volume] in Serum or Plasma: 260 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 65 (percent)\n- MCH [Entitic mass] by Automated count: 22.5 (picogram)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 2.4 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 27 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 11 (unit per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 4.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.79 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 14.8 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Manual count: 5.18 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 570 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 35 (percent)\n- MCHC [Mass/volume] by Automated count: 28.3 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 79.6 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 49 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hemochromatosis following repeated red blood cell transfusion\n- Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-09-19 08:50:00, ended at 2019-09-19 23:59:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Transfusion, blood or blood components\n\n### Condition\n- Beta thalassemia\n- Hemochromatosis following repeated red blood cell transfusion\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2019-09-19, presumably until 2019-09-19\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2019-09-19, presumably until 2019-09-19\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-09-27 00:00:00, ended at 2019-09-27 00:00:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Blood glucose abnormal\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-09-29 00:00:00, ended at 2019-09-29 00:00:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Beta thalassemia\n- Primary diagnosis: Blood glucose abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-10-03 10:29:05, ended at 2019-10-03 11:44:07\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.173\" (inch (US))\n\n### Procedure\n- Injection, intralesional; up to and including 7 lesions\n\n### Condition\n- Primary diagnosis: Callosity\n- Hypertrophic scar\n\n### Drug\n- triamcinolone acetonide 10 MG/ML Injectable Suspension, started on 2019-10-03, presumably until 2019-10-03\n- urea 400 MG/ML Topical Cream, started on 2019-10-03, presumably until 2023-01-05, with intended 11 refill(s). Instructions: Apply to affected area(s) topically twice daily as directed.\n- lidocaine 25 MG/ML / prilocaine 25 MG/ML Topical Cream, through Topical route, started on 2019-10-03, presumably until 2019-10-03\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-10-06 00:00:00, ended at 2019-10-06 00:00:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Beta thalassemia\n- Disorder of iron metabolism\n\n### Drug\n- deferasirox 360 MG Oral Tablet, through Oral route, started on 2019-10-06, presumably until 2020-02-29, with intended 2 refill(s). Instructions: take 1,080 mg by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-10-14 08:40:57, ended at 2019-10-14 10:55:32\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Psychiatric diagnostic evaluation\n\n### Condition\n- Primary diagnosis: Anxiety disorder\n- Cardiomyopathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-10-24 00:00:00, ended at 2019-10-24 00:00:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Beta thalassemia\n\n### Drug\n- zolpidem tartrate 10 MG Oral Tablet, through Oral route, started on 2019-10-24, presumably until 2019-12-19, with intended 1 refill(s). Instructions: take 1 Tab (10 mg total) by mouth every bedtime as needed for Insomnia\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-11-12 00:00:00, ended at 2019-11-12 00:00:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- furosemide 40 MG Oral Tablet, started on 2019-11-14, presumably until 2020-11-12, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH DAILY IN THE EVENING\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-11-17 00:00:00, ended at 2019-11-17 00:00:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- aspirin 81 MG Chewable Tablet, started on 2019-11-17, presumably until 2020-11-12, with intended 3 refill(s). Instructions: CHEW AND SWALLOW 1 TABLET BY MOUTH EVERY MORNING WITH BREAKFAST\n- carvedilol 6.25 MG Oral Tablet, through Oral route, started on 2019-11-17, presumably until 2021-01-11, with intended 3 refill(s). Instructions: take 1 Tab (6.25 mg total) by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-11-20 14:48:00, ended at 2019-11-20 23:59:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 90 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 15.3 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 4.74 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- MCHC [Mass/volume] by Automated count: 27.2 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 77.3 (femtoliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.92 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.8 (gram per deciliter)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 3.3 (percent)\n- Thyrotropin [Units/volume] in Serum or Plasma: 2.55 (micro-international unit per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.75 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.61 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 23.5 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 5.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 6.4 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 77 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 33.0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.04 (million per microliter)\n- Iron [Mass/volume] in Serum or Plasma: 248 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 52 (percent)\n- MCH [Entitic mass] by Automated count: 21.1 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Platelets [#/volume] in Blood by Automated count: 479 (thousand per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 93.7 (nanogram per milliliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 31 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 59 (percent)\n- Parathyrin.intact [Mass/volume] in Serum or Plasma: 34.8 (picogram per milliliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Beta thalassemia\n- Blood glucose abnormal\n- Hemochromatosis following repeated red blood cell transfusion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-11-21 00:00:00, ended at 2019-11-21 00:00:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-11-21 00:00:00, ended at 2019-11-21 00:00:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anemia\n- Beta thalassemia\n- Hemochromatosis following repeated red blood cell transfusion\n\n### Drug\n- deferiprone 500 MG Oral Tablet, through Oral route, started on 2019-11-21, presumably until 2019-11-23, with intended 11 refill(s). Instructions: take 1,000 mg by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-11-22 07:00:00, ended at 2019-11-22 23:59:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Transfusion, blood or blood components\n\n### Condition\n- Beta thalassemia\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2019-11-22, presumably until 2019-11-22\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2019-11-22, presumably until 2019-11-22\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-11-23 00:00:00, ended at 2019-11-23 00:00:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Beta thalassemia\n- Anemia\n- Hemochromatosis following repeated red blood cell transfusion\n\n### Drug\n- deferiprone 500 MG Oral Tablet, through Oral route, started on 2019-11-23, presumably until 2019-11-29, with intended 11 refill(s). Instructions: take 1,000 mg by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-11-23 00:00:00, ended at 2019-11-23 00:00:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hemochromatosis following repeated red blood cell transfusion\n- Beta thalassemia\n- Anemia\n\n### Drug\n- deferiprone 500 MG Oral Tablet, through Oral route, started on 2019-11-23, presumably until 2019-11-23, with intended 11 refill(s). Instructions: take 1,000 mg by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-11-29 00:00:00, ended at 2019-11-29 00:00:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hemochromatosis following repeated red blood cell transfusion\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- deferiprone 1000 MG Oral Tablet, through Oral route, started on 2019-11-29, presumably until 2021-03-20, with intended 5 refill(s). Instructions: take 1,000 mg by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-12-09 09:04:34, ended at 2019-12-09 10:23:02\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.173\" (inch (US))\n\n### Procedure\n- Injection, intralesional; up to and including 7 lesions\n\n### Condition\n- Asteatosis cutis\n- Hypertrophic scar\n- Beta thalassemia\n- Primary diagnosis: Hyperesthesia\n\n### Drug\n- lidocaine 25 MG/ML / prilocaine 25 MG/ML Topical Cream, through Topical route, started on 2019-12-09, presumably until 2019-12-09\n- triamcinolone acetonide 40 MG/ML Injectable Suspension, started on 2019-12-09, presumably until 2019-12-09\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-12-17 00:00:00, ended at 2019-12-17 00:00:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- potassium chloride 1.33 MEQ/ML Oral Solution, through Oral route, started on 2019-12-19, presumably until 2021-09-23, with intended 4 refill(s). Instructions: TAKE 15 ML BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-12-19 00:00:00, ended at 2019-12-19 00:00:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Beta thalassemia\n\n### Drug\n- zolpidem tartrate 10 MG Oral Tablet, through Oral route, started on 2019-12-19, presumably until 2020-02-28, with intended 1 refill(s). Instructions: take 1 Tab (10 mg total) by mouth every bedtime as needed for Insomnia\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-01-10 00:00:00, ended at 2020-01-10 00:00:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- levothyroxine sodium 0.125 MG Oral Tablet, started on 2020-01-11, presumably until 2021-03-21, with intended 12 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY MORNING BEFORE BREAKFAST\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-11 00:00:00, ended at 2020-01-11 00:00:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hemochromatosis following repeated red blood cell transfusion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-01-12 09:46:08, ended at 2020-01-12 12:38:47\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.882\" (inch (US))\n\n### Procedure\n- Medical nutrition therapy; initial assessment and intervention, individual, face-to-face with the patient, each 15 minutes\n\n### Condition\n- Heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-01-12 10:40:00, ended at 2020-01-12 23:59:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 3.30 (million per microliter)\n- Platelets [#/volume] in Blood by Automated count: 536 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 26 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 3 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 35.6 (percent)\n- Anion gap in Serum or Plasma: 15 (millimole per liter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 81 (percent)\n- MCV [Entitic volume] by Automated count: 78.8 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 45 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.9 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4 (percent)\n- Ferritin [Mass/volume] in Serum or Plasma: 219 (nanogram per milliliter)\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 18.6 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 5.41 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 92 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 38 (unit per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 26.5 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.9 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.69 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.0 (percent)\n- Iron [Mass/volume] in Serum or Plasma: 283 (microgram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 29 (percent)\n- MCH [Entitic mass] by Automated count: 20.9 (picogram)\n- Monocytes [#/volume] in Blood by Manual count: 1.86 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.9 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 4.0 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.75 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 6.9 (gram per deciliter)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 7.0 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hemochromatosis following repeated red blood cell transfusion\n- Beta thalassemia\n- Heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-01-13 13:30:00, ended at 2020-01-13 23:59:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Transfusion, blood or blood components\n\n### Condition\n- Beta thalassemia\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2020-01-13, presumably until 2020-01-13\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2020-01-13, presumably until 2020-01-13\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-01-23 09:16:00, ended at 2020-01-23 11:09:34\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.882\" (inch (US))\n\n### Procedure\n- Injection, intralesional; up to and including 7 lesions\n\n### Condition\n- Primary diagnosis: Pruritic rash\n- Beta thalassemia\n- Hyperesthesia\n- Hypertrophic scar\n\n### Drug\n- triamcinolone acetonide 40 MG/ML Injectable Suspension, started on 2020-01-23, presumably until 2020-01-23\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-26 00:00:00, ended at 2020-01-26 00:00:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n- Hemochromatosis following repeated red blood cell transfusion\n- Anemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-26 00:00:00, ended at 2020-01-26 00:00:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n- Hemochromatosis following repeated red blood cell transfusion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-02-17 10:50:51, ended at 2020-02-17 11:55:49\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.843\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic ulcer of skin of lower leg\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-02-23 13:55:55, ended at 2020-02-23 15:12:39\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Eruption\n- Primary diagnosis: Open wound of lower leg\n\n### Drug\n- lidocaine hydrochloride 20 MG/ML Mucous Membrane Topical Solution, through Topical route, started on 2020-02-23, presumably until 2020-02-23, with intended 0 refill(s). Instructions: 15 mL by Topical route One Time for 1 dose\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-28 00:00:00, ended at 2020-02-28 00:00:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- zolpidem tartrate 10 MG Oral Tablet, through Oral route, started on 2020-02-28, presumably until 2020-05-04, with intended 1 refill(s). Instructions: take 1 Tab (10 mg total) by mouth every bedtime as needed for Insomnia\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-29 00:00:00, ended at 2020-02-29 00:00:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Beta thalassemia\n- Disorder of iron metabolism\n\n### Drug\n- deferasirox 360 MG Oral Tablet, through Oral route, started on 2020-02-29, presumably until 2020-04-03, with intended 0 refill(s). Instructions: take 1,080 mg by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-03-01 00:00:00, ended at 2020-03-01 00:00:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Beta thalassemia\n- Disorder of iron metabolism\n\n### Drug\n- deferasirox 360 MG Oral Tablet, through Oral route, started on 2020-03-01, presumably until 2020-03-01, with intended 0 refill(s). Instructions: take 1,080 mg by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-03-06 14:07:19, ended at 2020-03-06 14:25:46\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute upper respiratory infection\n- Primary diagnosis: Viral disease\n\n### Drug\n- codeine phosphate 2 MG/ML / guaifenesin 20 MG/ML Oral Solution, through Oral route, started on 2020-03-06, presumably until 2020-07-13, with intended 0 refill(s). Instructions: take 5 mL by mouth every bedtime as needed for cough\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-03-11 14:02:00, ended at 2020-03-11 23:59:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 4.6 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.16 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 34 (percent)\n- MCHC [Mass/volume] by Automated count: 26.6 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 5.0 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.26 (millimole per liter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 81 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 55 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 33.9 (percent)\n- Ferritin [Mass/volume] in Serum or Plasma: 299 (nanogram per milliliter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 16.0 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.96 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.4 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 83 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 25.9 (percent)\n- MCH [Entitic mass] by Automated count: 21.8 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 660 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 30 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 75 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.0 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Manual count: 5.44 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.48 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 6.9 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.88 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3 (percent)\n- Iron [Mass/volume] in Serum or Plasma: 390 (microgram per deciliter)\n- MCV [Entitic volume] by Automated count: 82.0 (femtoliter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 3.9 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Beta thalassemia\n- Hemochromatosis following repeated red blood cell transfusion\n- Anemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-03-12 12:50:00, ended at 2020-03-12 23:59:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Transfusion, blood or blood components\n\n### Condition\n- Beta thalassemia\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2020-03-12, presumably until 2020-03-12\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2020-03-12, presumably until 2020-03-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-03-21 16:11:02, ended at 2020-03-21 16:15:30\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acquired absence of spleen\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-03-28 00:00:00, ended at 2020-03-28 00:00:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Traumatic or non-traumatic injury\n\n### Drug\n- mupirocin 0.02 MG/MG Topical Ointment, started on 2020-03-28, presumably until 2021-03-28, with intended 3 refill(s). Instructions: Apply topically as directed twice daily to affected area(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-03-28 13:00:09, ended at 2020-03-28 13:18:04\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Traumatic or non-traumatic injury\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-04-03 00:00:00, ended at 2020-04-03 00:00:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of iron metabolism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-04-03 00:00:00, ended at 2020-04-03 00:00:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Beta thalassemia\n- Disorder of iron metabolism\n\n### Drug\n- deferasirox 360 MG Oral Tablet, through Oral route, started on 2020-04-03, presumably until 2020-11-15, with intended 5 refill(s). Instructions: take 1,080 mg by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-05-02 00:00:00, ended at 2020-05-02 00:00:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Beta thalassemia\n\n### Drug\n- zolpidem tartrate 10 MG Oral Tablet, through Oral route, started on 2020-05-04, presumably until 2020-06-08, with intended 0 refill(s). Instructions: take 1 Tab (10 mg total) by mouth every bedtime as needed for Insomnia\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-05-03 00:00:00, ended at 2020-05-03 00:00:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Beta thalassemia\n\n### Drug\n- zolpidem tartrate 10 MG Oral Tablet, through Oral route, started on 2020-06-09, presumably until 2020-12-06, with intended 3 refill(s). Instructions: take 1 Tab (10 mg total) by mouth every bedtime as needed for Insomnia\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-05-06 14:57:00, ended at 2020-05-06 23:59:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.7 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 5.4 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.37 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 81.8 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Anion gap in Serum or Plasma: 15 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 76 (percent)\n- Monocytes [#/volume] in Blood by Manual count: 0.93 (thousand per microliter)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 3.8 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 85 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.82 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 6.51 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 32.7 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.91 (million per microliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 54 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Protein/Creatinine [Mass Ratio] in Urine: 0.24 (milligram per milligram)\n- Creatinine [Mass/volume] in Urine: 78.88 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 23.8 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.0 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 6.6 (gram per deciliter)\n- Leukocytes [#/volume] in Body fluid by Manual count: 730 (milli-international unit per milliliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 35 (percent)\n- MCH [Entitic mass] by Automated count: 22.7 (picogram)\n- MCHC [Mass/volume] by Automated count: 27.7 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 18.6 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 550 (thousand per microliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 19.0 (milligram per deciliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 414 (nanogram per milliliter)\n- Iron [Mass/volume] in Serum or Plasma: 337 (microgram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Beta thalassemia\n- Anemia\n- Hemochromatosis following repeated red blood cell transfusion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-05-08 00:00:00, ended at 2020-05-08 00:00:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anemia\n- Primary diagnosis: Disorder of iron metabolism\n- Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-05-08 08:20:00, ended at 2020-05-08 23:59:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Transfusion, blood or blood components\n\n### Condition\n- Hereditary hemolytic anemia\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2020-05-08, presumably until 2020-05-08\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2020-05-08, presumably until 2020-05-08\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-05-08 14:29:09, ended at 2020-05-08 14:36:16\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-05-24 16:13:06, ended at 2020-05-24 16:59:04\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Varicose ulcer of lower extremity\n- Primary diagnosis: Chronic ulcer of skin of lower leg\n\n### Drug\n- lidocaine hydrochloride 20 MG/ML Mucous Membrane Topical Solution, through Topical route, started on 2020-05-24, presumably until 2020-05-24, with intended 0 refill(s). Instructions: 15 mL by Topical route One Time for 1 dose\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-06-06 10:27:28, ended at 2020-06-06 10:56:15\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Heart failure\n- Hemochromatosis following repeated red blood cell transfusion\n- Atrial fibrillation\n- Postoperative state\n- Acquired absence of spleen\n- Primary diagnosis: Lupus anticoagulant disorder\n- Cardiomyopathy\n- Chronic ulcer of skin of ankle\n- Transplanted heart valve present\n- Vascular complication of medical care\n- Acute on chronic systolic heart failure\n- Beta thalassemia\n- Congestive heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-06-07 00:00:00, ended at 2020-06-07 00:00:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Beta thalassemia\n\n### Drug\n- zolpidem tartrate 10 MG Oral Tablet, through Oral route, started on 2020-06-08, presumably until 2020-06-19, with intended 0 refill(s). Instructions: take 1 Tab (10 mg total) by mouth every bedtime as needed for Insomnia\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-06-19 15:29:51, ended at 2020-06-19 15:59:19\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Iron deficiency anemia due to blood loss\n- Congenital absence of spleen\n- Beta thalassemia\n\n### Drug\n- 0.5 ML varicella-zoster virus vaccine live (Oka-Merck) strain 2700 UNT/ML Injection, through Subcutaneous route, started on 2020-06-19, presumably until 2020-06-19, with intended 0 refill(s). Instructions: inject 0.5 mL subcutaneous (under the skin) One Time for 1 dose\n- 0.5 ML meningococcal group B vaccine 0.1 MG/ML / Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen 0.1 MG/ML / Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen 0.1 MG/ML / Neisseria meningitidis serogr..., through Intramuscular route, started on 2020-06-19, presumably until 2020-06-19, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time for 1 dose\n- lidocaine 0.05 MG/MG Medicated Patch, through Transdermal route, started on 2020-06-19, presumably until 2021-06-19, with intended 0 refill(s). Instructions: apply 1 Patch to skin daily\n- zolpidem tartrate 6.25 MG Extended Release Oral Tablet, through Oral route, started on 2020-06-19, presumably until 2020-07-09, with intended 0 refill(s). Instructions: take 1 Tab (6.25 mg total) by mouth every bedtime as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-06-20 00:00:00, ended at 2020-06-20 00:00:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Asthenia\n- Primary diagnosis: Muscle pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-06-24 15:14:00, ended at 2020-06-24 23:59:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Hemoglobin [Mass/volume] in Blood: 6.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 77.4 (femtoliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 57 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 42 (percent)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Monocytes [#/volume] in Blood by Manual count: 0.89 (thousand per microliter)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 9.0 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 97 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 442 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 85 (unit per liter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.45 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.8 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3 (percent)\n- Ferritin [Mass/volume] in Serum or Plasma: 204 (nanogram per milliliter)\n- Sodium [Moles/volume] in Serum or Plasma: 129 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 24.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 14.9 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 5.36 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 5.2 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.93 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.10 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 36 (percent)\n- MCH [Entitic mass] by Automated count: 21.6 (picogram)\n- MCHC [Mass/volume] by Automated count: 27.9 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 35 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 3 (percent)\n- Iron [Mass/volume] in Serum or Plasma: 312 (microgram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Beta thalassemia\n- Hemochromatosis following repeated red blood cell transfusion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-06-26 07:00:00, ended at 2020-06-26 23:59:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Transfusion, blood or blood components\n\n### Condition\n- Hemochromatosis following repeated red blood cell transfusion\n- Beta thalassemia\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2020-06-26, presumably until 2020-06-26\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2020-06-26, presumably until 2020-06-26\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-07-09 00:00:00, ended at 2020-07-09 00:00:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- zolpidem tartrate 6.25 MG Extended Release Oral Tablet, through Oral route, started on 2020-07-13, presumably until 2021-01-09, with intended 0 refill(s). Instructions: take 1 Tab (6.25 mg total) by mouth every bedtime as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-07-25 14:30:00, ended at 2020-07-25 23:59:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)\n\n### Condition\n- Osteoporosis\n- Anemia\n- Beta thalassemia\n- Disorder of bone\n- Disorder of iron metabolism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-08-06 00:00:00, ended at 2020-08-06 00:00:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Insomnia\n\n### Drug\n- zolpidem tartrate 6.25 MG Extended Release Oral Tablet, through Oral route, started on 2020-08-13, presumably until 2020-10-09, with intended 0 refill(s). Instructions: take 1 Tab (6.25 mg total) by mouth every bedtime as needed for Insomnia\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-08-06 00:00:00, ended at 2020-08-06 00:00:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- zolpidem tartrate 6.25 MG Extended Release Oral Tablet, through Oral route, started on 2020-08-06, presumably until 2021-02-02, with intended 3 refill(s). Instructions: take 1 Tab (6.25 mg total) by mouth every bedtime as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-08-06 00:00:00, ended at 2020-08-06 00:00:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hemochromatosis following repeated red blood cell transfusion\n- Disorder of bone\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-08-19 14:54:00, ended at 2020-08-19 23:59:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 25.4 (percent)\n- MCH [Entitic mass] by Automated count: 21.5 (picogram)\n- MCHC [Mass/volume] by Automated count: 27.2 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 440 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.4 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 31 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 32.3 (percent)\n- Iron [Mass/volume] in Serum or Plasma: 295 (microgram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 47.0 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 74 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 4.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 6.9 (gram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 75 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Eosinophils [#/volume] in Blood by Manual count: 0.58 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.21 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 104 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.16 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 37.0 (percent)\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Ferritin [Mass/volume] in Serum or Plasma: 190 (nanogram per milliliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 5.37 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- MCV [Entitic volume] by Automated count: 79.1 (femtoliter)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 3.8 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 5.0 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.92 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 14.5 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.9 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.0 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Beta thalassemia\n- Hemochromatosis following repeated red blood cell transfusion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-08-21 09:00:00, ended at 2020-08-21 23:59:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Transfusion, blood or blood components\n\n### Condition\n- Hereditary hemolytic anemia\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2020-08-21, presumably until 2020-08-21\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2020-08-21, presumably until 2020-08-21\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-10-09 00:00:00, ended at 2020-10-09 00:00:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Insomnia\n\n### Drug\n- zolpidem tartrate 6.25 MG Extended Release Oral Tablet, through Oral route, started on 2020-10-15, presumably until 2020-12-18, with intended 1 refill(s). Instructions: take 1 Tab (6.25 mg total) by mouth every bedtime as needed for Insomnia\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-10-14 00:00:00, ended at 2020-10-14 00:00:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Heart failure\n- Chest pain\n\n### Drug\n- ondansetron 4 MG Oral Tablet, started on 2020-10-15, presumably until 2021-03-01, with intended 5 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 8 HOURS AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-10-14 15:02:00, ended at 2020-10-14 23:59:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 3.01 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 27.4 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 73 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 6.3 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 6.3 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.0 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 54.0 (percent)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 17.0 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 26 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 3.0 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.95 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 32.1 (percent)\n- MCV [Entitic volume] by Automated count: 76.4 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Ferritin [Mass/volume] in Serum or Plasma: 258 (nanogram per milliliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 23.0 (percent)\n- MCH [Entitic mass] by Automated count: 20.9 (picogram)\n- Monocytes [#/volume] in Blood by Manual count: 1.04 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 75.98 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 14.9 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 4.31 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 605 (thousand per microliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 0.22 (milligram per milligram)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 29.0 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hemochromatosis\n- Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-10-15 00:00:00, ended at 2020-10-15 00:00:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hemochromatosis following repeated red blood cell transfusion\n- Disorder of bone\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-10-16 09:50:00, ended at 2020-10-16 23:59:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.24 (millimole per liter)\n- Parathyrin.intact [Mass/volume] in Serum or Plasma: 34.1 (picogram per milliliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 88 (percent)\n- Thyrotropin [Units/volume] in Serum or Plasma: 5.29 (micro-international unit per milliliter)\n- Iron [Mass/volume] in Serum or Plasma: 249 (microgram per deciliter)\n\n### Procedure\n- Transfusion, blood or blood components\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hemochromatosis following repeated red blood cell transfusion\n- Beta thalassemia\n- Disorder of bone\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2020-10-16, presumably until 2020-10-16\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2020-10-16, presumably until 2020-10-16\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-11-10 00:00:00, ended at 2020-11-10 00:00:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Vascular complication of medical care\n- Primary diagnosis: Heart failure\n- Postoperative state\n- Transplanted heart valve present\n- Atrial fibrillation\n\n### Drug\n- furosemide 40 MG Oral Tablet, started on 2020-11-12, presumably until 2021-10-07, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH DAILY IN THE EVENING\n- aspirin 81 MG Chewable Tablet, started on 2020-11-12, presumably until 2021-11-04, with intended 3 refill(s). Instructions: CHEW AND SWALLOW ONE TABLET BY MOUTH EVERY MORNING WITH BREAKFAST\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-11-15 00:00:00, ended at 2020-11-15 00:00:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-11-15 00:00:00, ended at 2020-11-15 00:00:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of iron metabolism\n- Beta thalassemia\n\n### Drug\n- deferasirox 360 MG Oral Tablet, through Oral route, started on 2020-11-15, presumably until 2021-03-20, with intended 5 refill(s). Instructions: take 1,080 mg by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-12-09 14:32:00, ended at 2020-12-09 23:59:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 4.7 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 89 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.3 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.81 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.0 (percent)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 28.0 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 51.0 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 87 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 23.6 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 4.8 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 29.0 (percent)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 3.2 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 6.6 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 3.28 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 494 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 8.0 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.9 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.12 (million per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 189 (nanogram per milliliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.90 (thousand per microliter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 31.8 (percent)\n- MCV [Entitic volume] by Automated count: 75.6 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.23 (thousand per microliter)\n- Leukocytes [#/volume] in Body fluid by Manual count: 699.0 (milli-international unit per milliliter)\n- MCH [Entitic mass] by Automated count: 21.2 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.0 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Disorder of bone\n- Hemochromatosis following repeated red blood cell transfusion\n- Beta thalassemia\n- Disorder of iron metabolism\n- Acquired hypothyroidism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-12-11 00:00:00, ended at 2020-12-11 00:00:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 2.05 (nanogram per deciliter)\n- Triiodothyronine (T3) [Mass/volume] in Serum or Plasma: 55 (nanogram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of iron metabolism\n- Acquired hypothyroidism\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-12-11 09:50:00, ended at 2020-12-11 23:59:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Transfusion, blood or blood components\n\n### Condition\n- Hereditary hemolytic anemia\n- Beta thalassemia\n- Hemochromatosis following repeated red blood cell transfusion\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2020-12-11, presumably until 2020-12-11\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2020-12-11, presumably until 2020-12-11\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-12-18 00:00:00, ended at 2020-12-18 00:00:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Insomnia\n\n### Drug\n- zolpidem tartrate 6.25 MG Extended Release Oral Tablet, through Oral route, started on 2020-12-18, presumably until 2021-02-09, with intended 0 refill(s). Instructions: take 1 Tab (6.25 mg total) by mouth every bedtime as needed for Insomnia\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-01-09 13:27:27, ended at 2021-01-09 14:12:04\nThe patient in this visit was 41 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Open wound of ankle\n\n### Drug\n- trazodone hydrochloride 50 MG Oral Tablet, through Oral route, started on 2021-01-09, presumably until 2021-04-05, with intended 0 refill(s). Instructions: take 1 Tab (50 mg total) by mouth every bedtime Please take 30m prior to when you would like to go to bed.\n- melatonin 3 MG Oral Tablet, through Oral route, started on 2021-01-09, presumably until 2022-01-09, with intended 0 refill(s). Instructions: take 1 Tab (3 mg total) by mouth every bedtime Please take 30m prior to when you would like to go to bed.\n- gabapentin 100 MG Oral Capsule, started on 2021-01-09, presumably until 2021-05-01, with intended 0 refill(s). Instructions: Take 1 tab in the morning and afternoon for pain. Take up to three tabs at night 30m prior to bedtime.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-01-10 00:00:00, ended at 2021-01-10 00:00:00\nThe patient in this visit was 41 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- carvedilol 6.25 MG Oral Tablet, started on 2021-01-11, presumably until 2022-01-17, with intended 3 refill(s). Instructions: GENERIC FOR COREG, TAKE 1 TABLET BY MOUTH TWICE DAILY\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Systemic lupus erythematosus within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-04-05 00:00:00, ended at 2013-04-05 00:00:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Heterozygous thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-04-12 12:45:00, ended at 2013-04-12 12:59:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 139 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 50 (unit per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 49 (percent)\n- Monocytes [#/volume] in Blood by Manual count: 0.4 (thousand per microliter)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 7.68 (percent)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Iron [Mass/volume] in Serum or Plasma: 184 (microgram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 941 (nanogram per milliliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 6.0 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 3 (percent)\n- Neutrophils [#/volume] in Blood by Manual count: 5.8 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 113 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 118 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 17.0 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 5.72 (milli-international unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 101 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.6 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Manual count: 1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.3 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 56.1 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 52 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.03 (million per microliter)\n- Globulin [Mass/volume] in Serum: 4.8 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 5.1 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 16.8 (picogram)\n- MCHC [Mass/volume] by Automated count: 29.9 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 32.3 (percent)\n- Reticulocytes [#/volume] in Blood by Automated count: 247.6 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.1 (thousand per microliter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 183 (microgram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 38 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Heterozygous thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-04-12 13:00:00, ended at 2013-04-12 23:59:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3.701\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Heterozygous thalassemia\n- Primary diagnosis: Thalassemia\n\n### Drug\n- deferasirox 500 MG Tablet for Oral Suspension, through Oral route, started on 2013-04-12, presumably until 2013-06-13, with intended 2 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n- econazole nitrate 10 MG/ML Topical Cream, through Topical route, presumably until 2013-05-18. Instructions: by Topical route 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-04-13 00:00:00, ended at 2013-04-13 00:00:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-04-13 00:00:00, ended at 2013-04-13 00:00:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-04-14 00:00:00, ended at 2013-04-14 00:00:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-05-06 00:00:00, ended at 2013-05-06 00:00:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-05-06 00:00:00, ended at 2013-05-06 00:00:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acquired absence of organ\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-05-06 10:02:58, ended at 2013-05-06 10:54:08\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anemia\n- Splenomegaly\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- 0.5 ML Haemophilus influenzae type b strain 1482, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.068 MG/ML Injection, through Intramuscular route, started on 2013-05-06, presumably until 2013-05-07, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-05-06 11:28:00, ended at 2013-05-06 23:59:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Hemoglobin [Mass/volume] in Blood: 4.9 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 31.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 55.1 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 34 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 8.3 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.2 (thousand per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 980 (nanogram per milliliter)\n- Globulin [Mass/volume] in Serum: 4.4 (gram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.2 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.1 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 44 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 176 (microgram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 115 (thousand per microliter)\n- Thrombin time: 15.2 (second)\n- Thyrotropin [Units/volume] in Serum or Plasma: 6.41 (milli-international unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 110 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 31.5 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 15.5 (percent)\n- Iron [Mass/volume] in Serum or Plasma: 185 (microgram per deciliter)\n- MCH [Entitic mass] by Automated count: 17.5 (picogram)\n- Prothrombin time (PT): 15.2 (second)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 1.1 (nanogram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 62 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 85 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.3 (ratio)\n- aPTT in Platelet poor plasma by Coagulation assay: 69.4 (second)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Choriogonadotropin.intact+Beta subunit [Units/volume] in Serum or Plasma: 25336 (milli-international unit per milliliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.81 (million per microliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 105 (percent)\n- Neutrophils [#/volume] in Blood by Manual count: 3.8 (thousand per microliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 325 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 60 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Manual count: 2 (percent)\n- Lymphocytes [#/volume] in Blood by Manual count: 6.1 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 1 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Beta thalassemia\n- Splenomegaly\n- Thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-05-10 00:00:00, ended at 2013-05-10 00:00:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-05-10 00:00:00, ended at 2013-05-10 00:00:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-05-17 00:00:00, ended at 2013-05-17 00:00:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Cardiac arrhythmia\n- Premature beats\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-05-18 09:00:00, ended at 2013-05-18 23:59:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Cardiomyopathy associated with another disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-05-18 10:33:27, ended at 2013-05-18 11:54:52\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n- Unplanned pregnancy\n- Anemia\n\n### Drug\n- folic acid 1 MG Oral Tablet, through Oral route, presumably until 2014-02-01. Instructions: take 1 mg by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-05-20 00:00:00, ended at 2013-05-20 00:00:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ulcer of lower extremity\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-05-24 00:00:00, ended at 2013-05-24 00:00:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-05-24 16:00:00, ended at 2013-05-24 16:03:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3.78\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Beta thalassemia\n- Finding related to pregnancy\n- Primary diagnosis: Unplanned pregnancy\n- Blood coagulation disorder\n- Complication occurring during pregnancy\n- Anemia\n- Thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-05-24 16:04:00, ended at 2013-05-24 17:42:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.52 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 83 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.1 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.3 (ratio)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 112 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 16.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.6 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 3.6 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 47 (percent)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 1 (percent)\n- Neutrophils [#/volume] in Blood by Manual count: 3.9 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Ferritin [Mass/volume] in Serum or Plasma: 880 (nanogram per milliliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- MCHC [Mass/volume] by Automated count: 29.3 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 4.8 (gram per deciliter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 181 (microgram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 47 (percent)\n- MCH [Entitic mass] by Automated count: 18.8 (picogram)\n- aPTT in Platelet poor plasma by Coagulation assay: 57.8 (second)\n- Globulin [Mass/volume] in Serum: 4.2 (gram per deciliter)\n- Iron [Mass/volume] in Serum or Plasma: 137 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 76 (percent)\n- Platelets [#/volume] in Blood by Automated count: 156 (thousand per microliter)\n- Prothrombin time (PT): 15.6 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 38 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 33.3 (percent)\n- MCV [Entitic volume] by Automated count: 64.4 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.9 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-05-24 17:43:00, ended at 2013-05-24 23:59:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-05-25 00:00:00, ended at 2013-05-25 00:00:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-05-26 00:00:00, ended at 2013-05-26 00:00:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-05-31 15:18:00, ended at 2013-05-31 15:55:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Glucose [Mass/volume] in Serum or Plasma: 84 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 30.4 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.3 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.0 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 56.7 (femtoliter)\n- Neutrophils [#/volume] in Blood by Manual count: 3.7 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 50 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 152 (microgram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 4.8 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 3 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 32.0 (percent)\n- Ferritin [Mass/volume] in Serum or Plasma: 870 (nanogram per milliliter)\n- Iron [Mass/volume] in Serum or Plasma: 155 (microgram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 54 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 112 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 46 (unit per liter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.2 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 13.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 4.2 (gram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 102 (percent)\n- Platelets [#/volume] in Blood by Automated count: 131 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 7.8 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Manual count: 2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.45 (million per microliter)\n- MCH [Entitic mass] by Automated count: 17.2 (picogram)\n- Globulin [Mass/volume] in Serum: 3.9 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 33 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Beta thalassemia\n- Thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-05-31 15:56:00, ended at 2013-05-31 23:59:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3.78\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anemia\n- Hypercoagulability state\n- Postpartum finding\n- Primary diagnosis: Unplanned pregnancy\n- Complication occurring during pregnancy\n- Finding related to pregnancy\n- Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-06-07 14:58:47, ended at 2013-06-07 15:58:07\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Unplanned pregnancy\n- Anemia\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2013-06-09 00:00:00, ended at 2013-06-09 00:00:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for intraperitoneal procedures in upper abdomen including laparoscopy; not otherwise specified\n- Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous\n\n### Condition\n- Anemia\n- Beta thalassemia\n- Splenomegaly\n\n### Drug\n- neostigmine methylsulfate 0.5 MG/ML Injectable Solution, started on 2013-06-09, presumably until 2013-06-09\n- 10 ML calcium chloride 100 MG/ML Injection, through Intravenous route, started on 2013-06-09, presumably until 2013-06-09\n- glycopyrrolate 0.2 MG/ML Injectable Solution, started on 2013-06-09, presumably until 2013-06-09\n- 2 ML magnesium sulfate 500 MG/ML Injection, through Intravenous route, started on 2013-06-09, presumably until 2013-06-09\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2013-06-09, presumably until 2013-06-09\n- 50 ML clindamycin 12 MG/ML Injection, through Intravenous route, started on 2013-06-09, presumably until 2013-06-09\n- 2 ML lidocaine hydrochloride 20 MG/ML Injection, started on 2013-06-09, presumably until 2013-06-09\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2013-06-09, presumably until 2013-06-09\n- 2 ML ondansetron 2 MG/ML Injection, started on 2013-06-09, presumably until 2013-06-09\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2013-06-09, presumably until 2013-06-09\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-06-09 00:00:00, ended at 2013-06-09 00:00:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Unplanned pregnancy\n- Primary diagnosis: Beta thalassemia\n- Acquired absence of organ\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2013-06-09 09:10:00, ended at 2013-06-13 17:29:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.3 (ratio)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.82 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.4 (percent)\n- MCV [Entitic volume] by Automated count: 71.5 (femtoliter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Body height: 5' 4.016\" (inch (US))\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 30.6 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.4 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 21.0 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 295 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 64.3 (second)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.18 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 37.3 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): N/A (milliliter per minute per square meter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.9 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 74 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.7 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Prothrombin time (PT): 15.1 (second)\n\n### Procedure\n- Total splenectomy\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Packed blood cell transfusion\n- Collection of venous blood by venipuncture\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Splitting of blood or blood products, each unit\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Congestive heart failure\n- Electrocardiogram abnormal\n- Hemochromatosis following repeated red blood cell transfusion\n- Acquired hypothyroidism\n- Anemia\n- Chronic cor pulmonale\n- Blood coagulation disorder\n- Candidiasis\n- Heart disease in mother complicating pregnancy, childbirth AND/OR puerperium\n- Maternal AND/OR fetal condition affecting labor AND/OR delivery\n- Paroxysmal ventricular tachycardia\n- Right bundle branch block\n- Anemia during pregnancy - baby not yet delivered\n- Complication occurring during pregnancy\n- Thalassemia\n- Thyroid dysfunction during pregnancy, childbirth and the puerperium\n- Congenital arteriovenous malformation of gastrointestinal tract\n- Hypercoagulability state\n- Premature beats\n- Splenomegaly\n- Primary diagnosis: Acquired absence of organ\n- Beta thalassemia\n- Congenital anomaly of gastrointestinal tract\n- Finding related to pregnancy\n- Cardiac arrhythmia\n\n### Drug\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2013-06-09, presumably until 2013-06-11\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2013-06-11, presumably until 2013-06-11\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2013-06-12, presumably until 2013-06-13\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2013-06-10, presumably until 2013-06-22, with intended 1 refill(s). Instructions: inject 0.4 mL subcutaneous (under the skin) One Time.\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2013-06-10, presumably until 2013-06-10\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2013-06-12, presumably until 2013-07-15, with intended 1 refill(s). Instructions: take 1 Cap by mouth 2 times a day.\n- 10 ML furosemide 10 MG/ML Injection, started on 2013-06-10, presumably until 2013-06-10\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2013-06-09, presumably until 2013-06-12\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2013-06-12, presumably until 2014-01-03, with intended 1 refill(s). Instructions: take 1 Packet by mouth daily.\n- 2 ML ondansetron 2 MG/ML Injection, started on 2013-06-09, presumably until 2013-06-12\n- 1 ML hydromorphone hydrochloride 2 MG/ML Prefilled Syringe, started on 2013-06-09, presumably until 2013-06-09\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2013-06-09, presumably until 2013-06-09\n- levothyroxine sodium 0.075 MG Oral Tablet, through Oral route, started on 2013-06-10, presumably until 2013-06-13\n- 12 HR oxycodone hydrochloride 10 MG Extended Release Oral Tablet, through Oral route, started on 2013-06-10, presumably until 2013-12-10, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 12 hours.\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2013-06-10, presumably until 2013-12-10, with intended 0 refill(s). Instructions: take 1-4 Tabs by mouth every 4 hours as needed for Pain.\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2013-06-10, presumably until 2013-09-22, with intended 0 refill(s). Instructions: take 1 Tab by mouth every morning with breakfast.\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2013-06-11, presumably until 2013-06-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2013-06-10 00:00:00, ended at 2013-06-10 00:00:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 10 ML bupivacaine hydrochloride 2.5 MG/ML Injection, started on 2013-06-10, presumably until 2013-06-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-06-18 00:00:00, ended at 2013-06-18 00:00:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acquired absence of organ\n\n### Drug\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2013-06-18, presumably until 2013-12-15, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-06-21 00:00:00, ended at 2013-06-21 00:00:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acquired absence of organ\n\n### Drug\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2013-06-21, presumably until 2014-06-21, with intended 1 refill(s). Instructions: inject 0.4 mL subcutaneous (under the skin) One Time.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-06-21 15:15:00, ended at 2013-06-21 15:25:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Eosinophils/100 leukocytes in Blood by Manual count: 2 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 23.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 7.4 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 59 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.2 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 228 (microgram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 29 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 141 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 84 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 66.2 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 1081 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Manual count: 0.1 (thousand per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 2314 (nanogram per milliliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 17 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 60 (unit per liter)\n- Basophils/100 leukocytes in Blood by Manual count: 1 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- MCH [Entitic mass] by Automated count: 20.6 (picogram)\n- MCHC [Mass/volume] by Automated count: 31.0 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.9 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.2 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.61 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.0 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 3.2 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Manual count: 6.6 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- Monocytes/100 leukocytes in Blood by Manual count: 8 (percent)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 33.4 (percent)\n- Iron [Mass/volume] in Serum or Plasma: 38 (microgram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Unplanned pregnancy\n- Thalassemia\n- Beta thalassemia\n- Acquired absence of organ\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-06-21 15:26:00, ended at 2013-06-21 23:59:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3.78\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acquired absence of organ\n- Finding related to pregnancy\n- Disorder of iron metabolism\n- Unplanned pregnancy\n- Coag./bleeding tests abnormal\n- Complication occurring during pregnancy\n- Blood coagulation disorder\n- Anemia\n- Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-06-22 00:00:00, ended at 2013-06-22 00:00:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypercoagulability state\n\n### Drug\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2013-06-22, presumably until 2013-08-22, with intended 6 refill(s). Instructions: inject 0.4 mL subcutaneous (under the skin) daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-06-23 14:00:00, ended at 2013-06-23 23:59:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Transfusion, blood or blood components\n\n### Condition\n- Anemia\n- Beta thalassemia\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2013-06-23, presumably until 2013-06-23\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2013-06-23, presumably until 2013-06-23\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-06-27 00:00:00, ended at 2013-06-27 00:00:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-06-27 14:32:00, ended at 2013-06-27 14:44:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Hemoglobin [Mass/volume] in Blood: 9.4 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 73.1 (femtoliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.5 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 21.9 (picogram)\n- Urate [Mass/volume] in Serum or Plasma: 3.1 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 50 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 145 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 30.0 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 73 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.9 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.29 (million per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Lymphocytes [#/volume] in Blood by Manual count: 2.3 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.0 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 19 (percent)\n- Monocytes/100 leukocytes in Blood by Manual count: 8 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.0 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 891 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 80 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Manual count: 8.7 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 133 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 38.6 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.4 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-06-27 14:45:00, ended at 2013-06-27 23:59:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Beta thalassemia\n- Anemia\n- Primary diagnosis: Hypercoagulability state\n- Primary gout\n\n### Drug\n- colchicine 0.6 MG Oral Tablet, through Oral route, started on 2013-06-27, presumably until 2013-06-27\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2013-06-27, presumably until 2013-06-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-07-07 15:07:33, ended at 2013-07-07 17:00:47\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypercoagulability state\n- Primary diagnosis: Beta thalassemia\n- Unplanned pregnancy\n- Acquired absence of organ\n- Gout\n- Monoarthritis\n- Anemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-07-09 00:00:00, ended at 2013-07-09 00:00:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Gout\n\n### Drug\n- prednisone 20 MG Oral Tablet, through Oral route, started on 2013-07-09, presumably until 2013-08-23, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-07-10 00:00:00, ended at 2013-07-10 00:00:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Gout\n\n### Drug\n- colchicine 0.6 MG Oral Tablet, started on 2013-07-10, presumably until 2013-09-16, with intended 0 refill(s). Instructions: Please 2 tablets on the first day and take one tablet daily until symptoms resolve.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-07-15 00:00:00, ended at 2013-07-15 00:00:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acquired absence of organ\n- Beta thalassemia\n\n### Drug\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2013-07-15, presumably until 2013-11-08, with intended 1 refill(s). Instructions: take 1 Cap by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-07-26 13:20:00, ended at 2013-07-26 23:59:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 35.2 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.31 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 14 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 57 (percent)\n- Platelets [#/volume] in Blood by Automated count: 750 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 7.8 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Manual count: 2 (percent)\n- Iron [Mass/volume] in Serum or Plasma: 225 (microgram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.6 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.4 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 2.9 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 30.4 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 2.6 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.2 (thousand per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 1232 (nanogram per milliliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 25.8 (percent)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 194 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 116 (percent)\n- MCH [Entitic mass] by Automated count: 23.7 (picogram)\n- MCV [Entitic volume] by Automated count: 77.8 (femtoliter)\n- Neutrophils [#/volume] in Blood by Manual count: 6.7 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 104 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 25 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Transfusion, blood or blood components\n\n### Condition\n- Anemia\n- Primary diagnosis: Thalassemia\n- Beta thalassemia\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2013-07-26, presumably until 2013-07-26\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2013-07-26, presumably until 2013-07-26\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-08-19 00:00:00, ended at 2013-08-19 00:00:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-08-19 14:45:00, ended at 2013-08-19 23:59:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Manual count: 4 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 84 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 17.0 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 79.8 (femtoliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.27 (million per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 1031 (nanogram per milliliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- Iron [Mass/volume] in Serum or Plasma: 207 (microgram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.2 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Manual count: 11.2 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 659 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Basophils/100 leukocytes in Blood by Manual count: 2 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 2.4 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Hemoglobin [Mass/volume] in Blood: 8.3 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 3.6 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 28.5 (percent)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 21 (percent)\n- MCH [Entitic mass] by Automated count: 25.2 (picogram)\n- Prothrombin time (PT): 13.7 (second)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 107 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 191 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 108 (percent)\n- MCHC [Mass/volume] by Automated count: 31.6 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 58 (percent)\n- Eosinophils [#/volume] in Blood by Manual count: 0.7 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 4.1 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Basophils [#/volume] in Blood by Manual count: 0.3 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.1 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 7 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 34.1 (second)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Beta thalassemia\n- Anemia\n- Thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-08-22 00:00:00, ended at 2013-08-22 00:00:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-08-22 00:00:00, ended at 2013-08-22 00:00:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypercoagulability state\n\n### Drug\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2013-08-22, presumably until 2014-04-18, with intended 6 refill(s). Instructions: inject 0.4 mL subcutaneous (under the skin) daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-08-22 00:00:00, ended at 2013-08-22 00:00:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-08-23 00:00:00, ended at 2013-08-23 00:00:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Gout\n\n### Drug\n- prednisone 20 MG Oral Tablet, through Oral route, started on 2013-08-23, presumably until 2014-02-01, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-08-23 14:13:00, ended at 2013-08-23 14:25:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Monocytes [#/volume] in Blood by Manual count: 1.6 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Manual count: 13.1 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 27.9 (percent)\n- MCH [Entitic mass] by Automated count: 25.2 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 720 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 28.6 (percent)\n- Lymphocytes [#/volume] in Blood by Manual count: 1.5 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 79 (percent)\n- Hemoglobin [Mass/volume] in Blood: 8.3 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 9 (percent)\n- MCHC [Mass/volume] by Automated count: 29.7 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.28 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 16.2 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 85.1 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 10 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-08-23 14:26:00, ended at 2013-08-23 23:59:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3.78\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anemia\n- Unplanned pregnancy\n- Beta thalassemia\n- Acquired absence of organ\n- Primary diagnosis: Hypercoagulability state\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-09-07 00:00:00, ended at 2013-09-07 00:00:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Anemia\n- Beta thalassemia\n- Unplanned pregnancy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-09-08 13:38:00, ended at 2013-09-08 23:59:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Monocytes [#/volume] in Blood by Manual count: 1.8 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 50 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 38 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 921 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- MCV [Entitic volume] by Automated count: N/A (femtoliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 26 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.7 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.31 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 7.8 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 16 (percent)\n- Neutrophils [#/volume] in Blood by Manual count: 4.1 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 759 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 116 (unit per liter)\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.4 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 1.1 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 103 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.0 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Cells counted [#] in Chorionic villus sample by Molecular genetics method: 50 (cells)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.1 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Beta thalassemia\n- Primary diagnosis: Anemia\n- Thalassemia\n- Unplanned pregnancy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-09-09 14:30:00, ended at 2013-09-09 23:59:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Transfusion, blood or blood components\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-09-16 10:02:47, ended at 2013-09-16 11:09:16\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Cardiomyopathy associated with another disorder\n- Primary diagnosis: Beta thalassemia\n- Unplanned pregnancy\n- Anemia\n- Congestive heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-09-22 00:00:00, ended at 2013-09-22 00:00:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acquired absence of organ\n\n### Drug\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2013-09-22, presumably until 2014-09-22, with intended 0 refill(s). Instructions: take 1 Tab by mouth every morning with breakfast.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-10-11 14:06:00, ended at 2013-10-11 14:29:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Platelets [#/volume] in Blood by Automated count: 744 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 26 (percent)\n- Neutrophils [#/volume] in Blood by Manual count: 6.1 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Basophils [#/volume] in Blood by Manual count: 0.3 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.17 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 27.5 (percent)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 454 (microgram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 86.8 (femtoliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.5 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 2.9 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 119 (unit per liter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 52 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.2 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 30.0 (percent)\n- Ferritin [Mass/volume] in Serum or Plasma: 894 (nanogram per milliliter)\n- Globulin [Mass/volume] in Serum: 4.1 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 8.1 (gram per deciliter)\n- Iron [Mass/volume] in Serum or Plasma: 259 (microgram per deciliter)\n- MCH [Entitic mass] by Automated count: 25.4 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Manual count: 3 (percent)\n- Eosinophils/100 leukocytes in Blood by Manual count: 2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.0 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 29.2 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 14 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 57 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Beta thalassemia\n- Anemia\n- Thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-10-11 14:30:00, ended at 2013-10-11 23:59:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cardiomyopathy associated with another disorder\n- Acquired absence of organ\n- Abnormal glucose tolerance in mother complicating pregnancy, childbirth AND/OR puerperium\n- Finding related to pregnancy\n- Congestive heart failure\n- Hypercoagulability state\n- Anemia\n- Unplanned pregnancy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-10-12 00:00:00, ended at 2013-10-12 00:00:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-10-13 08:30:00, ended at 2013-10-13 23:59:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Transfusion, blood or blood components\n\n### Condition\n- Beta thalassemia\n- Anemia\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2013-10-13, presumably until 2013-10-13\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2013-10-13, presumably until 2013-10-13\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-11-08 13:22:00, ended at 2013-11-08 13:31:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.38 (million per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Iron [Mass/volume] in Serum or Plasma: 287 (microgram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 2.6 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Manual count: 9.6 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 144 (unit per liter)\n- Basophils [#/volume] in Blood by Manual count: 0.3 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 18 (percent)\n- MCH [Entitic mass] by Automated count: 22.8 (picogram)\n- MCHC [Mass/volume] by Automated count: 26.7 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 259 (microgram per deciliter)\n- Basophils/100 leukocytes in Blood by Manual count: 2 (percent)\n- Globulin [Mass/volume] in Serum: 4.2 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.8 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.9 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 7.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 85.3 (femtoliter)\n- Monocytes [#/volume] in Blood by Manual count: 2.0 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Ferritin [Mass/volume] in Serum or Plasma: 1085 (nanogram per milliliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 14.5 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 14 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 30.5 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 113 (milligram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 111 (percent)\n- Platelets [#/volume] in Blood by Automated count: 760 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 64 (percent)\n- Cells counted [#] in Chorionic villus sample by Molecular genetics method: 50 (cells)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Beta thalassemia\n- Thalassemia\n- Anemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-11-08 13:32:00, ended at 2013-11-08 23:59:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.173\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cardiomyopathy associated with another disorder\n- Beta thalassemia\n- Hypercoagulability state\n- Abnormal glucose tolerance in mother complicating pregnancy, childbirth AND/OR puerperium\n- Congestive heart failure\n- Finding related to pregnancy\n- Anemia\n- Unplanned pregnancy\n- Acquired absence of organ\n\n### Drug\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2013-11-08, presumably until 2014-01-03, with intended 3 refill(s). Instructions: take 1 Cap by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-11-10 00:00:00, ended at 2013-11-10 00:00:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-11-10 00:00:00, ended at 2013-11-10 00:00:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Unplanned pregnancy\n- Primary diagnosis: Beta thalassemia\n- Anemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-11-11 17:11:00, ended at 2013-11-11 23:59:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Beta thalassemia\n- Anemia\n- Unplanned pregnancy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-11-12 13:22:00, ended at 2013-11-12 23:59:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Transfusion, blood or blood components\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2013-11-12, presumably until 2013-11-12\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2013-11-12, presumably until 2013-11-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-12-09 00:00:00, ended at 2013-12-09 00:00:00\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 48 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-12-09 00:00:00, ended at 2013-12-09 08:37:12\nThe patient in this visit was 33 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Congestive heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-01-03 15:46:00, ended at 2014-01-03 16:03:00\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.6 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 2.4 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 1006 (thousand per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 86 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Manual count: 2 (percent)\n- Hemoglobin [Mass/volume] in Blood: 8.5 (gram per deciliter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 221 (microgram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 56 (percent)\n- Ferritin [Mass/volume] in Serum or Plasma: 3363 (nanogram per milliliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 13.2 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 26 (percent)\n- MCH [Entitic mass] by Automated count: 18.8 (picogram)\n- Monocytes/100 leukocytes in Blood by Manual count: 10 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.54 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 110 (milligram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 48 (percent)\n- MCHC [Mass/volume] by Automated count: 28.8 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 65.3 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Manual count: 2 (percent)\n- Iron [Mass/volume] in Serum or Plasma: 106 (microgram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.1 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 227 (unit per liter)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 149 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 42.1 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Anemia\n- Beta thalassemia\n- Thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-01-03 16:04:00, ended at 2014-01-03 23:59:00\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.173\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypercoagulability state\n- Acquired absence of organ\n- Anemia\n- Beta thalassemia\n- Primary diagnosis: Cardiomyopathy associated with another disorder\n- Essential thrombocythemia\n\n### Drug\n- levothyroxine sodium 0.1 MG Oral Tablet, started on 2013-12-06, presumably until 2014-02-01\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-02-21 00:00:00, ended at 2014-02-21 00:00:00\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-02-21 15:54:00, ended at 2014-02-21 23:59:00\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acquired absence of organ\n- Beta thalassemia\n- Disorder of iron metabolism\n- Hypercoagulability state\n- Primary diagnosis: Anemia\n- Thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-04-12 09:45:00, ended at 2014-04-12 23:59:00\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s)\n\n### Condition\n- Hemochromatosis\n- Thalassemia\n- Beta thalassemia\n- Chronic nonalcoholic liver disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-04-13 00:00:00, ended at 2014-04-13 00:00:00\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n- Anemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-04-18 12:59:00, ended at 2014-04-18 13:15:00\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 3.74 (million per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 28 (percent)\n- MCH [Entitic mass] by Automated count: 19.6 (picogram)\n- Monocytes/100 leukocytes in Blood by Manual count: 8 (percent)\n- Ferritin [Mass/volume] in Serum or Plasma: 4289 (nanogram per milliliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 106 (percent)\n- MCHC [Mass/volume] by Automated count: 26.6 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 170 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 4.3 (milligram per deciliter)\n- Cells counted [#] in Chorionic villus sample by Molecular genetics method: 25 (cells)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 190 (microgram per deciliter)\n- MCV [Entitic volume] by Automated count: 73.6 (femtoliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.7 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 114 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 114 (milligram per deciliter)\n- Iron [Mass/volume] in Serum or Plasma: 201 (microgram per deciliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 3.02 (milli-international unit per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.4 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 67 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 33.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 7.3 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Manual count: 6.0 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.3 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 2.6 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 56 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 607 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.5 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 27.5 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Anemia\n- Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-04-18 13:16:00, ended at 2014-04-18 23:59:00\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypercoagulability state\n- Refractory anemia (clinical)\n- Acquired absence of organ\n- Chronic combined systolic and diastolic heart failure\n- Sideroblastic anemia\n- Anemia\n- Cardiomyopathy associated with another disorder\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-04-19 00:00:00, ended at 2014-04-19 00:00:00\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- deferasirox 500 MG Tablet for Oral Suspension, through Oral route, started on 2014-04-19, presumably until 2014-07-05, with intended 2 refill(s). Instructions: take 3 Tabs by mouth as directed. Take 2 tabs (1000 mg) in am and 1 tab (500 mg ) in pm both with a glass of juice\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-05-30 00:00:00, ended at 2014-05-30 00:00:00\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n- Disorder of skin and/or subcutaneous tissue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-05-30 00:00:00, ended at 2014-05-30 00:00:00\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-30 12:35:00, ended at 2014-05-30 12:48:00\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Manual count: 0.2 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.7 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 7.0 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 28 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.1 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 104 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.4 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 167 (unit per liter)\n- Basophils/100 leukocytes in Blood by Manual count: 2 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 5.1 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Ferritin [Mass/volume] in Serum or Plasma: 5780 (nanogram per milliliter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 190 (microgram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 48 (percent)\n- Reticulocytes [#/volume] in Blood by Automated count: 106.3 (thousand per microliter)\n- Iron [Mass/volume] in Serum or Plasma: 262 (microgram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 5.5 (thousand per microliter)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 3.18 (percent)\n- Eosinophils/100 leukocytes in Blood by Manual count: 6 (percent)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 138 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.5 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 157 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.9 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 25.9 (percent)\n- Platelets [#/volume] in Blood by Automated count: 639 (thousand per microliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Cells counted [#] in Chorionic villus sample by Molecular genetics method: 50 (cells)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.35 (million per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 111 (unit per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Monocytes/100 leukocytes in Blood by Manual count: 12 (percent)\n- Neutrophils [#/volume] in Blood by Manual count: 3.7 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-30 12:49:00, ended at 2014-05-30 23:59:00\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypercoagulability state\n- Anemia\n- Ulcer of lower extremity\n- Acquired absence of organ\n- Cardiomyopathy associated with another disorder\n- Beta thalassemia\n- Primary diagnosis: Hemochromatosis following repeated red blood cell transfusion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-06-27 13:10:00, ended at 2014-06-27 18:51:00\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Beta thalassemia\n- Primary diagnosis: Ulcer of lower extremity\n- Hemochromatosis following repeated red blood cell transfusion\n\n### Drug\n- ciclopirox 7.7 MG/ML Topical Cream, through Topical route, started on 2014-06-27, presumably until 2014-07-12, with intended 1 refill(s). Instructions: by Topical route 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-06-27 18:52:00, ended at 2014-06-27 23:59:00\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ulcer of lower extremity\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-07-03 00:00:00, ended at 2014-07-03 00:00:00\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Ulcer of lower extremity\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-07-05 00:00:00, ended at 2014-07-05 00:00:00\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- deferasirox 500 MG Tablet for Oral Suspension, through Oral route, started on 2014-07-05, presumably until 2015-04-24, with intended 0 refill(s). Instructions: take 3.5 Tabs by mouth Every Day. Take 2 tabs (1000 mg) in am and 1.5 tab (750 mg ) in pm both with a glass of juice\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-07-07 15:00:00, ended at 2014-07-07 23:59:00\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Limited bilateral noninvasive physiologic studies of upper or lower extremity arteries, (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus bidirectional, Doppler waveform recording \n\n### Condition\n- Ulcer of lower extremity\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-07-12 14:30:00, ended at 2014-07-12 23:59:00\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.961\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Ulcer of lower extremity\n\n### Drug\n- tacrolimus 0.001 MG/MG Topical Ointment, started on 2014-07-12, presumably until 2014-11-14, with intended 3 refill(s). Instructions: Apply topically as directed once daily, for skin surround the ulcers.\n- fluocinonide 0.0005 MG/MG Topical Ointment, started on 2014-07-12, presumably until 2015-07-12, with intended 3 refill(s). Instructions: Apply topically to affected area once daily, to skin surrounding ulcers.\n- ciclopirox 7.7 MG/ML Topical Cream, started on 2014-07-12, presumably until 2014-11-14, with intended 2 refill(s). Instructions: Apply to affected area twice daily as directed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-07-26 15:14:00, ended at 2014-07-26 23:59:00\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.961\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Ulcer of lower extremity\n- Beta thalassemia\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2014-07-26, presumably until 2014-08-16, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed. As needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-08-16 15:15:00, ended at 2014-08-16 23:59:00\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.961\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Beta thalassemia\n- Localized infection of skin AND/OR subcutaneous tissue\n- Primary diagnosis: Ulcer of lower extremity\n\n### Drug\n- sulfamethoxazole 800 MG / trimethoprim 160 MG Oral Tablet, through Oral route, started on 2014-08-16, presumably until 2014-11-14, with intended 3 refill(s). Instructions: take 1 tablet by mouth 2 times a day. Stop medication immediately if rash or flu like symptoms develop and notify physician\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2014-08-16, presumably until 2014-11-14, with intended 0 refill(s). Instructions: take 1 tablet by mouth every 4 hours as needed. As needed for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-08-17 07:08:00, ended at 2014-08-17 23:59:00\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ulcer of lower extremity\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-08-24 14:46:00, ended at 2014-08-24 23:59:00\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.961\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic ulcer of skin\n\n### Drug\n- acetaminophen 300 MG / codeine phosphate 30 MG Oral Tablet, through Oral route, started on 2014-08-24, presumably until 2014-08-31, with intended 0 refill(s). Instructions: take 1 tablet by mouth every 4 hours as needed.\n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2014-08-24, presumably until 2014-09-03, with intended 0 refill(s). Instructions: take 1 tablet by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-08-31 14:30:00, ended at 2014-08-31 23:59:00\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ulcer of lower extremity\n- Primary diagnosis: Inflammatory dermatosis\n\n### Drug\n- triamcinolone acetonide 0.001 MG/MG Topical Ointment, started on 2014-08-31, presumably until 2014-11-14, with intended 0 refill(s). Instructions: Apply to itchy area of L upper thigh\n- acetaminophen 300 MG / codeine phosphate 30 MG Oral Tablet, through Oral route, started on 2014-08-31, presumably until 2014-09-12, with intended 0 refill(s). Instructions: take 1 tablet by mouth every 4 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-09-07 14:21:00, ended at 2014-09-07 23:59:00\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.961\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Ankle ulcer\n\n### Drug\n- lidocaine 25 MG/ML / prilocaine 25 MG/ML Topical Cream, through Topical route, started on 2014-09-07, presumably until 2014-11-14, with intended 0 refill(s). Instructions: by Topical route as needed.\n- collagenase 0.25 UNT/MG Topical Ointment, through Topical route, started on 2014-09-07, presumably until 2014-09-12, with intended 0 refill(s). Instructions: by Topical route daily. To affected area\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-09-12 15:30:00, ended at 2014-09-12 23:59:00\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Ankle ulcer\n\n### Drug\n- acetaminophen 300 MG / codeine phosphate 30 MG Oral Tablet, through Oral route, started on 2014-09-12, presumably until 2015-03-11, with intended 0 refill(s). Instructions: take 1 tablet by mouth every 4 hours as needed.\n- collagenase 0.25 UNT/MG Topical Ointment, through Topical route, started on 2014-09-12, presumably until 2014-09-17, with intended 0 refill(s). Instructions: by Topical route daily. To affected area\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-09-17 00:00:00, ended at 2014-09-17 00:00:00\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ankle ulcer\n\n### Drug\n- collagenase 0.25 UNT/MG Topical Ointment, through Topical route, started on 2014-09-17, presumably until 2014-10-26, with intended 0 refill(s). Instructions: by Topical route 2 times a day. To affected area\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-09-20 10:08:18, ended at 2014-09-20 13:18:50\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Ankle ulcer\n- Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-09-28 14:54:00, ended at 2014-09-28 23:59:00\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.961\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pain in limb\n- Primary diagnosis: Ankle ulcer\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-10-12 14:30:00, ended at 2014-10-12 23:59:00\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.961\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Ankle ulcer\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-10-24 09:10:01, ended at 2014-10-24 10:32:16\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic pain\n- Primary diagnosis: Pain in limb\n\n### Drug\n- deferasirox 250 MG Tablet for Oral Suspension, started on 2014-10-18, presumably until 2014-11-14, with intended 0 refill(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-10-24 09:11:00, ended at 2014-10-24 09:16:00\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, foot; complete, minimum of 3 views\n\n### Condition\n- Pain in limb\n- Swelling / lump finding\n- Thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-10-25 00:00:00, ended at 2014-10-25 00:00:00\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ankle ulcer\n\n### Drug\n- collagenase 0.25 UNT/MG Topical Ointment, through Topical route, started on 2014-10-26, presumably until 2014-11-14, with intended 4 refill(s). Instructions: by Topical route 2 times a day. To affected area\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-11-08 15:45:00, ended at 2014-11-08 23:59:00\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.961\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Ankle ulcer\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-11-13 00:00:00, ended at 2014-11-13 00:00:00\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-11-14 00:00:00, ended at 2014-11-14 00:00:00\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Anemia\n- Acquired absence of organ\n- Beta thalassemia\n- Hemochromatosis following repeated red blood cell transfusion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-11-14 15:22:00, ended at 2014-11-14 15:44:00\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Ferritin [Mass/volume] in Serum or Plasma: 2927 (nanogram per milliliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 191 (microgram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 637 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 35.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.28 (million per microliter)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Reticulocytes [#/volume] in Blood by Automated count: 191.7 (thousand per microliter)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 5.84 (percent)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.9 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 111 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 6.2 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 48 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 24.5 (percent)\n- MCH [Entitic mass] by Automated count: 19.5 (picogram)\n- Monocytes [#/volume] in Blood by Manual count: 0.5 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Manual count: 6.2 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 4.8 (milligram per deciliter)\n- Cells counted [#] in Chorionic villus sample by Molecular genetics method: 50 (cells)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 134 (percent)\n- Monocytes/100 leukocytes in Blood by Manual count: 4 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.4 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 6.4 (gram per deciliter)\n- Iron [Mass/volume] in Serum or Plasma: 256 (microgram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 46 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 144 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 26.1 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 74.5 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.9 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Beta thalassemia\n- Hemochromatosis following repeated red blood cell transfusion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-11-14 15:45:00, ended at 2014-11-14 23:59:00\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hemochromatosis following repeated red blood cell transfusion\n- Beta thalassemia\n- Ankle ulcer\n- Hemoglobin E/beta thalassemia disease\n- Primary diagnosis: Anemia\n- Hypercoagulability state\n- Acquired hypothyroidism\n- Sideroblastic anemia\n\n### Drug\n- levothyroxine sodium 0.1 MG Oral Tablet, through Oral route, started on 2014-11-14, presumably until 2015-04-24, with intended 3 refill(s). Instructions: take 1 Tab by mouth every morning before breakfast.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-12-19 14:30:00, ended at 2014-12-19 23:59:00\nThe patient in this visit was 34 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ulcer of lower extremity\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-01-12 12:45:00, ended at 2015-01-12 23:59:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n- Varicose veins of lower extremity with inflammation\n- Ankle ulcer\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-01-16 00:00:00, ended at 2015-01-16 00:00:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-01-16 00:00:00, ended at 2015-01-16 00:00:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-01-16 00:00:00, ended at 2015-01-16 00:00:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- deferasirox 500 MG Tablet for Oral Suspension, through Oral route, started on 2015-01-16, presumably until 2015-04-24, with intended 2 refill(s). Instructions: take 2 Tabs by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-01-16 13:29:00, ended at 2015-01-16 13:43:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 149 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 4.6 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Manual count: 3.4 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Iron [Mass/volume] in Serum or Plasma: 267 (microgram per deciliter)\n- MCH [Entitic mass] by Automated count: 19.5 (picogram)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 76 (unit per liter)\n- Basophils/100 leukocytes in Blood by Manual count: 2 (percent)\n- MCHC [Mass/volume] by Automated count: 24.7 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 583 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 72 (unit per liter)\n- Cells counted [#] in Chorionic villus sample by Molecular genetics method: 50 (cells)\n- Eosinophils [#/volume] in Blood by Manual count: 0.2 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 79.3 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 16 (percent)\n- Reticulocytes [#/volume] in Blood by Automated count: 228.9 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Ferritin [Mass/volume] in Serum or Plasma: 2447 (nanogram per milliliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 135 (percent)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 7.06 (percent)\n- Eosinophils/100 leukocytes in Blood by Manual count: 2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.24 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 69 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 6.3 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.6 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 3.4 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.4 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Basophils [#/volume] in Blood by Manual count: 0.2 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 25.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 34 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 198 (microgram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 40 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 36.9 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.1 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-01-16 13:44:00, ended at 2015-01-16 23:59:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypercoagulability state\n- Hemochromatosis following repeated red blood cell transfusion\n- Acquired absence of organ\n- Large liver\n- Primary diagnosis: Anemia\n- Beta thalassemia\n- Cardiomyopathy associated with another disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-01-18 11:12:00, ended at 2015-01-18 23:59:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Transfusion, blood or blood components\n\n### Condition\n- Beta thalassemia\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2015-01-18, presumably until 2015-01-18\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2015-01-18, presumably until 2015-01-18\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-01-19 13:00:00, ended at 2015-01-19 23:59:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.5\" (inch (US))\n\n### Procedure\n- Biopsy of skin, subcutaneous tissue and/or mucous membrane (including simple closure), unless otherwise listed; single lesion\n\n### Condition\n- Ankle ulcer\n- Ulcer of lower extremity\n- Varicose veins of lower extremity with inflammation\n- Primary diagnosis: Disorder of skin and/or subcutaneous tissue\n- Beta thalassemia\n- Pain in limb\n\n### Drug\n- acetaminophen 300 MG / codeine phosphate 30 MG Oral Tablet, through Oral route, started on 2015-01-19, presumably until 2015-07-18, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-01-30 00:00:00, ended at 2015-01-30 00:00:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Ankle ulcer\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-02-01 00:00:00, ended at 2015-02-01 00:00:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder due to infection\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-02-09 14:39:25, ended at 2015-02-09 17:19:16\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Debridement, subcutaneous tissue (includes epidermis and dermis, if performed); first 20 sq cm or less\n\n### Condition\n- Edema\n- Ankle ulcer\n- Primary diagnosis: Beta thalassemia\n- Anemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-02-26 12:15:00, ended at 2015-02-26 23:59:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of extremity veins including responses to compression and other maneuvers; unilateral or limited study\n\n### Condition\n- Peripheral vascular disease\n- Edema\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-02-28 11:12:08, ended at 2015-02-28 12:35:06\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Debridement (eg, high pressure waterjet with/without suction, sharp selective debridement with scissors, scalpel and forceps), open wound, (eg, fibrin, devitalized epidermis and/or dermis, exudate, debris, biofilm), including topical application(s), wound\n\n### Condition\n- Primary diagnosis: Ankle ulcer\n- Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-03-21 13:30:00, ended at 2015-03-21 23:59:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Ankle ulcer\n- Lichen\n\n### Drug\n- mupirocin 0.02 MG/MG Topical Ointment, started on 2015-03-21, presumably until 2015-12-13, with intended 3 refill(s). Instructions: Apply topically as directed twice daily to affected area(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-03-28 11:03:05, ended at 2015-03-28 11:50:27\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Ankle ulcer\n- Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-04-16 00:00:00, ended at 2015-04-16 00:00:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anemia\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-04-18 00:00:00, ended at 2015-04-18 00:00:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hemochromatosis\n- Acquired hypothyroidism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-04-24 15:03:00, ended at 2015-04-24 15:19:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.25 (million per microliter)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 89 (milligram per deciliter)\n- Leukocytes [#/volume] in Body fluid by Manual count: 2034 (milli-international unit per milliliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10 (percent)\n- Platelets [#/volume] in Blood by Automated count: 561 (thousand per microliter)\n- Thyroxine (T4) [Mass/volume] in Serum or Plasma: 10.9 (microgram per deciliter)\n- Iron [Mass/volume] in Serum or Plasma: 328 (microgram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 51 (percent)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Reticulocytes [#/volume] in Blood by Automated count: 1416.3 (thousand per microliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 6.74 (micro-international unit per milliliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 6.0 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 6.7 (gram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 174 (percent)\n- MCH [Entitic mass] by Automated count: 20.5 (picogram)\n- MCHC [Mass/volume] by Automated count: 25.3 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.06 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.1 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.4 (percent)\n- Triiodothyronine (T3) [Mass/volume] in Serum or Plasma: 90 (nanogram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 99 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 109 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 33.4 (percent)\n- Ferritin [Mass/volume] in Serum or Plasma: 2918.7 (nanogram per milliliter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 189 (microgram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 3 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.6 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 34 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 64 (unit per liter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.11 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 5.41 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 81.1 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 43.55 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Anemia\n- Hemochromatosis\n- Acquired hypothyroidism\n- Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-04-24 15:20:00, ended at 2015-04-24 23:59:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Thyrotropin [Units/volume] in Serum or Plasma: 6.76 (micro-international unit per milliliter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 1.2 (nanogram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Anemia\n- Thalassemia\n- Ankle ulcer\n- Hypercoagulability state\n- Hemochromatosis\n- Hemochromatosis following repeated red blood cell transfusion\n- Acquired hypothyroidism\n- Primary diagnosis: Beta thalassemia\n- Cardiomyopathy associated with another disorder\n- Acquired absence of organ\n\n### Drug\n- deferasirox 500 MG Tablet for Oral Suspension, through Oral route, started on 2015-04-24, presumably until 2015-05-04, with intended 0 refill(s). Instructions: take 4 Tabs by mouth Every Day Take 2 tabs (1000 mg) in am and 2 tab (750 mg ) in pm both with a glass of juice\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-04-25 00:00:00, ended at 2015-04-25 00:00:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- levothyroxine sodium 0.1 MG Oral Tablet, through Oral route, started on 2015-04-25, presumably until 2016-02-19, with intended 3 refill(s). Instructions: take 1 Tab by mouth every morning before breakfast\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-05-04 00:00:00, ended at 2015-05-04 00:00:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- deferasirox 500 MG Tablet for Oral Suspension, through Oral route, started on 2015-05-04, presumably until 2015-05-11, with intended 0 refill(s). Instructions: take 4 Tabs by mouth Every Day Take 2 tabs (1000 mg) in am and 2 tab (1000 mg ) in pm both with a glass of juice\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-05-11 00:00:00, ended at 2015-05-11 00:00:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- deferasirox 500 MG Tablet for Oral Suspension, started on 2015-05-11, presumably until 2015-06-01, with intended 1 refill(s). Instructions: DISSOLVE TWO TABLETS (1,000 MG) IN 8 OZ. OF WATER, APPLE OR ORANGE JUICE AND DRINK ENTIRE SOLUTION TWICE A DAY.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-05-18 12:55:00, ended at 2015-05-18 23:59:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.764\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acquired absence of organ\n- Primary diagnosis: Hereditary hemolytic anemia\n- Hypercoagulability state\n- Congestive heart failure\n- Hemochromatosis following repeated red blood cell transfusion\n- Beta thalassemia\n- Cardiomyopathy associated with another disorder\n- Ankle ulcer\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-05-28 11:30:00, ended at 2015-05-28 23:59:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.567\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Peripheral venous insufficiency\n- Primary diagnosis: Acne\n- Lichen\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-05-31 00:00:00, ended at 2015-05-31 00:00:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- deferasirox 500 MG Tablet for Oral Suspension, started on 2015-06-04, presumably until 2015-08-17, with intended 1 refill(s). Instructions: DISSOLVE TWO TABLETS (1,000 MG) IN 8 OZ. OF WATER, APPLE OR ORANGE JUICE AND DRINK ENTIRE SOLUTION TWICE A DAY.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-06-01 00:00:00, ended at 2015-06-01 00:00:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- deferasirox 500 MG Tablet for Oral Suspension, started on 2015-06-01, presumably until 2015-09-19, with intended 0 refill(s). Instructions: DISSOLVE TWO TABLETS (1,000 MG) IN 8 OZ. OF WATER, APPLE OR ORANGE JUICE AND DRINK ENTIRE SOLUTION TWICE A DAY.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-06-01 12:22:00, ended at 2015-06-01 23:59:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, lower extremity other than joint; without contrast material(s)\n\n### Condition\n- Chronic pain\n- Pain in limb\n- Beta thalassemia\n- Degenerative joint disease of ankle AND/OR foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-06-07 11:45:16, ended at 2015-06-07 14:36:49\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acne\n- Primary diagnosis: Lichen\n\n### Drug\n- clobetasol propionate 0.0005 MG/MG Topical Ointment, through Topical route, started on 2015-06-07, presumably until 2016-06-06, with intended 0 refill(s). Instructions: by Topical route 2 times a day To itchy skin of ankle. Avoid area of prior ulceration.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-07-26 12:56:16, ended at 2015-07-26 17:20:37\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Eruption\n- Lichen\n\n### Drug\n- biotin 1 MG Oral Capsule, through Oral route, presumably until 2017-02-10, with intended 0 refill(s). Instructions: take by mouth\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-08-17 00:00:00, ended at 2015-08-17 00:00:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- deferasirox 500 MG Tablet for Oral Suspension, started on 2015-08-17, presumably until 2015-09-19, with intended 0 refill(s). Instructions: DISSOLVE TWO TABLETS (1,000 MG) IN 8 OZ OF WATER, APPLE OR ORANGE JUICE AND DRINK ENTIRE SOLUTION TWICE A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-08-22 00:00:00, ended at 2015-08-22 00:00:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-08-22 00:00:00, ended at 2015-08-22 00:00:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-08-27 00:00:00, ended at 2015-08-27 00:00:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-08-28 00:00:00, ended at 2015-08-28 00:00:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Choriogonadotropin.intact+Beta subunit [Units/volume] in Serum or Plasma: <1 (milli-international unit per milliliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 2.43 (micro-international unit per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n- Pregnancy test equivocal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-08-28 00:00:00, ended at 2015-08-28 00:00:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- deferasirox 360 MG Oral Tablet, through Oral route, started on 2015-08-28, presumably until 2015-09-19, with intended 3 refill(s). Instructions: take 4 Tabs by mouth Every Day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-28 12:54:00, ended at 2015-08-28 23:59:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 100 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 6.7 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 20.5 (picogram)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 7.0 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 56 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 5.0 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Iron [Mass/volume] in Serum or Plasma: 221 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 45 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.26 (million per microliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.69 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.5 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Ferritin [Mass/volume] in Serum or Plasma: 1695.7 (nanogram per milliliter)\n- MCHC [Mass/volume] by Automated count: 26.9 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 37 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 35.1 (percent)\n- Lymphocytes [#/volume] in Blood by Manual count: 5.64 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 76.4 (femtoliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 24.9 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 49 (percent)\n- Platelets [#/volume] in Blood by Automated count: 609 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.35 (thousand per microliter)\n- Leukocytes [#/volume] in Body fluid by Manual count: 1381 (milli-international unit per milliliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Beta thalassemia\n- Pregnancy test equivocal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-08-28 13:03:53, ended at 2015-08-28 16:36:52\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hemoglobin E/beta thalassemia disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-30 12:30:00, ended at 2015-08-30 23:59:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Transfusion, blood or blood components\n\n### Condition\n- Beta thalassemia\n\n### Drug\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2015-08-30, presumably until 2015-08-30\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-09-19 00:00:00, ended at 2015-09-19 00:00:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- deferasirox 500 MG Tablet for Oral Suspension, started on 2015-09-19, presumably until 2015-09-26, with intended 2 refill(s). Instructions: DISSOLVE TWO TABLETS (1,000 MG) IN 8 OZ OF WATER, APPLE OR ORANGE JUICE AND DRINK ENTIRE SOLUTION TWICE A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-09-19 00:00:00, ended at 2015-09-19 00:00:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- deferasirox 500 MG Tablet for Oral Suspension, started on 2015-09-19, presumably until 2015-09-19, with intended 0 refill(s). Instructions: DISSOLVE TWO TABLETS (1,000 MG) IN 8 OZ. OF WATER, APPLE OR ORANGE JUICE AND DRINK ENTIRE SOLUTION TWICE A DAY.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-09-26 00:00:00, ended at 2015-09-26 00:00:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- deferasirox 500 MG Tablet for Oral Suspension, started on 2015-09-26, presumably until 2015-12-18, with intended 2 refill(s). Instructions: DISSOLVE TWO TABLETS (1,000 MG) IN 8 OZ OF WATER, APPLE OR ORANGE JUICE AND DRINK ENTIRE SOLUTION TWICE A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-10-12 00:00:00, ended at 2015-10-12 00:00:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- deferasirox 500 MG Tablet for Oral Suspension, started on 2015-10-14, presumably until 2015-10-14, with intended 2 refill(s). Instructions: DISSOLVE TWO TABLETS (1,000 MG) IN 8 OZ OF WATER, APPLE OR ORANGE JUICE AND DRINK ENTIRE SOLUTION TWICE A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-10-29 00:00:00, ended at 2015-10-29 00:00:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-10-30 00:00:00, ended at 2015-10-30 00:00:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- deferasirox 360 MG Oral Tablet, through Oral route, started on 2015-10-30, presumably until 2016-03-31, with intended 3 refill(s). Instructions: take 1,400 mg by mouth Every Day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-12-11 00:00:00, ended at 2015-12-11 00:00:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute bronchitis\n\n### Drug\n- benzonatate 100 MG Oral Capsule, through Oral route, started on 2015-12-14, presumably until 2016-06-11, with intended 0 refill(s). Instructions: take 1 Cap by mouth 3 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-12-13 11:24:30, ended at 2015-12-13 12:06:51\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute bronchitis\n\n### Drug\n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2015-12-13, presumably until 2017-02-10, with intended 0 refill(s). Instructions: 2 Puffs by Inhalation route every 6 hours as needed\n- 12 HR guaifenesin 1200 MG Extended Release Oral Tablet, through Oral route, started on 2015-12-13, presumably until 2016-06-11, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- benzonatate 100 MG Oral Capsule, through Oral route, started on 2015-12-13, presumably until 2015-12-14, with intended 0 refill(s). Instructions: take 1 Cap by mouth 3 times a day\n- azithromycin 250 MG Oral Tablet, through Oral route, started on 2015-12-13, presumably until 2015-12-18, with intended 0 refill(s). Instructions: take 1 Tab by mouth as directed for 5 days 2 tabs on day 1, then 1 tab daily thereafter\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-12-17 00:00:00, ended at 2015-12-17 00:00:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, started on 2015-12-25, presumably until 2016-06-11, with intended 2 refill(s). Instructions: USE 2 SPRAYS BY NASAL ROUTE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-12-17 15:15:53, ended at 2015-12-17 18:02:50\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.567\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Lichen simplex chronicus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-12-17 16:32:00, ended at 2015-12-17 23:59:00\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 97 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 88 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 39 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Eosinophils [#/volume] in Blood by Manual count: 0.20 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 6.9 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 6.53 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 34.9 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.2 (percent)\n- Iron [Mass/volume] in Serum or Plasma: 305 (microgram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 8.6 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 33 (percent)\n- Monocytes [#/volume] in Blood by Manual count: 2.18 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 40 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 50 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 6.7 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.43 (million per microliter)\n- Leukocytes [#/volume] in Body fluid by Manual count: 1087 (milli-international unit per milliliter)\n- Sodium [Moles/volume] in Serum or Plasma: 133 (millimole per liter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 2.75 (micro-international unit per milliliter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.2 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 26.3 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 687 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 22 (milligram per deciliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 1354.7 (nanogram per milliliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 19.8 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 20.1 (picogram)\n- MCV [Entitic volume] by Automated count: 76.3 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-12-18 16:46:14, ended at 2015-12-18 17:25:35\nThe patient in this visit was 35 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acquired absence of spleen\n- Beta thalassemia\n- Primary diagnosis: Hemochromatosis following repeated red blood cell transfusion\n- Disorder of bone\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-01-22 00:00:00, ended at 2016-01-22 00:00:00\nThe patient in this visit was 36 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n- Disorder of iron metabolism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-01-29 00:00:00, ended at 2016-01-29 00:00:00\nThe patient in this visit was 36 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n- Acquired hypothyroidism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-02-18 16:54:00, ended at 2016-02-18 23:59:00\nThe patient in this visit was 36 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.6 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 40 (percent)\n- MCH [Entitic mass] by Automated count: 19.5 (picogram)\n- MCHC [Mass/volume] by Automated count: 24.6 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 625 (thousand per microliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 29 (nanogram per milliliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 29 (nanogram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 48 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 105 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Globulin [Mass/volume] in Serum: 4.4 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 6.5 (gram per deciliter)\n- Iron [Mass/volume] in Serum or Plasma: 141 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 59 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 20.2 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 8.08 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 51 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 4.7 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.62 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.5 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 79.6 (femtoliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.34 (million per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 1244.7 (nanogram per milliliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 36 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 36.4 (percent)\n- Leukocytes [#/volume] in Body fluid by Manual count: 930 (milli-international unit per milliliter)\n- Sodium [Moles/volume] in Serum or Plasma: 132 (millimole per liter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 3.56 (micro-international unit per milliliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Disorder of iron metabolism\n- Beta thalassemia\n- Disorder of bone\n- Acquired hypothyroidism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-02-19 16:11:13, ended at 2016-02-19 16:45:27\nThe patient in this visit was 36 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-02-20 11:00:00, ended at 2016-02-20 23:59:00\nThe patient in this visit was 36 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Transfusion, blood or blood components\n\n### Condition\n- Acquired hypothyroidism\n- Beta thalassemia\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2016-02-20, presumably until 2016-02-20\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2016-02-20, presumably until 2016-02-20\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-03-31 00:00:00, ended at 2016-03-31 00:00:00\nThe patient in this visit was 36 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Beta thalassemia\n- Primary diagnosis: Disorder of iron metabolism\n\n### Drug\n- deferasirox 360 MG Oral Tablet, through Oral route, started on 2016-03-31, presumably until 2016-04-01, with intended 5 refill(s). Instructions: take 1,400 mg by mouth Every Day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-04-01 00:00:00, ended at 2016-04-01 00:00:00\nThe patient in this visit was 36 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Beta thalassemia\n- Disorder of iron metabolism\n\n### Drug\n- deferasirox 360 MG Oral Tablet, through Oral route, started on 2016-04-01, presumably until 2016-12-23, with intended 5 refill(s). Instructions: take 1,440 mg by mouth Every Day Weight: 65.5 kg\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-04-08 00:00:00, ended at 2016-04-08 00:00:00\nThe patient in this visit was 36 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- levothyroxine sodium 0.1 MG Oral Tablet, started on 2016-04-08, presumably until 2016-11-17, with intended 2 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY MORNING BEFORE BREAKFAST\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-06-23 00:00:00, ended at 2016-06-23 00:00:00\nThe patient in this visit was 36 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n- Anemia\n- Disorder of iron metabolism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-06-23 14:12:00, ended at 2016-06-23 23:59:00\nThe patient in this visit was 36 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.64 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.80 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 23.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 13.3 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 90 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Iron [Mass/volume] in Serum or Plasma: 195 (microgram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.06 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.9 (gram per deciliter)\n- Reticulocytes [#/volume] in Blood by Automated count: 201.9 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 32.1 (percent)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 6.2 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 4.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 50 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 28 (percent)\n- MCHC [Mass/volume] by Automated count: 26.9 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 6.37 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 80 (milligram per deciliter)\n- Leukocytes [#/volume] in Body fluid by Manual count: 1044 (milli-international unit per milliliter)\n- MCH [Entitic mass] by Automated count: 19.7 (picogram)\n- MCV [Entitic volume] by Automated count: 73.4 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 657 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.17 (million per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 657.6 (nanogram per milliliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 64 (percent)\n- Lymphocytes [#/volume] in Blood by Manual count: 3.72 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Anemia\n- Disorder of iron metabolism\n- Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-06-24 00:00:00, ended at 2016-06-24 00:00:00\nThe patient in this visit was 36 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-06-25 11:10:00, ended at 2016-06-25 23:59:00\nThe patient in this visit was 36 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Transfusion, blood or blood components\n\n### Condition\n- Beta thalassemia\n- Acquired hypothyroidism\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2016-06-25, presumably until 2016-06-25\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2016-06-25, presumably until 2016-06-25\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-08-14 00:00:00, ended at 2016-08-14 00:00:00\nThe patient in this visit was 36 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n- Disorder of iron metabolism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-08-19 15:18:00, ended at 2016-08-19 23:59:00\nThe patient in this visit was 36 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 48 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 37.3 (percent)\n- Ferritin [Mass/volume] in Serum or Plasma: 934.7 (nanogram per milliliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.3 (gram per deciliter)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 7.28 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 13.3 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 76.6 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 52 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 132 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.7 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 36 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 4.7 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.27 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 7.5 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Iron [Mass/volume] in Serum or Plasma: 175 (microgram per deciliter)\n- MCHC [Mass/volume] by Automated count: 28.2 (gram per deciliter)\n- Reticulocytes [#/volume] in Blood by Automated count: 261.0 (thousand per microliter)\n- Leukocytes [#/volume] in Body fluid by Manual count: 1056 (milli-international unit per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 69 (percent)\n- Monocytes [#/volume] in Blood by Manual count: 1.06 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 88 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.60 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.49 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 4.79 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 21.6 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 723 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Beta thalassemia\n- Disorder of iron metabolism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-11-03 00:00:00, ended at 2016-11-03 00:00:00\nThe patient in this visit was 36 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2016-11-27, presumably until 2016-12-08, with intended 0 refill(s). Instructions: take 1 Tab by mouth 3 times a day as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-11-05 00:00:00, ended at 2016-11-05 00:00:00\nThe patient in this visit was 36 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n- Disorder of iron metabolism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-11-11 00:00:00, ended at 2016-11-11 00:00:00\nThe patient in this visit was 36 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Beta thalassemia\n- Primary diagnosis: Meningitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-11-11 14:39:00, ended at 2016-11-11 23:59:00\nThe patient in this visit was 36 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- MCHC [Mass/volume] by Automated count: 29.9 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 61 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 41.3 (percent)\n- Leukocytes [#/volume] in Body fluid by Manual count: 30 (milli-international unit per milliliter)\n- Platelets [#/volume] in Blood by Automated count: 584 (thousand per microliter)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 9.50 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 27.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 16.5 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 73.5 (femtoliter)\n- Monocytes [#/volume] in Blood by Manual count: 2.15 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 22 (percent)\n- MCH [Entitic mass] by Automated count: 22.0 (picogram)\n- Ferritin [Mass/volume] in Serum or Plasma: 3664.8 (nanogram per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 8.2 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.71 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 3.63 (thousand per microliter)\n- Reticulocytes [#/volume] in Blood by Automated count: 352.9 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Beta thalassemia\n- Disorder of iron metabolism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-11-17 00:00:00, ended at 2016-11-17 00:00:00\nThe patient in this visit was 36 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- levothyroxine sodium 0.1 MG Oral Tablet, through Oral route, started on 2016-11-17, presumably until 2016-12-30, with intended 0 refill(s). Instructions: take 1 Tab by mouth every morning before breakfast\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2016-11-17, presumably until 2016-12-08, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed\n- ondansetron 4 MG Oral Tablet, through Oral route, started on 2016-11-17, presumably until 2016-12-08, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-11-27 14:44:48, ended at 2016-11-27 17:43:47\nThe patient in this visit was 36 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Localized edema\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-12-08 00:00:00, ended at 2016-12-08 00:00:00\nThe patient in this visit was 36 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2016-12-08, presumably until 2017-02-10, with intended 0 refill(s). Instructions: take 1 Tab by mouth 3 times a day as needed\n- ondansetron 4 MG Oral Tablet, through Oral route, started on 2016-12-08, presumably until 2017-06-11, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-12-17 00:00:00, ended at 2016-12-17 00:00:00\nThe patient in this visit was 36 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pneumococcal meningitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-12-18 08:51:03, ended at 2016-12-18 10:03:33\nThe patient in this visit was 36 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Rheumatic disease of mitral valve\n- Pneumococcal meningitis\n- Pyogenic arthritis of shoulder region\n- Primary diagnosis: Cough\n- Pneumococcal arthritis\n\n### Drug\n- codeine phosphate 2 MG/ML / guaifenesin 20 MG/ML Oral Solution, through Oral route, started on 2016-12-18, presumably until 2017-02-10, with intended 0 refill(s). Instructions: take 5 mL by mouth 3 times a day as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-18 10:11:00, ended at 2016-12-18 23:59:00\nThe patient in this visit was 36 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Abnormal findings on diagnostic imaging of lung\n- Cough\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-12-23 00:00:00, ended at 2016-12-23 00:00:00\nThe patient in this visit was 36 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of iron metabolism\n- Beta thalassemia\n\n### Drug\n- deferasirox 360 MG Oral Tablet, through Oral route, started on 2016-12-23, presumably until 2017-06-17, with intended 5 refill(s). Instructions: take 1,440 mg by mouth every day Weight: 65.5 kg\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-12-30 00:00:00, ended at 2016-12-30 00:00:00\nThe patient in this visit was 36 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- levothyroxine sodium 0.1 MG Oral Tablet, through Oral route, started on 2016-12-30, presumably until 2017-04-01, with intended 12 refill(s). Instructions: take 1 Tab by mouth every morning before breakfast\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-01-05 00:00:00, ended at 2017-01-05 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n- Blood chemistry abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-01-08 00:00:00, ended at 2017-01-08 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-01-17 08:50:00, ended at 2017-01-17 23:59:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material, followed by contrast material(s) and further sequences\n\n### Condition\n- Pneumococcal infectious disease\n- Streptococcal infectious disease\n- Disorder of brain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-02-02 15:25:22, ended at 2017-02-02 18:56:15\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Telogen effluvium\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-02-05 11:38:59, ended at 2017-02-05 12:25:33\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acquired absence of spleen\n- Rheumatic disease of mitral valve\n- Primary diagnosis: Nonspecific tuberculin test reaction\n- Imaging of brain abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-02-10 14:37:00, ended at 2017-02-10 23:59:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 89 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 107 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 6.8 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.90 (thousand per microliter)\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 32 (nanogram per milliliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 17.9 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 20.2 (picogram)\n- Eosinophils [#/volume] in Blood by Manual count: 0.54 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 35.4 (percent)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 40 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 44 (percent)\n- Thyrotropin [Units/volume] in Serum or Plasma: 4.30 (micro-international unit per milliliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 32 (nanogram per milliliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 6.9 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 8.8 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 25.9 (percent)\n- MCV [Entitic volume] by Automated count: 77.2 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 604 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.65 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.36 (million per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 1125.0 (nanogram per milliliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.0 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Leukocytes [#/volume] in Body fluid by Manual count: 1035 (milli-international unit per milliliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 7.16 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 26.1 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Meningitis\n- Beta thalassemia\n- Blood chemistry abnormal\n- Nonspecific tuberculin test reaction\n- Telogen effluvium\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-02-10 14:50:23, ended at 2017-02-10 15:47:52\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hemoglobin E/beta thalassemia disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-02-11 12:00:00, ended at 2017-02-11 23:59:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Transfusion, blood or blood components\n\n### Condition\n- Beta thalassemia\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2017-02-11, presumably until 2017-02-11\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2017-02-11, presumably until 2017-02-11\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-03-01 00:00:00, ended at 2017-03-01 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Non-rheumatic mitral valve stenosis with regurgitation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-03-02 14:04:44, ended at 2017-03-02 15:59:30\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Electrocardiogram abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-03-03 00:00:00, ended at 2017-03-03 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-03-30 09:00:00, ended at 2017-03-30 23:59:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 56.3 (percent)\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Non-rheumatic mitral valve stenosis with regurgitation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-04-01 13:20:44, ended at 2017-04-01 15:37:11\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypothyroidism\n\n### Drug\n- levothyroxine sodium 0.125 MG Oral Tablet, through Oral route, started on 2017-04-01, presumably until 2018-04-08, with intended 12 refill(s). Instructions: take 1 Tab by mouth every morning before breakfast\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-04-17 00:00:00, ended at 2017-04-17 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cardiomyopathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-04-20 09:25:07, ended at 2017-04-20 11:25:29\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Hemochromatosis following repeated red blood cell transfusion\n- Cardiomyopathy\n- Lupus anticoagulant disorder\n- Acquired absence of spleen\n- Primary diagnosis: Rheumatic disease of mitral AND aortic valves\n- Beta thalassemia\n- Electrocardiogram abnormal\n\n### Drug\n- losartan potassium 50 MG Oral Tablet, through Oral route, started on 2017-04-20, presumably until 2017-05-07, with intended 6 refill(s). Instructions: take 1 Tab by mouth daily\n- hydrochlorothiazide 25 MG / spironolactone 25 MG Oral Tablet, through Oral route, started on 2017-04-20, presumably until 2017-06-04, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-04-20 11:34:00, ended at 2017-04-20 23:59:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Glucose [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 6.9 (gram per deciliter)\n- Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma: 197 (picogram per milliliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 2.17 (micro-international unit per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 32.4 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 96 (unit per liter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 7.0 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.31 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 15.3 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.84 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- MCHC [Mass/volume] by Automated count: 27.9 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.5 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 37 (percent)\n- MCH [Entitic mass] by Automated count: 21.2 (picogram)\n- MCV [Entitic volume] by Automated count: 76.0 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 45 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 24.6 (percent)\n- Lymphocytes [#/volume] in Blood by Manual count: 5.66 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 572 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.23 (million per microliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 445 (unit per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 7.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.58 (milligram per deciliter)\n- Leukocytes [#/volume] in Body fluid by Manual count: 854 (milli-international unit per milliliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hypothyroidism\n- Acquired absence of spleen\n- Congestive heart failure\n- Rheumatic disease of mitral AND aortic valves\n- Beta thalassemia\n- Chronic combined systolic and diastolic heart failure\n- Cardiomyopathy\n- Hemochromatosis following repeated red blood cell transfusion\n- Lupus anticoagulant disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-04-22 00:00:00, ended at 2017-04-22 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n- Heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-04-23 13:22:36, ended at 2017-04-23 13:58:41\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute upper respiratory infection\n\n### Drug\n- codeine phosphate 2 MG/ML / guaifenesin 20 MG/ML Oral Solution, through Oral route, started on 2017-04-23, presumably until 2017-08-10, with intended 0 refill(s). Instructions: take 5 mL by mouth every bedtime as needed\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2017-04-23, presumably until 2017-08-10, with intended 0 refill(s). Instructions: 1 Spray by Nasal route 2 times a day\n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2017-04-23, presumably until 2017-08-17, with intended 0 refill(s). Instructions: 2 Puffs by Inhalation route every 6 hours as needed (coughing)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-04-30 00:00:00, ended at 2017-04-30 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Lupus anticoagulant disorder\n- Primary diagnosis: Cardiomyopathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-05-07 00:00:00, ended at 2017-05-07 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hemochromatosis following repeated red blood cell transfusion\n- Lupus anticoagulant disorder\n- Cardiomyopathy\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-05-07 00:00:00, ended at 2017-05-07 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acquired absence of spleen\n- Hemochromatosis following repeated red blood cell transfusion\n- Cardiomyopathy\n- Rheumatic disease of mitral AND aortic valves\n- Lupus anticoagulant disorder\n- Beta thalassemia\n\n### Drug\n- losartan potassium 50 MG Oral Tablet, through Oral route, started on 2017-05-07, presumably until 2017-07-10, with intended 6 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-05-07 00:00:00, ended at 2017-05-07 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-05-07 07:52:42, ended at 2017-05-07 14:14:40\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Cardiomyopathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-05-07 10:04:00, ended at 2017-05-07 23:59:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 0.53 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum: 1 (beta-2 GPI IgG Ab unit)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Beta thalassemia\n- Acquired absence of spleen\n- Anemia\n- Heart failure\n- Cardiomyopathy\n- Lupus anticoagulant disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-05-13 00:00:00, ended at 2017-05-13 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-05-13 00:00:00, ended at 2017-05-13 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n- Blood chemistry abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-05-15 00:00:00, ended at 2017-05-15 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n- Heart failure\n\n### Drug\n- hydrochlorothiazide 25 MG Oral Tablet, through Oral route, started on 2017-06-04, presumably until 2017-07-10, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n- eplerenone 25 MG Oral Tablet, through Oral route, started on 2017-06-04, presumably until 2017-08-10, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-05-17 14:26:00, ended at 2017-05-17 23:59:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum: 1 (beta-2 GPI IgG Ab unit)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Leukocytes [#/volume] in Body fluid by Manual count: 560 (milli-international unit per milliliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.60 (milligram per deciliter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 324 (microgram of fibrinogen equivalent unit per milliliter)\n- Glucose [Mass/volume] in Serum or Plasma: 113 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 20.4 (picogram)\n- Neutrophils/100 leukocytes in Blood by Manual count: 33 (percent)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 6.0 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Ferritin [Mass/volume] in Serum or Plasma: 799.0 (nanogram per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 6.3 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 10.18 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 28.0 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.1 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 48 (percent)\n- Platelets [#/volume] in Blood by Automated count: 570 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Monocytes [#/volume] in Blood by Manual count: 1.70 (thousand per microliter)\n- Prothrombin time (PT): 14.5 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 6.2 (milligram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 284 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 21.2 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 72.8 (femtoliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 33.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.11 (million per microliter)\n- Thrombin time: 15.3 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 29.5 (second)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 92 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.42 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 22.6 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Beta thalassemia\n- Blood chemistry abnormal\n- Cardiomyopathy\n- Lupus anticoagulant disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-05-19 07:10:00, ended at 2017-05-19 23:59:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Transfusion, blood or blood components\n\n### Condition\n- Beta thalassemia\n- Coag./bleeding tests abnormal\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2017-05-19, presumably until 2017-05-19\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2017-05-19, presumably until 2017-05-19\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-06-09 00:00:00, ended at 2017-06-09 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n- Coag./bleeding tests abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-06-11 00:00:00, ended at 2017-06-11 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-06-11 00:00:00, ended at 2017-06-11 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- ondansetron 4 MG Oral Tablet, through Oral route, started on 2017-06-11, presumably until 2017-07-10, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-06-11 07:30:00, ended at 2017-06-11 07:50:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s)\n- Cardiac magnetic resonance imaging for morphology and function without contrast material\n\n### Condition\n- Cardiomyopathy\n- Beta thalassemia\n- Hemochromatosis following repeated red blood cell transfusion\n- Lupus anticoagulant disorder\n- Splenomegaly\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-06-11 07:51:00, ended at 2017-06-11 23:59:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, abdominal, real time with image documentation; complete\n\n### Condition\n- Hemochromatosis following repeated red blood cell transfusion\n- Lupus anticoagulant disorder\n- Gallstone\n- Cardiomyopathy\n- Beta thalassemia\n- Disease of liver\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-06-17 00:00:00, ended at 2017-06-17 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Beta thalassemia\n- Disorder of iron metabolism\n\n### Drug\n- deferasirox 360 MG Oral Tablet, through Oral route, started on 2017-06-17, presumably until 2017-12-09, with intended 5 refill(s). Instructions: take 1,530 mg by mouth every day Weight: 65.5 kg\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-06-20 00:00:00, ended at 2017-06-20 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Non-rheumatic mitral valve stenosis with regurgitation\n- Rheumatic tricuspid valve regurgitation\n- Primary diagnosis: Aortic incompetence, non-rheumatic\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-06-20 15:06:00, ended at 2017-06-20 23:59:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 25.7 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.1 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 40 (percent)\n- MCHC [Mass/volume] by Automated count: 29.0 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 638 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 7.5 (gram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4 (percent)\n- Monocytes [#/volume] in Blood by Manual count: 0.92 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Eosinophils [#/volume] in Blood by Manual count: 0.62 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 36.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.29 (million per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 8.5 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin: 128 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 22.7 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 86 (unit per liter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 312 (microgram of fibrinogen equivalent unit per milliliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 300 (milligram per deciliter)\n- Leukocytes [#/volume] in Body fluid by Manual count: 807 (milli-international unit per milliliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 15.4 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 6.16 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.8 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Prothrombin time (PT): 14.3 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 78.3 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 39 (percent)\n- aPTT in Platelet poor plasma by Coagulation assay: 28.9 (second)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 7.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.91 (milligram per deciliter)\n- Thrombin time: 14.9 (second)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Rheumatic tricuspid valve regurgitation\n- Beta thalassemia\n- Non-rheumatic mitral valve stenosis with regurgitation\n- Aortic incompetence, non-rheumatic\n- Coag./bleeding tests abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-06-21 08:00:00, ended at 2017-06-21 23:59:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Transfusion, blood or blood components\n\n### Condition\n- Aortic incompetence, non-rheumatic\n- Beta thalassemia\n- Rheumatic tricuspid valve regurgitation\n- Hemoglobin E/beta thalassemia disease\n- Non-rheumatic mitral valve stenosis with regurgitation\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2017-06-21, presumably until 2017-06-21\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2017-06-21, presumably until 2017-06-21\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-06-22 00:00:00, ended at 2017-06-22 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-06-25 00:00:00, ended at 2017-06-25 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Non-rheumatic mitral valve stenosis with regurgitation\n- Aortic incompetence, non-rheumatic\n- Beta thalassemia\n- Rheumatic tricuspid valve regurgitation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-06-25 09:16:19, ended at 2017-06-25 10:19:32\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Leukocytes [#/volume] in Specimen by Automated count: 9.2 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 38 (percent)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 27.03 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.68 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 3.50 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.4 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 26 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.1 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 525 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 78.7 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Eosinophils [#/volume] in Blood by Manual count: 0.46 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 6.0 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5 (percent)\n- MCH [Entitic mass] by Automated count: 25.1 (picogram)\n- Monocytes [#/volume] in Blood by Manual count: 1.01 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 39 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 72 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 33.2 (percent)\n- MCHC [Mass/volume] by Automated count: 31.9 (gram per deciliter)\n- Reticulocytes [#/volume] in Blood by Automated count: 995.1 (thousand per microliter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.67 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.2 (gram per deciliter)\n- Leukocytes [#/volume] in Body fluid by Manual count: 642 (milli-international unit per milliliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11 (percent)\n- Body height: 5' 5\" (inch (US))\n- Glucose [Mass/volume] in Serum or Plasma: 84 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-06-25 10:45:18, ended at 2017-06-25 12:22:28\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5.315\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Primary diagnosis: Aortic incompetence, non-rheumatic\n- Non-rheumatic mitral valve stenosis with regurgitation\n- Rheumatic tricuspid valve regurgitation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-06-25 13:15:00, ended at 2017-06-25 23:59:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Beta thalassemia\n- Aortic incompetence, non-rheumatic\n- Rheumatic tricuspid valve regurgitation\n- Non-rheumatic mitral valve stenosis with regurgitation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-06-26 13:21:00, ended at 2017-06-26 23:59:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Aortic incompetence, non-rheumatic\n- Rheumatic tricuspid valve regurgitation\n- Non-rheumatic mitral valve stenosis with regurgitation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2017-07-01 00:00:00, ended at 2017-07-01 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Insertion of non-tunneled centrally inserted central venous catheter; age 5 years or older\n- Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous\n- Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (Lis\n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n- Insertion and placement of flow directed catheter (eg, Swan-Ganz) for monitoring purposes\n- Anesthesia for procedures on heart, pericardial sac, and great vessels of chest; with pump oxygenator, age 1 year or older, for all noncoronary bypass procedures (eg, valve procedures) or for re-operation for coronary bypass more than 1 month after origin\n- Echocardiography, transesophageal, real-time with image documentation (2D) (with or without M-mode recording); including probe placement, image acquisition, interpretation and report\n\n### Condition\n- Aortic incompetence, non-rheumatic\n- Rheumatic tricuspid valve regurgitation\n- Non-rheumatic mitral valve stenosis with regurgitation\n\n### Drug\n- 10 ML calcium chloride 100 MG/ML Injection, through Intravenous route, started on 2017-07-01, presumably until 2017-07-01\n- vancomycin 1000 MG Injection, through Intravenous route, started on 2017-07-01, presumably until 2017-07-01\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2017-07-01, presumably until 2017-07-01\n- 10 ML epinephrine 0.1 MG/ML Prefilled Syringe, through Intravenous route, started on 2017-07-01, presumably until 2017-07-01\n- 100 ML potassium chloride 0.4 MEQ/ML Injection, through Intravenous route, started on 2017-07-01, presumably until 2017-07-01\n- 5 ML protamine sulfate (USP) 10 MG/ML Injection, through Intravenous route, started on 2017-07-01, presumably until 2017-07-01\n- 1 ML ephedrine sulfate 50 MG/ML Injection, started on 2017-07-01, presumably until 2017-07-01\n- 250 ML norepinephrine 0.016 MG/ML Injection, through Intravenous route, started on 2017-07-01, presumably until 2017-07-01\n- 250 ML nitroglycerin 0.2 MG/ML Injection, through Intravenous route, started on 2017-07-01, presumably until 2017-07-01\n- 250 ML mannitol 200 MG/ML Injection, through Intravenous route, started on 2017-07-01, presumably until 2017-07-01\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2017-07-01, presumably until 2017-07-01\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2017-07-01, presumably until 2017-07-01\n- vasopressin (USP) 20 UNT/ML Injectable Solution, through Intravenous route, started on 2017-07-01, presumably until 2017-07-01\n- 2 ML lidocaine hydrochloride 20 MG/ML Injection, started on 2017-07-01, presumably until 2017-07-01\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2017-07-01, presumably until 2017-07-01\n- methadone hydrochloride 10 MG/ML Injectable Solution, started on 2017-07-01, presumably until 2017-07-01\n- 6-aminocaproic acid 250 MG/ML Injectable Solution, through Intravenous route, started on 2017-07-01, presumably until 2017-07-01\n- 2 ML dexmedetomidine 0.1 MG/ML Injection, through Intravenous route, started on 2017-07-01, presumably until 2017-07-01\n- midazolam 1 MG/ML Injectable Solution, started on 2017-07-01, presumably until 2017-07-01\n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2017-07-01, presumably until 2017-07-01\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2017-07-01 05:05:00, ended at 2017-07-10 13:08:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 70 (unit per liter)\n- Base excess in Blood by calculation: 3 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 30.0 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 99 (percent)\n- Procalcitonin [Mass/volume] in Serum or Plasma: 0.5 (nanogram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 124 (unit per liter)\n- Body height: 5' 5\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.16 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 3.1 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 41 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.67 (million per microliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 342 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.7 (percent)\n- Lymphocytes [#/volume] in Blood by Manual count: 9.20 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 5 (percent)\n- MCHC [Mass/volume] by Automated count: 32.9 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 89.5 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 359 (thousand per microliter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.40 (millimole per liter)\n- Carbon dioxide [Partial pressure] in Arterial blood: 46.3 (millimeter mercury column)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 84 (millimeter mercury column)\n- Oxygen [Partial pressure] in Arterial blood: >500.0 (millimeter mercury column)\n- Potassium [Moles/volume] in Serum or Plasma: 6.2 (millimole per liter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 39.6 (millimeter mercury column)\n- Leukocytes [#/volume] in Body fluid by Manual count: 681 (milli-international unit per milliliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 42.9 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 149 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4 (percent)\n- Monocytes [#/volume] in Blood by Manual count: 3.15 (thousand per microliter)\n- Prothrombin time (PT): 20.3 (second)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 6.2 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.99 (thousand per microliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 4 - 5 (per high power field)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.4 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 81 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Base excess in Arterial blood by calculation: 2.5 (millimole per liter)\n- Bicarbonate [Moles/volume] in Specimen: 27.1 (millimole per liter)\n- Glucose [Mass/volume] in Blood: 334 (milligram per deciliter)\n- Lactate [Moles/volume] in Blood: 2.7 (millimole per liter)\n- Phosphate [Mass/volume] in Serum or Plasma: 6.1 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 43 (milligram per deciliter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 5.5 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 27.6 (picogram)\n- aPTT in Platelet poor plasma by Coagulation assay: 65.8 (second)\n\n### Procedure\n- Treatment of swallowing dysfunction and/or oral function for feeding\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Drainage of Right Pleural Cavity with Drainage Device, Percutaneous Approach\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Replacement of Aortic Valve with Zooplastic Tissue, Open Approach\n- Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Inspection of Larynx, Via Natural or Artificial Opening Endoscopic\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A problem focused interval history; A problem focused examination; Medical decision making that is straightforward or o\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Repair Atrial Septum, Open Approach\n- Flexible endoscopic evaluation of swallowing by cine or video recording\n- Supplement Tricuspid Valve with Synthetic Substitute, Open Approach\n- Radiologic examination, chest; single view, frontal\n- Supplement Mitral Valve with Synthetic Substitute, Open Approach\n- Collection of venous blood by venipuncture\n- Demonstration and/or evaluation of patient utilization of an aerosol generator, nebulizer, metered dose inhaler or IPPB device\n- Evaluation of oral and pharyngeal swallowing function\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Physical therapy evaluation: moderate complexity, requiring these components: A history of present problem with 1-2 personal factors and/or comorbidities that impact the plan of care; An examination of body systems using standardized tests and measures in\n- Introduction of Vasopressor into Peripheral Vein, Percutaneous Approach\n- Controlled ventilation procedure and therapy, initiation and management\n- Therapeutic procedure, 1 or more areas, each 15 minutes; gait training (includes stair climbing)\n- Performance of Cardiac Output, Continuous\n- Behavioral and qualitative analysis of voice and resonance\n\n### Condition\n- Acquired absence of spleen\n- Blood coagulation disorder\n- Cardiomyopathy\n- Disorder of vocal cord\n- First degree atrioventricular block\n- Hemoglobinopathy\n- Non-rheumatic heart valve disorder\n- Pain in left foot\n- Pneumococcal meningitis\n- Tachycardia\n- Abnormal findings on diagnostic imaging of lung\n- Allergic condition\n- Pleural effusion\n- Transplanted heart valve present\n- Vascular complication of medical care\n- Beta thalassemia\n- Chronic pulmonary edema\n- Hyperkalemia\n- Lupus anticoagulant disorder\n- Atelectasis\n- Pneumothorax\n- Postoperative state\n- Rupture of chordae tendineae\n- Atrial flutter\n- Congenital absence of spleen\n- Primary diagnosis: Heart failure\n- Atrial fibrillation\n- Electrocardiogram abnormal\n- Acute pulmonary edema\n- Chronic ulcer of skin of ankle\n- Disorder of bilirubin metabolism\n- Disorder of bone\n- Hemochromatosis following repeated red blood cell transfusion\n- Paroxysmal atrial fibrillation\n- Pneumothorax due to and following procedure\n- Acute bronchitis\n- Anemia of chronic disease\n- Combined disorders of mitral, aortic and tricuspid valves\n- Hypothyroidism\n\n### Drug\n- amiodarone hydrochloride 200 MG Oral Tablet, through Oral route, started on 2017-07-07, presumably until 2017-08-11, with intended 0 refill(s). Instructions: 400 mg twice daily for one week, then 200 mg twice daily for one week then 200 mg daily for 2 weeks.\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2017-07-01, presumably until 2017-07-03\n- calcium carbonate 1000 MG Chewable Tablet, through Oral route, started on 2017-07-04, presumably until 2018-12-13, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed (indigestion)\n- folic acid 1 MG Oral Tablet, through Oral route, started on 2017-07-04, presumably until 2017-07-10\n- Abuse-Deterrent 12 HR oxycodone hydrochloride 10 MG Extended Release Oral Tablet, through Oral route, started on 2017-07-05, presumably until 2017-08-11, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 12 hours\n- chlorhexidine gluconate 1.2 MG/ML Mouthwash, through Submucosal route, started on 2017-07-01, presumably until 2017-07-02\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2017-07-08, presumably until 2017-08-11, with intended 0 refill(s). Instructions: 40 mg twice daily for one week, 20 mg twice daily for one week, then 20 mg daily.\n- 100 ML potassium chloride 0.1 MEQ/ML Injection, through Intravenous route, started on 2017-07-07, presumably until 2017-07-08\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2017-07-04, presumably until 2017-09-11, with intended 0 refill(s). Instructions: take 1 Tab by mouth every morning before breakfast\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2017-07-05, presumably until 2017-07-08\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2017-07-01, presumably until 2017-07-02\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2017-07-04, presumably until 2017-07-05\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2017-07-07, presumably until 2017-07-08\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2017-07-03, presumably until 2017-09-04, with intended 0 refill(s). Instructions: take 2 Caps by mouth 2 times a day as needed for Constipation\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2017-07-04, presumably until 2017-08-17, with intended 0 refill(s). Instructions: 3 mL by Nebulization route every 6 hours as needed\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2017-07-07, presumably until 2017-08-11, with intended 0 refill(s). Instructions: 40 meq twice daily for one week, 20 meq twice daily for one week, then 20 meq daily while on Lasix.\n- deferasirox 360 MG Oral Tablet, through Oral route, started on 2017-07-05, presumably until 2017-07-06\n- insulin isophane, human 100 UNT/ML Injectable Suspension, through Subcutaneous route, started on 2017-07-02, presumably until 2017-07-04\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2017-07-08, presumably until 2017-07-09\n- 10 ML furosemide 10 MG/ML Injection, started on 2017-07-04, presumably until 2017-07-10\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2017-07-03, presumably until 2017-08-11, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- levothyroxine sodium 0.1 MG Oral Tablet, through Oral route, started on 2017-07-03, presumably until 2017-07-10\n- levothyroxine sodium 0.025 MG Oral Tablet, through Oral route, started on 2017-07-03, presumably until 2017-07-10\n- ferrous sulfate 140 MG Extended Release Oral Tablet, through Oral route, started on 2017-07-04, presumably until 2017-07-04\n- levothyroxine sodium 0.1 MG Injection, through Intravenous route, started on 2017-07-02, presumably until 2017-07-02\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2017-07-10, presumably until 2017-08-10, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every bedtime as needed\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2017-07-02, presumably until 2017-07-02\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2017-07-01, presumably until 2017-07-02\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2017-07-02, presumably until 2017-07-03\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2017-07-03, presumably until 2017-09-11, with intended 0 refill(s). Instructions: take 1 Tab by mouth every morning with breakfast\n- eplerenone 25 MG Oral Tablet, through Oral route, started on 2017-07-09, presumably until 2017-07-10\n- 50 ML potassium chloride 0.4 MEQ/ML Injection, through Intravenous route, started on 2017-07-05, presumably until 2017-07-05\n- acetaminophen 32 MG/ML Oral Solution, through Oral route, started on 2017-07-05, presumably until 2017-07-10\n- sodium polystyrene sulfonate 250 MG/ML Oral Suspension, through Oral route, started on 2017-07-08, presumably until 2017-07-08\n- 2 ML ondansetron 2 MG/ML Injection, started on 2017-07-02, presumably until 2017-07-10\n- 1 ML ketorolac tromethamine 15 MG/ML Injection, started on 2017-07-06, presumably until 2017-07-09\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2017-07-02, presumably until 2017-07-07\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2017-07-01, presumably until 2017-07-01\n- 100 ML amiodarone hydrochloride 1.5 MG/ML Injection, through Intravenous route, started on 2017-07-03, presumably until 2017-07-07\n- magnesium sulfate 20 MG/ML Injection, through Intravenous route, started on 2017-07-10, presumably until 2017-07-10\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2017-07-02, presumably until 2017-08-11, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed\n- 100 ML clevidipine 0.5 MG/ML Injection, through Intravenous route, started on 2017-07-01, presumably until 2017-07-02\n- ascorbic acid 500 MG Oral Tablet, through Oral route, started on 2017-07-04, presumably until 2017-07-10\n- aluminum hydroxide 40 MG/ML / magnesium hydroxide 40 MG/ML / simethicone 4 MG/ML Oral Suspension, through Oral route, started on 2017-07-07, presumably until 2017-07-07\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2017-07-03, presumably until 2017-07-09\n- ondansetron 8 MG Disintegrating Oral Tablet, through Oral route, started on 2017-07-10, presumably until 2017-07-10\n- 100 ML dexmedetomidine 0.004 MG/ML Injection, through Intravenous route, started on 2017-07-01, presumably until 2017-07-02\n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2017-07-01, presumably until 2017-07-01\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2017-07-06, presumably until 2017-07-07\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-07-06 00:00:00, ended at 2017-07-06 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart valve present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-07-10 00:00:00, ended at 2017-07-10 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pleural effusion\n\n### Drug\n- ondansetron 4 MG Oral Tablet, through Oral route, started on 2017-07-10, presumably until 2017-08-24, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2017-07-14 00:00:00, ended at 2017-07-14 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 19 (millimole per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 4.7 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 7.3 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 96 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 53 (milligram per deciliter)\n- Leukocytes [#/volume] in Body fluid by Manual count: 74 (milli-international unit per milliliter)\n- MCV [Entitic volume] by Automated count: 75.3 (femtoliter)\n- Oxygen [Partial pressure] in Arterial blood: 44.3 (millimeter mercury column)\n- Sodium [Moles/volume] in Serum or Plasma: 126 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 7.4 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 4 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 2.2 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 40 (unit per liter)\n- Base excess in Blood by calculation: -7 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 7.1 (milligram per deciliter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 24.5 (millimeter mercury column)\n- Glucose [Mass/volume] in Serum or Plasma: 156 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 458 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 6.7 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 94 (unit per liter)\n- Base excess in Arterial blood by calculation: -8.9 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 39.4 (percent)\n- Glucose [Mass/volume] in Blood: 448 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 2.60 (thousand per microliter)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 82 (millimeter mercury column)\n- Bicarbonate [Moles/volume] in Specimen: 16.8 (millimole per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.00 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 20 (millimole per liter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 666 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 24.3 (percent)\n- Monocytes [#/volume] in Blood by Manual count: 1.95 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 41.7 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Carbon dioxide [Partial pressure] in Venous blood: 32.1 (millimeter mercury column)\n- Chloride [Moles/volume] in Serum or Plasma: 94 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.47 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.23 (million per microliter)\n- Hemoglobin [Mass/volume] in Arterial blood: 6.8 (gram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 824 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 30.4 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Carbon dioxide [Partial pressure] in Arterial blood: 34.6 (millimeter mercury column)\n- Globulin [Mass/volume] in Serum: 4.9 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 65.1 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 22.9 (picogram)\n- Methemoglobin/Hemoglobin.total in Blood: 1.6 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 62 (percent)\n- Prothrombin time (PT): 25.0 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-07-14 00:00:00, ended at 2017-07-14 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Dyspnea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2017-07-14 10:50:00, ended at 2017-08-11 12:15:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.55 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.72 (million per microliter)\n- Globulin [Mass/volume] in Serum: 4.9 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 11 - 20 (per high power field)\n- Magnesium [Mass/volume] in Serum or Plasma: 3.0 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 6.7 (millimole per liter)\n- Bicarbonate [Moles/volume] in Specimen: 32.5 (millimole per liter)\n- Body height: 5' 4.961\" (inch (US))\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 4 - 5 (per high power field)\n- Heparin unfractionated [Units/volume] in Platelet poor plasma: <0.10 (unit per milliliter)\n- Leukocytes [#/volume] in Body fluid by Manual count: 8 (milli-international unit per milliliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.41 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 27.9 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 27.88 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 86 (percent)\n- Oxygen [Partial pressure] in Arterial blood: 87.1 (millimeter mercury column)\n- Phosphate [Mass/volume] in Serum or Plasma: 7.2 (milligram per deciliter)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 10.7 (percent)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 6.0 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 8.9 (gram per deciliter)\n- Lactate [Moles/volume] in Serum or Plasma: 5.4 (millimole per liter)\n- Left ventricular Ejection fraction: 51.7 (percent)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 127 (unit per liter)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 99 (percent)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 3.703 (nanogram per milliliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- IgA [Mass/volume] in Serum or Plasma: 268 (milligram per deciliter)\n- IgG [Mass/volume] in Serum or Plasma: 1670 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Prothrombin time (PT): 25.6 (second)\n- Thyrotropin [Units/volume] in Serum or Plasma: 2.15 (micro-international unit per milliliter)\n- Base excess in Arterial blood by calculation: 7.9 (millimole per liter)\n- Carbon dioxide [Partial pressure] in Arterial blood: 47.8 (millimeter mercury column)\n- Ferritin [Mass/volume] in Serum or Plasma: 2657.1 (nanogram per milliliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 72.8 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 91.0 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 85.1 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: <10 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.6 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 94 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.18 (thousand per microliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 29.4 (milligram per deciliter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 43.7 (millimeter mercury column)\n- Erythrocyte sedimentation rate: 39 (millimeter per hour)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 10 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 824 (unit per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 148 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: <10 (unit per liter)\n- Base excess in Blood by calculation: 2 (millimole per liter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.59 (millimole per liter)\n- Glucose [Mass/volume] in Blood: 98 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.2 (percent)\n- Iron [Mass/volume] in Serum or Plasma: 47 (microgram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.0 (percent)\n- Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma: >30000 (picogram per milliliter)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 99 (millimeter mercury column)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 29.4 (microgram per milliliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 98.0 (second)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.47 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 42.0 (percent)\n- Erythropoietin (EPO) [Units/volume] in Serum or Plasma: 50.5 (milli-international unit per milliliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 6.19 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 2.08 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Manual count: 5.31 (thousand per microliter)\n- Procalcitonin [Mass/volume] in Serum or Plasma: 62.2 (nanogram per milliliter)\n- Basophils/100 leukocytes in Blood by Automated count: 4 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 7.4 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 3.32 (thousand per microliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 666 (milligram per deciliter)\n- Lactate [Moles/volume] in Blood: 4.9 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 643 (thousand per microliter)\n\n### Procedure\n- Radiologic examination, wrist; complete, minimum of 3 views\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A problem focused interval history; A problem focused examination; Medical decision making that is straightforward or o\n- Echocardiography, transesophageal, real-time with image documentation (2D) (with or without M-mode recording); including probe placement, image acquisition, interpretation and report\n- Continuous inhalation treatment with aerosol medication for acute airway obstruction; first hour\n- Treatment of swallowing dysfunction and/or oral function for feeding\n- Collection of venous blood by venipuncture\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Drainage of Right Pleural Cavity with Drainage Device, Open Approach\n- Physical therapy evaluation: low complexity, requiring these components: A history with no personal factors and/or comorbidities that impact the plan of care; An examination of body system(s) using standardized tests and measures addressing 1-2 elements f\n- Ultrasonography of Right and Left Heart, Transesophageal\n- Introduction of Vasopressor into Peripheral Vein, Percutaneous Approach\n- Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Computed tomography, thorax, diagnostic; without contrast material\n- Arterial puncture, withdrawal of blood for diagnosis\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n- Evaluation of oral and pharyngeal swallowing function\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Occupational therapy evaluation, moderate complexity, requiring these components: An occupational profile and medical and therapy history, which includes an expanded review of medical and/or therapy records and additional review of physical, cognitive, or\n- Replacement of Mitral Valve with Zooplastic Tissue, Open Approach\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Performance of Cardiac Output, Continuous\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Therapeutic procedure, 1 or more areas, each 15 minutes; gait training (includes stair climbing)\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Ultrasound, abdominal, real time with image documentation; limited (eg, single organ, quadrant, follow-up)\n- Continuous inhalation treatment with aerosol medication for acute airway obstruction; each additional hour (List separately in addition to code for primary procedure)\n- Radiologic examination, abdomen; single anteroposterior view\n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n- Computed tomographic angiography, chest (noncoronary), with contrast material(s), including noncontrast images, if performed, and image postprocessing\n- Reposition Coronary Artery, One Artery, Open Approach\n- Drainage of Sternum, Open Approach\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A detailed or comprehensive history; A detailed or comprehensive examination; and Medical decision making that is straightforward or of \n- Level III - Surgical pathology, gross and microscopic examination Abortion, induced Abscess Aneurysm - arterial/ventricular Anus, tag Appendix, other than incidental Artery, atheromatous plaque Bartholin's gland cyst Bone fragment(s), other than pathologi\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Computed tomography, abdomen and pelvis; without contrast material\n- Insertion of peripherally inserted central venous catheter (PICC), without subcutaneous port or pump, without imaging guidance; age 5 years or older\n- Replacement of Thoracic Aorta, Ascending/Arch with Zooplastic Tissue, Open Approach\n- Controlled ventilation procedure and therapy, initiation and management\n- Demonstration and/or evaluation of patient utilization of an aerosol generator, nebulizer, metered dose inhaler or IPPB device\n- Therapeutic procedure, 1 or more areas, each 15 minutes; neuromuscular reeducation of movement, balance, coordination, kinesthetic sense, posture, and/or proprioception for sitting and/or standing activities\n- Re-evaluation of physical therapy established plan of care, requiring these components: An examination including a review of history and use of standardized tests and measures is required; and Revised plan of care using a standardized patient assessment i\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); complete\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Radiologic examination, chest; single view, frontal\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, follow-up or limited study\n- Continuous positive airway pressure ventilation (CPAP), initiation and management\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n\n### Condition\n- Abnormal findings on diagnostic imaging of lung\n- Acute posthemorrhagic anemia\n- Allergic condition\n- Cardiogenic shock\n- Delirium\n- Late effect of complications of procedure\n- Paroxysmal atrial fibrillation\n- Pneumothorax\n- Acute ischemic heart disease\n- Anemia of chronic disease\n- Congestive heart failure\n- Electrocardiogram abnormal\n- Heart disease\n- Hypoxemia\n- Lower abdominal pain\n- Atelectasis\n- Non-rheumatic heart valve disorder\n- Sepsis due to methicillin resistant Staphylococcus aureus\n- Acute pulmonary edema\n- Beta thalassemia\n- Blood coagulation disorder\n- Cardiomegaly\n- Disorder of bilirubin metabolism\n- Disorder of iron metabolism\n- Generalized abdominal pain\n- Heart failure\n- Hypo-osmolality and or hyponatremia\n- Pleural effusion\n- Supraventricular tachycardia\n- Wrist joint pain\n- Abdominal distension, gaseous\n- Acquired absence of spleen\n- Acute on chronic systolic heart failure\n- Gallstone\n- Genetic anomaly of leukocyte\n- Hemoglobin E/beta thalassemia disease\n- Hyperkalemia\n- Osteomyelitis\n- Sepsis\n- Tachycardia\n- Transplanted heart valve present\n- Valvular endocarditis\n- Acquired coagulation factor deficiency\n- Acute hypoxemic respiratory failure\n- Cardiomyopathy\n- Dyspnea\n- Hemochromatosis following repeated red blood cell transfusion\n- Hepatic failure\n- Hereditary hemolytic anemia\n- Postprocedural infection\n- Systemic lupus erythematosus\n- Abdominal tenderness\n- Atrial fibrillation\n- Congenital absence of spleen\n- Fever\n- First degree atrioventricular block\n- Lupus anticoagulant disorder\n- Persistent pain following procedure\n- Pneumonia due to methicillin susceptible Staphylococcus aureus\n- Post-thoracotomy pain syndrome\n- Postoperative seroma\n- Primary diagnosis: Postoperative state\n- Acute tubular necrosis\n- Anemia\n- Bacteremia\n- Chronic pulmonary edema\n- Disorder of mediastinum\n- Disorder of skin and/or subcutaneous tissue\n- Hypothyroidism\n- Illness\n- Infective endocarditis\n- Inflammatory disorder of mediastinum\n- Large liver\n- Septic shock\n- Acute renal failure syndrome\n- Disorder of nasal cavity\n- Hemoglobinopathy\n\n### Drug\n- 0.5 ML filgrastim 0.6 MG/ML Prefilled Syringe, started on 2017-07-23, presumably until 2017-07-29\n- amiodarone hydrochloride 200 MG Oral Tablet, through Oral route, started on 2017-07-24, presumably until 2017-07-26\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2017-07-29, presumably until 2017-08-01\n- 50 ML sodium bicarbonate 84 MG/ML Injection, through Intravenous route, started on 2017-07-14, presumably until 2017-07-14\n- famotidine 20 MG Oral Tablet, through Oral route, started on 2017-08-03, presumably until 2017-08-11\n- folic acid 1 MG Oral Tablet, through Oral route, started on 2017-07-30, presumably until 2017-08-11\n- guaifenesin 20 MG/ML Oral Solution, through Oral route, started on 2017-08-03, presumably until 2017-08-03\n- vancomycin 1000 MG Injection, through Intravenous route, started on 2017-07-14, presumably until 2017-08-10\n- 100 ML milrinone lactate 0.2 MG/ML Injection, through Intravenous route, started on 2017-07-14, presumably until 2017-07-14\n- 1 ML ketorolac tromethamine 30 MG/ML Injection, started on 2017-07-27, presumably until 2017-07-27\n- gabapentin 50 MG/ML Oral Solution, through Oral route, started on 2017-07-31, presumably until 2017-08-02\n- 50 ML potassium chloride 0.2 MEQ/ML Injection, through Intravenous route, started on 2017-08-04, presumably until 2017-08-05\n- chlorhexidine gluconate 1.2 MG/ML Mouthwash, through Submucosal route, started on 2017-07-29, presumably until 2017-08-01\n- rifampin 300 MG Oral Capsule, through Oral route, started on 2017-07-23, presumably until 2017-08-20, with intended 0 refill(s). Instructions: take 3 Caps by mouth every day\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2017-08-10, presumably until 2017-08-20, with intended 0 refill(s). Instructions: take 2 Tabs by mouth 2 times a day For 2 weeks, then 1 tab po BID for 2 weeks then stop\n- 100 ML potassium chloride 0.1 MEQ/ML Injection, through Intravenous route, started on 2017-08-03, presumably until 2017-08-03\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2017-07-16, presumably until 2017-07-29\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2017-08-02, presumably until 2017-08-10\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, presumably until 2017-08-17, with intended 0 refill(s). Instructions: 1 Spray by Nasal route 2 times a day as needed\n- naloxone hydrochloride 0.4 MG/ML Injectable Solution, started on 2017-07-29, presumably until 2017-07-29\n- docusate sodium 10 MG/ML Oral Solution, through Oral route, started on 2017-07-18, presumably until 2017-08-01\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2017-07-15, presumably until 2023-01-05, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every 4 hours as needed\n- melatonin 1 MG Oral Tablet, through Oral route, started on 2017-07-31, presumably until 2017-08-10\n- potassium chloride 20 MEQ Powder for Oral Solution, through Oral route, started on 2017-08-05, presumably until 2017-08-10\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2017-07-30, presumably until 2017-07-30\n- mineral oil 0.15 MG/MG / petrolatum 0.83 MG/MG Ophthalmic Ointment, through Intraocular route, started on 2017-07-31, presumably until 2017-08-01\n- trazodone hydrochloride 50 MG Oral Tablet, through Oral route, started on 2017-07-31, presumably until 2017-07-31\n- vancomycin 500 MG Injection, through Intravenous route, started on 2017-07-27, presumably until 2017-07-27\n- oxymetazoline hydrochloride 0.5 MG/ML Nasal Spray, through Nasal route, started on 2017-07-29, presumably until 2017-07-29\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2017-07-14, presumably until 2017-08-07\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2017-07-25, presumably until 2017-08-11\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2017-07-18, presumably until 2017-07-29\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2017-08-10, presumably until 2017-08-17, with intended 0 refill(s). Instructions: take 4 Tabs by mouth 2 times a day 40 meq twice daily for 2 weeks, then 20 meq BID for 2 weeks.\n- levothyroxine sodium 0.125 MG Oral Tablet, through Oral route, started on 2017-07-25, presumably until 2017-07-26\n- deferasirox 360 MG Oral Tablet, through Oral route, started on 2017-07-29, presumably until 2017-08-07\n- 250 ML norepinephrine 0.016 MG/ML Injection, through Intravenous route, started on 2017-07-14, presumably until 2017-07-16\n- quetiapine 25 MG Oral Tablet, through Oral route, started on 2017-07-31, presumably until 2017-08-10\n- melatonin 3 MG Oral Tablet, through Oral route, started on 2017-07-31, presumably until 2017-08-10\n- magnesium hydroxide 80 MG/ML Oral Suspension, through Oral route, started on 2017-08-01, presumably until 2017-08-01\n- insulin isophane, human 100 UNT/ML Injectable Suspension, through Subcutaneous route, started on 2017-07-30, presumably until 2017-08-03\n- 10 ML furosemide 10 MG/ML Injection, started on 2017-07-14, presumably until 2017-08-11\n- levothyroxine sodium 0.1 MG Oral Tablet, through Oral route, started on 2017-07-27, presumably until 2017-08-11\n- levothyroxine sodium 0.025 MG Oral Tablet, through Oral route, started on 2017-07-27, presumably until 2017-08-11\n- oxycodone hydrochloride 1 MG/ML Oral Solution, through Oral route, started on 2017-07-15, presumably until 2017-08-11\n- levothyroxine sodium 0.1 MG Injection, through Intravenous route, started on 2017-07-14, presumably until 2017-07-24\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2017-07-30, presumably until 2017-08-01\n- chlorothiazide 500 MG Injection, through Intravenous route, started on 2017-07-14, presumably until 2017-07-20\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2017-08-03, presumably until 2017-08-24, with intended 0 refill(s). Instructions: take 1 Cap by mouth 3 times a day 1 week, then 300mg BID for 1 week, then 300mg DAILY for 1 week, then stop\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2017-07-14, presumably until 2017-08-02\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2017-07-14, presumably until 2017-07-14\n- 2 ML famotidine 10 MG/ML Injection, through Intravenous route, started on 2017-07-29, presumably until 2017-08-03\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2017-07-18, presumably until 2017-08-11\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2017-07-14, presumably until 2017-07-14\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2017-07-16, presumably until 2017-08-11\n- 50 ML glucose 500 MG/ML Prefilled Syringe, through Intravenous route, started on 2017-07-14, presumably until 2017-07-18\n- 50 ML potassium chloride 0.4 MEQ/ML Injection, through Intravenous route, started on 2017-07-17, presumably until 2017-07-27\n- acetaminophen 32 MG/ML Oral Solution, through Oral route, started on 2017-07-21, presumably until 2017-08-09\n- 2 ML ondansetron 2 MG/ML Injection, started on 2017-07-18, presumably until 2017-08-10\n- 1 ML ketorolac tromethamine 15 MG/ML Injection, started on 2017-07-19, presumably until 2017-08-04\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2017-07-14, presumably until 2017-08-11\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2017-07-16, presumably until 2017-07-27\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2017-08-10, presumably until 2017-08-10\n- magnesium sulfate 20 MG/ML Injection, through Intravenous route, started on 2017-07-19, presumably until 2017-08-11\n- chlorothiazide 250 MG Oral Tablet, through Oral route, started on 2017-07-24, presumably until 2017-07-29\n- loratadine 10 MG Oral Tablet, through Oral route, started on 2017-07-23, presumably until 2017-07-29\n- 1 ML epoetin alfa 40000 UNT/ML Injection, started on 2017-07-27, presumably until 2017-08-10\n- gabapentin 100 MG Oral Capsule, through Oral route, started on 2017-07-27, presumably until 2017-08-05\n- 100 ML propofol 10 MG/ML Injection, through Intravenous route, started on 2017-07-18, presumably until 2017-07-18\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2017-07-30, presumably until 2017-08-20, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed for Pain Take 1-2 tabs q 6 hours for pain\n- 100 ML clevidipine 0.5 MG/ML Injection, through Intravenous route, started on 2017-07-29, presumably until 2017-07-29\n- bumetanide 0.25 MG/ML Injectable Solution, through Intravenous route, started on 2017-07-14, presumably until 2017-07-14\n- glucose 4000 MG Chewable Tablet, through Oral route, started on 2017-07-18, presumably until 2017-07-29\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2017-07-30, presumably until 2017-07-30\n- sodium chloride 6.5 MG/ML Nasal Spray, through Nasal route, started on 2017-08-02, presumably until 2017-08-02\n- 100 ML dexmedetomidine 0.004 MG/ML Injection, through Intravenous route, started on 2017-07-29, presumably until 2017-07-30\n- alteplase 1 MG/ML Injectable Solution, through Intraluminal route, started on 2017-08-06, presumably until 2017-08-06\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2017-07-17, presumably until 2017-08-10\n- cefazolin 2000 MG Injection, through Intravenous route, started on 2017-07-15, presumably until 2017-07-31\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2017-07-18 00:00:00, ended at 2017-07-18 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for sternal debridement\n\n### Condition\n- Hypothyroidism\n- Paroxysmal atrial fibrillation\n- Postprocedural infection\n- Sepsis\n- Beta thalassemia\n\n### Drug\n- 10 ML furosemide 10 MG/ML Injection, started on 2017-07-18, presumably until 2017-07-18\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2017-07-18, presumably until 2017-07-18\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2017-07-18, presumably until 2017-07-18\n- midazolam 1 MG/ML Injectable Solution, started on 2017-07-18, presumably until 2017-07-18\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2017-07-18 00:00:00, ended at 2017-07-18 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- vancomycin 1000 MG Injection, through Intravenous route, started on 2017-07-18, presumably until 2017-07-18\n- gentamicin 40 MG/ML Injectable Solution, through Intravenous route, started on 2017-07-18, presumably until 2017-07-18\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-07-19 00:00:00, ended at 2017-07-19 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Cardiomyopathy\n- Lupus anticoagulant disorder\n- Rheumatic disease of mitral AND aortic valves\n- Acquired absence of spleen\n- Hemochromatosis following repeated red blood cell transfusion\n- Beta thalassemia\n\n### Drug\n- hydrochlorothiazide 25 MG / spironolactone 25 MG Oral Tablet, started on 2017-07-20, presumably until 2017-08-10, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-07-26 00:00:00, ended at 2017-07-26 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Cardiomyopathy\n- Atrial fibrillation\n- Atrial flutter\n- Electrocardiogram abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-07-28 00:00:00, ended at 2017-07-28 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Illness\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2017-07-28 00:00:00, ended at 2017-07-28 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sodium chloride 0.154 MEQ/ML Irrigation Solution, through Topical route, started on 2017-07-28, presumably until 2017-07-28\n- rifampin 600 MG Injection, through Intravenous route, started on 2017-07-28, presumably until 2017-07-28\n- povidone-iodine 50 MG/ML Ophthalmic Solution, through Intraocular route, started on 2017-07-28, presumably until 2017-07-28\n- thrombin, bovine 2000 UNT/ML Topical Solution, through Topical route, started on 2017-07-28, presumably until 2017-07-28\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2017-07-28 00:00:00, ended at 2017-07-28 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for procedures on heart, pericardial sac, and great vessels of chest; with pump oxygenator, age 1 year or older, for all noncoronary bypass procedures (eg, valve procedures) or for re-operation for coronary bypass more than 1 month after origin\n- Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous\n- Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); follow-up or limited study (List separately in addition to codes for echocardiographic imaging)\n- Echocardiography, transesophageal, real-time with image documentation (2D) (with or without M-mode recording); including probe placement, image acquisition, interpretation and report\n- Insertion of non-tunneled centrally inserted central venous catheter; age 5 years or older\n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n\n### Condition\n- Pleural effusion\n- Pneumothorax\n- Valvular endocarditis\n\n### Drug\n- hydrocortisone 100 MG Injection, started on 2017-07-28, presumably until 2017-07-28\n- 10 ML calcium chloride 100 MG/ML Injection, through Intravenous route, started on 2017-07-28, presumably until 2017-07-28\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2017-07-28, presumably until 2017-07-28\n- vancomycin 1000 MG Injection, through Intravenous route, started on 2017-07-28, presumably until 2017-07-28\n- 10 ML epinephrine 0.1 MG/ML Prefilled Syringe, through Intravenous route, started on 2017-07-28, presumably until 2017-07-28\n- rifampin 600 MG Injection, through Intravenous route, started on 2017-07-28, presumably until 2017-07-28\n- anti-inhibitor coagulant complex 1 UNT Injection, through Intravenous route, started on 2017-07-28, presumably until 2017-07-28\n- cefazolin 1000 MG Injection, started on 2017-07-28, presumably until 2017-07-28\n- 250 ML norepinephrine 0.016 MG/ML Injection, through Intravenous route, started on 2017-07-28, presumably until 2017-07-28\n- 10 ML furosemide 10 MG/ML Injection, started on 2017-07-28, presumably until 2017-07-28\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2017-07-28, presumably until 2017-07-28\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2017-07-28, presumably until 2017-07-28\n- vasopressin (USP) 20 UNT/ML Injectable Solution, through Intravenous route, started on 2017-07-28, presumably until 2017-07-28\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2017-07-28, presumably until 2017-07-28\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2017-07-28, presumably until 2017-07-28\n- 6-aminocaproic acid 250 MG/ML Injectable Solution, through Intravenous route, started on 2017-07-28, presumably until 2017-07-28\n- 2 ML dexmedetomidine 0.1 MG/ML Injection, through Intravenous route, started on 2017-07-28, presumably until 2017-07-28\n- midazolam 1 MG/ML Injectable Solution, started on 2017-07-28, presumably until 2017-07-29\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-08-17 00:00:00, ended at 2017-08-17 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2017-08-17, presumably until 2018-10-09, with intended 3 refill(s). Instructions: 3 mL by Nebulization route every 6 hours as needed\n- potassium chloride 1.33 MEQ/ML Oral Solution, started on 2017-08-17, presumably until 2017-08-20, with intended 0 refill(s). Instructions: Take 30ml two times a day for 2 weeks. Then take 15ml two times a day for 2 weeks.\n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2017-08-17, presumably until 2018-08-17, with intended 3 refill(s). Instructions: 2 Puffs by Inhalation route every 6 hours as needed (coughing)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-08-17 00:00:00, ended at 2017-08-17 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Blood chemistry abnormal\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2017-08-17 16:56:00, ended at 2017-08-20 14:06:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- C reactive protein [Mass/volume] in Serum or Plasma: 3.9 (milligram per deciliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 2.4 (ratio)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 4.3 (ratio)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.04 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 8.7 (gram per deciliter)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 5.68 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 128 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 25 (millimeter per hour)\n- Ferritin [Mass/volume] in Serum or Plasma: 1300.6 (nanogram per milliliter)\n- Glucose [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.1 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 31.1 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.52 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 74 (percent)\n- Reticulocytes [#/volume] in Blood by Automated count: 209.2 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 72 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 1.30 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 23.6 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 8 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.68 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 2.22 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.6 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.8 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 95 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 33.0 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 3 - 5 (per high power field)\n- MCV [Entitic volume] by Automated count: 76.3 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma: 2116 (picogram per milliliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.2 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 128 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 30 (milligram per deciliter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 14 (unit per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Leukocytes [#/volume] in Body fluid by Manual count: 291 (milli-international unit per milliliter)\n- Prothrombin time (PT): 15.9 (second)\n- Basophils/100 leukocytes in Blood by Automated count: 4 (percent)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Body height: 5' 5\" (inch (US))\n- Eosinophils/100 leukocytes in Blood by Automated count: 7 (percent)\n- Iron [Mass/volume] in Serum or Plasma: 96 (microgram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 614 (thousand per microliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 2.93 (micro-international unit per milliliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.1 (percent)\n\n### Procedure\n- Occupational therapy evaluation, low complexity, requiring these components: An occupational profile and medical and therapy history, which includes a brief history including review of medical and/or therapy records relating to the presenting problem; An \n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n- Physical therapy evaluation: low complexity, requiring these components: A history with no personal factors and/or comorbidities that impact the plan of care; An examination of body system(s) using standardized tests and measures addressing 1-2 elements f\n- Therapeutic procedure, 1 or more areas, each 15 minutes; gait training (includes stair climbing)\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of moderate complexity. Counseling and/or coordination\n- Hospital discharge day management; 30 minutes or less\n- Radiologic examination, chest; single view, frontal\n\n### Condition\n- Acute osteomyelitis\n- Chronic osteomyelitis\n- Non-rheumatic heart valve disorder\n- Postoperative state\n- Tachycardia\n- Acquired absence of spleen\n- Chronic pulmonary edema\n- Congestive heart failure\n- Paroxysmal atrial fibrillation\n- Disorder of prosthetic cardiac valve\n- Disorder of vein\n- Beta thalassemia\n- Hypokalemia\n- Infection by methicillin sensitive Staphylococcus aureus\n- Acute on chronic combined systolic and diastolic heart failure\n- Acute on chronic diastolic heart failure\n- Generalized skin eruption caused by drug and medicament\n- Heart failure\n- Primary diagnosis: Infective endocarditis\n- Localized edema\n- Lupus anticoagulant disorder\n- Hypothyroidism\n- Transplanted heart valve present\n\n### Drug\n- folic acid 1 MG Oral Tablet, through Oral route, started on 2017-08-17, presumably until 2017-08-20\n- daptomycin 500 MG Injection, through Intravenous route, started on 2017-08-18, presumably until 2017-08-20\n- rifampin 300 MG Oral Capsule, through Oral route, started on 2017-08-17, presumably until 2017-09-14, with intended 0 refill(s). Instructions: take 1 Cap by mouth 3 times a day after meals for 25 days\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2017-08-18, presumably until 2017-08-20\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2017-08-17, presumably until 2017-08-18\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2017-08-18, presumably until 2017-08-19\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2017-08-17, presumably until 2017-08-18\n- levothyroxine sodium 0.125 MG Oral Tablet, through Oral route, started on 2017-08-18, presumably until 2017-08-20\n- deferasirox 360 MG Oral Tablet, through Oral route, started on 2017-08-18, presumably until 2017-08-20\n- furosemide 40 MG Oral Tablet, through Oral route, started on 2017-08-20, presumably until 2017-11-11, with intended 3 refill(s). Instructions: take 2 Tabs by mouth every morning\n- melatonin 3 MG Oral Tablet, through Oral route, started on 2017-08-20, presumably until 2017-12-30, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every bedtime as needed\n- 10 ML furosemide 10 MG/ML Injection, started on 2017-08-17, presumably until 2017-08-20\n- oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2017-08-20, presumably until 2017-09-04, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2017-08-17, presumably until 2017-08-17\n- potassium chloride 1.33 MEQ/ML Oral Solution, through Oral route, started on 2017-08-20, presumably until 2018-03-29, with intended 0 refill(s). Instructions: take 15 mL by mouth daily\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2017-08-17, presumably until 2017-08-20\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2017-08-18, presumably until 2017-08-20\n- carvedilol 3.125 MG Oral Tablet, through Oral route, started on 2017-08-18, presumably until 2017-08-19\n- carvedilol 6.25 MG Oral Tablet, through Oral route, started on 2017-08-20, presumably until 2017-09-16, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- 2 ML ondansetron 2 MG/ML Injection, started on 2017-08-17, presumably until 2017-08-20\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2017-08-17, presumably until 2017-08-19\n- magnesium sulfate 20 MG/ML Injection, through Intravenous route, started on 2017-08-17, presumably until 2017-08-19\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2017-08-17, presumably until 2017-08-20\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2017-08-18, presumably until 2017-08-19\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2017-08-17, presumably until 2017-08-17\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-08-28 00:00:00, ended at 2017-08-28 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Heart failure\n- Malaise\n- Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-09-01 15:00:00, ended at 2017-09-01 23:59:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Glucose [Mass/volume] in Serum or Plasma: 112 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 74 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 68.6 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.9 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 1351 (unit per liter)\n- Erythrocyte sedimentation rate: 34 (millimeter per hour)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.7 (percent)\n- MCHC [Mass/volume] by Automated count: 32.5 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 22 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 37.6 (percent)\n- Globulin [Mass/volume] in Serum: 5.2 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 503 (thousand per microliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.73 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.6 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.90 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 8.7 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 93 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 97 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 22.3 (picogram)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hemoglobin E/beta thalassemia disease\n- Infective endocarditis\n- Acute insomnia\n- Beta thalassemia\n- Postoperative state\n- Transplanted heart valve present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-09-02 00:00:00, ended at 2017-09-02 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Heart failure\n- Chest pain\n\n### Drug\n- ondansetron 4 MG Oral Tablet, through Oral route, started on 2017-09-02, presumably until 2018-08-26, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2017-09-02, presumably until 2018-03-01, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-09-04 13:24:35, ended at 2017-09-04 15:48:53\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); each additional vaccine (single or combination vaccine/toxoid) (List separately in addition to code for primary procedure)\n\n### Condition\n- Acquired absence of spleen\n- Primary diagnosis: Congenital absence of spleen\n- Postoperative state\n- Beta thalassemia\n- Cardiomyopathy\n- Disorder of bilirubin metabolism\n- Hemochromatosis following repeated red blood cell transfusion\n- Transplanted heart valve present\n- Heart failure\n- Infective endocarditis\n- Hereditary hemolytic anemia\n\n### Drug\n- 0.5 ML meningococcal group B vaccine 0.1 MG/ML / Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen 0.1 MG/ML / Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen 0.1 MG/ML / Neisseria meningitidis serogr..., through Intramuscular route, started on 2017-09-04, presumably until 2017-09-04, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time\n- meningococcal group A polysaccharide 0.1 MG/ML / meningococcal group C polysaccharide 0.1 MG/ML / meningococcal polysaccharide vaccine group W-135 0.1 MG/ML / meningococcal polysaccharide vaccine group Y 0.1 MG/ML Injectable Solution, through Subcutaneous route, started on 2017-09-04, presumably until 2017-09-04, with intended 0 refill(s). Instructions: inject 0.5 mL subcutaneous (under the skin) One Time\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-09-10 00:00:00, ended at 2017-09-10 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2017-09-11, presumably until 2017-10-06, with intended 0 refill(s). Instructions: take 1 Tab by mouth every morning before breakfast\n- acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2017-09-11, presumably until 2017-09-23, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed for Pain (7-10/10 pain)\n- gabapentin 100 MG Oral Capsule, through Oral route, started on 2017-09-11, presumably until 2017-09-24, with intended 0 refill(s). Instructions: take 1 Cap by mouth 3 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-09-11 00:00:00, ended at 2017-09-11 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chest pain\n- Heart failure\n\n### Drug\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2017-09-11, presumably until 2017-11-03, with intended 11 refill(s). Instructions: take 1 Tab by mouth every morning with breakfast\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-09-14 15:24:06, ended at 2017-09-14 16:26:20\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Varicose veins of lower extremity with inflammation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-09-16 00:00:00, ended at 2017-09-16 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- carvedilol 6.25 MG Oral Tablet, through Oral route, started on 2017-09-16, presumably until 2017-11-03, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-09-22 14:21:00, ended at 2017-09-22 23:59:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Glucose [Mass/volume] in Serum or Plasma: 114 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 30.2 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.96 (million per microliter)\n- Globulin [Mass/volume] in Serum: 5.1 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 482 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.8 (gram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 22 (millimeter per hour)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 113 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 19.2 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 19.6 (picogram)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.63 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 25.7 (percent)\n- Hemoglobin [Mass/volume] in Blood: 7.8 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 65.0 (femtoliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Transfusion, blood or blood components\n\n### Condition\n- Transplanted heart valve present\n- Infective endocarditis\n- Postoperative state\n- Beta thalassemia\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2017-09-22, presumably until 2017-09-22\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2017-09-22, presumably until 2017-09-22\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-09-24 07:00:00, ended at 2017-09-24 23:59:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Transfusion, blood or blood components\n\n### Condition\n- Beta thalassemia\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2017-09-24, presumably until 2017-09-24\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2017-09-24, presumably until 2017-09-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-09-24 10:28:36, ended at 2017-09-24 14:26:23\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5.039\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Infective endocarditis\n\n### Drug\n- gabapentin 100 MG Oral Capsule, through Oral route, started on 2017-09-24, presumably until 2017-10-06, with intended 0 refill(s). Instructions: take 1 Cap by mouth 3 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-09-30 00:00:00, ended at 2017-09-30 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Lupus anticoagulant disorder\n- Acquired absence of spleen\n- Cardiomyopathy\n- Hemochromatosis following repeated red blood cell transfusion\n- Rheumatic disease of mitral AND aortic valves\n- Beta thalassemia\n\n### Drug\n- hydrochlorothiazide 25 MG / spironolactone 25 MG Oral Tablet, started on 2017-09-30, presumably until 2017-09-30, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-09-30 14:04:55, ended at 2017-09-30 15:59:32\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); each additional vaccine (single or combination vaccine/toxoid) (List separately in addition to code for primary procedure)\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n\n### Condition\n- Infection by methicillin sensitive Staphylococcus aureus\n- Late effect of medical and surgical care complication\n- Primary diagnosis: Acquired absence of spleen\n\n### Drug\n- levofloxacin 500 MG Oral Tablet, through Oral route, started on 2017-09-30, presumably until 2017-10-05, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily for 5 doses\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-10-06 00:00:00, ended at 2017-10-06 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2017-10-08, presumably until 2018-10-08, with intended 3 refill(s). Instructions: take 1 Tab by mouth every morning before breakfast\n- gabapentin 100 MG Oral Capsule, through Oral route, started on 2017-10-08, presumably until 2017-10-20, with intended 3 refill(s). Instructions: take 1 Cap by mouth 3 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-10-22 00:00:00, ended at 2017-10-22 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-10-22 00:00:00, ended at 2017-10-22 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute insomnia\n\n### Drug\n- zolpidem tartrate 10 MG Oral Tablet, through Oral route, started on 2017-10-22, presumably until 2017-11-24, with intended 0 refill(s). Instructions: take 1 Tab by mouth every bedtime as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-11-01 00:00:00, ended at 2017-11-01 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- furosemide 40 MG Oral Tablet, through Oral route, started on 2017-11-11, presumably until 2018-09-06, with intended 12 refill(s). Instructions: take 2 Tabs by mouth every morning\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-11-03 00:00:00, ended at 2017-11-03 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- furosemide 40 MG Oral Tablet, through Oral route, started on 2017-11-03, presumably until 2017-11-11, with intended 12 refill(s). Instructions: take 1 Tab by mouth daily in the evening\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2017-11-03, presumably until 2018-09-14, with intended 12 refill(s). Instructions: take 1 Tab by mouth every morning with breakfast\n- carvedilol 6.25 MG Oral Tablet, through Oral route, started on 2017-11-03, presumably until 2018-09-14, with intended 12 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-11-22 13:21:00, ended at 2017-11-22 23:59:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 7.6 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.5 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 30.6 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Prothrombin time (PT): 15.4 (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 7.2 (gram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 82 (percent)\n- MCV [Entitic volume] by Automated count: 69.9 (femtoliter)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 14.05 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 132 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Ferritin [Mass/volume] in Serum or Plasma: 1718.8 (nanogram per milliliter)\n- Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin: 166 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.4 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Monocytes [#/volume] in Blood by Manual count: 0.88 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.4 (gram per deciliter)\n- Reticulocytes [#/volume] in Blood by Automated count: 476.5 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Leukocytes [#/volume] in Body fluid by Manual count: 763 (milli-international unit per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.1 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 573 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 33.2 (second)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.63 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 106 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 23.7 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.6 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 36.7 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.39 (million per microliter)\n- Iron [Mass/volume] in Serum or Plasma: 248 (microgram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 5.50 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.63 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 21.4 (picogram)\n- Neutrophils/100 leukocytes in Blood by Manual count: 31 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 44 (percent)\n\n### Procedure\n- Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; read by instrument assisted direct optical observation (eg, utilizing immunoassay [eg, dipsticks, cups, cards, or cartridges]), includes sample validation when per\n- Collection of venous blood by venipuncture\n\n### Condition\n- Postoperative state\n- Transplanted heart valve present\n- Blood chemistry abnormal\n- Disorder of bilirubin metabolism\n- Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-11-24 00:00:00, ended at 2017-11-24 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-11-24 00:00:00, ended at 2017-11-24 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-11-24 00:00:00, ended at 2017-11-24 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute insomnia\n\n### Drug\n- zolpidem tartrate 10 MG Oral Tablet, through Oral route, started on 2017-11-24, presumably until 2017-12-29, with intended 0 refill(s). Instructions: take 1 Tab by mouth every bedtime as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-11-24 00:00:00, ended at 2017-11-24 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-11-24 12:30:00, ended at 2017-11-24 23:59:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5.039\" (inch (US))\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n\n### Procedure\n- Transfusion, blood or blood components\n\n### Condition\n- Beta thalassemia\n- Hemochromatosis following repeated red blood cell transfusion\n- Primary diagnosis: Disorder of bilirubin metabolism\n- Hemoglobin E/beta thalassemia disease\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2017-11-24, presumably until 2017-11-24\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2017-11-24, presumably until 2017-11-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-12-09 00:00:00, ended at 2017-12-09 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of iron metabolism\n- Beta thalassemia\n\n### Drug\n- deferasirox 360 MG Oral Tablet, through Oral route, started on 2017-12-09, presumably until 2017-12-15, with intended 5 refill(s). Instructions: take 1,530 mg by mouth every day Weight: 65.5 kg\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-12-15 00:00:00, ended at 2017-12-15 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute renal failure syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-12-18 14:31:37, ended at 2017-12-18 16:30:49\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 6.7 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 101 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 28 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.71 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 122 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 8.9 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hemochromatosis following repeated red blood cell transfusion\n- Disorder of bilirubin metabolism\n- Infective endocarditis\n- Primary diagnosis: Postoperative state\n- Transplanted heart valve present\n- Congenital absence of spleen\n- Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-12-22 00:00:00, ended at 2017-12-22 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Infective endocarditis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-12-29 00:00:00, ended at 2017-12-29 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hereditary hemolytic anemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-12-29 00:00:00, ended at 2017-12-29 00:00:00\nThe patient in this visit was 37 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute insomnia\n\n### Drug\n- zolpidem tartrate 10 MG Oral Tablet, through Oral route, started on 2017-12-29, presumably until 2018-01-28, with intended 0 refill(s). Instructions: take 1 Tab by mouth every bedtime as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-01-06 00:00:00, ended at 2018-01-06 00:00:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n- Disorder of iron metabolism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-01-12 08:41:23, ended at 2018-01-12 09:46:22\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acquired absence of spleen\n- Disorder of bilirubin metabolism\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-01-12 10:33:00, ended at 2018-01-12 23:59:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 6.7 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.73 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.25 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 4.2 (gram per deciliter)\n- Iron [Mass/volume] in Serum or Plasma: 324 (microgram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 22.4 (picogram)\n- Monocytes [#/volume] in Blood by Manual count: 1.51 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 8.8 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 7.4 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 24.9 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 669 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 105 (unit per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Erythrocyte sedimentation rate: 6 (millimeter per hour)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 36 (milligram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 58 (percent)\n- Lymphocytes [#/volume] in Blood by Manual count: 9.32 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 37 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.33 (million per microliter)\n- MCV [Entitic volume] by Automated count: 74.8 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 50 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 130 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 7.5 (gram per deciliter)\n- Leukocytes [#/volume] in Body fluid by Manual count: 327 (milli-international unit per milliliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 25.2 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 36.7 (percent)\n- Ferritin [Mass/volume] in Serum or Plasma: 1216.5 (nanogram per milliliter)\n- MCHC [Mass/volume] by Automated count: 29.9 (gram per deciliter)\n\n### Procedure\n- Transfusion, blood or blood components\n- Collection of venous blood by venipuncture\n\n### Condition\n- Disorder of iron metabolism\n- Hereditary hemolytic anemia\n- Infective endocarditis\n- Beta thalassemia\n- Disorder of bilirubin metabolism\n- Hemochromatosis following repeated red blood cell transfusion\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2018-01-12, presumably until 2018-01-12\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2018-01-12, presumably until 2018-01-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-01-12 16:17:17, ended at 2018-01-12 17:18:45\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- IgA [Mass/volume] in Serum or Plasma: 200 (milligram per deciliter)\n- IgG [Mass/volume] in Serum or Plasma: 2050 (milligram per deciliter)\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hemochromatosis following repeated red blood cell transfusion\n- Hereditary hemolytic anemia\n- Disorder of bilirubin metabolism\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-01-13 00:00:00, ended at 2018-01-13 00:00:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Stress\n- Primary diagnosis: Beta thalassemia\n- Emotional state finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-01-28 00:00:00, ended at 2018-01-28 00:00:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute insomnia\n\n### Drug\n- zolpidem tartrate 10 MG Oral Tablet, through Oral route, started on 2018-01-28, presumably until 2018-03-01, with intended 1 refill(s). Instructions: take 1 Tab by mouth every bedtime as needed for Insomnia\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-02-05 08:35:42, ended at 2018-02-05 09:56:41\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Major depression, single episode\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-03-01 00:00:00, ended at 2018-03-01 00:00:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Insomnia\n\n### Drug\n- zolpidem tartrate 10 MG Oral Tablet, through Oral route, started on 2018-03-01, presumably until 2018-03-31, with intended 1 refill(s). Instructions: take 1 Tab by mouth every bedtime as needed for Insomnia\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-03-09 14:43:00, ended at 2018-03-09 23:59:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Leukocytes [#/volume] in Body fluid by Manual count: 411 (milli-international unit per milliliter)\n- Reticulocytes [#/volume] in Blood by Automated count: 154.0 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 23.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 42 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Iron [Mass/volume] in Serum or Plasma: 309 (microgram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 43 (percent)\n- MCHC [Mass/volume] by Automated count: 30.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 72.1 (femtoliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.79 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 614 (thousand per microliter)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 4.68 (percent)\n- Lymphocytes [#/volume] in Blood by Manual count: 12.81 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 35.0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.29 (million per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 615.9 (nanogram per milliliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 73 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 29.8 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 22.1 (picogram)\n- Hemoglobin [Mass/volume] in Blood: 7.3 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Infective endocarditis\n- Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-03-09 14:50:47, ended at 2018-03-09 16:32:12\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 6.3 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 94 (unit per liter)\n- Body height: 5' 5\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.05 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.6 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 39 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 85 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 35 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.1 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hemochromatosis following repeated red blood cell transfusion\n- Acquired absence of spleen\n- Primary diagnosis: Beta thalassemia\n- Hereditary hemolytic anemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-03-10 00:00:00, ended at 2018-03-10 00:00:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Beta thalassemia\n- Anemia\n- Primary diagnosis: Hemochromatosis following repeated red blood cell transfusion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-03-10 12:20:00, ended at 2018-03-10 23:59:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Transfusion, blood or blood components\n\n### Condition\n- Hemochromatosis following repeated red blood cell transfusion\n- Acquired absence of spleen\n- Hereditary hemolytic anemia\n- Beta thalassemia\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2018-03-10, presumably until 2018-03-10\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2018-03-10, presumably until 2018-03-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-03-11 00:00:00, ended at 2018-03-11 00:00:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n- Hemochromatosis following repeated red blood cell transfusion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-03-12 00:00:00, ended at 2018-03-12 00:00:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- potassium chloride 1.33 MEQ/ML Oral Solution, through Oral route, started on 2018-03-29, presumably until 2018-11-08, with intended 3 refill(s). Instructions: take 15 mL by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-03-25 11:59:41, ended at 2018-03-25 13:51:38\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypertrophic scar\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-03-31 00:00:00, ended at 2018-03-31 00:00:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- zolpidem tartrate 10 MG Oral Tablet, through Oral route, started on 2018-03-31, presumably until 2018-06-04, with intended 1 refill(s). Instructions: take 1 Tab by mouth every bedtime as needed for Insomnia\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-04-01 00:00:00, ended at 2018-04-01 00:00:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of iron metabolism\n- Beta thalassemia\n\n### Drug\n- deferasirox 360 MG Oral Tablet, through Oral route, started on 2018-04-01, presumably until 2019-02-02, with intended 5 refill(s). Instructions: take 1,080 mg by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-04-05 00:00:00, ended at 2018-04-05 00:00:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-04-08 00:00:00, ended at 2018-04-08 00:00:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- levothyroxine sodium 0.125 MG Oral Tablet, through Oral route, started on 2018-04-08, presumably until 2018-12-17, with intended 12 refill(s). Instructions: take 1 Tab by mouth every morning before breakfast\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-04-22 07:17:00, ended at 2018-04-22 23:59:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s)\n- Cardiac magnetic resonance imaging for morphology and function without contrast material\n\n### Condition\n- Hemochromatosis\n- Beta thalassemia\n- Hemochromatosis following repeated red blood cell transfusion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-04-27 00:00:00, ended at 2018-04-27 00:00:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-04-27 00:00:00, ended at 2018-04-27 00:00:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hemochromatosis following repeated red blood cell transfusion\n- Anemia\n- Beta thalassemia\n\n### Drug\n- deferiprone 500 MG Oral Tablet, through Oral route, started on 2018-04-27, presumably until 2019-04-04, with intended 3 refill(s). Instructions: take 1,500 mg by mouth 3 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-05-03 00:00:00, ended at 2018-05-03 00:00:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-05-09 14:24:00, ended at 2018-05-09 23:59:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- MCH [Entitic mass] by Automated count: 20.2 (picogram)\n- Leukocytes [#/volume] in Body fluid by Manual count: 274 (milli-international unit per milliliter)\n- MCHC [Mass/volume] by Automated count: 29.7 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.31 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 30.9 (percent)\n- MCV [Entitic volume] by Automated count: 68.0 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7 (percent)\n- Monocytes [#/volume] in Blood by Manual count: 2.18 (thousand per microliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 75 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 56 (percent)\n- Ferritin [Mass/volume] in Serum or Plasma: 608.9 (nanogram per milliliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 22.8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 31.2 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 31 (percent)\n- Reticulocytes [#/volume] in Blood by Automated count: 149.1 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 4.49 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.36 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 6.8 (gram per deciliter)\n- Iron [Mass/volume] in Serum or Plasma: 281 (microgram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 9.67 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 681 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-05-10 11:52:59, ended at 2018-05-10 13:18:19\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n- Cardiomyopathy\n- Transplanted heart valve present\n- Hemochromatosis following repeated red blood cell transfusion\n- Hereditary hemolytic anemia\n- Heart failure\n- Postoperative state\n- Acquired absence of spleen\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-05-10 13:10:00, ended at 2018-05-10 23:59:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Transfusion, blood or blood components\n\n### Condition\n- Hemochromatosis following repeated red blood cell transfusion\n- Acquired absence of spleen\n- Beta thalassemia\n- Hereditary hemolytic anemia\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2018-05-10, presumably until 2018-05-10\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2018-05-10, presumably until 2018-05-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-05-17 00:00:00, ended at 2018-05-17 00:00:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- benzonatate 100 MG Oral Capsule, through Oral route, started on 2018-05-18, presumably until 2019-05-18, with intended 0 refill(s). Instructions: take 1 Cap by mouth 3 times a day as needed for Cough\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-05-28 00:00:00, ended at 2018-05-28 00:00:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-05-30 14:31:00, ended at 2018-05-30 23:59:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Ferritin [Mass/volume] in Serum or Plasma: 624.8 (nanogram per milliliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 19.0 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 7.79 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.38 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Manual count: 2.28 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12 (percent)\n- Iron [Mass/volume] in Serum or Plasma: 270 (microgram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 22.6 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 3 (percent)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 69 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 39 (percent)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 3.9 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 35.4 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 41 (percent)\n- MCH [Entitic mass] by Automated count: 22.4 (picogram)\n- MCHC [Mass/volume] by Automated count: 31.4 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 71.4 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 535 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Hemoglobin [Mass/volume] in Blood: 7.1 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.17 (million per microliter)\n- Leukocytes [#/volume] in Body fluid by Manual count: 163 (milli-international unit per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-06-04 00:00:00, ended at 2018-06-04 00:00:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- zolpidem tartrate 10 MG Oral Tablet, through Oral route, started on 2018-06-04, presumably until 2018-06-09, with intended 1 refill(s). Instructions: take 1 Tab by mouth every bedtime as needed for Insomnia\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-06-09 00:00:00, ended at 2018-06-09 00:00:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- zolpidem tartrate 10 MG Oral Tablet, through Oral route, started on 2018-06-09, presumably until 2018-08-25, with intended 1 refill(s). Instructions: take 1 Tab by mouth every bedtime as needed for Insomnia\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-06-09 00:00:00, ended at 2018-06-09 00:00:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-06-17 00:00:00, ended at 2018-06-17 00:00:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-07-01 12:00:00, ended at 2018-07-01 23:59:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Hematocrit [Volume Fraction] of Blood by Automated count: 24.4 (percent)\n- Iron [Mass/volume] in Serum or Plasma: 333 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 71 (percent)\n- MCH [Entitic mass] by Automated count: 21.7 (picogram)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.21 (million per microliter)\n- Platelets [#/volume] in Blood by Automated count: 560 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.40 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 19.8 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 28.6 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.99 (thousand per microliter)\n- Leukocytes [#/volume] in Body fluid by Manual count: 468 (milli-international unit per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 7.0 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 35.4 (percent)\n- Ferritin [Mass/volume] in Serum or Plasma: 465.6 (nanogram per milliliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 6.34 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 32 (percent)\n- MCV [Entitic volume] by Automated count: 75.8 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 55 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-07-02 08:50:00, ended at 2018-07-02 23:59:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Transfusion, blood or blood components\n\n### Condition\n- Hereditary hemolytic anemia\n- Hemochromatosis following repeated red blood cell transfusion\n- Beta thalassemia\n- Acquired absence of spleen\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2018-07-02, presumably until 2018-07-02\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2018-07-02, presumably until 2018-07-02\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-08-25 00:00:00, ended at 2018-08-25 00:00:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Beta thalassemia\n\n### Drug\n- zolpidem tartrate 10 MG Oral Tablet, through Oral route, started on 2018-08-25, presumably until 2018-11-12, with intended 1 refill(s). Instructions: take 1 Tab by mouth every bedtime as needed for Insomnia\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-08-26 00:00:00, ended at 2018-08-26 00:00:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Heart failure\n- Chest pain\n\n### Drug\n- ondansetron 4 MG Oral Tablet, through Oral route, started on 2018-08-26, presumably until 2019-09-02, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-08-29 13:20:00, ended at 2018-08-29 23:59:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 2.99 (million per microliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 19 (percent)\n- Ferritin [Mass/volume] in Serum or Plasma: 391.5 (nanogram per milliliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 30.1 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 22.1 (picogram)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 12.11 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 30.3 (percent)\n- Iron [Mass/volume] in Serum or Plasma: 383 (microgram per deciliter)\n- Leukocytes [#/volume] in Body fluid by Manual count: 410 (milli-international unit per milliliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.20 (thousand per microliter)\n- Reticulocytes [#/volume] in Blood by Automated count: 362.7 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 24.2 (percent)\n- Lymphocytes [#/volume] in Blood by Manual count: 20.77 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 80.9 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 581 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Eosinophils [#/volume] in Blood by Manual count: 0.60 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 27.3 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 6.6 (gram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 73 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 69 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-08-31 07:00:00, ended at 2018-08-31 23:59:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Transfusion, blood or blood components\n\n### Condition\n- Beta thalassemia\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2018-08-31, presumably until 2018-08-31\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2018-08-31, presumably until 2018-08-31\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-09-03 00:00:00, ended at 2018-09-03 00:00:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- furosemide 40 MG Oral Tablet, through Oral route, started on 2018-09-06, presumably until 2019-11-12, with intended 12 refill(s). Instructions: take 1 Tab by mouth daily in the evening\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-09-14 00:00:00, ended at 2018-09-14 00:00:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- aspirin 81 MG Chewable Tablet, started on 2018-09-14, presumably until 2018-10-25, with intended 11 refill(s). Instructions: CHEW AND SWALLOW 1 TABLET BY MOUTH EVERY MORNING WITH BREAKFAST\n- carvedilol 6.25 MG Oral Tablet, started on 2018-09-14, presumably until 2018-10-25, with intended 11 refill(s). Instructions: TAKE 1 TABLET BY MOUTH TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-09-16 00:00:00, ended at 2018-09-16 00:00:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Beta thalassemia\n- Primary diagnosis: Congenital absence of spleen\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-10-08 00:00:00, ended at 2018-10-08 00:00:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypertrophic scar\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-10-09 00:00:00, ended at 2018-10-09 00:00:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2018-10-11, presumably until 2019-06-13, with intended 3 refill(s). Instructions: 3 mL by Nebulization route every 6 hours as needed (Wheezing/ Shortness of breath) **APPT REQUIRED PRIOR TO NEXT REFILL\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-10-21 00:00:00, ended at 2018-10-21 00:00:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Blood glucose abnormal\n- Anemia\n- Fatigue\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-10-24 14:15:00, ended at 2018-10-24 23:59:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Ferritin [Mass/volume] in Serum or Plasma: 214.5 (nanogram per milliliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 3.17 (micro-international unit per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 77 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.74 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 107 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 23.7 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.3 (percent)\n- MCH [Entitic mass] by Automated count: 22.6 (picogram)\n- Monocytes [#/volume] in Blood by Manual count: 1.58 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.1 (gram per deciliter)\n- Iron [Mass/volume] in Serum or Plasma: 404 (microgram per deciliter)\n- Leukocytes [#/volume] in Body fluid by Manual count: 746 (milli-international unit per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 30 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Globulin [Mass/volume] in Serum: 3.9 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 6.8 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 78.9 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 22 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 7.3 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.53 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 29.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 17.5 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 10.68 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9 (percent)\n- Platelets [#/volume] in Blood by Automated count: 564 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 28.6 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.00 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 61 (percent)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 3.7 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Beta thalassemia\n- Anemia\n- Blood glucose abnormal\n- Fatigue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-10-25 00:00:00, ended at 2018-10-25 00:00:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-10-25 00:00:00, ended at 2018-10-25 00:00:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- aspirin 81 MG Chewable Tablet, started on 2018-10-25, presumably until 2019-11-17, with intended 3 refill(s). Instructions: CHEW AND SWALLOW 1 TABLET BY MOUTH EVERY MORNING WITH BREAKFAST\n- carvedilol 6.25 MG Oral Tablet, through Oral route, started on 2018-10-25, presumably until 2019-11-17, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-10-26 08:22:16, ended at 2018-10-26 09:47:33\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); each additional vaccine (single or combination vaccine/toxoid) (List separately in addition to code for primary procedure)\n\n### Condition\n- Primary diagnosis: Acquired absence of spleen\n\n### Drug\n- azithromycin 500 MG Oral Tablet, through Oral route, started on 2018-10-26, presumably until 2018-10-29, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily for 3 days\n- levofloxacin 500 MG Oral Tablet, through Oral route, started on 2018-10-26, presumably until 2018-10-31, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily for 5 days\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2018-10-26, presumably until 2018-11-02, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 7 days\n- typhoid Vi polysaccharide vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution, through Intramuscular route, started on 2018-10-26, presumably until 2018-10-26, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-10-26 11:00:00, ended at 2018-10-26 23:59:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Transfusion, blood or blood components\n\n### Condition\n- Congenital absence of spleen\n- Beta thalassemia\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2018-10-26, presumably until 2018-10-26\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2018-10-26, presumably until 2018-10-26\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-10-26 14:56:44, ended at 2018-10-26 16:12:22\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Congenital absence of spleen\n- Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-11-08 00:00:00, ended at 2018-11-08 00:00:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- potassium chloride 1.33 MEQ/ML Oral Solution, through Oral route, started on 2018-11-08, presumably until 2019-12-19, with intended 4 refill(s). Instructions: TAKE 15 ML BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-11-12 00:00:00, ended at 2018-11-12 00:00:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Beta thalassemia\n\n### Drug\n- zolpidem tartrate 10 MG Oral Tablet, through Oral route, started on 2018-11-12, presumably until 2018-12-17, with intended 1 refill(s). Instructions: take 1 Tab by mouth every bedtime as needed for Insomnia\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-12-03 00:00:00, ended at 2018-12-03 00:00:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- General finding of observation of patient\n- Primary diagnosis: Cough\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-12-09 00:00:00, ended at 2018-12-09 00:00:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-12-13 15:00:00, ended at 2018-12-13 23:59:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Non-rheumatic heart valve disorder\n- Non-rheumatic mitral valve disease\n- Tricuspid valve disorder, non-rheumatic\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-12-14 14:44:00, ended at 2018-12-14 23:59:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Heart failure\n- Hemochromatosis following repeated red blood cell transfusion\n- Beta thalassemia\n- Cough\n- Abnormal findings on diagnostic imaging of lung\n- Postoperative state\n- Transplanted heart valve present\n- Cardiomyopathy\n- Acquired absence of spleen\n- Hereditary hemolytic anemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-12-14 15:37:36, ended at 2018-12-14 17:05:19\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cough\n\n### Drug\n- codeine phosphate 2 MG/ML / guaifenesin 20 MG/ML Oral Solution, through Oral route, started on 2018-12-14, presumably until 2019-06-12, with intended 0 refill(s). Instructions: take 5 mL by mouth 3 times a day as needed\n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2018-12-14, presumably until 2019-12-14, with intended 0 refill(s). Instructions: 2 Puffs by Inhalation route every 6 hours as needed\n- 200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2018-12-14, presumably until 2019-12-14, with intended 0 refill(s). Instructions: 2 Puffs by Inhalation route every 6 hours\n- benzonatate 100 MG Oral Capsule, through Oral route, started on 2018-12-14, presumably until 2019-12-14, with intended 0 refill(s). Instructions: take 1 Cap by mouth 3 times a day\n- azithromycin 250 MG Oral Tablet, started on 2018-12-14, presumably until 2018-12-19, with intended 0 refill(s). Instructions: 2 tabs  (500mg) at once on day one, then 1 tab (250mg) daily for days 2-5.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-12-17 00:00:00, ended at 2018-12-17 00:00:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Beta thalassemia\n\n### Drug\n- levothyroxine sodium 0.125 MG Oral Tablet, through Oral route, started on 2018-12-17, presumably until 2020-01-11, with intended 12 refill(s). Instructions: take 1 Tab by mouth every morning before breakfast\n- zolpidem tartrate 10 MG Oral Tablet, through Oral route, started on 2018-12-17, presumably until 2019-02-07, with intended 1 refill(s). Instructions: take 1 Tab by mouth every bedtime as needed for Insomnia\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-12-19 15:02:00, ended at 2018-12-19 23:59:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 5.1 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.73 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.85 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.01 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 25 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 59 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4 (percent)\n- MCH [Entitic mass] by Automated count: 21.3 (picogram)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 24.1 (percent)\n- Lymphocytes [#/volume] in Blood by Manual count: 5.33 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 80.1 (femtoliter)\n- Monocytes [#/volume] in Blood by Manual count: 2.13 (thousand per microliter)\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 40 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 75 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 35.6 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 107 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 21.3 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 26.6 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.0 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 6.4 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 696 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-12-21 09:07:00, ended at 2018-12-21 23:59:00\nThe patient in this visit was 38 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Transfusion, blood or blood components\n\n### Condition\n- Beta thalassemia\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2018-12-21, presumably until 2018-12-21\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2018-12-21, presumably until 2018-12-21\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-02-02 00:00:00, ended at 2019-02-02 00:00:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of iron metabolism\n- Beta thalassemia\n\n### Drug\n- deferasirox 360 MG Oral Tablet, through Oral route, started on 2019-02-02, presumably until 2019-10-06, with intended 5 refill(s). Instructions: take 1,080 mg by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-02-07 00:00:00, ended at 2019-02-07 00:00:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Beta thalassemia\n\n### Drug\n- zolpidem tartrate 10 MG Oral Tablet, through Oral route, started on 2019-02-07, presumably until 2019-02-15, with intended 1 refill(s). Instructions: take 1 Tab by mouth every bedtime as needed for Insomnia\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-02-10 00:00:00, ended at 2019-02-10 00:00:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-02-13 13:58:00, ended at 2019-02-13 23:59:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.90 (million per microliter)\n- MCH [Entitic mass] by Automated count: 21.0 (picogram)\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 22.7 (percent)\n- Hemoglobin [Mass/volume] in Blood: 6.1 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 8.67 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 44 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 8.0 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 5.5 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 33.0 (percent)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 26 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 19.7 (thousand per microliter)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 6.3 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 4.7 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.71 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 40 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 66 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 132 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 26.9 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 78.3 (femtoliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.20 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.18 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 441 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Beta thalassemia\n- Hemochromatosis following repeated red blood cell transfusion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-02-15 00:00:00, ended at 2019-02-15 00:00:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Iron saturation [Mass Fraction] in Serum or Plasma: 40 (percent)\n- Ferritin [Mass/volume] in Serum or Plasma: 397 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hemochromatosis following repeated red blood cell transfusion\n- Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-02-15 00:00:00, ended at 2019-02-15 00:00:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Beta thalassemia\n- Primary diagnosis: Hemochromatosis following repeated red blood cell transfusion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-02-15 00:00:00, ended at 2019-02-15 00:00:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Beta thalassemia\n\n### Drug\n- zolpidem tartrate 10 MG Oral Tablet, through Oral route, started on 2019-02-15, presumably until 2019-05-13, with intended 1 refill(s). Instructions: take 1 Tab by mouth every bedtime as needed for Insomnia\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-02-15 08:00:00, ended at 2019-02-15 23:59:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Transfusion, blood or blood components\n\n### Condition\n- Beta thalassemia\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2019-02-15, presumably until 2019-02-15\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2019-02-15, presumably until 2019-02-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-03-04 10:10:37, ended at 2019-03-04 11:10:33\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- Injection, intralesional; up to and including 7 lesions\n\n### Condition\n- Primary diagnosis: Hypertrophic scar\n\n### Drug\n- triamcinolone acetonide 10 MG/ML Injectable Suspension, started on 2019-03-04, presumably until 2019-03-04\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-04-04 00:00:00, ended at 2019-04-04 00:00:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-04-04 00:00:00, ended at 2019-04-04 00:00:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hemochromatosis following repeated red blood cell transfusion\n- Anemia\n- Beta thalassemia\n\n### Drug\n- deferiprone 500 MG Oral Tablet, through Oral route, started on 2019-04-04, presumably until 2019-08-17, with intended 3 refill(s). Instructions: take 1,500 mg by mouth 3 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-04-08 00:00:00, ended at 2019-04-08 00:00:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- gabapentin 100 MG Oral Capsule, started on 2019-04-08, presumably until 2019-04-08, with intended 12 refill(s). Instructions: TAKE 1 CAPSULE BY MOUTH THREE TIMES DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-04-10 14:44:00, ended at 2019-04-10 23:59:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 32.1 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 21.2 (percent)\n- MCHC [Mass/volume] by Automated count: 28.3 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 5.3 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.72 (million per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 326 (nanogram per milliliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 39 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 125 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 40 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 4.7 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 62 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 22.2 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 8.87 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 22.1 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 8.0 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 6.0 (gram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 78 (percent)\n- MCV [Entitic volume] by Automated count: 77.9 (femtoliter)\n- Monocytes [#/volume] in Blood by Manual count: 2.88 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.70 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 460 (thousand per microliter)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 8.3 (percent)\n- Eosinophils [#/volume] in Blood by Manual count: 0.67 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Beta thalassemia\n- Hemochromatosis following repeated red blood cell transfusion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-04-11 10:30:00, ended at 2019-04-11 23:59:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Transfusion, blood or blood components\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n- Hypertrophic scar\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2019-04-11, presumably until 2019-04-11\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2019-04-11, presumably until 2019-04-11\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-05-13 00:00:00, ended at 2019-05-13 00:00:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Beta thalassemia\n\n### Drug\n- zolpidem tartrate 10 MG Oral Tablet, through Oral route, started on 2019-05-13, presumably until 2019-08-16, with intended 1 refill(s). Instructions: take 1 Tab (10 mg total) by mouth every bedtime as needed for Insomnia\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-05-26 00:00:00, ended at 2019-05-26 00:00:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n- Anemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-06-05 14:46:00, ended at 2019-06-05 23:59:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 5.0 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 60 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 6.2 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.76 (milligram per deciliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 230 (nanogram per milliliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 37 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 16.4 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 40 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 14 (percent)\n- Platelets [#/volume] in Blood by Automated count: 636 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 62 (percent)\n- Monocytes [#/volume] in Blood by Manual count: 2.30 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.9 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 30.6 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.0 (gram per deciliter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.80 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 28.8 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 76.8 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (unit per liter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.16 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 21.5 (percent)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 1.4 (percent)\n- Lymphocytes [#/volume] in Blood by Manual count: 6.56 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 4.6 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 22.1 (picogram)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hemochromatosis following repeated red blood cell transfusion\n- Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-06-06 07:22:00, ended at 2019-06-06 08:49:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Cardiac magnetic resonance imaging for morphology and function without contrast material\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s)\n\n### Condition\n- Hemochromatosis following repeated red blood cell transfusion\n- Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-06-06 08:50:00, ended at 2019-06-06 23:59:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Transfusion, blood or blood components\n\n### Condition\n- Anemia\n- Beta thalassemia\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2019-06-06, presumably until 2019-06-06\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2019-06-06, presumably until 2019-06-06\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-07-27 12:25:00, ended at 2019-07-27 23:59:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.77 (milligram per deciliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 141 (nanogram per milliliter)\n- MCHC [Mass/volume] by Automated count: 27.5 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.93 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 5.6 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 22.9 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 5 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 7 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 32.7 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 22 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 22.0 (picogram)\n- Neutrophils/100 leukocytes in Blood by Manual count: 45 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.9 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 33 (percent)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 4.4 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 61 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 97 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 6.3 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.0 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 16.0 (thousand per microliter)\n- Anion gap in Serum or Plasma: 15 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Manual count: 1.31 (thousand per microliter)\n- Iron [Mass/volume] in Serum or Plasma: 327 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 54 (percent)\n- Lymphocytes [#/volume] in Blood by Manual count: 6.16 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.86 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 80.1 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 511 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Beta thalassemia\n- Hemochromatosis following repeated red blood cell transfusion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-07-28 00:00:00, ended at 2019-07-28 00:00:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-07-28 10:20:00, ended at 2019-07-28 23:59:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Transfusion, blood or blood components\n\n### Condition\n- Hereditary hemolytic anemia\n- Beta thalassemia\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2019-07-28, presumably until 2019-07-28\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2019-07-28, presumably until 2019-07-28\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-08-01 10:01:48, ended at 2019-08-01 11:49:02\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.291\" (inch (US))\n\n### Procedure\n- Injection, intralesional; up to and including 7 lesions\n\n### Condition\n- Primary diagnosis: Hypertrophic scar\n- Neuralgia\n\n### Drug\n- triamcinolone acetonide 10 MG/ML Injectable Suspension, started on 2019-08-01, presumably until 2019-08-01\n- lidocaine 25 MG/ML / prilocaine 25 MG/ML Topical Cream, through Topical route, started on 2019-08-01, presumably until 2019-08-01\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-08-02 00:00:00, ended at 2019-08-02 00:00:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n- Emotional state finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-08-16 00:00:00, ended at 2019-08-16 00:00:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Beta thalassemia\n- Primary diagnosis: Disorder of hematopoietic structure\n\n### Drug\n- zolpidem tartrate 10 MG Oral Tablet, through Oral route, started on 2019-08-16, presumably until 2019-10-24, with intended 1 refill(s). Instructions: take 1 Tab (10 mg total) by mouth every bedtime as needed for Insomnia\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-08-17 00:00:00, ended at 2019-08-17 00:00:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Beta thalassemia\n- Anemia\n- Hemochromatosis following repeated red blood cell transfusion\n\n### Drug\n- deferiprone 500 MG Oral Tablet, through Oral route, started on 2019-08-17, presumably until 2019-09-01, with intended 3 refill(s). Instructions: take 1,500 mg by mouth 3 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-08-24 00:00:00, ended at 2019-08-24 00:00:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anemia\n- Beta thalassemia\n- Hemochromatosis following repeated red blood cell transfusion\n\n### Drug\n- deferiprone 500 MG Oral Tablet, through Oral route, started on 2019-08-24, presumably until 2019-08-24, with intended 3 refill(s). Instructions: take 1,500 mg by mouth 3 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-09-01 00:00:00, ended at 2019-09-01 00:00:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hemochromatosis following repeated red blood cell transfusion\n- Anemia\n- Beta thalassemia\n\n### Drug\n- deferiprone 500 MG Oral Tablet, through Oral route, started on 2019-09-01, presumably until 2019-11-21, with intended 11 refill(s). Instructions: take 1,500 mg by mouth 3 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-09-02 00:00:00, ended at 2019-09-02 00:00:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of hematopoietic structure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-09-02 00:00:00, ended at 2019-09-02 00:00:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Heart failure\n- Chest pain\n\n### Drug\n- ondansetron 4 MG Oral Tablet, started on 2019-09-02, presumably until 2020-10-15, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 8 HOURS AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-09-12 00:00:00, ended at 2019-09-12 00:00:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hemochromatosis following repeated red blood cell transfusion\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-09-12 00:00:00, ended at 2019-09-12 00:00:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cardiomyopathy\n- Heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-09-15 00:00:00, ended at 2019-09-15 00:00:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n- Hemochromatosis following repeated red blood cell transfusion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-09-18 13:30:00, ended at 2019-09-18 23:59:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 63 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 31.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 6.3 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.44 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 22.3 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 4.9 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Ferritin [Mass/volume] in Serum or Plasma: 141 (nanogram per milliliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.80 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.04 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.3 (gram per deciliter)\n- Iron [Mass/volume] in Serum or Plasma: 260 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 65 (percent)\n- MCH [Entitic mass] by Automated count: 22.5 (picogram)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 2.4 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 27 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 11 (unit per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 4.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.79 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 14.8 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Manual count: 5.18 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 570 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 35 (percent)\n- MCHC [Mass/volume] by Automated count: 28.3 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 79.6 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 49 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hemochromatosis following repeated red blood cell transfusion\n- Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-09-19 08:50:00, ended at 2019-09-19 23:59:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Transfusion, blood or blood components\n\n### Condition\n- Beta thalassemia\n- Hemochromatosis following repeated red blood cell transfusion\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2019-09-19, presumably until 2019-09-19\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2019-09-19, presumably until 2019-09-19\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-09-27 00:00:00, ended at 2019-09-27 00:00:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Blood glucose abnormal\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-09-29 00:00:00, ended at 2019-09-29 00:00:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Beta thalassemia\n- Primary diagnosis: Blood glucose abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-10-03 10:29:05, ended at 2019-10-03 11:44:07\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.173\" (inch (US))\n\n### Procedure\n- Injection, intralesional; up to and including 7 lesions\n\n### Condition\n- Primary diagnosis: Callosity\n- Hypertrophic scar\n\n### Drug\n- triamcinolone acetonide 10 MG/ML Injectable Suspension, started on 2019-10-03, presumably until 2019-10-03\n- urea 400 MG/ML Topical Cream, started on 2019-10-03, presumably until 2023-01-05, with intended 11 refill(s). Instructions: Apply to affected area(s) topically twice daily as directed.\n- lidocaine 25 MG/ML / prilocaine 25 MG/ML Topical Cream, through Topical route, started on 2019-10-03, presumably until 2019-10-03\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-10-06 00:00:00, ended at 2019-10-06 00:00:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Beta thalassemia\n- Disorder of iron metabolism\n\n### Drug\n- deferasirox 360 MG Oral Tablet, through Oral route, started on 2019-10-06, presumably until 2020-02-29, with intended 2 refill(s). Instructions: take 1,080 mg by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-10-14 08:40:57, ended at 2019-10-14 10:55:32\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Psychiatric diagnostic evaluation\n\n### Condition\n- Primary diagnosis: Anxiety disorder\n- Cardiomyopathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-10-24 00:00:00, ended at 2019-10-24 00:00:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Beta thalassemia\n\n### Drug\n- zolpidem tartrate 10 MG Oral Tablet, through Oral route, started on 2019-10-24, presumably until 2019-12-19, with intended 1 refill(s). Instructions: take 1 Tab (10 mg total) by mouth every bedtime as needed for Insomnia\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-11-12 00:00:00, ended at 2019-11-12 00:00:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- furosemide 40 MG Oral Tablet, started on 2019-11-14, presumably until 2020-11-12, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH DAILY IN THE EVENING\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-11-17 00:00:00, ended at 2019-11-17 00:00:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- aspirin 81 MG Chewable Tablet, started on 2019-11-17, presumably until 2020-11-12, with intended 3 refill(s). Instructions: CHEW AND SWALLOW 1 TABLET BY MOUTH EVERY MORNING WITH BREAKFAST\n- carvedilol 6.25 MG Oral Tablet, through Oral route, started on 2019-11-17, presumably until 2021-01-11, with intended 3 refill(s). Instructions: take 1 Tab (6.25 mg total) by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-11-20 14:48:00, ended at 2019-11-20 23:59:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 90 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 15.3 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 4.74 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- MCHC [Mass/volume] by Automated count: 27.2 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 77.3 (femtoliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.92 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.8 (gram per deciliter)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 3.3 (percent)\n- Thyrotropin [Units/volume] in Serum or Plasma: 2.55 (micro-international unit per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.75 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.61 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 23.5 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 5.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 6.4 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 77 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 33.0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.04 (million per microliter)\n- Iron [Mass/volume] in Serum or Plasma: 248 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 52 (percent)\n- MCH [Entitic mass] by Automated count: 21.1 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Platelets [#/volume] in Blood by Automated count: 479 (thousand per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 93.7 (nanogram per milliliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 31 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 59 (percent)\n- Parathyrin.intact [Mass/volume] in Serum or Plasma: 34.8 (picogram per milliliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Beta thalassemia\n- Blood glucose abnormal\n- Hemochromatosis following repeated red blood cell transfusion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-11-21 00:00:00, ended at 2019-11-21 00:00:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-11-21 00:00:00, ended at 2019-11-21 00:00:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anemia\n- Beta thalassemia\n- Hemochromatosis following repeated red blood cell transfusion\n\n### Drug\n- deferiprone 500 MG Oral Tablet, through Oral route, started on 2019-11-21, presumably until 2019-11-23, with intended 11 refill(s). Instructions: take 1,000 mg by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-11-22 07:00:00, ended at 2019-11-22 23:59:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Transfusion, blood or blood components\n\n### Condition\n- Beta thalassemia\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2019-11-22, presumably until 2019-11-22\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2019-11-22, presumably until 2019-11-22\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-11-23 00:00:00, ended at 2019-11-23 00:00:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Beta thalassemia\n- Anemia\n- Hemochromatosis following repeated red blood cell transfusion\n\n### Drug\n- deferiprone 500 MG Oral Tablet, through Oral route, started on 2019-11-23, presumably until 2019-11-29, with intended 11 refill(s). Instructions: take 1,000 mg by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-11-23 00:00:00, ended at 2019-11-23 00:00:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hemochromatosis following repeated red blood cell transfusion\n- Beta thalassemia\n- Anemia\n\n### Drug\n- deferiprone 500 MG Oral Tablet, through Oral route, started on 2019-11-23, presumably until 2019-11-23, with intended 11 refill(s). Instructions: take 1,000 mg by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-11-29 00:00:00, ended at 2019-11-29 00:00:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hemochromatosis following repeated red blood cell transfusion\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- deferiprone 1000 MG Oral Tablet, through Oral route, started on 2019-11-29, presumably until 2021-03-20, with intended 5 refill(s). Instructions: take 1,000 mg by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-12-09 09:04:34, ended at 2019-12-09 10:23:02\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.173\" (inch (US))\n\n### Procedure\n- Injection, intralesional; up to and including 7 lesions\n\n### Condition\n- Asteatosis cutis\n- Hypertrophic scar\n- Beta thalassemia\n- Primary diagnosis: Hyperesthesia\n\n### Drug\n- lidocaine 25 MG/ML / prilocaine 25 MG/ML Topical Cream, through Topical route, started on 2019-12-09, presumably until 2019-12-09\n- triamcinolone acetonide 40 MG/ML Injectable Suspension, started on 2019-12-09, presumably until 2019-12-09\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-12-17 00:00:00, ended at 2019-12-17 00:00:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- potassium chloride 1.33 MEQ/ML Oral Solution, through Oral route, started on 2019-12-19, presumably until 2021-09-23, with intended 4 refill(s). Instructions: TAKE 15 ML BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-12-19 00:00:00, ended at 2019-12-19 00:00:00\nThe patient in this visit was 39 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Beta thalassemia\n\n### Drug\n- zolpidem tartrate 10 MG Oral Tablet, through Oral route, started on 2019-12-19, presumably until 2020-02-28, with intended 1 refill(s). Instructions: take 1 Tab (10 mg total) by mouth every bedtime as needed for Insomnia\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-01-10 00:00:00, ended at 2020-01-10 00:00:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- levothyroxine sodium 0.125 MG Oral Tablet, started on 2020-01-11, presumably until 2021-03-21, with intended 12 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY MORNING BEFORE BREAKFAST\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-11 00:00:00, ended at 2020-01-11 00:00:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hemochromatosis following repeated red blood cell transfusion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-01-12 09:46:08, ended at 2020-01-12 12:38:47\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.882\" (inch (US))\n\n### Procedure\n- Medical nutrition therapy; initial assessment and intervention, individual, face-to-face with the patient, each 15 minutes\n\n### Condition\n- Heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-01-12 10:40:00, ended at 2020-01-12 23:59:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 3.30 (million per microliter)\n- Platelets [#/volume] in Blood by Automated count: 536 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 26 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 3 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 35.6 (percent)\n- Anion gap in Serum or Plasma: 15 (millimole per liter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 81 (percent)\n- MCV [Entitic volume] by Automated count: 78.8 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 45 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.9 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4 (percent)\n- Ferritin [Mass/volume] in Serum or Plasma: 219 (nanogram per milliliter)\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 18.6 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 5.41 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 92 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 38 (unit per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 26.5 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.9 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.69 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.0 (percent)\n- Iron [Mass/volume] in Serum or Plasma: 283 (microgram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 29 (percent)\n- MCH [Entitic mass] by Automated count: 20.9 (picogram)\n- Monocytes [#/volume] in Blood by Manual count: 1.86 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.9 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 4.0 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.75 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 6.9 (gram per deciliter)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 7.0 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hemochromatosis following repeated red blood cell transfusion\n- Beta thalassemia\n- Heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-01-13 13:30:00, ended at 2020-01-13 23:59:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Transfusion, blood or blood components\n\n### Condition\n- Beta thalassemia\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2020-01-13, presumably until 2020-01-13\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2020-01-13, presumably until 2020-01-13\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-01-23 09:16:00, ended at 2020-01-23 11:09:34\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.882\" (inch (US))\n\n### Procedure\n- Injection, intralesional; up to and including 7 lesions\n\n### Condition\n- Primary diagnosis: Pruritic rash\n- Beta thalassemia\n- Hyperesthesia\n- Hypertrophic scar\n\n### Drug\n- triamcinolone acetonide 40 MG/ML Injectable Suspension, started on 2020-01-23, presumably until 2020-01-23\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-26 00:00:00, ended at 2020-01-26 00:00:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n- Hemochromatosis following repeated red blood cell transfusion\n- Anemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-26 00:00:00, ended at 2020-01-26 00:00:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n- Hemochromatosis following repeated red blood cell transfusion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-02-17 10:50:51, ended at 2020-02-17 11:55:49\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.843\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic ulcer of skin of lower leg\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-02-23 13:55:55, ended at 2020-02-23 15:12:39\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Eruption\n- Primary diagnosis: Open wound of lower leg\n\n### Drug\n- lidocaine hydrochloride 20 MG/ML Mucous Membrane Topical Solution, through Topical route, started on 2020-02-23, presumably until 2020-02-23, with intended 0 refill(s). Instructions: 15 mL by Topical route One Time for 1 dose\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-28 00:00:00, ended at 2020-02-28 00:00:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- zolpidem tartrate 10 MG Oral Tablet, through Oral route, started on 2020-02-28, presumably until 2020-05-04, with intended 1 refill(s). Instructions: take 1 Tab (10 mg total) by mouth every bedtime as needed for Insomnia\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-29 00:00:00, ended at 2020-02-29 00:00:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Beta thalassemia\n- Disorder of iron metabolism\n\n### Drug\n- deferasirox 360 MG Oral Tablet, through Oral route, started on 2020-02-29, presumably until 2020-04-03, with intended 0 refill(s). Instructions: take 1,080 mg by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-03-01 00:00:00, ended at 2020-03-01 00:00:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Beta thalassemia\n- Disorder of iron metabolism\n\n### Drug\n- deferasirox 360 MG Oral Tablet, through Oral route, started on 2020-03-01, presumably until 2020-03-01, with intended 0 refill(s). Instructions: take 1,080 mg by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-03-06 14:07:19, ended at 2020-03-06 14:25:46\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute upper respiratory infection\n- Primary diagnosis: Viral disease\n\n### Drug\n- codeine phosphate 2 MG/ML / guaifenesin 20 MG/ML Oral Solution, through Oral route, started on 2020-03-06, presumably until 2020-07-13, with intended 0 refill(s). Instructions: take 5 mL by mouth every bedtime as needed for cough\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-03-11 14:02:00, ended at 2020-03-11 23:59:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 4.6 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.16 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 34 (percent)\n- MCHC [Mass/volume] by Automated count: 26.6 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 5.0 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.26 (millimole per liter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 81 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 55 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 33.9 (percent)\n- Ferritin [Mass/volume] in Serum or Plasma: 299 (nanogram per milliliter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 16.0 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.96 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.4 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 83 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 25.9 (percent)\n- MCH [Entitic mass] by Automated count: 21.8 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 660 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 30 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 75 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.0 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Manual count: 5.44 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.48 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 6.9 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.88 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3 (percent)\n- Iron [Mass/volume] in Serum or Plasma: 390 (microgram per deciliter)\n- MCV [Entitic volume] by Automated count: 82.0 (femtoliter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 3.9 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Beta thalassemia\n- Hemochromatosis following repeated red blood cell transfusion\n- Anemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-03-12 12:50:00, ended at 2020-03-12 23:59:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Transfusion, blood or blood components\n\n### Condition\n- Beta thalassemia\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2020-03-12, presumably until 2020-03-12\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2020-03-12, presumably until 2020-03-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-03-21 16:11:02, ended at 2020-03-21 16:15:30\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acquired absence of spleen\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-03-28 00:00:00, ended at 2020-03-28 00:00:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Traumatic or non-traumatic injury\n\n### Drug\n- mupirocin 0.02 MG/MG Topical Ointment, started on 2020-03-28, presumably until 2021-03-28, with intended 3 refill(s). Instructions: Apply topically as directed twice daily to affected area(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-03-28 13:00:09, ended at 2020-03-28 13:18:04\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Traumatic or non-traumatic injury\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-04-03 00:00:00, ended at 2020-04-03 00:00:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of iron metabolism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-04-03 00:00:00, ended at 2020-04-03 00:00:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Beta thalassemia\n- Disorder of iron metabolism\n\n### Drug\n- deferasirox 360 MG Oral Tablet, through Oral route, started on 2020-04-03, presumably until 2020-11-15, with intended 5 refill(s). Instructions: take 1,080 mg by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-05-02 00:00:00, ended at 2020-05-02 00:00:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Beta thalassemia\n\n### Drug\n- zolpidem tartrate 10 MG Oral Tablet, through Oral route, started on 2020-05-04, presumably until 2020-06-08, with intended 0 refill(s). Instructions: take 1 Tab (10 mg total) by mouth every bedtime as needed for Insomnia\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-05-03 00:00:00, ended at 2020-05-03 00:00:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Beta thalassemia\n\n### Drug\n- zolpidem tartrate 10 MG Oral Tablet, through Oral route, started on 2020-06-09, presumably until 2020-12-06, with intended 3 refill(s). Instructions: take 1 Tab (10 mg total) by mouth every bedtime as needed for Insomnia\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-05-06 14:57:00, ended at 2020-05-06 23:59:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.7 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 5.4 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.37 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 81.8 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Anion gap in Serum or Plasma: 15 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 76 (percent)\n- Monocytes [#/volume] in Blood by Manual count: 0.93 (thousand per microliter)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 3.8 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 85 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.82 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 6.51 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 32.7 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.91 (million per microliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 54 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Protein/Creatinine [Mass Ratio] in Urine: 0.24 (milligram per milligram)\n- Creatinine [Mass/volume] in Urine: 78.88 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 23.8 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.0 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 6.6 (gram per deciliter)\n- Leukocytes [#/volume] in Body fluid by Manual count: 730 (milli-international unit per milliliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 35 (percent)\n- MCH [Entitic mass] by Automated count: 22.7 (picogram)\n- MCHC [Mass/volume] by Automated count: 27.7 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 18.6 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 550 (thousand per microliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 19.0 (milligram per deciliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 414 (nanogram per milliliter)\n- Iron [Mass/volume] in Serum or Plasma: 337 (microgram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Beta thalassemia\n- Anemia\n- Hemochromatosis following repeated red blood cell transfusion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-05-08 00:00:00, ended at 2020-05-08 00:00:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anemia\n- Primary diagnosis: Disorder of iron metabolism\n- Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-05-08 08:20:00, ended at 2020-05-08 23:59:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Transfusion, blood or blood components\n\n### Condition\n- Hereditary hemolytic anemia\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2020-05-08, presumably until 2020-05-08\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2020-05-08, presumably until 2020-05-08\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-05-08 14:29:09, ended at 2020-05-08 14:36:16\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-05-24 16:13:06, ended at 2020-05-24 16:59:04\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Varicose ulcer of lower extremity\n- Primary diagnosis: Chronic ulcer of skin of lower leg\n\n### Drug\n- lidocaine hydrochloride 20 MG/ML Mucous Membrane Topical Solution, through Topical route, started on 2020-05-24, presumably until 2020-05-24, with intended 0 refill(s). Instructions: 15 mL by Topical route One Time for 1 dose\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-06-06 10:27:28, ended at 2020-06-06 10:56:15\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Heart failure\n- Hemochromatosis following repeated red blood cell transfusion\n- Atrial fibrillation\n- Postoperative state\n- Acquired absence of spleen\n- Primary diagnosis: Lupus anticoagulant disorder\n- Cardiomyopathy\n- Chronic ulcer of skin of ankle\n- Transplanted heart valve present\n- Vascular complication of medical care\n- Acute on chronic systolic heart failure\n- Beta thalassemia\n- Congestive heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-06-07 00:00:00, ended at 2020-06-07 00:00:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Beta thalassemia\n\n### Drug\n- zolpidem tartrate 10 MG Oral Tablet, through Oral route, started on 2020-06-08, presumably until 2020-06-19, with intended 0 refill(s). Instructions: take 1 Tab (10 mg total) by mouth every bedtime as needed for Insomnia\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-06-19 15:29:51, ended at 2020-06-19 15:59:19\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Iron deficiency anemia due to blood loss\n- Congenital absence of spleen\n- Beta thalassemia\n\n### Drug\n- 0.5 ML varicella-zoster virus vaccine live (Oka-Merck) strain 2700 UNT/ML Injection, through Subcutaneous route, started on 2020-06-19, presumably until 2020-06-19, with intended 0 refill(s). Instructions: inject 0.5 mL subcutaneous (under the skin) One Time for 1 dose\n- 0.5 ML meningococcal group B vaccine 0.1 MG/ML / Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen 0.1 MG/ML / Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen 0.1 MG/ML / Neisseria meningitidis serogr..., through Intramuscular route, started on 2020-06-19, presumably until 2020-06-19, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time for 1 dose\n- lidocaine 0.05 MG/MG Medicated Patch, through Transdermal route, started on 2020-06-19, presumably until 2021-06-19, with intended 0 refill(s). Instructions: apply 1 Patch to skin daily\n- zolpidem tartrate 6.25 MG Extended Release Oral Tablet, through Oral route, started on 2020-06-19, presumably until 2020-07-09, with intended 0 refill(s). Instructions: take 1 Tab (6.25 mg total) by mouth every bedtime as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-06-20 00:00:00, ended at 2020-06-20 00:00:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Asthenia\n- Primary diagnosis: Muscle pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-06-24 15:14:00, ended at 2020-06-24 23:59:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Hemoglobin [Mass/volume] in Blood: 6.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 77.4 (femtoliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 57 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 42 (percent)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Monocytes [#/volume] in Blood by Manual count: 0.89 (thousand per microliter)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 9.0 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 97 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 442 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 85 (unit per liter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.45 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.8 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3 (percent)\n- Ferritin [Mass/volume] in Serum or Plasma: 204 (nanogram per milliliter)\n- Sodium [Moles/volume] in Serum or Plasma: 129 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 24.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 14.9 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 5.36 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 5.2 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.93 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.10 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 36 (percent)\n- MCH [Entitic mass] by Automated count: 21.6 (picogram)\n- MCHC [Mass/volume] by Automated count: 27.9 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 35 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 3 (percent)\n- Iron [Mass/volume] in Serum or Plasma: 312 (microgram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Beta thalassemia\n- Hemochromatosis following repeated red blood cell transfusion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-06-26 07:00:00, ended at 2020-06-26 23:59:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Transfusion, blood or blood components\n\n### Condition\n- Hemochromatosis following repeated red blood cell transfusion\n- Beta thalassemia\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2020-06-26, presumably until 2020-06-26\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2020-06-26, presumably until 2020-06-26\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-07-09 00:00:00, ended at 2020-07-09 00:00:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- zolpidem tartrate 6.25 MG Extended Release Oral Tablet, through Oral route, started on 2020-07-13, presumably until 2021-01-09, with intended 0 refill(s). Instructions: take 1 Tab (6.25 mg total) by mouth every bedtime as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-07-25 14:30:00, ended at 2020-07-25 23:59:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)\n\n### Condition\n- Osteoporosis\n- Anemia\n- Beta thalassemia\n- Disorder of bone\n- Disorder of iron metabolism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-08-06 00:00:00, ended at 2020-08-06 00:00:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Insomnia\n\n### Drug\n- zolpidem tartrate 6.25 MG Extended Release Oral Tablet, through Oral route, started on 2020-08-13, presumably until 2020-10-09, with intended 0 refill(s). Instructions: take 1 Tab (6.25 mg total) by mouth every bedtime as needed for Insomnia\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-08-06 00:00:00, ended at 2020-08-06 00:00:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- zolpidem tartrate 6.25 MG Extended Release Oral Tablet, through Oral route, started on 2020-08-06, presumably until 2021-02-02, with intended 3 refill(s). Instructions: take 1 Tab (6.25 mg total) by mouth every bedtime as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-08-06 00:00:00, ended at 2020-08-06 00:00:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hemochromatosis following repeated red blood cell transfusion\n- Disorder of bone\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-08-19 14:54:00, ended at 2020-08-19 23:59:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 25.4 (percent)\n- MCH [Entitic mass] by Automated count: 21.5 (picogram)\n- MCHC [Mass/volume] by Automated count: 27.2 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 440 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.4 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 31 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 32.3 (percent)\n- Iron [Mass/volume] in Serum or Plasma: 295 (microgram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 47.0 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 74 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 4.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 6.9 (gram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 75 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Eosinophils [#/volume] in Blood by Manual count: 0.58 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.21 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 104 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.16 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 37.0 (percent)\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Ferritin [Mass/volume] in Serum or Plasma: 190 (nanogram per milliliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 5.37 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- MCV [Entitic volume] by Automated count: 79.1 (femtoliter)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 3.8 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 5.0 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.92 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 14.5 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.9 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.0 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Beta thalassemia\n- Hemochromatosis following repeated red blood cell transfusion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-08-21 09:00:00, ended at 2020-08-21 23:59:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Transfusion, blood or blood components\n\n### Condition\n- Hereditary hemolytic anemia\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2020-08-21, presumably until 2020-08-21\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2020-08-21, presumably until 2020-08-21\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-10-09 00:00:00, ended at 2020-10-09 00:00:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Insomnia\n\n### Drug\n- zolpidem tartrate 6.25 MG Extended Release Oral Tablet, through Oral route, started on 2020-10-15, presumably until 2020-12-18, with intended 1 refill(s). Instructions: take 1 Tab (6.25 mg total) by mouth every bedtime as needed for Insomnia\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-10-14 00:00:00, ended at 2020-10-14 00:00:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Heart failure\n- Chest pain\n\n### Drug\n- ondansetron 4 MG Oral Tablet, started on 2020-10-15, presumably until 2021-03-01, with intended 5 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 8 HOURS AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-10-14 15:02:00, ended at 2020-10-14 23:59:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 3.01 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 27.4 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 73 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 6.3 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 6.3 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.0 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 54.0 (percent)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 17.0 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 26 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 3.0 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.95 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 32.1 (percent)\n- MCV [Entitic volume] by Automated count: 76.4 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Ferritin [Mass/volume] in Serum or Plasma: 258 (nanogram per milliliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 23.0 (percent)\n- MCH [Entitic mass] by Automated count: 20.9 (picogram)\n- Monocytes [#/volume] in Blood by Manual count: 1.04 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 75.98 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 14.9 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 4.31 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 605 (thousand per microliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 0.22 (milligram per milligram)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 29.0 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hemochromatosis\n- Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-10-15 00:00:00, ended at 2020-10-15 00:00:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hemochromatosis following repeated red blood cell transfusion\n- Disorder of bone\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-10-16 09:50:00, ended at 2020-10-16 23:59:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.24 (millimole per liter)\n- Parathyrin.intact [Mass/volume] in Serum or Plasma: 34.1 (picogram per milliliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 88 (percent)\n- Thyrotropin [Units/volume] in Serum or Plasma: 5.29 (micro-international unit per milliliter)\n- Iron [Mass/volume] in Serum or Plasma: 249 (microgram per deciliter)\n\n### Procedure\n- Transfusion, blood or blood components\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hemochromatosis following repeated red blood cell transfusion\n- Beta thalassemia\n- Disorder of bone\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2020-10-16, presumably until 2020-10-16\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2020-10-16, presumably until 2020-10-16\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-11-10 00:00:00, ended at 2020-11-10 00:00:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Vascular complication of medical care\n- Primary diagnosis: Heart failure\n- Postoperative state\n- Transplanted heart valve present\n- Atrial fibrillation\n\n### Drug\n- furosemide 40 MG Oral Tablet, started on 2020-11-12, presumably until 2021-10-07, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH DAILY IN THE EVENING\n- aspirin 81 MG Chewable Tablet, started on 2020-11-12, presumably until 2021-11-04, with intended 3 refill(s). Instructions: CHEW AND SWALLOW ONE TABLET BY MOUTH EVERY MORNING WITH BREAKFAST\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-11-15 00:00:00, ended at 2020-11-15 00:00:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-11-15 00:00:00, ended at 2020-11-15 00:00:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of iron metabolism\n- Beta thalassemia\n\n### Drug\n- deferasirox 360 MG Oral Tablet, through Oral route, started on 2020-11-15, presumably until 2021-03-20, with intended 5 refill(s). Instructions: take 1,080 mg by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-12-09 14:32:00, ended at 2020-12-09 23:59:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 4.7 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 89 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.3 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.81 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.0 (percent)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 28.0 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 51.0 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 87 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 23.6 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 4.8 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 29.0 (percent)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 3.2 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 6.6 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 3.28 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 494 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 8.0 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.9 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.12 (million per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 189 (nanogram per milliliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.90 (thousand per microliter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 31.8 (percent)\n- MCV [Entitic volume] by Automated count: 75.6 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.23 (thousand per microliter)\n- Leukocytes [#/volume] in Body fluid by Manual count: 699.0 (milli-international unit per milliliter)\n- MCH [Entitic mass] by Automated count: 21.2 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.0 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Disorder of bone\n- Hemochromatosis following repeated red blood cell transfusion\n- Beta thalassemia\n- Disorder of iron metabolism\n- Acquired hypothyroidism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-12-11 00:00:00, ended at 2020-12-11 00:00:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 2.05 (nanogram per deciliter)\n- Triiodothyronine (T3) [Mass/volume] in Serum or Plasma: 55 (nanogram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of iron metabolism\n- Acquired hypothyroidism\n- Primary diagnosis: Beta thalassemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-12-11 09:50:00, ended at 2020-12-11 23:59:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Transfusion, blood or blood components\n\n### Condition\n- Hereditary hemolytic anemia\n- Beta thalassemia\n- Hemochromatosis following repeated red blood cell transfusion\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2020-12-11, presumably until 2020-12-11\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2020-12-11, presumably until 2020-12-11\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-12-18 00:00:00, ended at 2020-12-18 00:00:00\nThe patient in this visit was 40 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Insomnia\n\n### Drug\n- zolpidem tartrate 6.25 MG Extended Release Oral Tablet, through Oral route, started on 2020-12-18, presumably until 2021-02-09, with intended 0 refill(s). Instructions: take 1 Tab (6.25 mg total) by mouth every bedtime as needed for Insomnia\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-01-09 13:27:27, ended at 2021-01-09 14:12:04\nThe patient in this visit was 41 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Open wound of ankle\n\n### Drug\n- trazodone hydrochloride 50 MG Oral Tablet, through Oral route, started on 2021-01-09, presumably until 2021-04-05, with intended 0 refill(s). Instructions: take 1 Tab (50 mg total) by mouth every bedtime Please take 30m prior to when you would like to go to bed.\n- melatonin 3 MG Oral Tablet, through Oral route, started on 2021-01-09, presumably until 2022-01-09, with intended 0 refill(s). Instructions: take 1 Tab (3 mg total) by mouth every bedtime Please take 30m prior to when you would like to go to bed.\n- gabapentin 100 MG Oral Capsule, started on 2021-01-09, presumably until 2021-05-01, with intended 0 refill(s). Instructions: Take 1 tab in the morning and afternoon for pain. Take up to three tabs at night 30m prior to bedtime.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-01-10 00:00:00, ended at 2021-01-10 00:00:00\nThe patient in this visit was 41 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- carvedilol 6.25 MG Oral Tablet, started on 2021-01-11, presumably until 2022-01-17, with intended 3 refill(s). Instructions: GENERIC FOR COREG, TAKE 1 TABLET BY MOUTH TWICE DAILY\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Systemic lupus erythematosus within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of lupus means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "a8ba71cd34aa48f5cec8e5ee2ecb2465667be6265201c76aaed0fc99ad568bfd", "prompt_hash": "3c848afae7510fff967af22d69b2d8193123bebf92c34d8c8f14d7256c4b3c65", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 4, "doc": {"person_id": 115971150, "visit_occurrence_id": 189923383, "death_date": null, "visit_concept_name": "Pharmacy visit", "visit_start_datetime": "2021-11-07 00:00:00", "visit_end_datetime": "2021-11-07 00:00:00", "visit_length_in_hours": 0.0, "integrated_visit_record": "## Visit\nThis visit record, was from Pharmacy visit, started at 2021-11-07 00:00:00, ended at 2021-11-07 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 24 HR diltiazem hydrochloride 120 MG Extended Release Oral Capsule, through Oral route, started on 2021-11-07, presumably until 2022-06-05, with intended 3 refill(s). Instructions: take 1 Capsule (120 mg total) by mouth daily\n\n", "approximate_token_count": 134, "patient_first_visit_date": "2020-08-09 00:00:00", "patient_last_visit_date": "2023-01-19 00:00:00", "end_obs_date": "2022-11-07", "hypertension_type": "recurrent", "hypertension_one_year_diagnosis": 1, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "recurrent", "hyperlipidemia_one_year_diagnosis": 1, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 1, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "recurrent", "lupus_one_year_diagnosis": 1, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 1, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 25, "cumulated_visit_num": 25, "cumulated_approximate_token_count": 5858, "visit_cumulated": "## Visit\nThis visit record, was from Case Management Visit, started at 2020-08-09 00:00:00, ended at 2020-08-09 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Heart murmur\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2020-08-09 07:33:00, ended at 2020-08-09 08:13:05\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 61.3 (percent)\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Heart murmur\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-10-06 12:07:02, ended at 2020-10-06 13:02:28\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pain in thoracic spine\n- Low back pain\n- Primary diagnosis: Osteoarthritis of knee\n\n### Drug\n- potassium nitrate 0.05 MG/MG / sodium fluoride 0.011 MG/MG Toothpaste, started on 2020-02-07, presumably until 2021-08-09, with intended 0 refill(s)\n- sertraline 100 MG Oral Tablet, started on 2020-06-16, presumably until 2021-04-05, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH  EVERY DAY\n- chondroitin sulfates 400 MG / glucosamine hydrochloride 500 MG Oral Tablet, through Oral route, presumably until 2021-08-09, with intended 0 refill(s). Instructions: take by mouth daily\n- cholecalciferol, through Oral route, with intended 0 refill(s). Instructions: Take 0.05 g (5,000 units total) by mouth\n- chondroitin sulfates 400 MG / glucosamine hydrochloride 500 MG Oral Capsule, through Oral route, presumably until 2021-06-08, with intended 0 refill(s). Instructions: take by mouth\n- levothyroxine sodium 0.15 MG Oral Tablet, started on 2020-06-16, presumably until 2020-10-28, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH  EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-10-07 00:00:00, ended at 2020-10-07 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Lumbar spondylosis\n- Spondylolisthesis\n- Idiopathic scoliosis of thoracic and lumbar spine\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-10-28 00:00:00, ended at 2020-10-28 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- levothyroxine sodium 0.15 MG Oral Tablet, through Oral route, started on 2020-10-28, presumably until 2021-01-27, with intended 3 refill(s). Instructions: take 1 Tab (150 mcg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-12-27 10:49:04, ended at 2020-12-27 14:59:40\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 77 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.5 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (international unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.47 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 168 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.7 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.3 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 27 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 55 (international unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.28 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.2 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.4 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Body height: 5' 5\" (inch (US))\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 80 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (international unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.8 (percent)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 58 (percent)\n- Platelets [#/volume] in Blood by Automated count: 248 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 21 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.2 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.6 (gram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.5 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 53 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 29.4 (picogram)\n- MCHC [Mass/volume] by Automated count: 31.9 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 92 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 11 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypothyroidism\n- Mixed hyperlipidemia\n- Dermatomyositis\n- Gastroesophageal reflux disease without esophagitis\n- Non-scarring alopecia\n- Seborrheic dermatitis\n\n### Drug\n- atorvastatin 20 MG Oral Tablet, through Oral route, started on 2020-12-27, presumably until 2021-09-26, with intended 3 refill(s). Instructions: take 1 Tab (20 mg total) by mouth daily\n- omeprazole 20 MG Delayed Release Oral Capsule, through Oral route, started on 2020-12-27, presumably until 2021-12-16, with intended 3 refill(s). Instructions: take 20 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-01-26 00:00:00, ended at 2021-01-26 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- levothyroxine sodium 0.15 MG Oral Tablet, through Oral route, started on 2021-01-27, presumably until 2021-11-01, with intended 3 refill(s). Instructions: take 1 Tab (150 mcg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-04-05 00:00:00, ended at 2021-04-05 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sertraline 100 MG Oral Tablet, through Oral route, started on 2021-04-05, presumably until 2022-01-24, with intended 3 refill(s). Instructions: take 1 Tab (100 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2021-05-20 10:27:44, ended at 2021-05-20 12:17:54\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report\n\n### Condition\n- Mixed hyperlipidemia\n- Primary diagnosis: Chest pain\n- Atrial flutter\n- Hypothyroidism\n- Systemic lupus erythematosus\n\n### Drug\n- 0.5 ML varicella zoster virus glycoprotein E, recombinant 0.1 MG/ML Injection, through Intramuscular route, started on 2021-05-20, presumably until 2021-05-20, with intended 1 refill(s). Instructions: inject 0.5 mL into a muscle One Time for 1 dose\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2021-06-08 09:46:14, ended at 2021-06-08 10:51:50\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Atrial fibrillation\n- Heart murmur\n\n### Drug\n- apixaban 5 MG Oral Tablet, through Oral route, started on 2021-05-20, presumably until 2021-07-14, with intended 0 refill(s). Instructions: take 1 Tablet by mouth 2 times a day\n- diltiazem hydrochloride 30 MG Oral Tablet, started on 2021-05-20, presumably until 2021-07-19, with intended 0 refill(s). Instructions: as needed \n- 24 HR diltiazem hydrochloride 180 MG Extended Release Oral Capsule, through Oral route, started on 2021-06-08, presumably until 2021-07-14, with intended 3 refill(s). Instructions: take 1 Capsule (180 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-06-27 00:00:00, ended at 2021-06-27 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Prothrombin time (PT): 11.5 (second)\n- aPTT in Platelet poor plasma by Coagulation assay: 29 (second)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.44 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 88 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 91 (femtoliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.05 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.9 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 64 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.0 (gram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.8 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 10 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23 (percent)\n- MCH [Entitic mass] by Automated count: 29.6 (picogram)\n- MCHC [Mass/volume] by Automated count: 32.4 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.6 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.3 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.6 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 21 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.0 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 289 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2021-06-30 10:20:24, ended at 2021-06-30 11:18:18\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report\n\n### Condition\n- Primary diagnosis: Atrial fibrillation\n- Electrocardiogram abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-07-14 00:00:00, ended at 2021-07-14 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 24 HR diltiazem hydrochloride 120 MG Extended Release Oral Capsule, through Oral route, started on 2021-07-14, presumably until 2021-07-14, with intended 3 refill(s). Instructions: take 1 Capsule (120 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-07-14 00:00:00, ended at 2021-07-14 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- apixaban 5 MG Oral Tablet, through Oral route, started on 2021-07-14, presumably until 2022-07-21, with intended 3 refill(s). Instructions: take 1 Tablet by mouth 2 times a day\n- 24 HR diltiazem hydrochloride 120 MG Extended Release Oral Capsule, through Oral route, started on 2021-07-14, presumably until 2021-11-07, with intended 3 refill(s). Instructions: take 1 Capsule (120 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2021-07-19 10:19:43, ended at 2021-07-19 11:22:39\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report\n\n### Condition\n- Primary diagnosis: Atrial flutter\n- Electrocardiogram abnormal\n- Atrial fibrillation\n\n### Drug\n- diltiazem hydrochloride 30 MG Oral Tablet, started on 2021-07-19, presumably until 2022-06-05, with intended 3 refill(s). Instructions: Take 1 tablet three times daily as needed for palpitations.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2021-08-02 09:57:53, ended at 2021-08-02 10:36:19\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Sleep study, unattended, simultaneous recording of, heart rate, oxygen saturation, respiratory airflow, and respiratory effort (eg, thoracoabdominal movement)\n\n### Condition\n- Atrial fibrillation\n- Obstructive sleep apnea syndrome\n- Cardiac arrhythmia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-08-09 00:00:00, ended at 2021-08-09 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2021-08-09 09:21:15, ended at 2021-08-09 10:13:16\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report\n\n### Condition\n- Primary diagnosis: Cardiomegaly\n- Longstanding persistent atrial fibrillation\n- Non-rheumatic aortic sclerosis\n- Electrocardiogram abnormal\n- Atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-09-01 11:06:00, ended at 2021-09-01 23:59:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-09-01 11:06:00, ended at 2021-09-01 23:59:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; supervision only, without interpretation and report\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; tracing only, without interpretation and report\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; interpretation and report only\n- Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or \n\n### Condition\n- Chest pain\n- Longstanding persistent atrial fibrillation\n- Persistent atrial fibrillation\n- Cardiomegaly\n- Non-rheumatic aortic sclerosis\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-09-24 00:00:00, ended at 2021-09-24 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- atorvastatin 20 MG Oral Tablet, started on 2021-09-26, presumably until 2022-08-11, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH  DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2021-10-05 14:13:41, ended at 2021-10-05 15:15:32\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Abnormal results of cardiovascular function studies\n- Atrial fibrillation\n- Chest pain\n- Primary diagnosis: Atrial flutter\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-10-31 00:00:00, ended at 2021-10-31 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- levothyroxine sodium 0.15 MG Oral Tablet, started on 2021-11-01, presumably until 2021-11-10, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH  DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-11-07 00:00:00, ended at 2021-11-07 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 12 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.7 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 64 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 165 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 90 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.2 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 90 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 311 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 12 (international unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.58 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.2 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20 (percent)\n- MCH [Entitic mass] by Automated count: 29.5 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 5.1 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.5 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.2 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 60 (international unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (international unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 63 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.8 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.8 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4 (percent)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.0 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 61 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.52 (milligram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Fatigue\n- Hypothyroidism\n- Primary diagnosis: Mixed hyperlipidemia\n\n### Drug\n- betamethasone 0.0005 MG/MG Topical Ointment, through Topical route, started on 2021-09-22, presumably until 2021-09-22, with intended 0 refill(s). Instructions: 1 Application by Topical route 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-11-07 00:00:00, ended at 2021-11-07 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 24 HR diltiazem hydrochloride 120 MG Extended Release Oral Capsule, through Oral route, started on 2021-11-07, presumably until 2022-06-05, with intended 3 refill(s). Instructions: take 1 Capsule (120 mg total) by mouth daily\n\n"}, "target": "Yes", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Systemic lupus erythematosus within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-08-09 00:00:00, ended at 2020-08-09 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Heart murmur\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2020-08-09 07:33:00, ended at 2020-08-09 08:13:05\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 61.3 (percent)\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Heart murmur\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-10-06 12:07:02, ended at 2020-10-06 13:02:28\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pain in thoracic spine\n- Low back pain\n- Primary diagnosis: Osteoarthritis of knee\n\n### Drug\n- potassium nitrate 0.05 MG/MG / sodium fluoride 0.011 MG/MG Toothpaste, started on 2020-02-07, presumably until 2021-08-09, with intended 0 refill(s)\n- sertraline 100 MG Oral Tablet, started on 2020-06-16, presumably until 2021-04-05, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH  EVERY DAY\n- chondroitin sulfates 400 MG / glucosamine hydrochloride 500 MG Oral Tablet, through Oral route, presumably until 2021-08-09, with intended 0 refill(s). Instructions: take by mouth daily\n- cholecalciferol, through Oral route, with intended 0 refill(s). Instructions: Take 0.05 g (5,000 units total) by mouth\n- chondroitin sulfates 400 MG / glucosamine hydrochloride 500 MG Oral Capsule, through Oral route, presumably until 2021-06-08, with intended 0 refill(s). Instructions: take by mouth\n- levothyroxine sodium 0.15 MG Oral Tablet, started on 2020-06-16, presumably until 2020-10-28, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH  EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-10-07 00:00:00, ended at 2020-10-07 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Lumbar spondylosis\n- Spondylolisthesis\n- Idiopathic scoliosis of thoracic and lumbar spine\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-10-28 00:00:00, ended at 2020-10-28 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- levothyroxine sodium 0.15 MG Oral Tablet, through Oral route, started on 2020-10-28, presumably until 2021-01-27, with intended 3 refill(s). Instructions: take 1 Tab (150 mcg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-12-27 10:49:04, ended at 2020-12-27 14:59:40\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 77 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.5 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (international unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.47 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 168 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.7 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.3 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 27 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 55 (international unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.28 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.2 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.4 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Body height: 5' 5\" (inch (US))\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 80 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (international unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.8 (percent)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 58 (percent)\n- Platelets [#/volume] in Blood by Automated count: 248 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 21 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.2 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.6 (gram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.5 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 53 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 29.4 (picogram)\n- MCHC [Mass/volume] by Automated count: 31.9 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 92 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 11 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypothyroidism\n- Mixed hyperlipidemia\n- Dermatomyositis\n- Gastroesophageal reflux disease without esophagitis\n- Non-scarring alopecia\n- Seborrheic dermatitis\n\n### Drug\n- atorvastatin 20 MG Oral Tablet, through Oral route, started on 2020-12-27, presumably until 2021-09-26, with intended 3 refill(s). Instructions: take 1 Tab (20 mg total) by mouth daily\n- omeprazole 20 MG Delayed Release Oral Capsule, through Oral route, started on 2020-12-27, presumably until 2021-12-16, with intended 3 refill(s). Instructions: take 20 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-01-26 00:00:00, ended at 2021-01-26 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- levothyroxine sodium 0.15 MG Oral Tablet, through Oral route, started on 2021-01-27, presumably until 2021-11-01, with intended 3 refill(s). Instructions: take 1 Tab (150 mcg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-04-05 00:00:00, ended at 2021-04-05 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sertraline 100 MG Oral Tablet, through Oral route, started on 2021-04-05, presumably until 2022-01-24, with intended 3 refill(s). Instructions: take 1 Tab (100 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2021-05-20 10:27:44, ended at 2021-05-20 12:17:54\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report\n\n### Condition\n- Mixed hyperlipidemia\n- Primary diagnosis: Chest pain\n- Atrial flutter\n- Hypothyroidism\n- Systemic lupus erythematosus\n\n### Drug\n- 0.5 ML varicella zoster virus glycoprotein E, recombinant 0.1 MG/ML Injection, through Intramuscular route, started on 2021-05-20, presumably until 2021-05-20, with intended 1 refill(s). Instructions: inject 0.5 mL into a muscle One Time for 1 dose\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2021-06-08 09:46:14, ended at 2021-06-08 10:51:50\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Atrial fibrillation\n- Heart murmur\n\n### Drug\n- apixaban 5 MG Oral Tablet, through Oral route, started on 2021-05-20, presumably until 2021-07-14, with intended 0 refill(s). Instructions: take 1 Tablet by mouth 2 times a day\n- diltiazem hydrochloride 30 MG Oral Tablet, started on 2021-05-20, presumably until 2021-07-19, with intended 0 refill(s). Instructions: as needed \n- 24 HR diltiazem hydrochloride 180 MG Extended Release Oral Capsule, through Oral route, started on 2021-06-08, presumably until 2021-07-14, with intended 3 refill(s). Instructions: take 1 Capsule (180 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-06-27 00:00:00, ended at 2021-06-27 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Prothrombin time (PT): 11.5 (second)\n- aPTT in Platelet poor plasma by Coagulation assay: 29 (second)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.44 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 88 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 91 (femtoliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.05 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.9 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 64 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.0 (gram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.8 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 10 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23 (percent)\n- MCH [Entitic mass] by Automated count: 29.6 (picogram)\n- MCHC [Mass/volume] by Automated count: 32.4 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.6 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.3 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.6 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 21 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.0 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 289 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2021-06-30 10:20:24, ended at 2021-06-30 11:18:18\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report\n\n### Condition\n- Primary diagnosis: Atrial fibrillation\n- Electrocardiogram abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-07-14 00:00:00, ended at 2021-07-14 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 24 HR diltiazem hydrochloride 120 MG Extended Release Oral Capsule, through Oral route, started on 2021-07-14, presumably until 2021-07-14, with intended 3 refill(s). Instructions: take 1 Capsule (120 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-07-14 00:00:00, ended at 2021-07-14 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- apixaban 5 MG Oral Tablet, through Oral route, started on 2021-07-14, presumably until 2022-07-21, with intended 3 refill(s). Instructions: take 1 Tablet by mouth 2 times a day\n- 24 HR diltiazem hydrochloride 120 MG Extended Release Oral Capsule, through Oral route, started on 2021-07-14, presumably until 2021-11-07, with intended 3 refill(s). Instructions: take 1 Capsule (120 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2021-07-19 10:19:43, ended at 2021-07-19 11:22:39\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report\n\n### Condition\n- Primary diagnosis: Atrial flutter\n- Electrocardiogram abnormal\n- Atrial fibrillation\n\n### Drug\n- diltiazem hydrochloride 30 MG Oral Tablet, started on 2021-07-19, presumably until 2022-06-05, with intended 3 refill(s). Instructions: Take 1 tablet three times daily as needed for palpitations.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2021-08-02 09:57:53, ended at 2021-08-02 10:36:19\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Sleep study, unattended, simultaneous recording of, heart rate, oxygen saturation, respiratory airflow, and respiratory effort (eg, thoracoabdominal movement)\n\n### Condition\n- Atrial fibrillation\n- Obstructive sleep apnea syndrome\n- Cardiac arrhythmia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-08-09 00:00:00, ended at 2021-08-09 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2021-08-09 09:21:15, ended at 2021-08-09 10:13:16\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report\n\n### Condition\n- Primary diagnosis: Cardiomegaly\n- Longstanding persistent atrial fibrillation\n- Non-rheumatic aortic sclerosis\n- Electrocardiogram abnormal\n- Atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-09-01 11:06:00, ended at 2021-09-01 23:59:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-09-01 11:06:00, ended at 2021-09-01 23:59:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; supervision only, without interpretation and report\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; tracing only, without interpretation and report\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; interpretation and report only\n- Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or \n\n### Condition\n- Chest pain\n- Longstanding persistent atrial fibrillation\n- Persistent atrial fibrillation\n- Cardiomegaly\n- Non-rheumatic aortic sclerosis\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-09-24 00:00:00, ended at 2021-09-24 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- atorvastatin 20 MG Oral Tablet, started on 2021-09-26, presumably until 2022-08-11, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH  DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2021-10-05 14:13:41, ended at 2021-10-05 15:15:32\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Abnormal results of cardiovascular function studies\n- Atrial fibrillation\n- Chest pain\n- Primary diagnosis: Atrial flutter\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-10-31 00:00:00, ended at 2021-10-31 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- levothyroxine sodium 0.15 MG Oral Tablet, started on 2021-11-01, presumably until 2021-11-10, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH  DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-11-07 00:00:00, ended at 2021-11-07 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 12 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.7 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 64 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 165 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 90 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.2 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 90 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 311 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 12 (international unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.58 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.2 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20 (percent)\n- MCH [Entitic mass] by Automated count: 29.5 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 5.1 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.5 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.2 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 60 (international unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (international unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 63 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.8 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.8 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4 (percent)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.0 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 61 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.52 (milligram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Fatigue\n- Hypothyroidism\n- Primary diagnosis: Mixed hyperlipidemia\n\n### Drug\n- betamethasone 0.0005 MG/MG Topical Ointment, through Topical route, started on 2021-09-22, presumably until 2021-09-22, with intended 0 refill(s). Instructions: 1 Application by Topical route 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-11-07 00:00:00, ended at 2021-11-07 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 24 HR diltiazem hydrochloride 120 MG Extended Release Oral Capsule, through Oral route, started on 2021-11-07, presumably until 2022-06-05, with intended 3 refill(s). Instructions: take 1 Capsule (120 mg total) by mouth daily\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Systemic lupus erythematosus within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of lupus means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "54260b58931116a9dd0e6a76d8f2806a982536de46a85e70412d2f26eb477872", "prompt_hash": "237e5525a2b778f0f8b6cd31079a606e8cb1bf3e4b7986e73e536cb52c75bda8", "target_hash": "85a39ab345d672ff8ca9b9c6876f3adcacf45ee7c1e2dbd2408fd338bd55e07e", "exact_match": 0.0, "f1_gu_yn": [1, 0], "recall_gu_yn": [1, 0]}
{"doc_id": 5, "doc": {"person_id": 115972272, "visit_occurrence_id": 183370215, "death_date": null, "visit_concept_name": "Telehealth", "visit_start_datetime": "2021-07-02 16:21:24", "visit_end_datetime": "2021-07-02 16:25:30", "visit_length_in_hours": 0.06833333333333333, "integrated_visit_record": "## Visit\nThis visit record, was from Telehealth, started at 2021-07-02 16:21:24, ended at 2021-07-02 16:25:30\nThe patient in this visit was 45 years old, Black or African American, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Constipation\n\n### Drug\n- linaclotide 0.145 MG Oral Capsule, through Oral route, started on 2021-07-02, presumably until 2022-01-14, with intended 5 refill(s). Instructions: take 145 mcg by mouth every day\n\n", "approximate_token_count": 130, "patient_first_visit_date": "2008-08-31 18:00:00", "patient_last_visit_date": "2022-08-27 00:00:00", "end_obs_date": "2022-07-02", "hypertension_type": "new", "hypertension_one_year_diagnosis": 0, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "new", "hyperlipidemia_one_year_diagnosis": 0, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "recurrent", "lupus_one_year_diagnosis": 1, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 21, "cumulated_visit_num": 21, "cumulated_approximate_token_count": 4819, "visit_cumulated": "## Visit\nThis visit record, was from Emergency Room Visit, started at 2008-08-31 18:00:00, ended at 2008-09-01 01:07:00\nThe patient in this visit was 32 years old, Black or African American, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 86 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.7 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.41 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.9 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.60 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 111 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.5 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.3 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.40 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.1 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 212 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 7.45 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 312 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 102 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 4.9 (percent)\n- MCH [Entitic mass] by Automated count: 28.8 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 87.8 (percent)\n- MCV [Entitic volume] by Automated count: 84.0 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Epigastric pain\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-04-17 14:15:22, ended at 2016-04-17 15:07:09\nThe patient in this visit was 39 years old, Black or African American, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Injection, intralesional; up to and including 7 lesions\n\n### Condition\n- Systemic lupus erythematosus\n- Primary diagnosis: Traumatic or non-traumatic injury\n- Hypertrophic scar\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-04-21 00:00:00, ended at 2016-04-21 00:00:00\nThe patient in this visit was 39 years old, Black or African American, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- cephalexin 500 MG Oral Capsule, through Oral route, started on 2016-04-21, presumably until 2016-05-01, with intended 0 refill(s). Instructions: take 1 Cap by mouth 3 times a day for 10 days Stop medication immediately if rash or flu like symptoms develop and notify physician.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-07-25 12:27:24, ended at 2016-07-25 13:09:51\nThe patient in this visit was 40 years old, Black or African American, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Discoid lupus erythematosus\n\n### Drug\n- folic acid 1 MG Oral Tablet, through Oral route, started on 2016-07-25, presumably until 2016-11-24, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily Use as directed\n- thalidomide 100 MG Oral Capsule, started on 2016-07-25, presumably until 2016-09-04, with intended 0 refill(s). Instructions: Take 1 capsule by mouth daily.\n- methotrexate 2.5 MG Oral Tablet, started on 2016-07-25, presumably until 2016-11-24, with intended 3 refill(s). Instructions: Take 8 tablets weekly\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-09-04 00:00:00, ended at 2016-09-04 00:00:00\nThe patient in this visit was 40 years old, Black or African American, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- thalidomide 100 MG Oral Capsule, started on 2016-09-05, presumably until 2016-10-03, with intended 0 refill(s). Instructions: Take 1 capsule by mouth daily. Auth # [000000]\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-10-03 00:00:00, ended at 2016-10-03 00:00:00\nThe patient in this visit was 40 years old, Black or African American, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- thalidomide 100 MG Oral Capsule, started on 2016-10-05, presumably until 2016-10-30, with intended 0 refill(s). Instructions: Take 1 capsule by mouth daily. Auth # [000000]\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-10-28 00:00:00, ended at 2016-10-28 00:00:00\nThe patient in this visit was 40 years old, Black or African American, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- thalidomide 100 MG Oral Capsule, started on 2016-10-28, presumably until 2016-10-28, with intended 0 refill(s). Instructions: Take 1 capsule by mouth daily. Auth # [000000]\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-10-30 00:00:00, ended at 2016-10-30 00:00:00\nThe patient in this visit was 40 years old, Black or African American, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- thalidomide 100 MG Oral Capsule, started on 2016-10-30, presumably until 2017-01-06, with intended 0 refill(s). Instructions: Take 1 capsule by mouth daily. Auth # [000000]\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-11-24 00:00:00, ended at 2016-11-24 00:00:00\nThe patient in this visit was 40 years old, Black or African American, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- folic acid 1 MG Oral Tablet, through Oral route, started on 2016-11-26, presumably until 2017-11-26, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily Use as directed\n- methotrexate 2.5 MG Oral Tablet, started on 2016-11-26, presumably until 2016-11-26, with intended 3 refill(s). Instructions: Take 8 tablets weekly\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-12-01 00:00:00, ended at 2016-12-01 00:00:00\nThe patient in this visit was 40 years old, Black or African American, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- thalidomide 100 MG Oral Capsule, started on 2016-12-01, presumably until 2016-12-01, with intended 0 refill(s). Instructions: Take 1 capsule by mouth daily. Auth # [000000]\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-01-02 00:00:00, ended at 2017-01-02 00:00:00\nThe patient in this visit was 40 years old, Black or African American, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- thalidomide 100 MG Oral Capsule, started on 2017-01-02, presumably until 2017-01-02, with intended 0 refill(s). Instructions: Take 1 capsule by mouth daily. Auth # [000000]\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-01-06 00:00:00, ended at 2017-01-06 00:00:00\nThe patient in this visit was 40 years old, Black or African American, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- thalidomide 100 MG Oral Capsule, started on 2017-01-06, presumably until 2021-03-01, with intended 0 refill(s). Instructions: Take 1 capsule by mouth daily. Auth # [000000]\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-01-28 00:00:00, ended at 2017-01-28 00:00:00\nThe patient in this visit was 40 years old, Black or African American, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- thalidomide 100 MG Oral Capsule, started on 2017-01-28, presumably until 2017-01-28, with intended 0 refill(s). Instructions: Take 1 capsule by mouth daily. Auth # [000000]\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-03-01 00:00:00, ended at 2021-03-01 00:00:00\nThe patient in this visit was 44 years old, Black or African American, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- thalidomide 100 MG Oral Capsule, started on 2021-03-01, presumably until 2021-04-11, with intended 0 refill(s). Instructions: Take 1 capsule by mouth daily. Auth # [000000]\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-04-11 00:00:00, ended at 2021-04-11 00:00:00\nThe patient in this visit was 44 years old, Black or African American, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- thalidomide 100 MG Oral Capsule, started on 2021-04-12, presumably until 2021-05-15, with intended 0 refill(s). Instructions: Take 1 capsule by mouth daily. Auth # [000000]\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-05-15 00:00:00, ended at 2021-05-15 00:00:00\nThe patient in this visit was 44 years old, Black or African American, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- thalidomide 100 MG Oral Capsule, started on 2021-05-15, presumably until 2021-06-13, with intended 0 refill(s). Instructions: Take 1 capsule by mouth daily. Auth #[000000]\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-06-04 14:19:08, ended at 2021-06-04 14:45:07\nThe patient in this visit was 44 years old, Black or African American, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of upper gastrointestinal tract\n- Primary diagnosis: Epigastric pain\n\n### Drug\n- folic acid 1 MG Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: take 1 mg by mouth\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: take 50 mg by mouth daily \n- zolpidem tartrate 5 MG Oral Tablet, started on 2020-12-20, presumably until 2020-12-20, with intended 0 refill(s). Instructions: GENERIC FOR AMBIEN. TAKE 1 TABLET BY MOUTH AT BEDTIME AS NEEDED FOR SLEEP\n- ergocalciferol 1.25 MG Oral Capsule, through Oral route, started on 2020-11-30, presumably until 2020-11-30, with intended 0 refill(s). Instructions: take 1 Capsule by mouth\n- hydroxychloroquine sulfate 200 MG Oral Tablet, through Oral route, started on 2021-01-06, presumably until 2022-04-06, with intended 0 refill(s). Instructions: take 200 mg by mouth daily\n- cetirizine hydrochloride 10 MG Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: take 10 mg by mouth daily\n- belimumab 400 MG Injection, through Intravenous route, started on 2021-04-09, presumably until 2021-04-09, with intended 0 refill(s). Instructions: by Intravenous route every month\n- topiramate 50 MG Oral Tablet, through Oral route, started on 2021-01-09, presumably until 2021-01-09, with intended 0 refill(s). Instructions: take 50 mg by mouth\n- ibuprofen 800 MG Oral Tablet, through Oral route, started on 2020-11-30, presumably until 2020-11-30, with intended 0 refill(s). Instructions: take 800 mg by mouth\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2021-01-09, presumably until 2021-01-09, with intended 0 refill(s). Instructions: take 50 mg by mouth\n- cyclobenzaprine hydrochloride 10 MG Oral Tablet, started on 2021-01-06, presumably until 2021-01-06, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH TWICE DAILY AS NEEDED FOR MUSCLE SPASMS\n- clonazepam 0.5 MG Oral Tablet, started on 2021-01-14, presumably until 2021-01-14, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY NIGHT AT BEDTIME. MAY INCREASE TO 2 TABLETS EVERY NIGHT AT BEDTIME FOR SLEEP WALKING\n- ondansetron 4 MG Disintegrating Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: take 4 mg by mouth \n- testosterone cypionate 200 MG/ML Injectable Solution, through Subcutaneous route, started on 2021-04-05, presumably until 2021-04-05, with intended 0 refill(s). Instructions: inject 50 mg subcutaneous (under the skin)\n- gabapentin 100 MG Oral Capsule, through Oral route, with intended 0 refill(s). Instructions: take 100 mg by mouth\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2021-04-09, presumably until 2021-04-09, with intended 0 refill(s). Instructions: take 81 mg by mouth daily\n- pilocarpine hydrochloride 5 MG Oral Tablet, started on 2021-01-11, presumably until 2021-01-11, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH DAILY AT BEDTIME\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-06-13 00:00:00, ended at 2021-06-13 00:00:00\nThe patient in this visit was 45 years old, Black or African American, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- thalidomide 100 MG Oral Capsule, started on 2021-06-13, presumably until 2021-07-18, with intended 0 refill(s). Instructions: Take 1 capsule by mouth daily. Auth #[000000]\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2021-06-18 13:53:00, ended at 2021-06-18 14:48:00\nThe patient in this visit was 45 years old, Black or African American, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Primary diagnosis: Chest pain\n- Dyspnea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2021-06-18 15:34:00, ended at 2021-06-18 17:33:00\nThe patient in this visit was 45 years old, Black or African American, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Catecholamines [Interpretation] in Plasma Narrative: 54.3 (femtoliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.0 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.83 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.36 (million per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.02 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 310 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 18 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 14.0 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.6 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.17 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 79.5 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 55.8 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 82 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 7 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Body height: 5' 2.008\" (inch (US))\n- Eosinophils [#/volume] in Blood by Automated count: 0.32 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 65 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.5 (percent)\n- MCHC [Mass/volume] by Automated count: 32.9 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 2.4 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 111 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.2 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 27.3 (percent)\n- Chromatin IgG Ab [Units/volume] in Serum or Plasma: <0.27 (microgram per milliliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.6 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.96 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 26.1 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.69 (thousand per microliter)\n\n### Procedure\n- Radiologic examination, chest; single view\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary diagnosis: Chest pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-07-02 16:21:24, ended at 2021-07-02 16:25:30\nThe patient in this visit was 45 years old, Black or African American, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Constipation\n\n### Drug\n- linaclotide 0.145 MG Oral Capsule, through Oral route, started on 2021-07-02, presumably until 2022-01-14, with intended 5 refill(s). Instructions: take 145 mcg by mouth every day\n\n"}, "target": "Yes", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Systemic lupus erythematosus within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2008-08-31 18:00:00, ended at 2008-09-01 01:07:00\nThe patient in this visit was 32 years old, Black or African American, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 86 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.7 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.41 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.9 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.60 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 111 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.5 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.3 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.40 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.1 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 212 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 7.45 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 312 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 102 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 4.9 (percent)\n- MCH [Entitic mass] by Automated count: 28.8 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 87.8 (percent)\n- MCV [Entitic volume] by Automated count: 84.0 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Epigastric pain\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-04-17 14:15:22, ended at 2016-04-17 15:07:09\nThe patient in this visit was 39 years old, Black or African American, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Injection, intralesional; up to and including 7 lesions\n\n### Condition\n- Systemic lupus erythematosus\n- Primary diagnosis: Traumatic or non-traumatic injury\n- Hypertrophic scar\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-04-21 00:00:00, ended at 2016-04-21 00:00:00\nThe patient in this visit was 39 years old, Black or African American, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- cephalexin 500 MG Oral Capsule, through Oral route, started on 2016-04-21, presumably until 2016-05-01, with intended 0 refill(s). Instructions: take 1 Cap by mouth 3 times a day for 10 days Stop medication immediately if rash or flu like symptoms develop and notify physician.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-07-25 12:27:24, ended at 2016-07-25 13:09:51\nThe patient in this visit was 40 years old, Black or African American, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Discoid lupus erythematosus\n\n### Drug\n- folic acid 1 MG Oral Tablet, through Oral route, started on 2016-07-25, presumably until 2016-11-24, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily Use as directed\n- thalidomide 100 MG Oral Capsule, started on 2016-07-25, presumably until 2016-09-04, with intended 0 refill(s). Instructions: Take 1 capsule by mouth daily.\n- methotrexate 2.5 MG Oral Tablet, started on 2016-07-25, presumably until 2016-11-24, with intended 3 refill(s). Instructions: Take 8 tablets weekly\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-09-04 00:00:00, ended at 2016-09-04 00:00:00\nThe patient in this visit was 40 years old, Black or African American, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- thalidomide 100 MG Oral Capsule, started on 2016-09-05, presumably until 2016-10-03, with intended 0 refill(s). Instructions: Take 1 capsule by mouth daily. Auth # [000000]\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-10-03 00:00:00, ended at 2016-10-03 00:00:00\nThe patient in this visit was 40 years old, Black or African American, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- thalidomide 100 MG Oral Capsule, started on 2016-10-05, presumably until 2016-10-30, with intended 0 refill(s). Instructions: Take 1 capsule by mouth daily. Auth # [000000]\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-10-28 00:00:00, ended at 2016-10-28 00:00:00\nThe patient in this visit was 40 years old, Black or African American, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- thalidomide 100 MG Oral Capsule, started on 2016-10-28, presumably until 2016-10-28, with intended 0 refill(s). Instructions: Take 1 capsule by mouth daily. Auth # [000000]\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-10-30 00:00:00, ended at 2016-10-30 00:00:00\nThe patient in this visit was 40 years old, Black or African American, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- thalidomide 100 MG Oral Capsule, started on 2016-10-30, presumably until 2017-01-06, with intended 0 refill(s). Instructions: Take 1 capsule by mouth daily. Auth # [000000]\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-11-24 00:00:00, ended at 2016-11-24 00:00:00\nThe patient in this visit was 40 years old, Black or African American, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- folic acid 1 MG Oral Tablet, through Oral route, started on 2016-11-26, presumably until 2017-11-26, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily Use as directed\n- methotrexate 2.5 MG Oral Tablet, started on 2016-11-26, presumably until 2016-11-26, with intended 3 refill(s). Instructions: Take 8 tablets weekly\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-12-01 00:00:00, ended at 2016-12-01 00:00:00\nThe patient in this visit was 40 years old, Black or African American, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- thalidomide 100 MG Oral Capsule, started on 2016-12-01, presumably until 2016-12-01, with intended 0 refill(s). Instructions: Take 1 capsule by mouth daily. Auth # [000000]\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-01-02 00:00:00, ended at 2017-01-02 00:00:00\nThe patient in this visit was 40 years old, Black or African American, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- thalidomide 100 MG Oral Capsule, started on 2017-01-02, presumably until 2017-01-02, with intended 0 refill(s). Instructions: Take 1 capsule by mouth daily. Auth # [000000]\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-01-06 00:00:00, ended at 2017-01-06 00:00:00\nThe patient in this visit was 40 years old, Black or African American, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- thalidomide 100 MG Oral Capsule, started on 2017-01-06, presumably until 2021-03-01, with intended 0 refill(s). Instructions: Take 1 capsule by mouth daily. Auth # [000000]\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-01-28 00:00:00, ended at 2017-01-28 00:00:00\nThe patient in this visit was 40 years old, Black or African American, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- thalidomide 100 MG Oral Capsule, started on 2017-01-28, presumably until 2017-01-28, with intended 0 refill(s). Instructions: Take 1 capsule by mouth daily. Auth # [000000]\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-03-01 00:00:00, ended at 2021-03-01 00:00:00\nThe patient in this visit was 44 years old, Black or African American, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- thalidomide 100 MG Oral Capsule, started on 2021-03-01, presumably until 2021-04-11, with intended 0 refill(s). Instructions: Take 1 capsule by mouth daily. Auth # [000000]\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-04-11 00:00:00, ended at 2021-04-11 00:00:00\nThe patient in this visit was 44 years old, Black or African American, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- thalidomide 100 MG Oral Capsule, started on 2021-04-12, presumably until 2021-05-15, with intended 0 refill(s). Instructions: Take 1 capsule by mouth daily. Auth # [000000]\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-05-15 00:00:00, ended at 2021-05-15 00:00:00\nThe patient in this visit was 44 years old, Black or African American, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- thalidomide 100 MG Oral Capsule, started on 2021-05-15, presumably until 2021-06-13, with intended 0 refill(s). Instructions: Take 1 capsule by mouth daily. Auth #[000000]\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-06-04 14:19:08, ended at 2021-06-04 14:45:07\nThe patient in this visit was 44 years old, Black or African American, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of upper gastrointestinal tract\n- Primary diagnosis: Epigastric pain\n\n### Drug\n- folic acid 1 MG Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: take 1 mg by mouth\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: take 50 mg by mouth daily \n- zolpidem tartrate 5 MG Oral Tablet, started on 2020-12-20, presumably until 2020-12-20, with intended 0 refill(s). Instructions: GENERIC FOR AMBIEN. TAKE 1 TABLET BY MOUTH AT BEDTIME AS NEEDED FOR SLEEP\n- ergocalciferol 1.25 MG Oral Capsule, through Oral route, started on 2020-11-30, presumably until 2020-11-30, with intended 0 refill(s). Instructions: take 1 Capsule by mouth\n- hydroxychloroquine sulfate 200 MG Oral Tablet, through Oral route, started on 2021-01-06, presumably until 2022-04-06, with intended 0 refill(s). Instructions: take 200 mg by mouth daily\n- cetirizine hydrochloride 10 MG Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: take 10 mg by mouth daily\n- belimumab 400 MG Injection, through Intravenous route, started on 2021-04-09, presumably until 2021-04-09, with intended 0 refill(s). Instructions: by Intravenous route every month\n- topiramate 50 MG Oral Tablet, through Oral route, started on 2021-01-09, presumably until 2021-01-09, with intended 0 refill(s). Instructions: take 50 mg by mouth\n- ibuprofen 800 MG Oral Tablet, through Oral route, started on 2020-11-30, presumably until 2020-11-30, with intended 0 refill(s). Instructions: take 800 mg by mouth\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2021-01-09, presumably until 2021-01-09, with intended 0 refill(s). Instructions: take 50 mg by mouth\n- cyclobenzaprine hydrochloride 10 MG Oral Tablet, started on 2021-01-06, presumably until 2021-01-06, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH TWICE DAILY AS NEEDED FOR MUSCLE SPASMS\n- clonazepam 0.5 MG Oral Tablet, started on 2021-01-14, presumably until 2021-01-14, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY NIGHT AT BEDTIME. MAY INCREASE TO 2 TABLETS EVERY NIGHT AT BEDTIME FOR SLEEP WALKING\n- ondansetron 4 MG Disintegrating Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: take 4 mg by mouth \n- testosterone cypionate 200 MG/ML Injectable Solution, through Subcutaneous route, started on 2021-04-05, presumably until 2021-04-05, with intended 0 refill(s). Instructions: inject 50 mg subcutaneous (under the skin)\n- gabapentin 100 MG Oral Capsule, through Oral route, with intended 0 refill(s). Instructions: take 100 mg by mouth\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2021-04-09, presumably until 2021-04-09, with intended 0 refill(s). Instructions: take 81 mg by mouth daily\n- pilocarpine hydrochloride 5 MG Oral Tablet, started on 2021-01-11, presumably until 2021-01-11, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH DAILY AT BEDTIME\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-06-13 00:00:00, ended at 2021-06-13 00:00:00\nThe patient in this visit was 45 years old, Black or African American, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- thalidomide 100 MG Oral Capsule, started on 2021-06-13, presumably until 2021-07-18, with intended 0 refill(s). Instructions: Take 1 capsule by mouth daily. Auth #[000000]\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2021-06-18 13:53:00, ended at 2021-06-18 14:48:00\nThe patient in this visit was 45 years old, Black or African American, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Primary diagnosis: Chest pain\n- Dyspnea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2021-06-18 15:34:00, ended at 2021-06-18 17:33:00\nThe patient in this visit was 45 years old, Black or African American, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Catecholamines [Interpretation] in Plasma Narrative: 54.3 (femtoliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.0 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.83 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.36 (million per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.02 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 310 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 18 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 14.0 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.6 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.17 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 79.5 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 55.8 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 82 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 7 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Body height: 5' 2.008\" (inch (US))\n- Eosinophils [#/volume] in Blood by Automated count: 0.32 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 65 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.5 (percent)\n- MCHC [Mass/volume] by Automated count: 32.9 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 2.4 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 111 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.2 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 27.3 (percent)\n- Chromatin IgG Ab [Units/volume] in Serum or Plasma: <0.27 (microgram per milliliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.6 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.96 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 26.1 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.69 (thousand per microliter)\n\n### Procedure\n- Radiologic examination, chest; single view\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary diagnosis: Chest pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-07-02 16:21:24, ended at 2021-07-02 16:25:30\nThe patient in this visit was 45 years old, Black or African American, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Constipation\n\n### Drug\n- linaclotide 0.145 MG Oral Capsule, through Oral route, started on 2021-07-02, presumably until 2022-01-14, with intended 5 refill(s). Instructions: take 145 mcg by mouth every day\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Systemic lupus erythematosus within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of lupus means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "e1b7e298260cdd58f50f811d547c56c320483f822d4cc7a6c73921495df64fbe", "prompt_hash": "5fd75662ffa998744670fb0e869229a78a3139c5af0daaad52bad12fada536e1", "target_hash": "85a39ab345d672ff8ca9b9c6876f3adcacf45ee7c1e2dbd2408fd338bd55e07e", "exact_match": 0.0, "f1_gu_yn": [1, 0], "recall_gu_yn": [1, 0]}
{"doc_id": 6, "doc": {"person_id": 115973555, "visit_occurrence_id": 139024248, "death_date": null, "visit_concept_name": "Outpatient Visit", "visit_start_datetime": "2019-07-16 00:00:00", "visit_end_datetime": "2019-07-16 00:00:00", "visit_length_in_hours": 0.0, "integrated_visit_record": "## Visit\nThis visit record, was from Outpatient Visit, started at 2019-07-16 00:00:00, ended at 2019-07-16 00:00:00\nThe patient in this visit was 25 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Suspected fetal abnormality affecting management of mother\n- Illness\n\n### Drug\n- No drugs.\n\n", "approximate_token_count": 93, "patient_first_visit_date": "2016-11-04 20:17:00", "patient_last_visit_date": "2021-06-28 10:28:53", "end_obs_date": "2020-07-15", "hypertension_type": "new", "hypertension_one_year_diagnosis": 0, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "new", "hyperlipidemia_one_year_diagnosis": 0, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "recurrent", "lupus_one_year_diagnosis": 1, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 23, "cumulated_visit_num": 23, "cumulated_approximate_token_count": 6339, "visit_cumulated": "## Visit\nThis visit record, was from Inpatient Visit, started at 2016-11-04 20:17:00, ended at 2016-11-10 16:07:00\nThe patient in this visit was 22 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 247 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 40 (milligram per deciliter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 159 (milligram per deciliter)\n- Complement C3 [Mass/volume] in Serum or Plasma: 60 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 28.2 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 275 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 59 (unit per liter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 5.0 (ratio)\n- Iron [Mass/volume] in Serum or Plasma: 69 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 31 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Monocytes [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.1 (percent)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Body height: 5' 2.795\" (inch (US))\n- Cholesterol [Mass/volume] in Serum or Plasma: 199 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 121 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 1.16 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 55 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 192 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.6 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Cardiolipin IgA Ab [Units/volume] in Serum by Immunoassay: 4.5 (IgA phospholipid unit)\n- Ferritin [Mass/volume] in Serum or Plasma: 536.6 (nanogram per milliliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 87.8 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 3.0 (ratio)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.40 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.18 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 163 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Erythrocytes [#/volume] in Cerebral spinal fluid: <1 (per microliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Leukocytes [#/volume] in Cerebral spinal fluid: 1 (per microliter)\n- MCV [Entitic volume] by Automated count: 82.9 (femtoliter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 265 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 8.8 (gram per deciliter)\n- Protein [Mass/volume] in Cerebral spinal fluid: 27 (milligram per deciliter)\n- Thrombin time: 16.5 (second)\n- aPTT in Platelet poor plasma by Coagulation assay: 24.5 (second)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 3830 (microgram of fibrinogen equivalent unit per milliliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 1.6 (thousand per microliter)\n- Prothrombin time (PT): 13.4 (second)\n\n### Procedure\n- Introduction of Other Antineoplastic into Spinal Canal, Percutaneous Approach\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Radiologic examination, chest; single view, frontal\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Collection of venous blood by venipuncture\n- Drainage of Spinal Canal, Percutaneous Approach, Diagnostic\n- Introduction of Other Antineoplastic into Central Vein, Percutaneous Approach\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of moderate complexity. Counseling and/or coordination\n- Hospital discharge day management; more than 30 minutes\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A problem focused interval history; A problem focused examination; Medical decision making that is straightforward or o\n\n### Condition\n- Eosinophil count raised\n- Eruption\n- Hemophagocytic lymphohistiocytosis\n- Primary diagnosis: Elevated level of transaminase and lactic acid dehydrogenase\n- Pancytopenia\n- Herpesvirus infection\n- Lesion of oral mucosa\n\n### Drug\n- fluconazole 200 MG Oral Tablet, through Oral route, started on 2016-11-10, presumably until 2016-12-10, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily\n- bisacodyl 10 MG Rectal Suppository, through Rectal route, started on 2016-11-05, presumably until 2016-11-05\n- atovaquone 150 MG/ML Oral Suspension, through Oral route, started on 2016-11-05, presumably until 2016-11-10, with intended 2 refill(s). Instructions: take 10 mL by mouth every morning with breakfast Until instructed\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2016-11-05, presumably until 2016-11-05\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2016-11-06, presumably until 2017-11-09, with intended 3 refill(s). Instructions: take 1 Tab by mouth every morning before breakfast While taking decadron (2 weeks)\n- ibuprofen 200 MG Oral Tablet, through Oral route, presumably until 2016-11-13, with intended 0 refill(s). Instructions: take 200 mg by mouth as needed (cramps)\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2016-11-06, presumably until 2016-11-10\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2016-11-09, presumably until 2016-11-13, with intended 0 refill(s). Instructions: take 2 Tabs by mouth 2 times a day For two weeks\n- sodium chloride 9 MG/ML Injection, started on 2016-11-07, presumably until 2016-11-07\n- 0.8 ML filgrastim 0.6 MG/ML Prefilled Syringe, started on 2016-11-09, presumably until 2016-11-10\n- valacyclovir 500 MG Oral Tablet, through Oral route, started on 2016-11-07, presumably until 2017-11-09, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day Until instructed\n- itraconazole 100 MG Oral Capsule, through Oral route, started on 2016-11-10, presumably until 2016-11-10, with intended 0 refill(s). Instructions: take 2 Caps by mouth daily\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2016-11-05, presumably until 2016-11-10\n- posaconazole 100 MG Delayed Release Oral Tablet, through Oral route, started on 2016-11-05, presumably until 2016-11-10, with intended 1 refill(s). Instructions: take 3 Tabs by mouth daily Until instructed\n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2016-11-08, presumably until 2016-11-09\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-11-09 00:00:00, ended at 2016-11-09 00:00:00\nThe patient in this visit was 22 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hemophagocytic lymphohistiocytosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-11-12 00:00:00, ended at 2016-11-12 00:00:00\nThe patient in this visit was 22 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anemia\n- Primary diagnosis: Hemophagocytic lymphohistiocytosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-11-12 18:37:00, ended at 2016-11-12 23:59:00\nThe patient in this visit was 22 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Consultation and report on referred slides prepared elsewhere\n\n### Condition\n- Neoplastic disease of uncertain behavior\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-11-13 00:00:00, ended at 2016-11-13 00:00:00\nThe patient in this visit was 22 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- IgG [Mass/volume] in Serum or Plasma: 851 (milligram per deciliter)\n- IgA [Mass/volume] in Serum or Plasma: 157 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hemophagocytic lymphohistiocytosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-11-13 00:00:00, ended at 2016-11-13 00:00:00\nThe patient in this visit was 22 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2016-11-13, presumably until 2016-11-27, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed For anxiety\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-11-13 00:00:00, ended at 2016-11-13 00:00:00\nThe patient in this visit was 22 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Iron [Mass/volume] in Serum or Plasma: 50 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 21 (percent)\n- Methylmalonate [Moles/volume] in Serum or Plasma: 0.07 (micromole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hemophagocytic lymphohistiocytosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-11-13 00:00:00, ended at 2016-11-13 00:00:00\nThe patient in this visit was 22 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 2.6 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Autoimmune hemolytic anemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-11-13 12:05:15, ended at 2016-11-13 13:15:38\nThe patient in this visit was 22 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2.795\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Systemic lupus erythematosus\n- Autoimmune hemolytic anemia\n- Primary diagnosis: Hemophagocytic lymphohistiocytosis\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2016-11-13, presumably until 2016-11-13, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed (anxiety, may repeat dose x 1)\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2016-11-13, presumably until 2016-11-27, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day For two weeks\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-11-13 13:41:13, ended at 2016-11-13 17:06:39\nThe patient in this visit was 22 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2.795\" (inch (US))\n\n### Procedure\n- Biopsy of skin, subcutaneous tissue and/or mucous membrane (including simple closure), unless otherwise listed; single lesion\n- Biopsy of skin, subcutaneous tissue and/or mucous membrane (including simple closure), unless otherwise listed; each separate/additional lesion (List separately in addition to code for primary procedure)\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n\n### Condition\n- Elevated level of transaminase and lactic acid dehydrogenase\n- Inflammatory dermatosis\n- Primary diagnosis: Eruption\n- Atrophic condition of skin\n- Systemic lupus erythematosus\n- Hemophagocytic lymphohistiocytosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-11-13 14:30:00, ended at 2016-11-13 23:59:00\nThe patient in this visit was 22 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Lymphocytes/100 leukocytes in Blood by Automated count: 4 (percent)\n- MCV [Entitic volume] by Automated count: 87.4 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 64 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 143 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 7.4 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 321 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.34 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 21.0 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 154 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 55 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 150 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.51 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.7 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 23.8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.4 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 196 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 158 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.9 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.44 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 7.9 (gram per deciliter)\n- Prothrombin time (PT): 13.1 (second)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.7 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.73 (million per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 297.0 (nanogram per milliliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 18 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 5.7 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Collection of venous blood by venipuncture\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n\n### Condition\n- Anemia\n- Eruption\n- Inflammatory dermatosis\n- Hemophagocytic lymphohistiocytosis\n\n### Drug\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2016-11-13, presumably until 2016-11-13\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2016-11-13, presumably until 2016-11-13\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2016-11-13, presumably until 2016-11-13\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-11-30 00:00:00, ended at 2016-11-30 00:00:00\nThe patient in this visit was 22 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Systemic lupus erythematosus\n- Primary diagnosis: Hemophagocytic lymphohistiocytosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-04 11:16:00, ended at 2016-12-04 23:59:00\nThe patient in this visit was 22 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Ferritin [Mass/volume] in Serum or Plasma: 90.9 (nanogram per milliliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.3 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.82 (million per microliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 358 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.3 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.83 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 395 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 23.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.9 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.0 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10 (percent)\n- MCV [Entitic volume] by Automated count: 92.5 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 77 (percent)\n- Monocytes [#/volume] in Blood by Manual count: 0.42 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hemophagocytic lymphohistiocytosis\n- Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-12-04 11:48:46, ended at 2016-12-04 15:29:07\nThe patient in this visit was 22 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2.8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hemophagocytic lymphohistiocytosis\n- Systemic lupus erythematosus\n\n### Drug\n- prednisone 10 MG Oral Tablet, through Oral route, presumably until 2017-01-10, with intended 0 refill(s). Instructions: take 10 mg by mouth daily\n- hydroxychloroquine sulfate 200 MG Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: take 400 mg by mouth daily\n- mycophenolate mofetil 500 MG Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: take by mouth\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-12-04 13:16:19, ended at 2016-12-04 16:18:10\nThe patient in this visit was 22 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Polyneuropathy\n- Primary diagnosis: Hemophagocytic lymphohistiocytosis\n- Disorder of brain\n- Mental alertness - finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-12-10 00:00:00, ended at 2016-12-10 00:00:00\nThe patient in this visit was 22 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hemophagocytic lymphohistiocytosis\n\n### Drug\n- fluconazole 200 MG Oral Tablet, through Oral route, started on 2016-12-10, presumably until 2017-01-10, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times per week\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-25 10:00:00, ended at 2016-12-25 14:15:00\nThe patient in this visit was 23 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Nerve conduction studies; 9-10 studies\n- Needle electromyography, each extremity, with related paraspinal areas, when performed, done with nerve conduction, amplitude and latency/velocity study; limited (List separately in addition to code for primary procedure)\n\n### Condition\n- Paresthesia\n- Hemophagocytic lymphohistiocytosis\n- Anesthesia of skin\n- Polyneuropathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-25 14:16:00, ended at 2016-12-25 23:59:00\nThe patient in this visit was 23 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electroencephalogram (EEG); including recording awake and drowsy\n\n### Condition\n- Mental alertness - finding\n- Sensory nervous system finding\n- Disorder of brain\n- Hemophagocytic lymphohistiocytosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-01-10 00:00:00, ended at 2017-01-10 00:00:00\nThe patient in this visit was 23 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hemophagocytic lymphohistiocytosis\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2017-01-10, presumably until 2017-01-10, with intended 0 refill(s). Instructions: take 1.5 Tabs by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-03-14 12:30:00, ended at 2017-03-14 23:59:00\nThe patient in this visit was 23 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Neuropsychological testing (eg, Halstead-Reitan Neuropsychological Battery, Wechsler Memory Scales and Wisconsin Card Sorting Test), per hour of the psychologist's or physician's time, both face-to-face time administering tests to the patient and time int\n- Neuropsychological testing (eg, Halstead-Reitan Neuropsychological Battery, Wechsler Memory Scales and Wisconsin Card Sorting Test), with qualified health care professional interpretation and report, administered by technician, per hour of technician time\n- Neurobehavioral status exam (clinical assessment of thinking, reasoning and judgment, [eg, acquired knowledge, attention, language, memory, planning and problem solving, and visual spatial abilities]), by physician or other qualified health care professio\n\n### Condition\n- Hemophagocytic lymphohistiocytosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-06-18 00:00:00, ended at 2019-06-18 00:00:00\nThe patient in this visit was 25 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Illness\n- Suspected fetal abnormality affecting management of mother\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-07-16 00:00:00, ended at 2019-07-16 00:00:00\nThe patient in this visit was 25 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Suspected fetal abnormality affecting management of mother\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-07-16 00:00:00, ended at 2019-07-16 00:00:00\nThe patient in this visit was 25 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Suspected fetal abnormality affecting management of mother\n- Illness\n\n### Drug\n- No drugs.\n\n"}, "target": "Yes", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Systemic lupus erythematosus within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2016-11-04 20:17:00, ended at 2016-11-10 16:07:00\nThe patient in this visit was 22 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 247 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 40 (milligram per deciliter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 159 (milligram per deciliter)\n- Complement C3 [Mass/volume] in Serum or Plasma: 60 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 28.2 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 275 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 59 (unit per liter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 5.0 (ratio)\n- Iron [Mass/volume] in Serum or Plasma: 69 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 31 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Monocytes [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.1 (percent)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Body height: 5' 2.795\" (inch (US))\n- Cholesterol [Mass/volume] in Serum or Plasma: 199 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 121 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 1.16 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 55 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 192 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.6 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Cardiolipin IgA Ab [Units/volume] in Serum by Immunoassay: 4.5 (IgA phospholipid unit)\n- Ferritin [Mass/volume] in Serum or Plasma: 536.6 (nanogram per milliliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 87.8 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 3.0 (ratio)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.40 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.18 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 163 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Erythrocytes [#/volume] in Cerebral spinal fluid: <1 (per microliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Leukocytes [#/volume] in Cerebral spinal fluid: 1 (per microliter)\n- MCV [Entitic volume] by Automated count: 82.9 (femtoliter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 265 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 8.8 (gram per deciliter)\n- Protein [Mass/volume] in Cerebral spinal fluid: 27 (milligram per deciliter)\n- Thrombin time: 16.5 (second)\n- aPTT in Platelet poor plasma by Coagulation assay: 24.5 (second)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 3830 (microgram of fibrinogen equivalent unit per milliliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 1.6 (thousand per microliter)\n- Prothrombin time (PT): 13.4 (second)\n\n### Procedure\n- Introduction of Other Antineoplastic into Spinal Canal, Percutaneous Approach\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Radiologic examination, chest; single view, frontal\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Collection of venous blood by venipuncture\n- Drainage of Spinal Canal, Percutaneous Approach, Diagnostic\n- Introduction of Other Antineoplastic into Central Vein, Percutaneous Approach\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of moderate complexity. Counseling and/or coordination\n- Hospital discharge day management; more than 30 minutes\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A problem focused interval history; A problem focused examination; Medical decision making that is straightforward or o\n\n### Condition\n- Eosinophil count raised\n- Eruption\n- Hemophagocytic lymphohistiocytosis\n- Primary diagnosis: Elevated level of transaminase and lactic acid dehydrogenase\n- Pancytopenia\n- Herpesvirus infection\n- Lesion of oral mucosa\n\n### Drug\n- fluconazole 200 MG Oral Tablet, through Oral route, started on 2016-11-10, presumably until 2016-12-10, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily\n- bisacodyl 10 MG Rectal Suppository, through Rectal route, started on 2016-11-05, presumably until 2016-11-05\n- atovaquone 150 MG/ML Oral Suspension, through Oral route, started on 2016-11-05, presumably until 2016-11-10, with intended 2 refill(s). Instructions: take 10 mL by mouth every morning with breakfast Until instructed\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2016-11-05, presumably until 2016-11-05\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2016-11-06, presumably until 2017-11-09, with intended 3 refill(s). Instructions: take 1 Tab by mouth every morning before breakfast While taking decadron (2 weeks)\n- ibuprofen 200 MG Oral Tablet, through Oral route, presumably until 2016-11-13, with intended 0 refill(s). Instructions: take 200 mg by mouth as needed (cramps)\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2016-11-06, presumably until 2016-11-10\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2016-11-09, presumably until 2016-11-13, with intended 0 refill(s). Instructions: take 2 Tabs by mouth 2 times a day For two weeks\n- sodium chloride 9 MG/ML Injection, started on 2016-11-07, presumably until 2016-11-07\n- 0.8 ML filgrastim 0.6 MG/ML Prefilled Syringe, started on 2016-11-09, presumably until 2016-11-10\n- valacyclovir 500 MG Oral Tablet, through Oral route, started on 2016-11-07, presumably until 2017-11-09, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day Until instructed\n- itraconazole 100 MG Oral Capsule, through Oral route, started on 2016-11-10, presumably until 2016-11-10, with intended 0 refill(s). Instructions: take 2 Caps by mouth daily\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2016-11-05, presumably until 2016-11-10\n- posaconazole 100 MG Delayed Release Oral Tablet, through Oral route, started on 2016-11-05, presumably until 2016-11-10, with intended 1 refill(s). Instructions: take 3 Tabs by mouth daily Until instructed\n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2016-11-08, presumably until 2016-11-09\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-11-09 00:00:00, ended at 2016-11-09 00:00:00\nThe patient in this visit was 22 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hemophagocytic lymphohistiocytosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-11-12 00:00:00, ended at 2016-11-12 00:00:00\nThe patient in this visit was 22 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anemia\n- Primary diagnosis: Hemophagocytic lymphohistiocytosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-11-12 18:37:00, ended at 2016-11-12 23:59:00\nThe patient in this visit was 22 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Consultation and report on referred slides prepared elsewhere\n\n### Condition\n- Neoplastic disease of uncertain behavior\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-11-13 00:00:00, ended at 2016-11-13 00:00:00\nThe patient in this visit was 22 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- IgG [Mass/volume] in Serum or Plasma: 851 (milligram per deciliter)\n- IgA [Mass/volume] in Serum or Plasma: 157 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hemophagocytic lymphohistiocytosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-11-13 00:00:00, ended at 2016-11-13 00:00:00\nThe patient in this visit was 22 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2016-11-13, presumably until 2016-11-27, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed For anxiety\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-11-13 00:00:00, ended at 2016-11-13 00:00:00\nThe patient in this visit was 22 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Iron [Mass/volume] in Serum or Plasma: 50 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 21 (percent)\n- Methylmalonate [Moles/volume] in Serum or Plasma: 0.07 (micromole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hemophagocytic lymphohistiocytosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-11-13 00:00:00, ended at 2016-11-13 00:00:00\nThe patient in this visit was 22 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 2.6 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Autoimmune hemolytic anemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-11-13 12:05:15, ended at 2016-11-13 13:15:38\nThe patient in this visit was 22 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2.795\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Systemic lupus erythematosus\n- Autoimmune hemolytic anemia\n- Primary diagnosis: Hemophagocytic lymphohistiocytosis\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2016-11-13, presumably until 2016-11-13, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed (anxiety, may repeat dose x 1)\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2016-11-13, presumably until 2016-11-27, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day For two weeks\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-11-13 13:41:13, ended at 2016-11-13 17:06:39\nThe patient in this visit was 22 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2.795\" (inch (US))\n\n### Procedure\n- Biopsy of skin, subcutaneous tissue and/or mucous membrane (including simple closure), unless otherwise listed; single lesion\n- Biopsy of skin, subcutaneous tissue and/or mucous membrane (including simple closure), unless otherwise listed; each separate/additional lesion (List separately in addition to code for primary procedure)\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n\n### Condition\n- Elevated level of transaminase and lactic acid dehydrogenase\n- Inflammatory dermatosis\n- Primary diagnosis: Eruption\n- Atrophic condition of skin\n- Systemic lupus erythematosus\n- Hemophagocytic lymphohistiocytosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-11-13 14:30:00, ended at 2016-11-13 23:59:00\nThe patient in this visit was 22 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Lymphocytes/100 leukocytes in Blood by Automated count: 4 (percent)\n- MCV [Entitic volume] by Automated count: 87.4 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 64 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 143 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 7.4 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 321 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.34 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 21.0 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 154 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 55 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 150 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.51 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.7 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 23.8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.4 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 196 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 158 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.9 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.44 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 7.9 (gram per deciliter)\n- Prothrombin time (PT): 13.1 (second)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.7 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.73 (million per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 297.0 (nanogram per milliliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 18 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 5.7 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Collection of venous blood by venipuncture\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n\n### Condition\n- Anemia\n- Eruption\n- Inflammatory dermatosis\n- Hemophagocytic lymphohistiocytosis\n\n### Drug\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2016-11-13, presumably until 2016-11-13\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2016-11-13, presumably until 2016-11-13\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2016-11-13, presumably until 2016-11-13\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-11-30 00:00:00, ended at 2016-11-30 00:00:00\nThe patient in this visit was 22 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Systemic lupus erythematosus\n- Primary diagnosis: Hemophagocytic lymphohistiocytosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-04 11:16:00, ended at 2016-12-04 23:59:00\nThe patient in this visit was 22 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Ferritin [Mass/volume] in Serum or Plasma: 90.9 (nanogram per milliliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.3 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.82 (million per microliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 358 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.3 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.83 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 395 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 23.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.9 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.0 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10 (percent)\n- MCV [Entitic volume] by Automated count: 92.5 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 77 (percent)\n- Monocytes [#/volume] in Blood by Manual count: 0.42 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hemophagocytic lymphohistiocytosis\n- Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-12-04 11:48:46, ended at 2016-12-04 15:29:07\nThe patient in this visit was 22 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2.8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hemophagocytic lymphohistiocytosis\n- Systemic lupus erythematosus\n\n### Drug\n- prednisone 10 MG Oral Tablet, through Oral route, presumably until 2017-01-10, with intended 0 refill(s). Instructions: take 10 mg by mouth daily\n- hydroxychloroquine sulfate 200 MG Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: take 400 mg by mouth daily\n- mycophenolate mofetil 500 MG Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: take by mouth\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-12-04 13:16:19, ended at 2016-12-04 16:18:10\nThe patient in this visit was 22 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Polyneuropathy\n- Primary diagnosis: Hemophagocytic lymphohistiocytosis\n- Disorder of brain\n- Mental alertness - finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-12-10 00:00:00, ended at 2016-12-10 00:00:00\nThe patient in this visit was 22 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hemophagocytic lymphohistiocytosis\n\n### Drug\n- fluconazole 200 MG Oral Tablet, through Oral route, started on 2016-12-10, presumably until 2017-01-10, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times per week\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-25 10:00:00, ended at 2016-12-25 14:15:00\nThe patient in this visit was 23 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Nerve conduction studies; 9-10 studies\n- Needle electromyography, each extremity, with related paraspinal areas, when performed, done with nerve conduction, amplitude and latency/velocity study; limited (List separately in addition to code for primary procedure)\n\n### Condition\n- Paresthesia\n- Hemophagocytic lymphohistiocytosis\n- Anesthesia of skin\n- Polyneuropathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-25 14:16:00, ended at 2016-12-25 23:59:00\nThe patient in this visit was 23 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electroencephalogram (EEG); including recording awake and drowsy\n\n### Condition\n- Mental alertness - finding\n- Sensory nervous system finding\n- Disorder of brain\n- Hemophagocytic lymphohistiocytosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-01-10 00:00:00, ended at 2017-01-10 00:00:00\nThe patient in this visit was 23 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hemophagocytic lymphohistiocytosis\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2017-01-10, presumably until 2017-01-10, with intended 0 refill(s). Instructions: take 1.5 Tabs by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-03-14 12:30:00, ended at 2017-03-14 23:59:00\nThe patient in this visit was 23 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Neuropsychological testing (eg, Halstead-Reitan Neuropsychological Battery, Wechsler Memory Scales and Wisconsin Card Sorting Test), per hour of the psychologist's or physician's time, both face-to-face time administering tests to the patient and time int\n- Neuropsychological testing (eg, Halstead-Reitan Neuropsychological Battery, Wechsler Memory Scales and Wisconsin Card Sorting Test), with qualified health care professional interpretation and report, administered by technician, per hour of technician time\n- Neurobehavioral status exam (clinical assessment of thinking, reasoning and judgment, [eg, acquired knowledge, attention, language, memory, planning and problem solving, and visual spatial abilities]), by physician or other qualified health care professio\n\n### Condition\n- Hemophagocytic lymphohistiocytosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-06-18 00:00:00, ended at 2019-06-18 00:00:00\nThe patient in this visit was 25 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Illness\n- Suspected fetal abnormality affecting management of mother\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-07-16 00:00:00, ended at 2019-07-16 00:00:00\nThe patient in this visit was 25 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Suspected fetal abnormality affecting management of mother\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-07-16 00:00:00, ended at 2019-07-16 00:00:00\nThe patient in this visit was 25 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Suspected fetal abnormality affecting management of mother\n- Illness\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Systemic lupus erythematosus within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of lupus means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "392fd950fe27f016f5ee77a65d1ccac31d6ffc4df766930df08b750136508248", "prompt_hash": "5d9280a2b832af6028269423a92309a6af6a65d28ce24aa81c5ceb7756424804", "target_hash": "85a39ab345d672ff8ca9b9c6876f3adcacf45ee7c1e2dbd2408fd338bd55e07e", "exact_match": 0.0, "f1_gu_yn": [1, 0], "recall_gu_yn": [1, 0]}
{"doc_id": 7, "doc": {"person_id": 115969165, "visit_occurrence_id": 114567937, "death_date": null, "visit_concept_name": "Outpatient Visit", "visit_start_datetime": "2018-02-21 00:00:00", "visit_end_datetime": "2018-02-21 00:00:00", "visit_length_in_hours": 0.0, "integrated_visit_record": "## Visit\nThis visit record, was from Outpatient Visit, started at 2018-02-21 00:00:00, ended at 2018-02-21 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Hemoglobin [Mass/volume] in Blood: 14.8 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 101.6 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.5 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.28 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.5 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.6 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 246.0 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.3 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.5 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20.0 (percent)\n- MCH [Entitic mass] by Automated count: 34.6 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 9.0 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n", "approximate_token_count": 320, "patient_first_visit_date": "2014-05-08 00:00:00", "patient_last_visit_date": "2023-02-03 00:00:00", "end_obs_date": "2019-02-21", "hypertension_type": "recurrent", "hypertension_one_year_diagnosis": 1, "obesity_type": "recurrent", "obesity_one_year_diagnosis": 1, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "new", "hyperlipidemia_one_year_diagnosis": 0, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "recurrent", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "recurrent", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 144, "cumulated_visit_num": 144, "cumulated_approximate_token_count": 27704, "visit_cumulated": "## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-08 00:00:00, ended at 2014-05-08 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Reticulocytes/100 erythrocytes in Blood: 0.5 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-08 00:00:00, ended at 2014-05-08 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Leukocytes [#/volume] in Specimen by Automated count: 3.3 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 21.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.2 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 96.2 (femtoliter)\n- MCHC [Mass/volume] by Automated count: 29.8 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.7 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 2.0 (thousand per microliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 6.7 (femtoliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 33.2 (percent)\n- Platelets [#/volume] in Blood by Automated count: 201 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.9 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.1 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.21 (million per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-08 00:00:00, ended at 2014-05-08 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Ferritin [Mass/volume] in Serum or Plasma: 141 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-08 00:00:00, ended at 2014-05-08 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Folate [Mass/volume] in Serum or Plasma: >19.9 (nanogram per milliliter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 1038 (picogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-08 00:00:00, ended at 2014-05-08 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-08 00:00:00, ended at 2014-05-08 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma: 269 (international unit per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-08 00:00:00, ended at 2014-05-08 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Haptoglobin [Mass/volume] in Serum or Plasma: 176 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-08 00:00:00, ended at 2014-05-08 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 320 (microgram per deciliter)\n- Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma: 174 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 46 (percent)\n- Iron [Mass/volume] in Serum or Plasma: 146 (microgram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-08 00:00:00, ended at 2014-05-08 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythropoietin (EPO) [Units/volume] in Serum or Plasma: 169.3 (milli-international unit per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-22 00:00:00, ended at 2014-05-22 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- aPTT in Platelet poor plasma by Coagulation assay: 25 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-22 00:00:00, ended at 2014-05-22 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Prothrombin time (PT): 10.0 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-22 00:00:00, ended at 2014-05-22 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-22 00:00:00, ended at 2014-05-22 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 105 (international unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (international unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 1.09 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.3 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.3 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (international unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 115 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-22 00:00:00, ended at 2014-05-22 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Leukocytes [#/volume] in Specimen by Automated count: 2.9 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 96.1 (femtoliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.68 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.2 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 1.5 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 21.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 8.0 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 29.9 (picogram)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 25.8 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 40.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 344 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 31.0 (gram per deciliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 6.1 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-06-05 00:00:00, ended at 2014-06-05 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-06-05 00:00:00, ended at 2014-06-05 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Lymphocytes/100 leukocytes in Blood by Automated count: 27.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 340 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 24.0 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.5 (percent)\n- MCH [Entitic mass] by Automated count: 32.3 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 2.6 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.0 (gram per deciliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 7.5 (femtoliter)\n- Hemoglobin [Mass/volume] in Blood: 12.0 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 100.7 (femtoliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.72 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.9 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.3 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-07-03 00:00:00, ended at 2014-07-03 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-07-03 00:00:00, ended at 2014-07-03 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Hemoglobin [Mass/volume] in Blood: 11.7 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.5 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 230 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.0 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 22.2 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.1 (percent)\n- MCHC [Mass/volume] by Automated count: 31.5 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.6 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20.7 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.56 (million per microliter)\n- MCH [Entitic mass] by Automated count: 32.9 (picogram)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 8.1 (femtoliter)\n- MCV [Entitic volume] by Automated count: 104.1 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-07-17 00:00:00, ended at 2014-07-17 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Injury of free lower limb\n- Primary diagnosis: Soft tissue injury\n- Joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-07-17 10:37:50, ended at 2014-07-17 12:34:28\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Osteoarthritis of knee\n\n### Drug\n- nortriptyline 25 MG Oral Capsule, through Oral route, started on 2016-09-24, presumably until 2016-09-24, with intended 0 refill(s). Instructions: Take 2 capsules (50 mg total) by mouth every bedtime\n- folic acid 1 MG Oral Tablet, through Oral route, started on 2016-09-24, presumably until 2017-10-27, with intended 0 refill(s). Instructions: take 1 mg by mouth daily \n- furosemide 20 MG Oral Tablet, through Oral route, presumably until 2018-04-15, with intended 0 refill(s). Instructions: take 20 mg by mouth daily.\n- allopurinol 100 MG Oral Tablet, through Oral route, presumably until 2020-11-26, with intended 0 refill(s). Instructions: take 200 mg by mouth 2 times a day \n- lisinopril 20 MG Oral Tablet, through Oral route, started on 2016-09-24, presumably until 2020-11-07, with intended 0 refill(s). Instructions: take 10 mg by mouth daily\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, presumably until 2015-01-15, with intended 0 refill(s). Instructions: take 50 mg by mouth every 6 hours as needed.\n- aspirin 81 MG Chewable Tablet, through Oral route, presumably until 2014-10-29, with intended 0 refill(s). Instructions: take 81 mg by mouth daily.\n- omeprazole 20 MG Delayed Release Oral Tablet, through Oral route, presumably until 2020-08-22, with intended 0 refill(s). Instructions: take 20 mg by mouth Every Day.\n- 24 HR diltiazem hydrochloride 240 MG Extended Release Oral Capsule, through Oral route, presumably until 2014-10-08, with intended 0 refill(s). Instructions: take 240 mg by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-07-17 12:37:00, ended at 2014-07-17 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocyte sedimentation rate: 73 (millimeter per hour)\n- C reactive protein [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Soft tissue injury\n- Joint pain\n- Injury of free lower limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-07-18 00:00:00, ended at 2014-07-18 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-07-18 00:00:00, ended at 2014-07-18 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Lymphocytes [#/volume] in Blood by Automated count: 1.8 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.9 (picogram)\n- MCHC [Mass/volume] by Automated count: 30.9 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 295 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.28 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 10.8 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.1 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.0 (percent)\n- MCV [Entitic volume] by Automated count: 106.7 (femtoliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 8.3 (femtoliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.7 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-08-01 00:00:00, ended at 2014-08-01 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-08-01 00:00:00, ended at 2014-08-01 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- MCHC [Mass/volume] by Automated count: 31.4 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.7 (picogram)\n- MCV [Entitic volume] by Automated count: 107.2 (femtoliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 7.8 (femtoliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.56 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.1 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.9 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 27.4 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.2 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.0 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.5 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 316 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-08-15 00:00:00, ended at 2014-08-15 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Leukocytes [#/volume] in Specimen by Automated count: 7.5 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 31.3 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 105.5 (femtoliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.0 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.2 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 28.8 (percent)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 8.8 (femtoliter)\n- MCH [Entitic mass] by Automated count: 33.1 (picogram)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.6 (million per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.3 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 11.9 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 268 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-08-15 00:00:00, ended at 2014-08-15 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-08-29 00:00:00, ended at 2014-08-29 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma: 271 (international unit per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-08-29 00:00:00, ended at 2014-08-29 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 1.15 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 110 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 125 (international unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.7 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (international unit per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (international unit per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-08-29 00:00:00, ended at 2014-08-29 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 712 (picogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-08-29 00:00:00, ended at 2014-08-29 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-08-29 00:00:00, ended at 2014-08-29 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Platelets [#/volume] in Blood by Automated count: 313 (thousand per microliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 8.2 (femtoliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.83 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.8 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 103.0 (femtoliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.4 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.8 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.3 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.1 (picogram)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 26.1 (percent)\n- MCHC [Mass/volume] by Automated count: 31.2 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.5 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.0 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-09-12 00:00:00, ended at 2014-09-12 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 15.7 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.1 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 279 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.1 (percent)\n- MCHC [Mass/volume] by Automated count: 31.2 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.2 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 29.5 (percent)\n- MCV [Entitic volume] by Automated count: 101.1 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.4 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.87 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.0 (thousand per microliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 8.8 (femtoliter)\n- MCH [Entitic mass] by Automated count: 31.5 (picogram)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-09-12 00:00:00, ended at 2014-09-12 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-09-26 00:00:00, ended at 2014-09-26 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-09-26 00:00:00, ended at 2014-09-26 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- MCHC [Mass/volume] by Automated count: 30.9 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 99.8 (femtoliter)\n- MCH [Entitic mass] by Automated count: 30.9 (picogram)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.92 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.6 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.1 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.3 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 283 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.6 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.1 (percent)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 8.5 (femtoliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.5 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-10-08 09:16:08, ended at 2014-10-08 11:45:15\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Pre-surgery evaluation\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Chronic kidney disease stage 2\n- Gastroesophageal reflux disease\n- Primary diagnosis: Systemic lupus erythematosus\n- Disorder of muscle\n- Cardiac arrhythmia\n- Gout\n- Joint pain\n- Obesity\n- Hypercoagulability state\n- Disorder of hematopoietic structure\n- Essential hypertension\n- Left bundle branch block\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-10-08 09:18:00, ended at 2014-10-08 14:06:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, knee; 3 views\n\n### Condition\n- Joint pain\n- Closed fracture of patella\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-10-08 12:14:45, ended at 2014-10-08 12:48:03\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 24 HR diltiazem hydrochloride 240 MG Extended Release Oral Tablet, through Oral route, presumably until 2020-09-18, with intended 0 refill(s). Instructions: take 1 Tab by mouth Every Day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-10-08 13:27:24, ended at 2014-10-08 14:04:13\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Pre-surgery evaluation\n\n### Condition\n- Cardiac arrhythmia\n- Hypercoagulability state\n- Disorder of hematopoietic structure\n- Chronic kidney disease stage 2\n- Essential hypertension\n- Systemic lupus erythematosus\n\n### Drug\n- nortriptyline 25 MG Oral Capsule, through Oral route, started on 2014-02-20, presumably until 2014-10-24, with intended 0 refill(s). Instructions: take 125 mg by mouth.\n- folic acid 1 MG Oral Tablet, through Oral route, presumably until 2014-10-24, with intended 0 refill(s). Instructions: take 2 mg by mouth.\n- lisinopril 40 MG Oral Tablet, through Oral route, presumably until 2014-10-24, with intended 0 refill(s). Instructions: take 40 mg by mouth.\n- furosemide 20 MG Oral Tablet, through Oral route, presumably until 2014-10-24, with intended 0 refill(s). Instructions: take  by mouth.\n- aspirin 81 MG Effervescent Oral Tablet, through Oral route, presumably until 2014-10-24, with intended 0 refill(s). Instructions: take 81 mg by mouth.\n- acetaminophen 500 MG Oral Tablet, through Oral route, presumably until 2014-10-24, with intended 0 refill(s). Instructions: take  by mouth.\n- allopurinol 100 MG Oral Tablet, through Oral route, started on 2012-11-19, presumably until 2014-10-24, with intended 0 refill(s). Instructions: take 100 mg by mouth.\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, presumably until 2014-10-24, with intended 0 refill(s). Instructions: take 50 mg by mouth.\n- omeprazole 20 MG Delayed Release Oral Tablet, through Oral route, presumably until 2014-10-24, with intended 0 refill(s). Instructions: take 20 mg by mouth.\n- 24 HR diltiazem hydrochloride 240 MG Extended Release Oral Capsule, through Oral route, presumably until 2014-10-24, with intended 0 refill(s). Instructions: take 240 mg by mouth daily.\n- omeprazole 20 MG Delayed Release Oral Capsule, started on 2014-07-30, presumably until 2014-10-24, with intended 0 refill(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-10-08 14:07:00, ended at 2014-10-08 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.0 (percent)\n- MCV [Entitic volume] by Automated count: 95.2 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.85 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.6 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 31.1 (second)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 49 (milliliter per minute per square meter)\n- Platelets [#/volume] in Blood by Automated count: 302 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n- Neutrophils/100 leukocytes in Blood by Automated count: 68.9 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.9 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 166 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.34 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.8 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.6 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 6.62 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 125 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.2 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.6 (percent)\n- Prothrombin time (PT): 13.2 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.7 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.02 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.54 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 21.0 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Pre-surgery evaluation\n\n### Condition\n- Cardiac arrhythmia\n- Gastroesophageal reflux disease\n- Obesity\n- Gout\n- Hypercoagulability state\n- Disorder of hematopoietic structure\n- Joint pain\n- Systemic lupus erythematosus\n- Chronic kidney disease stage 2\n- Disorder of muscle\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-10-16 00:00:00, ended at 2014-10-16 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Leukocytes [#/volume] in Specimen by Automated count: 7.5 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 99.3 (femtoliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.83 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.0 (percent)\n- MCH [Entitic mass] by Automated count: 30.5 (picogram)\n- Hemoglobin [Mass/volume] in Blood: 11.7 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 30.8 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.9 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 27.0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.0 (thousand per microliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 8.4 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 274 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.7 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-10-16 00:00:00, ended at 2014-10-16 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2014-10-25 00:00:00, ended at 2014-10-25 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for open or surgical arthroscopic procedures on knee joint; total knee arthroplasty\n\n### Condition\n- Mechanical complication of internal joint prosthesis\n\n### Drug\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2014-10-25, presumably until 2014-10-25\n- cefazolin 1000 MG Injection, started on 2014-10-25, presumably until 2014-10-25\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2014-10-25, presumably until 2014-10-25\n- 2 ML lidocaine hydrochloride 20 MG/ML Injection, started on 2014-10-25, presumably until 2014-10-25\n- 2 ML ondansetron 2 MG/ML Injection, started on 2014-10-25, presumably until 2014-10-25\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2014-10-25, presumably until 2014-10-25\n- ketamine 100 MG/ML Injectable Solution, started on 2014-10-25, presumably until 2014-10-25\n- succinylcholine chloride 20 MG/ML Injectable Solution, started on 2014-10-25, presumably until 2014-10-25\n- 10 ML tranexamic acid 100 MG/ML Injection, through Intravenous route, started on 2014-10-25, presumably until 2014-10-25\n- midazolam 1 MG/ML Injectable Solution, started on 2014-10-25, presumably until 2014-10-25\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2014-10-25 00:00:00, ended at 2014-10-25 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Injection(s), anesthetic agent(s) and/or steroid; femoral nerve, continuous infusion by catheter (including catheter placement)\n- Ultrasonic guidance for needle placement (eg, biopsy, aspiration, injection, localization device), imaging supervision and interpretation\n\n### Condition\n- Acute postoperative pain\n\n### Drug\n- midazolam 1 MG/ML Injectable Solution, started on 2014-10-25, presumably until 2014-10-25\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2014-10-25 00:00:00, ended at 2014-10-25 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sodium chloride 0.154 MEQ/ML Irrigation Solution, through Topical route, started on 2014-10-25, presumably until 2014-10-25\n- 1 ML ketorolac tromethamine 30 MG/ML Injection, started on 2014-10-25, presumably until 2014-10-25\n- 30 ML ropivacaine hydrochloride 5 MG/ML Injection, started on 2014-10-25, presumably until 2014-10-25\n- 1 ML epinephrine 1 MG/ML Injection, started on 2014-10-25, presumably until 2014-10-25\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2014-10-25 05:16:00, ended at 2014-10-29 12:25:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 184 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): N/A (milliliter per minute per square meter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.9 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.7 (percent)\n- MCH [Entitic mass] by Automated count: 31.2 (picogram)\n- MCV [Entitic volume] by Automated count: 95.7 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.02 (million per microliter)\n- INR in Platelet poor plasma by Coagulation assay: >60.0 (ratio)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.4 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.6 (gram per deciliter)\n- Body height: 5' 3\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 25.5 (second)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 124 (milligram per deciliter)\n- Prothrombin time (PT): >300.0 (second)\n- Hemoglobin [Mass/volume] in Blood: 9.4 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Radiologic examination, knee; 1 or 2 views\n- Revision of knee replacement\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Division of joint capsule, ligament, or cartilage, knee\n- Tendon pulley reconstruction other than hand\n- Synovectomy of knee joint\n- Application of long leg cast\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Physical therapy evaluation\n- Occupational therapy evaluation\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n\n### Condition\n- Left bundle branch block\n- Tachycardia\n- Anemia\n- Benign hypertensive renal disease with renal failure\n- Complication of internal device\n- Gastroesophageal reflux disease\n- Late effect of medical and surgical care complication\n- Acquired absence of cervix and uterus\n- Acute posthemorrhagic anemia\n- Disorder of hematopoietic structure\n- Acute postoperative pain\n- Chronic glomerulonephritis associated with another disorder\n- Chronic kidney disease stage 3\n- Primary diagnosis: Hypercoagulability state\n- Systemic lupus erythematosus\n- Chronic kidney disease stage 2\n- Joint pain\n- Essential hypertension\n- Gout\n- Mechanical complication of internal orthopedic device, implant AND/OR graft\n- Morbid obesity\n- Obesity\n- Cardiac arrhythmia\n- Chronic pain\n- Disorder of muscle\n\n### Drug\n- Lactobacillus acidophilus, through Oral route, started on 2014-10-25, presumably until 2014-10-29\n- Bifidobacterium bifidum, through Oral route, started on 2014-10-25, presumably until 2014-10-29\n- diltiazem hydrochloride 60 MG Oral Tablet, through Oral route, started on 2014-10-26, presumably until 2014-10-29\n- warfarin sodium 5 MG Oral Tablet, started on 2014-10-26, presumably until 2014-12-04, with intended 0 refill(s). Instructions: Please take as instructed in your discharge instructions.\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2014-10-25, presumably until 2014-10-29\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2014-10-26, presumably until 2014-10-29\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2014-10-26, presumably until 2014-10-29\n- Streptococcus thermophilus, through Oral route, started on 2014-10-25, presumably until 2014-10-29\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2014-10-27, presumably until 2014-10-27\n- warfarin sodium 7.5 MG Oral Tablet, through Oral route, started on 2014-10-26, presumably until 2014-10-28\n- cefazolin 1000 MG Injection, started on 2014-10-25, presumably until 2014-10-26\n- celecoxib 100 MG Oral Capsule, through Oral route, started on 2014-10-25, presumably until 2014-10-27\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2014-10-25, presumably until 2015-10-26, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day.\n- allopurinol 100 MG Oral Tablet, through Oral route, started on 2014-10-26, presumably until 2014-10-29\n- hydralazine hydrochloride 10 MG Oral Tablet, through Oral route, started on 2014-10-25, presumably until 2014-10-25\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2014-10-26, presumably until 2015-10-26, with intended 0 refill(s). Instructions: take 2 Tabs by mouth 2 times a day.\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2014-10-25, presumably until 2014-10-25\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2014-10-26, presumably until 2014-10-28\n- celecoxib 200 MG Oral Capsule, through Oral route, started on 2014-10-25, presumably until 2014-10-25\n- 2 ML ondansetron 2 MG/ML Injection, started on 2014-10-25, presumably until 2014-10-27\n- warfarin sodium 2 MG Oral Tablet, started on 2014-10-26, presumably until 2014-12-04, with intended 0 refill(s). Instructions: Please take as instructed in your discharge instructions.\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2014-10-25, presumably until 2014-10-25\n- Lactobacillus delbrueckii subsp. bulgaricus, through Oral route, started on 2014-10-25, presumably until 2014-10-29\n- warfarin sodium 1 MG Oral Tablet, started on 2014-10-26, presumably until 2014-12-04, with intended 0 refill(s). Instructions: Please take as instructed in your discharge instructions.\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2014-10-25, presumably until 2014-11-15, with intended 0 refill(s). Instructions: take 1-3 Tabs by mouth every 4 hours as needed for Pain.\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2014-10-25, presumably until 2014-10-26\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-11-05 00:00:00, ended at 2014-11-05 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.0 (percent)\n- MCHC [Mass/volume] by Automated count: 29.8 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 420 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 95.2 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 7.4 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.7 (thousand per microliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 7.0 (femtoliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.9 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.7 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.14 (million per microliter)\n- MCH [Entitic mass] by Automated count: 28.3 (picogram)\n- Hemoglobin [Mass/volume] in Blood: 8.9 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-11-05 00:00:00, ended at 2014-11-05 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma: 402 (international unit per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-11-05 00:00:00, ended at 2014-11-05 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Ferritin [Mass/volume] in Serum or Plasma: 108 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-11-05 00:00:00, ended at 2014-11-05 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Iron saturation [Mass Fraction] in Serum or Plasma: 7 (percent)\n- Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma: 233 (microgram per deciliter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 250 (microgram per deciliter)\n- Iron [Mass/volume] in Serum or Plasma: 17 (microgram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-11-05 00:00:00, ended at 2014-11-05 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (international unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 129 (international unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (international unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 97 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.6 (gram per deciliter)\n- Creatinine [Mass/volume] in Urine: 1.00 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 131 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.0 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-11-05 00:00:00, ended at 2014-11-05 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-11-19 00:00:00, ended at 2014-11-19 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-11-19 00:00:00, ended at 2014-11-19 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- MCHC [Mass/volume] by Automated count: 29.1 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.54 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.3 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 28.0 (picogram)\n- MCV [Entitic volume] by Automated count: 96.1 (femtoliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 24.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.8 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 320 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.9 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.3 (thousand per microliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 8.3 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-11-22 00:00:00, ended at 2014-11-22 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-11-29 00:00:00, ended at 2014-11-29 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-11-29 00:00:00, ended at 2014-11-29 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Subsequent stage of staged operation\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-12-03 00:00:00, ended at 2014-12-03 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Prothrombin time (PT): 27.4 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-12-03 00:00:00, ended at 2014-12-03 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 21.9 (percent)\n- MCHC [Mass/volume] by Automated count: 30.6 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.8 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.9 (picogram)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.74 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.2 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.0 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.3 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.6 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 22.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 255 (thousand per microliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 8.3 (femtoliter)\n- MCV [Entitic volume] by Automated count: 94.4 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-12-03 00:00:00, ended at 2014-12-03 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma: 262 (international unit per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-12-03 00:00:00, ended at 2014-12-03 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-12-04 00:00:00, ended at 2014-12-04 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- warfarin sodium 2 MG Oral Tablet, started on 2014-12-04, presumably until 2016-09-25, with intended 0 refill(s). Instructions: Please take as instructed in your discharge instructions.\n- warfarin sodium 1 MG Oral Tablet, started on 2014-12-04, presumably until 2016-09-25, with intended 0 refill(s). Instructions: Please take as instructed in your discharge instructions.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-12-04 13:09:00, ended at 2014-12-04 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, knee; 1 or 2 views\n\n### Condition\n- Joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-12-17 00:00:00, ended at 2014-12-17 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Hemoglobin [Mass/volume] in Blood: 12.8 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 29.3 (picogram)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 8.4 (femtoliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 22.6 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.7 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 96.5 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.8 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 288 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.37 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.0 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 24.0 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.2 (percent)\n- MCHC [Mass/volume] by Automated count: 30.3 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-12-17 00:00:00, ended at 2014-12-17 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Prothrombin time (PT): 13.4 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-12-17 00:00:00, ended at 2014-12-17 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-12-31 00:00:00, ended at 2014-12-31 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Ferritin [Mass/volume] in Serum or Plasma: 339 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-12-31 00:00:00, ended at 2014-12-31 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 4.49 (million per microliter)\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.0 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 25.5 (percent)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 8.8 (femtoliter)\n- Hemoglobin [Mass/volume] in Blood: 13.5 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 31.4 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 254 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.9 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 95.7 (femtoliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.7 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.4 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-12-31 00:00:00, ended at 2014-12-31 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Prothrombin time (PT): 17.8 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-12-31 00:00:00, ended at 2014-12-31 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-12-31 00:00:00, ended at 2014-12-31 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Iron [Mass/volume] in Serum or Plasma: 51 (microgram per deciliter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 230 (microgram per deciliter)\n- Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma: 179 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 22 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-01-15 00:00:00, ended at 2015-01-15 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2015-01-15, presumably until 2020-12-18, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-01-18 00:00:00, ended at 2015-01-18 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Subsequent stage of staged operation\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-01-28 00:00:00, ended at 2015-01-28 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 4.42 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.6 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.7 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.1 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.9 (percent)\n- MCHC [Mass/volume] by Automated count: 30.4 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 97.4 (femtoliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.3 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 270 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 26.4 (percent)\n- MCH [Entitic mass] by Automated count: 29.6 (picogram)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 8.7 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-01-28 00:00:00, ended at 2015-01-28 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Prothrombin time (PT): 16.4 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-01-28 00:00:00, ended at 2015-01-28 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-01-29 13:33:00, ended at 2015-01-29 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, knee; 1 or 2 views\n\n### Condition\n- Closed fracture of patella\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-01-29 13:33:36, ended at 2015-01-29 15:51:48\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Osteoarthritis of knee\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-03-12 08:15:00, ended at 2015-03-12 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, knee; 3 views\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-03-25 00:00:00, ended at 2015-03-25 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-03-25 00:00:00, ended at 2015-03-25 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Lymphocytes/100 leukocytes in Blood by Automated count: 26.7 (percent)\n- MCH [Entitic mass] by Automated count: 31.3 (picogram)\n- MCHC [Mass/volume] by Automated count: 30.1 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.22 (million per microliter)\n- MCV [Entitic volume] by Automated count: 103.7 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.9 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.2 (percent)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 9.1 (femtoliter)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.1 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 284 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.0 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-04-23 13:30:00, ended at 2015-04-23 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, knee; 3 views\n\n### Condition\n- Joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-04-23 13:31:41, ended at 2015-04-23 15:44:17\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Osteoarthritis of knee\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-05-28 09:09:00, ended at 2015-05-28 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, knee; 1 or 2 views\n\n### Condition\n- Joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-05-28 09:11:27, ended at 2015-05-28 10:53:21\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Localized, primary osteoarthritis\n- Primary diagnosis: Osteoarthritis of knee\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-05-29 00:00:00, ended at 2015-05-29 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-05-29 00:00:00, ended at 2015-05-29 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Lymphocytes/100 leukocytes in Blood by Automated count: 22.5 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.19 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.5 (picogram)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.3 (percent)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 8.6 (femtoliter)\n- MCHC [Mass/volume] by Automated count: 30.5 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 103.4 (femtoliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.3 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.6 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.3 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 226 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-07-30 10:55:18, ended at 2015-07-30 13:01:52\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Localized, primary osteoarthritis\n- Primary diagnosis: Osteoarthritis of knee\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-30 11:00:00, ended at 2015-07-30 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, knee; 3 views\n\n### Condition\n- Localized, primary osteoarthritis\n- Osteoarthritis of knee\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-02 00:00:00, ended at 2015-09-02 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-02 00:00:00, ended at 2015-09-02 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 950 (picogram per milliliter)\n- Folate [Mass/volume] in Serum or Plasma: >19.9 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-02 00:00:00, ended at 2015-09-02 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Ferritin [Mass/volume] in Serum or Plasma: 120 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-02 00:00:00, ended at 2015-09-02 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Iron [Mass/volume] in Serum or Plasma: 45 (microgram per deciliter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 266 (microgram per deciliter)\n- Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma: 221 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 17 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-02 00:00:00, ended at 2015-09-02 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Globulin [Mass/volume] in Serum: 2.6 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 125 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (international unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (international unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 148 (international unit per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.4 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 0.88 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-02 00:00:00, ended at 2015-09-02 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 4.37 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.4 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.7 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 291 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 31.3 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.8 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.2 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.8 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.1 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.7 (picogram)\n- MCV [Entitic volume] by Automated count: 97.9 (femtoliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 9.0 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-11-19 00:00:00, ended at 2015-11-19 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pain of right knee joint\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-19 14:14:00, ended at 2015-11-19 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, knee; 3 views\n\n### Condition\n- Pain of right knee joint\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-11-19 14:14:06, ended at 2015-11-19 15:24:25\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Osteoarthritis of knee\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-02-10 00:00:00, ended at 2016-02-10 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-02-10 00:00:00, ended at 2016-02-10 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 4.51 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.4 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.9 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.6 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 96.3 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.5 (thousand per microliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 9.4 (femtoliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.4 (percent)\n- MCHC [Mass/volume] by Automated count: 32.0 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.8 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 303 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.9 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 24.7 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-02-10 00:00:00, ended at 2016-02-10 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (international unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 136 (international unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.0 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (international unit per liter)\n- Creatinine [Mass/volume] in Urine: 0.94 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.5 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 104 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-09-25 10:34:08, ended at 2016-09-25 11:05:34\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report\n\n### Condition\n- Left bundle branch block\n- Non-rheumatic aortic sclerosis\n- Aortic incompetence, non-rheumatic\n- Primary diagnosis: Essential hypertension\n- Electrocardiogram abnormal\n\n### Drug\n- hydroxychloroquine sulfate 200 MG Oral Tablet, through Oral route, started on 2016-09-24, presumably until 2017-10-27, with intended 0 refill(s). Instructions: take by mouth 2 times a day\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2016-09-24, presumably until 2016-09-24, with intended 0 refill(s). Instructions: Take 1 tablet (81 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-10-06 00:00:00, ended at 2016-10-06 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pain of right knee joint\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-10-06 10:45:00, ended at 2016-10-06 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, knee; 3 views\n\n### Condition\n- Pain of right knee joint\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-10-08 00:00:00, ended at 2016-10-08 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Iron saturation [Mass Fraction] in Serum or Plasma: 4 (percent)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 429 (microgram per deciliter)\n- Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma: 411 (microgram per deciliter)\n- Iron [Mass/volume] in Serum or Plasma: 18 (microgram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-10-08 00:00:00, ended at 2016-10-08 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-10-08 00:00:00, ended at 2016-10-08 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Ferritin [Mass/volume] in Serum or Plasma: 25 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-10-08 00:00:00, ended at 2016-10-08 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (international unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 129 (international unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (international unit per liter)\n- Creatinine [Mass/volume] in Urine: 0.98 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 128 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-10-08 00:00:00, ended at 2016-10-08 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 4.4 (million per microliter)\n- Platelets [#/volume] in Blood by Automated count: 384 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 25.9 (picogram)\n- MCHC [Mass/volume] by Automated count: 30.1 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.7 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 86.2 (femtoliter)\n- Hemoglobin [Mass/volume] in Blood: 11.4 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.2 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.9 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.3 (thousand per microliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 8.2 (femtoliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 7.7 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-10-13 00:00:00, ended at 2016-10-13 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2016-10-15 11:07:49, ended at 2016-10-15 13:43:04\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 60.8 (percent)\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Non-rheumatic aortic sclerosis\n- Aortic incompetence, non-rheumatic\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-10-20 00:00:00, ended at 2016-10-20 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-11-19 00:00:00, ended at 2016-11-19 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Ferritin [Mass/volume] in Serum or Plasma: 382 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-11-19 00:00:00, ended at 2016-11-19 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Iron saturation [Mass Fraction] in Serum or Plasma: 27 (percent)\n- Iron [Mass/volume] in Serum or Plasma: 61 (microgram per deciliter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 229 (microgram per deciliter)\n- Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma: 168 (microgram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-11-19 00:00:00, ended at 2016-11-19 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (international unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.4 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 117 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (international unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 118 (international unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 0.94 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.3 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-11-19 00:00:00, ended at 2016-11-19 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-11-19 00:00:00, ended at 2016-11-19 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 25.9 (percent)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 9.5 (femtoliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.8 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.6 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 29.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.7 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.9 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 30.2 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 91.6 (femtoliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 290 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.58 (million per microliter)\n- MCH [Entitic mass] by Automated count: 27.7 (picogram)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-02-15 00:00:00, ended at 2017-02-15 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Ferritin [Mass/volume] in Serum or Plasma: 196 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-02-15 00:00:00, ended at 2017-02-15 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 104 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (international unit per liter)\n- Creatinine [Mass/volume] in Urine: 0.97 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (international unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 110 (international unit per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-02-15 00:00:00, ended at 2017-02-15 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 1231 (picogram per milliliter)\n- Folate [Mass/volume] in Serum or Plasma: >20.0 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-02-15 00:00:00, ended at 2017-02-15 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma: 233 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 23 (percent)\n- Iron [Mass/volume] in Serum or Plasma: 70 (microgram per deciliter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 303 (microgram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-02-15 00:00:00, ended at 2017-02-15 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 4.63 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 46.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.1 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 100.1 (femtoliter)\n- Hemoglobin [Mass/volume] in Blood: 14.2 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 29.8 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.4 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.7 (picogram)\n- MCHC [Mass/volume] by Automated count: 30.7 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.8 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 266 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.3 (percent)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 9.6 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-02-15 00:00:00, ended at 2017-02-15 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-05-17 00:00:00, ended at 2017-05-17 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 10.2 (femtoliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.3 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.8 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 24.4 (percent)\n- MCV [Entitic volume] by Automated count: 99.9 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.8 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 243 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.4 (picogram)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.23 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.3 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 31.4 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-05-17 00:00:00, ended at 2017-05-17 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (international unit per liter)\n- Creatinine [Mass/volume] in Urine: 1.06 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 114 (international unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.9 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (international unit per liter)\n- Globulin [Mass/volume] in Serum: 2.5 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 104 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 22 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-05-17 00:00:00, ended at 2017-05-17 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-05-17 00:00:00, ended at 2017-05-17 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Ferritin [Mass/volume] in Serum or Plasma: 124 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-05-17 00:00:00, ended at 2017-05-17 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Iron [Mass/volume] in Serum or Plasma: 51 (microgram per deciliter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 279 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 18 (percent)\n- Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma: 228 (microgram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-05-27 00:00:00, ended at 2017-05-27 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-07-01 00:00:00, ended at 2017-07-01 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 120 (international unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (international unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 0.95 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 117 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (international unit per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.7 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-07-01 00:00:00, ended at 2017-07-01 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 10.1 (femtoliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.46 (million per microliter)\n- Platelets [#/volume] in Blood by Automated count: 278 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.5 (percent)\n- MCV [Entitic volume] by Automated count: 102.0 (femtoliter)\n- MCH [Entitic mass] by Automated count: 32.1 (picogram)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.1 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.3 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 25.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.6 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.5 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 31.4 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-07-01 00:00:00, ended at 2017-07-01 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-07-01 00:00:00, ended at 2017-07-01 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Iron [Mass/volume] in Serum or Plasma: 94 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 38 (percent)\n- Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma: 151 (microgram per deciliter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 245 (microgram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-07-01 00:00:00, ended at 2017-07-01 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Ferritin [Mass/volume] in Serum or Plasma: 1229 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-10-28 10:03:52, ended at 2017-10-28 10:42:56\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report\n\n### Condition\n- Supraventricular tachycardia\n- Left bundle branch block\n- Non-rheumatic aortic sclerosis\n- Antiphospholipid syndrome\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-11-18 00:00:00, ended at 2017-11-18 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Iron saturation [Mass Fraction] in Serum or Plasma: 35 (percent)\n- Iron [Mass/volume] in Serum or Plasma: 91 (microgram per deciliter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 257 (microgram per deciliter)\n- Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma: 166 (microgram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-11-18 00:00:00, ended at 2017-11-18 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Folate [Mass/volume] in Serum or Plasma: >20.0 (nanogram per milliliter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 1161 (picogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-11-18 00:00:00, ended at 2017-11-18 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Ferritin [Mass/volume] in Serum or Plasma: 755 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-11-18 00:00:00, ended at 2017-11-18 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-11-18 00:00:00, ended at 2017-11-18 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 0.92 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (international unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 120 (international unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (international unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.3 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 106 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-11-18 00:00:00, ended at 2017-11-18 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 4.36 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.1 (thousand per microliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 9.7 (femtoliter)\n- Hemoglobin [Mass/volume] in Blood: 14.3 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 31.3 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.0 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.8 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 21.0 (percent)\n- MCH [Entitic mass] by Automated count: 32.8 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 6.7 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 258 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.7 (percent)\n- MCV [Entitic volume] by Automated count: 104.8 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-02-21 00:00:00, ended at 2018-02-21 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Iron [Mass/volume] in Serum or Plasma: 50 (microgram per deciliter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 253 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 20 (percent)\n- Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma: 203 (microgram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-02-21 00:00:00, ended at 2018-02-21 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Hemoglobin [Mass/volume] in Blood: 14.8 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 101.6 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.5 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.28 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.5 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.6 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 246.0 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.3 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.5 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20.0 (percent)\n- MCH [Entitic mass] by Automated count: 34.6 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 9.0 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Systemic lupus erythematosus within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-08 00:00:00, ended at 2014-05-08 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Reticulocytes/100 erythrocytes in Blood: 0.5 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-08 00:00:00, ended at 2014-05-08 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Leukocytes [#/volume] in Specimen by Automated count: 3.3 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 21.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.2 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 96.2 (femtoliter)\n- MCHC [Mass/volume] by Automated count: 29.8 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.7 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 2.0 (thousand per microliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 6.7 (femtoliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 33.2 (percent)\n- Platelets [#/volume] in Blood by Automated count: 201 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.9 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.1 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.21 (million per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-08 00:00:00, ended at 2014-05-08 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Ferritin [Mass/volume] in Serum or Plasma: 141 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-08 00:00:00, ended at 2014-05-08 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Folate [Mass/volume] in Serum or Plasma: >19.9 (nanogram per milliliter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 1038 (picogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-08 00:00:00, ended at 2014-05-08 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-08 00:00:00, ended at 2014-05-08 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma: 269 (international unit per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-08 00:00:00, ended at 2014-05-08 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Haptoglobin [Mass/volume] in Serum or Plasma: 176 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-08 00:00:00, ended at 2014-05-08 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 320 (microgram per deciliter)\n- Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma: 174 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 46 (percent)\n- Iron [Mass/volume] in Serum or Plasma: 146 (microgram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-08 00:00:00, ended at 2014-05-08 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythropoietin (EPO) [Units/volume] in Serum or Plasma: 169.3 (milli-international unit per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-22 00:00:00, ended at 2014-05-22 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- aPTT in Platelet poor plasma by Coagulation assay: 25 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-22 00:00:00, ended at 2014-05-22 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Prothrombin time (PT): 10.0 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-22 00:00:00, ended at 2014-05-22 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-22 00:00:00, ended at 2014-05-22 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 105 (international unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (international unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 1.09 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.3 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.3 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (international unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 115 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-22 00:00:00, ended at 2014-05-22 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Leukocytes [#/volume] in Specimen by Automated count: 2.9 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 96.1 (femtoliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.68 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.2 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 1.5 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 21.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 8.0 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 29.9 (picogram)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 25.8 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 40.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 344 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 31.0 (gram per deciliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 6.1 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-06-05 00:00:00, ended at 2014-06-05 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-06-05 00:00:00, ended at 2014-06-05 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Lymphocytes/100 leukocytes in Blood by Automated count: 27.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 340 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 24.0 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.5 (percent)\n- MCH [Entitic mass] by Automated count: 32.3 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 2.6 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.0 (gram per deciliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 7.5 (femtoliter)\n- Hemoglobin [Mass/volume] in Blood: 12.0 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 100.7 (femtoliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.72 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.9 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.3 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-07-03 00:00:00, ended at 2014-07-03 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-07-03 00:00:00, ended at 2014-07-03 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Hemoglobin [Mass/volume] in Blood: 11.7 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.5 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 230 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.0 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 22.2 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.1 (percent)\n- MCHC [Mass/volume] by Automated count: 31.5 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.6 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20.7 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.56 (million per microliter)\n- MCH [Entitic mass] by Automated count: 32.9 (picogram)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 8.1 (femtoliter)\n- MCV [Entitic volume] by Automated count: 104.1 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-07-17 00:00:00, ended at 2014-07-17 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Injury of free lower limb\n- Primary diagnosis: Soft tissue injury\n- Joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-07-17 10:37:50, ended at 2014-07-17 12:34:28\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Osteoarthritis of knee\n\n### Drug\n- nortriptyline 25 MG Oral Capsule, through Oral route, started on 2016-09-24, presumably until 2016-09-24, with intended 0 refill(s). Instructions: Take 2 capsules (50 mg total) by mouth every bedtime\n- folic acid 1 MG Oral Tablet, through Oral route, started on 2016-09-24, presumably until 2017-10-27, with intended 0 refill(s). Instructions: take 1 mg by mouth daily \n- furosemide 20 MG Oral Tablet, through Oral route, presumably until 2018-04-15, with intended 0 refill(s). Instructions: take 20 mg by mouth daily.\n- allopurinol 100 MG Oral Tablet, through Oral route, presumably until 2020-11-26, with intended 0 refill(s). Instructions: take 200 mg by mouth 2 times a day \n- lisinopril 20 MG Oral Tablet, through Oral route, started on 2016-09-24, presumably until 2020-11-07, with intended 0 refill(s). Instructions: take 10 mg by mouth daily\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, presumably until 2015-01-15, with intended 0 refill(s). Instructions: take 50 mg by mouth every 6 hours as needed.\n- aspirin 81 MG Chewable Tablet, through Oral route, presumably until 2014-10-29, with intended 0 refill(s). Instructions: take 81 mg by mouth daily.\n- omeprazole 20 MG Delayed Release Oral Tablet, through Oral route, presumably until 2020-08-22, with intended 0 refill(s). Instructions: take 20 mg by mouth Every Day.\n- 24 HR diltiazem hydrochloride 240 MG Extended Release Oral Capsule, through Oral route, presumably until 2014-10-08, with intended 0 refill(s). Instructions: take 240 mg by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-07-17 12:37:00, ended at 2014-07-17 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocyte sedimentation rate: 73 (millimeter per hour)\n- C reactive protein [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Soft tissue injury\n- Joint pain\n- Injury of free lower limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-07-18 00:00:00, ended at 2014-07-18 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-07-18 00:00:00, ended at 2014-07-18 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Lymphocytes [#/volume] in Blood by Automated count: 1.8 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.9 (picogram)\n- MCHC [Mass/volume] by Automated count: 30.9 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 295 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.28 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 10.8 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.1 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.0 (percent)\n- MCV [Entitic volume] by Automated count: 106.7 (femtoliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 8.3 (femtoliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.7 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-08-01 00:00:00, ended at 2014-08-01 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-08-01 00:00:00, ended at 2014-08-01 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- MCHC [Mass/volume] by Automated count: 31.4 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.7 (picogram)\n- MCV [Entitic volume] by Automated count: 107.2 (femtoliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 7.8 (femtoliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.56 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.1 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.9 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 27.4 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.2 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.0 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.5 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 316 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-08-15 00:00:00, ended at 2014-08-15 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Leukocytes [#/volume] in Specimen by Automated count: 7.5 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 31.3 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 105.5 (femtoliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.0 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.2 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 28.8 (percent)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 8.8 (femtoliter)\n- MCH [Entitic mass] by Automated count: 33.1 (picogram)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.6 (million per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.3 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 11.9 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 268 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-08-15 00:00:00, ended at 2014-08-15 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-08-29 00:00:00, ended at 2014-08-29 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma: 271 (international unit per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-08-29 00:00:00, ended at 2014-08-29 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 1.15 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 110 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 125 (international unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.7 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (international unit per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (international unit per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-08-29 00:00:00, ended at 2014-08-29 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 712 (picogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-08-29 00:00:00, ended at 2014-08-29 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-08-29 00:00:00, ended at 2014-08-29 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Platelets [#/volume] in Blood by Automated count: 313 (thousand per microliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 8.2 (femtoliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.83 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.8 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 103.0 (femtoliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.4 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.8 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.3 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.1 (picogram)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 26.1 (percent)\n- MCHC [Mass/volume] by Automated count: 31.2 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.5 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.0 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-09-12 00:00:00, ended at 2014-09-12 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 15.7 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.1 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 279 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.1 (percent)\n- MCHC [Mass/volume] by Automated count: 31.2 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.2 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 29.5 (percent)\n- MCV [Entitic volume] by Automated count: 101.1 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.4 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.87 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.0 (thousand per microliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 8.8 (femtoliter)\n- MCH [Entitic mass] by Automated count: 31.5 (picogram)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-09-12 00:00:00, ended at 2014-09-12 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-09-26 00:00:00, ended at 2014-09-26 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-09-26 00:00:00, ended at 2014-09-26 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- MCHC [Mass/volume] by Automated count: 30.9 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 99.8 (femtoliter)\n- MCH [Entitic mass] by Automated count: 30.9 (picogram)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.92 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.6 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.1 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.3 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 283 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.6 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.1 (percent)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 8.5 (femtoliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.5 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-10-08 09:16:08, ended at 2014-10-08 11:45:15\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Pre-surgery evaluation\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Chronic kidney disease stage 2\n- Gastroesophageal reflux disease\n- Primary diagnosis: Systemic lupus erythematosus\n- Disorder of muscle\n- Cardiac arrhythmia\n- Gout\n- Joint pain\n- Obesity\n- Hypercoagulability state\n- Disorder of hematopoietic structure\n- Essential hypertension\n- Left bundle branch block\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-10-08 09:18:00, ended at 2014-10-08 14:06:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, knee; 3 views\n\n### Condition\n- Joint pain\n- Closed fracture of patella\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-10-08 12:14:45, ended at 2014-10-08 12:48:03\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 24 HR diltiazem hydrochloride 240 MG Extended Release Oral Tablet, through Oral route, presumably until 2020-09-18, with intended 0 refill(s). Instructions: take 1 Tab by mouth Every Day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-10-08 13:27:24, ended at 2014-10-08 14:04:13\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Pre-surgery evaluation\n\n### Condition\n- Cardiac arrhythmia\n- Hypercoagulability state\n- Disorder of hematopoietic structure\n- Chronic kidney disease stage 2\n- Essential hypertension\n- Systemic lupus erythematosus\n\n### Drug\n- nortriptyline 25 MG Oral Capsule, through Oral route, started on 2014-02-20, presumably until 2014-10-24, with intended 0 refill(s). Instructions: take 125 mg by mouth.\n- folic acid 1 MG Oral Tablet, through Oral route, presumably until 2014-10-24, with intended 0 refill(s). Instructions: take 2 mg by mouth.\n- lisinopril 40 MG Oral Tablet, through Oral route, presumably until 2014-10-24, with intended 0 refill(s). Instructions: take 40 mg by mouth.\n- furosemide 20 MG Oral Tablet, through Oral route, presumably until 2014-10-24, with intended 0 refill(s). Instructions: take  by mouth.\n- aspirin 81 MG Effervescent Oral Tablet, through Oral route, presumably until 2014-10-24, with intended 0 refill(s). Instructions: take 81 mg by mouth.\n- acetaminophen 500 MG Oral Tablet, through Oral route, presumably until 2014-10-24, with intended 0 refill(s). Instructions: take  by mouth.\n- allopurinol 100 MG Oral Tablet, through Oral route, started on 2012-11-19, presumably until 2014-10-24, with intended 0 refill(s). Instructions: take 100 mg by mouth.\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, presumably until 2014-10-24, with intended 0 refill(s). Instructions: take 50 mg by mouth.\n- omeprazole 20 MG Delayed Release Oral Tablet, through Oral route, presumably until 2014-10-24, with intended 0 refill(s). Instructions: take 20 mg by mouth.\n- 24 HR diltiazem hydrochloride 240 MG Extended Release Oral Capsule, through Oral route, presumably until 2014-10-24, with intended 0 refill(s). Instructions: take 240 mg by mouth daily.\n- omeprazole 20 MG Delayed Release Oral Capsule, started on 2014-07-30, presumably until 2014-10-24, with intended 0 refill(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-10-08 14:07:00, ended at 2014-10-08 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.0 (percent)\n- MCV [Entitic volume] by Automated count: 95.2 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.85 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.6 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 31.1 (second)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 49 (milliliter per minute per square meter)\n- Platelets [#/volume] in Blood by Automated count: 302 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n- Neutrophils/100 leukocytes in Blood by Automated count: 68.9 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.9 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 166 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.34 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.8 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.6 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 6.62 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 125 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.2 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.6 (percent)\n- Prothrombin time (PT): 13.2 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.7 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.02 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.54 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 21.0 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Pre-surgery evaluation\n\n### Condition\n- Cardiac arrhythmia\n- Gastroesophageal reflux disease\n- Obesity\n- Gout\n- Hypercoagulability state\n- Disorder of hematopoietic structure\n- Joint pain\n- Systemic lupus erythematosus\n- Chronic kidney disease stage 2\n- Disorder of muscle\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-10-16 00:00:00, ended at 2014-10-16 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Leukocytes [#/volume] in Specimen by Automated count: 7.5 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 99.3 (femtoliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.83 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.0 (percent)\n- MCH [Entitic mass] by Automated count: 30.5 (picogram)\n- Hemoglobin [Mass/volume] in Blood: 11.7 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 30.8 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.9 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 27.0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.0 (thousand per microliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 8.4 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 274 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.7 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-10-16 00:00:00, ended at 2014-10-16 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2014-10-25 00:00:00, ended at 2014-10-25 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for open or surgical arthroscopic procedures on knee joint; total knee arthroplasty\n\n### Condition\n- Mechanical complication of internal joint prosthesis\n\n### Drug\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2014-10-25, presumably until 2014-10-25\n- cefazolin 1000 MG Injection, started on 2014-10-25, presumably until 2014-10-25\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2014-10-25, presumably until 2014-10-25\n- 2 ML lidocaine hydrochloride 20 MG/ML Injection, started on 2014-10-25, presumably until 2014-10-25\n- 2 ML ondansetron 2 MG/ML Injection, started on 2014-10-25, presumably until 2014-10-25\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2014-10-25, presumably until 2014-10-25\n- ketamine 100 MG/ML Injectable Solution, started on 2014-10-25, presumably until 2014-10-25\n- succinylcholine chloride 20 MG/ML Injectable Solution, started on 2014-10-25, presumably until 2014-10-25\n- 10 ML tranexamic acid 100 MG/ML Injection, through Intravenous route, started on 2014-10-25, presumably until 2014-10-25\n- midazolam 1 MG/ML Injectable Solution, started on 2014-10-25, presumably until 2014-10-25\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2014-10-25 00:00:00, ended at 2014-10-25 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Injection(s), anesthetic agent(s) and/or steroid; femoral nerve, continuous infusion by catheter (including catheter placement)\n- Ultrasonic guidance for needle placement (eg, biopsy, aspiration, injection, localization device), imaging supervision and interpretation\n\n### Condition\n- Acute postoperative pain\n\n### Drug\n- midazolam 1 MG/ML Injectable Solution, started on 2014-10-25, presumably until 2014-10-25\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2014-10-25 00:00:00, ended at 2014-10-25 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sodium chloride 0.154 MEQ/ML Irrigation Solution, through Topical route, started on 2014-10-25, presumably until 2014-10-25\n- 1 ML ketorolac tromethamine 30 MG/ML Injection, started on 2014-10-25, presumably until 2014-10-25\n- 30 ML ropivacaine hydrochloride 5 MG/ML Injection, started on 2014-10-25, presumably until 2014-10-25\n- 1 ML epinephrine 1 MG/ML Injection, started on 2014-10-25, presumably until 2014-10-25\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2014-10-25 05:16:00, ended at 2014-10-29 12:25:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 184 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): N/A (milliliter per minute per square meter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.9 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.7 (percent)\n- MCH [Entitic mass] by Automated count: 31.2 (picogram)\n- MCV [Entitic volume] by Automated count: 95.7 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.02 (million per microliter)\n- INR in Platelet poor plasma by Coagulation assay: >60.0 (ratio)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.4 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.6 (gram per deciliter)\n- Body height: 5' 3\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 25.5 (second)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 124 (milligram per deciliter)\n- Prothrombin time (PT): >300.0 (second)\n- Hemoglobin [Mass/volume] in Blood: 9.4 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Radiologic examination, knee; 1 or 2 views\n- Revision of knee replacement\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Division of joint capsule, ligament, or cartilage, knee\n- Tendon pulley reconstruction other than hand\n- Synovectomy of knee joint\n- Application of long leg cast\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Physical therapy evaluation\n- Occupational therapy evaluation\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n\n### Condition\n- Left bundle branch block\n- Tachycardia\n- Anemia\n- Benign hypertensive renal disease with renal failure\n- Complication of internal device\n- Gastroesophageal reflux disease\n- Late effect of medical and surgical care complication\n- Acquired absence of cervix and uterus\n- Acute posthemorrhagic anemia\n- Disorder of hematopoietic structure\n- Acute postoperative pain\n- Chronic glomerulonephritis associated with another disorder\n- Chronic kidney disease stage 3\n- Primary diagnosis: Hypercoagulability state\n- Systemic lupus erythematosus\n- Chronic kidney disease stage 2\n- Joint pain\n- Essential hypertension\n- Gout\n- Mechanical complication of internal orthopedic device, implant AND/OR graft\n- Morbid obesity\n- Obesity\n- Cardiac arrhythmia\n- Chronic pain\n- Disorder of muscle\n\n### Drug\n- Lactobacillus acidophilus, through Oral route, started on 2014-10-25, presumably until 2014-10-29\n- Bifidobacterium bifidum, through Oral route, started on 2014-10-25, presumably until 2014-10-29\n- diltiazem hydrochloride 60 MG Oral Tablet, through Oral route, started on 2014-10-26, presumably until 2014-10-29\n- warfarin sodium 5 MG Oral Tablet, started on 2014-10-26, presumably until 2014-12-04, with intended 0 refill(s). Instructions: Please take as instructed in your discharge instructions.\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2014-10-25, presumably until 2014-10-29\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2014-10-26, presumably until 2014-10-29\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2014-10-26, presumably until 2014-10-29\n- Streptococcus thermophilus, through Oral route, started on 2014-10-25, presumably until 2014-10-29\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2014-10-27, presumably until 2014-10-27\n- warfarin sodium 7.5 MG Oral Tablet, through Oral route, started on 2014-10-26, presumably until 2014-10-28\n- cefazolin 1000 MG Injection, started on 2014-10-25, presumably until 2014-10-26\n- celecoxib 100 MG Oral Capsule, through Oral route, started on 2014-10-25, presumably until 2014-10-27\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2014-10-25, presumably until 2015-10-26, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day.\n- allopurinol 100 MG Oral Tablet, through Oral route, started on 2014-10-26, presumably until 2014-10-29\n- hydralazine hydrochloride 10 MG Oral Tablet, through Oral route, started on 2014-10-25, presumably until 2014-10-25\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2014-10-26, presumably until 2015-10-26, with intended 0 refill(s). Instructions: take 2 Tabs by mouth 2 times a day.\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2014-10-25, presumably until 2014-10-25\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2014-10-26, presumably until 2014-10-28\n- celecoxib 200 MG Oral Capsule, through Oral route, started on 2014-10-25, presumably until 2014-10-25\n- 2 ML ondansetron 2 MG/ML Injection, started on 2014-10-25, presumably until 2014-10-27\n- warfarin sodium 2 MG Oral Tablet, started on 2014-10-26, presumably until 2014-12-04, with intended 0 refill(s). Instructions: Please take as instructed in your discharge instructions.\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2014-10-25, presumably until 2014-10-25\n- Lactobacillus delbrueckii subsp. bulgaricus, through Oral route, started on 2014-10-25, presumably until 2014-10-29\n- warfarin sodium 1 MG Oral Tablet, started on 2014-10-26, presumably until 2014-12-04, with intended 0 refill(s). Instructions: Please take as instructed in your discharge instructions.\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2014-10-25, presumably until 2014-11-15, with intended 0 refill(s). Instructions: take 1-3 Tabs by mouth every 4 hours as needed for Pain.\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2014-10-25, presumably until 2014-10-26\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-11-05 00:00:00, ended at 2014-11-05 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.0 (percent)\n- MCHC [Mass/volume] by Automated count: 29.8 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 420 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 95.2 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 7.4 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.7 (thousand per microliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 7.0 (femtoliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.9 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.7 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.14 (million per microliter)\n- MCH [Entitic mass] by Automated count: 28.3 (picogram)\n- Hemoglobin [Mass/volume] in Blood: 8.9 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-11-05 00:00:00, ended at 2014-11-05 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma: 402 (international unit per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-11-05 00:00:00, ended at 2014-11-05 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Ferritin [Mass/volume] in Serum or Plasma: 108 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-11-05 00:00:00, ended at 2014-11-05 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Iron saturation [Mass Fraction] in Serum or Plasma: 7 (percent)\n- Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma: 233 (microgram per deciliter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 250 (microgram per deciliter)\n- Iron [Mass/volume] in Serum or Plasma: 17 (microgram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-11-05 00:00:00, ended at 2014-11-05 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (international unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 129 (international unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (international unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 97 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.6 (gram per deciliter)\n- Creatinine [Mass/volume] in Urine: 1.00 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 131 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.0 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-11-05 00:00:00, ended at 2014-11-05 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-11-19 00:00:00, ended at 2014-11-19 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-11-19 00:00:00, ended at 2014-11-19 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- MCHC [Mass/volume] by Automated count: 29.1 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.54 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.3 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 28.0 (picogram)\n- MCV [Entitic volume] by Automated count: 96.1 (femtoliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 24.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.8 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 320 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.9 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.3 (thousand per microliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 8.3 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-11-22 00:00:00, ended at 2014-11-22 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-11-29 00:00:00, ended at 2014-11-29 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-11-29 00:00:00, ended at 2014-11-29 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Subsequent stage of staged operation\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-12-03 00:00:00, ended at 2014-12-03 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Prothrombin time (PT): 27.4 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-12-03 00:00:00, ended at 2014-12-03 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 21.9 (percent)\n- MCHC [Mass/volume] by Automated count: 30.6 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.8 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.9 (picogram)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.74 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.2 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.0 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.3 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.6 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 22.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 255 (thousand per microliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 8.3 (femtoliter)\n- MCV [Entitic volume] by Automated count: 94.4 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-12-03 00:00:00, ended at 2014-12-03 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma: 262 (international unit per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-12-03 00:00:00, ended at 2014-12-03 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-12-04 00:00:00, ended at 2014-12-04 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- warfarin sodium 2 MG Oral Tablet, started on 2014-12-04, presumably until 2016-09-25, with intended 0 refill(s). Instructions: Please take as instructed in your discharge instructions.\n- warfarin sodium 1 MG Oral Tablet, started on 2014-12-04, presumably until 2016-09-25, with intended 0 refill(s). Instructions: Please take as instructed in your discharge instructions.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-12-04 13:09:00, ended at 2014-12-04 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, knee; 1 or 2 views\n\n### Condition\n- Joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-12-17 00:00:00, ended at 2014-12-17 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Hemoglobin [Mass/volume] in Blood: 12.8 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 29.3 (picogram)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 8.4 (femtoliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 22.6 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.7 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 96.5 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.8 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 288 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.37 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.0 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 24.0 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.2 (percent)\n- MCHC [Mass/volume] by Automated count: 30.3 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-12-17 00:00:00, ended at 2014-12-17 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Prothrombin time (PT): 13.4 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-12-17 00:00:00, ended at 2014-12-17 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-12-31 00:00:00, ended at 2014-12-31 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Ferritin [Mass/volume] in Serum or Plasma: 339 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-12-31 00:00:00, ended at 2014-12-31 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 4.49 (million per microliter)\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.0 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 25.5 (percent)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 8.8 (femtoliter)\n- Hemoglobin [Mass/volume] in Blood: 13.5 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 31.4 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 254 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.9 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 95.7 (femtoliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.7 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.4 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-12-31 00:00:00, ended at 2014-12-31 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Prothrombin time (PT): 17.8 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-12-31 00:00:00, ended at 2014-12-31 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-12-31 00:00:00, ended at 2014-12-31 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Iron [Mass/volume] in Serum or Plasma: 51 (microgram per deciliter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 230 (microgram per deciliter)\n- Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma: 179 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 22 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-01-15 00:00:00, ended at 2015-01-15 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2015-01-15, presumably until 2020-12-18, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-01-18 00:00:00, ended at 2015-01-18 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Subsequent stage of staged operation\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-01-28 00:00:00, ended at 2015-01-28 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 4.42 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.6 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.7 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.1 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.9 (percent)\n- MCHC [Mass/volume] by Automated count: 30.4 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 97.4 (femtoliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.3 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 270 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 26.4 (percent)\n- MCH [Entitic mass] by Automated count: 29.6 (picogram)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 8.7 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-01-28 00:00:00, ended at 2015-01-28 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Prothrombin time (PT): 16.4 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-01-28 00:00:00, ended at 2015-01-28 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-01-29 13:33:00, ended at 2015-01-29 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, knee; 1 or 2 views\n\n### Condition\n- Closed fracture of patella\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-01-29 13:33:36, ended at 2015-01-29 15:51:48\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Osteoarthritis of knee\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-03-12 08:15:00, ended at 2015-03-12 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, knee; 3 views\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-03-25 00:00:00, ended at 2015-03-25 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-03-25 00:00:00, ended at 2015-03-25 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Lymphocytes/100 leukocytes in Blood by Automated count: 26.7 (percent)\n- MCH [Entitic mass] by Automated count: 31.3 (picogram)\n- MCHC [Mass/volume] by Automated count: 30.1 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.22 (million per microliter)\n- MCV [Entitic volume] by Automated count: 103.7 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.9 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.2 (percent)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 9.1 (femtoliter)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.1 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 284 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.0 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-04-23 13:30:00, ended at 2015-04-23 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, knee; 3 views\n\n### Condition\n- Joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-04-23 13:31:41, ended at 2015-04-23 15:44:17\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Osteoarthritis of knee\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-05-28 09:09:00, ended at 2015-05-28 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, knee; 1 or 2 views\n\n### Condition\n- Joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-05-28 09:11:27, ended at 2015-05-28 10:53:21\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Localized, primary osteoarthritis\n- Primary diagnosis: Osteoarthritis of knee\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-05-29 00:00:00, ended at 2015-05-29 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-05-29 00:00:00, ended at 2015-05-29 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Lymphocytes/100 leukocytes in Blood by Automated count: 22.5 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.19 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.5 (picogram)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.3 (percent)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 8.6 (femtoliter)\n- MCHC [Mass/volume] by Automated count: 30.5 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 103.4 (femtoliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.3 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.6 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.3 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 226 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-07-30 10:55:18, ended at 2015-07-30 13:01:52\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Localized, primary osteoarthritis\n- Primary diagnosis: Osteoarthritis of knee\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-30 11:00:00, ended at 2015-07-30 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, knee; 3 views\n\n### Condition\n- Localized, primary osteoarthritis\n- Osteoarthritis of knee\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-02 00:00:00, ended at 2015-09-02 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-02 00:00:00, ended at 2015-09-02 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 950 (picogram per milliliter)\n- Folate [Mass/volume] in Serum or Plasma: >19.9 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-02 00:00:00, ended at 2015-09-02 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Ferritin [Mass/volume] in Serum or Plasma: 120 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-02 00:00:00, ended at 2015-09-02 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Iron [Mass/volume] in Serum or Plasma: 45 (microgram per deciliter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 266 (microgram per deciliter)\n- Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma: 221 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 17 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-02 00:00:00, ended at 2015-09-02 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Globulin [Mass/volume] in Serum: 2.6 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 125 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (international unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (international unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 148 (international unit per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.4 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 0.88 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-02 00:00:00, ended at 2015-09-02 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 4.37 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.4 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.7 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 291 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 31.3 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.8 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.2 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.8 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.1 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.7 (picogram)\n- MCV [Entitic volume] by Automated count: 97.9 (femtoliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 9.0 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-11-19 00:00:00, ended at 2015-11-19 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pain of right knee joint\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-19 14:14:00, ended at 2015-11-19 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, knee; 3 views\n\n### Condition\n- Pain of right knee joint\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-11-19 14:14:06, ended at 2015-11-19 15:24:25\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Osteoarthritis of knee\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-02-10 00:00:00, ended at 2016-02-10 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-02-10 00:00:00, ended at 2016-02-10 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 4.51 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.4 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.9 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.6 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 96.3 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.5 (thousand per microliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 9.4 (femtoliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.4 (percent)\n- MCHC [Mass/volume] by Automated count: 32.0 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.8 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 303 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.9 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 24.7 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-02-10 00:00:00, ended at 2016-02-10 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (international unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 136 (international unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.0 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (international unit per liter)\n- Creatinine [Mass/volume] in Urine: 0.94 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.5 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 104 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-09-25 10:34:08, ended at 2016-09-25 11:05:34\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report\n\n### Condition\n- Left bundle branch block\n- Non-rheumatic aortic sclerosis\n- Aortic incompetence, non-rheumatic\n- Primary diagnosis: Essential hypertension\n- Electrocardiogram abnormal\n\n### Drug\n- hydroxychloroquine sulfate 200 MG Oral Tablet, through Oral route, started on 2016-09-24, presumably until 2017-10-27, with intended 0 refill(s). Instructions: take by mouth 2 times a day\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2016-09-24, presumably until 2016-09-24, with intended 0 refill(s). Instructions: Take 1 tablet (81 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-10-06 00:00:00, ended at 2016-10-06 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pain of right knee joint\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-10-06 10:45:00, ended at 2016-10-06 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, knee; 3 views\n\n### Condition\n- Pain of right knee joint\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-10-08 00:00:00, ended at 2016-10-08 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Iron saturation [Mass Fraction] in Serum or Plasma: 4 (percent)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 429 (microgram per deciliter)\n- Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma: 411 (microgram per deciliter)\n- Iron [Mass/volume] in Serum or Plasma: 18 (microgram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-10-08 00:00:00, ended at 2016-10-08 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-10-08 00:00:00, ended at 2016-10-08 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Ferritin [Mass/volume] in Serum or Plasma: 25 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-10-08 00:00:00, ended at 2016-10-08 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (international unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 129 (international unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (international unit per liter)\n- Creatinine [Mass/volume] in Urine: 0.98 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 128 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-10-08 00:00:00, ended at 2016-10-08 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 4.4 (million per microliter)\n- Platelets [#/volume] in Blood by Automated count: 384 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 25.9 (picogram)\n- MCHC [Mass/volume] by Automated count: 30.1 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.7 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 86.2 (femtoliter)\n- Hemoglobin [Mass/volume] in Blood: 11.4 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.2 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.9 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.3 (thousand per microliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 8.2 (femtoliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 7.7 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-10-13 00:00:00, ended at 2016-10-13 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2016-10-15 11:07:49, ended at 2016-10-15 13:43:04\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 60.8 (percent)\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Non-rheumatic aortic sclerosis\n- Aortic incompetence, non-rheumatic\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-10-20 00:00:00, ended at 2016-10-20 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-11-19 00:00:00, ended at 2016-11-19 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Ferritin [Mass/volume] in Serum or Plasma: 382 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-11-19 00:00:00, ended at 2016-11-19 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Iron saturation [Mass Fraction] in Serum or Plasma: 27 (percent)\n- Iron [Mass/volume] in Serum or Plasma: 61 (microgram per deciliter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 229 (microgram per deciliter)\n- Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma: 168 (microgram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-11-19 00:00:00, ended at 2016-11-19 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (international unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.4 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 117 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (international unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 118 (international unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 0.94 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.3 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-11-19 00:00:00, ended at 2016-11-19 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-11-19 00:00:00, ended at 2016-11-19 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 25.9 (percent)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 9.5 (femtoliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.8 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.6 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 29.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.7 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.9 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 30.2 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 91.6 (femtoliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 290 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.58 (million per microliter)\n- MCH [Entitic mass] by Automated count: 27.7 (picogram)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-02-15 00:00:00, ended at 2017-02-15 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Ferritin [Mass/volume] in Serum or Plasma: 196 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-02-15 00:00:00, ended at 2017-02-15 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 104 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (international unit per liter)\n- Creatinine [Mass/volume] in Urine: 0.97 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (international unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 110 (international unit per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-02-15 00:00:00, ended at 2017-02-15 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 1231 (picogram per milliliter)\n- Folate [Mass/volume] in Serum or Plasma: >20.0 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-02-15 00:00:00, ended at 2017-02-15 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma: 233 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 23 (percent)\n- Iron [Mass/volume] in Serum or Plasma: 70 (microgram per deciliter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 303 (microgram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-02-15 00:00:00, ended at 2017-02-15 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 4.63 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 46.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.1 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 100.1 (femtoliter)\n- Hemoglobin [Mass/volume] in Blood: 14.2 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 29.8 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.4 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.7 (picogram)\n- MCHC [Mass/volume] by Automated count: 30.7 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.8 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 266 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.3 (percent)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 9.6 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-02-15 00:00:00, ended at 2017-02-15 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-05-17 00:00:00, ended at 2017-05-17 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 10.2 (femtoliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.3 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.8 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 24.4 (percent)\n- MCV [Entitic volume] by Automated count: 99.9 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.8 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 243 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.4 (picogram)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.23 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.3 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 31.4 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-05-17 00:00:00, ended at 2017-05-17 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (international unit per liter)\n- Creatinine [Mass/volume] in Urine: 1.06 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 114 (international unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.9 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (international unit per liter)\n- Globulin [Mass/volume] in Serum: 2.5 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 104 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 22 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-05-17 00:00:00, ended at 2017-05-17 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-05-17 00:00:00, ended at 2017-05-17 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Ferritin [Mass/volume] in Serum or Plasma: 124 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-05-17 00:00:00, ended at 2017-05-17 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Iron [Mass/volume] in Serum or Plasma: 51 (microgram per deciliter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 279 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 18 (percent)\n- Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma: 228 (microgram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-05-27 00:00:00, ended at 2017-05-27 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-07-01 00:00:00, ended at 2017-07-01 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 120 (international unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (international unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 0.95 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 117 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (international unit per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.7 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-07-01 00:00:00, ended at 2017-07-01 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 10.1 (femtoliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.46 (million per microliter)\n- Platelets [#/volume] in Blood by Automated count: 278 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.5 (percent)\n- MCV [Entitic volume] by Automated count: 102.0 (femtoliter)\n- MCH [Entitic mass] by Automated count: 32.1 (picogram)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.1 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.3 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 25.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.6 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.5 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 31.4 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-07-01 00:00:00, ended at 2017-07-01 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-07-01 00:00:00, ended at 2017-07-01 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Iron [Mass/volume] in Serum or Plasma: 94 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 38 (percent)\n- Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma: 151 (microgram per deciliter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 245 (microgram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-07-01 00:00:00, ended at 2017-07-01 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Ferritin [Mass/volume] in Serum or Plasma: 1229 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-10-28 10:03:52, ended at 2017-10-28 10:42:56\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report\n\n### Condition\n- Supraventricular tachycardia\n- Left bundle branch block\n- Non-rheumatic aortic sclerosis\n- Antiphospholipid syndrome\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-11-18 00:00:00, ended at 2017-11-18 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Iron saturation [Mass Fraction] in Serum or Plasma: 35 (percent)\n- Iron [Mass/volume] in Serum or Plasma: 91 (microgram per deciliter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 257 (microgram per deciliter)\n- Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma: 166 (microgram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-11-18 00:00:00, ended at 2017-11-18 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Folate [Mass/volume] in Serum or Plasma: >20.0 (nanogram per milliliter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 1161 (picogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-11-18 00:00:00, ended at 2017-11-18 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Ferritin [Mass/volume] in Serum or Plasma: 755 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-11-18 00:00:00, ended at 2017-11-18 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-11-18 00:00:00, ended at 2017-11-18 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 0.92 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (international unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 120 (international unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (international unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.3 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 106 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-11-18 00:00:00, ended at 2017-11-18 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 4.36 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.1 (thousand per microliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 9.7 (femtoliter)\n- Hemoglobin [Mass/volume] in Blood: 14.3 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 31.3 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.0 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.8 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 21.0 (percent)\n- MCH [Entitic mass] by Automated count: 32.8 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 6.7 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 258 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.7 (percent)\n- MCV [Entitic volume] by Automated count: 104.8 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-02-21 00:00:00, ended at 2018-02-21 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Iron [Mass/volume] in Serum or Plasma: 50 (microgram per deciliter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 253 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 20 (percent)\n- Iron binding capacity.unsaturated [Mass/volume] in Serum or Plasma: 203 (microgram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-02-21 00:00:00, ended at 2018-02-21 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Hemoglobin [Mass/volume] in Blood: 14.8 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 101.6 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.5 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.28 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.5 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.6 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 246.0 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.3 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.5 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20.0 (percent)\n- MCH [Entitic mass] by Automated count: 34.6 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 9.0 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Systemic lupus erythematosus within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of lupus means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "d984e76dd897241521998311a9bfbf6296a58ebc9556abc80d55c0e628192019", "prompt_hash": "659e13f0b283ddef48c603c62454a75874722ec900a1d8b9200c5f21079e163c", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 8, "doc": {"person_id": 115969365, "visit_occurrence_id": 49302577, "death_date": null, "visit_concept_name": "Outpatient Visit", "visit_start_datetime": "2012-07-24 09:52:00", "visit_end_datetime": "2012-07-24 23:59:00", "visit_length_in_hours": 14.116666666666667, "integrated_visit_record": "## Visit\nThis visit record, was from Outpatient Visit, started at 2012-07-24 09:52:00, ended at 2012-07-24 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 49 (milliliter per minute per square meter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 160 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.7 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.6 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.5 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.34 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 38.3 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 4.7 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 181 (unit per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.9 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 200 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.2 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 9.3 (nanogram per milliliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 97 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.7 (percent)\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.6 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 44 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.28 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.45 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 47.8 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 1.67 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 184 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n", "approximate_token_count": 936, "patient_first_visit_date": "2008-03-10 21:46:00", "patient_last_visit_date": "2022-05-23 00:00:00", "end_obs_date": "2013-07-24", "hypertension_type": "recurrent", "hypertension_one_year_diagnosis": 0, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "recurrent", "hyperlipidemia_one_year_diagnosis": 1, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "recurrent", "chronic_kidney_disease_one_year_diagnosis": 1, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "recurrent", "lupus_one_year_diagnosis": 1, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "recurrent", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 56, "cumulated_visit_num": 56, "cumulated_approximate_token_count": 26614, "visit_cumulated": "## Visit\nThis visit record, was from Inpatient Visit, started at 2008-03-10 21:46:00, ended at 2008-03-11 14:25:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.10 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.3 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.50 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.2 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7.0 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Vancomycin [Mass/volume] in Serum or Plasma: 34.2 (microgram per milliliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.7 (percent)\n- Hemoglobin [Mass/volume] in Blood: 8.7 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.5 (picogram)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.28 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.9 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 94.0 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 133 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Base deficit in Blood: 4.0 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.4 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 94.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 135 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.0 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.4 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.0 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 97 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 78 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.85 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 69 (unit per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2008-07-20 01:45:00, ended at 2008-07-22 12:47:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 2.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 76 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Body height: 5' 4\" (inch (US))\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.21 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.3 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.7 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 40.5 (percent)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 38 (percent)\n- Sodium [Moles/volume] in Blood: 130 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 148 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 27.3 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- Lymphocytes [#/volume] in Blood by Manual count: 1.6 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 88.7 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 95 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 85 (unit per liter)\n- Base deficit in Blood: 4.0 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.6 (picogram)\n- Phosphate [Mass/volume] in Serum or Plasma: 6.5 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 6.2 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 54.6 (second)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.87 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.8 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 4 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 80.9 (percent)\n- Prothrombin time (PT): 14.2 (second)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.5 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.44 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Manual count: 2.5 (thousand per microliter)\n- Potassium [Moles/volume] in Blood: 5.2 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 62 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.10 (million per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.53 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.2 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.5 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Manual count: 1 (percent)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood: 22 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 55 (percent)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood by calculation: 7.5 (gram per deciliter)\n- Basophils [#/volume] in Blood by Manual count: 0.0 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.5 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 5.0 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n- Chronic kidney disease stage 5 due to hypertension\n- Diaphragmatic hernia\n- Anemia in chronic kidney disease\n- Systemic lupus erythematosus\n- Nausea\n- Stricture of esophagus\n- Acute posthemorrhagic anemia\n- Mitral valve disorder\n- Hematochezia\n- Hepatic necrosis\n\n### Drug\n- lansoprazole 30 MG Delayed Release Oral Capsule, through Oral route, presumably until 2008-07-22. Instructions: take 30 mg by mouth daily. \n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2008-07-21, presumably until 2008-07-22\n- benzocaine 140 MG/ML / butamben 20 MG/ML / tetracaine 20 MG/ML Mucosal Spray, through Topical route, started on 2008-07-20, presumably until 2008-07-21\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2008-07-19, presumably until 2008-07-20\n- prochlorperazine 5 MG/ML Injectable Solution, started on 2008-07-20, presumably until 2008-07-20\n- lamotrigine 200 MG Oral Tablet, through Oral route, presumably until 2009-04-03. Instructions: take 200 mg by mouth 2 times a day. \n- atorvastatin 10 MG Oral Tablet, through Oral route, presumably until 2009-04-03. Instructions: take 10 mg by mouth every bedtime. \n- 500 ML glucose 50 MG/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2008-07-21, presumably until 2008-07-21\n- rabeprazole sodium 20 MG Delayed Release Oral Tablet, through Oral route, started on 2008-07-22, presumably until 2009-04-03, with quantity of 90.0, with intended 5 refill(s). Instructions: take 20 mg by mouth 2 times a day. Take Aciphex 1 pill two times a day for 2 weeks and then switch to once daily indefinitely. \n- prednisone 1 MG Oral Tablet, through Oral route, started on 2008-07-20, presumably until 2009-04-03. Instructions: take 2 mg by mouth daily. \n- 0.5 ML darbepoetin alfa 0.2 MG/ML Prefilled Syringe, started on 2008-07-20, presumably until 2008-07-22\n- lamotrigine 100 MG Oral Tablet, through Oral route, started on 2008-07-20, presumably until 2009-04-03. Instructions: take 200 mg by mouth 2 times a day. \n- lanthanum carbonate 750 MG Chewable Tablet, through Oral route, presumably until 2009-04-03. Instructions: take by mouth. \n- 2 ML ondansetron 2 MG/ML Injection, started on 2008-07-19, presumably until 2008-07-20\n- 1000 ML glucose 50 MG/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2008-07-20, presumably until 2008-07-20\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2008-07-21, presumably until 2008-07-21\n- lidocaine hydrochloride 0.02 MG/MG Topical Gel, through Submucosal route, started on 2008-07-19, presumably until 2008-07-19\n- simethicone 66.7 MG/ML Oral Suspension, through Oral route, started on 2008-07-21, presumably until 2008-07-21\n- albuterol 5 MG/ML Inhalation Solution, through Intravenous route, started on 2008-07-20, presumably until 2008-07-20\n- midazolam 1 MG/ML Injectable Solution, started on 2008-07-20, presumably until 2008-07-21\n- 1 ML promethazine hydrochloride 25 MG/ML Injection, started on 2008-07-20, presumably until 2008-07-20\n- 1 ML morphine sulfate 4 MG/ML Prefilled Syringe, started on 2008-07-20, presumably until 2008-07-20\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2008-10-01 07:25:00, ended at 2008-10-01 17:15:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of body wall\n- Inguinal hernia\n\n### Drug\n- epoetin alfa 10000 UNT/ML Injectable Solution, presumably until 2009-04-03. Instructions: 1 mL by Injection route as needed Every other week\n- 2 ML ondansetron 2 MG/ML Injection, started on 2008-10-01, presumably until 2008-10-01\n- 1 ML promethazine hydrochloride 25 MG/ML Injection, started on 2008-10-01, presumably until 2008-10-01\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2009-02-24 15:00:00, ended at 2009-02-26 15:40:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Glucose [Mass/volume] in Serum or Plasma: 97 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.2 (percent)\n- Hemoglobin [Mass/volume] in Blood by calculation: 17.7 (gram per deciliter)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 39 (millimeter mercury column)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 80 (milligram per deciliter)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 16.3 (microgram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 64 (unit per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 99 (percent)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.23 (millimole per liter)\n- Phosphate [Mass/volume] in Serum or Plasma: 6.1 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 42.5 (millimeter mercury column)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 33 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n- MCV [Entitic volume] by Automated count: 96.1 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.8 (percent)\n- Prothrombin time (PT): 14.9 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 67 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood: 52 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.3 (gram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 373 (unit per liter)\n- Monocytes [#/volume] in Blood by Automated count: 1.42 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.3 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 99 (thousand per microliter)\n- Base deficit in Blood: 5.0 (millimole per liter)\n- Base excess in Blood by calculation: 4.0 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Bicarbonate [Moles/volume] in Specimen: 21.5 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.33 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 4.9 (percent)\n- MCH [Entitic mass] by Automated count: 33.0 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.3 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 65.6 (second)\n- Creatinine [Mass/volume] in Serum or Plasma: 7.7 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.7 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.88 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 66 (unit per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.24 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 91.1 (percent)\n- Potassium [Moles/volume] in Blood: 4.0 (millimole per liter)\n- Sodium [Moles/volume] in Blood: 132 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Low blood pressure\n- Sepsis\n- End-stage renal disease\n- Gastroesophageal reflux disease\n- Disorder of phosphorus metabolism\n- Nausea and vomiting\n- Epilepsy\n- Hyperparathyroidism due to renal insufficiency\n- Kidney disease\n- Primary bacterial peritonitis\n- Systemic lupus erythematosus\n- Essential hypertension\n- Peritonitis\n\n### Drug\n- hydrocortisone 100 MG Injection, started on 2009-02-24, presumably until 2009-02-26\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2009-02-24, presumably until 2009-02-24\n- piperacillin 2000 MG / tazobactam 250 MG Injection, through Intravenous route, started on 2009-02-24, presumably until 2009-02-24\n- 100 ML ciprofloxacin 2 MG/ML Injection, through Intravenous route, started on 2009-02-24, presumably until 2009-02-26\n- 0.4 ML darbepoetin alfa 0.5 MG/ML Prefilled Syringe, started on 2009-02-25, presumably until 2009-02-25\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2009-02-24, presumably until 2009-02-26\n- diatrizoate, through Oral route, started on 2009-02-24, presumably until 2009-02-24\n- prochlorperazine 5 MG/ML Injectable Solution, started on 2009-02-24, presumably until 2009-02-24\n- heparin sodium, porcine 10000 UNT/ML Injectable Solution, started on 2009-02-24, presumably until 2009-02-26\n- diatrizoic acid, through Oral route, started on 2009-02-24, presumably until 2009-02-24\n- piperacillin 4000 MG / tazobactam 500 MG Injection, through Intravenous route, started on 2009-02-24, presumably until 2009-02-24\n- lamotrigine 100 MG Oral Tablet, through Oral route, started on 2009-02-24, presumably until 2009-02-26\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2009-02-25, presumably until 2009-02-25\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2009-02-24, presumably until 2009-02-26\n- acetaminophen 32 MG/ML Oral Solution, through Oral route, started on 2009-02-24, presumably until 2009-02-24\n- 2 ML ondansetron 2 MG/ML Injection, started on 2009-02-24, presumably until 2009-02-24\n- 1000 ML glucose 50 MG/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2009-02-24, presumably until 2009-02-24\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2009-02-24, presumably until 2009-02-24\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2009-02-24, presumably until 2009-02-24\n- lidocaine hydrochloride 0.02 MG/MG Topical Gel, through Submucosal route, started on 2009-02-24, presumably until 2009-02-24\n- 200 ML ciprofloxacin 2 MG/ML Injection, through Intravenous route, started on 2009-02-24, presumably until 2009-02-24\n- 0.5 ML Streptococcus pneumoniae type 1 capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 10A capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 11A capsular polysaccharide antigen 0.05 MG/ML / Streptococ..., started on 2009-02-26, presumably until 2009-02-26\n- ceftazidime 1000 MG Injection, through Intravenous route, started on 2009-02-26, presumably until 2009-04-03, with quantity of 0.0, with intended 0 refill(s). Instructions: 1 g by Intravenous route daily. \n- ciprofloxacin 750 MG Oral Tablet, through Oral route, started on 2009-02-26, presumably until 2009-04-03, with quantity of 13.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. \n- methylprednisolone 125 MG Injection, started on 2009-02-24, presumably until 2009-02-24\n- 1 ML morphine sulfate 4 MG/ML Prefilled Syringe, started on 2009-02-24, presumably until 2009-02-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2009-04-03 16:31:00, ended at 2009-04-04 10:50:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 122 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.3 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 92.1 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.48 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 39 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Body height: 5' 4.961\" (inch (US))\n- Chloride [Moles/volume] in Serum or Plasma: 92 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 13.3 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.2 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 1.79 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 55.3 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 87 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.8 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 83 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.9 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.74 (million per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- Sodium [Moles/volume] in Serum or Plasma: 128 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.0 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 34.5 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 5.5 (millimole per liter)\n- Prothrombin time (PT): 13.6 (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Anion gap in Serum or Plasma: 18 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.2 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.8 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.2 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.08 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.1 (picogram)\n- Phosphate [Mass/volume] in Serum or Plasma: 6.1 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 135 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 57.5 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease stage 5 due to hypertension\n- Congenital anomaly of esophagus\n- Kidney disease\n- Disorder of peritoneal dialysis catheter\n- Gastroesophageal reflux disease\n- Systemic lupus erythematosus\n- Hyperparathyroidism\n- Hypo-osmolality and or hyponatremia\n- Infection AND/OR inflammatory reaction due to internal prosthetic device, implant AND/OR graft\n- Primary bacterial peritonitis\n- Anemia of chronic disease\n- Epilepsy\n\n### Drug\n- gentamicin 0.003 MG/MG Ophthalmic Ointment, through Intraocular route, started on 2009-04-04, presumably until 2010-04-04, with intended 1 refill(s). Instructions: 0.5 Inches by Both Eyes route 3 times a day. \n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2009-04-03, presumably until 2009-04-04\n- lanthanum carbonate 1000 MG Chewable Tablet, through Oral route, presumably until 2009-04-03. Instructions: take 1 Tab by mouth 3 times a day. \n- sevelamer hydrochloride 800 MG Oral Tablet, through Oral route, presumably until 2009-09-21. Instructions: take 1 Tab by mouth 3 times a day with meals. \n- ergocalciferol 1.25 MG Oral Capsule, through Oral route, presumably until 2011-06-04. Instructions: take 50000 Units by mouth every month. \n- atorvastatin 10 MG Oral Tablet, through Oral route, started on 2009-04-03, presumably until 2011-06-04. Instructions: take 10 mg by mouth daily. \n- ciprofloxacin 250 MG Oral Tablet, through Oral route, started on 2009-04-04, presumably until 2009-04-04\n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2009-04-04, presumably until 2009-04-04\n- rabeprazole sodium 20 MG Delayed Release Oral Tablet, through Oral route, presumably until 2011-06-04. Instructions: take 20 mg by mouth daily. \n- prednisone 1 MG Oral Tablet, through Oral route, started on 2009-04-03, presumably until 2009-09-21. Instructions: take 4 mg by mouth daily. \n- sevelamer hydrochloride 400 MG Oral Tablet, through Oral route, started on 2009-04-03, presumably until 2009-04-03\n- lamotrigine 100 MG Oral Tablet, through Oral route, started on 2009-04-03, presumably until 2009-04-04\n- promethazine hydrochloride 25 MG Rectal Suppository, through Rectal route, presumably until 2011-06-04. Instructions: 25 mg by Rectal route daily as needed \n- levofloxacin 500 MG Oral Tablet, through Oral route, started on 2009-04-04, presumably until 2010-04-04, with quantity of 11.0, with intended 0 refill(s). Instructions: take 0.5 Tabs by mouth every other day. \n- 2 ML ondansetron 2 MG/ML Injection, started on 2009-04-04, presumably until 2009-04-04\n- 200 ML ciprofloxacin 2 MG/ML Injection, through Intravenous route, started on 2009-04-03, presumably until 2009-04-03\n- metoclopramide 10 MG Oral Tablet, through Oral route, presumably until 2011-06-04. Instructions: take 10 mg by mouth daily as needed \n- ceftazidime 1000 MG Injection, through Intravenous route, started on 2009-04-03, presumably until 2009-04-04\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-09-21 16:19:39, ended at 2009-09-21 18:10:30\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.842\" (inch (US))\n\n### Procedure\n- Pre-surgery evaluation\n\n### Condition\n- Systemic lupus erythematosus\n- End-stage renal disease\n\n### Drug\n- lanthanum carbonate 1000 MG Chewable Tablet, through Oral route, presumably until 2011-06-04. Instructions: take 1000 mg by mouth daily. \n- sevelamer hydrochloride 800 MG Oral Tablet, through Oral route, presumably until 2012-05-12. Instructions: take 2-3 Tabs by mouth 3 times a day with meals. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-03 09:36:00, ended at 2010-03-03 14:10:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- Radiologic examination, abscess, fistula or sinus tract study, radiological supervision and interpretation\n- Exchange of previously placed abscess or cyst drainage catheter under radiological guidance (separate procedure)\n- Change of percutaneous tube or drainage catheter with contrast monitoring (eg, genitourinary system, abscess), radiological supervision and interpretation\n- X-ray, other and unspecified\n- Contrast injection for assessment of abscess or cyst via previously placed drainage catheter or tube (separate procedure)\n\n### Condition\n- Abdominal pain\n- End-stage renal disease\n- Mechanical complication of device\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-09 10:20:00, ended at 2010-04-09 23:59:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Systemic lupus erythematosus\n- Chronic glomerulonephritis associated with another disorder\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-14 10:20:00, ended at 2010-04-14 15:07:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n- Chronic glomerulonephritis associated with another disorder\n- Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-14 15:08:00, ended at 2010-04-14 23:59:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Systemic lupus erythematosus\n- Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-12-20 00:10:00, ended at 2010-12-20 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-12-22 22:24:00, ended at 2010-12-23 00:05:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Peritoneal dialysis catheter maintenance\n\n### Condition\n- Infection AND/OR inflammatory reaction due to internal prosthetic device, implant AND/OR graft\n- Complication associated with device\n- Disorder of peritoneal dialysis catheter\n- Epilepsy\n- Complication of renal dialysis\n- Complication of internal prosthetic device\n- Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-12-26 15:23:00, ended at 2010-12-26 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-01-01 00:10:00, ended at 2011-01-01 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-01-08 14:30:00, ended at 2011-01-08 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-01-09 00:00:00, ended at 2011-01-09 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-01-25 14:30:00, ended at 2011-01-25 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-01-30 14:30:00, ended at 2011-01-30 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-02-02 14:30:00, ended at 2011-02-02 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-06-04 09:20:00, ended at 2011-06-04 18:35:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 90 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.2 (thousand per microliter)\n- Body height: 5' 4\" (inch (US))\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 45 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 9.9 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.34 (million per microliter)\n- MCH [Entitic mass] by Automated count: 33.4 (picogram)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 97.0 (femtoliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.2 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 131 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 89 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 211 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n\n### Procedure\n- Insertion of tunneled intraperitoneal catheter for dialysis, open\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Collection of venous blood by venipuncture\n- Creation of cutaneoperitoneal fistula\n\n### Condition\n- Systemic lupus erythematosus\n- End-stage renal disease\n\n### Drug\n- estrogens, conjugated (USP) 0.625 MG/ML Vaginal Cream, through Topical route, presumably until 2012-05-12. Instructions: 0.5 g by Topical route daily. Pt reports not using  \n- simvastatin 10 MG Oral Tablet, through Oral route, presumably until 2012-05-12. Instructions: take  by mouth every bedtime.\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2011-06-04, presumably until 2012-05-19, with intended 0 refill(s). Instructions: take 1 Cap by mouth daily.\n- epoetin alfa 10000 UNT/ML Injectable Solution, presumably until 2012-05-12. Instructions: by Injection route. Every other week \n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2011-06-04, presumably until 2011-12-01, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-06-18 11:05:00, ended at 2011-06-18 17:08:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n- Potassium [Moles/volume] in Serum or Plasma: 5.3 (millimole per liter)\n\n### Procedure\n- Removal of peritoneal drainage device\n- Incision of peritoneum\n- Level III - Surgical pathology, gross and microscopic examination Abortion, induced Abscess Aneurysm - arterial/ventricular Anus, tag Appendix, other than incidental Artery, atheromatous plaque Bartholin's gland cyst Bone fragment(s), other than pathologi\n- Collection of venous blood by venipuncture\n- Removal of tunneled intraperitoneal catheter\n\n### Condition\n- Disorder of peritoneal dialysis catheter\n- End-stage renal disease\n- Infection AND/OR inflammatory reaction due to internal prosthetic device, implant AND/OR graft\n- Kidney disease\n- Systemic lupus erythematosus\n\n### Drug\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2011-06-18, presumably until 2012-05-11, with intended 0 refill(s). Instructions: take 1 Cap by mouth daily.\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2011-06-18, presumably until 2011-12-15, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2012-01-25 12:29:00, ended at 2012-01-25 19:12:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Lymphocytes [#/volume] in Blood by Automated count: 0.64 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.9 (percent)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 4.25 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.10 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 20.0 (percent)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.26 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 78.1 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.5 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.3 (percent)\n- Platelets [#/volume] in Blood by Automated count: 401 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.49 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 6.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 95.1 (femtoliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.8 (percent)\n- MCH [Entitic mass] by Automated count: 31.8 (picogram)\n- Reticulocytes [#/volume] in Blood by Automated count: 88.8 (thousand per microliter)\n\n### Procedure\n- Splitting of blood or blood products, each unit\n- Transfusion, blood or blood components\n\n### Condition\n- Gastroesophageal reflux disease\n- Systemic lupus erythematosus\n- Anemia\n- End-stage renal disease\n- Hyperparathyroidism due to renal insufficiency\n- Dieulafoy's vascular malformation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-02-18 00:00:00, ended at 2012-02-18 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-02-19 16:13:00, ended at 2012-02-19 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Prothrombin time (PT): 12.6 (second)\n- aPTT in Platelet poor plasma by Coagulation assay: 57.4 (second)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-04-11 16:23:00, ended at 2012-04-11 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-04-29 00:00:00, ended at 2012-04-29 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-04-30 15:33:00, ended at 2012-04-30 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Leukocytes [#/volume] in Specimen by Automated count: 3.0 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 29.3 (picogram)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.5 (percent)\n- MCV [Entitic volume] by Automated count: 88.9 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.43 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 209 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.5 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.9 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 1.38 (thousand per microliter)\n- Prothrombin time (PT): 13.0 (second)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.06 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.6 (percent)\n- aPTT in Platelet poor plasma by Coagulation assay: 67.7 (second)\n- Hemoglobin [Mass/volume] in Blood: 11.1 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 35.6 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 46.5 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.77 (million per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-05-01 00:00:00, ended at 2012-05-01 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-05-01 20:25:00, ended at 2012-05-01 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2012-05-06 13:25:00, ended at 2012-05-11 13:30:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.11 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 30.5 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.8 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.62 (million per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n- Magnesium [Mass/volume] in Serum or Plasma: 3.9 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 167 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.8 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.75 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.32 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 91.9 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 7.2 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 7.8 (nanogram per milliliter)\n- MCV [Entitic volume] by Automated count: 91.2 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.2 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.1 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Prothrombin time (PT): 12.7 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 56 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Body height: 5' 3.386\" (inch (US))\n- Creatinine [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.2 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 194 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 56 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.2 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.51 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 59.1 (second)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 213 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.0 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Incision of peritoneum\n- Removal of peritoneal drainage device\n- Other kidney transplantation\n- Peritoneal dialysis\n- Dialysis procedure other than hemodialysis (eg, peritoneal dialysis, hemofiltration, or other continuous renal replacement therapies), with single evaluation by a physician or other qualified health care professional\n- Collection of venous blood by venipuncture\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Radiologic examination, chest; single view, frontal\n- Transplant from live related donor\n\n### Condition\n- Gastroesophageal reflux disease\n- Hypercoagulability state\n- Mitral valve disorder\n- Disorder of peritoneal dialysis catheter\n- End-stage renal disease\n- Hyperparathyroidism due to renal insufficiency\n- Disorder of phosphorus metabolism\n- Disorder of nasal cavity\n- Atelectasis\n- Dieulafoy's vascular malformation\n- Cardiomegaly\n- Degeneration of intervertebral disc\n- Infection AND/OR inflammatory reaction due to internal prosthetic device, implant AND/OR graft\n- Epilepsy\n- Chronic glomerulonephritis associated with another disorder\n- Hypo-osmolality and or hyponatremia\n- Primary diagnosis: Systemic lupus erythematosus\n- Anemia\n\n### Drug\n- polysaccharide iron complex, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- ferrous gluconate, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- ferrous fumarate, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2012-05-09, presumably until 2012-05-11\n- ferrous ascorbate, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- famotidine 20 MG Oral Tablet, through Oral route, started on 2012-05-07, presumably until 2012-05-11\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- iron,peptonized, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- ferrous succinate, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- ferrous bisglycinate, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- ferrous cysteine glycinate, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- ferrous aspartate, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- ammonium ferrous sulfate, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- soy protein-iron complex, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2012-05-09, presumably until 2012-05-09\n- ferrous carbonate, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2012-05-07, presumably until 2012-05-11\n- ferrous glycine sulfate, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- folic acid, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2012-05-07, presumably until 2012-05-10\n- cefazolin 1000 MG Injection, through Intravenous route, started on 2012-05-07, presumably until 2012-05-08\n- iron succinyl milk protein complex, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- iron-dextran complex, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- teferrol, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2012-05-07, presumably until 2012-05-07\n- 1 ML hydralazine hydrochloride 20 MG/ML Injection, started on 2012-05-07, presumably until 2012-05-07\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- tacrolimus 5 MG Oral Capsule, through Oral route, started on 2012-05-09, presumably until 2012-05-11\n- ferrous asparto glycinate, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- prednisone 1 MG Oral Tablet, through Oral route, started on 2012-05-07, presumably until 2012-05-07\n- ferrous cacodylate, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- nystatin 100000 UNT/ML Oral Suspension, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- 10 ML furosemide 10 MG/ML Injection, started on 2012-05-09, presumably until 2012-05-09\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2012-05-06, presumably until 2012-05-09\n- lamotrigine 100 MG Oral Tablet, through Oral route, started on 2012-05-06, presumably until 2012-05-11\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2012-05-09, presumably until 2012-05-10\n- iron, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- carvedilol 6.25 MG Oral Tablet, through Oral route, started on 2012-05-09, presumably until 2012-05-11\n- ferrous oxalate, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- 2 ML ondansetron 2 MG/ML Injection, started on 2012-05-07, presumably until 2012-05-09\n- 1000 ML glucose 50 MG/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2012-05-07, presumably until 2012-05-09\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2012-05-07, presumably until 2012-05-08\n- iron sucrose, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- ferrous sulfate, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- iron carbonyl, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2012-05-08, presumably until 2012-05-09\n- ferrous lactate, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- ferrous chloride, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- prednisone 20 MG Oral Tablet, through Oral route, started on 2012-05-11, presumably until 2012-05-11\n- valganciclovir 450 MG Oral Tablet, through Oral route, started on 2012-05-09, presumably until 2012-05-09\n- iron sorbitex, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- ferrous phosphate, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- ascorbic acid 500 MG Oral Tablet, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- methylprednisolone 125 MG Injection, started on 2012-05-08, presumably until 2012-05-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-05-09 00:00:00, ended at 2012-05-09 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-05-09 00:00:00, ended at 2012-05-09 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-05-12 08:52:00, ended at 2012-05-12 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 135 (unit per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.7 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 133 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 5.0 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.4 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.43 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 156 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 29.8 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.5 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 60 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 9.3 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 42.7 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 196 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.58 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.6 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 1.61 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 50 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.2 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 43.5 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 207 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 11.4 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.11 (million per microliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 222 (unit per liter)\n- MCV [Entitic volume] by Automated count: 91.3 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.7 (percent)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 54 (milliliter per minute per square meter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n- Chronic glomerulonephritis associated with another disorder\n- Dizziness and giddiness\n- Chronic postoperative pain\n- End-stage renal disease\n- Epigastric pain\n- Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-05-12 09:26:05, ended at 2012-05-12 10:46:20\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- carvedilol 6.25 MG Oral Tablet, through Oral route, presumably until 2012-05-15. Instructions: take 6.25 mg by mouth 2 times a day with meals.  \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-05-15 09:31:00, ended at 2012-05-15 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.14 (million per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.00 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 9.5 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.6 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.49 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 85 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 205 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 27.0 (percent)\n- MCH [Entitic mass] by Automated count: 30.2 (picogram)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.9 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.0 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.3 (percent)\n- MCV [Entitic volume] by Automated count: 90.2 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 241 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.8 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 195 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.96 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.1 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 198 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 114 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 56.3 (percent)\n- Tacrolimus [Mass/volume] in Blood: 4.5 (nanogram per milliliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 173 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-05-15 09:52:43, ended at 2012-05-15 10:43:21\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.567\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-05-19 10:41:00, ended at 2012-05-19 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 46 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.3 (picogram)\n- Triglyceride [Moles/volume] in Serum or Plasma: 112 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.14 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.5 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: >30.0 (nanogram per milliliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 211 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 4.3 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 107 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20.1 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 73.4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.0 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 90.8 (femtoliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 179 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.16 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 79 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 224 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.8 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.1 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.5 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.80 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.93 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 266 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-05-19 11:09:34, ended at 2012-05-19 12:30:09\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Immune defect\n- Systemic lupus erythematosus\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-05-22 10:24:00, ended at 2012-05-22 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 8.1 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 107 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 3.8 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 160 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.5 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.7 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 186 (unit per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 72.4 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20.4 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.20 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.1 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 78 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- MCH [Entitic mass] by Automated count: 30.9 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 2.89 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 220 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 227 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.11 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.81 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 92.4 (femtoliter)\n- Hemoglobin [Mass/volume] in Blood: 9.6 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 269 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.0 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hyperparathyroidism due to renal insufficiency\n- Systemic lupus erythematosus\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-05-22 11:00:36, ended at 2012-05-22 12:04:54\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Systemic lupus erythematosus\n- Hyperparathyroidism due to renal insufficiency\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-05-26 00:00:00, ended at 2012-05-26 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-05-26 09:21:52, ended at 2012-05-26 10:13:43\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Transplanted kidney present\n- Immune defect\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-05-26 10:17:00, ended at 2012-05-26 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 236 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.38 (million per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.17 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 176 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 3.5 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 71 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.4 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.0 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 17.1 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 217 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 252 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 4.2 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 92.1 (femtoliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 194 (unit per liter)\n- MCH [Entitic mass] by Automated count: 30.8 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 78.7 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.69 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 12.1 (nanogram per milliliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n- Immune defect\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-05-28 12:00:00, ended at 2012-05-28 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Cystourethroscopy, with removal of foreign body, calculus, or ureteral stent from urethra or bladder (separate procedure); simple\n\n### Condition\n- End-stage renal disease\n- Transplanted kidney present\n- Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-05-29 09:38:00, ended at 2012-05-29 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.9 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.4 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 187 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 26.0 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 168 (unit per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.0 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.18 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 120 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.93 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.3 (picogram)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.6 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 212 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 187 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 65 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 239 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.25 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.1 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 66.1 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 10.1 (nanogram per milliliter)\n- Urate [Mass/volume] in Serum or Plasma: 4.7 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 92.7 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.37 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-06-05 09:13:00, ended at 2012-06-05 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 54 (milliliter per minute per square meter)\n- Glucose [Mass/volume] in Serum or Plasma: 112 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 181 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.59 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 46.0 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.28 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 200 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 10.6 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 92.3 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 45.1 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 234 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.0 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 231 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 168 (unit per liter)\n- Phosphate [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 4.5 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.5 (percent)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.6 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.5 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 1.56 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 14.5 (nanogram per milliliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.43 (million per microliter)\n- MCH [Entitic mass] by Automated count: 31.0 (picogram)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Anemia\n- Leukopenia\n- Immune defect\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-06-05 09:52:37, ended at 2012-06-05 10:52:38\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.567\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anemia\n- Transplanted kidney present\n- Immune defect\n- Leukopenia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-06-12 09:23:00, ended at 2012-06-12 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 177 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 92.3 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.26 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.7 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 54 (milliliter per minute per square meter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 193 (unit per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 42.4 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 159 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.9 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 49.5 (percent)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.0 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.5 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 112 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 9.2 (nanogram per milliliter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 232 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.3 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.52 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 11.1 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.91 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 184 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 1.64 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-06-19 10:36:00, ended at 2012-06-19 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.4 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.0 (picogram)\n- MCV [Entitic volume] by Automated count: 95.1 (femtoliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 194 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 4.7 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.2 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 178 (unit per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 1.59 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 46.7 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.39 (million per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 54 (milliliter per minute per square meter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.4 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.8 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 11.1 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.41 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.35 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 131 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 190 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 212 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 41.6 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-06-19 11:19:17, ended at 2012-06-19 11:44:05\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Hyperlipidemia\n- Primary diagnosis: Systemic lupus erythematosus\n- Transplanted kidney present\n\n### Drug\n- simvastatin 10 MG Oral Tablet, through Oral route, started on 2012-06-20, presumably until 2013-06-20, with intended 6 refill(s). Instructions: take 1 Tab by mouth every bedtime.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-06-26 09:55:00, ended at 2012-06-26 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 3.49 (million per microliter)\n- MCH [Entitic mass] by Automated count: 31.9 (picogram)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 210 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 213 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 49 (milliliter per minute per square meter)\n- Glucose [Mass/volume] in Serum or Plasma: 102 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.6 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 9.7 (nanogram per milliliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.3 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 39.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 197 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.3 (percent)\n- MCV [Entitic volume] by Automated count: 94.1 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.17 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.1 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 38 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 107 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 47 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 11.1 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.34 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.0 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 233 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.69 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 51.0 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-06-26 10:26:03, ended at 2012-06-26 13:37:29\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.764\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n- Transplanted kidney present\n- Chronic kidney disease\n- Immune defect\n- Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-07-10 09:09:00, ended at 2012-07-10 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 14.5 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.29 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 54 (milliliter per minute per square meter)\n- MCH [Entitic mass] by Automated count: 32.3 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 197 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 168 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.0 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 1.29 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 42.7 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 104 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.6 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 212 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 10.6 (gram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 232 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.0 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 47.2 (percent)\n- MCV [Entitic volume] by Automated count: 94.2 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.26 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 121 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.43 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 8.9 (nanogram per milliliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.2 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.7 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Leukopenia\n- Transplanted kidney present\n- Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-07-10 09:28:21, ended at 2012-07-10 10:23:22\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Systemic lupus erythematosus\n- Transplanted kidney present\n- Primary diagnosis: Leukopenia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-07-17 09:08:00, ended at 2012-07-17 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.1 (gram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 201 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.56 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.2 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 172 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 1.22 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 13.5 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 214 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.50 (million per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 49 (milliliter per minute per square meter)\n- Monocytes [#/volume] in Blood by Automated count: 0.47 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.6 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 5.7 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 42 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 97 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.3 (thousand per microliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 47.2 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.3 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.8 (percent)\n- MCV [Entitic volume] by Automated count: 93.8 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 37.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 188 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 132 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-07-24 09:52:00, ended at 2012-07-24 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 49 (milliliter per minute per square meter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 160 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.7 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.6 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.5 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.34 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 38.3 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 4.7 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 181 (unit per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.9 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 200 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.2 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 9.3 (nanogram per milliliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 97 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.7 (percent)\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.6 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 44 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.28 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.45 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 47.8 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 1.67 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 184 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n"}, "target": "Yes", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Systemic lupus erythematosus within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2008-03-10 21:46:00, ended at 2008-03-11 14:25:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.10 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.3 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.50 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.2 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7.0 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Vancomycin [Mass/volume] in Serum or Plasma: 34.2 (microgram per milliliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.7 (percent)\n- Hemoglobin [Mass/volume] in Blood: 8.7 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.5 (picogram)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.28 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.9 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 94.0 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 133 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Base deficit in Blood: 4.0 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.4 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 94.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 135 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.0 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.4 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.0 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 97 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 78 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.85 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 69 (unit per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2008-07-20 01:45:00, ended at 2008-07-22 12:47:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 2.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 76 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Body height: 5' 4\" (inch (US))\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.21 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.3 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.7 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 40.5 (percent)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 38 (percent)\n- Sodium [Moles/volume] in Blood: 130 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 148 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 27.3 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- Lymphocytes [#/volume] in Blood by Manual count: 1.6 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 88.7 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 95 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 85 (unit per liter)\n- Base deficit in Blood: 4.0 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.6 (picogram)\n- Phosphate [Mass/volume] in Serum or Plasma: 6.5 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 6.2 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 54.6 (second)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.87 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.8 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 4 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 80.9 (percent)\n- Prothrombin time (PT): 14.2 (second)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.5 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.44 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Manual count: 2.5 (thousand per microliter)\n- Potassium [Moles/volume] in Blood: 5.2 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 62 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.10 (million per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.53 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.2 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.5 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Manual count: 1 (percent)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood: 22 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 55 (percent)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood by calculation: 7.5 (gram per deciliter)\n- Basophils [#/volume] in Blood by Manual count: 0.0 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.5 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 5.0 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n- Chronic kidney disease stage 5 due to hypertension\n- Diaphragmatic hernia\n- Anemia in chronic kidney disease\n- Systemic lupus erythematosus\n- Nausea\n- Stricture of esophagus\n- Acute posthemorrhagic anemia\n- Mitral valve disorder\n- Hematochezia\n- Hepatic necrosis\n\n### Drug\n- lansoprazole 30 MG Delayed Release Oral Capsule, through Oral route, presumably until 2008-07-22. Instructions: take 30 mg by mouth daily. \n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2008-07-21, presumably until 2008-07-22\n- benzocaine 140 MG/ML / butamben 20 MG/ML / tetracaine 20 MG/ML Mucosal Spray, through Topical route, started on 2008-07-20, presumably until 2008-07-21\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2008-07-19, presumably until 2008-07-20\n- prochlorperazine 5 MG/ML Injectable Solution, started on 2008-07-20, presumably until 2008-07-20\n- lamotrigine 200 MG Oral Tablet, through Oral route, presumably until 2009-04-03. Instructions: take 200 mg by mouth 2 times a day. \n- atorvastatin 10 MG Oral Tablet, through Oral route, presumably until 2009-04-03. Instructions: take 10 mg by mouth every bedtime. \n- 500 ML glucose 50 MG/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2008-07-21, presumably until 2008-07-21\n- rabeprazole sodium 20 MG Delayed Release Oral Tablet, through Oral route, started on 2008-07-22, presumably until 2009-04-03, with quantity of 90.0, with intended 5 refill(s). Instructions: take 20 mg by mouth 2 times a day. Take Aciphex 1 pill two times a day for 2 weeks and then switch to once daily indefinitely. \n- prednisone 1 MG Oral Tablet, through Oral route, started on 2008-07-20, presumably until 2009-04-03. Instructions: take 2 mg by mouth daily. \n- 0.5 ML darbepoetin alfa 0.2 MG/ML Prefilled Syringe, started on 2008-07-20, presumably until 2008-07-22\n- lamotrigine 100 MG Oral Tablet, through Oral route, started on 2008-07-20, presumably until 2009-04-03. Instructions: take 200 mg by mouth 2 times a day. \n- lanthanum carbonate 750 MG Chewable Tablet, through Oral route, presumably until 2009-04-03. Instructions: take by mouth. \n- 2 ML ondansetron 2 MG/ML Injection, started on 2008-07-19, presumably until 2008-07-20\n- 1000 ML glucose 50 MG/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2008-07-20, presumably until 2008-07-20\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2008-07-21, presumably until 2008-07-21\n- lidocaine hydrochloride 0.02 MG/MG Topical Gel, through Submucosal route, started on 2008-07-19, presumably until 2008-07-19\n- simethicone 66.7 MG/ML Oral Suspension, through Oral route, started on 2008-07-21, presumably until 2008-07-21\n- albuterol 5 MG/ML Inhalation Solution, through Intravenous route, started on 2008-07-20, presumably until 2008-07-20\n- midazolam 1 MG/ML Injectable Solution, started on 2008-07-20, presumably until 2008-07-21\n- 1 ML promethazine hydrochloride 25 MG/ML Injection, started on 2008-07-20, presumably until 2008-07-20\n- 1 ML morphine sulfate 4 MG/ML Prefilled Syringe, started on 2008-07-20, presumably until 2008-07-20\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2008-10-01 07:25:00, ended at 2008-10-01 17:15:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of body wall\n- Inguinal hernia\n\n### Drug\n- epoetin alfa 10000 UNT/ML Injectable Solution, presumably until 2009-04-03. Instructions: 1 mL by Injection route as needed Every other week\n- 2 ML ondansetron 2 MG/ML Injection, started on 2008-10-01, presumably until 2008-10-01\n- 1 ML promethazine hydrochloride 25 MG/ML Injection, started on 2008-10-01, presumably until 2008-10-01\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2009-02-24 15:00:00, ended at 2009-02-26 15:40:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Glucose [Mass/volume] in Serum or Plasma: 97 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.2 (percent)\n- Hemoglobin [Mass/volume] in Blood by calculation: 17.7 (gram per deciliter)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 39 (millimeter mercury column)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 80 (milligram per deciliter)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 16.3 (microgram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 64 (unit per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 99 (percent)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.23 (millimole per liter)\n- Phosphate [Mass/volume] in Serum or Plasma: 6.1 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 42.5 (millimeter mercury column)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 33 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n- MCV [Entitic volume] by Automated count: 96.1 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.8 (percent)\n- Prothrombin time (PT): 14.9 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 67 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood: 52 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.3 (gram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 373 (unit per liter)\n- Monocytes [#/volume] in Blood by Automated count: 1.42 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.3 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 99 (thousand per microliter)\n- Base deficit in Blood: 5.0 (millimole per liter)\n- Base excess in Blood by calculation: 4.0 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Bicarbonate [Moles/volume] in Specimen: 21.5 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.33 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 4.9 (percent)\n- MCH [Entitic mass] by Automated count: 33.0 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.3 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 65.6 (second)\n- Creatinine [Mass/volume] in Serum or Plasma: 7.7 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.7 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.88 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 66 (unit per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.24 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 91.1 (percent)\n- Potassium [Moles/volume] in Blood: 4.0 (millimole per liter)\n- Sodium [Moles/volume] in Blood: 132 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Low blood pressure\n- Sepsis\n- End-stage renal disease\n- Gastroesophageal reflux disease\n- Disorder of phosphorus metabolism\n- Nausea and vomiting\n- Epilepsy\n- Hyperparathyroidism due to renal insufficiency\n- Kidney disease\n- Primary bacterial peritonitis\n- Systemic lupus erythematosus\n- Essential hypertension\n- Peritonitis\n\n### Drug\n- hydrocortisone 100 MG Injection, started on 2009-02-24, presumably until 2009-02-26\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2009-02-24, presumably until 2009-02-24\n- piperacillin 2000 MG / tazobactam 250 MG Injection, through Intravenous route, started on 2009-02-24, presumably until 2009-02-24\n- 100 ML ciprofloxacin 2 MG/ML Injection, through Intravenous route, started on 2009-02-24, presumably until 2009-02-26\n- 0.4 ML darbepoetin alfa 0.5 MG/ML Prefilled Syringe, started on 2009-02-25, presumably until 2009-02-25\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2009-02-24, presumably until 2009-02-26\n- diatrizoate, through Oral route, started on 2009-02-24, presumably until 2009-02-24\n- prochlorperazine 5 MG/ML Injectable Solution, started on 2009-02-24, presumably until 2009-02-24\n- heparin sodium, porcine 10000 UNT/ML Injectable Solution, started on 2009-02-24, presumably until 2009-02-26\n- diatrizoic acid, through Oral route, started on 2009-02-24, presumably until 2009-02-24\n- piperacillin 4000 MG / tazobactam 500 MG Injection, through Intravenous route, started on 2009-02-24, presumably until 2009-02-24\n- lamotrigine 100 MG Oral Tablet, through Oral route, started on 2009-02-24, presumably until 2009-02-26\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2009-02-25, presumably until 2009-02-25\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2009-02-24, presumably until 2009-02-26\n- acetaminophen 32 MG/ML Oral Solution, through Oral route, started on 2009-02-24, presumably until 2009-02-24\n- 2 ML ondansetron 2 MG/ML Injection, started on 2009-02-24, presumably until 2009-02-24\n- 1000 ML glucose 50 MG/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2009-02-24, presumably until 2009-02-24\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2009-02-24, presumably until 2009-02-24\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2009-02-24, presumably until 2009-02-24\n- lidocaine hydrochloride 0.02 MG/MG Topical Gel, through Submucosal route, started on 2009-02-24, presumably until 2009-02-24\n- 200 ML ciprofloxacin 2 MG/ML Injection, through Intravenous route, started on 2009-02-24, presumably until 2009-02-24\n- 0.5 ML Streptococcus pneumoniae type 1 capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 10A capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 11A capsular polysaccharide antigen 0.05 MG/ML / Streptococ..., started on 2009-02-26, presumably until 2009-02-26\n- ceftazidime 1000 MG Injection, through Intravenous route, started on 2009-02-26, presumably until 2009-04-03, with quantity of 0.0, with intended 0 refill(s). Instructions: 1 g by Intravenous route daily. \n- ciprofloxacin 750 MG Oral Tablet, through Oral route, started on 2009-02-26, presumably until 2009-04-03, with quantity of 13.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. \n- methylprednisolone 125 MG Injection, started on 2009-02-24, presumably until 2009-02-24\n- 1 ML morphine sulfate 4 MG/ML Prefilled Syringe, started on 2009-02-24, presumably until 2009-02-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2009-04-03 16:31:00, ended at 2009-04-04 10:50:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 122 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.3 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 92.1 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.48 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 39 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Body height: 5' 4.961\" (inch (US))\n- Chloride [Moles/volume] in Serum or Plasma: 92 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 13.3 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.2 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 1.79 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 55.3 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 87 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.8 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 83 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.9 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.74 (million per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- Sodium [Moles/volume] in Serum or Plasma: 128 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.0 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 34.5 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 5.5 (millimole per liter)\n- Prothrombin time (PT): 13.6 (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Anion gap in Serum or Plasma: 18 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.2 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.8 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.2 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.08 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.1 (picogram)\n- Phosphate [Mass/volume] in Serum or Plasma: 6.1 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 135 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 57.5 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease stage 5 due to hypertension\n- Congenital anomaly of esophagus\n- Kidney disease\n- Disorder of peritoneal dialysis catheter\n- Gastroesophageal reflux disease\n- Systemic lupus erythematosus\n- Hyperparathyroidism\n- Hypo-osmolality and or hyponatremia\n- Infection AND/OR inflammatory reaction due to internal prosthetic device, implant AND/OR graft\n- Primary bacterial peritonitis\n- Anemia of chronic disease\n- Epilepsy\n\n### Drug\n- gentamicin 0.003 MG/MG Ophthalmic Ointment, through Intraocular route, started on 2009-04-04, presumably until 2010-04-04, with intended 1 refill(s). Instructions: 0.5 Inches by Both Eyes route 3 times a day. \n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2009-04-03, presumably until 2009-04-04\n- lanthanum carbonate 1000 MG Chewable Tablet, through Oral route, presumably until 2009-04-03. Instructions: take 1 Tab by mouth 3 times a day. \n- sevelamer hydrochloride 800 MG Oral Tablet, through Oral route, presumably until 2009-09-21. Instructions: take 1 Tab by mouth 3 times a day with meals. \n- ergocalciferol 1.25 MG Oral Capsule, through Oral route, presumably until 2011-06-04. Instructions: take 50000 Units by mouth every month. \n- atorvastatin 10 MG Oral Tablet, through Oral route, started on 2009-04-03, presumably until 2011-06-04. Instructions: take 10 mg by mouth daily. \n- ciprofloxacin 250 MG Oral Tablet, through Oral route, started on 2009-04-04, presumably until 2009-04-04\n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2009-04-04, presumably until 2009-04-04\n- rabeprazole sodium 20 MG Delayed Release Oral Tablet, through Oral route, presumably until 2011-06-04. Instructions: take 20 mg by mouth daily. \n- prednisone 1 MG Oral Tablet, through Oral route, started on 2009-04-03, presumably until 2009-09-21. Instructions: take 4 mg by mouth daily. \n- sevelamer hydrochloride 400 MG Oral Tablet, through Oral route, started on 2009-04-03, presumably until 2009-04-03\n- lamotrigine 100 MG Oral Tablet, through Oral route, started on 2009-04-03, presumably until 2009-04-04\n- promethazine hydrochloride 25 MG Rectal Suppository, through Rectal route, presumably until 2011-06-04. Instructions: 25 mg by Rectal route daily as needed \n- levofloxacin 500 MG Oral Tablet, through Oral route, started on 2009-04-04, presumably until 2010-04-04, with quantity of 11.0, with intended 0 refill(s). Instructions: take 0.5 Tabs by mouth every other day. \n- 2 ML ondansetron 2 MG/ML Injection, started on 2009-04-04, presumably until 2009-04-04\n- 200 ML ciprofloxacin 2 MG/ML Injection, through Intravenous route, started on 2009-04-03, presumably until 2009-04-03\n- metoclopramide 10 MG Oral Tablet, through Oral route, presumably until 2011-06-04. Instructions: take 10 mg by mouth daily as needed \n- ceftazidime 1000 MG Injection, through Intravenous route, started on 2009-04-03, presumably until 2009-04-04\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-09-21 16:19:39, ended at 2009-09-21 18:10:30\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.842\" (inch (US))\n\n### Procedure\n- Pre-surgery evaluation\n\n### Condition\n- Systemic lupus erythematosus\n- End-stage renal disease\n\n### Drug\n- lanthanum carbonate 1000 MG Chewable Tablet, through Oral route, presumably until 2011-06-04. Instructions: take 1000 mg by mouth daily. \n- sevelamer hydrochloride 800 MG Oral Tablet, through Oral route, presumably until 2012-05-12. Instructions: take 2-3 Tabs by mouth 3 times a day with meals. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-03 09:36:00, ended at 2010-03-03 14:10:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- Radiologic examination, abscess, fistula or sinus tract study, radiological supervision and interpretation\n- Exchange of previously placed abscess or cyst drainage catheter under radiological guidance (separate procedure)\n- Change of percutaneous tube or drainage catheter with contrast monitoring (eg, genitourinary system, abscess), radiological supervision and interpretation\n- X-ray, other and unspecified\n- Contrast injection for assessment of abscess or cyst via previously placed drainage catheter or tube (separate procedure)\n\n### Condition\n- Abdominal pain\n- End-stage renal disease\n- Mechanical complication of device\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-09 10:20:00, ended at 2010-04-09 23:59:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Systemic lupus erythematosus\n- Chronic glomerulonephritis associated with another disorder\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-14 10:20:00, ended at 2010-04-14 15:07:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n- Chronic glomerulonephritis associated with another disorder\n- Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-14 15:08:00, ended at 2010-04-14 23:59:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Systemic lupus erythematosus\n- Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-12-20 00:10:00, ended at 2010-12-20 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-12-22 22:24:00, ended at 2010-12-23 00:05:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Peritoneal dialysis catheter maintenance\n\n### Condition\n- Infection AND/OR inflammatory reaction due to internal prosthetic device, implant AND/OR graft\n- Complication associated with device\n- Disorder of peritoneal dialysis catheter\n- Epilepsy\n- Complication of renal dialysis\n- Complication of internal prosthetic device\n- Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-12-26 15:23:00, ended at 2010-12-26 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-01-01 00:10:00, ended at 2011-01-01 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-01-08 14:30:00, ended at 2011-01-08 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-01-09 00:00:00, ended at 2011-01-09 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-01-25 14:30:00, ended at 2011-01-25 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-01-30 14:30:00, ended at 2011-01-30 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-02-02 14:30:00, ended at 2011-02-02 23:59:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-06-04 09:20:00, ended at 2011-06-04 18:35:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 90 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.2 (thousand per microliter)\n- Body height: 5' 4\" (inch (US))\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 45 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 9.9 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.34 (million per microliter)\n- MCH [Entitic mass] by Automated count: 33.4 (picogram)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 97.0 (femtoliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.2 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 131 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 89 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 211 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n\n### Procedure\n- Insertion of tunneled intraperitoneal catheter for dialysis, open\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Collection of venous blood by venipuncture\n- Creation of cutaneoperitoneal fistula\n\n### Condition\n- Systemic lupus erythematosus\n- End-stage renal disease\n\n### Drug\n- estrogens, conjugated (USP) 0.625 MG/ML Vaginal Cream, through Topical route, presumably until 2012-05-12. Instructions: 0.5 g by Topical route daily. Pt reports not using  \n- simvastatin 10 MG Oral Tablet, through Oral route, presumably until 2012-05-12. Instructions: take  by mouth every bedtime.\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2011-06-04, presumably until 2012-05-19, with intended 0 refill(s). Instructions: take 1 Cap by mouth daily.\n- epoetin alfa 10000 UNT/ML Injectable Solution, presumably until 2012-05-12. Instructions: by Injection route. Every other week \n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2011-06-04, presumably until 2011-12-01, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-06-18 11:05:00, ended at 2011-06-18 17:08:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n- Potassium [Moles/volume] in Serum or Plasma: 5.3 (millimole per liter)\n\n### Procedure\n- Removal of peritoneal drainage device\n- Incision of peritoneum\n- Level III - Surgical pathology, gross and microscopic examination Abortion, induced Abscess Aneurysm - arterial/ventricular Anus, tag Appendix, other than incidental Artery, atheromatous plaque Bartholin's gland cyst Bone fragment(s), other than pathologi\n- Collection of venous blood by venipuncture\n- Removal of tunneled intraperitoneal catheter\n\n### Condition\n- Disorder of peritoneal dialysis catheter\n- End-stage renal disease\n- Infection AND/OR inflammatory reaction due to internal prosthetic device, implant AND/OR graft\n- Kidney disease\n- Systemic lupus erythematosus\n\n### Drug\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2011-06-18, presumably until 2012-05-11, with intended 0 refill(s). Instructions: take 1 Cap by mouth daily.\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2011-06-18, presumably until 2011-12-15, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2012-01-25 12:29:00, ended at 2012-01-25 19:12:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Lymphocytes [#/volume] in Blood by Automated count: 0.64 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.9 (percent)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 4.25 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.10 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 20.0 (percent)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.26 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 78.1 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.5 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.3 (percent)\n- Platelets [#/volume] in Blood by Automated count: 401 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.49 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 6.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 95.1 (femtoliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.8 (percent)\n- MCH [Entitic mass] by Automated count: 31.8 (picogram)\n- Reticulocytes [#/volume] in Blood by Automated count: 88.8 (thousand per microliter)\n\n### Procedure\n- Splitting of blood or blood products, each unit\n- Transfusion, blood or blood components\n\n### Condition\n- Gastroesophageal reflux disease\n- Systemic lupus erythematosus\n- Anemia\n- End-stage renal disease\n- Hyperparathyroidism due to renal insufficiency\n- Dieulafoy's vascular malformation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-02-18 00:00:00, ended at 2012-02-18 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-02-19 16:13:00, ended at 2012-02-19 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Prothrombin time (PT): 12.6 (second)\n- aPTT in Platelet poor plasma by Coagulation assay: 57.4 (second)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-04-11 16:23:00, ended at 2012-04-11 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-04-29 00:00:00, ended at 2012-04-29 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-04-30 15:33:00, ended at 2012-04-30 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Leukocytes [#/volume] in Specimen by Automated count: 3.0 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 29.3 (picogram)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.5 (percent)\n- MCV [Entitic volume] by Automated count: 88.9 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.43 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 209 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.5 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.9 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 1.38 (thousand per microliter)\n- Prothrombin time (PT): 13.0 (second)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.06 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.6 (percent)\n- aPTT in Platelet poor plasma by Coagulation assay: 67.7 (second)\n- Hemoglobin [Mass/volume] in Blood: 11.1 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 35.6 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 46.5 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.77 (million per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-05-01 00:00:00, ended at 2012-05-01 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-05-01 20:25:00, ended at 2012-05-01 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2012-05-06 13:25:00, ended at 2012-05-11 13:30:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.11 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 30.5 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.8 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.62 (million per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n- Magnesium [Mass/volume] in Serum or Plasma: 3.9 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 167 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.8 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.75 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.32 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 91.9 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 7.2 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 7.8 (nanogram per milliliter)\n- MCV [Entitic volume] by Automated count: 91.2 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.2 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.1 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Prothrombin time (PT): 12.7 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 56 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Body height: 5' 3.386\" (inch (US))\n- Creatinine [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.2 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 194 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 56 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.2 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.51 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 59.1 (second)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 213 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.0 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Incision of peritoneum\n- Removal of peritoneal drainage device\n- Other kidney transplantation\n- Peritoneal dialysis\n- Dialysis procedure other than hemodialysis (eg, peritoneal dialysis, hemofiltration, or other continuous renal replacement therapies), with single evaluation by a physician or other qualified health care professional\n- Collection of venous blood by venipuncture\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Radiologic examination, chest; single view, frontal\n- Transplant from live related donor\n\n### Condition\n- Gastroesophageal reflux disease\n- Hypercoagulability state\n- Mitral valve disorder\n- Disorder of peritoneal dialysis catheter\n- End-stage renal disease\n- Hyperparathyroidism due to renal insufficiency\n- Disorder of phosphorus metabolism\n- Disorder of nasal cavity\n- Atelectasis\n- Dieulafoy's vascular malformation\n- Cardiomegaly\n- Degeneration of intervertebral disc\n- Infection AND/OR inflammatory reaction due to internal prosthetic device, implant AND/OR graft\n- Epilepsy\n- Chronic glomerulonephritis associated with another disorder\n- Hypo-osmolality and or hyponatremia\n- Primary diagnosis: Systemic lupus erythematosus\n- Anemia\n\n### Drug\n- polysaccharide iron complex, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- ferrous gluconate, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- ferrous fumarate, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2012-05-09, presumably until 2012-05-11\n- ferrous ascorbate, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- famotidine 20 MG Oral Tablet, through Oral route, started on 2012-05-07, presumably until 2012-05-11\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- iron,peptonized, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- ferrous succinate, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- ferrous bisglycinate, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- ferrous cysteine glycinate, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- ferrous aspartate, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- ammonium ferrous sulfate, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- soy protein-iron complex, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2012-05-09, presumably until 2012-05-09\n- ferrous carbonate, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2012-05-07, presumably until 2012-05-11\n- ferrous glycine sulfate, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- folic acid, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2012-05-07, presumably until 2012-05-10\n- cefazolin 1000 MG Injection, through Intravenous route, started on 2012-05-07, presumably until 2012-05-08\n- iron succinyl milk protein complex, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- iron-dextran complex, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- teferrol, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2012-05-07, presumably until 2012-05-07\n- 1 ML hydralazine hydrochloride 20 MG/ML Injection, started on 2012-05-07, presumably until 2012-05-07\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- tacrolimus 5 MG Oral Capsule, through Oral route, started on 2012-05-09, presumably until 2012-05-11\n- ferrous asparto glycinate, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- prednisone 1 MG Oral Tablet, through Oral route, started on 2012-05-07, presumably until 2012-05-07\n- ferrous cacodylate, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- nystatin 100000 UNT/ML Oral Suspension, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- 10 ML furosemide 10 MG/ML Injection, started on 2012-05-09, presumably until 2012-05-09\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2012-05-06, presumably until 2012-05-09\n- lamotrigine 100 MG Oral Tablet, through Oral route, started on 2012-05-06, presumably until 2012-05-11\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2012-05-09, presumably until 2012-05-10\n- iron, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- carvedilol 6.25 MG Oral Tablet, through Oral route, started on 2012-05-09, presumably until 2012-05-11\n- ferrous oxalate, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- 2 ML ondansetron 2 MG/ML Injection, started on 2012-05-07, presumably until 2012-05-09\n- 1000 ML glucose 50 MG/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2012-05-07, presumably until 2012-05-09\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2012-05-07, presumably until 2012-05-08\n- iron sucrose, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- ferrous sulfate, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- iron carbonyl, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2012-05-08, presumably until 2012-05-09\n- ferrous lactate, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- ferrous chloride, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- prednisone 20 MG Oral Tablet, through Oral route, started on 2012-05-11, presumably until 2012-05-11\n- valganciclovir 450 MG Oral Tablet, through Oral route, started on 2012-05-09, presumably until 2012-05-09\n- iron sorbitex, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- ferrous phosphate, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- ascorbic acid 500 MG Oral Tablet, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2012-05-08, presumably until 2012-05-11\n- methylprednisolone 125 MG Injection, started on 2012-05-08, presumably until 2012-05-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-05-09 00:00:00, ended at 2012-05-09 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-05-09 00:00:00, ended at 2012-05-09 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-05-12 08:52:00, ended at 2012-05-12 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 135 (unit per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.7 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 133 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 5.0 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.4 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.43 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 156 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 29.8 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.5 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 60 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 9.3 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 42.7 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 196 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.58 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.6 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 1.61 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 50 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.2 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 43.5 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 207 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 11.4 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.11 (million per microliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 222 (unit per liter)\n- MCV [Entitic volume] by Automated count: 91.3 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.7 (percent)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 54 (milliliter per minute per square meter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n- Chronic glomerulonephritis associated with another disorder\n- Dizziness and giddiness\n- Chronic postoperative pain\n- End-stage renal disease\n- Epigastric pain\n- Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-05-12 09:26:05, ended at 2012-05-12 10:46:20\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- carvedilol 6.25 MG Oral Tablet, through Oral route, presumably until 2012-05-15. Instructions: take 6.25 mg by mouth 2 times a day with meals.  \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-05-15 09:31:00, ended at 2012-05-15 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.14 (million per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.00 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 9.5 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.6 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.49 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 85 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 205 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 27.0 (percent)\n- MCH [Entitic mass] by Automated count: 30.2 (picogram)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.9 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.0 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.3 (percent)\n- MCV [Entitic volume] by Automated count: 90.2 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 241 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.8 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 195 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.96 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.1 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 198 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 114 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 56.3 (percent)\n- Tacrolimus [Mass/volume] in Blood: 4.5 (nanogram per milliliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 173 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-05-15 09:52:43, ended at 2012-05-15 10:43:21\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.567\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-05-19 10:41:00, ended at 2012-05-19 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 46 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.3 (picogram)\n- Triglyceride [Moles/volume] in Serum or Plasma: 112 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.14 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.5 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: >30.0 (nanogram per milliliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 211 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 4.3 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 107 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20.1 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 73.4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.0 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 90.8 (femtoliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 179 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.16 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 79 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 224 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.8 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.1 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.5 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.80 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.93 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 266 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-05-19 11:09:34, ended at 2012-05-19 12:30:09\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Immune defect\n- Systemic lupus erythematosus\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-05-22 10:24:00, ended at 2012-05-22 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 8.1 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 107 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 3.8 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 160 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.5 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.7 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 186 (unit per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 72.4 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20.4 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.20 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.1 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 78 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- MCH [Entitic mass] by Automated count: 30.9 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 2.89 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 220 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 227 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.11 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.81 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 92.4 (femtoliter)\n- Hemoglobin [Mass/volume] in Blood: 9.6 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 269 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.0 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hyperparathyroidism due to renal insufficiency\n- Systemic lupus erythematosus\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-05-22 11:00:36, ended at 2012-05-22 12:04:54\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Systemic lupus erythematosus\n- Hyperparathyroidism due to renal insufficiency\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-05-26 00:00:00, ended at 2012-05-26 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-05-26 09:21:52, ended at 2012-05-26 10:13:43\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Transplanted kidney present\n- Immune defect\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-05-26 10:17:00, ended at 2012-05-26 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 236 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.38 (million per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.17 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 176 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 3.5 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 71 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.4 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.0 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 17.1 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 217 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 252 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 4.2 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 92.1 (femtoliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 194 (unit per liter)\n- MCH [Entitic mass] by Automated count: 30.8 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 78.7 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.69 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 12.1 (nanogram per milliliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n- Immune defect\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-05-28 12:00:00, ended at 2012-05-28 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Cystourethroscopy, with removal of foreign body, calculus, or ureteral stent from urethra or bladder (separate procedure); simple\n\n### Condition\n- End-stage renal disease\n- Transplanted kidney present\n- Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-05-29 09:38:00, ended at 2012-05-29 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.9 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.4 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 187 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 26.0 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 168 (unit per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.0 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.18 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 120 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.93 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.3 (picogram)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.6 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 212 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 187 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 65 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 239 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.25 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.1 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 66.1 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 10.1 (nanogram per milliliter)\n- Urate [Mass/volume] in Serum or Plasma: 4.7 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 92.7 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.37 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-06-05 09:13:00, ended at 2012-06-05 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 54 (milliliter per minute per square meter)\n- Glucose [Mass/volume] in Serum or Plasma: 112 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 181 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.59 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 46.0 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.28 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 200 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 10.6 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 92.3 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 45.1 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 234 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.0 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 231 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 168 (unit per liter)\n- Phosphate [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 4.5 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.5 (percent)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.6 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.5 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 1.56 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 14.5 (nanogram per milliliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.43 (million per microliter)\n- MCH [Entitic mass] by Automated count: 31.0 (picogram)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Anemia\n- Leukopenia\n- Immune defect\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-06-05 09:52:37, ended at 2012-06-05 10:52:38\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.567\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anemia\n- Transplanted kidney present\n- Immune defect\n- Leukopenia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-06-12 09:23:00, ended at 2012-06-12 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 177 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 92.3 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.26 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.7 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 54 (milliliter per minute per square meter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 193 (unit per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 42.4 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 159 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.9 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 49.5 (percent)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.0 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.5 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 112 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 9.2 (nanogram per milliliter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 232 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.3 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.52 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 11.1 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.91 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 184 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 1.64 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-06-19 10:36:00, ended at 2012-06-19 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.4 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.0 (picogram)\n- MCV [Entitic volume] by Automated count: 95.1 (femtoliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 194 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 4.7 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.2 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 178 (unit per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 1.59 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 46.7 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.39 (million per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 54 (milliliter per minute per square meter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.4 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.8 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 11.1 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.41 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.35 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 131 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 190 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 212 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 41.6 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-06-19 11:19:17, ended at 2012-06-19 11:44:05\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Hyperlipidemia\n- Primary diagnosis: Systemic lupus erythematosus\n- Transplanted kidney present\n\n### Drug\n- simvastatin 10 MG Oral Tablet, through Oral route, started on 2012-06-20, presumably until 2013-06-20, with intended 6 refill(s). Instructions: take 1 Tab by mouth every bedtime.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-06-26 09:55:00, ended at 2012-06-26 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 3.49 (million per microliter)\n- MCH [Entitic mass] by Automated count: 31.9 (picogram)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 210 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 213 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 49 (milliliter per minute per square meter)\n- Glucose [Mass/volume] in Serum or Plasma: 102 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.6 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 9.7 (nanogram per milliliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.3 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 39.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 197 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.3 (percent)\n- MCV [Entitic volume] by Automated count: 94.1 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.17 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.1 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 38 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 107 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 47 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 11.1 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.34 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.0 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 233 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.69 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 51.0 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-06-26 10:26:03, ended at 2012-06-26 13:37:29\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.764\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n- Transplanted kidney present\n- Chronic kidney disease\n- Immune defect\n- Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-07-10 09:09:00, ended at 2012-07-10 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 14.5 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.29 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 54 (milliliter per minute per square meter)\n- MCH [Entitic mass] by Automated count: 32.3 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 197 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 168 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.0 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 1.29 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 42.7 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 104 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.6 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 212 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 10.6 (gram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 232 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.0 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 47.2 (percent)\n- MCV [Entitic volume] by Automated count: 94.2 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.26 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 121 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.43 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 8.9 (nanogram per milliliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.2 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.7 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Leukopenia\n- Transplanted kidney present\n- Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-07-10 09:28:21, ended at 2012-07-10 10:23:22\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Systemic lupus erythematosus\n- Transplanted kidney present\n- Primary diagnosis: Leukopenia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-07-17 09:08:00, ended at 2012-07-17 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.1 (gram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 201 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.56 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.2 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 172 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 1.22 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 13.5 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 214 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.50 (million per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 49 (milliliter per minute per square meter)\n- Monocytes [#/volume] in Blood by Automated count: 0.47 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.6 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 5.7 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 42 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 97 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.3 (thousand per microliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 47.2 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.3 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.8 (percent)\n- MCV [Entitic volume] by Automated count: 93.8 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 37.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 188 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 132 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-07-24 09:52:00, ended at 2012-07-24 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 49 (milliliter per minute per square meter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 160 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.7 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.6 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.5 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.34 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 38.3 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 4.7 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 181 (unit per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.9 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 200 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.2 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 9.3 (nanogram per milliliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 97 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.7 (percent)\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.6 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 44 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.28 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.45 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 47.8 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 1.67 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 184 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Systemic lupus erythematosus within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of lupus means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "f33c524e957f0bc5539b59258cb6215da761de280c5b4a44e8d1f3c79ab3e737", "prompt_hash": "9640a0c7120243217eb63b394f68c9ce802dc6cd289fe625cfefb3e5c525b12f", "target_hash": "85a39ab345d672ff8ca9b9c6876f3adcacf45ee7c1e2dbd2408fd338bd55e07e", "exact_match": 0.0, "f1_gu_yn": [1, 0], "recall_gu_yn": [1, 0]}
{"doc_id": 9, "doc": {"person_id": 115972725, "visit_occurrence_id": 190402061, "death_date": null, "visit_concept_name": "Pharmacy visit", "visit_start_datetime": "2021-11-13 00:00:00", "visit_end_datetime": "2021-11-13 00:00:00", "visit_length_in_hours": 0.0, "integrated_visit_record": "## Visit\nThis visit record, was from Pharmacy visit, started at 2021-11-13 00:00:00, ended at 2021-11-13 00:00:00\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of soft tissues\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2021-11-13, presumably until 2021-11-13, with intended 6 refill(s). Instructions: take 1 Tablet (8 mg total) by mouth every 8 hours as needed for Nausea (and vomiting)\n\n", "approximate_token_count": 141, "patient_first_visit_date": "2020-07-06 13:49:50", "patient_last_visit_date": "2023-01-30 17:27:11", "end_obs_date": "2022-11-13", "hypertension_type": "new", "hypertension_one_year_diagnosis": 0, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "recurrent", "asthma_one_year_diagnosis": 1, "hyperlipidemia_type": "new", "hyperlipidemia_one_year_diagnosis": 0, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "recurrent", "lupus_one_year_diagnosis": 1, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 1, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "recurrent", "lung_cancer_one_year_diagnosis": 1, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 43, "cumulated_visit_num": 43, "cumulated_approximate_token_count": 10934, "visit_cumulated": "## Visit\nThis visit record, was from Telehealth, started at 2020-07-06 13:49:50, ended at 2020-07-06 15:02:26\nThe patient in this visit was 33 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-07-11 00:00:00, ended at 2020-07-11 00:00:00\nThe patient in this visit was 33 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-07-11 12:00:00, ended at 2020-07-11 23:59:00\nThe patient in this visit was 33 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Consultation and report on referred slides prepared elsewhere\n\n### Condition\n- Secondary malignant neoplasm of left lung\n- Malignant neoplasm of connective and soft tissue of hip and lower limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-07-28 00:00:00, ended at 2020-07-28 00:00:00\nThe patient in this visit was 33 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-10-19 07:55:13, ended at 2020-10-19 08:32:36\nThe patient in this visit was 33 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-02-01 10:50:14, ended at 2021-02-01 11:34:48\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-02-02 00:00:00, ended at 2021-02-02 00:00:00\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-02-05 00:00:00, ended at 2021-02-05 00:00:00\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-02-08 00:00:00, ended at 2021-02-08 00:00:00\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-03-29 15:22:00, ended at 2021-03-29 23:59:00\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n\n### Condition\n- Abnormal findings on diagnostic imaging of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-03-30 00:00:00, ended at 2021-03-30 00:00:00\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-04-09 10:08:23, ended at 2021-04-09 11:20:47\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Secondary malignant neoplasm of left lung\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-04-10 13:22:16, ended at 2021-04-10 13:53:28\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n- Nausea and vomiting\n- Postoperative state\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-04-12 00:00:00, ended at 2021-04-12 00:00:00\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for non-invasive imaging or radiation therapy\n\n### Condition\n- Solitary nodule of lung\n- Malignant neoplasm of connective and soft tissue of hip and lower limb\n\n### Drug\n- 2 ML sugammadex 100 MG/ML Injection, through Intravenous route, started on 2021-04-12, presumably until 2021-04-12\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2021-04-12, presumably until 2021-04-12\n- cefazolin 1000 MG Injection, started on 2021-04-12, presumably until 2021-04-12\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2021-04-12, presumably until 2021-04-12\n- 2 ML lidocaine hydrochloride 20 MG/ML Injection, started on 2021-04-12, presumably until 2021-04-12\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2021-04-12, presumably until 2021-04-12\n- 2 ML ondansetron 2 MG/ML Injection, started on 2021-04-12, presumably until 2021-04-12\n- 72 HR scopolamine 0.0139 MG/HR Transdermal System, through Transdermal route, started on 2021-04-12, presumably until 2021-04-12\n- midazolam 1 MG/ML Injectable Solution, started on 2021-04-12, presumably until 2021-04-12\n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2021-04-12, presumably until 2021-04-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-04-12 00:00:00, ended at 2021-04-12 00:00:00\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Secondary malignant neoplasm of left lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2021-04-12 00:00:00, ended at 2021-04-12 00:00:00\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2021-04-12, presumably until 2021-04-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-04-12 05:01:00, ended at 2021-04-13 12:54:00\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 93.5 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 13.0 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.5 (thousand per microliter)\n- Prothrombin time (PT): 12.7 (second)\n- MCH [Entitic mass] by Automated count: 31.3 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.16 (million per microliter)\n- Platelets [#/volume] in Blood by Automated count: 226 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.70 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.5 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.9 (percent)\n\n### Procedure\n- Radiologic examination, chest; single view\n- Collection of venous blood by venipuncture\n- Ablation therapy for reduction or eradication of 1 or more pulmonary tumor(s) including pleura or chest wall when involved by tumor extension, percutaneous, including imaging guidance when performed, unilateral; radiofrequency\n\n### Condition\n- Atelectasis\n- Primary malignant neoplasm of soft tissues\n- Gastroesophageal reflux disease without esophagitis\n- Secondary malignant neoplasm of left lung\n- Abnormal findings on diagnostic imaging of lung\n- Malignant neoplasm of connective and soft tissue of hip and lower limb\n- Postoperative state\n- Uncomplicated asthma\n- Solitary nodule of lung\n- Absence of lung\n- Systemic lupus erythematosus\n- Acquired absence of organ\n\n### Drug\n- benzocaine 15 MG / menthol 3.6 MG Oral Lozenge, through Submucosal route, started on 2021-04-12, presumably until 2021-04-13\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2021-04-13, presumably until 2021-04-13\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2021-04-12, presumably until 2021-04-12\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2021-04-13, presumably until 2021-04-13\n- 2 ML ondansetron 2 MG/ML Injection, started on 2021-04-12, presumably until 2021-04-12\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2021-04-12, presumably until 2021-04-13\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2021-04-13, presumably until 2021-04-13, with intended 0 refill(s). Instructions: take 1 Tab (5 mg total) by mouth every 6 hours as needed\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2021-04-13, presumably until 2021-10-08, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-04-16 00:00:00, ended at 2021-04-16 00:00:00\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-04-16 00:00:00, ended at 2021-04-16 00:00:00\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-05-03 00:00:00, ended at 2021-05-03 00:00:00\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-05-12 11:14:00, ended at 2021-05-12 23:59:00\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Secondary malignant neoplasm of lung\n- Secondary malignant neoplasm of left lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-05-30 00:00:00, ended at 2021-05-30 00:00:00\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-07-02 09:36:00, ended at 2021-07-02 23:59:00\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, lower extremity other than joint; without contrast material(s), followed by contrast material(s) and further sequences\n\n### Condition\n- Disorder of bone\n- Primary malignant neoplasm of soft tissues\n- Localized edema\n\n### Drug\n- gadoxetate, through Intravenous route, started on 2021-07-02, presumably until 2021-07-02\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-07-04 08:00:06, ended at 2021-07-04 08:25:50\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-07-06 00:00:00, ended at 2021-07-06 00:00:00\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Secondary malignant neoplasm of left lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-09-22 00:00:00, ended at 2021-09-22 00:00:00\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.6 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-09-23 00:00:00, ended at 2021-09-23 00:00:00\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.5 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2021-09-28 05:39:00, ended at 2021-10-11 15:04:00\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.64 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.58 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 97.0 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.4 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 96.2 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.01 (thousand per microliter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.20 (milligram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 3 - 5 (per high power field)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Procalcitonin [Mass/volume] in Serum or Plasma: 0.23 (nanogram per milliliter)\n- Sodium/Creatinine [Molar ratio] in Urine: 71 (millimole per liter)\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.8 (percent)\n- Creatinine [Mass/volume] in Urine: 43.23 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 29.8 (picogram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 115 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 97 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.7 (percent)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.78 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.4 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.5 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.5 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 97.4 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.6 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 9.97 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 88 (thousand per microliter)\n- Body height: 5' 1.024\" (inch (US))\n- Eosinophils [#/volume] in Blood by Manual count: 0.04 (thousand per microliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: Full Field (per high power field)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.29 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.5 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.53 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Prothrombin time (PT): 19.4 (second)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 91 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.17 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.6 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 75.4 (percent)\n\n### Procedure\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Transfusion, blood or blood components\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Hospital discharge day management; more than 30 minutes\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n- Introduction of Other Antineoplastic into Peripheral Vein, Percutaneous Approach\n- Radiologic examination, chest; single view\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Chemotherapy administration, intravenous infusion technique; initiation of prolonged chemotherapy infusion (more than 8 hours), requiring use of a portable or implantable pump\n- Duplex scan of extremity veins including responses to compression and other maneuvers; unilateral or limited study\n- Occupational therapy evaluation, low complexity, requiring these components: An occupational profile and medical and therapy history, which includes a brief history including review of medical and/or therapy records relating to the presenting problem; An \n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Physical therapy evaluation: low complexity, requiring these components: A history with no personal factors and/or comorbidities that impact the plan of care; An examination of body system(s) using standardized tests and measures addressing 1-2 elements f\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Therapeutic procedure, 1 or more areas, each 15 minutes; gait training (includes stair climbing)\n- Computed tomography, head or brain; without contrast material\n- Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Fever\n- Non-infectious systemic inflammatory response syndrome without acute organ failure\n- Drug-induced constipation\n- Secondary malignant neoplasm of intrathoracic lymph nodes\n- Acute deep venous thrombosis of internal jugular vein\n- Secondary malignant neoplasm of left lung\n- Acute deep venous thrombosis of axillary vein\n- Acute renal failure syndrome\n- Anemia due to and following chemotherapy\n- Disorder of phosphorus metabolism\n- Secondary malignant neoplasm of lymph node\n- Systemic lupus erythematosus\n- Tachycardia\n- Altered mental status\n- Anxiety disorder\n- Leukocytosis\n- Acute deep venous thrombosis of upper extremity\n- Delirium\n- Disorder of lip\n- Dysphonia\n- Hemothorax\n- Malignant neoplasm of connective and soft tissue of hip and lower limb\n- Neutropenia due to and following chemotherapy\n- Pleural effusion\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n- Acute posthemorrhagic anemia\n- Acute thrombosis of subclavian vein\n- Hypokalemia\n- Hypoxemia\n- Malignant neoplastic disease\n- Pleural effusion due to malignant neoplastic disease\n- Uncomplicated asthma\n- Cough\n- Empyema of pleura\n\n### Drug\n- dibasic potassium phosphate, through Oral route, started on 2021-10-02, presumably until 2021-11-09, with intended 0 refill(s). Instructions: take 1 Packet by mouth 4 times a day with meals and bedtime\n- 1.6 ML filgrastim-aafi 0.3 MG/ML Injection, started on 2021-10-10, presumably until 2021-11-09, with intended 0 refill(s). Instructions: 480 mcg by Injection route every day\n- loperamide hydrochloride 2 MG Oral Capsule, through Oral route, started on 2021-10-09, presumably until 2021-11-09, with intended 0 refill(s). Instructions: take 1 Capsule (2 mg total) by mouth every 6 hours as needed for Diarrhea\n- codeine phosphate 2 MG/ML / guaifenesin 20 MG/ML Oral Solution, through Oral route, started on 2021-09-28, presumably until 2021-11-21, with intended 0 refill(s). Instructions: take 10 mL by mouth every 4 hours as needed for Cough\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2021-09-29, presumably until 2021-09-29\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2021-09-29, presumably until 2021-10-03\n- potassium phosphate, through Oral route, started on 2021-10-02, presumably until 2021-11-09, with intended 0 refill(s). Instructions: take 1 Packet by mouth 4 times a day with meals and bedtime\n- tribasic potassium phosphate, through Oral route, started on 2021-10-02, presumably until 2021-11-09, with intended 0 refill(s). Instructions: take 1 Packet by mouth 4 times a day with meals and bedtime\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2021-10-01, presumably until 2021-10-05\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2021-09-29, presumably until 2021-10-01\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2021-09-28, presumably until 2021-10-04\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2021-10-09, presumably until 2021-10-11\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2021-10-05, presumably until 2021-10-11\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2021-09-28, presumably until 2021-11-09, with intended 0 refill(s). Instructions: take 2 Tablets (650 mg total) by mouth every 6 hours as needed\n- 0.8 ML filgrastim-aafi 0.6 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2021-10-10, presumably until 2021-10-18, with intended 0 refill(s). Instructions: inject 0.8 mL (480 mcg total) subcutaneous (under the skin) daily in the evening\n- 10 ML methylene blue 5 MG/ML Injection, through Intravenous route, started on 2021-10-03, presumably until 2021-10-04\n- tribasic sodium phosphate, through Oral route, started on 2021-10-02, presumably until 2021-11-09, with intended 0 refill(s). Instructions: take 1 Packet by mouth 4 times a day with meals and bedtime\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2021-09-28, presumably until 2021-10-06\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2021-09-29, presumably until 2021-10-05\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2021-10-03, presumably until 2021-10-10\n- 1 ML epinephrine 1 MG/ML Injection, started on 2021-09-28, presumably until 2021-09-28\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2021-09-28, presumably until 2021-10-04\n- 0.8 ML filgrastim 0.6 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2021-10-08, presumably until 2022-01-03, with intended 0 refill(s). Instructions: inject 0.8 mL (480 mcg total) subcutaneous (under the skin) daily in the evening\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2021-09-28, presumably until 2021-09-30\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2021-09-28, presumably until 2021-10-03\n- sodium phosphate, through Oral route, started on 2021-10-02, presumably until 2021-11-09, with intended 0 refill(s). Instructions: take 1 Packet by mouth 4 times a day with meals and bedtime\n- sodium phosphate, monobasic, through Oral route, started on 2021-10-02, presumably until 2021-11-09, with intended 0 refill(s). Instructions: take 1 Packet by mouth 4 times a day with meals and bedtime\n- 50 ML potassium chloride 0.4 MEQ/ML Injection, through Intravenous route, started on 2021-09-28, presumably until 2021-09-28\n- acetaminophen 32 MG/ML Oral Solution, through Oral route, started on 2021-09-30, presumably until 2021-10-06\n- 2 ML ondansetron 2 MG/ML Injection, started on 2021-09-30, presumably until 2021-10-11\n- 1 ML morphine sulfate 2 MG/ML Prefilled Syringe, through Intravenous route, started on 2021-10-01, presumably until 2021-10-01\n- sodium phosphate, dibasic, through Oral route, started on 2021-10-02, presumably until 2021-11-09, with intended 0 refill(s). Instructions: take 1 Packet by mouth 4 times a day with meals and bedtime\n- benzonatate 100 MG Oral Capsule, through Oral route, started on 2021-09-28, presumably until 2021-11-05, with intended 0 refill(s). Instructions: take 1 Capsule (100 mg total) by mouth 3 times a day as needed for Cough\n- 100 ML metronidazole 5 MG/ML Injection, through Intravenous route, started on 2021-09-28, presumably until 2021-09-28\n- lidocaine 0.05 MG/MG Medicated Patch, through Transdermal route, started on 2021-10-04, presumably until 2021-11-09, with intended 0 refill(s). Instructions: apply 1 Patch to skin daily\n- dibasic sodium phosphate heptahydrate, through Oral route, started on 2021-10-02, presumably until 2021-11-09, with intended 0 refill(s). Instructions: take 1 Packet by mouth 4 times a day with meals and bedtime\n- sodium chloride 6.5 MG/ML Nasal Spray, through Nasal route, started on 2021-10-11, presumably until 2021-10-11\n- alteplase 1 MG/ML Injectable Solution, through Intraluminal route, started on 2021-10-09, presumably until 2021-10-09\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-10-01 00:00:00, ended at 2021-10-01 00:00:00\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-10-03 00:00:00, ended at 2021-10-03 00:00:00\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 0.6 ML pegfilgrastim 10 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2021-10-03, presumably until 2021-10-11, with intended 11 refill(s). Instructions: inject 0.6 mL (6 mg total) subcutaneous (under the skin) One Time for 1 dose 24 hours after chemo ends every 3 weeks. First dose on 10/07/2021\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-10-04 00:00:00, ended at 2021-10-04 00:00:00\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 0.6 ML pegfilgrastim 10 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2021-10-04, presumably until 2021-10-11, with intended 11 refill(s). Instructions: inject 0.6 mL (6 mg total) subcutaneous (under the skin) One Time for 1 dose 24 hours after chemotherapy ends every 3 weeks. First dose on 10/07/2021\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-10-05 00:00:00, ended at 2021-10-05 00:00:00\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 0.6 ML pegfilgrastim-bmez 10 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2021-10-05, presumably until 2021-10-11, with intended 11 refill(s). Instructions: inject 0.6 mL (6 mg total) subcutaneous (under the skin) One Time for 1 dose 24 hours after chemo ends every 3 weeks. First dose on 10/07/2021\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-10-05 00:00:00, ended at 2021-10-05 00:00:00\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 64.6 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-10-26 00:00:00, ended at 2021-10-26 00:00:00\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 13.1 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.4 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 56 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.0 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 18 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 1.1 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 8.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 89 (femtoliter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 191 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.95 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.4 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 29.5 (picogram)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-10-26 07:55:44, ended at 2021-10-26 08:43:55\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-10-31 00:00:00, ended at 2021-10-31 00:00:00\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Consultation and report on referred slides prepared elsewhere\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n- Secondary malignant neoplasm of pleura\n- Secondary malignant neoplasm of left lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-10-31 08:31:45, ended at 2021-10-31 09:26:11\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- 200 ACTUAT levalbuterol 0.045 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2021-10-31, presumably until 2021-11-21, with intended 1 refill(s). Instructions: 1-2 Puffs by Inhalation route every 4 hours as needed for Bronchospasm/Wheezing\n- ondansetron 4 MG Oral Tablet, through Oral route, presumably until 2021-11-05, with intended 0 refill(s). Instructions: take 4 mg by mouth\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-11-02 08:58:08, ended at 2021-11-02 10:12:28\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute deep venous thrombosis of axillary vein\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2021-11-05, presumably until 2021-12-20, with intended 1 refill(s). Instructions: take 1-2 Tablets (0.5-1 mg total) by mouth every 6 hours as needed (for nausea and vomiting)\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2021-11-05, presumably until 2021-11-30, with intended 6 refill(s). Instructions: take 1 Tablet (8 mg total) by mouth every 8 hours as needed for Nausea (and vomiting)\n- olanzapine 5 MG Oral Tablet, through Oral route, started on 2021-11-05, presumably until 2021-12-20, with intended 0 refill(s). Instructions: take 1 Tablet (5 mg total) by mouth every bedtime as needed (nausea and vomiting) for 5 days\n- omeprazole 20 MG Delayed Release Oral Capsule, through Oral route, started on 2021-11-05, presumably until 2022-02-13, with intended 2 refill(s). Instructions: take 20 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-11-04 00:00:00, ended at 2021-11-04 00:00:00\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- benzonatate 100 MG Oral Capsule, through Oral route, started on 2021-11-05, presumably until 2021-12-05, with intended 0 refill(s). Instructions: take 1 Capsule (100 mg total) by mouth 3 times a day as needed for Cough\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-11-05 00:00:00, ended at 2021-11-05 00:00:00\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2021-11-08 10:09:00, ended at 2021-11-09 16:20:00\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.0 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.21 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.0 (percent)\n- MCH [Entitic mass] by Automated count: 28.4 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.84 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.0 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 8.86 (thousand per microliter)\n- Body height: 5' 2.992\" (inch (US))\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 20 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.69 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 352 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 113 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 142 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Catecholamines [Interpretation] in Plasma Narrative: 46.7 (femtoliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.41 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.9 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 80.6 (percent)\n- Anion gap in Serum or Plasma: 15 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 32.4 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.6 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.0 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 87.7 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n\n### Procedure\n- Hospital discharge day management; more than 30 minutes\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)\n- Introduction of Other Antineoplastic into Central Vein, Percutaneous Approach\n- Collection of venous blood by venipuncture\n- Chemotherapy administration, intravenous infusion technique; initiation of prolonged chemotherapy infusion (more than 8 hours), requiring use of a portable or implantable pump\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n\n### Condition\n- Malignant neoplasm of connective and soft tissue of hip and lower limb\n- Anemia due to and following chemotherapy\n- Iron deficiency anemia\n- Anxiety disorder\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n- Secondary malignant neoplasm of left lung\n- Gastroesophageal reflux disease without esophagitis\n- Tachycardia\n- Anemia in neoplastic disease\n- Systemic lupus erythematosus\n- Uncomplicated asthma\n\n### Drug\n- famotidine 20 MG Oral Tablet, through Oral route, started on 2021-11-08, presumably until 2021-11-08\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2021-11-09, presumably until 2021-11-09\n- sodium chloride 9 MG/ML Injectable Solution, started on 2021-11-08, presumably until 2021-11-09\n- 2 ML famotidine 10 MG/ML Injection, through Intravenous route, started on 2021-11-08, presumably until 2021-11-08\n- 2 ML ondansetron 2 MG/ML Injection, started on 2021-11-08, presumably until 2021-11-09\n- benzonatate 100 MG Oral Capsule, through Oral route, started on 2021-11-08, presumably until 2021-11-09\n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2021-11-08, presumably until 2021-11-08\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-11-12 00:00:00, ended at 2021-11-12 00:00:00\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of soft tissues\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2021-11-12, presumably until 2021-11-12, with intended 1 refill(s). Instructions: take 1-2 Tablets (0.5-1 mg total) by mouth every 6 hours as needed (for nausea and vomiting)\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2021-11-12, presumably until 2021-11-12, with intended 6 refill(s). Instructions: take 1 Tablet (8 mg total) by mouth every 8 hours as needed for Nausea (and vomiting)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-11-13 00:00:00, ended at 2021-11-13 00:00:00\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of soft tissues\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2021-11-13, presumably until 2021-11-13, with intended 6 refill(s). Instructions: take 1 Tablet (8 mg total) by mouth every 8 hours as needed for Nausea (and vomiting)\n\n"}, "target": "Yes", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Systemic lupus erythematosus within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-07-06 13:49:50, ended at 2020-07-06 15:02:26\nThe patient in this visit was 33 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-07-11 00:00:00, ended at 2020-07-11 00:00:00\nThe patient in this visit was 33 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-07-11 12:00:00, ended at 2020-07-11 23:59:00\nThe patient in this visit was 33 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Consultation and report on referred slides prepared elsewhere\n\n### Condition\n- Secondary malignant neoplasm of left lung\n- Malignant neoplasm of connective and soft tissue of hip and lower limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-07-28 00:00:00, ended at 2020-07-28 00:00:00\nThe patient in this visit was 33 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-10-19 07:55:13, ended at 2020-10-19 08:32:36\nThe patient in this visit was 33 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-02-01 10:50:14, ended at 2021-02-01 11:34:48\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-02-02 00:00:00, ended at 2021-02-02 00:00:00\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-02-05 00:00:00, ended at 2021-02-05 00:00:00\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-02-08 00:00:00, ended at 2021-02-08 00:00:00\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-03-29 15:22:00, ended at 2021-03-29 23:59:00\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n\n### Condition\n- Abnormal findings on diagnostic imaging of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-03-30 00:00:00, ended at 2021-03-30 00:00:00\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-04-09 10:08:23, ended at 2021-04-09 11:20:47\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Secondary malignant neoplasm of left lung\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-04-10 13:22:16, ended at 2021-04-10 13:53:28\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n- Nausea and vomiting\n- Postoperative state\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-04-12 00:00:00, ended at 2021-04-12 00:00:00\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for non-invasive imaging or radiation therapy\n\n### Condition\n- Solitary nodule of lung\n- Malignant neoplasm of connective and soft tissue of hip and lower limb\n\n### Drug\n- 2 ML sugammadex 100 MG/ML Injection, through Intravenous route, started on 2021-04-12, presumably until 2021-04-12\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2021-04-12, presumably until 2021-04-12\n- cefazolin 1000 MG Injection, started on 2021-04-12, presumably until 2021-04-12\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2021-04-12, presumably until 2021-04-12\n- 2 ML lidocaine hydrochloride 20 MG/ML Injection, started on 2021-04-12, presumably until 2021-04-12\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2021-04-12, presumably until 2021-04-12\n- 2 ML ondansetron 2 MG/ML Injection, started on 2021-04-12, presumably until 2021-04-12\n- 72 HR scopolamine 0.0139 MG/HR Transdermal System, through Transdermal route, started on 2021-04-12, presumably until 2021-04-12\n- midazolam 1 MG/ML Injectable Solution, started on 2021-04-12, presumably until 2021-04-12\n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2021-04-12, presumably until 2021-04-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-04-12 00:00:00, ended at 2021-04-12 00:00:00\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Secondary malignant neoplasm of left lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2021-04-12 00:00:00, ended at 2021-04-12 00:00:00\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2021-04-12, presumably until 2021-04-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-04-12 05:01:00, ended at 2021-04-13 12:54:00\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 93.5 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 13.0 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.5 (thousand per microliter)\n- Prothrombin time (PT): 12.7 (second)\n- MCH [Entitic mass] by Automated count: 31.3 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.16 (million per microliter)\n- Platelets [#/volume] in Blood by Automated count: 226 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.70 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.5 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.9 (percent)\n\n### Procedure\n- Radiologic examination, chest; single view\n- Collection of venous blood by venipuncture\n- Ablation therapy for reduction or eradication of 1 or more pulmonary tumor(s) including pleura or chest wall when involved by tumor extension, percutaneous, including imaging guidance when performed, unilateral; radiofrequency\n\n### Condition\n- Atelectasis\n- Primary malignant neoplasm of soft tissues\n- Gastroesophageal reflux disease without esophagitis\n- Secondary malignant neoplasm of left lung\n- Abnormal findings on diagnostic imaging of lung\n- Malignant neoplasm of connective and soft tissue of hip and lower limb\n- Postoperative state\n- Uncomplicated asthma\n- Solitary nodule of lung\n- Absence of lung\n- Systemic lupus erythematosus\n- Acquired absence of organ\n\n### Drug\n- benzocaine 15 MG / menthol 3.6 MG Oral Lozenge, through Submucosal route, started on 2021-04-12, presumably until 2021-04-13\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2021-04-13, presumably until 2021-04-13\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2021-04-12, presumably until 2021-04-12\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2021-04-13, presumably until 2021-04-13\n- 2 ML ondansetron 2 MG/ML Injection, started on 2021-04-12, presumably until 2021-04-12\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2021-04-12, presumably until 2021-04-13\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2021-04-13, presumably until 2021-04-13, with intended 0 refill(s). Instructions: take 1 Tab (5 mg total) by mouth every 6 hours as needed\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2021-04-13, presumably until 2021-10-08, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-04-16 00:00:00, ended at 2021-04-16 00:00:00\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-04-16 00:00:00, ended at 2021-04-16 00:00:00\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-05-03 00:00:00, ended at 2021-05-03 00:00:00\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-05-12 11:14:00, ended at 2021-05-12 23:59:00\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Secondary malignant neoplasm of lung\n- Secondary malignant neoplasm of left lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-05-30 00:00:00, ended at 2021-05-30 00:00:00\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-07-02 09:36:00, ended at 2021-07-02 23:59:00\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, lower extremity other than joint; without contrast material(s), followed by contrast material(s) and further sequences\n\n### Condition\n- Disorder of bone\n- Primary malignant neoplasm of soft tissues\n- Localized edema\n\n### Drug\n- gadoxetate, through Intravenous route, started on 2021-07-02, presumably until 2021-07-02\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-07-04 08:00:06, ended at 2021-07-04 08:25:50\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-07-06 00:00:00, ended at 2021-07-06 00:00:00\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Secondary malignant neoplasm of left lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-09-22 00:00:00, ended at 2021-09-22 00:00:00\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.6 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-09-23 00:00:00, ended at 2021-09-23 00:00:00\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.5 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2021-09-28 05:39:00, ended at 2021-10-11 15:04:00\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.64 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.58 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 97.0 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.4 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 96.2 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.01 (thousand per microliter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.20 (milligram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 3 - 5 (per high power field)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Procalcitonin [Mass/volume] in Serum or Plasma: 0.23 (nanogram per milliliter)\n- Sodium/Creatinine [Molar ratio] in Urine: 71 (millimole per liter)\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.8 (percent)\n- Creatinine [Mass/volume] in Urine: 43.23 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 29.8 (picogram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 115 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 97 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.7 (percent)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.78 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.4 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.5 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.5 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 97.4 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.6 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 9.97 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 88 (thousand per microliter)\n- Body height: 5' 1.024\" (inch (US))\n- Eosinophils [#/volume] in Blood by Manual count: 0.04 (thousand per microliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: Full Field (per high power field)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.29 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.5 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.53 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Prothrombin time (PT): 19.4 (second)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 91 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.17 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.6 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 75.4 (percent)\n\n### Procedure\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Transfusion, blood or blood components\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Hospital discharge day management; more than 30 minutes\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n- Introduction of Other Antineoplastic into Peripheral Vein, Percutaneous Approach\n- Radiologic examination, chest; single view\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Chemotherapy administration, intravenous infusion technique; initiation of prolonged chemotherapy infusion (more than 8 hours), requiring use of a portable or implantable pump\n- Duplex scan of extremity veins including responses to compression and other maneuvers; unilateral or limited study\n- Occupational therapy evaluation, low complexity, requiring these components: An occupational profile and medical and therapy history, which includes a brief history including review of medical and/or therapy records relating to the presenting problem; An \n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Physical therapy evaluation: low complexity, requiring these components: A history with no personal factors and/or comorbidities that impact the plan of care; An examination of body system(s) using standardized tests and measures addressing 1-2 elements f\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Therapeutic procedure, 1 or more areas, each 15 minutes; gait training (includes stair climbing)\n- Computed tomography, head or brain; without contrast material\n- Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Fever\n- Non-infectious systemic inflammatory response syndrome without acute organ failure\n- Drug-induced constipation\n- Secondary malignant neoplasm of intrathoracic lymph nodes\n- Acute deep venous thrombosis of internal jugular vein\n- Secondary malignant neoplasm of left lung\n- Acute deep venous thrombosis of axillary vein\n- Acute renal failure syndrome\n- Anemia due to and following chemotherapy\n- Disorder of phosphorus metabolism\n- Secondary malignant neoplasm of lymph node\n- Systemic lupus erythematosus\n- Tachycardia\n- Altered mental status\n- Anxiety disorder\n- Leukocytosis\n- Acute deep venous thrombosis of upper extremity\n- Delirium\n- Disorder of lip\n- Dysphonia\n- Hemothorax\n- Malignant neoplasm of connective and soft tissue of hip and lower limb\n- Neutropenia due to and following chemotherapy\n- Pleural effusion\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n- Acute posthemorrhagic anemia\n- Acute thrombosis of subclavian vein\n- Hypokalemia\n- Hypoxemia\n- Malignant neoplastic disease\n- Pleural effusion due to malignant neoplastic disease\n- Uncomplicated asthma\n- Cough\n- Empyema of pleura\n\n### Drug\n- dibasic potassium phosphate, through Oral route, started on 2021-10-02, presumably until 2021-11-09, with intended 0 refill(s). Instructions: take 1 Packet by mouth 4 times a day with meals and bedtime\n- 1.6 ML filgrastim-aafi 0.3 MG/ML Injection, started on 2021-10-10, presumably until 2021-11-09, with intended 0 refill(s). Instructions: 480 mcg by Injection route every day\n- loperamide hydrochloride 2 MG Oral Capsule, through Oral route, started on 2021-10-09, presumably until 2021-11-09, with intended 0 refill(s). Instructions: take 1 Capsule (2 mg total) by mouth every 6 hours as needed for Diarrhea\n- codeine phosphate 2 MG/ML / guaifenesin 20 MG/ML Oral Solution, through Oral route, started on 2021-09-28, presumably until 2021-11-21, with intended 0 refill(s). Instructions: take 10 mL by mouth every 4 hours as needed for Cough\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2021-09-29, presumably until 2021-09-29\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2021-09-29, presumably until 2021-10-03\n- potassium phosphate, through Oral route, started on 2021-10-02, presumably until 2021-11-09, with intended 0 refill(s). Instructions: take 1 Packet by mouth 4 times a day with meals and bedtime\n- tribasic potassium phosphate, through Oral route, started on 2021-10-02, presumably until 2021-11-09, with intended 0 refill(s). Instructions: take 1 Packet by mouth 4 times a day with meals and bedtime\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2021-10-01, presumably until 2021-10-05\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2021-09-29, presumably until 2021-10-01\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2021-09-28, presumably until 2021-10-04\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2021-10-09, presumably until 2021-10-11\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2021-10-05, presumably until 2021-10-11\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2021-09-28, presumably until 2021-11-09, with intended 0 refill(s). Instructions: take 2 Tablets (650 mg total) by mouth every 6 hours as needed\n- 0.8 ML filgrastim-aafi 0.6 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2021-10-10, presumably until 2021-10-18, with intended 0 refill(s). Instructions: inject 0.8 mL (480 mcg total) subcutaneous (under the skin) daily in the evening\n- 10 ML methylene blue 5 MG/ML Injection, through Intravenous route, started on 2021-10-03, presumably until 2021-10-04\n- tribasic sodium phosphate, through Oral route, started on 2021-10-02, presumably until 2021-11-09, with intended 0 refill(s). Instructions: take 1 Packet by mouth 4 times a day with meals and bedtime\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2021-09-28, presumably until 2021-10-06\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2021-09-29, presumably until 2021-10-05\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2021-10-03, presumably until 2021-10-10\n- 1 ML epinephrine 1 MG/ML Injection, started on 2021-09-28, presumably until 2021-09-28\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2021-09-28, presumably until 2021-10-04\n- 0.8 ML filgrastim 0.6 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2021-10-08, presumably until 2022-01-03, with intended 0 refill(s). Instructions: inject 0.8 mL (480 mcg total) subcutaneous (under the skin) daily in the evening\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2021-09-28, presumably until 2021-09-30\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2021-09-28, presumably until 2021-10-03\n- sodium phosphate, through Oral route, started on 2021-10-02, presumably until 2021-11-09, with intended 0 refill(s). Instructions: take 1 Packet by mouth 4 times a day with meals and bedtime\n- sodium phosphate, monobasic, through Oral route, started on 2021-10-02, presumably until 2021-11-09, with intended 0 refill(s). Instructions: take 1 Packet by mouth 4 times a day with meals and bedtime\n- 50 ML potassium chloride 0.4 MEQ/ML Injection, through Intravenous route, started on 2021-09-28, presumably until 2021-09-28\n- acetaminophen 32 MG/ML Oral Solution, through Oral route, started on 2021-09-30, presumably until 2021-10-06\n- 2 ML ondansetron 2 MG/ML Injection, started on 2021-09-30, presumably until 2021-10-11\n- 1 ML morphine sulfate 2 MG/ML Prefilled Syringe, through Intravenous route, started on 2021-10-01, presumably until 2021-10-01\n- sodium phosphate, dibasic, through Oral route, started on 2021-10-02, presumably until 2021-11-09, with intended 0 refill(s). Instructions: take 1 Packet by mouth 4 times a day with meals and bedtime\n- benzonatate 100 MG Oral Capsule, through Oral route, started on 2021-09-28, presumably until 2021-11-05, with intended 0 refill(s). Instructions: take 1 Capsule (100 mg total) by mouth 3 times a day as needed for Cough\n- 100 ML metronidazole 5 MG/ML Injection, through Intravenous route, started on 2021-09-28, presumably until 2021-09-28\n- lidocaine 0.05 MG/MG Medicated Patch, through Transdermal route, started on 2021-10-04, presumably until 2021-11-09, with intended 0 refill(s). Instructions: apply 1 Patch to skin daily\n- dibasic sodium phosphate heptahydrate, through Oral route, started on 2021-10-02, presumably until 2021-11-09, with intended 0 refill(s). Instructions: take 1 Packet by mouth 4 times a day with meals and bedtime\n- sodium chloride 6.5 MG/ML Nasal Spray, through Nasal route, started on 2021-10-11, presumably until 2021-10-11\n- alteplase 1 MG/ML Injectable Solution, through Intraluminal route, started on 2021-10-09, presumably until 2021-10-09\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-10-01 00:00:00, ended at 2021-10-01 00:00:00\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-10-03 00:00:00, ended at 2021-10-03 00:00:00\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 0.6 ML pegfilgrastim 10 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2021-10-03, presumably until 2021-10-11, with intended 11 refill(s). Instructions: inject 0.6 mL (6 mg total) subcutaneous (under the skin) One Time for 1 dose 24 hours after chemo ends every 3 weeks. First dose on 10/07/2021\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-10-04 00:00:00, ended at 2021-10-04 00:00:00\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 0.6 ML pegfilgrastim 10 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2021-10-04, presumably until 2021-10-11, with intended 11 refill(s). Instructions: inject 0.6 mL (6 mg total) subcutaneous (under the skin) One Time for 1 dose 24 hours after chemotherapy ends every 3 weeks. First dose on 10/07/2021\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-10-05 00:00:00, ended at 2021-10-05 00:00:00\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 0.6 ML pegfilgrastim-bmez 10 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2021-10-05, presumably until 2021-10-11, with intended 11 refill(s). Instructions: inject 0.6 mL (6 mg total) subcutaneous (under the skin) One Time for 1 dose 24 hours after chemo ends every 3 weeks. First dose on 10/07/2021\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-10-05 00:00:00, ended at 2021-10-05 00:00:00\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 64.6 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-10-26 00:00:00, ended at 2021-10-26 00:00:00\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 13.1 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.4 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 56 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.0 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 18 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 1.1 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 8.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 89 (femtoliter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 191 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.95 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.4 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 29.5 (picogram)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-10-26 07:55:44, ended at 2021-10-26 08:43:55\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-10-31 00:00:00, ended at 2021-10-31 00:00:00\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Consultation and report on referred slides prepared elsewhere\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n- Secondary malignant neoplasm of pleura\n- Secondary malignant neoplasm of left lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-10-31 08:31:45, ended at 2021-10-31 09:26:11\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- 200 ACTUAT levalbuterol 0.045 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2021-10-31, presumably until 2021-11-21, with intended 1 refill(s). Instructions: 1-2 Puffs by Inhalation route every 4 hours as needed for Bronchospasm/Wheezing\n- ondansetron 4 MG Oral Tablet, through Oral route, presumably until 2021-11-05, with intended 0 refill(s). Instructions: take 4 mg by mouth\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-11-02 08:58:08, ended at 2021-11-02 10:12:28\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute deep venous thrombosis of axillary vein\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2021-11-05, presumably until 2021-12-20, with intended 1 refill(s). Instructions: take 1-2 Tablets (0.5-1 mg total) by mouth every 6 hours as needed (for nausea and vomiting)\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2021-11-05, presumably until 2021-11-30, with intended 6 refill(s). Instructions: take 1 Tablet (8 mg total) by mouth every 8 hours as needed for Nausea (and vomiting)\n- olanzapine 5 MG Oral Tablet, through Oral route, started on 2021-11-05, presumably until 2021-12-20, with intended 0 refill(s). Instructions: take 1 Tablet (5 mg total) by mouth every bedtime as needed (nausea and vomiting) for 5 days\n- omeprazole 20 MG Delayed Release Oral Capsule, through Oral route, started on 2021-11-05, presumably until 2022-02-13, with intended 2 refill(s). Instructions: take 20 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-11-04 00:00:00, ended at 2021-11-04 00:00:00\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- benzonatate 100 MG Oral Capsule, through Oral route, started on 2021-11-05, presumably until 2021-12-05, with intended 0 refill(s). Instructions: take 1 Capsule (100 mg total) by mouth 3 times a day as needed for Cough\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-11-05 00:00:00, ended at 2021-11-05 00:00:00\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2021-11-08 10:09:00, ended at 2021-11-09 16:20:00\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.0 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.21 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.0 (percent)\n- MCH [Entitic mass] by Automated count: 28.4 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.84 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.0 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 8.86 (thousand per microliter)\n- Body height: 5' 2.992\" (inch (US))\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 20 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.69 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 352 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 113 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 142 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Catecholamines [Interpretation] in Plasma Narrative: 46.7 (femtoliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.41 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.9 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 80.6 (percent)\n- Anion gap in Serum or Plasma: 15 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 32.4 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.6 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.0 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 87.7 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n\n### Procedure\n- Hospital discharge day management; more than 30 minutes\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)\n- Introduction of Other Antineoplastic into Central Vein, Percutaneous Approach\n- Collection of venous blood by venipuncture\n- Chemotherapy administration, intravenous infusion technique; initiation of prolonged chemotherapy infusion (more than 8 hours), requiring use of a portable or implantable pump\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n\n### Condition\n- Malignant neoplasm of connective and soft tissue of hip and lower limb\n- Anemia due to and following chemotherapy\n- Iron deficiency anemia\n- Anxiety disorder\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n- Secondary malignant neoplasm of left lung\n- Gastroesophageal reflux disease without esophagitis\n- Tachycardia\n- Anemia in neoplastic disease\n- Systemic lupus erythematosus\n- Uncomplicated asthma\n\n### Drug\n- famotidine 20 MG Oral Tablet, through Oral route, started on 2021-11-08, presumably until 2021-11-08\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2021-11-09, presumably until 2021-11-09\n- sodium chloride 9 MG/ML Injectable Solution, started on 2021-11-08, presumably until 2021-11-09\n- 2 ML famotidine 10 MG/ML Injection, through Intravenous route, started on 2021-11-08, presumably until 2021-11-08\n- 2 ML ondansetron 2 MG/ML Injection, started on 2021-11-08, presumably until 2021-11-09\n- benzonatate 100 MG Oral Capsule, through Oral route, started on 2021-11-08, presumably until 2021-11-09\n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2021-11-08, presumably until 2021-11-08\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-11-12 00:00:00, ended at 2021-11-12 00:00:00\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of soft tissues\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2021-11-12, presumably until 2021-11-12, with intended 1 refill(s). Instructions: take 1-2 Tablets (0.5-1 mg total) by mouth every 6 hours as needed (for nausea and vomiting)\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2021-11-12, presumably until 2021-11-12, with intended 6 refill(s). Instructions: take 1 Tablet (8 mg total) by mouth every 8 hours as needed for Nausea (and vomiting)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-11-13 00:00:00, ended at 2021-11-13 00:00:00\nThe patient in this visit was 34 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of soft tissues\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2021-11-13, presumably until 2021-11-13, with intended 6 refill(s). Instructions: take 1 Tablet (8 mg total) by mouth every 8 hours as needed for Nausea (and vomiting)\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Systemic lupus erythematosus within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of lupus means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "c7f2ac1c02d5a7f68907b2687c82eaaf62283d87427d7e3732c7094b3f4dbaf6", "prompt_hash": "60f6afef39ddbc32927fd9d745229485a513f9c4044f096d72018da3a2540990", "target_hash": "85a39ab345d672ff8ca9b9c6876f3adcacf45ee7c1e2dbd2408fd338bd55e07e", "exact_match": 0.0, "f1_gu_yn": [1, 0], "recall_gu_yn": [1, 0]}
